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Introduction To assess cerebral hemodynamics in an experimental 
sepsis model.
Methods Nineteen juvenile female Hungahib pigs were subjected into 
control group (n = 9) or septic group (n = 10). Under general anesthesia 
in animals of the sepsis group, Escherichia coli culture (2.5  ×  105/ml; 
strain: ATCC 25922) was intravenously administrated in a continuously 
increasing manner as follows: 2  ml in the fi rst 30  minutes, then 4  ml 
in 30  minutes and afterwards 16  ml/hour for 2  hours (so a total of 
9.5  ×  106 E. coli within 3  hours). In the control group the anesthesia 
was maintained for 8  hours, infusion was administered as a similar 
volume of isotonic saline solution and no other intervention was 
made. Hemodynamic monitoring of all animals was performed by 
PiCCo monitoring system. The middle cerebral artery of the pigs was 
insonated through the transorbital window and cerebral blood fl ow 
velocity (MCAV) and pulsatility index was registered.
Results In the septic group, as expected, all animals developed 
fulminant sepsis and died within 3 to 7 hours two animals in 3 to 4 hours, 
and three in 6 to 7 hours). In the septic animals the heart rate rose and 
mean arterial pressure dropped, their ratio increased signifi cantly 
compared with both the base values (at the 6th  hour: P  <0.001) and 
the control group (P  =  0.004). The control animals showed stable 
condition over the 8-hour anesthesia. MCAV signifi cantly decreased 
during the development of sepsis (from 23.6 ± 6.6 cm/s to 16.0 ± 3.9 
cm/s, P  <0.01) and pulsatility indices increased (from 0.68  ±  0.22 to 
1.37  ±  0.58, P  <0.01), indicating vasoconstriction of the resistance 
vessels. A signifi cant relationship was fund between percent change of 
the MAP and the pulsatility index in septic animals (R2 = 0.32) referring 
to maintained cerebral autoregulation.
Conclusion Cerebral autoregulation is preserved in the pig model of 
experimentally induced fulminant sepsis.
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Introduction Healthy bowel function is an important factor when 
judging the advisability of early enteral nutrition in critically ill patients, 
but long-term observation and objective evaluation of gastrointestinal 
motility are diffi  cult. We developed a non-invasive monitoring system 
capable of quantifying and visualizing gastrointestinal motility in real 
time. In the study gastrointestinal motility was performed in patients 
with severe sepsis using this developed bowel sound analysis system, 
and the correlation between bowel sounds and changes over time in 
blood concentrations of IL-6, which is associated with sepsis severity, 
was evaluated.
Methods The study was a prospective, observational pilot study 
conducted in our hospital. Consecutive adult patients with severe 
sepsis, on a mechanical ventilator with an IL-6 blood concentration 
≥100 pg/ml in the acute phase, defi ned as being up to the 28th day of 
illness in the ICU, were entered in this study between June 2011 and 
December 2012. Subjects were divided into those who were treated 
with steroids (steroid treatment group) and those who were not (no-
steroids group) during the target period, because steroids strongly 
aff ect IL-6 blood levels.
Results The subjects were fi ve adult patients in the acute phase of 
severe sepsis on a mechanical ventilator. Gastrointestinal motility 
was measured for a total of 62,399  minutes: 31,544  minutes in three 
subjects in the no-steroids group and 30,855 minutes in two subjects 
in the steroid treatment group. In the no-steroids group, the bowel 
sound counts were negatively correlated with IL-6 blood concentration 
(r  = –0.76, P  <0.01), suggesting that gastrointestinal motility was 
suppressed as IL-6 blood concentration increased. However, in 
the steroid treatment group, gastrointestinal motility showed no 
correlation with IL-6 blood concentration (r = –0.25, P = 0.27). The IL-6 
blood concentration appears to have decreased with steroid treatment 
irrespective of changes in the state of sepsis, whereas bowel sound 
counts with the monitoring system refl ected the changes in the state 
of sepsis, resulting in no correlation.
Conclusion The new real-time bowel sound analysis system provides 
a useful method of continuously, quantitatively, and non-invasively 
evaluating gastrointestinal motility in severe patients. Furthermore, 
this analysis may predict disease severity in septic patients.
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Introduction Sepsis is defi ned as the presence of infection with systemic 
signs of infection, and severe sepsis as sepsis plus sepsis-induced organ 
dysfunction or tissue hypoperfusion [1]. Since the Surviving Sepsis 
Campaign (SSC) in 2002, the Health Service Ombudsman for England 
published recommendations for improving recognition and treatment 
of sepsis [2], the Royal College of Physicians issued a toolkit for the 
management of sepsis in the acute medical unit [3], and NHS England 
released a patient safety alert to support prompt recognition and 
treatment of sepsis [4]. In 2012 our Trust introduced a sepsis screening 
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tool and electronic order set (EPR alert) alongside an education 
programme to improve delivery of the SSC bundle. Previous audits 
showed only 43% full bundle compliance in those that were alerted, 
and this raised concerns regarding the burden of unalerted sepsis. We 
sought to estimate the number of unalerted sepsis episodes to assess 
the effi  cacy of our screening tool and improve early recognition.
Methods All referrals to our critical care response team with a diagnosis 
of sepsis over a 3-month period (September to November 2014) 
were investigated to determine how many had an EPR sepsis alert 
comprising a prompt for blood cultures, serum lactate measurement, 
fl uid challenge if hypotensive, and antibiotics within 1 hour.
Results Only 25/174 (14%) patients with a diagnosis of sepsis had an 
EPR sepsis alert. There was no signifi cant diff erence between acute and 
nonacute ward areas in their likelihood of using the screening tool or 
alert, in contrast to previous audits of the alerted population which 
showed that acute areas such as A&E and medical acute admission 
wards had higher utilisation and bundle completion rates.
Conclusion Despite these interventions, most patients still do not 
receive the full recommended treatment bundle. These fi ndings have 
prompted a point prevalence audit at ward level, which will examine 
all patients’ notes for the preceding 24  hours to ascertain if sepsis is 
truly unrecognised or whether it is simply that our current tool is not 
a helpful adjunct to care. With national guidelines expected within the 
year, we will redesign and re-launch our screening tools and education 
programme to improve awareness and management of this common 
medical emergency.
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Introduction An elevated body temperature is one of the four criteria 
in diagnosing systemic infl ammatory response syndrome (SIRS), 
and is often used at the bedside to trigger diagnostic investigations 
for infection. Standard intermittent temperature measurement may, 
however, delay the detection of an elevated temperature or miss 
this altogether. The aim of the study is to compare intermittent non-
invasive versus continuous invasive body temperature measurement 
as a tool to detect an elevated body temperature.
Methods This was a secondary analysis of a prospective study in 25 
critically ill patients comparing diff erent measurement techniques. 
Temperature was measured intermittently with an axillary digital 
thermometer every 4 hours, and a urinary bladder thermistor catheter 
was used for continuous temperature measurement; the latter was 
considered the reference method. Fever (core temperature ≥38.3°C) 
episodes occurring within 60 minutes after each other were classifi ed 
as one episode. We compared the fever detection rate of both methods 
and calculated the diff erence in timing between both techniques.
Results Twenty-nine episodes of fever were detected in 10 patients 
(seven male) with a median APACHE II score of 10 (IQR 3 to 24) and 
a median SOFA score of 10 (IQR 8 to 11). Median duration of a fever 
episode was 1 hour 24 minutes (IQR 47 minutes to 2 hours 59 minutes) 
and median maximum temperature was 38.4°C (IQR 38.3 to 38.7). 
Median axillary temperature was 0.7°C (IQR 0.3 to 0.9) lower than core 
temperature. Using intermittent, non-invasive measurement, 27 out of 
29 fever episodes (93.1%) remained undetected.
Conclusion Intermittent, non-invasive temperature measurement 
failed to detect most of the fever episodes as measured by a bladder 
thermistor catheter and should not be used to screen for elevated body 
temperature in critically ill patients.
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Introduction Severe sepsis results in ~36,800 UK deaths each year 
[1]. Prior studies demonstrate the benefi t of early recognition and 
treatment of sepsis in reducing mortality [2]. The Sepsis Six [1] bundle 
aims to optimise the fi rst hour of sepsis management. We assessed the 
proportion of emergency department (ED) patients with severe sepsis 
receiving the Sepsis Six bundle and whether this was improved by a 
combination of staff  education and use of Sepsis Six management 
stickers in patient notes.
Methods A closed loop audit was completed in the ED at Ipswich 
Hospital, UK. Each cycle was 14  days with interventions made in a 
4-week period between the two cycles. The interventions consisted 
of: Sepsis Six management stickers and posters placed in the ED; 
two training sessions for all ED nurses on sepsis recognition and 
management; a teaching session for all middle-grade doctors; and a 
trolley in the ED with equipment required for the Sepsis Six. The notes 
of all patients with lactate ≥2  mmol/l were retrospectively reviewed. 
Those with ≥2 systemic infl ammatory response syndrome criteria and a 
documented suspicion of infection were deemed to have severe sepsis. 
The times at which these patients had each of the Sepsis Six completed 
were recorded, as were the fi nal diagnosis and 7/28 day mortality.
Results In Cycle 1, 31/106 patients met the criteria for severe sepsis, 
compared with 36/120 in Cycle 2. The delivery of the Sepsis Six 
interventions was highly variable. In Cycle 1 lactate levels and i.v. 
access had the highest 60-minute completion rates (90.3%, 83.9% 
respectively). Blood cultures and i.v. fl uid resuscitation were completed 
for 61.3% and 64.5% of patients within 60 minutes. Only 38.7% of septic 
patients were given i.v. antibiotics within 60  minutes. In total, 58.9% 
of patients received antibiotics in accordance with trust guidelines. 
High fl ow oxygen, catheters and fl uid balance charts had the lowest 
60-minute completion rates (35.5%, 6.5%, 6.5% respectively). In Cycle 
2, post intervention, there was no signifi cant change in the percentage 
of patients receiving the Sepsis Six bundle.
Conclusion The low rates of Sepsis Six completion require improvement 
to meet the targets set out by the College of Emergency Medicine. Our 
results suggest that simple interventions are ineff ective in increasing 
Sepsis Six completion and thus lend support to the case for integrated 
interventions such as electronic recording and alert systems.
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Introduction The objective of this study was to evaluate six general 
symptoms as markers for severe sepsis in patients with suspected 
bacterial infections. Severe sepsis is a common cause of death and 
morbidity. Early detection and treatment is critical for outcome. Clinical 
presentation varies widely and no single test is able to discriminate 
severe sepsis from uncomplicated infections or non-infectious 
emergencies. Apart from local symptoms of infection, the systemic 
infl ammatory reaction itself may give rise to general symptoms such as 
muscle weakness and vomiting.
Methods We present an observational, consecutive study. Data from 
ambulance and hospital medical records were analyzed. The survey 
included 290 patients (mean age: 70.6  years; median age: 74  years; 
male: 47%) who were admitted to a 550-bed secondary care hospital, 
receiving intravenous antibiotics for suspected community-acquired 
infections. General symptoms (fever/shivering, dyspnea, muscle 
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weakness, gastrointestinal symptoms, localized pain, altered mental 
status) that were part of the reason the patient sought medical care 
were registered. Additionally, age, sex, vital signs, C-reactive protein, 
and blood cultures were registered. Patients that within 48 hours from 
admission fulfi lled any criteria for severe sepsis were compared with 
patients that did not. Odds ratios for severe sepsis were computed 
using univariable as well as multivariable logistic regression, controlling 
for age and gender as confounders.
Results Severe sepsis criteria were fulfi lled in 31% (n  = 91) of the 
patients. These were older (median age: 79  years vs. 71  years) and 
experienced more symptoms (mean: 2.2, SD 0.9 vs. mean: 1.4, SD 0.7) 
than patients without severe sepsis, while there was no diff erence in 
C-reactive protein levels (OR per 50  mg/l: 1.07, 95% CI: 0.96 to 1.20). 
Among individual symptoms, altered mental status (OR: 4.4, 95% CI: 
2.2 to 9.0), dyspnea (OR: 3.5, 95% CI: 2.1 to 5.9), and muscle weakness 
(OR: 2.2, 95% CI: 1.0 to 4.4) were signifi cantly related to severe sepsis. 
Adjusting for age and sex, altered mental status (adj. OR: 4.1, 95% CI: 2.0 
to 8.4) and dyspnea (adj. OR: 3.1, 05% CI: 1.8 to 5.3) remained signifi cant.
Conclusion General symptoms, especially altered mental status and 
dyspnea, appear to be more common in severe sepsis than in milder 
infections. These symptoms might be utilized as a diagnostic aid for 
severe sepsis in the clinical setting, complementing vital signs and 
laboratory tests.
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Introduction Collection of blood cultures is routinely performed in 
patients with suspicion of infection in the emergency department (ED) 
despite a low yield of positive culture results. To increase sensitivity, 
diff erent clinical prediction rules and blood biomarkers have been put 
forward. Herein, we validated the performance of diff erent promising 
clinical prediction rules alone and in combination with novel blood 
biomarkers to predict blood culture positivity.
Methods This is an observational cohort study including consecutive 
medical patients with suspected infection and collection of ED 
admission blood cultures. Five clinical prediction rules were calculated 
and admission concentrations of procalcitonin (PCT), C-reactive 
protein, neutrophil–lymphocyte count ratio (NLCR), lymphocyte 
count, white blood cell count, and red blood cell distribution width 
were measured. True blood culture positivity was assessed by two 
independent physicians. We used logistic regression models with 
area under the curve (AUC) to establish associations between clinical 
prediction rules and blood culture positivity.
Results Of 1,083 included patients, 106 (9.8%) cultures were positive. 
Of the clinical prediction rules, the Shapiro rule performed best (AUC 
0.733) followed by the Metersky rule (AUC 0.609). The best biomarkers 
were PCT (AUC 0.796), NLCR (0.692) and lymphocyte count (AUC 0.671). 
Combination of the Shapiro rule and PCT showed the best combination 
result (AUC of combined model 0.822). Limiting blood cultures to either 
the Shapiro rule ≥4 points or PCT >0.11  μg/l would reduce negative 
sampling by 25.6% while still identifying 100% of positive cultures. 
Using a Shapiro rule ≥3 points or PCT >0.25  μg/l limit would reduce 
negative sampling by 42.1% while still identifying 96.2% of positive 
cultures.
Conclusion Combination of clinical parameters combined in the 
Shapiro rule together with admission levels of PCT allows reduction of 
unnecessary blood cultures with minimal false negative rates.
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Introduction The aim of the study is to evaluate the calibration and 
discrimination of two specifi c risk scores for community-acquired 
pneumonia (CAP) in patients with this illness who required ICU 
admission.
Methods A retrospective descriptive study of patients with severe CAP 
admitted to the ICU between January 2008 and September 2013. We 
analyzed clinical and epidemiological variables and APACHE II, SAPS 
III, CURB-65 and Pneumonia Severity Index (PSI) that were recorded in 
the fi rst 24 hours. We used the Student t test to compare means and 
the chi-square test for univariate analysis. The standardized mortality 
ratio (SMR) and Hosmer–Lemershow test were calculated to analyze 
the calibration and ROC curve analysis for discrimination of diff erent 
scores.
Results We analyzed 111 patients aged 57.5 ± 17.7 years, with 63.1% 
(70) males. The APACHE II score at admission was 19.8 ± 17.7 and SAPS 
III was 60.6 ± 16.7. ICU mortality was 29.7% (33). There was association 
between the four scores and mortality. The SMR for APACHE II was 0.87 
and 0.85 for the SAPS III. Figure  1 shows the ROC curve for the four 
scores, the best observed discrimination obtained was for SAPS III score 
(AuC 0.79) and the worst was obtained for CURB-65 score (AuC 0.7). The 
Hosmer–Lemeshow test showed acceptable calibration for the four 
predictive systems (P > 0.05).
Conclusion The four analyzed scores presented good calibration, 
but discrimination seems better in SAPS III. Given the diffi  culty of 
calculating PSI, and its low discrimination (similar to CURB-65), we 
prefer to use the CURB-65 score in routine clinical practice.
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Introduction The aim of our study was to investigate perioperative risk 
factors associated with deep sternal wound infections in complicated 
cardiac surgery.
Methods A total of 1,017 patients underwent cardiac surgery in a 
2-year period. We investigate the correlation between deep sternal 
Figure 1 (abstract P9).
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wound infection with the following 14 preoperative characteristics 
and perioperative parameters: age >75, female gender, diabetes 
mellitus (DM), insulin dependence, body mass index (BMI) >30, current 
smokers, COPD, cardiopulmonary bypass time (CBP) >120 minutes, use 
of steroids, emergency operation, prolonged mechanical ventilation 
(>48  hours), reintubation, transfusion with more than 3 units of red 
blood cells, and the postoperative use of non-invasive ventilation (NIV). 
The chi-square test was used for statistical analysis.
Results A total of 35 patients (3.44%) were complicated by deep 
sternal wound infections. No statistical correlation was found with age 
>75, gender, DM, BMI >30, steroids, emergent operation, prolonged 
ventilation, CBP time >120 minutes, reintubation and NIV. Factors with 
statistical signifi cant correlation are presented in Table 1.
Table 1 (abstract P10)
 Sternal infection P value
Insulin 9/85 0.001
Current smoker 4/272 0.037
COPD 11/197 <0.001
Transfusion >3 19/302 0.001
Conclusion Postoperative deep sternal wound infections have statistical 
signifi cant correlation with the following parameters: transfusion with 
>3 red blood cell units, history of COPD, insulin dependence and when 
the patient is a current smoker. Also there is a tendency for correlation 
with CBP time >120 minutes (P = 0.056).
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Introduction Blood culture is a critical procedure for detecting 
potentially life-threatening bloodstream infections (BSI). At the same 
time, early diagnosis and appropriate treatment of BSI are the key 
factors in order to improve prognosis. The purpose of the current 
analysis was to identify risk factors for bacteremia in adult febrile 
patients in emergency settings.
Methods We conducted a retrospective case–control study within a 
population of adult patients visiting the emergency department at a 
community hospital (St Luke’s International Hospital, Tokyo, Japan) and 
who underwent two sets of blood culture testing between 2003 and 
2012. Among a total of 13,582 patients, 1,322 (10%) were detected as 
bacteremia. We included in this study 179 randomly selected patients 
from the bacteremia group and 321 randomly selected patients from 
the negative blood culture group to serve as the comparison group. 
Multivariate logistic regression was used to evaluate the relationship 
between clinical characteristics factors and bacteremia.
Results In a multivariate logistic regression model, a statistically 
signifi cant independent eff ect was found for body temperature 
(BT) >38°C (OR  = 2.58, 95% CI, 1.76 to 3.79, P  <0.001), systolic blood 
pressure (SBP) <100 mmHg (OR = 1.72, 95% CI, 1.11 to 2.65, P = 0.01), 
CRP >10 mg/dl (OR = 3.03, 95% CI, 2.05 to 4.49, P <0.001) and PaCO2 
<32 mmHg (OR = 2.3, 95% CI, 1.57 to 3.37, P <0.001). Receiver operating 
characteristic curve analysis revealed an area under the curve value 
of 0.725 for diff erentiating patients with bacteremia from negative 
culture.
Conclusion BT >38°C, SBP  <100  mmHg, CRP >10  mg/dl and PaCO2 
<32  mmHg are independently associated with bacteremia. These 
factors might be useful to know whether or not adult febrile patients 
have bacteremia.
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Introduction Overproduction of nitric oxide (NO) is correlated with 
adverse outcomes in sepsis. NO is additionally a central part of the 
innate immune system defense against pathogens causing ventilator-
associated pneumonia (VAP), which can complicate the clinical 
course during mechanical ventilation (MV). We hypothesized that 
pre-exposure to MV and systemic infl ammation from endotoxin each 
would infl uence bacterial growth in lung tissue, based on an altered 
immune response in experimental pneumonia. We used a porcine 
Pseudomonas aeruginosa VAP model with ventilatory and infl ammatory 
pre-exposures before inoculation to evaluate bacterial growth, 
development of lung damage, total NO production and infl ammatory 
cytokine response.
Methods Three groups of mechanically ventilated pigs were subjected 
to experimental VAP for 6  hours with intrapulmonary 1  ×  1011 CFU 
P. aeruginosa at baseline. Two groups were pre-exposed to MV for 
24  hours before bacterial inoculation: MV  + Etx (n  = 6, received 
endotoxin 0.063 μg × kg–1 × hour–1) and MV (n = 6, received saline in 
equivalent volume). One group, Un (n  = 8), started the experiment 
unexposed to both MV and endotoxin, directly from the initiation of 
VAP. Postmortem lung tissue samples rendered bacterial cultures. NO 
production was measured with urinary nitrate levels over 6  hours of 
VAP.
Results The animals pre-exposed to endotoxin (MV  + Etx) displayed 
higher bacterial growth (CFU × g–1) (P <0.05), lower PaO2/FiO2 (P <0.05) 
and lower nitrate levels (P  <0.01) than the unexposed animals (Un). 
Plasma TNFα levels were higher in Un than in both pre-exposed groups 
MV  + Etx and MV (P  <0.01). There were no signifi cant diff erences 
between the two pre-exposed groups.
Conclusion Mechanical ventilation for 24  hours with concomitant 
endotoxin exposure enhances bacterial growth and lung damage 
during P. aeruginosa VAP, compared with inoculation without any pre-
exposure to MV or endotoxin. The greater bacterial clearance in the 
unexposed animals was associated with higher NO production and 
higher levels of pro-infl ammatory cytokines.
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Introduction Cervical necrotizing fasciitis (CNF) is a rapidly evolving 
and life-threatening condition. Therefore, it is important for physicians 
to evaluate the severity of illness and to predict clinical outcome exactly 
in the early phase. We focused on extension of acute fl uid collection 
along the deep cervical space by CT fi ndings. The purpose of this study 
was to produce the CT grade and to analyze whether our CT grade is 
related to the clinical features and the responses to treatment of CNF.
Methods Between June 2004 and December 2012, 42 patients 
diagnosed and treated for CNF in two institutions were included in 
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this study. Cervical spaces were subdivided into three components 
according to the concept of interfascial planes. The extension of acute 
fl uid collection in cervical spaces was classifi ed into three grades: Grade 
I, fl uid collection confi ned to one component; Grade II, fl uid collection 
spreading into two or three components; and Grade III, fl uid collection 
spreading into four components or mediastinum. We analyzed 
association with CT grades and severity of illness (SOFA score, APACHE 
II score, CRP). All patients underwent percutaneous catheter drainage 
either ultrasonography guided or CT guided. We compared treatment 
outcome of CNF with CT grades.
Results According to elevation of CT grades, severity of illness was 
signifi cantly associated with high score (APACHE II: 10.5 to 4.0, 12.8 to 
4.2, 16 to 4.2, SOFA: 2.6 to 1.5, 2.9 to 1.9, 6.8 to 3.7, CRP: 17.8 to 10.6, 22.4 
to 10.1, 33.3 to 11.9) and also duration of mechanical ventilation and 
length of hospital stay were longer (duration of mechanical ventilation: 
10.9 to 6.6, 11.5 to 6.7, 15.8 to 7.2, length of hospital stay: 23.4 to 10.6, 
27.9 to 21.4, 48.7 to 36.2).
Conclusion Novel classifi cation of CNF based on CT fi ndings showing 
the extension of fl uid collection is a useful indicator of the disease 
severity and predicting clinical outcome. These fi ndings may infl uence 
the strategy for the success of percutaneous catheter drainage.
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Introduction The aim of the study was to evaluate the diff erence in 
mortality rates between those admitted to the ICU with and without 
sepsis, and to assess the proportion of patients who had sepsis. 
Septic patients are one of the key groups of patients admitted to ICUs 
around the world. Septic patients have an extremely poor prognosis 
with published mortality rates ranging from 20.7% (severe sepsis) to 
45.7% (septic shock) [1]. With septic patients making up roughly 21% of 
patients admitted to ICUs, it is important to assess whether these rates 
of mortality hold true to a district general ICU and to assess the extent 
of the diff erence in prognosis between patients with and without 
sepsis [2].
Methods We performed a retrospective case note review, looking at a 
sample of 5,954 patients 18 years or older who were admitted to East 
Surrey Hospital (ESH) ICU, which has an elective admissions rate of 3%, 
between 1 January 2005 and 31 October 2014. The total number of 
patients with sepsis was 941 compared with 5,013 without sepsis. We 
looked at mortality rates, APACHE II scores and length of stay on the 
unit.
Results From the beginning of 2005 to the end of October 2014, 
mortality rates in septic patients were 44.6% compared with 26.2% 
in nonseptic patients. Fisher’s two-tailed test showed a signifi cant 
diff erence (P <0.0001) between the mortality in septic and nonseptic 
patients. There was a signifi cant diff erence (Mann–Whitney) between 
APACHE II scores, with median scores of 18 and 13 in septic and 
nonseptic patients respectively. Septic patients had longer lengths 
of stay, with the mean and median 8.73 and 3.89  days respectively, 
compared with 4.90 and 2.5 in nonseptic patients. Septic patients 
made up 15.8% of all patients admitted to the ICU.
Conclusion Patients with sepsis admitted to ESH ICU made up a 
signifi cant minority of patients admitted to the ICU. Septic patients had 
a 70% relative higher mortality rate compared with nonseptic patients. 
The mortality rate of 44.6% fi ts with previously quoted mortality rates 
in septic shock. Patients with sepsis had a signifi cantly higher predicted 
mortality, recorded by their APACHE II score, which was statistically 
signifi cant. This also meant they needed longer ICU care, with the 
average length of stay almost doubled.
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Introduction The aim of this study was to evaluate the eff ect of the 
Surviving Sepsis Campaigns on mortality rates, before and after the 
second surviving sepsis publication, and to assess whether patients 
with sepsis being admitted to the ICU had a lower APACHE II score on 
admission. Patients with sepsis, who require ICU care, have an extremely 
poor prognosis. It has been shown that the mortality rates range from 
20.7% (severe sepsis) to 45.7% (septic shock) [1]. The surviving sepsis 
campaign was initiated in 2002. The fi rst, second and third publications 
were published in 2004, 2008 and 2012 respectively [2].
Methods A retrospective case note review was performed, looking at 
a sample of 5,954 patients who were 18 years or older who had been 
admitted to East Surrey Hospital (ESH) ICU between 1 January 2005 
and 31 October 2014. The total number of patients with sepsis was 941. 
We compared results before and after the second publication of the 
surviving sepsis campaign, looking at mortality rates, age of patients, 
admission length prior to ICU transfer, APACHE II score and the length 
of stay on the ICU.
Results From the beginning of 2005 to the end of 2008, the mortality 
rates for septic patients was 51.9% compared with 41.3% from the 
beginning of 2009 to end of October 2014. Fisher’s two-tailed test 
showed a signifi cant diff erence (P = 0.003) between the mortality before 
and after the second publication. The median ages before and after 
2009 were 63.9 and 64.8 years. The time in hospital before admission to 
the ICU was greater before 2009 (6.15 days) compared with after 2009 
(5.53  days). There was no signifi cant diff erence (Mann–Whitney test) 
between the APACHE II scores, with the mean and median score the 
same at 17.6 and 18 for both groups. The mean length of stay was 1 day 
longer after 2009 (8.07 days compared with 9.07 days).
Conclusion Patients with sepsis admitted to ESH ICU had a 20% 
relative decrease in mortality after the second publication of surviving 
sepsis guidelines. The original aim of the campaign was to reduce 
mortality from sepsis by 25% in 5 years [3]. This decrease was not due 
to a signifi cant diff erence between the sets of patients. The decreased 
time to admittance to ICU may be due to improved recognition of the 
need for ICU care. Overall the surviving sepsis campaign has had a 
signifi cantly benefi cial eff ect on mortality rates in patients with sepsis.
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Introduction The purpose of this study was to examine long-term 
mortality, 5  years after severe infection, and to identify independent 
risk factors associated with it.
Methods A prospective cohort study developed at a tertiary care 
university-affi  liated 600-bed hospital including all patients with severe 
infection admitted into intensive care, medical, surgical, haematology 
and nephrology wards, over a 1-year period (2008/2009). The outcome 
of interest was mortality 5  years following hospitalisation and its 
association with specifi c risk factors was studied through logistic 
regression.
Results There were 1,013 patients included in the study. Hospital 
mortality rate was 14% (n = 137) and 5-year mortality was 37% (n = 379). 
Factors independently associated with 5-year mortality were (adjusted 
odds ratio (95% confi dence interval)): age = 1.04 per year (1.03 to 1.05), 
cancer  = 8.00 (3.06 to 20.88), chronic hepatic disease  = 3.06 (1.06 to 
8.87), chronic respiratory disease  = 2.21 (1.06 to 4.62), haematologic 
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disease = 3.40 (1.64 to 7.04), Karnovsky Index <70 = 2.56 (1.63 to 3.71), 
infection by an ESKAPE pathogen = 1.65 (1.02 to 2.66) and severity of 
infection (reference is infection without SIRS): sepsis = 1.14 (0.7 to 1.83), 
severe sepsis  = 1.18 (0.73 to 1.93), septic shock  = 3.69 (1.78 to 7.65). 
The fi nal model had a very good discrimination for long-term mortality 
with an area under the ROC curve of 0.78 (Figure 1).
Conclusion The authors identifi ed several factors that were signifi cantly 
associated with increased long-term mortality in patients with severe 
infection. This information will help clinicians in the discussion of 
individual prognosis and clinical decision-making.
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Introduction Costs of severe sepsis care from middle-income countries 
are lacking. This study investigated direct ICU costs and factors that 
could aff ect the fi nancial outcomes.
Methods A prospective cohort study was conducted in the medical 
ICU of a tertiary referral university teaching hospital in Thailand over 
a 4-year period.
Results A total of 897 patients, with 683 (76.1%) having septic shock. 
Overall ICU mortality was 38.3%. The median (interquartile range) ICU 
length of stay (LOS) was 4 (2 to 9) days. Community, nosocomial and 
ICU-acquired infection were documented in 574, 282 and 41 patients, 
respectively. The median ICU costs were €2,067.2 (986.3 to 4.084.6) per 
patient and €456.6 (315.3 to 721.8) per day. The ICU costs accounted for 
64.7% of the hospital costs. In 2008 to 2011, the ICU costs signifi cantly 
decreased by 40% from €2,695.7 to €1,617, whereas the daily ICU costs 
decreased only 3.3% from €463.9 to €448.7 (Figure  1). The average 
ICU costs of patient with nosocomial and ICU-acquired infection 
were signifi cantly higher than patients with community-acquired 
infection. By multivariate logistic regression analysis, age, nosocomial 
or ICU infection, admission from emergency department, number of 
organ failures, ICU LOS, and fl uid balance in the fi rst 72  hours were 
independently associated with total ICU costs.
Conclusion The ICU costs of severe sepsis management signifi cantly 
declined in Thailand. However, the ICU costs were a fi nancial burden 
accounting for two-thirds of the hospital costs. It is essential for 
intensivists to contribute a high standard of care within a restricted 
budget. The cost-eff ectiveness analysis should be evaluated in sepsis 
care cases.
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Introduction Survivors of sepsis report persistent problems that can 
last years after hospital discharge. The main aim of this study was to 
investigate long-term health-related quality of life in survivors of 
SIRS and sepsis compared with Welsh normative data, controlling for 
age, length of stay and pre-existing conditions. The second aim was 
to investigate any diff erences in long-term health-related quality of 
life specifi cally with the patients categorised into three groups: SIRS, 
uncomplicated sepsis, and severe sepsis/septic shock.
Methods A prospective study design was used in order to investigate 
all sepsis patients either presenting to the emergency department or 
admitted to the ICU of a regional trauma centre. A total of 106 patients 
were recruited and all patients were considered eligible as per the SIRS 
and sepsis criteria [1]. The Sepsis-related Organ Failure Assessment 
score was determined over the fi rst 24 hours to assess organ function. 
Patients were assigned to groups as follows: sterile SIRS; uncomplicated 
sepsis; severe sepsis or septic shock as per the criteria. Assignment 
into groups was blinded and performed by an intensive care 
specialist independent of the study. Baseline demographics, clinical 
characteristics and outcomes were collected and surviving patients 
were sent a SF-12v2 survey at between 6 months and 2  years post 
hospital discharge.
Results A total of 106 patients were included in the study. A mortality 
rate of 34% was recorded, leading to a fi nal response rate of 72% by 
the end of the data collection period. Quality of life was signifi cantly 
reduced in all patients when compared with local normative data (all 
P  <0.0001). Reductions in the physical components of health-related 
quality of life were more pronounced in severe sepsis/septic shock 
patients when compared with uncomplicated sepsis and SIRS patients.
Conclusion This is the fi rst observational study to specifi cally focus on 
the diff erent groups of SIRS and sepsis patients to assess long-term 
quality of life. Local population norms were used for comparison, 
rather than wide geographical norms that fail to refl ect the intricacies 
of a country’s population. Signifi cant reductions in quality of life 
were found in severe sepsis/septic shock patients compared with in 
uncomplicated sepsis and SIRS patients, when controlling for age, pre-
existing conditions, hospital and ICU length of stay.
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Figure 1 (abstract P16).
Figure 1 (abstract P17). Median ICU costs per patients and ICU cost per 
day according to study years.




Analysis of the mortality rate in patients admitted to the ICU for 
severe community-acquired pneumonia
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Introduction The aim of the study was to analyze the factors associated 
with hospital mortality in patients with severe community-acquired 
pneumonia (CAP) who required ICU admission.
Methods An observational, retrospective study of patients with severe 
CAP admitted to the ICU between January 2008 and September 
2013. We analyzed clinical, epidemiological and outcome variables. 
Quantitative variables were expressed as the mean and standard 
deviation. Qualitative variables are expressed as the percentage and 
absolute value. We applied the Mann–Whitney and Fisher’s exact test, 
as needed, with an alpha error of 5%.
Results We analyzed 111 patients, 57.5 ± 17.7 years old, with 63.1% (70) 
males and APACHE II score on admission of 19.8 ± 17.7. ICU mortality 
was 29.7% (33) and in-hospital mortality was 32.4% (36). Ten percent 
of patients met criteria for medical care-associated pneumonia (HCAP); 
there were no signifi cant diff erences in mortality between HCAP 
and CAP (P  =  0.075). Patients chronically taking immunosuppressive 
therapy had a signifi cantly higher mortality compared with the rest 
of the patients (47.8% vs. 28.4%, P = 0.07). The mortality rate was also 
higher in patients in whom NIV fail in the fi rst 24  hours (42.9% vs. 
17.6% with P = 0.09). Patients who required intubation and mechanical 
ventilation in the fi rst 24 hours had a higher mortality rate (47.2% vs. 
19%, P = 0.002). Regarding the etiology of pneumonia, in 11 patients 
the viral origin of infection was confi rmed (10 patients had H1N1 
pneumonia and one patient CMV pneumonia), with a mortality rate 
signifi cantly lower than in patients with bacterial pneumonia (3.6% vs. 
35.3%, P = 0.06). The use of the right antibiotic therapy at admission 
was associated with mortality (P = 0.0001).
Conclusion Patients admitted to the ICU with severe CAP and 
immunosuppressive therapy have higher mortality, with no diff erences 
between HCAP and CAP. The delay in intubation as well as bacterial and 
inappropriate antibiotic treatment are factors that increase mortality.
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Introduction Sepsis is a high-prevalence disease in ICUs, associated 
with high mortality and high costs, mainly in developing countries. The 
aim of this study is to demonstrate the ICU costs, in a private hospital, 
in patients admitted with severe sepsis and septic shock.
Methods A retrospective, observational, single-center study of patients 
admitted from November 2013 to March 2014 with severe sepsis and 
septic shock. The records data were taken from the Software Epimed, 
MV System, and IBM SPSS Statistics 21. The classifi cation was based 
on the Surviving Sepsis Campaign 2012. We included all 50 beds of 
an adult ICU, clinical and surgical. All patients older than 18 years with 
severe sepsis and septic shock were included. We evaluated the costs 
of patients during their ICU stay, and its relation to clinical presentation 
(severe sepsis and septic shock), antibiotic start time, permanence of 
ICU stay, and mortality. Only the fi rst episode per patient was recorded.
Results From November 2013 to March 2014 were included 82 patients 
with criteria for severe sepsis and septic shock. The mean age of 
patients was 62.5 ± 21.8 years, divided equally between the genres. The 
overall mortality rate was 34.15%. The SAPS 3 was 56.43, with death 
probability set to Latin America 38.83%. Patients with severe sepsis 
had a mortality of 23.2% and those with septic shock had a mortality 
rate of 58%. The average total cost during ICU admission per patient 
was US$17,834 and the average daily cost was US$1,641. The daily 
cost in patients with severe sepsis and septic shock was US$1,263 and 
US$2,465 (P  =  0.002), respectively, and in survivors and nonsurvivors 
was US$1,189 and US$2,512 (P = 0.001). The length of stay of patients 
in the ICU was 11.09 days, being 11.3 days in patients with severe sepsis 
and 10.7 days in patients with septic shock (P = 0.785). The beginning 
of the antibiotics in nonsurvivors was 73.7  minutes and in survivors 
was 64.7 minutes (P = 0.757), with the earliest onset in patients with 
septic shock than in patients with severe sepsis (38.5 vs. 81.5 minutes, 
P = 0.141).
Conclusion Severe sepsis and septic shock are conditions that 
consume large amounts of resources. Nonsurvivors had higher average 
spending than survivors. Patients admitted with septic shock had 
higher mortality than patients with severe sepsis with high mortality 
in relation to the prognostic indices adopted. The beginning of the 
antibiotics was longer in the nonsurvivors. We should adopt measures 
aimed at recognizing and earlier treatment of sepsis. If we improve 
our treatment, especially in septic shock, we will prevent deaths and 
decrement costs.
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Introduction Sepsis is a global healthcare challenge. However, 
comprehensive information on sepsis morbidity and mortality across 
the world is scarce. We aimed to estimate the global burden of sepsis 
and to identify knowledge gaps based on available evidence from 
observational epidemiological studies.
Methods We searched 15 international and national citation 
databases for population-level estimates on incidence rates of sepsis 
or severe sepsis per 100,000 person-years and case fatality rates in 
adult populations using consensus criteria and published in the last 
40 years. No language or publication restrictions were applied. Studies 
were stratifi ed into four subgroups (setting: hospital or ICU for sepsis 
and severe sepsis) and meta-analyzed using metaprop of the R 3.0.2 
package. Heterogeneity of the underlying eff ects across studies was 
expressed by the estimated τ, the square root of the between-study 
variance.
Results The search yielded 1,553 reports from 1979 to 2013, of which 37 
met our criteria and 33 provided data for meta-analysis. The included 
studies were from 15 high-income countries in North America, Europe, 
Asia, and Australia. For these countries, the population incidence rate 
was 256 (95% CI, 182 to 360, τ = 0.43) hospital-treated sepsis cases and 
151 (95% CI, 94 to 242, τ = 0.98) hospital-treated severe sepsis cases 
per 100,000 person-years, with large between-study heterogeneity. 
Restricted to the last decade, the incidence rate was 427 (95% CI, 281 
to 648, τ  = 0.24) sepsis cases and 331 (95% CI, 207 to 530, τ  = 0.59) 
severe sepsis cases per 100,000 person-years. Hospital mortality was 
15% for sepsis and 25% for severe sepsis during this period of time. 
There were no population-level sepsis incidence estimates from lower 
income countries. A tentative extrapolation from high-income-country 
data suggests global estimates of 30.7 million sepsis and 23.8 million 
severe sepsis cases, with potentially six million deaths each year.
Conclusion Our analyses underline the urgent need to implement global 
strategies to monitor sepsis morbidity and mortality  – especially in 
low-income and middle-income countries. For further epidemiological 
studies, more consistent and standardized methodological approaches 
are needed to reduce between-study heterogeneity. In particular, 
further research on sepsis coding using administrative data seems 
necessary to derive sensitive and specifi c sepsis case identifi cations.
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Introduction Disparities in the incidence and outcomes of sepsis have 
been documented in observational studies but little is known about 
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how these occur and how we might prevent them. Our objective is to 
identify disparities by race, language, gender, socioeconomic status, 
insurance status and geography in acute sepsis care in emergency 
department (ED) or ICU settings in the published literature.
Methods We performed a systematic review of disparities in sepsis 
care. The search strategy and inclusion and exclusion criteria were 
defi ned a priori. A medical librarian searched the entire MEDLINE 
(PubMed), EMBASE and Cinahl databases prior to 2013. One author 
reviewed all abstracts and a second author reviewed 10% of all 
abstracts for agreement. Both reviewers independently reviewed each 
included article using an explicit study review tool. We included studies 
that met the following inclusion criteria: ED or ICU setting; disparities 
due to race, language, gender, socioeconomic status, insurance status 
or geography; process of care measures (antibiotics, lactate, i.v. fl uid 
resuscitation, central line placement, vasopressor use) or outcome 
measures (mortality, length of stay, complications, costs). We excluded 
studies involving organ-specifi c infectious conditions, pediatric 
populations, case reports, and review articles.
Results We identifi ed 778 abstracts; yielding 31 for inclusion (k = 0.95), 
26 of 31 studies were excluded due to quality issues. Five articles met 
our inclusion criteria. Only one of the studies [1] contained data on 
process of care measures, showing that central venous monitoring was 
less likely to occur in older patients. Three studies [2-4] showed that 
Black patients had a higher incidence of sepsis, a higher hospitalization 
rate, and higher mortality rate. Plurad and colleagues [5] reported that 
Asian patients had increased incidence of post-traumatic sepsis. Overall, 
Black patients with sepsis were younger, had lower socioeconomic 
status and were more likely to be cared for in urban settings compared 
with their cohorts.
Conclusion We found little published data addressing whether 
disparities due to race, language, gender, socioeconomic status, 
insurance status or geography exist in the acute care of sepsis. As 
sepsis is a leading cause of in-hospital mortality, future research should 
determine whether such disparities exist. Specifi cally, prospective 
studies of the process of care in sepsis management may further 
elucidate additional factors that may contribute to these disparities.
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Introduction The objective of this study was to compare the number 
of rolling and adhered leukocytes in patients with severe sepsis/septic 
shock with non-infected controls. Microcirculatory fl ow alterations and 
endothelial cell dysfunction are elements of sepsis pathophysiology. 
Traditionally, microcirculatory emphasis has been on red blood cell 
vessel perfusion. However, assessment of interactions between white 
blood cells and endothelial cells may be another early diagnostic 
modality.
Methods We included adult (age >18  years) ED patients presenting 
with severe sepsis/septic shock (sepsis with elevated lactate 
(>4  mmol/l)) or hypotension) from the prospective clinical ProCESS 
trial. We studied a subset of patients with microcirculatory videos 
obtained along with non-infected control patients. Using a sidestream 
dark-fi eld videomicroscope, we obtained image sequences from the 
sublingual mucosa and used video stabilization and frame averaging 
techniques to visualize slowly-moving leukocytes. We quantifi ed the 
number of rolling and adhered leukocytes present per 1 mm × 1 mm 
visual fi eld in a standardized 3-second clip. Furthermore, we extracted 
the total length of vessels candidate for counting of rolling/adhered 
leukocytes (vessels with an adequate focus). We report sample means 
with standard deviation and compare them with Student’s t test.
Results We included a total of 64 patients with severe sepsis/septic 
shock and 32 non-infected controls. The mean number of adhered 
leukocytes per fi eld in the sepsis group was 2.1 (SD 2.3) compared with 
0.4 (SD 0.8) in the non-infected group (P  <0.001). This corresponded 
to a mean number of adhered leukocytes per unit vessel length of 
0.16/mm (SD 0.22) and 0.03/mm (SD 0.06) for sepsis and non-infected 
groups, respectively (P <0.001). For the rolling leukocytes, we observed 
a mean number of 27.8 (SD 19.4) in the sepsis group and 12.0 (SD 8.7) 
in the non-infected group (P <0.001) per fi eld. This corresponded to a 
mean number of rolling leukocytes per unit vessel length of 2.00/mm 
(SD 1.67) and 0.75/mm (SD 0.55), respectively (P <0.001).
Conclusion Our results show a higher number of rolling and adhered 
leukocytes in patients with severe sepsis/septic shock when compared 
with non-infected controls. This also applies when taking the total 
vessel length in the fi eld of view into consideration. This may hold 
potential as a useful tool in sepsis assessment.
P24
Time course of redox potential and antioxidant capacity in patients 
undergoing cardiac surgery
C Stoppe1, G Schaelte1, S Kraemer2, C Benstoem2, D Bar-Or3, A Goetzenich2
1RWTH Aachen University, Aachen, Germany; 2RWTH Aachen University, 
University Hospital, Aachen, Germany; 3Swedish Medical Center, Trauma 
Research, Engelwood, CO, USA
Critical Care 2015, 19(Suppl 1):P24 (doi: 10.1186/cc14104)
Introduction Cardiac surgery regularly provokes infl ammation and 
oxidative stress which contribute to the development of organ failure 
and mortality of patients. While the assessment of single markers 
does not refl ect a comprehensive investigation of redox status, the 
measurement of oxidation–reduction potential (ORP) provides a 
reliable measure to assess the balance between total prooxidant and 
antioxidant balance in the blood. The aim of the present study was to 
investigate the overall redox potential in patients undergoing cardiac 
surgery.
Methods This is a prospective observational study in patients scheduled 
for elective cardiac surgery. Serum samples were drawn prior to 
surgery, after connection to cardiopulmonary bypass (ischemia), after 
opening of cross-clamp (reperfusion) and after termination of surgery. 
The redox status of patients was measured using the bedside point 
of care RedoxSYS Diagnostic System™ (Luoxis, USA). Simultaneously 
the antioxidant capacity in serum samples were calculated in all 
perioperatively obtained serum samples.
Results All patients’ sera (n = 17) demonstrated a signifi cant increase of 
ORP upon start of myocardial ischemia (141.0 ± 4.8 mV vs. 157.9 ± 4.9 
mV; P  =  0.002) and compared with reperfusion (141.0  ±  4.8 mV 
vs. 158.6  ±  4.9mV; P  <0.001, Figure  1A). In parallel, the antioxidant 
capacity signifi cantly decreased during surgery (0.505  ±  0.190 μC vs. 
0.384 ± 0.120 μC; P = 0.022) corresponding to the increase of oxidative 
stress (Figure 1B).
Conclusion This preliminary study is the fi rst to highlight the time 
course of overall redox potential and antioxidant capacity in cardiac 
surgery patients. Further studies are underway to evaluate the clinical 
signifi cance on outcome in cardiac surgery patients.
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Introduction Change in fatty acid composition of erythrocytes and 
blood plasma in cases of various pathological conditions is evidence 
of lipid metabolism disorder and can indicate the reasons for and the 
degree of these disorders [1]. The aim of this study was to assess the 
FA composition of plasma and erythrocytes in patients with multiple 
organ dysfunction syndrome (MODS).
Methods The objects of study were 19 people with MODS 
(37.6  ±  8.3  years) of various etiologies. The blood of 17 healthy 
volunteers aged 38.4 ± 3.3 years served as control. The FA analysis was 
conducted using capillary gas–liquid chromatography. Quantitative 
evaluation of individual FA content was made as a mass percentage 
of their total (C14:0 to C22:6). Statistical analysis was performed using the 
Mann–Whitney U test (P <0.05).
Results Our data indicate that changes in blood plasma FA composition 
in patients with MODS are mainly caused by activation of lipolysis in fat 
depots and are accompanied by an increase of monounsaturated fatty 
acids, a decrease in saturated stearic acid and polyunsaturated fatty 
acids in the ratio. In conditions of increased level of monounsaturated 
palmitoleic (C16:1) and oleic (C18:1) FA in blood plasma (2.53 ± 0.40% vs. 
1.55 ± 0.29%, P <0.001 and 25.18 ± 2.15% vs. 16.55 ± 1.17%, P <0.001, 
respectively), only the level of palmitoleic (C16:1) acid is increased in 
erythrocytes (0.56  ±  0.12% vs. 0.16  ±  0.12%, P  <0.001). Despite the 
high content of oleic (C18:1) acid in blood plasma in case of MODS, 
in erythrocytes its relative level is not changed as compared with 
the control group. The disorder of lipid composition constancy in 
erythrocyte membranes is also manifested by change in the content 
of saturated palmitic (C16:0) and polyunsaturated linoleic (C18:2) fatty 
acids. In the test group of patients, as compared with the control 
group there was an elevated level (27.12  ±  0.78% vs. 25.80 ±0.77%, 
P <0.05) of saturated palmitic (C16:0) acid combined with the reduced 
(11.46 ± 0.52% vs. 13.95 ± 1.09%, P <0.001) level of linoleic (C18:2) acid.
Conclusion The changes revealed in fatty acid composition of 
erythrocytes may indicate systemic modifi cations of cell membranes 
in MODS.
Reference
1. Kremmyda LS, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech 
Repub. 2011;155:195-218.
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Introduction The oxidative phosphorylation system (OXPHOS) in 
septic patients has been scarcely analyzed in studies of small sample 
size and the results are apparently inconsistent. Previously, including 
96 severe septic patients, we found that nonsurviving severe septic 
patients showed lower platelet respiratory complex IV (CIV) activity 
than surviving patients at the moment of severe sepsis diagnosis and 
during the fi rst week of sepsis diagnosis. However, we did not examine 
this enzyme activity in normal individuals. Thus, the objective of this 
study was to compare the CIV activity between severe septic patients 
and healthy control individuals in a larger series of patients (including 
198 severe septic patients).
Methods This was a prospective, multicenter, observational study in 
six Spanish ICUs. We obtained blood samples from 198 severe septic 
patients at days 1, 4 and 8 of the severe sepsis diagnosis and from 
96 sex-matched and age-matched healthy control individuals and 
determined platelet CIV activity/protein quantity. The endpoint of the 
study was 30-day mortality.
Results We found that severe septic patients showed lower CIV activity/
protein quantity than controls at day 1 (P  <0.001), day 4 (P  <0.001) 
and day 8 (P <0.001) of severe sepsis diagnosis. Survivor severe septic 
patients (n  = 130) showed lower CIV activity/protein quantity than 
controls at day 1 (P <0.001), day 4 (P <0.001) and day 8 (P <0.001) of 
severe sepsis diagnosis. In addition, nonsurvivor severe septic patients 
(n  = 68) showed lower CIV activity/protein quantity than controls at 
day 1 (P <0.001), day 4 (P <0.001) and day 8 (P <0.001) of severe sepsis 
diagnosis. Besides, nonsurvivor severe septic patients showed lower 
CIV activity/protein quantity than survivor ones at day 1 (P <0.001), day 
4 (P <0.001) and day 8 (P <0.001) of severe sepsis diagnosis.
Conclusion The major fi nding of our work, that represents the largest 
series of severe septic patients with data on OXPHOS function, was that 
survivor and nonsurvivor severe septic patients showed lower platelet 
CIV activity than healthy controls during the fi rst week of severe sepsis 
diagnosis.
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Introduction The role of genetic variability in the susceptibility and 
outcome of infl uenza virus infection (IVI) remains largely unknown. We 
Figure 1 (abstract P24). (A), (B) Perioperative time course of oxidative 
stress and antioxidant capacity.
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have previously demonstrated that variants at SFTPA2 infl uence the 
severity of H1N1pdm infection. We have now studied genetic variants 
at diff erent genes, some of them previously associated with infections 
by infl uenza and/or other viruses. The purpose of this study was to 
analyze the role of genetic variants in the susceptibility and outcome 
of IVI.
Methods In total, 136 white Spanish patients developed IVI (80.3% 
of them by H1N1pdm virus). The general population group consisted 
of 1,466 unrelated healthy volunteers. Patients and controls were 
analyzed for diff erent polymorphisms at 13 genes (FCGR2A, FCGR3A, 
FCGR3B, IL1RN, IL6, LTA, TIRAP, TLR1, TLR2, TLR3, TLR4, CCR5, IGHG2).
IVI was detected in nasopharyngeal swabs using real-time PCR. The 
Hardy–Weinberg equilibrium was analyzed by Haploview v. 4.2. The 
comparisons of genotypes distribution based on susceptibility and 
severity were performed using the chi-squared test or Fisher’s exact 
test when needed. The relationship between severity in hospitalized 
patients and genotypes was evaluated by binary logistic regression 
models.
Results No associations were found between the diff erent genetic 
variants and susceptibility or severity of IVI. Variants at LTA, FCGR2A, 
IGHG2, TLR3 and CCR5, previously associated with severity of IVI were 
not replicated in our study.
Conclusion Our study does not suggest that polymorphisms at LTA, 
FCGR2A, IGHG2, TLR3 and CCR5 genes are associated with susceptibility 
or severity of IVI.
P28
Phenotypic factors associated with outcome in 977 intensive care 
patients with faecal peritonitis: analysis of trends in the GenOSept 
cohort
A Tridente, G Clarke, A Walden, A Gordon, P Hutton, J Chiche, P Holloway, 
G Mills, J Bion, F Stuber, C Garrard, C Hinds, GenOSept Investigators
St Helens and Knowsley, Liverpool, UK
Critical Care 2015, 19(Suppl 1):P28 (doi: 10.1186/cc14108)
Introduction Patients admitted to intensive care following surgery 
for faecal peritonitis present particular challenges in terms of clinical 
management and risk assessment that require close collaboration 
between surgical and intensive care teams [1]. We aimed at establishing 
whether dynamic assessment of trends in selected variables 
may be associated with outcomes, and therefore inform medical 
decision-making.
Methods We analysed trends in all 35 variables available for the fi rst 
week of ICU stay in 977 patients from 102 centres across 17 countries. 
The primary study outcome was 6-month mortality. Secondary 
outcomes were ICU, hospital and 28-day mortality. For each trend, 
Cox proportional hazards (PH) regression analyses, adjusted for age 
and gender, were performed for each endpoint. Trends found to be 
signifi cant in these analyses, after Bonferroni correction for multiple 
testing, were entered into a multivariate Cox PH model, to determine 
independent associations with mortality.
Results The trends over the fi rst 7 days of ICU stay (primary analysis) 
retained as independently associated with 6-month outcome were 
worsening thrombocytopaenia (mortality HR = 1.02, 95% CI = 1.01 to 
1.03, P <0.001) and changes in renal function (total daily urine output 
HR = 1.02, 95% CI = 1.01 to 1.03, P <0.001; renal SOFA subscore HR = 0.87, 
95% CI = 0.75 to 0.99, P = 0.047), highest recorded level of bilirubin (HR = 
0.99, 95% CI = 0.99 to 0.99, P = 0.02) and GCS SOFA subscore (HR = 0.81, 
95% CI = 0.68 to 0.98, P = 0.028). Changes in renal function (total daily 
urine output and renal component of the SOFA score), GCS component 
of the SOFA score, total SOFA and worsening thrombocytopaenia were 
also independently associated with secondary outcomes. Dynamic 
trends over the fi rst 7 days of ICU stay in all other measured laboratory 
variables, physiological parameters or radiological fi ndings failed to be 
retained as independently associated with outcome on multivariate 
analyses. Furthermore, changes in respiratory support, renal 
replacement therapy and inotropic and/or vasopressor requirements 
appeared not to be independently associated with any of the primary 
or secondary outcomes. Secondary post hoc analyses on trends over 
the fi rst 3 and 5 days corroborated these fi ndings.
Conclusion Only deterioration in renal function, thrombocytopaenia 
and hyperbilirubinaemia over the fi rst 7  days of ICU stay were 
consistently associated with mortality at all endpoints.
Reference
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Introduction Platelets are now considered to be immune and infl am-
matory agents as well as key cells in coagulation, and as such have been 
implicated in the pathophysiology of sepsis [1]. Thrombocytopenia is 
associated with sepsis severity and poor prognosis, and hyperactivated 
platelets probably contribute to microvascular thrombosis and organ 
failure. In the present study, we evaluated platelet activation markers 
as potential predictive markers of sepsis and of mortality among four 
commonly encountered populations of patients admitted to ICUs.
Methods Ninety-nine non-infected ICU patients were prospectively 
screened at day 1 (T1) and day 3 (T2) of admission after elective cardiac 
surgery, trauma, acute neurologic dysfunction or prolonged ventilation 
(>48 hours). A third sample was drawn when infection was diagnosed 
(Tx). We evaluated platelet activation by measuring the expression of 
P-selectin (CD62P) and fi brinogen binding on the cell surface before 
and after stimulation with major platelet agonists (ADP, collagen, 
and TRAP) through fl ow cytometry. Clinical scores were obtained at 
admission.
Results Patients who developed sepsis (n  = 18) presented with 
signifi cantly higher platelet fi brinogen binding at T1 compared with 
patients who did not get infected (basal: P = 0.0014, upon stimulation: 
P <0.0035). At T1, ROC AUC for association of basal fi brinogen binding 
with the occurrence of sepsis was 0.79 (95% CI: 0.68 to 0.89). Elevated 
basal CD62P expression level was associated with increased 90-day 
mortality (P  =  0.042, ROC AUC  = 0.78 (0.64 to 0.88)). Kaplan–Meier 
survival curves illustrated that mortality was signifi cantly higher after 
stratifi cation based on T1 basal CD62P level (cutoff  MFI >31.56, HR = 
13.6, P  =  8.23  ×  10–6). Multivariate logistic regression analysis using 
clinical scores (SOFA, APACHE II, SAPS II, SAPS III) indicated that addition 
of CD62P level or of bound fi brinogen level signifi cantly improved 
prediction of mortality (odds ratio 1.078, P = 0.003) and sepsis (odds 
ratio 1.033, P = 0.0012), respectively.
Conclusion Predisposition to severe infection in selected critically ill 
medico-surgical adults can be identifi ed on day 1 of admission based 
on circulating basally activated platelets. Levels of activated platelets 
may add incremental prognostic information to clinical scoring.
Reference
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Thromb Haemost. 2014;11:666-77.
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Introduction Sepsis is a life-threatening condition, during which 
triggering of infl ammatory and coagulation cascades, together 
with endothelial damage, invariably leads to activation of platelets. 
Although platelets are essential components of primary hemostasis, 
uncontrolled platelet activation during sepsis may contribute to 
organ failure. The aim of this study was to investigate whether chronic 
antiplatelet therapy impacts on the presentation and outcome of, and 
the host response to, sepsis.
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Methods We performed a prospective observational study in patients 
admitted with sepsis to the mixed ICUs of two hospitals in the 
Netherlands between January 2011 and July 2013. Cox proportional 
hazards regression was used to estimate the eff ect of antiplatelet 
therapy on mortality. To account for indication bias, a propensity 
score was constructed, and used to match antiplatelet therapy users 
to nonusers. Plasma biomarker levels, providing insight into hallmark 
host responses to sepsis, including activation of endothelial cells and 
the cytokine network, were determined during the fi rst 4 days after ICU 
admission.
Results Of 1,070 sepsis patients, 297 (27.8%) were on antiplatelet 
therapy, including acetylsalicylic acid, clopidogrel and dipyridamole, 
prior to ICU admission. Antiplatelet users and nonusers diff ered 
signifi cantly with regard to several baseline characteristics, such as 
age, gender and cardiovascular disease. Antiplatelet therapy was 
not related to sepsis severity at presentation, the primary source of 
infection, causative pathogens, the development of organ failure or 
shock during ICU stay, or mortality up to 90  days after admission, in 
either the unmatched or propensity-matched analyses. Antiplatelet 
therapy did also not modify plasma concentrations of biomarkers.
Conclusion Pre-existing antiplatelet therapy does not infl uence clinical 
disease severity at presentation, nor the host response or outcome 
following sepsis.
Acknowledgement This research was performed within the framework 
of CTMM, the Center for Translational Molecular Medicine (http://www.
ctmm.nl), project MARS (grant 04I-201).
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Introduction Programmed death-1 (PD-1) has been reported to be an 
immunoinhibitory receptor expressed by chronically stimulated T cells 
after T-cell activation. The present study was designed to evaluate the 
relationship between perioperative PD-1 expression on CD4+ T cells 
and the incidence of postoperative infectious complications in patients 
undergoing gastroenterological surgery.
Methods This was a prospective observational study. The subjects of 
this study included 101 patients with gastroenterological disease who 
underwent elective abdominal surgery via laparotomy at the National 
Defense Medical College Hospital. Blood samples were taken on the 
preoperative day (Pre) and the fi rst postoperative day (POD1). We 
calculated CD4+ T-cell count and PD-1 expression on CD4+ T cells by fl ow 
cytometer. The occurrence of postoperative infectious complications 
was defi ned according to a combination of clinical fi ndings and the 
results of laboratory and other tests. The postoperative infectious 
complications in this study included incisional surgical site infections 
(SSIs), organ/space SSIs, enterocolitis, urinary tract infections, and 
pneumonia. Incisional and organ/space SSIs were diagnosed according 
to the defi nitions stated in the guidelines issued by the Center for 
Disease Control and Prevention.
Results Postoperative infectious complications occurred in 30 of the 
101 patients. CD4+ T-cell count was signifi cantly lower in the patients 
who developed postoperative infectious complications at POD1 
compared with those from the patients who did not. In addition, PD-1 
expression on CD4+ T cells was signifi cantly higher at Pre or POD1 in 
patients who developed postoperative infectious complications. 
Those results were similar for the incidence of organ/space surgical 
site infection. Preoperative PD-1 expression on CD4+ T cells tended to 
be higher in males than in females. We found there was a signifi cant 
negative correlation between preoperative PD-1 expression on CD4+ T 
cells and CD4+ T-cell count.
Conclusion Perioperative CD4+ T-cell count or PD-1 expression on CD4+ 
T cells could be an early predictive marker for the development of 
postoperative infectious complications.
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Introduction Ischemia and mitochondrial dysfunction have been 
implicated in critical illness. The potential of MD to diagnose and 
separate ischemia and mitochondrial dysfunction in ICU patients 
remains currently unknown.
Methods A retrospective, observational study of 203 mechanically 
ventilated patients studied over a 6-year period with MD including 
medical, surgical and trauma patients. Sepsis stages: SIRS (n  = 24), 
severe sepsis (n = 46) and septic shock (n = 133). Median age 67 years 
(range: 17 to 92  years). Mortality was 53%. All subjects had a MD 
catheter placed in femoral adipose tissue upon admission to the 
ICU. Interstitial fl uid samples were collected six times per day, for 3 
consecutive days, and were analyzed for glucose, lactate, pyruvate, 
and glycerol levels. The lactate to pyruvate (LP) ratio was calculated. 
Blood lactate was measured. Ischemia was defi ned as LP ratio >30 and 
pyruvate level <70 mmol, while mitochondrial dysfunction was defi ned 
as LP ratio >30 and pyruvate >70 mmol.
Results Analysis during the course of the 3-day period revealed three 
distinct patterns: no ischemia/mitochondrial dysfunction (n  = 150 or 
74%), ischemia (n = 27 or 13%) and mitochondrial dysfunction (n = 26 
or 13%). On day 1, median blood lactate was higher in mitochondrial 
dysfunction (2.2  mmol/l) compared with both ischemia (1.3  mmol/l) 
and with no ischemia/mitochondrial dysfunction (1.3  mmol/l) 
(P = 0.004). Again on day 1, median interstitial fl uid lactate was higher 
in mitochondrial dysfunction (8.4 mmol/l), in comparison with ischemia 
(1.4  mmol/l) and with the group without ischemia/mitochondrial 
dysfunction (2.5 mmol/l) (P <0.001). Similar results were obtained with 
interstitial fl uid glycerol levels (P = 0.009). Median LP ratio was higher in 
ischemia (LP = 36), and mitochondrial dysfunction (LP = 33) compared 
with those without ischemia/mitochondrial dysfunction (LP  =  17) 
(P  <0.001). Median interstitial fl uid glucose was lower in ischemia 
(2 mmol/l) compared with both mitochondrial dysfunction (4 mmol/l) 
and with no ischemia/mitochondrial dysfunction (5 mmol/l) (P <0.001). 
ICU mortality was 77% in mitochondrial dysfunction, 52% in ischemia 
and 49% in the group without ischemia/mitochondrial dysfunction 
(P = 0.033).
Conclusion Bedside subcutaneous adipose tissue MD is possible 
to diagnose and separate ischemia and mitochondrial dysfunction 
in general ICU patients. These two conditions are not so common; 
however, mitochondrial dysfunction seems to be associated with 
higher mortality rates.
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Introduction Pyruvate dehydrogenase (PDH) is a key component of 
aerobic metabolism. Multiple rodent studies have shown that PDH 
levels are low in sepsis. This leads to a shift to anaerobic metabolism, 
resulting in increased lactic acid. Alteration in PDH levels during sepsis, 
however, has never been studied in humans. The aim of this study was 
to identify whether PDH levels (activity and quantity) were altered in 
humans in sepsis.
Methods We conducted a case–control study at a single urban 
tertiary care center. We compared PDH levels between sepsis and 
healthy control subjects by measuring PDH levels in peripheral blood 
mononuclear cells via a novel assay. We measured PDH levels in control 
subjects at baseline and in sepsis subjects at 0, 24, 48 and 72 hours.
Results There were 39 sepsis (age 67 ± 14 years, M ± SD) and 19 control 
(age 50 ± 12 years) subjects of similar gender (56% and 63% female, 
respectively) and race (79% and 68% Caucasian, respectively). PDH 
levels in the sepsis group were signifi cantly lower than the control 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S11
group at all time points (Figures  1 and 2). After controlling for age, 
gender, race, and assay plate via multivariable linear regression, the 
eff ect of treatment group remained signifi cant. We were unable to 
control for comorbid illness, which was exclusively concentrated in the 
sepsis group.
Conclusion PDH levels are signifi cantly lowered in humans during 
sepsis when compared with healthy controls, even when controlling 
for age, race and gender. Further research is needed to determine 
whether this fi nding persists after adjustment for comorbid disease, 
and whether lower PDH levels are associated with clinical outcomes.
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Introduction C1 inhibitor (C1INH), belonging to the superfamily of 
serine protease inhibitors, regulates not only complement system, 
but also the plasma kallikrein–kinin system, fi brinolytic system and 
coagulation system. The biologic activities of C1INH can be divided 
into the regulation of vascular permeability and anti-infl ammatory 
functions. In recent years, hereditary angioedema (HAE), caused 
by an inherited defi ciency of C1INH, has been focused. During HAE 
attacks, vascular permeability was markedly increased, which leads 
to angioedema. In sepsis, signifi cant endothelial hyperpermeability 
is similarly observed systemically, but the role of C1INH has not been 
clarifi ed in the pathogenesis. The serial change of C1INH in patients 
with sepsis is not clear. The objective of this study was to clarify the 
serial change in C1INH in patients with sepsis and evaluate the impact 
of C1INH on their clinical course.
Methods We serially examined C1INH activity values (normal range 70 
to 130%) and quantitative values (normal range 160 to 330 μg/ml) in 
patients with sepsis during the period between December 2012 and 
February 2013. We also analyzed their clinical course: prognosis, volume 
of infusion, body weight, urine volume, catecholamine administration, 
and steroid administration.
Results The serial change of C1INH was evaluated in fi ve patients with 
sepsis (three male and two female; four survivors and one nonsurvivor; 
mean age, 68  ±  11  years). In the nonsurvivor, C1INH activity on 
admission value was 97.2% (normal range), and quantitative value 
was 133.1  μg/ml (below normal). In the patient with severe sepsis 
requiring fl uid resuscitation, catecholamine and steroid administration 
to maintain hemodynamics, C1INH activity value on admission was 
94.4% (normal range), and quantitative value was 126.7 μg/ml (below 
normal range). His general condition was improved on day 6, and 
C1INH activity value and quantitative value increased (139.9%; above 
normal range, 250.1 μg/ml; normal range). In the other three patients 
with sepsis not requiring steroid administration, C1INH activity value 
on admission was 130.6 ± 8.7% (above normal range), and quantitative 
value was 215 ± 26.5 μg/ml (normal range).
Conclusion In the nonsurvivor or the severe patient with sepsis 
requiring steroid administration, the enhancement of C1INH activity 
was not observed, and the C1INH quantitative values were low. Further 
evaluation of the serial change of C1INH and the validity of C1INH 
replacement therapy in patients with septic shock may lead to a new 
strategy for management in sepsis.
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Introduction Sepsis is characterized by a strong systemic infl ammatory 
reaction. The pathogenesis is driven by alterations in the immune 
system and is associated with high neutrophil counts related to a 
specifi c delay in apoptosis [1]. The apolipoproteins L (ApoLs) family 
comprises six members in humans (ApoL1 to ApoL6). In light of their 
deregulated expression in several pathologies, they are likely to be 
important molecular players of programmed cell death [2]. We analyzed 
ApoL expression in cohorts of septic and nonseptic ICU patients and 
healthy volunteers in order to test whether ApoLs could be involved in 
the neutrophil apoptotic program.
Methods By means of magnetic cell sorting, peripheral neutrophils 
were purifi ed from 20 healthy volunteers and 40 ICU patients with (n = 
20) or without sepsis (n  = 20). ApoL expression was analyzed at the 
mRNA and protein levels by real-time PCR and western blot analysis 
respectively. Apoptosis of purifi ed neutrophils was assessed using 
fl ow cytometry following 4 and 24  hours of in vitro incubation. We 
monitored the expression of C-reactive protein (CRP), an infl ammatory 
marker, and its correlation with ApoL expression in PMNs was studied 
by linear regression analysis.
Results Our results showed a signifi cant downregulation in mRNA 
expression of ApoL1 (P <0.0001), ApoL2 (P = 0.0009), ApoL3 (P <0.0001) 
Figure 1 (abstract P33).
Figure 2 (abstract P33).
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and ApoL6 (P = 0.0003) in purifi ed PMNs from ICU patients as compared 
with the healthy individuals. This downregulation was also validated at 
the protein level for ApoL1 and ApoL2, whereas ApoL 6 was upregulated 
in septic patients. We could not detect ApoL3 protein in any of the 
cohorts. This was accompanied by a signifi cant delay in PMN apoptosis 
in septic patients as compared with healthy volunteers (P <0.05) at 4 
and 24 hours. We also showed a strong negative correlation in the three 
mixed groups between CRP and ApoL1 (R = –0.607), ApoL2 (R = –0.651), 
ApoL3 (R = –0.578) and ApoL6 (R = –0.506).
Conclusion The altered apoptotic fate of neutrophils in sepsis was 
correlated with the modifi cation of the expression profi le of ApoLs, a 
family of proteins thought to be involved in the apoptotic process. The 
role of these proteins in the sepsis-associated phenotype of neutrophils 
remains to be further elucidated.
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Introduction The primary aim of this study was to determine the 
diff erences in ex vivo generation of neutrophil extracellular traps (NETs) 
by neutrophils from septic and nonseptic patients. We further sought 
to examine plasma levels of cell-free DNA (cf-DNA) and histones to 
assess in vivo NET formation.
Methods We isolated neutrophils from consecutive patients with sepsis 
(n = 17) and without sepsis (n = 18) admitted to the ICU. Neutrophils 
were activated by incubation with phorbol myristate acetate to induce 
release of NETs and NET formation was assessed by measuring the 
extracellular DNA level. Immunolabeling and fl uorescence imaging 
were also performed. Extracellular killing of bacteria by NETs was 
studied by co-culture of Escherichia coli and neutrophils in the presence 
of the phagocytosis inhibitor cytochalasin D. To assess in vivo NET 
formation, plasma levels of cf-DNA and histones were measured.
Results The condition of the nonseptic patients was signifi cantly less 
severe than that of the septic patients. The SOFA score of septic patients 
and the nonseptic patients was 6 (3 to 18) and 2.5 (1 to 8), respectively 
(median (IQR), P  =  0.02). The overall mortality rate was 29%. After 
stimulation with PMA, neutrophils isolated from septic patients released 
4.08 ± 1.02% of their total DNA, whereas neutrophils from nonseptic 
patients released 29.06  ±  2.94% (P  <0.0001). Immunofl uorescent 
staining of released DNA, elastase, and myeloperoxidase also revealed 
similar results. Neutrophils from nonseptic patients showed eff ective 
extracellular killing of E. coli through NETs, whereas neutrophils from 
septic patients did not (P <0.001). Plasma levels of cf-DNA and histones 
were higher in septic patients than in nonseptic patients (P <0.001).
Conclusion The increase of the immature PMN count and immature/
total PMN ratio confi rmed recruitment of immature neutrophils from 
the bone marrow into the circulation. The ex vivo generation of NETs 
is downregulated in neutrophils isolated from patients with sepsis. 
However, it is unclear whether in vivo NET formation is also impaired 
during sepsis, so further investigation is necessary.
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Introduction The infl ammatory response of sepsis is developed in two 
phases, an infl ammatory phase (SIRS) and a phase more variable in 
frequency and intensity (CARS): this balance has an important eff ect on 
morbidity and mortality. Lymphopenia aff ects particularly T cells, and 
correlates inversely with outcome. The aim of the study was to identify 
phenotypic and functional early markers of T cells and NK cells related 
to prognosis in the septic patient population.
Methods We collected peripheral blood mononuclear cells from 
47 patients with severe sepsis or septic shock at ICU admission 
(T0) and from 50 healthy controls. On these subjects we evaluated 
frequency and absolute numbers of CD4+ and CD8+ T cells and of NK 
and B lymphocytes, the rates of regulatory CD4+CD25+Foxp3+ T cells 
(Tregs), the cytotoxic potential of CD4+, CD8+ T cells and of NK cells 
by evaluation of perforin (PER) and granzyme (GRA) expression and 
production of eff ector cytokines (namely IL-2, IL-17, IL-4, TNFα, IFNγ) 
by CD4+, CD8+ T cells and NK cells upon polyclonal stimulation. The 
markers were compared in patients with diff erent outcome.
Results Septic patients, compared with healthy donors, were 
characterized by global lymphopenia; we found increased frequencies 
of CD4+ T cells producing IL-2 (P = 0.0000000003), increased percentage 
of CD8 T cells producing IFNγ (P  =  0.03), and reduced proportion of 
CD4+ T cells (P = 0.00007) and NK cells (P = 0.002) producing IFNγ. We 
also noticed an increased frequency of CD8+ T cells expressing PER 
(P = 0.00000025) and GRA (P = 0.01); moreover, the proportion of NK 
cells expressing GRA was also signifi cantly increased (P  =  0.000019). 
To establish the prognostic value of these biological markers, we 
compared the cytokine expression by lymphocytes in septic patients 
that survived with those that died (D). We found that CD4+ and CD8+ 
TNFα-producing T cells were signifi cantly increased in D (P  =  0.01 
and P = 0.0001 respectively); similarly the percentage of CD8+ T cells 
producing IFNγ was more elevated in D (P  =  0.006). The same was 
observed for IL-17 production by CD4+ T cells (P = 0.03) in D. On the 
contrary we observed a tendency to the reduction of circulating 
CD4+CD25+foxp3 (Tregs) in D (P = 0.08).
Conclusion Septic patients are characterized by a peculiar 
immunophenotype which includes global lymphopenia and a 
specifi c pattern of cytokines. Some of the evaluated markers seem to 
individuate those with worse outcome; in particular, this group showed 
an infl ammatory phenotype with a higher expression of IFNγ, TNFα, IL-
17 and a tendency to a reduction of Tregs.
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Introduction Critically ill patients show signs of immune suppression, 
which is considered to increase vulnerability to nosocomial infections. 
Whole blood stimulation is a frequently used functional test for immune 
suppression. We here aimed to assess the association between whole 
blood leukocyte responsiveness to lipopolysaccharide (LPS) and the 
subsequent occurrence of nosocomial infections in critically ill patients 
admitted to the ICU.
Methods All consecutive critically ill patients admitted to the ICU 
between April 2012 and June 2013 with two or more systemic 
infl ammatory response syndrome criteria and an expected length 
of ICU stay of more than 24  hours were enrolled. Age-matched and 
gender-matched healthy individuals were included as controls. Blood 
was drawn the fi rst morning after ICU admission and stimulated ex vivo 
with 100 ng/ml ultrapure LPS for 3 hours. Tumor necrosis factor (TNF)α, 
interleukin (IL)-1β and IL-6 were measured in supernatants.
Results Seventy-three critically ill patients were included, 10 of whom 
developed an ICU-acquired infection. Compared with healthy subjects, 
whole blood leukocytes of patients were less responsive to ex vivo 
stimulation with LPS, as refl ected by strongly reduced TNFα, IL-1β and 
IL-6 levels in culture supernatants. However, results were not diff erent 
between patients who did and those who did not develop an ICU-
acquired infection (Figure 1).
Conclusion The extent of reduced LPS responsiveness of blood 
leukocytes in critically ill patients on the fi rst day after ICU admission 
does not relate to the subsequent development of ICU-acquired 
infections.
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Introduction The endothelium is a complex organ infl uenced by 
circulating mediators, adjacent cells, physico-chemical factors, and 
shear stress. During systemic infl ammation and sepsis, excessive and 
sustained activation of the endothelium result in the loss of its anti-
coagulant and anti-adhesive characteristics as well as in a loss of 
endothelial barrier function. We set up a cell-culture model to study 
endothelial activation induced by lipopolysaccharide (LPS) or by 
plasma from septic patients and studied the eff ect of adsorbent-based 
mediator modulation on endothelial activation.
Methods Human whole blood was stimulated with LPS (100 ng/
ml) from Escherichia coli for 4 hours. The stimulated blood or plasma 
from septic patients was treated in vitro with 10 vol% polystyrene–
divinylbenzene (PS-DVB)-based polymers (CG161, mean pore size 16 
nm; CG300, mean pore size 30 nm) or left untreated. After adsorption, 
the plasma was separated and diluted with cell culture medium. The 
resulting conditioned medium was used to stimulate human umbilical 
vein endothelial cells (HUVEC) for 16  hours. HUVEC activation was 
assessed by the release of interleukin (IL)-1β, IL-6, IL-8, IL-10, and 
tumor necrosis factor (TNF)α, plasminogen activator inhibitor-1 (PAI-
1), as well as the expression of intercellular adhesion molecule (ICAM)-
1 and E-selectin. HUVEC were cultured at a shear stress of 5 dyne/
cm2 using the Ibidi perfusion system. Adhesion of monocytic THP-1 
cells to HUVEC was studied after 4  hours of HUVEC stimulation with 
conditioned media. THP-1 cells were perfused over HUVEC at 1 dyne/
cm2 for 15 minutes, and adhering THP-1 were quantifi ed over time.
Results The adsorbents CG161 and CG300 substantially decreased 
levels of TNFα, IL-1β, IL-6, IL-8 and IL-10 in LPS-stimulated blood. 
TNFα, a key stimulus for HUVEC, was reduced to 12% and 8% of the 
initial concentration by CG161 and CG300, respectively. Stimulation 
of HUVEC with the adsorbent-treated plasma resulted in signifi cantly 
diminished release of IL-6, IL-8, PAI-1 and decreased ICAM-1 and 
E-selectin expression, indicating reduced HUVEC activation. THP-1 
adhesion was substantially decreased when HUVEC were stimulated 
with CG300-treated plasma as compared with untreated controls.
Conclusion The fl ow model allows to study the eff ect of cytokine 
modulation on endothelial activation and to assess the interaction of 
activated endothelial cells with blood cells. Modulation of infl ammatory 
mediators with porous polystyrene-based polymers attenuates 
endothelial activation and reduces monocyte adhesion.
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Introduction Extracellular heat shock proteins (HSP) act as inducers 
of interleukins (IL) and stimulants for immune cells during systemic 
infl ammatory response syndrome (SIRS). Little is known about the 
alarming roles of extracellular HSP72 and HSP90α in the acute phase [1] 
of sepsis (S) or severe sepsis (SS). We determined serum HSP90α, HSP72 
and neutrophil CD64 expression, IL-6, IL-8, IL-10, and TNFα in children 
with S or SS compared with SIRS (brain injury) or healthy children (H).
Methods Critically ill children with S (n = 16), SS (n = 15) or SIRS (n = 18) 
and H (n = 21) were enrolled in the study. ELISA was used to evaluate 
HSPs, chemiluminescence to measure ILs, and fl ow cytometry to 
evaluate nCD64 expression (IRB approved).
Results Patients in both septic groups had elevated HSP90α (P <0.0001), 
HSP72 (P  <0.05), IL-6 (P  <0.0001), IL-8 (P  <0.02) and IL-10 (P  <0.05) 
levels compared with H, whereas SS had increased HSP72, IL6 and 
TNFα compared with SIRS (P <0.05). SIRS patients presented increased 
HSP90α, IL-6 and IL-8 compared with H (P  <0.05). Both HSPs were 
dramatically increased among nonsurvivors. In a logistic regression 
model, only HSP90α was independently associated with mortality 
(P <0.0001). HSP90α related positively (P <0.001) to nCD64, IL-8, IL-10, 
CRP, PRISM, PELOD, TISS, and LOS and negatively to HDL (P <0.001) and 
LDL (P <0.02). HSP72 also related negatively to HDL (P <0.001).
Conclusion Extracellular HSP72 and HSP90α are alarmingly elevated 
in critically ill children, especially in severe sepsis. HSP90α levels are 
independently associated with mortality, related to CD64, IL-8, IL-10, 
severity of illness, and outcome. Both HSPs are inversely related to the 
low LDL/low HDL septic metabolic pattern [2].
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Figure 1 (abstract P38). Similarly reduced responsiveness of whole blood leukocytes to lipopolysaccharide.
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Introduction Heat shock proteins (HSPs) have intracellular cyto pro tec-
tive actions, while they act extracellularly as inducers of cytokines and 
stimulants for immune cells during stress. Their induction constitutes 
a highly conserved cellular defense mechanism against all kinds of 
stress. Our objective was to determine the intracellular as well as 
extracellular levels of HSP72 and HSP90α in patients with severe sepsis 
(SS) or systemic infl ammatory response syndrome (SIRS) admitted to a 
general ICU, compared with those of healthy individuals; to correlate 
their expression with severity of illness.
Methods Eighty-two consecutively admitted patients in the ICU (35 
SIRS, 47 SS) as well as 35 healthy controls (H) were fi nally enrolled in the 
study. Patients’ demographic characteristics, laboratory examinations 
and Acute Physiology and Chronic Health Evaluation (APACHE II) score 
were recorded on admission. HSP levels were determined intracellularly 
using four-color fl ow cytometry. Mean fl uorescence intensity (MFI) 
values for each HSP were measured and analyzed. Extracellular levels 
of HSPs were determined via ELISA.
Results HSP expression diff ered signifi cantly between groups 
(Kruskal–Wallis), both intracellularly (HSP72 lower in SS, P  <0.001), 
and extracellularly (higher levels of HSP90α (P  <0.001) and HSP72 
(P  =  0.003) in SS). HSP72 and HSP90α intracellular expression was 
inversely correlated to severity of illness, as expressed by APACHE II 
score (Spearman’s, P = 0.003 and P = 0.025 respectively). Intracellular 
HSP72 was correlated to mortality when confounding factors were 
excluded from the analysis (logistic regression, P = 0.05). Extracellular 
HSP90α levels correlated with prolonged PT (P  =  0.021) and INR 
(P = 0.008). Finally, in the SIRS group, intracellular levels of HSP90α were 
higher in nonsurvivors (P <0.001).
Conclusion SS is characterized by high levels of extracellular HSPs. 
Intracellular HSP72 is highly expressed during the acute phase of 
stress in SIRS, while being downregulated in SS. HSP72 and HSP90α 
intracellular expression and extracellular level variations correlate with 
severity of illness and mortality.
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Introduction CD14/HLADR is an index of immune suppression. Heat 
shock proteins (hsp) regulate cell response to oxidative stress. We 
evaluated the relationship of CD14/HLADR and hsp70/90 in patients 
with SIRS and severe sepsis versus healthy volunteers.
Methods We evaluated 31 patients with SIRS or severe sepsis against 
a group of sex-matched healthy volunteers. Demographic data were 
obtained for all patients. APACHE score was calculated upon admission. 
Blood samples were collected upon diagnosis of SIRS or severe sepsis. 
To evaluate the %HLA-DR expression on monocytes, the fresh whole 
blood was stained with anti-CD14-FITC, anti-HLA-DR-PE and CD45-
PC5 while staining with anti-CD33-PE, anti-CD45-PC7, anti-hsp70-FITC 
and anti-hsp90-PE allowed evaluation of the MFI expression of hsps 
on CD33+ monocytes. Cells were then analyzed using fl ow cytometry. 
ANOVA with post hoc tests was used to compare CD14/HLADR cell 
counts and hsp70 and hsp90 levels among the three groups.
Results Nineteen controls, six SIRS patients and 25 severe sepsis 
patients were studied. The percent expression of HLADR on CD14+ 
monocytes was signifi cantly diff erent between the three groups 
showing progressive decrease from controls (mean 90.5  ±  3.8%) to 
SIRS (mean 61.2 ± 5.9%) to severe sepsis (mean 39.2 ± 5.5%) patients 
(controls vs. severe sepsis, P  <0.001; controls vs. SIRS, P  =  0.006; SIRS 
vs. severe sepsis, P  =  0.03). hsp70 and hsp90 MFI were signifi cantly 
diff erent between controls (mean 49.5 ± 4.9 and 33.5 ± 3.4 respectively), 
SIRS (mean 69.9 ± 16.5 and 46.5 ± 5.7 respectively) and severe sepsis 
patients (mean 33.3  ±  4.5 and 21.7  ±  2.7 respectively) (P  <0.05 for 
all comparisons). Notably, the hsp level rose from controls to SIRS 
and fell from SIRS to severe sepsis patients. APACHE score increased 
signifi cantly (P = 0.023) in septic patients compared with SIRS.
Conclusion There were a signifi cant diff erence in CD14/HLADR, a 
marker of immune paralysis, between controls and patients with 
SIRS or severe sepsis. hsp70 and hsp90 showed an initial stimulation 
followed by exhaustion as sepsis progressed.
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Introduction Rethinking the host’s defense mechanisms during severe 
infection has led to the use of fl ow cytometry (FCM) and to the current 
concept of sepsis-induced immunosuppression. However, organ 
dysfunctions that develop in the period preceding severe sepsis as a 
consequence of surgery, trauma or burn might also trigger immune 
reprogramming predisposing to overwhelming infection. Our aim was 
to look for correlation of specifi c phenotypes among four commonly 
encountered populations of patients and the later occurrence of severe 
sepsis and septic shock.
Methods In total, 114 non-infected patients were prospectively 
screened via FCM on days 1 (T1) and 3 (T2) of elective cardiac 
surgery, trauma, acute neurologic dysfunction and prolonged 
ventilation (>48 hours). A third sample was drawn when infection was 
diagnosed (Tx) and 7  days later (Tx  + 7). Exclusion criteria included 
use of immunosuppressive agent(s). The broad panel of cell-specifi c 
antibodies focused on B, T lymphocytes (Tregs, Th17, NKT), NK cells, 
monocytes and neutrophils. Plasmatic levels of IL-2/IL-6/IL-7/TNFα/
IFNγ were also determined.
Results Ninety-nine patients were included in the fi nal analysis. 
Eighteen patients developed severe sepsis or septic shock. They 
presented with signifi cantly higher levels of intermediate (CD14++/16+) 
and CD62L– monocytes and lower IL-2 levels at T1 compared with 
patients who did not get septic. ROC AUC for association of these 
parameters with the occurrence of sepsis were 0.78 (95% CI: 0.63 
to 0.91), 0.72 (0.62 to 0.82) and 0.73 (0.65 to 0.82), respectively. High 
counts of these monocytic cells were also associated with increased 90-
day mortality (P <0.01, ROC AUC = 0.87 (0.77 to 0.95), 0.79 (0.66 to 0.9)). 
Kaplan–Meier survival curves showed signifi cantly higher mortality 
after stratifi cation based on these cell counts at T1 (CD14++CD16+: cutoff  
>236.8 cells/μl, HR = 23.6 (P = 1.24 × 10–5); CD62L–: cutoff  >95.4 cells/μl, 
HR = 6.67 (P = 7.6 × 10–4)). Multivariate logistic regression analysis using 
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clinical scores indicated that addition of IL-2 levels at T1 signifi cantly 
improved prediction of sepsis (OR = 0.834, P = 0.02).
Conclusion Predisposition to sepsis in selected critically ill medico-
surgical adults can be identifi ed on day 1 of admission based on high 
counts of circulating intermediate and CD62L– monocytes and low 
levels of IL-2 (the latter provide incremental prognostic information). 
High counts of these specifi c monocytes correlate with higher 90-day 
mortality.
P44
Macrophage phenotype in sepsis immunosuppression
E Theodorakis, E Diamantaki, C Tsatsanis, D Georgopoulos, K Vaporidi
University of Crete, School of Medicine, Heraklion, Greece
Critical Care 2015, 19(Suppl 1):P44 (doi: 10.1186/cc14124)
Introduction Sepsis is followed by profound, yet poorly characterized, 
innate immune system suppression. While low monocyte HLA-DR 
expression is observed in septic patients, its clinical signifi cance has not 
been established [1]. In vitro, repeated LPS stimulation induces a tolerant 
or M2 macrophage phenotype, characterized by decreased cytokine 
production [2], which could contribute to sepsis immunosuppression. 
The present study examines macrophage phenotype in a mouse model 
and in patients with sepsis immunosuppression.
Methods Sepsis was induced in C57Bl6 mice by cecal ligation and 
puncture (CLP) followed by intratracheal instillation of Pseudomonas 
aeruginosa. Bronchoalveolar lavage fl uid (BALF), cells and serum, 
collected 12 hours after lung infection, were analyzed for bacterial load, 
cytokine levels and the classical M1 marker, iNOS. Peripheral blood 
monocytes isolated from septic adult patients admitted to the ICU on 
the 1st and 7th day after admission were analyzed by fl ow cytometry 
for the expression of HLA-DR and CD86 (co-stimulatory molecule and 
M1 marker), and for the M2 markers, CD163 and CD206. Additional 
blood samples from patients and healthy volunteers were exposed ex 
vivo to LPS prior to isolation and analysis of monocyte markers.
Results CLP-induced sepsis resulted in immunosuppression in mice, 
indicated by higher BALF bacterial load after infection in CLP than 
in sham-operated mice, and more severe injury on histology. Serum 
cytokines TNF and MIP2 were greater in CLP than in sham-operated 
mice. Although recruitment of CD11c+ alveolar macrophages post 
infection was threefold greater in CLP than in sham-operated mice, 
those macrophages expressed 40% lower levels of iNOS. Evidence of 
sepsis immunosuppression was present in most patients on the 7th 
day after ICU admission. Low expression of CD86 and/or HLA-DR was 
observed in 71% of patients, and increased expression of M2 markers 
in 15% of patients. Upon LPS stimulation the normal decrease in M2 
markers was absent in all patients on day 1, and partially restored in 
50% of patients on day 7.
Conclusion Sepsis is associated with decreased monocyte expression 
of M1 markers and increased expression of M2 markers in septic mice 
and critically ill patients. Therefore, in addition to decreased HLA-DR 
expression, M2 macrophage polarization appears to be a component 
of sepsis-induced monocyte dysfunction, and should be considered for 
immune monitoring and targeted intervention.
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Introduction Decreased monocyte surface HLA-DR (mHLA-DR) 
measured by fl ow cytometry (FCM) is an independent marker of 
immunosuppression in sepsis. In a previous report we demonstrated 
that septic patients display a strong correlation between mHLA-DR 
and mRNA-levels of HLA-DRA in whole blood [1]. mRNA-based HLA-
DR monitoring by PCR would improve the clinical usage and facilitate 
conduction of multicentre studies. The primary focus in this study 
was to evaluate the correlation between mHLA-DR and HLA-DRA 
at diff erent time points during sepsis. In addition, we assessed the 
dynamic expression of both mHLA-DR and HLA-DRA, in relation to 
sepsis severity.
Methods Study patients (n  = 54) were included at day 1 to 2 after 
hospital admission if blood cultures turned positive. Repeated 
sampling at days 1 to 2, 3, 7, 14 and 28 was performed. mHLA-DR was 
monitored by FCM and HLA-DRA by quantitative RT-PCR. Mixed models 
for longitudinal data were used after logarithmic transformation to 
calculate the interactional eff ects of time and severity on HLA-DR 
expression.
Figure 1 (abstract P45). Box plots of mHLA-DR, measured by fl ow 
cytometry.
Figure 2 (abstract P45). Box plots of HLA-DRA, measured by qRT-PCR.
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Results Correlation between mHLA-DR(FCM) and HLA-DRA(PCR) at day 
1 to 2 (R = 0.78) and day 14 (R = 0.27). Both HLA-DR markers increased 
linearly on a log scale over time. The linear association was signifi cantly 
diff erent between the severe (n  = 16) and nonsevere septic patients 
(n = 38) when measuring either mHLA-DR(FCM) or HLA-DRA(PCR). By 
pairwise comparison of means between the two severity groups, at 
every time point, the diff erences between groups were shown to be 
signifi cant at days 1 to 2 and 3 when monitoring mHLA-DR(FCM) and at 
days 1 to 2, 3 and 7 for HLA-DRA(PCR) (Figures 1 and 2).
Conclusion The correlation between fl ow cytometry and PCR-based 
HLA-DR monitoring is stronger in the early phase of sepsis. However, the 
linear associations over time, in relation to sepsis severity, display similar 
results for both HLA-DR markers. HLA-DRA(PCR) as a biomarker could be 
an alternative approach in monitoring immune status in sepsis but needs 
to be evaluated in relation to clinically relevant immunosuppression.
Reference
1. Cajander S, et al. Crit Care. 2013;17:R223.
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Introduction The aim of the present study was to evaluate the 
prognostic value of HLA-DR antigen expression in monocytes, in 
patients with community-acquired infections presenting with fever, as 
possible markers for the patients’ fi nal outcome.
Methods A total of 81 patients (males = 46; females = 35) presenting 
with fever >38°C to the emergency room (ER) of the Department of 
Internal Medicine of the Patras University Hospital were enrolled in 
the study during a period of 12 months. Sera for monocyte HLA-DR 
expression were obtained from the patients on admission (day 1) and 
on days 3, 7 or discharge/death. Results were expressed as percentages 
of HLA-DR-positive monocytes, calculated by the coexpression of 
CD14 and HLA-DR antigens in the total CD14+ population. Additionally, 
the patients were evaluated using the Simplifi ed Acute Physiology 
Score (SAPS-II), the Sequential Organ Failure Assessment (SOFA) and 
the Mortality in Emergency Department Sepsis (MEDS) score on the 
same days while all the indicated clinical, laboratory and imaging 
procedures as required for fever’s diff erential diagnosis were followed. 
A questionnaire regarding demographic characteristics, comorbidities, 
medications used and patients’ survival was also completed. All 
statistical analyses were performed using SPSS v.21.
Results Lower mean HLA-DR monocyte antigen expression percen-
tages were signifi cantly correlated to lower Glasgow Scale scores 
on all days of measurement. HLA-DR expression was signifi cantly 
negatively correlated to MEDS, SOFA and SAPS-II scores whereas 
patients who developed sepsis, severe sepsis, septic shock and MODS 
had signifi cantly lower HLA-DR values compared with the ones who 
did not. HLA-DR expression on day 1 was lower in patients who would 
develop SIRS and/or sepsis on days 3 and 7 (P <0.01). Additionally, HLA-
DR expression was signifi cantly decreased in nonsurvivors (n  = 33) 
compared with survivors (n  = 48), whereas lower HLA-DR expression 
was correlated to longest duration of hospital stay at all time points 
(P <0.01).
Conclusion Monocyte HLA-DR appears to be an early indicator for 
survival and infection progression and therefore it can be used as a 
predictive marker for the fi nal outcome of patients presenting in ER 
departments with fever.
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Introduction The idea of using the eosinophil count (EC) as a diagnostic 
marker for clarifying the nature of systemic infl ammatory response 
syndrome (SIRS) belongs to K Abidi, who showed that EC could be 
used as a diagnostic criterion of sepsis. There are no published data 
to defi ne the role of dynamic control of EC in the process of intensive 
therapy as a prognostic marker and indicator of severity condition in 
critically ill patients. The aim was to determine the informative value of 
EC in the development of SIRS as a biomarker of sepsis and indicator of 
the severity condition and prognosis of outcome in the pathological 
process.
Methods A total of 143 patients were enrolled in this study who were 
admitted to the ICU and had SIRS. All patients were divided into a septic 
group  – patients with community-acquired pneumonia, complicated 
by sepsis – and two SIRS groups of noninfectious genesis – patients who 
had an acute cerebrovascular accident (CVA) and an acute myocardial 
infarction (AMI). The absolute EC was measured at admission and in the 
dynamics on days 3 to 5 of stay.
Results The median EC was 75 cells/mm3 in septic patients on admission, 
which was signifi cantly lower than in patients with CVA (120 cells/mm3) 
and AMI (130 cells/mm3). Comparison of EC in septic patients between 
survivors and those who died showed signifi cant diff erences (Table 1). 
Receiver operating characteristic (ROC) analysis determined a value 
less than 80 cells/mm3 as the optimal diagnostic cutoff  value with a 
high level of confi dence in the comparison of septic and noninfectious 
groups. Area under the ROC curves was 0.94, sensitivity of 80.8%, 
specifi city of 95.6%, P <0.0001. There was a signifi cant increase of EC in 
survivors, while the EC did not change signifi cantly among those who 
died in the dynamics. ROC analysis determined the cutoff  values of EC, 
which indicated a high risk of an adverse outcome in septic patients 
(Table 2).
Table 1 (abstract P47). Dynamics of eosinophil count depending on outcome 
in groups
 EC (cells/mm3) at EC (cells/mm3) on the
 admission 3rd to 5th days
Group Survivors Died P value Survivors Died P value
Sepsis 100 50 0.006 240 70 0.0004
CVA 120 115 0.74 150 90 0.001
AMI 145 120 0.60 195 120 0.017
Table 2 (abstract P47). Informational value of eosinophil count in 
assessment of disease outcome
   Cutoff  (EC,  Sensitivity Specifi city 
Day/group AUC cells/mm3) (%) (%) P value
At admission 
 Sepsis 0.83 ≤220 100 61.5 0.0001
 CVA 0.53 ≤150 78.3 37.5 0.743
 AMI 0.56 ≤190 85.7 35.7 0.6136
On the 3rd to 5th days
 Sepsis 0.91 ≤120 92.3 69.2 <0.0001
 CVA 0.81 ≤140 91.3 68.8 <0.0001
 AMI 0.75 ≤90 92.9 46.7 0.0052
Conclusion EC may be an additional diagnostic marker which 
characterizes the nature of SIRS. Eosinopenia associated with prognosis 
of outcome in critical conditions.
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Introduction The endotoxin activity (EA) assay is a useful test to risk 
stratify critically ill patients and assess for Gram-negative (GN) infection. 
However, the prevalence and signifi cance of early high levels of EA in 
patients with septic shock (SS) has yet to be elucidated.
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Methods We designed a prospective observational study including 
adult patients with clinically diagnosed SS. EA was measured on 
arterial blood by a chemiluminescent assay within the fi rst 24  hours 
from SS diagnosis. The fi nding of an EA value ≥0.6 was used as the 
cutoff  for test positivity, as described elsewhere. In addition, laboratory, 
microbiological and clinical data were collected at inclusion. In-hospital 
follow-up was also conducted.
Results A total of 107 consecutive patients were included. The overall 
median EA was 0.56 (0.44 to 0.71), with 46/107 (43%) patients testing 
positive for elevated EA (≥0.6). GN species were identifi ed in microbial 
cultures as the infective etiology in 49/107 (46%) patients, of which 
28 (57%) developed bacteremia. GN infections were associated with 
higher levels of EA compared with other microbial causatives (0.61 
(0.52 to 0.77) vs. 0.52 (0.38 to 0.64), P = 0.021). Patients with EA ≥0.6 
showed signifi cantly higher lactate levels (2 (1 to 3) vs. 3.8 (1.7 to 
6.4), P = 0.01), Sequential Organ Failure Assessment (9 (6 to 12) vs. 10 
(8 to 14), P = 0.04) and inotropic score (20 (5 to 50) vs. 50 (16 to 100), 
P = 0.003) at inclusion. See Figure 1.
Conclusion Elevated EA is a common fi nding in SS patients. In patients 
developing SS from a GN infection, higher levels of endotoxin activity 
could be measured within 24  hours. Furthermore, in our study, EA 
≥0.6 identifi ed a subgroup of subjects at greater risk for worse clinical 
outcomes. We therefore propose use of the EA assay for the early 
identifi cation and risk stratifi cation of SS patients.
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Introduction The purpose of this study was to evaluate the diagnostic 
and prognostic value of the endotoxin activity assay (EAA) of sepsis in 
patients with systemic infl ammatory response syndrome (SIRS) and 
organ failure in ICU setting.
Methods In total, 76 patients with SIRS and organ failure or who were 
suspected of sepsis during critical care were included. According 
to the levels of EAA, all patients were classifi ed into three groups 
(group L, EAA <0.4; group M, EAA ≥0.4 or EAA <0.6; group H, EAA ≥0.6). 
In order to evaluate the severity of illness, the Acute Physiology and 
Chronic Health Evaluation II (APACHE II) score, Sequential Organ Failure 
Assessment (SOFA) score and catecholamine (CA) index were recorded. 
Blood samples were obtained to measure EAA levels, infl ammatory 
markers (procalcitonin, C-reactive protein and white blood cells), 
serum lactate level as an indicator of tissue hypoxia, and for blood 
culture. All patients were followed up for 6 months. APACHE II score, 
SOFA score, CA index, infl ammatory markers, serum lactate levels and 
blood culture results were examined for diagnosis of sepsis, severe 
sepsis, septic shock and for prognosis of 30-day mortality. Each value 
was also compared with EAA levels.
Results Patient age was 69 ± 9.9 years (male: n = 48, female: n = 25). 
The total number of samples was 106 (group L/group M/group H: 
35/35/36). Twenty-seven specimens were obtained from nonseptic 
patients and 83 specimens were obtained from septic patients. 
APACHE II score was highly correlated with SOFA score (P  <0.05). In 
group H, the APACHE II score was signifi cantly higher (22.2 ± 0.8) than 
that in group M (18.4 ± 0.87) (P = 0.01). The SOFA score in group H was 
signifi cantly higher (9.9  ±  0.5) than that in group M (7.5  ±  0.6) and 
group L (7.9 ± 0.6) (P = 0.006). EAA levels were signifi cantly increased 
in septic patients (septic patients: 0.56 ±0.03, nonseptic patients: 0.42 
±0.05) (P  =  0.011) and in the positive blood culture group (positive 
group: 0.66 ± 0.05, negative group: 0.48 ± 0.03) (P = 0.006). There was 
no relationship between EAA levels and other infl ammation markers or 
30-day mortality.
Conclusion In patients with suspected sepsis and positive blood culture, 
EAA levels were signifi cantly increased and had strong correlation with 
severity of disease. This result suggests that EAA indicates the state of 
sepsis regardless of the possibility of infection in patients with SIRS 
with organ failure.
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Introduction Sepsis is a common reason for admission to ICUs 
throughout the world. During the past two decades, the incidence 
of sepsis in the USA has tripled and is now the 10th leading cause 
of death. As sepsis continues to impact negatively on critically ill 
patients, it is clear that early diagnosis and eff ective management 
could improve patient morbidity and mortality. Numerous studies 
have attempted to examine biomarkers and their ability to diagnose 
and prognosticate septic patients. Despite multiple eff orts, currently 
there are no reliable markers that can eff ectively improve our clinical 
eff ectiveness in diagnosing and managing septic patients. The purpose 
of our systematic review was to evaluate the diagnostic and prognostic 
value of various biomarkers used in septic patients.
Methods A systematic search of the literature was performed with 
MEDLINE, EMBASE, and the Cochrane Central Register of Controlled 
Trials databases using terminology selected for biomarkers (through 
to and including November 2013). All articles involving neonates 
and not in English were excluded. Inclusion was agreed on by two 
independent reviewers of abstracts or full text. Assessment was based 
on the biomarker’s ability to diagnose septic patients and its ability to 
predict mortality.
Results Of 5,257 articles identifi ed, all abstracts were screened, and 
750 full-text articles were selected for review. These included primarily 
randomized controlled trials, cohort studies and postmortem studies. 
Of 49 biomarkers examined, 72% of the studies examined procalcitonin. 
Comparing the serum of septic patients with that of controls, most 
biomarkers were elevated in septic patients, even though only a few 
had high sensitivity (>85%) and high specifi city (>80%). It was often 
Figure 1 (abstract P48).
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diffi  cult to compare study group with control group as the control 
group patients were usually not healthy controls.
Conclusion Overall the heterogeneity of studies, small sample size 
and the lack of true healthy controls infl uenced the ability to use the 
biomarker for prognostication of a septic patient. Furthermore, the lack 
of healthy control raises the question of redefi ning selection criteria in 
order to better study septic patients.
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Introduction The aim of this study was to investigate the laboratory 
parameters as an indicator of sepsis. Sepsis is one of the most common 
reasons of mortality and morbidity in the ICU [1]. Thus, it is important to 
distinguish sepsis from nonsepsis SIRS. CRP and hemogram parameters 
may be fast, easy and aff ordable alternatives in distinguishing sepsis 
from nonsepsis SIRS. Eosinophil count (EoC), lymphocyte count (LymC) 
and neutrophil–lymphocyte count ratio (NLCR) are used as sepsis 
indicators [1,2].
Methods A total of 2,777 patients admitted to the ICU of two centers 
between 2006 and 2013 were evaluated retrospectively. The patients 
were diagnosed as SIRS(–), nonsepsis SIRS or sepsis at ICU admission 
by the consensus of two doctors in accordance with 1992 sepsis 
guidelines [3]. The patients who were under 18 years old, readmitted, 
immunosuppressive, SIRS(–) and whose laboratory values and 
outcomes were unknown were excluded. In total, 1,302 patients were 
divided into two groups as the nonsepsis SIRS group and the sepsis 
group. The patient’s age, gender, diagnoses (medical, elective and 
urgent surgery), APACHE II, SOFA, CRP, WBC, neutrophil count (NeuC), 
LymC, NLCR, EoC, platelet, mean platelet volume, length of ICU stay and 
mortality were recorded by a third doctor. In the fully adjusted model, 
WBC, CRP, LymC, NeuC, NLCR and EoC were entered into the model.
Results A total of 1,302 patients were categorized as nonsepsis SIRS 
(816, 62.7%) and sepsis (486, 37.3%). In the sepsis group, age, APACHE 
II, SOFA, mortality, length of ICU stay, CRP, NLCR and EoC were higher; 
LymC was lower than in the nonsepsis SIRS group (P <0.001 for each). 
Likelihood of sepsis (reference to nonsepsis SIRS) increased 2.62 (2.05 
to 3.34), 2.02 (1.42 to 2.88) and 1.88 (1.36 to 2.60) times (OR (95% CI)) 
by the values of CRP >4.4  mg/dl, LmyC <500/mm3 and NLCR >15.7 
respectively in mutually adjusted multivariate logistic regression 
(P <0.001 for each).
Conclusion CRP, LymC and NLCR may distinguish sepsis from nonsepsis 
SIRS. Thus, CRP and hemogram parameters may contribute to early 
diagnosis of sepsis.
References
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Introduction Early diagnosis of systemic infl ammation, a generalised 
response to noxious stimuli, is fundamentally important for eff ective 
and goal-directed therapy. Various infl ammation biomarkers have 
been used in clinical and experimental practice. However, a defi nitive 
diagnostic tool for an early detection of systemic infl ammation 
remains to be identifi ed. Acetylcholine (Ach) has been shown to play 
an important role in the infl ammatory response. Serum cholinesterase 
(butyrylcholinesterase (BChE)) is the major Ach hydrolyzing enzyme in 
plasma. The role of this enzyme during infl ammation has not yet been 
fully understood. Here, we describe a correlation between the BChE 
activity and the early systemic infl ammatory response upon traumatic 
injury.
Methods We measured BChE activity in patients with traumatic injury 
admitted to the emergency room using a point-of-care-test (POCT) 
system. In addition, we measured levels of routine infl ammation 
biomarkers during the initial treatment period. We used the Injury 
Severity Score to assess the trauma severity. Data were statistically 
analyzed using the Friedman test. Correlation analysis was performed 
using Spearman’s rank correlation test. P  <0.05 was considered 
statistically signifi cant.
Results Reduced BChE activity correlated with trauma severity and 
the resulting systemic infl ammation. Compared with serum levels of 
routinely measured infl ammatory biomarkers, changes in the BChE 
activity were detected signifi cantly earlier, suggesting that the BChE 
activity might serve as an early indicator of systemic infl ammation.
Conclusion Our results suggest that BChE activity, measured using a 
POCT system, might play an important role in the early diagnosis of 
trauma-induced systemic infl ammation.
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Introduction The apoptotic process, in which cells are actively elimi-
nated by a programmed pathway, is increased in sepsis. Extrinsic and 
intrinsic apoptotic death cell pathways activate caspase-3, which leads 
to cell apoptosis. Cytokeratin 18 (CK-18), a protein present in most 
epithelial and parenchymal cells, is cleaved by the action of caspases 
and released into the blood as caspase-cleaved CK (CCCK)-18 during 
apoptotic death. The novel objectives of this study were to determine 
whether there are associations between serum caspase-3 levels, serum 
CK-18 levels and mortality in septic patients.
Methods A prospective, multicenter, observational study in six Spanish 
ICUs, including 216 patients with severe sepsis. We collected blood 
samples at the severe sepsis diagnosis moment to determine serum 
levels of caspase-3 (to assess the main executor of apoptosis) and CCCK-
18 (to assess the apoptosis level). The endpoint was 30-day mortality.
Results We found that nonsurvivor (n = 76) in comparison with survivor 
(n = 140) septic patients showed higher serum levels of caspase-3 (0.41 
ng/ml (0.14 to 0.52) vs. 0.11 ng/ml (0.10 to 0.25); P <0.001) and CCCK-
18 (448 (310 to 723) vs. 319 (236 to 445); P  <0.001). Multiple logistic 
regression showed that serum caspase-3 levels >0.25 ng/ml were 
associated with mortality at 30 days (odds ratio = 6.51; 95% confi dence 
interval = 3.32 to 12.77; P <0.001), controlling for SOFA score and age. 
Kaplan–Meier survival analysis showed a higher risk of death in septic 
patients with serum caspase-3 levels >0.25 ng/ml than in patients with 
lower levels (hazard ratio = 3.80; 95% CI = 2.35 to 6.15; P <0.001). We 
found a positive association between serum levels of caspase-3 and 
CCCK-18 (ρ = 0.32; P <0.001).
Conclusion The novel fi ndings of our study were that there is an 
association between serum caspase-3 levels, serum CK-18 levels 
and mortality in septic patients. There has been reported decreased 
apoptosis and increased survival in septic rats with the administration 
of caspase inhibitors; thus, it may be interesting to explore those 
agents in septic patients.
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Introduction During sepsis a leading symptom is capillary leakage 
caused by endothelial damage, followed by multiorgan dysfunction. 
Sphingosine-1-phosphate (S1P) is a bioactive lipid with multiple 
functions. Cellular reactions depend on the S1P concentration in the 
blood and its binding to fi ve specifi c G-protein coupled receptors. 
S1P-regulated functions include: control of endothelial permeability; 
lymphocyte migration across microvessels depending on an S1P 
gradient; and control of vascular tone [1]. This clinical study will address 
the question of whether S1P blood concentrations are associated with 
sepsis severity.
Methods Following ethical approval we enrolled patients fulfi lling the 
ACCP/SCCM sepsis criteria into three groups (Group A: sepsis; Group 
B: severe sepsis; Group C: septic shock). A group of 20 healthy donors 
served as controls. Serum blood samples, laboratory data and clinical 
parameters are presented for day 1. The primary outcome variable 
was serum S1P concentration (μg/l) quantifi ed by mass spectrometry 
(Agilent®). The SOFA score was used to describe disease severity.
Results We included 87 patients (32 Group A, 25 Group B, 30 Group 
C). The serum concentration of S1P (mean ± SD) in the control group 
was 484.6  ±  152.6  μg/l and signifi cantly higher compared with 
Group A 239.4  ±  61.3  μg/l, Group B 248.6  ±  93.7  μg/l and Group C 
141.6 ± 46.3 μg/l. We observed a negative correlation between S1P and 
SOFA score (Pearson r  = –0.45, P  <0.001, R2  = 0.2). The median SOFA 
score in our cohort was 6. We divided the cohort into two groups: SOFA 
score <6; and SOFA score >6. We tested the sensitivity and specifi city of 
S1P to indicate disease severity by ROC analysis. In our cohort the area 
under the curve (AUC) for S1P was 0.77 (CI 0.670 to 0.870) and therefore 
higher when compared with common markers of infl ammation (PCT, 
IL-6, CRP with AUC of 0.68 (0.560 to 0.796), 0.68 (0.554 to 0.786) and 0.67 
(0.571 to 0.794), resp.).
Conclusion Our fi ndings suggest that S1P is a novel marker for severity 
of sepsis with severe sepsis and septic shock being associated with low 
levels of S1P. Moreover, blood concentrations of S1P might play a key 
role in sepsis pathophysiology.
Acknowledgements MSW and AN are equal contributors.
Reference
1. Maceyka M, et al. Sphingosine-1-phosphate signaling and its role in disease. 
Trends Cell Biol. 2012;22:50-60.
P55
Diagnostic accuracy and clinical relevance of an infl ammatory 
biomarker panel in early sepsis in adult critical care patients
P Bauer, R Kashyap, S League, J Park, D Block, N Baumann, 
A Algeciras-Schimnich, S Jenkins, C Smith, O Gajic, R Abraham
Mayo Clinic, Rochester, MN, USA
Critical Care 2015, 19(Suppl 1):P55 (doi: 10.1186/cc14135)
Introduction Low awareness, late recognition and delayed treatment 
of sepsis are still common. CD64 is a marker of the innate immune 
response upregulated in sepsis. The primary goal of this prospective, 
double-blind study was to compare the diagnostic accuracy of 
neutrophil CD64 and other cellular markers, along with C-reactive 
protein (CRP) and procalcitonin (PCT) levels, in early sepsis.
Methods Adult ICU patients, between 2012 and 2014 were eligible. The 
eight-color fl ow cytometric biomarker panel included CD64, CD163, 
HLA DR, CD15 and others. Diagnostic test results were compared with 
infection as the reference standard and sepsis as the target condition, 
using receiver operating characteristic curve analyses. Multivariable 
logistic regression was used to assess the relationship of sets of markers 
with the probability of sepsis, adjusting for other patient characteristics.
Results A total of 219 patients were enrolled, 120 with sepsis, 99 served 
as controls. APACHE IV (median 70 vs. 57), SOFA (8 vs. 7), ICU (2 vs. 1) 
and hospital length of stay (6 vs. 4) were higher in the sepsis group. 
Mortality was not diff erent. After adjustment for APACHE IV, CRP and 
PCT, CD64 molecules/neutrophil measure remained a signifi cant 
predictor of sepsis (OR = 1.852 for one-unit increase on the log scale, 
95% CI = 1.083 to 3.168, P = 0.02, AUC = 0.90). See Table 1.
Table 1 (abstract P55). Area under the curve (AUC) for individual biomarkers
   Cutoff   
   for Sensitivity Specifi city
Measure N AUC sepsis (%) (%)
C-reactive protein (mg/l) 208 0.86 43 76.9 76.9
CD64 molecules/neutrophil 196 0.83 1,040.5 76.4 76.7
Procalcitonin (ng/ml) 216 0.82 0.74 73.1 73.2
%CD64+ neutrophils 196 0.81 49.96 74.5 74.4
Conclusion Neutrophil CD64 expression is an accurate predictor of 
early sepsis.
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Introduction Procalcitonin (PCT) is increasingly the standard in the 
emergency department (ED) for the diagnostic and prognostic workup 
of patients with suspected infections. Recently, B·R·A·H·M·S PCT direct, 
a new high-sensitive point-of-care test, has been developed for fast PCT 
measurement on capillary or venous blood samples with a measuring 
range of 0.1 to 10.0 μg/l.
Methods This is a prospective, comparative international study 
conducted in three European EDs. Consecutive patients with suspicion 
of bacterial infection were included. Duplicate determination of PCT 
was performed on two distinct B·R·A·H·M·S PCT direct test devices on 
capillary (fi ngertip) and venous whole blood (EDTA), and compared 
with the reference method (B·R·A·H·M·S PCT sensitive Kryptor or Elecsys 
B·R·A·H·M·S PCT, respectively). The diagnostic accuracy was evaluated 
by correlation and concordance analyses.
Results A total of 303 patients were included over a 6-month period 
(60.4% male, median age 65.2 years). The correlation between capillary 
or venous whole blood and the reference method was excellent: r2 = 
0.96 and 0.97, sensitivity 88.1% and 93.0%, specifi city 96.5% and 96.8%, 
concordance 93% and 95% respectively at a 0.25  μg/l threshold. No 
signifi cant bias was observed (–0.04 and –0.02 for capillary and venous 
whole blood) although there were 6.8% and 5.1% outliers, respectively. 
B·R·A·H·M·S PCT direct had a shorter time to result as compared with 
the reference method (25 vs. 147 minutes, diff erence 122 minutes, 95% 
CI = 110 to 134 minutes, P <0.0001).
Conclusion This study found a high diagnostic accuracy and a faster 
time to result of the PCT direct in the ED setting. The B·R·A·H·M·S PCT 
direct may allow a more widespread use of PCT tests in outpatient 
clinics and smaller institutions.
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Introduction Endotoxin, a key component on the outer membrane of 
Gram-negative bacteria, is considered to be the most important toxin 
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involved in the development of septic shock, and procalcitonin (PCT) 
serum concentration has been strongly associated with the severity 
of sepsis. The eff ect of elevated endotoxin activity (EA) on PCT serum 
level, organ function and mortality of patients with septic shock was 
evaluated on the day of admission to the ICU.
Methods ICU patients with diagnosis of septic shock were consecutively 
added to the study group within the fi rst 24 hours. Serum PCT level and 
whole blood EA was immediately measured in all patients on admission 
(n = 157). Endotoxemia was defi ned as EA >0.4 EAU.
Results Endotoxemia was present in 61% of patients (group 1, n = 95, 
age 66 (57 to 75)), and in 39% of patients EA was low (group 2, n = 62, 
age 63 (55 to 76)). Median EA was 0.57 EAU (0.46 to 0.67) in group 1 and 
0.27 EAU (0.17 to 0.36) in group 2 (P <0.001). The PCT level was six times 
higher in group 1 than in group 2 (19.6 ng/ml vs. 3.1 ng/ml, P <0.001) 
and was correlated with EA (P <0.001, R = 0.5). Median APACHE II score 
was 23 points (16 to 29) in group 1 and 19 (16 to 25) in group 2; but 
observed diff erence was not signifi cant. The severity of clinical status 
estimated by SOFA score was similar in both groups (10 (7 to 13) in 
group 1 and 11 (8 to 12) in group 2; NS). Forty-six percent of patients 
in group 1 and 27% in group 2 required renal replacement therapy 
(P  =  0.01). ICU mortality of patients was 41%. The mortality rate was 
higher in group 1, compared with group 2, and Kaplan–Meier survival 
analysis of time to death showed statistical signifi cance between the 
two groups (P = 0.001, log-rank test). A Gram-negative pathogen as the 
primary source of infection was identifi ed in 64% of patients in group 
1 and in 44% in group 2 (P = 0.004); bacteremia was detected in 26% of 
cases in group 1 and in 12% in group 2 (P = 0.02).
Conclusion Septic shock with endotoxemia was associated with 
biochemical and clinical consequences including a higher PCT level, 
higher frequency of bacteremia, kidney failure, and death.
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Introduction We evaluated the utility of procalcitonin (PCT) as a marker 
of outcome in severe sepsis of abdominal origin (SSAO). SSAO is one 
of the most prevalent pathologies in surgical ICUs (sICUs). Mortality 
from 19 to 70% has been reported. Biomarkers are basic tools for 
diagnosis, follow-up and outcome of sepsis. One of the most studied 
in last decades has been PCT. Its levels and kinetics could be useful to 
evaluate the outcome of septic patients.
Methods We studied all patients admitted to a sICU with SSAO, from 
2007 to 2008. Data collected were: PCT levels on days 1, 3 and 7, 
gender, age, APACHE II on admission, positivity of surgical cultures, 
microorganisms isolated and sepsis origin (community or nosocomial).
Results Sixty-nine patients were included. Mortality was 23%. Median 
age was 64.94  years. Median APACHE II was 16.43 points. At day 1, 
PCT levels were higher in survivors (S) than in exitus (E) (S: 29.22 ng/
ml vs. E: 14.93 ng/ml, P <0.05). PCT levels were infl uenced by gender 
(males: 27.74 ng/ml vs. females: 15.04 ng/ml, P <0.05), positive cultures 
(positive: 25.25 ng/ml vs. negative: 13.49 ng/ml, P <0.05) and isolation 
of Gram-negative microorganisms (Gram-negative: 27.53 ng/ml 
vs. Gram-positive: 14.77 ng/ml, P  <0.05). Patients with community-
acquired sepsis had higher levels of PCT on admission (37.53 ng/ml 
vs. 13.29 ng/ml, P  <0.02). None of these factors had an infl uence on 
mortality. On day 3 PCT levels where higher in S (S: 20.65 ng/ml vs. E: 
16.23 ng/ml, P <0.05). On day 7 PCT levels were higher in E (S: 3.54 ng/
ml vs. E: 12.88 ng/ml, P <0.05). PCT kinetics was diff erent depending on 
outcome. E patients presented persistently higher levels, whereas PCT 
in S decreased over time (P <0.05). PCT on day 7 best identifi ed outcome 
(AUC ROC 0.768). PCT ≥3.5 ng/ml predicted mortality (sensitivity 55%, 
specifi city 73%).
Conclusion PCT on day 7 and PCT kinetics can be useful to predict 
outcome in SSAO. PCT is higher in community-acquired sepsis, when 
surgical cultures are positive, in Gram-negative isolations and in males.
References
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Introduction Blood lactate level is a routinely used biomarker for 
management of patients in septic conditions in the ICU. There is a lack of 
clinical research data comparing lactate with novel sepsis biomarkers, 
such as procalcitonin, in regard to the diagnostic and prognostic 
potential. Herein, we investigated the diagnostic and prognostic value 
of initial lactate and procalcitonin levels and their kinetics within the 
ICU stay for prediction of positive blood cultures and fatal outcome in a 
well characterized cohort of sepsis patients in a US critical care setting.
Methods This is a retrospective, observational cohort study of adult 
patients with confi rmed severe sepsis or septic shock and with at least 
one procalcitonin and lactate measurement on admission to the ICU of 
Morton Plant Hospital (Clearwater, FL, USA). Logistic regression models 
were calculated to assess the association of biomarkers with blood 
culture positivity and fatal ICU outcome with area under the curve 
(AUC) as a measure of discrimination.
Results The in-hospital mortality rate of the 1,075 included patients 
(age 68 years) was 23.8% (95% CI = 21.2 to 26.3%) and 18.4% of patients 
had positive cultures. In regard to the diagnostic value for bacteremic 
disease, initial procalcitonin had a higher discriminatory value (AUC 
0.71) compared with initial lactate levels (AUC 0.52). In regard to 
prognosis, initial lactate level was the better mortality predictor (AUC 
0.69) compared with procalcitonin (AUC 0.55), although both initial 
levels were signifi cantly lower compared with APACHE III (P >0.05 for 
both comparisons). When looking at biomarker kinetics, procalcitonin 
decrease was more strongly associated with fatal outcome compared 
with initial levels alone (AUC 0.66), but still lower compared with lactate 
kinetics (AUC 0.73).
Conclusion Both biomarkers, procalcitonin and lactate provide 
diagnostic and prognostic information in ICU patients with sepsis, 
particularly when looking at biomarker kinetics. An evidence-
based protocol incorporating both markers may further improve 
management of septic patients.
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Introduction Emergency physicians are able to identify severely ill 
older patients with SIRS in the emergency department (ED). A previous 
study showed that elevated procalcitonin (PCT) and IL-6 level is a 
known marker of sepsis and predicts bacteremia and mortality. We 
assessed the diagnostic value of PCT and IL-6 in older patients and 
other patients with SIRS and sepsis in the ED.
Methods This retrospective cohort study was conducted from January 
2013 to December 2013. We enrolled 122 patients with SIRS, 55 were 
classifi ed as the older age group (>65 years of age). Measurement of 
serum PCT, IL-6, and white blood cell count was performed on initial 
admission to the ED. We analyzed these markers in older patients and 
other patients groups with sepsis.
Results Of the 55 patients in the older group 33 (60%) patients had 
sepsis, and 40 (59.7%) patients of the other group had sepsis. PCT 
and IL-6 levels were signifi cantly higher in other patients with sepsis 
(P <0.001, P <0.001). But PCT and IL-6 levels were not higher in old age 
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patients with sepsis (P = 0.400, P = 0.169). The area under the receiver 
operating characteristic curve (AUC) for diagnosis of sepsis according 
to PCT and IL-6 was 0.823, and 0.772 for the other patients group. 
The diagnostic sensitivity, specifi city, positive predictive value, and 
negative predictive value of PCT for sepsis in other patients group were 
79.5%, 81.5%, 86.1%, and 73.3% respectively, with a PCT cutoff  value 
of 0.18 ng/ml. The diagnostic sensitivity, specifi city, positive predictive 
value, and negative predictive value of IL-6 for sepsis in other patients 
group were 67.5%, 81.5%, 84.4%, and 62.9% respectively, with a IL-6 
cutoff  value of 74.43 pg/ml.
Conclusion PCT and IL-6 is useful predictive markers for diagnosing 
sepsis in adult patients (<65 years of age) with SIRS in the ED. But these 
markers are not useful for identifi cation of sepsis in older patients.
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Introduction Procalcitonin (PCT) is used for diagnosis of a bacterial 
infection. Several works described nonspecifi c elevation of PCT after 
cardiac surgery with cardiopulmonary bypass (CPB) caused by systemic 
infl ammatory response syndrome (SIRS) with various cutoff  values for 
the presence of the infection (0.47 to 2.47 μg/l). However, in patients 
undergoing left ventricular assist device (LVAD), implantation data 
about PCT dynamics are lacking.
Methods PCT levels in 25 patients indicated for LVAD were prospectively 
assessed before surgery and during the postoperative period (days 
1, 2, 14 and 30). Values were compared according to the presence of 
infectious complications (IC) and non-infectious complications such as 
acute renal failure (ARF) defi ned as injury by RIFLE criteria or necessity 
of right ventricular assist device (RVAD). Data were also analyzed using 
combined endpoints A (ARF, RVAD) and B (IC, ARF, RVAD). Values are 
presented as median with interquartile range (in μg/l).
Results PCT levels were low before surgery (0.16, 0.10 to 0.35), increased 
signifi cantly within the fi rst (5.72, 2.18 to 9.75; P  <0.001) and second 
(5.94, 2.54 to 11.99; P <0.001) day after operation and decreased on the 
14th (0.27, 0.11 to 0.74) and 30th (0.10, 0.06 to 0.19) day. There was no 
signifi cant diff erence in PCT values between patients with or without 
IC as well as with or without RVAD. ARF increased PCT level signifi cantly 
only 14 days after LVAD implantation (0.68, 0.37 to 1.65 vs. 0.15, 0.11 
to 0.34; P = 0.015). Subjects with endpoint A had signifi cantly higher 
PCT values on the second (19.53, 5.66 to 63.12 vs. 3.95, 2.33 to 8.85; 
P = 0.033), 14th (0.55, 0.31 to 1.44 vs. 0.15, 0. to 0.34; P = 0.020) and 30th 
(0.19, 0.11 to 0.29 vs. 0.08, 0.05 to 0.13; P = 0.016) day after operation. 
Patients with endpoint B had signifi cantly elevated PCT levels 2 (11.99, 
3.23 to 24.16 vs. 3.95, 2.54 to 7.39; P = 0.027) and 14 (0.55, 0.28 to 0.90 
vs. 0.13, 0.09 to 0.23; P = 0.005) days after surgery.
Conclusion PCT levels in patients undergoing LVAD implantation 
rise signifi cantly in the fi rst 2  days after surgery. Interestingly, this 
elevation is much higher than after routine cardiac surgery with CPB. 
Recent works suggest that PCT concentrations are aff ected by SIRS 
caused by contact with a nonphysiological surface. In the case of LVAD 
this immunological stimulation is long lasting and even more potent 
with additional RVAD or ARF treated with renal replacement therapy. 
In accordance with this hypothesis, our data show that the ability 
of PCT to detect infectious complication in LVAD patients is limited 
and its concentrations more probably correlate with postoperative 
complications in general.
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Introduction The potentially envisaged actions of intravenous 
immunoglobulin (IVIg) on severe infectious disease include: virus or 
toxin neutralizing action; opsonic eff ect; complement bacteriolytic 
activity; and enhancement of sensitivity to antibiotics. In the case of 
severe infectious disease, antibiotics are often supplemented with 
administration of IVIg.
Methods The changes in sepsis markers (procalcitonin, presepsin, 
interleukin-6, C-reactive protein) followed by IVIg administration were 
investigated in severe sepsis or septic shock patients. The subjects were 
410 patients admitted to an ICU with a diagnosis of severe sepsis or 
septic shock and from whom informed consent had been obtained for 
the present study. IVIg was administered intravenously for 3 days (5.0 g/
day) and measurements were undertaken before administration (day 
1), on the day after completion of administration (day 4), and on day 7. 
The items measured were procalcitonin, presepsin, IL-6, and CRP. The 
eff ect of IVIg administration on these markers was then studied. The 
IVIg studied was polyethylene glycol-treated human immunoglobulin 
injection fl uid (2.5 g, 50 ml, one vial).
Results The patient APACHE II score were 24.9  ±  8.2, the SOFA score 
9.1 ± 3.7, and the survival rate after 28 days 83.4%. The values before 
IVIg administration were: procalcitonin 36.0  ±  463.3 (median 110) 
ng/ml, presepsin 4,548 ± 4,250 (median 3,337) pg/ml, CRP 15.6 ± 9.6 
(median 14.7)  mg/dl, and IL-6 13,860  ±  47,299 (median 630)  pg/ml. 
All values were thus elevated. On the days after the completion of 
IVIg administration and on day 7, the level of almost all mediators 
(procalcitonin, presepsin, CRP, IL-6) decreased signifi cantly. In patients 
with suspected severe sepsis and septic shock, presepsin reveals 
valuable diagnostic capacity to diff erentiate sepsis severity compared 
with procalcitonin, IL-6, CRP, and WBC. Additionally, presepsin and IL-6 
reveal prognostic value with respect to 30 days and 6 months all-cause 
mortality throughout the fi rst week of ICU treatment [1].
Conclusion The results of the present study found signifi cant 
decreases of procalcitonin, presepsin and IL-6 resulting from 3 days of 
immunoglobulin administration, but evidence is still limited and this 
needs to be confi rmed in larger studies.
Reference
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Introduction Presepsin (sCD14-ST) serves as a mediator of the response 
to infectious agents. First evidence suggested that presepsin may be 
utilized as a sepsis marker.
Methods Presepsin was determined at presentation (T0), after 8, 
24 and 72  hours in 123 individuals admitted with signs of SIRS and/
or infection. Primary endpoint was death within 30  days. Presepsin 
was determined using the POC assay PATHFAST Presepsin (Mitsubishi 
Chemical, Japan).
Results Mean presepsin concentrations of the patient group at 
presentation and of the control group were 1,945 and 130  pg/ml, 
respectively (P <0.0001). Baseline presepsin diff ered highly signifi cant 
between patients with SIRS, sepsis, severe sepsis and septic shock. 
Table 1 (abstract P63). Presepsin levels during the course of the disease in 
survivors and nonsurvivors
 PSEP, median (IQR) (pg/ml)
 T0 T8 hours T24 hours T72 hours
Survivors 590 622 574 533
 (345 to 1,396) (367 to 1,912) (336 to 1,610) (324 to 1,246)
Nonsurvivors 1,763 1,859 1,731 2,056
 (705 to 6,616) (1,001 to 5,744) (809 to 4,586) (811 to 5,540)
P value 0.0046 0.0005 0.0003 0.0013
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S22
Twenty-four patients died during 30  days. The 30-day mortality was 
19.5% in total, ranging from 10 to 32% between the fi rst and the 
fourth quartile of presepsin concentration. Nonsurvivors showed high 
presepsin values with increasing tendency during the course of the 
disease while in surviving patients this tendency was decreasing. See 
Table 1.
Conclusion Presepsin demonstrated a strong relationship with disease 
severity and outcome. Presepsin provided reliable discrimination 
between SIRS and sepsis as well as prognosis and early prediction of 30-
day mortality already at admission. Presepsin showed close association 
with the course of the disease.
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Introduction At the moment, we have few reports about the diagnostic 
accuracy of procalcitonin (PCT), presepsin (P-SEP) and CD64 as a 
diagnostic marker of sepsis for patients with acute kidney injury (AKI). 
This study aimed to clarify which is a more useful diagnostic biomarker 
for sepsis using PCT, P-SEP and CD64 with or without AKI in ICU patients.
Methods This study was a single-center observational retrospective 
study. Blood samples were collected from 334 patients admitted to 
our ICU between April 2013 and March 2014. Then, we classifi ed the 
patients with or without AKI. In this study, we adopted RIFLE criteria 
for AKI diagnosis. After that, the patients in each group were classifi ed 
into the sepsis group and the nonsepsis group. We measured PCT, 
P-SEP and CD64 levels at the time of ICU admission and subsequently 
investigated the diagnostic accuracy of these biomarkers for detecting 
sepsis.
Results In this study we met 225 patients with non-AKI and 109 
patients with AKI. We conducted ROC analysis for diagnosing sepsis. 
In non-AKI patients, the AUC of PCT, P-SEP and CD64 were 0.904 (95% 
CI: 0.824 to 0.950), 0.892 (95% CI: 0.794 to 0.947) and 0.917 (95% CI: 
0.842 to 0.958), respectively. In AKI patients, the AUC were 0.933 (95% 
CI: 0.859 to 0.970), 0.755 (95% CI: 0.642 to 0.840) and 0.905 (95% CI: 
0.803 to 0.957), respectively.
Conclusion CD64 and PCT were a useful biomarker for detecting sepsis 
for ICU patients with AKI.
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Introduction Whether the infl ammatory biomarker procalcitonin (PCT) 
provides prognostic information across clinical settings and diff erent 
acute respiratory tract infections (ARI) is poorly understood. Herein, we 
investigated the prognostic value of admission PCT levels to predict 
adverse clinical outcome in a large ARI population.
Methods We analyzed data from 14 trials and 4,211 ARI patients 
to study associations of admission PCT levels and setting specifi c 
treatment failure and mortality alone at 30 days. We used multivariable 
hierarchical logistic regression and conducted sensitivity analyses 
stratifi ed by clinical settings and ARI diagnoses to assess the results’ 
consistency.
Results Overall, 864 patients (20.5%) experienced treatment failure and 
252 (6.0%) died. The ability of PCT to diff erentiate patients with and 
without treatment failure was highest in the emergency department 
setting (treatment failure; area under the curve (AUC): 0.64 (95% 
confi dence interval (CI): 0.61, 0.67), adjusted odds ratio (OR): 1.85 
(95% CI: 1.61, 2.12), P <0.001 – mortality; AUC: 0.67 (95% CI: 0.63, 0.71), 
adjusted OR: 1.82 (95% CI: 1.45, 2.29), P  <0.001). In lower respiratory 
tract infections, PCT was a good predictor of identifying patients at risk 
for mortality (AUC: 0.71 (95% CI: 0.68, 0.74), adjusted OR: 2.13 (95% CI: 
1.82, 2.49), P  <0.001). In primary care and ICU patients no signifi cant 
associations of initial PCT levels and outcome were found. See Figure 1.
Conclusion Admission PCT levels are associated with setting specifi c 
treatment failure and provide most prognostic information in ARI in the 
emergency department setting.
Reference
1. Schuetz P, Briel M, Christ-Crain M, et al. Procalcitonin to guide initiation and 
duration of antibiotic treatment in acute respiratory infections: an individual 
patient data meta-analysis. Clin Infect Dis. 2012;55:651-62.
Figure 1 (abstract P65). Multivariate regression analysis for estimation of predictive value of PCT levels on admission stratifi ed by adverse events and 
mortality in diff erent settings and diagnoses. *Treatment failure, ~mortality. ARI, acute respiratory tract infection; ECOPD, exacerbated chronic obstructive 
pulmonary disease; CAP, community-acquired pneumonia; VAP, ventilator-associated pneumonia; Adj., adjusted; OR, odds ratio; CI, confi dence interval.
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Introduction The objective of this study was to evaluate the neutrophil 
to lymphocyte count ratio (NLCR) versus procalcitonin (PCT) in 
diagnosing bacteremia in the emergency department (ED). The NLCR is 
a biomarker that appears early in the course of the acute infl ammatory 
response and reaches maximum levels within 4 hours after onset. An 
elevated NLCR has been shown to correlate to bacteremia at a cutoff  
level of >10 [1]. It is rapidly analyzed on a full blood cell count at low 
cost. The lowest recommended cutoff  level for PCT is <0.5 ng/ml.
Methods We randomly chose 425 patients from a 9-month 
epidemiologic study on the incidence of community-onset severe 
sepsis and septic shock in western Sweden 2011 to 2012. In total, 207 
had severe sepsis and 218 had sepsis, mean age 71.2 versus 64.2 years; 
males 51%. Sampling was made on arrival in the ED. The NLCR was 
analyzed immediately, PCT later on plasma frozen at –80°C. A total of 
122/425 patients had bacteremia, 72 (35%) in the severe sepsis group 
versus 50 (23%) in the sepsis group. Most common fi ndings were 
Escherichia coli (n = 33), Staphylococcus aureus (n = 24), streptococcal 
spp. (n = 33) and other enterobacteriacae spp. (n = 17).
Results The NLCR shows signifi cantly higher sensitivity than PCT at 
recommended cutoff  levels for bacteremia. Interestingly, this is true 
even for all 207 patients with severe sepsis, irrespective of bacteremia 
or not. Sensitivity fi gures with 95% confi dence interval: bacteremia (n = 
122): NLCR 80% (0.73 to 0.87) versus PCT 66% (0.58 to 0.75), P = 0.01; 
severe sepsis with bacteremia (n = 72): NLCR 85% (0.77 to 0.93) versus 
PCT 70% (0.59 to 0.81), P = 0.03; and severe sepsis but no bacteremia 
(n = 135): NLCR 71% (0.65 to 0.77) versus PCT 61% (0.54 to 0.68), P = 0.03.
Conclusion The NLCR can be used in the ED as a biomarker for 
bacteremia as well as severe sepsis and seems to perform as well as or 
even better than PCT in this setting. Rapid response, low cost and no 
need for extra sampling make it useful as a screening tool.
Reference
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Introduction The purpose of the study was to assess the prognosis 
value of pro-adrenomedullin (pADM), C-reactive protein (CRP) and 
procalcitonin (PCT), lactate (LT), albumin (ALB), cholesterol (CHOL), 
white blood cell (WBC) and severity score in patients with severe sepsis 
or septic shock.
Methods A prospective, observational study in adult patients with 
severe sepsis or septic shock in a polyvalent ICU. Demographics, 
severity scores (APACHE II and SOFA) and all of the biomarkers were 
studied within 24  hours from septic shock onset. Descriptive and 
comparative statistical analysis was performed using the statistical 
software packages SPSS v.15 and MedCalc® 9.2.1.0.
Results We analyzed 246 consecutive episodes of severe sepsis (38%) 
or septic shock (62%). The 28-day mortality was 36.2%. The profi le of 
dead patients had a signifi cantly higher average age (65 (IQR: 75.5 to 
57.5) vs. 63 (47 to 72); P <0.06), APACHE II (27 (22 to 30) vs. 23 (18 to 27); 
P <0.001) and SOFA (11 (9 to 12.75) vs. 9 (7 to 10); P <0.001). CRP (168.4 
(106 to 285) vs. 165.4 (87.8 to 275) mg/dl; P = NS), PCT (6.5 (0.94 to 23.8) 
vs. 5.8 (0.97 to 19.59) ng/ml; P = NS) and WBC 14.7 (9.5 to 21.4) vs. 12.9 
(5.5 to 17.5); P = NS) were increased in those who died, but CHOL (102 
(75 to 134) vs. 108 (86 to 141) mg/dl; P = NS) had lower values. These 
diff erences were signifi cant in pADM (2.46 (1.21 to 4.89) vs. 1.68 (0.94 to 
3.32) nmol/l; P = 0.012), LT (2.6 (1.6 to 3.94) vs. 1.6 (1.2 to 2.43) mmol/l; 
P <0.001) and ALB (2 (1.55 to 2.38) vs. 2.22 (1.96 to 2.7) g/dl; P = 0.001).
Conclusion The protein pADM, LT and ALB showed good prognosis 
accuracy when measured on admission of septic patients to the ICU.
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Introduction Early diff erentiation of bacterial from candidal 
bloodstream infections (BSIs) in the presence of sepsis or septic shock 
is crucial because of the need for appropriate treatment initiation. 
Clinical data, although limited, suggest a role for procalcitonin (PCT) 
[1-3]. The aim of this study was to investigate a possible association 
between the etiology of BSIs and the serum PCT levels.
Methods ICU patients with clinical and laboratory signs of sepsis or 
septic shock, with documented BSIs and with both serum PCT and 
CRP measurements on the day of the positive blood sample (±1 day), 
were included. Illness severity was assessed by SOFA score on both 
admission and BSI day. Demographic, clinical, and laboratory data 
including PCT and CRP levels, as well as the white blood cell (WBC) 
count on the day of the BSI were recorded. PCT was measured by an 
electrochemiluminescence analyzer and CRP by the tholosimetric 
method (Roche, Switzerland).
Results A total of 64 ICU patients (mean age 58 ± 18 years, 39 males) 
with BSIs were included. SOFA sore was 9  ±  4 on ICU admission and 
8 ± 4 on the day of BSI. In 30 of these patients Candida spp. were isolated 
in blood culture (candidemia group) whereas the remaining 34 had a 
bacterial etiology of BSI (bacteremia group). Serum PCT concentrations 
remained within normal ranges in most patients with candidemia 
whereas a wide range was observed in patients with bacteremia. Mean 
values of PCT and CRP levels were higher in the bacterial than in the 
candidemia BSI group: 18.5 ± 33.2 versus 0.73 ± 1.40 ng/ml, P <0.001 
and 17.7 ± 10.3 versus 8.9 ± 8.0 mg/dl, P = 0.001, respectively. There 
was a signifi cant diff erence in WBC count between the two groups: 
19,460  ±  10.174 versus 11,000  ±  5,440, P  <0.001 for the bacteremia 
and candidemia BSI group, respectively. A ROC curve analysis of the 
predictive ability of PCT showed an AUC of 0.79 (P  <0.001). When a 
cutoff  point of 0.40 ng/ml was selected using Youden’s J statistic, a low 
value of PCT had in our sample a negative predictive value of 0.76 and 
a likelihood ratio (negative) of 0.30.
Conclusion A low serum PCT value could be considered as a diagnostic 
marker in distinguishing between BSIs of candidal or bacterial origin in 
ICU patients with varying severity of sepsis.
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Introduction Early initiation of antifungal therapy (AFT) improves the 
outcome in candidemic patients, but empiric AFT is not considered the 
standard of care.
Methods We used a scoring system based on the presence of a central 
venous catheter and receipt of antibiotics, plus at least two of the 
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following: dialysis, surgery, pancreatitis, and receipt of corticosteroids, 
other immunosuppressive agents or parenteral nutrition. Diff erent 
from the original description of the score which considered only the 
fi rst 7 days of ICU stay, we selected patients who fulfi lled these criteria 
at any time during the ICU stay. Once a patient fulfi lled these criteria, 
AFT (anidulafungin 200  mg followed by 100  mg daily) was initiated 
provided that the patients also presented with any of the following: 
fever, hypothermia, hypotension, leukocytosis, acidosis or elevated 
C-reactive protein. Blood cultures (days 1 to 2) and baseline serum BDG 
(days 1 to 3) were performed. Patients with candidemia were treated for 
≥14 days, those without candidemia but ≥1 positive BDG (≥80 pg/ml) 
received AFT for ≥10 days, and patients with negative blood cultures 
and negative BDG discontinued anidulafungin.
Results A total of 2,148 patients were screened, and 85 (4%) fulfi lled 
entry criteria. The incidence of candidemia in these 85 patients was 
8.2%, compared with 0.5% in the remaining 2,063 patients (relative risk 
16.9%, 95% confi dence interval (CI) = 6.63 to 43.55). Baseline BDG was 
positive in 74 patients (87%), with a median number of positive tests of 
3 (range 1 to 3) and a median value of 523 pg/ml (range 83 to 6,860). 
All seven patients with candidemia had positive baseline BDG (median 
value 523 pg/ml, range 203 to 3,660). The best cutoff  of baseline BDG 
for the diagnosis of candidemia was 522  pg/ml (area under the ROC 
curve 0.883, 95% CI = 0.769 to 0.997), with sensitivity and specifi city of 
86% and 88%, respectively. The cutoff  value of 80 pg/ml had sensitivity 
and specifi city of 73% and 27%, respectively.
Conclusion This dynamic prediction rule was able to diff erentiate 
a group of ICU patients at high risk to develop candidemia, with a 
relative risk of 16.9. BDG is frequently positive in ICU patients. A cutoff  
value of 522 pg/ml was able to discriminate between candidemic and 
noncandidemic patients. A revision of the cutoff  value for BDG in the 
ICU is needed.
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Introduction Bloodstream infections in the ICU are a major trigger of 
morbidity and mortality. Several risk factors for bacteremia have been 
previously identifi ed, such as presence of a central venous catheter 
or invasive ventilation [1,2]. Iron is a key element for bacteria growth, 
and its metabolism is extensively altered by infl ammation. We aim 
to determine whether iron defi ciency is a risk or protective factor for 
bacteremia in the ICU.
Methods We performed a retrospective analysis of patients included 
in the MIMIC-II database, an ICU database that collected data from 
patients admitted to the medical, surgical, coronary and cardiac 
surgery ICU of Boston’s Beth Israel Deaconess Medical Center during 
a period of 7 years. We performed logistic regression models to assess 
the association between iron and bloodstream infection.
Results We included 3,980 patients, 2,988 with low serum iron (<60 ng/
ml) and 992 with normal/high serum iron (≥60 ng/ml). During their fi rst 
stay in the ICU, 351 (8.82%) patients developed bloodstream infections. 
Low serum iron was associated with increased odds of bloodstream 
infection (OR: 1.37; 95% CI: 1.04 to 1.80). After adjusting for age, gender, 
Simplifi ed Acute Physiology Score, presence of central venous catheter, 
ICU type, transfusions performed before iron measured, neoplastic 
disease, diabetes mellitus, hepatic disease, congestive heart failure and 
ferritin levels, low levels of iron were still associated with an increased 
odds of bacteremia (OR: 1.41; 95% CI: 1.03 to 1.9). In contrast, low serum 
iron was associated with a decreased risk of death in the hospital (adj 
OR: 0.73, CI: 0.57 to 0.95).
Conclusion Low serum iron increases the risk of bloodstream infection 
in the ICU, and should be considered as a risk factor to stratify patients’ 
risk of bacteremia during ICU stay.
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Introduction The aim of this study was to investigate whether clinicians 
can estimate, at the time of insertion, the length of time a central 
venous catheter (CVC) will remain in place, and to identify clinical 
variables which may predict CVC duration. CVC-related bloodstream 
infection is a known complication among critically ill patients. As 
infection rates may increase with duration of catheterization, more 
expensive antimicrobial-coated catheters may be used in patients with 
anticipated long duration of CVC use.
Methods We conducted a single-center, prospective study from 
January 2012 to November 2012. Clinicians prospectively estimated 
the anticipated duration of CVC at the time of line placement in 
an electronic procedure note. We collected demographics, past 
medical history, type of ICU, vital signs, laboratory values, SOFA 
score, mechanical ventilation and use of vasopressors at the time of 
placement. Continuous variables were compared with the Wilcoxon 
rank-sum test and categorical variables with the Fisher’s exact test. 
Pearson’s correlation coeffi  cient was used to assess the correlation 
between estimated CVC time and actual time. Duration of CVC use was 
dichotomized into long (≥7 days) or short (<7 days), based on previous 
literature, and sensitivity and specifi city for predicting long duration 
was calculated. We performed a logistic regression analysis to identify 
variables associated with long CVC duration and calculated the area 
under the ROC curve (AUC).
Results We enrolled 150 patients; median age was 65 (IQR: 52 to 74), 
63 (42%) were female and mortality was 22%. Median time from CVC 
placement to removal was 5 (IQR: 3 to 8) days. The correlation between 
estimated CVC time and actual time was low (r = 0.36, P <0.001). Forty-
eight (32%) patients had a long CVC duration. Clinician estimate had 
46% sensitivity and 76% specifi city for predicting long duration of CVC. 
Of 30 variables tested, only temperature at the time of insertion was 
signifi cantly associated with long duration (OR: 1.30, 95% CI: 1.04 to 
1.63, P = 0.02). The AUC for this model was 0.59 (95% CI: 0.49 to 0.69).
Conclusion Our results suggest a low correlation between clinician 
prediction at time of insertion and actual duration of CVC. We did not 
fi nd any good predictors of long duration of CVC. Given our relatively 
low sample size, we may have been underpowered. It may not be 
feasible to identify patients at the time of insertion who may benefi t 
from antimicrobial-coated catheters.
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Introduction Catheter-related bloodstream infections (CRBSI) are 
common and an important cause of morbidity and mortality in critical 
patients. Optimum approaches for preventing infections are presented 
in guidelines. This study aims to evaluate effi  cacy of diff erent care 
techniques and education, to defi ne risk factors for decreasing ratio of 
CRBSIs and to analyze eff ects on morbidity and mortality.
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Methods After ethics committee approval, patients admitted to the 
ICU, older than 18 years, who were thought to have a central venous 
catheter (CVC) for more than 48  hours, and whose fi rst catheter was 
inserted in the ICU were included in the study. Staff  were educated 
before the study and periodically during the study. Catheter care and 
insertion were applied according to the guidelines. The study was 
planned as three sequences. In the fi rst group, catheter care was made 
with a sterile gauze pad. In the second and third groups, catheter care 
was made with chlorhexidine gluconate impregnated dressing. Also in 
the third group, a silver-coated needleless connector was inserted into 
the tip of venous catheters.
Results Totally 105 patients were included in the study and every group 
included 35 patients. There was no diff erence between groups when 
evaluating reasons for catheter insertion. There was no statistically 
signifi cant diff erence according to emergent or elective catheterization, 
trying times, or catheter insertion side (P >0.05). CRBSI was determined 
in two patients in group 1, in one patient in group 2, and in no patient 
in group 3. In group 1 it was observed on the 4th and 11th days. In 
group 2 it was observed on the 18th day after catheterization. Before 
the study, a statistically signifi cant decrease was determined in CRBSI 
ratios before and after education (16.4/1,000, 12.9/1,000 catheter-days 
(P  <0.001)). According to Group 1 a statistically meaningful decrease 
was assigned in CRBSI ratios in Groups 2 and 3 (4.84/1,000, 2.22/1,000, 
0/1,000 catheter-days) (P <0.001, P <0.001, P <0.001).
Conclusion Continued education is important in preventing CRBSIs. 
Maximum precautions must be taken. Usage of antiseptic solutions 
with clorhexidine and chlorhexidine gluconate impregnated dressing 
decreased insertion side infections and usage of silver-coated 
needleless connectors reduced microorganism entry through the 
catheter lumen and provided a severe decrease in infection ratio.
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Introduction The current CDC guideline for the prevention of 
intravascular catheter-related infections recommends skin preparation 
with a greater than 0.5% chlorhexidine with alcohol solution before 
central venous catheter (CVC) or peripheral arterial catheter (AC) 
placement. However, few studies investigated the superiority of 1% 
alcoholic chlorhexidine gluconate (1% CHG) over either 0.5% alcoholic 
chlorhexidine gluconate (0.5% CHG) or 10% aqueous povidone iodine 
(10% PVI) for the prevention of catheter colonization. The aim of this 
study is to compare the eff ectiveness of three skin antiseptic solutions 
for the prevention of intravascular catheter colonization.
Methods This multicenter prospective randomized controlled trial was 
conducted in 15 Japanese ICUs from December 2012 to March 2014. 
Patients over 18 years of age undergoing CVC and AC placement in the 
ICU are randomized to have one of three skin antiseptic preparations 
before catheter insertion. After removal of the catheter, the distal tip 
is cultured using semiquantitative or quantitative techniques. The 
incidence of catheter colonization and catheter-related bloodstream 
infection (CRBSI) is compared between the three groups.
Results A total of 997 catheters were placed, including 339 catheters 
using 1% CHG, 329 using 0.5% CHG, and 329 using 10% PVI. The 
median duration of catheter indwelling in the entire population was 
3.7 days with an interquartile range of 2.0 to 6.7 days, with no signifi cant 
diff erence between the groups (P = 0.36). Thirteen catheters (5.1%) in 
the 10% PVI group were positive for catheter-tip colonization, whereas 
six catheters (2.2%) in the 1% CHG group and fi ve catheters (1.9%) in 
the 0.5% CHG group were positive (P = 0.07). The probability of catheter 
colonization was signifi cantly higher in the 10% PVI group than each 
CHG groups (P  =  0.028, log-rank test). The incidence of catheter 
colonization and CRBSI is compared between the three groups.
Conclusion In this randomized controlled trial comparing the eff ective-
ness of three cutaneous antiseptic solutions for the prevention of 
catheter colonization, either 0.5% or 1.0% CHG was superior to 10% PVI.
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Introduction Catheter-associated bloodstream infections are serious 
but potentially possible to reduce complication of treatment in the 
ICU. The aim of the study was to evaluate the frequency and etiology 
of central line-associated bloodstream infections (CLA-BSI) in ICU 
patients according to the International Nosocomial Infection Control 
Consortium (INICC) project.
Methods A prospective, observational study was conducted in the 
20-bed ICU of the University Hospital in Wroclaw from January 2011 
to November 2014. CLA-BSI were diagnosed and evaluated according 
to protocols standardized by the INICC. The density of CLA-BSI/1,000 
central line-days, the incidence index/100 admissions to the hospital, 
the central line utilization ratio (CL-UR) as well as the microbiological 
profi le of CLA-BSI were evaluated. The results were compared with our 
earlier published data and with the fi ndings of international reports.
Results Among 1,746 ICU patients, CLA-BSI were diagnosed in 69 cases. 
The incidence index was 3.88/100 admissions to the ICU. CLA-BSI were 
diagnosed in 18% of the overall number (381) of device-associated 
healthcare-associated infections. Central line was used in 91.41 ± 4.4% 
patients during 19,819 patient-days and 18,155 central line-days. The 
median density of CLA-BSI/1,000 central line-days was 3.88/3.77/3.36 
and 0.0 accordingly in years 2011/2012/2013 and 2014 (from January 
to November). The main pathogens of CLA-BSI were CN staphylococci 
(22%), Staphylococcus aureus (21%), and Enterobacteriaceae (29%). In 
this study, the density of CLA-BSI was about 50% lower (2.75 (2.0 to 
6.06)) than in our previous study and in the INICC’s report (2014), but 
higher than in the CDC’s NHSN (2012) report.
Conclusion The implementation of the infection control program and 
preventive interventions for patients with central venous catheters 
improved the safety and quality of healthcare in the ICU by reducing 
CLA-BSI rate.
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Introduction Long experience in the treatment of neutropenic patients 
admitted to the ICU has taught us the importance of removing the 
permanent central venous catheter when infection is suspected, 
because of the great mortality associated. The problem usually comes 
when the origin of sepsis is not clear and we assume that mortality is 
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not easy to avoid. It is important to know what happens to neutropenic 
patients admitted to the ICU because of sepsis from any source, in 
whom catheter infection cannot be excluded.
Methods A retrospective, cohort, descriptive study was carried out 
between January 2013 and November 2014. Epidemiology data were 
collected from all neutropenic patients admitted to the ICU who came 
from hemato-oncology services and had an implanted central venous 
catheter. Microbiology results and data related to the catheter removal 
were described.
Results A total of 15 patients were included, mean age was 53 years 
old and 66% were male. The implanted catheter was removed in 80% 
of patients. Platelet transfusion was needed in 100% of patients before 
catheter removal and no complication was observed during catheter 
removal or in the insertion of a new one. In 53% of patients, catheter 
infection was confi rmed a posteriori.
Conclusion Removal of an implanted central venous catheter from 
neutropenic patients admitted to the ICU due to sepsis from any source 
can be benefi cial for this kind of patient as it was found that in more 
than 50% of patients catheter infection was confi rmed a posteriori.
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Introduction Femoral, jugular or subclavian central venous 
catheterization (CVC) is routinely performed during the care of 
the critically ill. These invasive procedures contribute to additional 
morbidity, mortality, and costs derived from the interactions between 
traumatic, infectious and other complications. The aim of this study 
is to determine whether the subclavian, jugular or femoral central 
venous access (CVA) routes have an eff ect on the incidence of CLABSI 
in critically ill patients and to compare between these routes regarding 
major complications and ICU mortality.
Methods A retrospective observational study in a medical and surgical 
ICU in a tertiary care hospital on adult patients admitted from January 
2010 to December 2013. The study enrolled 845 patients divided 
into 283 internal jugular CVC (IJC), 270 subclavian CVC (SCC) and 287 
femoral CVC (FC) in which the catheters were inserted in the ICU by 
experienced physicians with at least 50 previously successful trials of 
central line insertion, using CVC bundle checklist. ICU length of stay, 
incidence of complications, APACHE II score adjusted severity and 
mortality were calculated for each group.
Results Patient and catheter characteristics including the duration of 
catheterization were similar in all groups. The rate of CLABSI in the IJC, 
SCC and FC groups was 5.8 versus 7.2 versus 3.45 per 1,000 catheter-
days respectively with P = 0.35. ICU mortality was 134 (47%) cases of 
the IJC group, 108 (39%) cases of the SCC group and 113 (39%) cases 
of the FC group. There was no signifi cant diff erence between the three 
groups of CVC in the incidence of CLABSI rate in the critically ill patients, 
and a slight increase in ICU mortality in the IJC group compared with 
the other two groups. Pneumothorax occurred in six (2.2%) cases of 
SCC and 11 (3.8%) cases of IJC with no signifi cant diff erence between 
the two groups as the P value was 0.3.
Conclusion Site of insertion of CVC does not appear to aff ect the rate of 
CLABSI among critically ill patients. Pneumothorax was recorded in SCC 
and IJC groups with no statistical preference to either group.
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Introduction Neutrophils work as the frontline of defense against 
infections and neutrophil extracellular traps (NETs) are one of the 
immune systems to suppress dissemination of infection by the netted 
chromatin decorated with antibacterial molecules. It was reported 
that NETs play an important role in various kinds of infections such 
as pneumonia. However, there is no report on NETs in patients of soft 
tissue infections. In this study, we evaluated NET production in pus 
and clarifi ed the role of NETs as a host defense in patients of soft tissue 
infections.
Methods This study was conducted in the ICU of the Trauma and Acute 
Critical Care Center at Osaka University Hospital. We collected pus 
from the patients of soft tissue infections at the time when drainage 
or debridement was performed and when clinical improvement 
was observed. The smears of pus specimens were examined by 
immunohistochemistry to visualize the major NET components: 
DNA, neutrophil elastase, and histone H1. Concurrently, the patients’ 
clinical data and laboratory data of blood were recorded to analyze the 
relationship with NET production.
Results A total of fi ve patients were included in this study and drainage 
of abscess or debridement of infection site was performed in all of 
the cases. Four patients of them were diagnosed as necrotizing soft 
tissue infections by Clostridium spp. (n = 1) and Bacteroides spp. (n = 
3) and the other was diagnosed as cervical abscess by Streptococcus 
spp. In all cases, no NETs but neutrophils were identifi ed in the fi rst pus: 
however, NETs appeared in the later smears as the patients’ condition 
was getting better.
Conclusion These results suggested that NETs also worked as an 
immune system against soft tissue infections. Drainage or debridement 
of infection focus might promote NET production.
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Introduction In our study, we aimed to compare the application of 
benzalkonium chloride (BC) – a nanotechnology-based product – for 
24-hour periods and didecyl dimethyl ammonium chloride (DDAC) 
for 12-hour periods regarding effi  ciency in application of surface 
antiseptics in the ICU.
Methods Two diff erent areas with eight beds at both sides of a common 
corridor in the ICU were named as areas A and B. BC was applied in 
area A with 24-hour periods and DDCA was applied in area B with 12-
hour periods for surface cleaning. Samples were taken from a total of 
20 diff erent surfaces including nurse-station desks, phones, keyboards, 
beds, bedside monitors and ventilators by the same infection control 
nurse every 24 hours from area A and every 12 hours from area B for 
7  days. Swab samples were cultured on 5% sheep bloody agar and 
McConkey agar in the laboratory. Then the cultured mediums were 
incubated at 35 to 37°C in an aerobic environment for 18 to 24 hours. 
NCSS (Number Cruncher Statistical System) 2007 and PASS 2008 
Statistical Software (UT, USA) programs were used for the statistical 
analysis.
Results There were no statistical diff erences between two groups 
(Table 1).
Table 1 (abstract P78). Isolated pathogen ratio percentage
 A (BC) B (DDCA) P value
First day 25  20 1.000
Second day 5 15 0.605
Third day 30 20 0.715
Fourth day 65 50 0.527
Fifth day 45 60 0.527
Sixth day 25 25 1.000
Seventh day 60 45 0.527
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S27
Conclusion The eff ect of a good surface disinfectant should begin 
immediately and it should have a long-lasting disinfecting eff ect on 
the surface. DDAC is an effi  cient disinfectant used in medicine and the 
food industry to protect the surfaces. However, it may cause severe 
skin itching. BC, which is a nanotechnology-based product, leaves its 
active metabolites on the surface; it is applied by constituting a spongy 
layer. Since the effi  ciency of BC lasts for 24 hours and it is applied to 
perform cleaning with 24-hour intervals, we think that it is preferable 
with regards to workforce gain and cost.
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Reduction of deep surgical site infections in cardiac surgery by 
introducing a multimodal infection control program
A Rutten, JP Ory, L Jamaer, A Van Assche, J Dubois
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Introduction Deep surgical site infections (DSSI) are a major compli-
cation after cardiac surgery with a high mortality rate and reported 
incidences between 0.5 and 5%. Implementing a comprehensive 
infection control program (ICP) reduces this incidence [1]. The 
incidence in our hospital varied from 3.1 to 3.8%, which was considered 
too high. We evaluated the impact of introducing a multimodal ICP on 
the incidence of DSSI.
Methods We noticed a too high incidence of DSSI after cardiac 
surgery during an observational 3-year period (Figure 1). In February 
2013 we introduced a bundle of interdisciplinary infection control 
measures. Medical and nursing staff  of all involved departments 
took part in developing and implementing these guidelines. Besides 
emphasizing the importance of existing guidelines (antiseptic 
shower, hair removal by clipper, strict hand hygiene, prophylactic 
antibiotics, limiting OR traffi  c, tight glycemic control (80 to 110  mg/
dl), and so on), new strategies were introduced. The most important 
new strategies were nasal decolonization with mupirocin twice daily 
48  hours perioperatively, preoperative antiseptic skin preparation 
twice (chlorhexidine gluconate 0.5%), applying topical skin adhesive to 
the sternal wound postoperatively and in the case of CABG procedures 
maintaining a strict barrier between the vein harvesting procedure and 
the chest procedure.
Results We observed a signifi cant reduction in DSSI rates in cardiac 
surgery following implementation of a multimodal ICP from 3.1% in 
2010 down to 0.23% in November 2014 (Figure 1).
Conclusion Implementing a multimodal ICP signifi cantly reduced the 
incidence of DSSI in our hospital but it remains diffi  cult to identify 
which interventions were most eff ective.
Reference
1. Guide for the prevention of mediastinitis surgical site infections following 
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Introduction Urinary catheter insertion is a common procedure in ICUs 
and can be an important cause of infection in the hospital environment 
[1,2]. We aimed to analyze the eff ect of chlorhexidine on long-term 
urinary catheter insertion and urinary tract infection (UTI) during a 
5-year period in patients admitted to a coronary ICU.
Methods Analysis of patients admitted to a coronary ICU of a medium-
sized hospital in Brazil from January 2010 to May 2014. The institutional 
protocol of periprocedural antisepsis was changed from iodine-based 
antiseptic to chlorhexidine in 2012. The UTI diagnosis was based on urine 
culture (>105 colony-forming units per  ml of urine) associated with at 
least one clinical/laboratory abnormality (fever >38°C, urination urgency, 
increased urinary frequency, dysuria, or suprapubic or lumbar pain). The 
UTI rate represents the urinary tract infections associated with long-term 
urinary catheter (patient with UTI associated with long-term urinary 
catheter divided by patients with long-term urinary catheter × 1,000).
Results The urinary tract infection rates were 4.8 (year 2010: 
patients·day–1 (n: 2,511), long-term urinary catheter·day–1 (n: 1,455), 
device usage rate (958%)), 4.4 (year 2011: patients·day–1 (n: 2,529), long-
term urinary catheter·day–1 (n: 1,140), device usage rate (45%)), 0.0 (year 
2012: patients·day–1 (n: 2,660), long-term urinary catheter·day–1 (n: 783), 
device usage rate (29%)), 0.0 (year 2013: patients·day–1 (n: 2,573), long-
term urinary catheter·day–1 (n: 960), device usage rate (37%)), and 0.0 
(year 2014: patients·day–1 (n: 1,070), long-term urinary catheter·day–1 (n: 
444), device usage rate (42%)).
Conclusion The use of chlorhexidine in the periprocedural antisepsis 
of urinary catheterization contributed to the decrease of urinary tract 
infections associated with long-term urinary catheter in patients 
admitted to the coronary ICU.
References
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Introduction Whole-body skin decolonization with chlorhexidine in 
critically ill patients reduces multidrug-resistant bacterial colonization, 
and catheter-related bloodstream infection (BSI). We performed a 
meta-analysis of randomized controlled trials to determine whether 
daily bathing with chlorhexidine decreased hospital-acquired BSIs in 
critically ill patients.
Methods We searched the MEDLINE, EMBASE, and Cochrane Central 
Register of Controlled Trials databases to identify randomized 
controlled trials that compared daily bathing with chlorhexidine and 
a control (daily bathing with soap and water or nonantimicrobial 
washcloths, or implementation of MRSA screening and isolation) in 
critically ill patients. The primary outcome was hospital-acquired BSIs. 
Secondary outcomes were adverse eff ects of chlorhexidine and the 
incidence of identifi ed pathogens.
Results This meta-analysis included four studies. The overall incidence 
of hospital-acquired BSIs was signifi cantly lower in the chlorhexidine 
group compared with the control 0.80 (95% CI, 0.71 to 0.90; P <0.001; 
I2 = 29.4%). Gram-positive (RR = 0.59, 95% CI, 0.44 to 0.79, P = 0.000; 
I2 = 46.0%) and MRSA-induced (pooled RR = 0.64; 95% CI, 0.47 to 0.88, 
P  =  0.006; I2  = 0.0%) bacteremias were signifi cantly less common in 
the chlorhexidine group. Chlorhexidine did not aff ect Gram-negative 
bacteremia or fungemia. The overall incidence of adverse events, such 
as skin rashes, was similar in both groups.
Figure 1 (abstract P79). Incidence of DSSI.
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Conclusion Daily bathing with chlorhexidine was associated with 
a reduction in the rates of hospital-acquired BSI without signifi cant 
complications in critically ill patients. It also decreased the incidence of 
Gram-positive hospital-acquired BSIs, especially MRSA.
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Introduction Hand hygiene is the single most eff ective but least 
practiced action in breaking the chain of transmission of microbes. 
Studies have shown a correlation between the compliance of hand 
hygiene and its impact on the health outcome.
Methods A quasi-experimental study was done in three level III ICUs 
of a tertiary care hospital in Kolkata (January to April 2014). Data 
were collected on existing hand hygiene compliance rate, ventilator-
associated pneumonia (VAP) rate, catheter-related bloodstream 
infection (CRBSI) rate, catheter-related urinary tract infection (CAUTI) 
rate, standardized mortality ratio (SMR) and average ICU length of 
stay in the abovementioned units. Root cause analysis was done and 
interventions were developed to improve hand hygiene compliance 
and was implemented (July to October 2014). Comparison was done 
between preintervention and postintervention periods.
Results In the preintervention period (January to April 2014) the hand 
hygiene compliance among the caregivers was found to be 40%, VAP 
rate (8.77), CRBSI rate (3.42), CAUTI rate (5.27), SMR (1.14) and average 
ICU length of stay was 6 days ± 5.85 SD (median 4.5). Interventions were 
developed and implemented as follows: education and awareness  – 
road shows; positive reinforcement; secret watch nurse; e-ICU  – 
electronic surveillance; ring the bell once every hour – baseline hand 
hygiene; visual reminders; availability of alcohol-based hand rub, soap 
and water and sinks; random hand swabs; and compliance audits. 
In the postintervention period (July to October 2014) data showed 
a signifi cant improvement in the hand hygiene compliance (75%). 
Further analysis showed an association with decrease in the incidence 
of VAP rate (4.71), CAUTI rate (3.51), CRBSI rate (2.65), SMR (1.05) and 
average ICU LOS 5.05 days ± 4.03 SD (median 4).
Conclusion Improved hand hygiene compliance can be attributed to 
decreased incidence of VAP, CRBSI, CAUTI, SMR and average ICU LOS. 
This does defi nitely impact the overall clinical outcome. However, 
continued surveillance of hand hygiene compliance and regular audits 
is of utmost importance to make the change sustainable.
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Introduction Multidrug-resistant organism (MDRO) infections in 
critically ill patients are often life-threatening. To prevent nosocomial 
infections of MDRO, we made an infection control bundle in our ICU 
in 2013. In this study we evaluated the eff ect of our infection control 
bundle to prevent nosocomial MDRO transmission and infection.
Methods Our infection control bundle consists of preemptive contact 
precaution to all care, active surveillance culture and isolation of patients 
with MDRO. This bundle was applied to all patients admitted to our ICU 
since 2013. The study period to evaluate the eff ects of the bundle was from 
April 2012 to March 2014, and we divided it into two periods; fi rst period 
(before introduction of the bundle) and second period (after introduction 
of the bundle). We compared the incidence of nosocomial transmission 
and infection of MDRO between the two periods. MDRO was defi ned 
as bacteria that were resistant to more than three kinds of antibiotics. 
Nosocomial transmission was defi ned when MDRO was detected later 
than 48  hours after admission. Nosocomial infection was diagnosed 
according to the National Nosocomial Infection Surveillance Manual.
Results Admission to the ICU comprised 363 patients in the fi rst period 
and 380 patients in the second period. The incidence of transmission 
was decreased from 48 (13.2%) to 21 (5.5%) in methicillin-resistant 
Staphylococcus aureus (MRSA), from 16 (4.4%) to zero (0%) in multidrug-
resistant Acinetobacter baumannii. The incidence of nosocomial 
infection by MDRO was also decreased from 23 (6.3%) to 17 (4.5%) in 
pneumonia, from fi ve (1.4%) to two (0.3%) in urinary tract infection, and 
from 12 (3.3%) to one (0.3%) in surgical site infection. The incidence of 
antibiotic use for MDRO infection was decreased from 41 (11.3%) to 24 
(6.3%) in anti-MRSA antibiotics, and from 19 (5.2%) to eight (2.1%) in 
carbapenems.
Conclusion Introduction of infection control bundle in the ICU reduced 
the incidence of nosocomial MDRO transmission and infection, which 
resulted in the reduction of anti-MRSA antibiotics and carbapenems 
use in critically ill patients.
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Introduction Good hand hygiene (HH) is critical to infection control in 
the ICU. Electronic HH surveillance systems are purported to improve 
HH practices. Such a system was recently trialed in our ICU. The system 
is based on radiofrequency transponders in three locations: bracelets 
worn by ICU personnel; on all HH product dispensers; and above each 
patient’s bed. By correlating input from these three sources the system 
detects whether HH was performed before and after each patient 
contact. In the event that HH is not performed, the bracelet alerts the 
user (by vibration) in real time. This study represents a clinical validation 
of the system.
Methods ICU staff  (nurses and physicians) were followed by a 
trained observer over 60-minute periods. Each movement and 
contact during the period was documented. HH opportunities were 
determined according to WHO criteria and actual HH performance 
recorded. Observer and electronic data were compared for number 
of opportunities, HH performance and compliance. A satisfaction 
questionnaire was distributed to all users. Paired Student’s t test was 
used for comparison of the observer and electronic data.
Results Observations were made over 56 time periods that included 
836 HH opportunities and 485 occasions when HH was performed. 
The observer recorded 10.9  ±  7.6 HH opportunities/hour compared 
with 6.8  ±  6.9 for the electronic system (P  <0.001). HH performance 
occurred on 8.7 ± 3.9 occasions/hour versus 6.0 ± 3.1 occasions/hour 
as recorded by the electronic system (P <0.001). Overall HH compliance 
was 62.5  ±  17.7% versus 57.5  ±  21.0% respectively (P  =  0.523). On 
comparison of specifi c observation periods, there was poor correlation 
between compliance as recorded by the observer and electronic 
system (r = 0.03, P = 0.915). Satisfaction questionnaires were completed 
by 41 personnel. Satisfaction with the system was low or very low for 
21/41 (61%). System inaccuracy (either bracelet alerts without cause, or 
lack of bracelet alerts when HH was required) was the most common 
reason for dissatisfaction (31/41, 76%), followed by physical discomfort 
from the bracelet (18/41, 44%).
Conclusion The electronic HH system consistently underestimated 
both HH opportunities and HH performance. The main reason for 
dissatisfaction with the system was inaccuracy of bracelet alerts. These 
data suggest that for an electronic system to be accepted by ICU staff , it 
has to be highly accurate and comfortable for the user.
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Introduction The use of intravascular catheter devices is often 
associated with serious bloodstream infections due to microbial 
contaminations. To minimize risk of such infections NIOSH recommends 
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the use of closed system transfer devices (CSTDs). To evaluate the 
microbial tightness of CSTDs we developed two methods which 
simulate the bioburden in ambient air of operating rooms and ICUs.
Methods The methods simulate airborne and touch contamination. 
We tested the microbial tightness of the integrated Safefl ow® valve 
of a Mini-Spike® which is used for drug admixture. The airborne 
contamination was done in an exposure chamber in which a nebulizer 
distributed defi ned B. subtilis spore aerosols [1]. A Mini-Spike® was 
inserted into a vial of 0.9% sodium chloride solution (NaCl). A nebulizer 
with a suspension of 4.8 × 105 CFU spores of B. subtilis per ml was used 
to generate an aerosol for 1 minute. The volume of B. subtilis suspension 
nebulized per minute was 0.278  ml. This corresponds to 1.34  ×  103 
aerosolized spores in the exposure chamber, which has a volume of 
0.24 m3 (5.6  ×  103 CFU per m3 air). The used concentration was 100 
times higher than the microbial burden found in hospitals [2]. After 
nebulization the valve was disinfected and NaCl was withdrawn into a 
syringe at certain time intervals. The NaCl was incubated on tryptic soy 
agar at 37°C for 48 hours. Results were documented as CFU. For touch 
contamination, a Mini-Spike® was attached to a vial of NaCl. The valve 
of the Mini-Spike® was contaminated with 105 CFU Staphylococcus 
aureus. The subsequent procedure was done as described above.
Results Out of nine tested valves, none showed transmission of B. 
subtilis spores after airborne contamination. Three out of nine tested 
valves were contaminated with S. aureus after touch contamination.
Conclusion Our study shows that both methods are suitable for 
evaluating the microbial tightness of CSTDs.
References
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Introduction We conducted a survey to assess clinicians’ knowledge 
of personal protective equipment (PPE) requirements for infectious 
diseases and biochemical warfare agents. A safe level of PPE is 
essential when treating patients with highly infectious diseases or 
those contaminated with hazardous substances. The recent Ebola virus 
disease (EVD) outbreak in West Africa has highlighted that, although 
uncommon, contagious diseases with high mortality rates can be a 
threat to healthcare systems at local, national, and international levels 
[1]. Chemical, biological, radiological or nuclear (CBRN) contamination 
presents similar risks.
Methods A validated, hand-delivered, multiple-choice questionnaire 
[2] was used to assess intensive care, emergency medicine, and 
anesthetics specialist registrars’ knowledge of respiratory and skin 
protection needed during a resuscitation scenario with advanced 
life support. Participants selected the PPE required for the biological 
hazards: EVD, severe acute respiratory syndrome (SARS), inhalational 
anthrax, plague and smallpox; and the biochemical hazards: sarin, 
hydrogen cyanide, phosgene and mustard gas (dichlordiethyl sulfi de). 
Responses were compared with UK national recommendations and a 
previous survey in 2009 [2].
Results Ninety-eight clinicians (anesthetics n  = 51, emergency 
medicine n = 21, intensive care medicine n = 26) completed surveys. 
The best knowledge (76% correct) was for SARS, with less knowledge 
for anthrax, plague, EVD, and smallpox (60%). We found limited 
knowledge for chemical warfare agents (20 to 30%). Sixty to 80% of 
all incorrect responses were over-rated. There was no diff erence in 
knowledge compared with previous published results [2].
Conclusion Despite national and regional training since previous 
surveys [2], the results indicate that further training on PPE is required 
for clinicians treating patients exposed to infectious diseases and CBRN 
agents, ideally in a simulation setting. Further research into whether 
the required levels of PPE are readily available to clinicians would be 
pertinent.
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Introduction To describe the characteristics of the patients with 
tuberculosis (TB) requiring intensive care and to identify the factors 
associated with in-hospital mortality in an ICU in Portugal.
Methods A retrospective cohort study between January 2007 and 
July 2014 of all patients with TB admitted to the ICU of the Infectious 
Diseases Department of Centro Hospitalar de São João. Comorbid 
diagnoses, clinical features, radiological and laboratory investigations 
and outcomes were reviewed. The primary outcome was the in-
hospital mortality. A univariate analysis was performed to identify risk 
factors for death.
Results During the study period, 40 patients with TB were admitted 
to the ICU; 75% male and median age of 52  years (IQR 37.5 to 62.8). 
Overall, 22 (55%) patients died in the hospital, of whom 16 (40%) died 
in the ICU. Comorbid illness was identifi ed in 32 (80%) patients, with HIV 
infection being the most common, present in 15 (37.5%) patients. The 
main reason for ICU admission was respiratory failure (70%), followed by 
sepsis/septic shock (22.5%). Twenty-eight (70%) patients had isolated 
pulmonary disease, four (10%) had isolated extrapulmonary disease 
and eight (20%) had association of pulmonary and extrapulmonary 
disease. Mycobacterial cultures were positive in 31 (77.5%) patients; 
three patients presented monoresistant strains. Twenty-nine (72.5%) 
patients required mechanical ventilation and 21 (52.5%) required 
vasopressor infusion in the ICU; two patients were treated with ECMO. 
Thirty-four (85%) patients received antituberculosis therapy. The 
median length of stay was 11.5 (IQR 3.25 to 28.5) days in the ICU and 
40.5 (IQR 21.0 to 62.8) days in the hospital. The presence of at least one 
comorbidity, smoking, age, sepsis/septic shock on admission, high 
SAPS II and APACHE II score, positive direct examination and PCR in 
respiratory samples, the need for mechanical ventilation or vasopressor 
infusion were signifi cantly associated with mortality (P  <0.05). There 
was no association between mortality and HIV status, site of TB disease, 
concomitant acute disease or development of hospital infections.
Conclusion In this cohort we found a high mortality rate in the TB 
patients requiring intensive care. The risk factors for mortality due to 
severe TB are mainly related to the severity of organ failure, patient 
characteristics and burden of disease and not to HIV status or site of 
TB disease.
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Introduction Mucormycosis is a devastating disease most commonly 
seen in immunosuppressed individuals. It has the propensity 
to disseminate in humans and cause rhinocerebral, pulmonary, 
gastrointestinal, and cutaneous infections. This study focuses on 
cutaneous mucormycosis, incidence, epidemiologic characteristics and 
mortality in intensive care medicine.
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Methods We present a descriptive study in an ICU between the 
years 2001 and 2013 on the incidence of patients with cutaneous 
mucormycosis. Sociodemographics, comorbidities and laboratory 
data were recorded. Clinical data were collected to calculate the 
APACHE score. The main outcome was to analyze the epidemiological 
characteristics of patients with cutaneous mucormycosis and mortality.
Results Seven patients were identifi ed with cutaneous mucormycosis 
between the years 2001 and 2013. The mean age of patients was 
52 ± 4, with an APACHE score of 19 ± 9, and 57% died. All patients were 
admitted for trauma-related injury suff ering blast, abrasive injuries or 
burns. Mortality among patients with signs of sepsis was 100%, and 
only in one of them was empirically antifungal therapy started; in the 
others antibiotic treatment was directed. Among patients without 
signs of sepsis, the survivor was treated with amputation where 
mucoral infection was isolated. Procalcitonin rose in all patients with 
signs of sepsis.
Conclusion Cutaneous mucormycosis is less common than other 
clinical forms, most frequently seen in inmunocompetent patients 
but potentially lethal if treatment is not rapid. Patients at risk are 
those with disruption of the normal protective cutaneous barrier. 
In these patients, if signs are of sepsis it is very important to suspect 
the possibility of infection by Mucor and initiate empiric antifungal 
treatment with surgery to avoid high mortality. Surprisingly, in our 
series, determination of procalcitonin showed high levels in spite of 
not having value in fungal infection.
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Introduction Ventilator-associated pneumonia (VAP) remains a 
signifi cant problem within ICUs. There is a growing recognition of the 
impact of critical-illness-induced immunoparesis on the pathogenesis 
of VAP, but the mechanisms of this immunoparesis remain incompletely 
understood. We hypothesised that, because of limitations in their 
routine detection, Mycoplasmataceae are more prevalent amongst 
patients with VAP than previously recognised, and that these organisms 
potentially impair immune cell function.
Methods Two cohorts [1,2], totalling 159 patients, were recruited 
from 12 UK ICUs; all patients had suspected VAP and underwent 
bronchoscopy and bronchoalveolar lavage. VAP was defi ned as 
growth of organisms at >104 CFU/ml on conventional culture. Thirty-
six healthy donors underwent lavage for comparison. Samples were 
tested for Mycoplasmataceae (Mycoplasma and Ureaplasma spp.) by 
PCR, and positive samples underwent sequencing for speciation. 
Additionally, healthy donor monocytes and macrophages (MDM) 
were exposed to Mycoplasma salivarium and their ability to respond to 
lipopolysaccharide and undertake phagocytosis was assessed.
Results Mycoplasmataceae were found in 48% of patients with VAP, 
compared with 14% of patients without VAP (P <0.0001). Patients with 
sterile lavage had a similar prevalence to healthy donor lavage (10 vs. 
8%, P = 0.54). The commonest organism identifi ed was M. salivarium. 
Human blood monocytes and MDM incubated with M. salivarium 
displayed impaired cytokine responses to lipopolysaccharide and 
MDM demonstrated impaired phagocytosis.
Conclusion This study demonstrates a high prevalence of 
Mycoplasmataceae amongst patients with VAP, with a markedly lower 
prevalence amongst patients with suspected VAP in whom subsequent 
cultures refuted the diagnosis. The commonest organism found, M. 
salivarium, is able to profoundly impair the functions of key immune 
cells and thus suggests that Mycoplasmataceae may contribute to VAP 
pathogenesis.
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Introduction Changes in infection agents and their sensitivity to 
antibiotics are the main cause of severity of surgical infections. In 
spite of development and introduction of new drugs and methods of 
treatment, the number of patients with sepsis increases, so the problem 
in diagnosing and treatment is still far from resolution.
Methods A comparative retrospective analysis of 52 histories of 
patients with sepsis, which were treated in the Department of Surgical 
Infections in 1999 and 2013.
Results The number of patients with sepsis in 2013 was raised 2.7 
times, in comparison with 1999. Mortality decreased from 79% in 
1999 to 55% in 2013. In most cases sepsis was accompanied with 
immunosuppressive disorders, such as diabetes, oncology, alcohol 
and drug addiction, and HIV infection. We analyzed crops of discharge 
from the wound and blood cultures in 52 patients with sepsis. Crops of 
wound were taken during the initial surgical intervention, then every 
3 to 7 days, as well as the surgical interventions being repeated. Blood 
cultures were performed in the presence or suspected diagnosis of 
sepsis, in accordance with the classifi cation Bone criteria. In comparison 
of spectrum of infection agents, Staphylococcus aureus is still leading 
(1999 – 36.6% of isolates, 2013 – 25%), and the percentage of MRSA was 
0% in 1999 and 37.5% in 2013. The frequency of Gram-negative fl ora 
has increased: E. coli (8.5%/20%), P. aeruginosa (8.5%/12%), Klebsiella 
pneumoniae (0%/16%) and Acinetobacter spp. (0%/16%). Speaking 
about the resistance of microorganisms, there is still a high percentage 
of sensitivity to aminoglycoside antibiotics (79.4%/75%), glycopeptides 
(77.2%/71%), carbapenems (88.4%/78%) and also to the combination 
therapy (71.8%/62.4%), but also a reduction in sensitivity to the 
group of beta-lactam antibiotics (58.2%/32.5%) and fl uoroquinolones 
(64.6%/36.4%).
Conclusion The number of patients with sepsis has increased; 
the mortality of sepsis has decreased. The frequency of S. aureus 
isolation is still high, MRSA is the same. The frequency of Gram-
negative fl ora isolation has increased, especially K. pneumoniae and 
Acinetobacter spp. The resistance of microorganisms to beta-lactams 
and fl uoroquinolones is rising but the sensitivity to aminoglycosides, 
glycopeptides, and carbapenems is still maintained.
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Introduction The eff ectiveness of initially used antimicrobials 
represents an important factor in infectious events in coronary intensive 
care units (CICU) [1]. This study aimed to analyze the prevalence of 
infectious events and the prescribed antimicrobial in CICU.
Methods We analyzed the data of 2,005 patients admitted to the CICU 
for 3 years. The infectious events were based on general characteristics, 
main sites and outbreaks of infectious events in addition to the main 
microorganisms and pathogens. The prescription of antimicrobials was 
analyzed based on the isolated or associated use of antimicrobials. We 
also analyzed the adequacy of initial empirical antimicrobial according 
to the microbiological evidence. The general characteristics of events – 
that is, time, evidence of infection, infections by multidrug-resistant 
pathogens – are also presented.
Results The prevalence of infection was 4% (n  = 81). Ventilator-
associated pneumonia was 35% (n = 28), whereas urinary and primary 
bloodstream associated with catheters was 14% (n = 11) and 9% (n = 
7), respectively. There was 82% (n  = 66) evidence of microbiological 
infection. The main pathogens and microorganisms found were 
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Gram-positive bacteria (n = 24, 30%; Staphylococcus aureus (n = 16, 20%), 
Enterococcus faecalis (n = 4, 5%), Staphylococcus epidermidis (n = 3, 4%)), 
Gram-negative (n = 43, 53%; klebsiella sp. (n = 13, 16%), Pseudomonas 
aeruginosa (n  = 7, 9%), Escherichia coli (n  = 7, 9%)) and fungi (n  = 5, 
6%; candida sp. (n  = 2, 3%), Candida albicans (n  = 1, 1%), Candida 
dubliniensis (n  = 1, 1%)). The commonly prescribed antimicrobials 
were piperacillin/tazobactam (n = 32, 40%), vancomycin (n = 30, 37%), 
polymyxin B (n = 23, 28%), cefepime (n = 16, 20%), meropenem (n = 12, 
15%), cefuroxime (n = 8, 10%), ciprofl oxacin (n = 6, 7%), tigecycline (n = 
6, 7%), ampicillin (n = 5, 6%), clindamycin (n = 4, 5%), chloramphenicol 
(n = 4, 5%), oxacillin (n = 4, 5%) and others (n = 32, 28%). There was 75% 
(n = 46) infection during hospitalization in the unit. Approximately 32% 
of infections were caused by multidrug-resistant pathogens, although 
there was effi  ciency of 81% in the proper use of initial antimicrobials.
Conclusion We conclude that infection is prevalent even in CICU, and 
that the microbiological profi le is quite diverse, as well as the antibiotics. 
This allows us to better understand the profi le of this kind of unit.
Reference
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Introduction The aim was to analyze the Gram-negative bacteremia 
profi le and the predisposing factors for length of stay in the surgical 
and medical ICU and outcome.
Methods Retrospective data analysis of patients during 4 years treated 
in a surgical and medical ICU with positive blood culture for Gram-
negative rod.
Results Gram-negative rod monobacteremia (n = 160) cultures revealed: 
Escherichia coli (n  = 52, 32.5%), Acinetobacter spp. (n  = 47, 29.4%), 
Klebsiella spp. (n = 22, 13.7%), Enterobacter spp. (n = 20, 12.5%), Proteus 
spp. (n = 11, 6.9%), anaerobes (n = 3, 1.9%) and other Gram-negative 
rods, including Stenotrophomonas maltophilia, Haemophilus infl uenzae, 
Neisseria meningitidis, Achromobacter spp. and Actinobacillus limirensi 
(n = 5, 3.1%). Both E. coli and Acinetobacter spp. were responsible for 
the vast majority of Gram-negative rod monobacteremia (n  = 99, 
61.8%, P = 0.0128). Also most often (n = 50, 72.5%, P = 0.049) primary 
bacteremia was caused by E. coli and Acinetobacter spp. Separate 
group’s multidrug resistance was found: E. coli in 12 (23.1%) cases, 
Acinetobacter spp. in 45 (95.7%, P = 0.02), Klebsiella spp. in nine (40.9%), 
Enterobacter spp. in 11 (55.0%), Proteus spp. in six (54.6%) cases. The 
vast majority of patients with multidrug-resistant bacteremia were 
aged over 65  years (n  = 64, 77.1%, P  =  0.042), stayed in the ICU less 
than 14 days (n = 70, 84.3%, P = 0.039), and had lethal outcome (n = 
74, 89.2%, P = 0.03). Patients who stayed in the ICU less than 14 days 
presented with primary Gram-negative rod bacteremia (n = 67, 57.7%, 
P  =  0.03), need for mechanical ventilation (n  = 90, 77.6%, P  =  0.043) 
and lethal outcome (n  = 112, 96.6%, P  =  0.01). Lethal outcome was 
confi rmed in patients with primary Gram-negative rod bacteremia 
(n = 55, 79.7%, P = 0.03), MDR strain (n = 74, 89.2%, P = 0.03), presence 
of shock (n  = 120, 75.0%, P  <0.001), mechanical ventilation (n  = 133, 
74.3%, P <0.001), cancer chemotherapy (n = 18, 90.0%, P = 0.03), and 
chronic obstructive pulmonary disease (n = 13, 100%, P = 0.03).
Conclusion E. coli and Acinetobacter spp. – the most often pathogens 
of Gram-negative rod bacteremia  – were mostly multidrug resistant. 
Multidrug-resistant bacteremia was related to age, length of stay less 
than 14  days, and lethal outcome. Predisposing factors for shorter 
length of stay: primary bacteremia, mechanical ventilation, lethal 
outcome, and for lethal outcome: primary bacteremia, multidrug 
resistance, presence of shock, mechanical ventilation, cancer 
chemotherapy, chronic obstructive pulmonary disease.
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Introduction The objective was to evaluate whether asymptomatic 
carriage of methicillin-resistant Staphylococcus aureus (MRSA), 
vancomycin-resistant enterococci (VRE) and extended-spectrum beta-
lactamase producing Gram-negative bacilli (ESBL-GN) on admittance 
to the ICU of the University Hospital of Infectious Diseases Cluj-Napoca, 
Romania is a risk factor for infection due to these multidrug-resistant 
organisms (MDRO) during hospitalization.
Methods A prospective study during a 6-month period (June to 
November 2014), including all adult patients admitted to our ICU. 
All patients were screened on admittance for nasal MRSA, intestinal 
VRE and ESBL-GN carriage. Patients admitted with any localization 
of infections due to these organisms were excluded. Patients were 
monitored for developing nosocomial infections due to MDRO during 
hospitalization. We evaluated previous colonization as a risk factor for 
future infections. We used bioMerieux selective chromogenic media for 
MDRO for screening and Vitek2Compact for identifi cation. Statistical 
analysis was performed with chi-square test and univariate analysis.
Results From 119 screened adult patients, 65 women (54.6%), average 
age 67  years, we had at screening on admittance into the ICU: 14 
positive MRSA (11.8%), 63 positive ESBL-GN (52.9%  – 41 strains of 
Escherichia coli, 26 strains of Klebsiella sp., 11 strains of Proteus mirabilis 
and one strain of Enterobacter cloacae) and 35 positive VRE (29.4%  – 
33 strains of Enterococcus faecium and two strains of Enterococcus 
faecalis) without concomitant infection with these MDRO. The average 
duration of ICU stay was 7.32 days. During hospitalization, 14 patients 
(11.8%) developed nosocomial infections due to MDRO. Colonization 
with MDRO preceded nosocomial infections in: one of four patients 
with MRSA-positive blood cultures (P = 0.96), seven of eight patients 
with ESBL-GN infections (P = 0.10) and three of four patients with VRE 
urinary tract infections (P = 0.14). Although not statistically signifi cant, 
owing to the low number, most patients who developed infections 
with ESBL-GN had previous intestinal colonization.
Conclusion The carriage of MDRO in ICU-admitted patients is important, 
especially for ESBL-GN. The incidence of nosocomial infections with 
MDRO in the ICU is high. ESBL-GN intestinal colonization could be a 
risk factor for nosocomial infections but further studies are needed to 
confi rm this.
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Introduction We describe the type of patient and the main nosocomial 
infections in a level II hospital ICU unit, 18 beds (12 polyvalent-general, 
six coronary).
Methods We used the ENVIN-HELICS database and made statistical 
calculations for all patients admitted to the ICU between 1 October 
2012 and 30 September 2013 using SPSS v.15.
Results Patients admitted (1,126): 65.1% were male; mean age 61.72 
(SD ±15.8), CI (60.7 to 62.7); mean APACHE II 12.6 (SD ±8.42), CI (12.12 
to 13.11); and a mean time stay of 4.84 days (SD ±6.26). In total, 68.9% 
were provided from the community. A total of 44.1% were coronary, 
2.84% trauma and 53.02% medical–surgical patients. A total of 29.8% 
had antibiotic therapy in the ICU, 20% had it before incoming. In total, 
18.38% were treated with artifi cial airway (MV, tracheostomy). In total, 
54.09% used a urinary catheter and 38.8% needed a central venous 
catheter. Fifteen percent of patients had some kind of surgery before 
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admission; 4.8% required the extrarenal depuration technique. In total, 
497 patients (44.1%) were coronary, 49.5% male, mean age 66.18 (SD 
±12.6), CI (64.88 to 67.48); mean APACHE II 9.74 (SD ± 6.1), CI (9.1 to 10.3); 
and a mean time stay of 3.62 days (SD ±4.7), CI (3.1 to 4.1). Mortality in 
this group was 3.7%. In 61.9% of cases the diagnosis of admission was 
AMI, 16% arrhythmia and 11.6% unstable angina. Of patients, 629 were 
polyvalent (55.8%), 53.85% male, mean age 58.05 (SD ±17.2), CI (56.7 
to 59.4); mean APACHE II 14.6 (SD ±9.1), CI (13.8 to 15.3); and a mean 
time stay of 4.64  days (SD ±7.7), CI (4 to 5.25). Mortality was 11.6%. 
In 33.2% the cause of income was digestive, 23.2% acute or chronic 
exacerbated respiratory failure, 12.4% severe sepsis/septic shock and 
10.1% postoperative cardiovascular surgery. The incidence density (ID) 
of catheter-related bacteremia was 5.5, 92.8% from the fourth day of 
ICU admission; ID of ventilator-associated pneumonia (VAP) was 5.94, 
88.9% since the fourth day; and ID of urinary tract infections (UTI) 
related to urinary catheter was 2.88, 80% of them since the fourth day. 
From all patients who developed intra-ICU infections, mean APACHE II 
in admission was 21.3 (SD ±9.6) with a mean time stay of 23.4 days (SD 
±12.9) and a mortality percentage of 19.6%.
Conclusion In our ICU the main cause of admission was the polyvalent 
patient, who is younger and has more severity with not much diff erence 
in mean time of stay compared with the coronary patient. The intra-ICU 
infections provide an increase of morbi-mortality risk and consumption 
of resources.
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Introduction Poor infection control practices along with irrational 
usage of antibiotics lead to emergence of multidrug-resistant (MDR) 
organisms. Increasing use of colistin for treating MDR infections leads 
to selection of organisms that are intrinsically resistant to colistin. 
There are limited Indian literatures which evaluated the incidence of 
intrinsically resistant isolates to colistin in critically ill patients. Our 
study aimed to investigate the incidence of true pathogen or colonizer 
with the prior antibiotic exposure and patient’s clinical outcome.
Methods The prospective, cross-sectional study was carried out from 
March 2013 to April 2014. Clinical samples included culture positivity 
for isolates intrinsically resistant to colistin from patients who were 
admitted to the ICU or had a prior ICU stay in the same admission.
Results A total of 93 unusual Gram-negative rods were isolated from 76 
patients. This included 19.4% (n = 18) Serratia marcescens, 12.9% (n = 
12) Stenotrophomonas maltophilia, 14% (n = 13) Burkholderia cepacia, 
24.7% (n  = 23) Proteus mirabilis, 17.2% (n  = 16) Morganella morganii, 
9.7% (n = 9) Elizebethkingia meningoseptica and 2.1% (n = 2) Providencia 
species. A total of 68.4% (n = 52) patients had prior exposure to either 
colistin or carbapenems or both. In total, 71% (n  = 66) of the total 
isolates from patients had previous antibiotic exposure. Among the 
total 93 intrinsically resistant isolates to colistin, 37.6% (n  = 35) of 
isolates from all clinical sources (endotracheal, pus, urine and blood 
samples) were true pathogens and the remaining 62.3% (n = 58) were 
colonizers. There was a statistically signifi cant increase in length of ICU 
stay and duration of hospitalization in the presence of true pathogen.
Conclusion Selection pressure due to extensive use of higher antibiotics 
may lead to emergence of intrinsically resistant isolates, which narrows 
the therapeutic options in the ICU. Our study emphasizes the paramount 
importance of establishing clinical relevance of these organisms before 
treating them as true pathogens. This calls for judicious use of higher 
antibiotics, implementation of an antibiotic stewardship program and 
strict infection control practices.
References
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Introduction In the era of rising prevalence of serious infections 
caused by multidrug-resistant (MDR) organisms and the paucity of 
in-fl ow of newer antimicrobial agents, the relatively older antibiotics 
that had been left out of clinical practice for various reasons are now 
being increasingly considered as the potential agents to combat such 
infections. Fosfomycin, known for almost four decades, has a broad 
spectrum of activity against several Gram-negative and Gram-positive 
bacteria.
Methods This study, conducted in the Microbiology Department of 
Medica Superspecialty Hospital between July and November 2014, 
was aimed at testing the in vitro sensitivity of fosfomycin against 
isolates identifi ed from various clinical specimens from diff erent parts 
of Kolkata. After confi rming the identity and antibiogram by Microscan 
Autoscan 4, the isolates were tested for fosfomycin sensitivity by 
the Epsilometer test. MIC values were interpreted in accordance 
with the currently recommended Clinical and Laboratory Standards 
Institute (CLSI) criteria for urinary tract isolates of Escherichia coli and 
Enterococcus faecalis and the European Committee on Antimicrobial 
Susceptibility Testing (EUCAST) criteria for Enterobacteriaceae and 
Staphylococcus aureus.
Results Out of the 1,895 isolates tested, fosfomycin displayed an overall 
in vitro susceptibility against 90%, but only 64% against MDR strains. 
Among the MDR organisms nearly 78% of E. coli and 70% of Klebsiella 
spp. and 40% of MRSA isolates showed provisional MICs in the sensitive 
range while among the sensitive strains fosfomycin showed around 
92% susceptibility. Our study results were comparable with the results 
obtained from an Indian study published from CMC Vellore in 2013 
showing a fosfomycin susceptibility of around 75% among MDR 
uropathogenic E. coli.
Conclusion Being a broad-spectrum bactericidal agent usable both 
orally and parenterally with low toxicity profi les and lesser prevalence 
of cross-resistance with other antimicrobials, fosfomycin can be an 
alternative to other broad-spectrum agents to treat uncomplicated 
infections as well as in the case of infections with MDR organisms where 
treatment options are very few. This study possibly reveals a much-
needed solution for the rising carbapenem resistance and also for the 
treatment of infections with such MDR pathogens, thereby bringing 
down the length of stay in hospital, cost of therapy and suff ering on 
the part of the patients.
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Introduction The emergence of multidrug-resistant (MDR) pathogens 
is a major cause of infection-related mortality among critically ill 
patients. The synergistic eff ect between commonly used antibiotics 
against diffi  cult to treat nosocomial MDR Gram-negative strains, if 
present, could provide a viable option as an alternative therapy. The 
aim of this study was to investigate the potential of antibiotic synergy 
against MDR A. baumannii, K. pneumonia and P. aeruginosa strains, 
isolated from critically ill patients in a Greek ICU.
Methods We tested 59 A. baumannii, 41 K. pneumoniae and 64 P. 
aeruginosa strains, isolated during the period 2010 to 2013. All strains 
were resistant to carbapenems and showed reduced susceptibility or 
resistance to tigecycline or colistin (MIC >2), in accordance with CLSI 
guidelines. We evaluated double-drug combinations of carbapenem 
(CRB)/colistin (COL), tigecycline (TG)/COL, rifampicin (RIF)/COL, CRB/
gentamicin (GEN), CRB/amikacin (AMK) for A. baumannii, TG/COL, 
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CRB/COL, piperacillin–tazobactam (PIP/TAZ)/GEN, CRB/GEN for K. 
pneumoniae and AMK/(PIP/TAZ), AMK/aztreonam (AZT), AMK/cefepime 
(CEF), AMK/CRB and CRB/COL for P. aeruginosa strains. In order to 
perform synergy tests, the E-test methodology (BioMerieux, Marcy 
l’E’toile, France) was used. Synergy was defi ned as a fraction inhibitory 
concentration (FIC) index ≤0.5, additive eff ect 0.5 to 1, indiff erent or 
antagonistic eff ect >2 (Lorian defi nition).
Results Against 59 MDR A. baumannii strains, the synergy eff ect of CRB/
COL was 55.9%, RIF/COL 38.9%, CRB/GEN 22%, CRB/AMK 20.3% and 
TG/COL 16.9%, respectively. Against 41 K. pneumoniae strains, synergy 
rates were: CRB/COL 43.9%, CRB/GEN 31.7%, PIP/TAZ/GEN 29.2% and 
TG/COL 24.4% respectively. Against 64 P. aeruginosa strains, synergy 
rates were: AMK/PIP/TAZ 64.6%, AMK/AZT 64.6%, AMK/CEF 58.3%, CRB/
COL 52%, AMK/CRB 25%.
Conclusion The most eff ective combination for both the A. baumannii 
and K. pneumoniae strains tested was CRB/COL. The next most eff ective 
combination was RIF/COL and CRB/GEN respectively. No competitive 
eff ect was observed for RIF/COL combination in all cases tested. The 
most eff ective combinations for P. aeruginosa strains were AMK plus 
PIP/TAZ or AZT or CEF. The next most eff ective combination was CRB/
COL. We recommend implementation of an antibiotic synergy test 
for MDR pathogens as a routine antimicrobial test in the hospitals’ 
microbiology laboratories, especially for critically ill patients, since 
some combinations seem to excel. Further studies are needed for the 
correlation of these combinations with clinical effi  cacy.
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Introduction Ventilator-associated pneumonia (VAP) is a common 
and serious problem in ICUs. Several studies have been conducted 
to determine the eff ectiveness of Gram stain of tracheal aspirates for 
diagnosing VAP. However, the eff ectiveness for predicting causative 
microorganisms and guiding appropriate initial antibiotic therapy has 
not been evaluated. The purpose of this study is to determine whether 
Gram stain of tracheal aspirates can guide appropriate initial antibiotic 
therapy for VAP.
Methods We retrospectively assessed two hypothetical empirical 
antibiotic treatment algorithms for VAP on an 18-bed ICU. Data 
on consecutive episodes of microbiologically confi rmed VAP were 
collected over a period of 22  months and divided into a derivation 
(1 February 2013 to 30 November 2013) and validation (1 December 
2013 until 15 November 2014) cohort. We constructed two algorithms 
in the derivation cohort. One is a local ecology-based algorithm (LEBA), 
according to clinical risk factors for MDR and susceptibility results in 
our hospital. The other is a Gram stain-based algorithm (GSBA). The 
selection of antibiotics on GSBA was directed against pathogens 
predicted from the results of bedside Gram staining of tracheal 
aspirates collected just before antibiotic therapy. Subsequently, LEBA 
and GSBA were retrospectively reviewed and compared with actually 
prescribed antibiotics in the validation cohort.
Results The fi rst 50 VAP episodes made up the derivation cohort and 
the subsequent 50 VAP episodes the validation cohort. Antibiotic 
coverage rates by applying LEBA and GSBA were identical (96% vs. 
96%). GSBA proposed more narrow spectrum therapy as compared 
with LEBA (P <0.001). GSBA recommended carbapenems in signifi cantly 
less episodes than LEBA (P <0.001) and the same episodes as actually 
prescribed initial therapy (P  =  1). However, there was signifi cant 
increase of antibiotic coverage rates in GSBA compared with the 
actually prescribed initial therapy (96% vs. 78%, P = 0.015).
Conclusion Antibiotic coverage rates on GSBA were comparable with 
LEBA. The use of GSBA would result in a signifi cant reduction of the 
administration of broad-spectrum antibiotics. Bedside Gram staining 
may be useful to guide appropriate initial antibiotic therapy for VAP.
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Introduction Urinary tract infection (UTI) is one of the most common 
bacterial infections in humans. Gram-negative organisms being the 
most common causative agent, the rising prevalence of resistance 
to a number of antibiotics and more importantly the production of 
extended spectrum beta-lactamase (ESBL) by these organisms is a 
growing concern worldwide. As the scenario is no better in community 
isolates, the choice of empirical antimicrobials for such infections 
becomes a great challenge for the clinicians.
Methods In this retrospective observational study we aimed at 
knowing the prevalence of ESBL production by organisms causing UTI 
in the community and to study the antibiogram of such isolates. Urine 
samples from patients with suspected UTI in the community were 
cultured for uropathogen by routine microbiological methods and 
susceptibility testing was done on Microscan Autoscan 4 (Siemens).
Results Out of 527 isolates of Enterobactereaceae, 314 (59.58%) were 
ESBL producers from the community samples compared with 315 
(67.30%) from hospital samples, with Escherichia coli being the most 
commonly isolated pathogen. Enterobacter spp. showed highest 
prevalence (80%) of ESBL production from the community samples. 
Among the ESBL producing strains from the community, the sensitivity 
to ciprofl oxacin, levofl oxacin and nitrofurantoin was 18%, 21% and 
44% respectively while in the non-ESBL producers the sensitivity rates 
were 52%, 51% and 73% respectively.
Conclusion Organisms producing the ESBL phenotype present with 
an added possibility of being resistant to other broad-spectrum 
antimicrobial agents which are commonly prescribed in the community 
to empirically treat such infections. This makes the choice of empirical 
antibiotic much more challenging in the community, drawing errors 
in judgment. A possibility of frequent overcorrection lies on the other 
side of the coin. This study also shows the possible need for empirical 
institution of class I carbapenems as one of the treatment options and 
outpatient parenteral antimicrobial therapy.
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Introduction We tried to develop a predictive model for patients 
colonized/infected by any multidrug-resistant organism (MDRO-C/I) 
at ICU admission based on risk factors easy to obtain (not depending 
on complex clinical records), being aware that foreseeing MDRO-C/I at 
ICU admission is key for appropriate empirical treatment and infection 
control.
Methods Data were collected prospectively from admission to 
discharge of 16,950 patients admitted consecutively (at least 
>24  hours) to 147 Spanish ICUs of the ENVIN (National Surveillance 
Study of Nosocomial Infections in ICUs) registry, from April to June 
2010. To create the predictive model, 11,998 (2/3) patients were used 
for univariable and multivariable logistic regression model and 4,952 
(1/3) for subsequent validation.
Results With a MDRO prevalence of 2.12% (359 MDROs at ICU admission 
were detected in 314 patients), 87.58% patients had only one MDRO, 
meanwhile 12.42% were MDRO-C/I by two or more simultaneously. 
Risk factors used in the development of the predictive model and 
independently associated with MDRO-C/I at ICU admission were 
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(relative risk not shown due to space limitation): age 65 to 74, medical or 
surgical critical patient (especially urgent surgery), admitted from other 
ICU or long-term facility, immunosuppression and deep postsurgical 
skin or skin-soft tissue infections. Admitted from the community and 
female gender emerged as protective factors. Although the predictive 
model showed good discrimination (AUC-ROC = 0.775 (95% CI, 0.744 to 
0.807)), sensitivity was only 67.4%. Validation with the remaining 4,952 
patients (1/3) showed an AUC-ROC = 0.712 (95% CI, 0.665 to 0.759) and 
a P value on the Hosmer–Lemeshow goodness of fi t test of 0.855. Even 
creating a new model, including variables obtained after ICU admission 
(severity by APACHE score, mechanical ventilation, central venous, 
arterial or urinary catheter, immunodefi ciency, parenteral nutrition, 
ventricular derivation, extrarenal depuration, non-invasive ventilation, 
tracheotomy, enteral nutrition and nasogastric tube), prediction 
capability did not improve (AUC-ROC = 0.801 (95% CI, 0.774 to 0.828), 
sensitivity 71.4%).
Conclusion MDRO prediction at ICU admission could not be based 
merely on clinical–demographic risk factors. Taking into account local 
particularities and combining risk factors with a rapid laboratory test 
might be the most eff ective way forward.
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Introduction Being capable of predicting MRSA on ICU admission 
is crucial to enhance infection control and to avoid inappropriate 
empirical treatment. Two objectives were studied: to describe risk 
factors for MRSA colonization/infection (MRSA-C/I) once admitted to 
the ICU; and to develop a predictive model at ICU admission, based on 
easy-to-obtain admission factors.
Methods Data were collected prospectively from 69,894 patients 
admitted consecutively (stay >24  hours) to 147 Spanish ICUs 
participating in the National Surveillance Study of Nosocomial 
Infections in ICU registry (ENVIN) during April to June 2006 to 2010. 
Univariable and multivariable analysis was performed for both 
objectives but we used only easy-to-obtain variables for the predictive 
model exclusively from those admitted in 2010 (n  = 16,950, 2/3 for 
analysis and 1/3 for subsequent validation).
Results In the 2006 to 2010 period, 1,046 were C/I by MRSA (note 
that relative risks are not included due to space limitations). First 
objective: previous antibiotic, APACHE II score >18, skin-soft tissue 
or postsurgical superfi cial skin infections, trauma or medical patient, 
age >65 (especially >75), urinary catheter and admitted from a long-
term care facility were independent risk factors for MRSA-C/I in ICU. 
Multicolonization increased signifi cantly the risk of MRSA-C/I, and 
immunodefi ciency and gender male emerged as protective factors. 
Second objective: independent risk factors on ICU admission were 
male gender, trauma critical patient, urgent surgery, admitted from 
other ICU, community or long-term facility, being immunosuppressed 
and skin-soft tissue infection. All confi gured the risk model for which, 
although showing good discrimination (AUC-ROC, 0.77; 95% CI, 0.72 
to 0.82), sensitivity (67%) and specifi city (76.5%) were insuffi  cient for 
the ICU setting. Afterwards validation with the remaining 4,952 (1/3) 
showed AUC-ROC  = 0.72 (95% CI, 0.65 to 0.79) and P value on the 
Hosmer–Lemeshow goodness of fi t test  = 0.539. The model did not 
improve even after including more complex variables (AUC-ROC = 0.82; 
95% CI, 0.77 to 0.86, sensitivity 63.64%, specifi city 78.48%).
Conclusion Independent risk factors for MRSA-C/I in the ICU and at 
ICU admission are described. To predict MRSA-C/I at ICU admission 
we should not rely on clinical–demographic risk factors alone. Its 
combination with a rapid laboratory test could be the way to proceed 
in future studies.
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Introduction Recently, extracorporeal cardiopulmonary resuscitation 
(ECPR) has become a common measure against cardiopulmonary 
arrest. In cases with ECPR, we usually insert cannulae for extracorporeal 
membrane oxygenation (ECMO) via the femoral artery and vein. 
However, the cannulation site is often contaminated by feces due 
to incontinence. Moreover, patients tend to be compromised by 
hypothermia due to the target temperature management, so we 
often experience central line-associated bloodstream infection of 
patients undergoing ECMO. We investigated the protective eff ect of a 
fecal incontinence management system (FMS) against bacteremia in 
patients undergoing ECMO.
Methods We studied 41 consecutive patients undergoing ECMO for 
out-of-hospital cardiac arrest (OHCA) between April 2010 and May 2014. 
Patients were divided into two groups according to the use or no use 
of FMS (Flexi-Seal™). Patients who died within 48 hours or from whom 
cannulae for ECMO were removed within 48  hours were excluded. 
Patients’ characteristics, underlying disease, target temperature 
management, prophylactic antibiotic use and incidence of bacteremia 
during admission were recorded and analyzed retrospectively.
Results Among 41 patients, 15 (37%) underwent FMS. There was 
no diff erence in age, sex, underlying disease, target temperature 
management, and prophylactic antibiotic use between two groups. 
Mean duration of ECMO was 4 days in both groups. The incidence of 
bacteremia was none in the group with FMS and fi ve (19%) in the group 
without FMS. Within fi ve cases of bacteremia, three were caused by 
enterobacterium.
Conclusion FMS may be protective against bacteremia for OHCA 
patients undergoing ECMO.
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Introduction Secondary bacterial pneumonia after infl uenza infection 
can cause severe disease with a high mortality. Recently, a new 
group 2 infl uenza A antibody (AT10_002) has been developed, which 
binds to multiple H3 and H7 subtypes. In a mouse model of primary 
infl uenza infection, treatment with AT10_002 as a fusion antibody 
protects against lethal infection, and reduces loss of bodyweight [1]. 
We hypothesized that treatment with AT10_002 reduces weight loss, 
lung injury and bacterial outgrowth, in a mouse model of viral infection 
followed by secondary pneumococcal infection.
Methods Male C57Bl/6 mice were intranasally inoculated with 400 
TCID50 Infl uenza A (H3N2). Two days after infection, mice were injected 
with either AT10_002 i.v. (n = 8) or a control antibody (n = 7). After 7 days, 
both groups were intranasally inoculated with 5 × 103 S. pneumoniae 
type 3 and were sacrifi ced 18  hours later. Outcome measures were 
weight loss, wet lung weight, cell count in bronchoalveolar lavage fl uid 
(BALF), and colony-forming units (CFUs) in lung homogenate. Data are 
represented as medians, and treatment groups are compared using 
nonparametric tests.
Results Mice receiving AT10_002 showed signifi cantly lower weight 
loss at the time of sacrifi ce compared with the control group (+1% vs. 
–12% change in weight; P = 0.0003). Also wet lung weight was lower 
(68 vs. 96 mg; P = 0.0003), cell counts in BALF were lower (4.9 × 105 vs. 
7.0 × 105 cells/ml; P = 0.0037) and CFUs in lung homogenate were lower 
(33 vs. 25 × 104 CFUs/mg; P = 0.0003) compared with controls.
Conclusion Early treatment with infl uenza antibody AT10_002 
signifi cantly reduces weight loss, lung injury and bacterial outgrowth, 
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in a mouse model of infl uenza infection followed by secondary 
pneumococcal pneumonia.
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Introduction The prevalence of viral respiratory tract infections in 
critically ill patients is uncertain, as well as the optimal diagnostic 
method to detect these. The aim of this study was to assess the 
prevalence of viral respiratory tract infections in mechanically 
ventilated patients, in both the upper and lower respiratory tract.
Methods A prospective observational study was performed in fi ve ICUs 
in the Netherlands. From September 2013 to April 2014, consecutive 
acutely admitted, mechanically ventilated patients were included, 
regardless of diagnosis at admission. Nasopharyngeal (NP) swabs and 
tracheal aspirates (TA) were collected at intubation, and were tested 
via multiplex RT-PCR for the following viruses: infl uenza A and B, 
parainfl uenzaviruses, RSV, human metapneumoviruses, bocaviruses, 
coronaviruses, rhinoviruses, enteroviruses, parechoviruses and 
adenoviruses. Viral DNA/RNA copies were expressed by crossing-point 
(cp) values.
Results In total, 1,499 patients were included, of whom 265 patients 
(18%) had a viral respiratory tract infection with at least one virus. In 
17 patients, two viruses were found; two patients had an infection with 
three viruses. The most prevalent was parainfl uenzavirus-3 (5.7%); 17 
patients (1.1%) had an infection with infl uenza. The lowest prevalence 
of viral infections occurred in September (12%), the highest in October 
and February (both 26%). Of the patients tested positive in TA, only 46% 
also tested positive in NP. The median cp values were not signifi cantly 
diff erent between TA and NP swabs (31.1 vs. 31.6, P = 0.75).
Conclusion The prevalence of viral respiratory tract infections is high in 
unselected ICU patients. Testing tracheal aspirate in combination with 
nasopharynx greatly increased detection of viruses, and yields similar 
cp values. Whether these viral infections are associated with prolonged 
mechanical ventilation and worse outcomes remains to be determined.
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Introduction The early identifi cation of severe sepsis and septic 
shock and early implementation of the SSC bundles were associated 
with reduced mortality [1]. The failure to initiate appropriate 
antimicrobial therapy increased mortality of septic shock patients [2]. 
We hypothesized that the parameter ‘Consensus initial antimicrobial 
therapy with microbial cultures’ correlates with outcome of septic 
shock patients.
Methods We analyzed 535 consecutive patients with septic shock 
(sepsis-induced hypotension persisting despite adequate fl uid 
resuscitation) from the EPOSS database (Data-based Evaluation and 
Prediction of Outcome in Severe Sepsis), which was developed to 
monitor and assess treatment effi  cacy in patient with severe sepsis 
and septic shock. Patients were admitted to participating ICUs (12 
hospitals  – 17 high-volume care units) in the Czech Republic from 1 
January 2011 to 5 November 2013. Patients were divided into two 
groups: survivors (n = 274) and nonsurvivors (n = 261).
Results Survivors versus nonsurvivors were similar in: age 65.8 (64.2; 
67.5) versus 66.5 (64.7; 68.3) P  =  0.583, men 159 (58.0%) versus 160 
(62.0%) P  =  0.376, APACHE II score 27 (15 to 40) versus 28 (15 to 40) 
P  =  0.737. Statistically signifi cant diff erences between survivors 
versus nonsurvivors were found in the parameter ‘Consensus initial 
antimicrobial therapy with microbial cultures’ 178 (79.5%) versus 128 
(58.4%) P <0.001 and in the parameter ‘Administration antimicrobials 
within the fi rst hour’ 163 (59.9%) versus 171 (70.7%) P  =  0.001. 
Administration of 30  ml/kg crystalloid for hypotension or lactate 
4 mmol/l (3 hours) and application of vasopressors (6 hours) were in 
both groups without statistically signifi cant diff erences.
Conclusion We found that correct choice of antibiotics improves 
outcome of septic shock patients. The choice of empirical antimicrobial 
therapy depends on complex factors related to the underlying disease, 
susceptibility of pathogens, patient’s history and clinical syndrome. 
Adequate initial antimicrobial therapy as an important factor of 
survival along with suitable initial fl uid resuscitation and application of 
vasopressors should be a priority for healthcare in human septic shock.
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Introduction MDR infections in the ICU are not nosocomial all the time, 
as perceived commonly. We performed a 2-year retrospective study to 
analyze the source of culture positivity in a medical ICU and to identify 
which types of infections are more prevalent.
Methods The data of a 35-bed medical ICU were analyzed from 
November 2012 to October 2014. The source of culture positivity 
was divided into three groups: patients admitted from the ER to the 
ICU who were referred from other hospitals or direct admissions, the 
second group was patients admitted within the hospital but outside 
the ICU for the fi rst 48  hours, and the third group was ICU-acquired 
infections. We also analyzed the data for type of infections, whether 
Gram-negative, Gram-positive or fungal.
Results There were 1,051 cultures positive in a 2-year period. In 
total, 46.8% (n = 492) of cultures were already positive on admission, 
which denotes community-acquired and referred patients from other 
hospitals. A total of 31.1% (n  = 327) of cultures were positive from 
patients admitted to general wards for more than 48 hours and then 
transferred to the ICU. Twenty-two percent (n = 232) of cultures were 
ICU-acquired infections. The data show community-acquired and 
hospital-acquired infections are the bulk of the culture load in an 
ICU. This could be attributed to increased surveillance and adherence 
to infection control practices in the ICU which may not be followed 
stringently in other parts of the hospital. Overuse of broad-spectrum 
antibiotics in community and primary care hospitals has resulted in a 
spurt in growth of resistant infections. This has reached an alarming 
level in developing countries. Out of total cultures positive 78.3% (n = 
822) were Gram-negative infections which included community-based 
and non-ICU infections.
Conclusion Antibiotic stewardship and strict adherence to infection 
control protocols in hospitals and guidelines for general practitioners 
can signifi cantly reduce the load of resistant organisms in the ICU. This 
may eventually improve patient outcomes and help in preserving the 
antibiotics for future generations.
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Introduction Early microbiological documentation may reduce 
attributable mortality and excessive use of broad-spectrum antibiotics 
in ventilator-associated pneumonia (VAP). Using bronchoalveolar 
lavage (BAL) and endotracheal aspirates (ETA), we studied a new 
molecular biology-based approach to detect and quantify bacteria in 
less than 3 hours. This prospective multicenter trial aimed at comparing 
the microbiological results obtained using this molecular protocol 
(easyMAG® system) and semiquantitative culture in suspected VAP.
Methods ETA and BAL samples were consecutively collected during 
10 months in adult patients in four ICUs of France. The molecular 
method includes a preprocessing liquefaction for ETA before DNA 
extraction. DNAs were extracted using the easyMAG® system. Real-
time PCR (qPCR) was run using the ABI7500FastDx PCR instrument. The 
results presented here concern: Staphylococcus aureus, Pseudomonas 
aeruginosa and Enterobacteriaceae. Quantifi cation was performed 
using qPCR standard curves, by converting the cycle threshold to CFU/
ml.
Results A total of 125 suspected VAP were included from 122 patients. 
In total, 125 BAL and 107 ETA were collected. Sex ratio (M/F) was 76%, 
and CPIS ≥6 was calculated in 74.6% of the suspected VAP patients. 
Mean ventilation duration before sampling was 6 days. Seventy-eight 
percent and 65% of the BAL and ETA culture were positive respectively. 
Correlations between molecular method and culture on BAL and ETA 
are reported in Table 1.
Table 1 (abstract P107). Concordance between qPCR and culture on BAL/ETA 
in VAP patients
 Positive  Agreement Sensitivity Specifi city
 culture  qPCR  (%) (%) (%)
S. aureus 28/20 31/25 96.7/89.7 96.6/76.9 96.8/93.8
(BAL/ETA)
P. aeruginosa 23/20 20/23 97.6/93.5 100/100 97.1/92.4
(BAL/ETA)
Enterobacteriaceae 27/7 36/18 90.3/85.0 90.0/58.3 90.4/88.4
(BAL/ETA)
Conclusion Sensitivity and specifi city of the new molecular approach 
for these main bacteria found in VAP could enable targeted fi rst-line 
antibiotic therapy. In the future, the development of this approach will 
aim at obtaining a bedside diagnostic in only a few hours.
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Introduction Xpert Carba-R® (Cepheid®, USA) is a PCR-based assay for 
rapid (<1 hour) detection of bacteria carrying carbapenem-resistance 
genes (KPC, NDM, VIM, OXA-48, IMP-1). The aim of the study is to 
compare PCR with microbiological cultures in critically ill, abdominal 
surgical patients.
Methods We performed an observational study at University Hospital ‘P. 
Giaccone’ Palermo. We enrolled abdominal surgical patients admitted 
to the ICU with suspected abdominal sepsis or developing sepsis during 
the ICU stay. We obtained two rectal swab specimens and two drainage 
samples to perform PCR assay and classic culture tests. We used Cohen’s 
K to test concordance of results. We considered concordant those results 
of positive detection of carbapenemase-producing bacteria by both 
methods (even if a polymicrobial growth was observed by cultures) or 
negative results by both methods. Concordance was studied for rectal 
swab and drainage specimens. Antibiotic susceptibility testing was 
performed through a semiquantitative method.
Results Eight complete samples sets were collected from seven 
patients. Seven rectal swab specimens were negative for both PCR and 
cultures. In one patient a positive culture from carbapenem-resistant 
P. aeruginosa was detected from the rectal swab resulting negative 
to PCR. In one patient a positive culture from carbapenem-resistant 
A. baumanii was detected by drainage culture resulting negative to 
PCR. In two cases a positive result was observed from both PCR and 
cultures of rectal swab and drainage specimens. Vim and KPC genes 
were detected in one case and A. baumanii and K. pneumoniae with 
carbapenem resistance were isolated from cultures. A KPC gene was 
detected by PCR in the other case, and K. pneumoniae with carbapenem 
resistance was isolated from cultures. In all other cases a negative result 
was observed by both PCR and cultures. Cohen’s K of 0.71 (95% CI = 
0.21 to 1) was observed for rectal swab and drainage specimens.
Conclusion We need more data to evaluate the performance of PCR 
for rapid detection of carbapenemase-producing bacteria from rectal 
swabs and drainage of critically ill surgical patients even though its 
concordance with cultures seems to be good.
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Introduction Antimicrobial resistance constitutes a growing global 
threat, driven in part by inappropriate antimicrobial prescribing [1]. 
Most hospitals implement antibiotic policies to promote antimicrobial 
stewardship. This audit examined the Royal Cornwall Hospital Trust 
(RCHT) Critical Care Department’s compliance with the current 
standard defi ned in our local antimicrobial policy. This states that 
all antimicrobial prescriptions are to have an indication and review 
date recorded [2]. Sequential strategies to improve compliance were 
introduced prior to re-auditing the eff ects.
Methods The RCHT Critical Care Department utilizes the Phillips Care 
Vue electronic patient record. Data from this system were interrogated 
at three stages to assess our compliance with the trust’s antimicrobial 
policy. The fi rst data interrogation was performed prior to any 
intervention, and refl ected baseline antimicrobial prescribing habits. 
The second data interrogation was performed during a period of active 
antibiotic stewardship promotion. The third data interrogation was 
performed following the addition of a care bundle to the prescribing 
module of Care Vue. This daily tick-box prompt reminded clinicians 
to check that all antimicrobial prescriptions had an indication and 
review date recorded. The records of all of the patients admitted to the 
critical care department during the periods of data interrogations were 
assessed for antimicrobial indication and review date transcription.
Results From the fi rst data interrogation, antimicrobial prescriptions 
had an indication and review date transcription in 57% and 60% of cases 
respectively. Following the awareness campaign, the indication and 
review date transcription rate increased to 78% and 85% respectively. A 
daily electronic prompt was then added to our care bundle list. The fi nal 
data interrogation, performed after this intervention, demonstrated 
that the transcription rates for both the indication and the review date 
had increased to 96%.
Conclusion We have demonstrated that the use of a daily prompt 
within an electronic patient record can greatly improve compliance 
in recording the indication and review date for all antimicrobials. 
These data support the widespread implementation of an electronic 
prescribing system where daily reminders are integrated in an eff ort to 
improve compliance with antimicrobial stewardship.
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Introduction Multidrug-resistant (MDR) bacterial pneumonia is 
associated with signifi cant morbidity and mortality in severely ill 
ICU patients. The assessment of factors associated with the onset 
and clinical course of MDR pneumonia may improve treatment 
eff ectiveness. The purpose of this study is to identify factors associated 
with outcome in mechanically ventilated patients with ventilator-
associated pneumonia (VAP) caused by MDR bacteria.
Methods We studied retrospectively all mechanically ventilated 
patients treated in the A’ ICU of KAT General Hospital in Athens from 1 
January 2011 to 31 December 2013 and showed ventilator-associated 
pneumonia from MDR Gram-negative bacteria. Standard demographic 
and clinical data, the causative organisms and outcome were recorded. 
For statistical signifi cance, chi-square and Student t tests were used.
Results A total of 102 mechanically ventilated patients, 75 men and 27 
women, were included in the study. All patients showed VAP caused 
by MDR bacteria. They were stratifi ed by outcome into survivors and 
nonsurvivors. ICU mortality was 55%. Gender, cause of admission, the 
causative microbe, colonization of bronchial secretions and secondary 
bacteremia had no correlation with outcome. Age and APACHE II score 
were higher in nonsurvivors (P  <0.01 and P  <0.05 respectively). The 
time-onset of pneumonia after admission was longer in patients with 
VAP caused by Klebsiella or Pseudomonas than those with VAP caused 
by acinetobacter (P  <0.01). Patients with Klebsiella or Pseudomonas 
pneumoniae needed more time on mechanical ventilation than those 
with pneumonia from acinetobacter (P <0.01).
Conclusion VAP caused by MDR bacteria is a leading cause of ICU 
death. Age and APACHE II score are signifi cant risk factors of death.
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Introduction Prescription of antifungal treatments (AFT) in ICUs in case 
of suspected or confi rmed invasive candidiasis (SIC or CIC) has been 
challenged by diff erent guidelines. The study aimed to describe the 
epidemiology of the invasive candidiasis (IC), analyze the criteria for the 
AFT initiation, the AFT type, and its changes during patient follow-up.
Methods A prospective observational multicenter cohort study. 
Consecutive adult patients with SIC or CIC and treated with systemic 
AFT were included between October 2012 and September 2013 in 104 
French ICUs.
Results In total, 870 patients were included and 835 evaluable, the IC 
was confi rmed at study inclusion for 291 and suspected for 544 patients. 
Eventually, the IC was confi rmed for 403/835 patients (peritonitis: 
177; candidaemia: 141; deep candidiasis: 61; mixed infection sites: 
24). Candida albicans was the main pathogen (67%), then C. glabrata 
(16%). At inclusion, CIC were treated with caspofungin (Cas): 55%, and 
fl uconazole (Flu): 34%, whereas these antifungals were administered to 
46% and 45% of SIC, respectively. Patients with SIC were more severe 
than those with CIC. The two main criteria for initiating empirically 
an AFT were a central venous catheter (79%) and severe septic shock 
(70%). The rate of change of the initial AFT was higher in the CIC group 
(49%) than in the SIC group (33%, P <0.0001). In the CIC group, it was 
mostly for changing the antifungal agent (de-escalation Cas  Flu in 
half of the patients) based on mycological tests results. In the SIC group, 
the AFT was modifi ed almost as often for changing the drugs (including 
22% de-escalation Cas  Flu) as for stopping the AFT. The 28-day 
mortality of candidaemia was 42% in cases of C. glabrata, 40% in cases 
of C. albicans, and 20% in cases of C. parapsilosis. Among survivors, 
the median duration of treatment was 17 to 21 days according to the 
infection site in cases of CIC, and 10 days in cases of SIC.
Conclusion French ICU patients are treated with antifungal agents 
selected according to the candidiasis severity, contrary to ESCMID 
guidelines which recommend initiating with echinocandins regardless 
of severity. As recommended, the therapy was secondarily adapted to 
microbiological results.
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Introduction Micafungin (MCF) is an echinocandin agent with 
broad activity against Candida spp., which are frequently isolated in 
blood and eschar cultures of burned patients, who present diff erent 
pharmacokinetics (PK) characteristics. Due to the limited information 
about its PK, we investigate MCF levels in plasma and burn eschar 
tissues in this population.
Methods A PK study of MCF at standard dosage (100 mg/day). Cmax 
(end of the infusion) and Cmin (before next dose) plasma levels of 
MCF were obtained after fi rst dose and at steady state (days 4 and 5 
of therapy); and on day 5 in eschars (1 to 3 hours after infusion). They 
were measured by HPLC. Spearman’s rho test was used for bivariate 
correlations between MCF exposure and patient’s clinical factors.
Results There were 10 patients (eight men; age: 18 to 77 years). Patients’ 
characteristics and PK are shown in Table  1. A high interindividual 
variability was observed in the concentrations of MCF. Peak plasma 
concentrations after the fi rst and repeated doses of MCF were inversely 
correlated with % burned TBSA (Spearman’s ρ  = –0.695 and –0.750 
(P  <0.05), respectively), but not with the time from burn injury. MCF 
concentrations in burn eschars were not correlated with % burned 
TBSA. MCF was well tolerated. One patient had candidemia. The crude 
mortality was 40%.
Conclusion This is the largest PK study of 100  mg daily of MCF in 
severely burned critically ill patients. The inverse correlation between 
MCF exposure and % burned TBSA suggests that patients with large 
burned TBSA may need higher doses of MCF. Nevertheless, MCF levels 
in plasma and burn eschar tissues after the fi rst and multiple doses were 
above the MIC90 against most clinically important Candida species.
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Introduction Tedizolid is an oxazolidinone antibiotic approved to treat 
acute bacterial skin and soft tissue infection and is under investigation 
Critical Care 2015, Volume 19 Suppl 1 
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for treatment of nosocomial pneumonia, common in critically ill 
patients with acute kidney injury. There are limited data on tedizolid 
disposition in continuous renal replacement therapy (CRRT). This 
study’s purpose was to assess continuous hemofi ltration (CHF) and 
continuous hemodialysis (CHD) infl uence on tedizolid clearance.
Methods Validated, bovine blood-based, in vitro CHF and CHD models 
were used with six new HF 1400 (polysulfone) and six new Multifl ow 
150 (AN 69) hemodiafi lters. Tedizolid’s transmembrane clearances 
(CLTM) during CHF and CHD were assessed by measuring sieving (SC) 
and saturation (SA) coeffi  cients at various ultrafi ltrate (Quf) (1, 2, 3 l/
hour) and dialysate fl ow rates (Qd) (1, 2, 3 and 6 l/hour), using a blood 
fl ow rate (Qb) of 200 ml/minute. Tedizolid adsorption was tested in a 
1 l recirculating CHF model at Quf of 2 l/hour and Qb of 200 ml/minute 
over 4  hours. Adsorption (%) was calculated after correcting for the 
dilution by CHF priming volume. Urea was added as a control in all 
experiments.
Results Urea SC and SA were ~1 in all experiments. In CHF, mean 
tedizolid SC ranged from 0.52 to 0.57 for HF1400 and from 0.50 to 0.54 
for M150. CLTM did not diff er between fi lter types for Quf of 1, 2, and 3 
l/hour. In CHD, mean tedizolid SA ranged from 0.46 to 0.56 for HF1400 
and from 0.38 to 0.44 for M 150. Tedizolid CLTM with the HF1400 was 
higher than M150 values at Qd of 6 l/hours (P <0.02). Tedizolid exhibited 
irreversible adsorption within 10 minutes. See Figure 1.
Conclusion Tedizolid’s CLTM is dependent on hemodiafi lter type and 
Qd for CHD and Quf in CHF. At conventional CRRT rates, tedizolid 
CLTM appears modest relative to total body clearance and is unlikely 
to require dose adjustments. CRRT adsorption in the clinical setting 
is likely less than what we observed in this in vitro, continuously 
recirculating blood model.
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Introduction Tedizolid phosphate, a novel oxazolidinone antibacterial 
prodrug recently approved by the US Food and Drug Administration 
for the treatment of acute bacterial skin and skin structure infections, 
is available as oral (that is, tablets) and intravenous formulations. The 
clinical pharmacokinetics of tedizolid, the active moiety of tedizolid 
phosphate, are similar when orally administered tedizolid phosphate 
is given as powder in a capsule or as tablets. This suggests that 
crushing tablets prior to administration is unlikely to alter tedizolid 
pharmacokinetics, provided no drug is lost during administration. To 
determine whether the expected dose of tedizolid phosphate can be 
delivered via nasogastric (NG) tube in critically ill patients who have 
diffi  culty swallowing, this study evaluated the stability and recovery of 
tedizolid phosphate 200 mg tablets after crushing, dispersion in water, 
and passage through an NG tube.
Methods For each assay, run in triplicate, one 200 mg tablet of tedizolid 
phosphate was crushed, dispersed in water, drained under gravity 
through one of two types of NG tubes (type 1, Kangaroo Nasogastric 
Feeding Tube, 10 Fr 43" (109 cm); type 2, Salem Sump Dual Lumen 
Stomach Tube, 18 Fr/CH (6.0 m) 48" (122 cm)), and collected for 
recovery analysis by high-performance liquid chromatography with 
UV detection. To analyze the chemical stability of the crushed tablet 
dispersed in water, the aqueous preparation was assayed initially after 
dispersion and again after 4 hours at room temperature, without NG 
tube passage. The prespecifi ed limit for tedizolid phosphate in recovery 
samples was 90 to 110% of the dose. Limits were also specifi ed for 
levels of certain impurities.
Results The average and individual recovery values of tedizolid 
phosphate were within 90 to 110% of the 200 mg dose when crushed 
tablets, dispersed in water at room temperature, were transferred 
through the 2 NG tubes (type 1: 95.8%; type 2: 93.6%). There was 
Table 1 (abstract P112). Clinical and pharmacokinetic characteristics of patients
     Plasma Plasma  Days from SOFA 
    MCF dose Cmax/Cmin Cmax/Cmin Burn eschar admission at the 
 % burned    (mg/kg after fi rst dose at steady state tissue on day 5 to the start beginning LOS in BICU
Patient TBSA % FT ABSI body weight) (μg/ml) (μg/ml) (μg/g) of MCF of MCF (days)
1 35 20 9 1.3 8.6/0.8 7.4/1.0 2.3 38 1 75
2 40 35 8 2.0 8.5/1.1 9.4/1.8 <LQ 15 6 23
3 23 16 8 1.3 6.4/0.8 10.3/1.2 <LQ 12 2 17
4 70 40 12 1.1 3.9/0.5 4.5/0.8 0.4 8 6 43
5 23 12 7 1.3 7.5/1.8 8.0/1.4 0.6 10 5 19
6 70 60 11 1.2 3.4/0.5 5.0/0.9 1.5 12 5 70
7 80 70 12 1.1 3.8/0.4 4.0/0.4 0.2 34 2 61
8 60 50 10 1.4 4.8/0.5 4.3/1.0 0.2 34 2 90
9 44 34 10 1.3 4.5/1.1 9.1/2.3 0.2 8 6 34
10 34 28 9 1.3 4.1/0.7 5.4/1.0 0.7 10 5 35
Median 42 34.5 9.5 1.3 4.7/0.7 6.4/1.0 0.5 12 5.0 39
IQR 31.3 to 70.0 19.0 to 52.5 8 to 11.3 1.1 to 1.4 3.9 to 7.5/0.5 to 1.1 4.5 to 9.1/0.9 to 1.4 0.3 to 1.1 9.5 to 19.8 3.5 to 5.6 22.7 to 71.3
ABSI, Abbreviated Burn Severity Index; BICU, burn intensive care unit; FT, full thickness; IQR, interquartile range; LOS, length of hospital stay; LQ, limit of quantifi cation 
(<0.1 μg/ml); SOFA, Sequential Organ Failure Assessment; TBSA, total body surface area.
Figure 1 (abstract P113).
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no signifi cant change in recovery values after 4  hours of storage at 
room temperature (93.9% initially and 94.7% after 4  hours). Results 
for degradation products and impurities were also within specifi ed 
limits in NG recovery samples and in the 0-hour and 4-hour aqueous 
preparations.
Conclusion The stability and recovery of tedizolid phosphate were not 
infl uenced by crushing the tablets and passing through an NG tube. 
Therefore, administration of crushed tedizolid phosphate tablets to 
patients is unlikely to alter the pharmacokinetics of tedizolid compared 
with whole tablets.
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Introduction Reactivation of latent cytomegalovirus (CMV) can lead to 
viraemia or CMV disease and has been detected in up to 30% of critically 
ill patients without prior history of immune suppression. However, the 
clinical importance of this observation remains unclear. We report a 
proof-of-concept randomised controlled trial of two antiviral drugs in 
intensive care patients to determine their impact on CMV reactivation.
Methods We conducted a single-centre randomised controlled study 
of high-dose valaciclovir or low-dose valganciclovir prophylaxis, as 
compared with standard care, in CMV seropositive patients in the ICU 
at Queen Elizabeth Hospital Birmingham, UK. Patients were excluded 
if CMV seronegative. Study participants randomised to a study drug 
received either 450  mg valganciclovir daily enterally (or ganciclovir 
intravenously) or 2 g valaciclovir four times daily enterally (or aciclovir 
intravenously) for a period of up to 28  days. Blood was collected for 
CMV viral load during the 28-day study period. The primary outcome 
measure was reactivation of CMV in blood above 20 copies.ml–1 (assay 
detection limit) by day 28.
Results A total of 124 patients were randomised; 44 control, 34 
valaciclovir, and 46 valganciclovir. Recruitment to the valaciclovir arm 
was halted early because of an imbalance in mortality (44% mortality 
vs. 19% in other arms). Independent blinded review of all deaths did 
not reveal any deaths attributable to unexpected causes. Fourteen 
patients were excluded from the primary analysis because of baseline 
CMV reactivation. CMV reactivation occurred in 30% (12/40) of the 
control arm but only 3% (1/39) in the valganciclovir arm (RR: 0.09 (95% 
CI: 0.01, 0.6)). When the two treatment arms were considered together, 
reactivation was observed in only 4% (3/70) (RR: 0.1 (95% CI: 0.04, 0.5)). 
See Figure 1.
Conclusion This is the fi rst study in critical care to assess the feasibility of 
antiviral prophylaxis to prevent CMV reactivation in a mixed population 
of critically ill patients. Low-dose valganciclovir was shown to suppress 
CMV reactivation as eff ectively as higher-dose valaciclovir.
Acknowledgements Research funded by the NIHR under the RfPB 
Programme (PG 1010 23225). Views expressed are of the authors and 
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Introduction In daptomycin (DAP), 1,061  mg hour/l of the area 
under the concentration–time curve (AUC)/MIC was required to 
obtain clinical success [1], and a trough serum concentration (Cmin) 
cutoff  point of 24.3 g/ml was most signifi cantly associated with CPK 
elevation [2]. Reportedly, DAP at a recommended dosage of 8 mg/kg 
is removed in patients undergoing high-fl ow continuous venovenous 
hemodiafi ltration (CVVHDF) (blood fl ow and fi ltration rates were 
150 ± 48 and 2 l/hour). In Japan, CVVHDF is preferentially performed 
with lower fl ow rates. Investigating eff ects of fl ow rate on DAP removal 
during continuous renal replacement therapy is essential to adjust 
therapeutic dosages. We aimed to investigate the pharmacokinetics of 
DAP in CVVHDF patients in this setting.
Methods DAP (6  mg/kg) was administered intravenously every 
48 hours to CVVHDF patients in the ICU. Blood and fi ltrate samples were 
collected at 0, 1, 1.5, 2, 5, 12, 24, and 48 hours after infusion. All collected 
samples were analyzed using HPLC according to the method of Tobin 
and colleagues [3]. Maximum concentration (Cmax), elimination half-
life (t1/2), area AUC, Cmin, volume of distribution (Vd), clearance (CL), 
fraction unbound, and sieving coeffi  cient (Sc) were evaluated. Patient 
characteristics and CVVHDF parameters including blood, dialysate, and 
fi ltration fl ow rates were recorded.
Results Three patients were included in the study. Mean blood, 
dialysate, and fi ltration fl ow rates were 86.7  ±  11.5  ml/minute, 
417  ±  29  ml/hour, and 417  ±  29  ml/hour, respectively, confi rming 
that CVVHDF was performed under low-fl ow setting. Cmax was 
50.1  ±  12.7  mg/l (31.9, 70.5, 49.7  mg/l); t1/2, 35.1  ±  34.8  hours (18.6, 
11.5, 70.5 hours); AUC, 889 ± 399 mg hour/l (471, 967, 1,260 mg hour/l); 
Cmin, 16.0  ±  10.3  mg/l (2.3, 24.7, 14.0  mg/l); Vd, 26.0  ±  20.9 l (23.8, 
6.34, 47.9 l); CL, 9.47  ±  4.56  ml/minute (14.7, 6.35, 7.37  ml/minute); 
and fraction unbound, 5.8% (5.7, 4.1, 7.6%). Sc and CL of dialyzer were 
0.08  ±  0.03 (0.11, 0.04, 0.07) and 1.20  ±  0.39  ml/minute (1.70, 0.88, 
0.96 ml/minute), respectively.
Conclusion DAP (6  mg/kg daptomycin every 48  hours) in patients 
receiving low-fl ow CVVHDF resulted in showing variability of AUC and 
avoiding accumulation. Owing to small case numbers, it needs further 
study.
References
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Figure 1 (abstract P115). CMV reactivation over time. Each line represents a single patient.
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Introduction In vitro studies suggest that there is signifi cant adsorption 
of amikacin, netilmicin, gentamicin and tobramycin to polyacrylonitrile 
haemofi lters. This occurs rapidly and has the potential to substantially 
reduce the peak aminoglycoside concentration, which will reduce 
effi  cacy [1]. However, whether signifi cant adsorption occurs in vivo 
is unknown. We therefore carried out a controlled in vivo study of 
the eff ect of amikacin adsorption by polyacrylonitrile fi lters during 
haemofi ltration, using a porcine model of acute renal failure.
Methods A porcine model of acute renal failure was created by 
bilateral ligation of the renal arteries and veins. Eight pigs underwent 
haemofi ltration using a 0.6 m2 polyacrylonitrile fi lter, blood fl ow 200 ml/
minute, ultrafi ltration rate 1,000 ml/hour. All ultrafi ltrate was returned 
to the pigs via a separate venous catheter so that any elimination of 
amikacin by haemofi ltration could only be due to adsorption. Another 
eight pigs underwent sham haemofi ltration in which blood was 
pumped around a haemofi ltration circuit without a haemofi lter and 
without ultrafi ltration. Both groups of pigs were given intravenous 
amikacin, 15 mg/kg body weight over 30 minutes, and blood samples 
were taken from the arterial limb of the haemofi lter circuit at 0, 5, 10, 
15, 20, 25, 30, 40, 50, 60, 75, 90, 105, 120, 150, and 180 minutes after the 
start of the amikacin administration to assay amikacin concentrations.
Results Post-distribution peak concentration of amikacin was slightly, 
but signifi cantly, lower in the CRRT group than that in sham group 
(55.0 ± 4.5 vs. 61.1 ± 5.9 mg/l, P <0.05).
Conclusion This study shows that the eff ect of adsorption by 
polyacrylonitrile haemofi lters on in vivo amikacin peak concentrations 
is small, and less than would be expected from in vitro data.
Acknowledgement This work was supported by a grant from the Hong 
Kong Research Grants Committee, CUHK 4644/08M.
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Introduction Studies in the ICU showed that a single amikacin dose 
of ≥25 mg/kg should be used in conditions of increased distribution 
volume (Vd) such as severe sepsis/shock [1]. However, no data are 
available for emergency department (ED) patients in the early phase 
of sepsis/septic shock. The purpose of this study was to determine 
whether a single amikacin dose of 25 versus 15 mg/kg results in PK/PD 
target attainment for ED patients.
Methods ED patients with severe sepsis/shock were randomly treated 
with a single amikacin dose of 25 versus 15  mg/kg. Blood samples 
were collected at  +1 (peak),  +6  hours and  +24  hours (trough) after 
the start of infusion. Primary outcome was PK/PD target attainment 
defi ned as a peak/MIC >8, corresponding with both actual MIC values 
documented from isolated pathogens, as well as EUCAST susceptibility 
breakpoints for Enterobacteriaceae and P. aeruginosa; that is, 8  mg/l. 
Noncompartmental analysis was used to calculate PK parameters.
Results During a study duration of 20 months, 50 patients were 
enrolled in each dosing regimen resulting in 100 peak concentrations, 
92 and 88 +6 hours and +24 hours concentrations respectively. Target 
attainment using local MIC values (median 2  mg/l, documented in 
56 isolated Gram-negative pathogens) was achieved in 95% in both 
groups (P = 0.98). Using EUCAST susceptibility breakpoints, the target 
was attained in 76% versus 40% in the 25 versus 15  mg/kg group, 
respectively (P < 0.0001). Single-dose PK parameters are displayed in 
Table 1 and compared with the ones reported in the ICU [1].
Table 1 (abstract P118)
PK parameter 15 mg/kg ED 25 mg/kg ED 25 mg/kg ICU
Peak (mg/l) 58 (47 to 70)a 91 (72 to 105)a 73 (62 to 90)
Trough (mg/l) 6 (3 to 12) 5 (3 to 15) 7 (2 to 15)
Vd (l/kg) 0.3 (0.3 to 0.5) 0.4 (0.2 to 0.6) 0.4 (0.3 to 0.5)
Cl (ml/minute/kg) 1.6 (1 to 2.3)a 2.2 (1.4 to 3)a 1.9 (1.3 to 3.5)
Cl, clearance. aMann–Whitney U <0.05, 15 versus 25 mg/kg ED patients.
Conclusion The EUCAST-based PK/PD target was only attained in 76% 
of patients treated with 25 mg/kg. However, in contrast to ICU patients, 
the majority of ED patients are treated for community-acquired 
infections, so MIC values are signifi cantly lower than the EUCAST 
susceptibility breakpoints, warranting PK/PD target attainment in both 
25 and 15 mg/kg dosing regimens when local epidemiology is taken 
into account.
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Introduction Carbapenem-resistant enterobacteriacae emerged in 
recent years as one of the most challenging groups of antibiotic-
resistant pathogens. Polymyxins are considered as the last resort for 
the treatment of infections with carbapenem-resistant Gram-negative 
bacilli (GNB). Inadequate or extensive use of colistin leads to emergence 
of colistin resistance in GNB, jeopardizing treatment options in ICUs, 
potentially increasing mortality and morbidity and necessitating 
prudent use of alternative antibiotics. Fosfomycin, a phosponic 
acid derivative which acts primarily by disrupting bacterial cell wall 
synthesis, is a broad-spectrum antibiotic. Fosfomycin tromethamine 
is an oral formulation approved for the treatment of uncomplicated 
urinary tract infection caused by multidrug-resistant (MDR) bacteria. 
Recently fosfomycin is also available as a sodium/disodium formulation 
for intravenous use, which is showing promising result against MDR/
potentially drug-resistant pathogens.
Methods A total of four colistin-resistant (MIC ≥4) GNB were isolated 
from ICU patients with nosocomial MDR infections. All four isolates were 
Klebsiella pneumonia. Among these isolates three were from blood 
and one from endotracheal aspirate and all four isolates were sensitive 
to fosfomycin in vitro. All of these patients had multiple comorbidities 
with recent history of colistin exposure. Intravenous fosfomycin sodium 
(inj Fosmicin; Meiji, Japan) was started as a combination therapy with 
carbapenem.
Results Among the three bacteremic patients, two recovered 
completely from sepsis as well as the patient with ventilator-associated 
pneumonia. There was clinical as well as microbiological cure with 
normalization of sepsis markers. The only one bacteremic patient who 
died during the course of therapy was later diagnosed to have azole-
resistant fungemia as a superinfection.
Conclusion Based on the evidence of clinical experience and available 
studies, intravenous fosfomycin therapy may be considered as the 
last option for the treatment of MDR GNB infection where there is 
documented colistin resistance and where there is literally no other 
choice of antibiotic therapy.
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Introduction Amikacin Inhale is an integrated drug–device combi-
nation in development by Bayer HealthCare through a collaboration 
with Nektar Therapeutics, to improve clinical outcome in intubated 
and mechanically ventilated patients with Gram-negative pneumonia. 
It is available in two confi gurations: on-vent for intubated patients and 
hand-held for extubated patients to complete aerosolized antibiotic 
therapy. Amikacin Inhale is a smart system that consists of the 
pulmonary drug delivery system with a vibrating mesh nebulizer and 
the specially formulated Amikacin Inhalation Solution (400 mg every 
12  hours for 10  days). The objectives of this study were to evaluate 
the performance of the Amikacin Inhale hand-held confi guration with 
supplemental O2 concentration supplied at diff erent fl ow rates and 
in diff erent orientations. We hypothesize that the delivered dose of 
amikacin will not signifi cantly change with increased O2 fl ow rate or 
varying orientation.
Methods In the hand-held confi guration of Amikacin Inhale, amikacin 
is aerosolized into a holding chamber. Amikacin aerosol is inhaled 
with ambient air entering the bottom of the chamber through the 
inhalation valve. Supplemental O2 may be supplied through the O2 
port and mixes with ambient air entering through the inhalation valve. 
O2 concentration and delivered dose at the mouthpiece exit were 
characterized in vitro at various O2 fl ow rates (2 to 10  l/minute). O2 
concentrations were measured every minute until the end of dosing. 
A ventilator was connected to the set up to simulate patient breathing. 
The delivered dose was measured at the exit of the mouthpiece. 
Drug distribution within the test setup compartments was analyzed 
using HPLC. The in vitro delivered amikacin dose was also measured 
at nebulizer orientations of 0° and 45° (n = 3 per orientation) using a 
simulated breathing profi le with no supplemental O2.
Results The mean O2 concentration ranged from 36 to 70% over 2 
to 10  l/minute and was ≥40% at ≥3  l/minute. The delivered dose did 
not change substantially with increasing enriched O2 fl ow rate (72 to 
82% of nominal dose). At 0° and 45° orientations, the delivered dose of 
amikacin was 74 to 80% and 73 to 76% of the nominal dose (400 mg), 
respectively.
Conclusion Amikacin Inhale was shown in vitro to be suitable for 
extubated patients who require supplemental O2. The delivered dose 
was independent of supplemental O2 and device orientation.
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Introduction Nosocomial pneumonia (NP) occurs in 30 to 50% of 
multiple trauma patients. It is mostly caused by multiresistant Gram-
negative bacteria. Use of inhaled antibiotics as adjuncts to systemic 
antibiotics presents a great outlook for the prevention of NP in multiple 
trauma patients. The aim of the study was to evaluate the effi  cacy 
of early administration of inhaled tobtamycin (IT) as an adjunct to 
systemic antibiotics for the prevention of NP in polytrauma.
Methods Fifty-four ICU mechanically ventilated patients with multiple 
trauma (ISS >30; car accident 55.6%; fall 29.6%; train accident 11.1%; 
domestic 3.7%) were enrolled in the single-center randomized trial. 
Groups were comparable in ISS, age, sex, type of trauma, and blood 
loss. Patients were randomized into two groups: Group 1 (n  = 27), 
addition of IT to systemic antibiotics (ciprofl oxacin 800  mg/day; 
metronidazol 1,500 mg/day); Group 2 (n = 27), only systemic antibiotics 
(same regimen). Inhaled tobramycin (300 mg twice daily via nebulizer) 
and systemic antibiotics were administered within the fi rst 24  hours 
after ICU admission. After obtaining the results of bronchoalveolar 
lavage microbiology, the antibiotic regimen was switched according 
to the sensitivity. The primary outcome measure was new onset of NP 
and duration of ICU stay. Microbiological, X-ray, CPIS, signs of sepsis 
and oxygenation index were used as objective indicators of the clinical 
progress. The secondary outcome measure was 30-day mortality. 
Diagnosis of NP was made according to the standard clinical and 
CPIS criteria. The data were statistically analyzed by SPSS 11.5 (M, σ, 
Newman–Keuls test; chi-square-test P <0.05).
Results Preventive administration of IT as an adjunct to systemic 
antibiotics was associated with a lower incidence of NP in group 1 
(group 1 33.3%, group 2 66.7%, χ2  = 6,000; P  =  0.014) and a shorter 
duration of ICU stay (group 1 8.0  ±  4.6  days vs. 17.1  ±  18.4  days, 
P = 0.03). The mortality did not diff er between groups: 11.1% in group 1 
and 22.2% in group 2 (P ≥0.99). On day 3 Acinetobacter spp. (30.5%), K. 
pneumoniae (22.0%), B. cepacia (13.2%) and P. aeruginosa (34.3%) were 
detected in BAL, there were no diff erences between groups. In group 
1 CPIS remained stable and APACHE II decreased. CPIS and APACHE II 
were lower in group 1 on day 5 (P = 0.0004).
Conclusion Early administration of IT as an adjunct to systemic 
antibiotics is eff ective in prevention of NP in multiple trauma patients: 
it promotes decrease of NP incidence and decrease of ICU stay.
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Introduction Central nervous system (CNS) infections in ICU patients 
after neurosurgery are a diffi  cult and life-threatening complication 
demanding immediate action. In many cases intravenous (i.v.) 
administration of antibiotics is not suffi  cient; thus, intrathecal (i.t.) 
administration is required.
Methods From January 2013 to November 2014 all cases with CNS 
infections were recorded. Inclusion criteria were the presence of fever 
≥38.5°C, increased infl ammatory markers, compatible lumbar puncture 
(LP) fi ndings (increased number of polymorphonuclear leukocytes, 
increased protein and low glucose compared with serum levels) and 
no evidence of other site of infection. All subjects were receiving 
appropriate i.v. antibiotic treatment based on cultures. Intrathecal 
administration of 300,000 iu colistin, 25  mg vancomycin and 25  mg 
amikacin was performed taking under consideration that neurosurgical 
patients in the ICU have CNS infection attributed to Gram-negative 
bacteria or/and to Staphylococcus species.
Results Overall, nine cases with CNS infection were recorded aged from 
22 to 74, all males. LP was performed between the second and 17th day 
(average 8.3 days) and the CSF analysis showed 40 to 6,000 cells – mainly 
PMNs, protein 161 mg% to 287 mg% and glucose from 3 to 58 mg/dl. 
They were all colonized with Acinetobacter baumannii sensitive only 
to colistin. CSF cultures were negative for all patients besides one, 
who grew A. baumannii. Of those, seven (77%) were receiving i.v. 
colistin, eight (88%) carbapenems, and eight (88%) glycopeptides, all 
in combination with other antibiotics. Median i.t. administration time 
was 9.1 days. All patients responded to i.v. and i.t. antibiotics but there 
was one case in which fever relapsed and increased number of cells in 
subsequent LP was observed which was attributed to colistin, which 
was withdrawn. All these patients survived, and were discharged to the 
ward.
Conclusion Patients treated with the abovementioned regime showed 
clinical and biochemical improvement. The above drug combination 
turned out to be successful in neurosurgical ICU patients with CNS 
infection.
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Introduction Septic shock is characterized by systemic infl ammation 
coupled with upregulation of coagulation. Heparin is an inexpensive 
and widely available anticoagulant with anti-infl ammatory properties. 
The objectives our study were to evaluate the effi  cacy and safety 
of heparin in patients with sepsis, septic shock or disseminated 
intravascular coagulation (DIC) associated with infection.
Methods We included randomized controlled trials from MEDLINE, 
EMBASE, CENTRAL, Global Health, Scopus, Web of Science, the 
International Clinical Trials Registry Platform (inception to April 2014), 
conference proceedings, and reference lists of relevant articles. Two 
reviewers independently identifi ed and extracted trial-level data 
from randomized trials investigating unfractionated or low molecular 
heparin administered to patients with sepsis, severe sepsis, septic 
shock or DIC associated with infection. Internal validity was assessed 
in duplicate using the Risk of Bias tool. Our primary outcome was 
mortality. Safety outcomes included hemorrhage, transfusion and 
thrombocytopenia.
Results We included nine trials enrolling 2,637 patients. Eight trials 
were of unclear risk of bias and one was classifi ed as having low risk 
of bias. In trials comparing heparin with placebo or usual care, the 
risk ratio for death associated with heparin was 0.88 (95% CI  = 0.77 
to 1.00, I2  = 0%, 2477 patients, six trials). In trials comparing heparin 
with other anticoagulants, the risk ratio for death was 1.30 (95% CI = 
0.78 to 2.18, I2  = 0%, 160 patients, three trials). In trials comparing 
heparin with placebo or usual care, major hemorrhage was not 
statistically signifi cantly increased (risk ratio 0.79, 95% CI  = 0.53 to 
1.17, I2 = 0%, 2,392 patients, three trials). In one small trial of heparin 
compared with other anticoagulants, the risk of major hemorrhage 
was signifi cantly increased (2.14, 95% CI  = 1.07 to 4.30, 48 patients). 
Important secondary and safety outcomes, including minor bleeding, 
were sparsely reported.
Conclusion Heparin in patients with sepsis, septic shock, and DIC 
associated with infection may be associated with decreased mortality; 
however, the overall impact remains uncertain. Safety outcomes have 
been under-reported and require further study. Large randomized trials 
are needed to evaluate the effi  cacy and safety of heparin in patients 
with sepsis, severe sepsis, and septic shock.
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Introduction Sepsis is a major cause of admission to the ICU, and a 
leading cause of death for ICU patients. Intravenous immunoglobulin 
(IVIg) is indicated in the treatment of some patients with sepsis, 
although the evidence for this remains controversial. The use of IVIg is 
regulated due to its high cost, and prescription guidelines have been 
revised by the NHS, coordinated by the National Demand Management 
Programme for Immunoglobulin.
Methods We conducted a retrospective audit of pharmacy records of 
IVIg prescriptions issued to ICU patients with severe sepsis and septic 
shock from 2009 to 2014 against national prescription guidelines. 
Microbiology results were examined to support prescriptions, and 
admission APACHE II scores and unit outcomes were examined.
Results From 2009 to 2014, 644 patients were admitted to the ICU with 
severe sepsis and septic shock, with a mortality rate of 41%. Seventeen 
patients received IVIg. Of these, eight patients met the national 
guidelines for prescription, with a mortality rate of 25%. Nine patients 
did not meet the national guidelines for prescription, with a mortality 
rate of 44%. The diff erence in mortality rates between the two groups 
did not reach statistical signifi cance (P = 0.6). There was no signifi cant 
diff erence in APACHE II scores between the two groups. There was also 
no diff erence in mortality between those receiving IVIg and those who 
did not. We also found no diff erence in those receiving single or double 
doses of IVIg.
Conclusion The use of IVIg does not appear to aff ect mortality in sepsis. 
There was also no statistical benefi t or harm demonstrated by using 
IVIg. This also holds true whether IVIg is given either according to the 
guidelines or not; however, stricter adherence to the guidelines does 
have fi nancial implications.
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Introduction Clinical trials yielded confl icting data about the benefi t of 
adding systemic corticosteroids for community-acquired pneumonia 
(CAP). We evaluated whether short-term corticosteroid treatment 
reduces time to clinical stability in patients hospitalized for CAP.
Methods This randomized, placebo-controlled multicenter trial 
compared prednisone 50  mg for 7  days with placebo in patients 
hospitalized with CAP. The primary endpoint was time to clinical stability.
Results Overall, 802 patients were randomized in seven Swiss hospitals 
from December 2009 to May 2014. Time to clinical stability was shorter 
in the prednisone group compared with placebo (3.0 vs. 4.4  days, 
HR = 1.33, 95% CI = 1.15 to 1.50, P <0.001). The prednisone group as 
compared with the placebo group had a shorter time to hospital 
discharge (6 vs. 7 days (HR = 1.19, 1.04 to 1.38), P = 0.012) and a shorter 
duration of intravenous antibiotic treatment (4 vs. 5 days (diff erence, 
–0.89 days, –0.20 to –1.57 days), P = 0.011). All-cause mortality, ICU stay, 
recurrent pneumonia and rehospitalization rate were similar in both 
groups. Incidence of pneumonia-associated complications until day 
30 tended to be lower in the prednisone group (2.8% vs. 5.6%, OR = 
0.49, 0.23 to 1.02, P = 0.06). The prednisone group had a higher rate of 
in-hospital hyperglycemia needing insulin treatment (19.4% vs. 10.9%, 
OR  = 1.96, 1.31 to 2.93, P  =  0.001). Other adverse events compatible 
with corticosteroid use were rare and similar in both groups.
Conclusion Prednisone treatment for 7  days in hospitalized patients 
with CAP shortens time to clinical stability, time to hospital discharge 
and duration of intravenous antibiotic treatment without an increase 
in complications.
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Introduction Clinical trials showed renal protective eff ects of 
bovine intestinal alkaline phosphatase in critically ill patients with 
Critical Care 2015, Volume 19 Suppl 1 
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sepsis-associated acute kidney injury (AKI) [1,2]. Recently, human 
recombinant AP (recAP) was developed as a pharmacological 
attractive replacement. We conducted a phase I clinical trial to evaluate 
tolerability, safety and pharmacokinetics of recAP in healthy volunteers.
Methods In a randomized, double-blind, placebo-controlled phase I 
trial, healthy volunteers received via a 1-hour i.v. infusion a single dose 
of recAP (200, 500, 1,000 or 2,000 U/kg; n  = 33) or multiple doses of 
recAP (500 or 1,000 U/kg; n = 18) on three consecutive days (n = 18). 
Serum recAP concentrations, AP activity levels and anti-drug antibodies 
were measured, and safety parameters were monitored.
Results RecAP administration resulted in a terminal elimination half-
life and plasma clearance of 49 to 58 hours and 2.8 to 3.4 l/hour after 
single ascending doses, respectively, and 63 to 66 hours and 3.1 to 3.8 
l/hour after multiple ascending doses. Peak recAP concentrations and 
AP activity levels were reached at the end of the 1-hour infusion and 
showed a rapid decline with about 10% of the maximum concentration 
remaining at 4 hours and less than 5% at 24 hours post start. Although 
the maximal concentration and total systemic exposure of recAP 
and AP activity increased slightly more than dose proportionally this 
is of no signifi cance in the estimated therapeutic dose range. RecAP 
treatment was generally well tolerated and anti-drug antibodies could 
not be detected in serum.
Conclusion RecAP is characterized by a long serum terminal half-life, 
by stable serum AP levels and did not exert any safety concerns when 
administered to healthy volunteers. These results pave the way to 
investigate the potential of recAP as a new treatment option for sepsis-
associated AKI in a phase II clinical trial, which will start at the end of 
2014 [Clinical Trial Register:NCT02182440].
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Introduction Direct hemoperfusion with a polymyxin B immobilized 
column (PMX-DHP) adsorbs endotoxin and has been used for the 
treatment of septic shock [1]. However, the mechanisms of action 
behind PMX-DHP are not fully understood. Therefore, the purpose of 
this study was to elucidate mechanisms of action behind PMX-DHP in a 
rat model of cecal ligation and puncture.
Methods Sprague–Dawley rats were anesthetized and were 
mechanical ventilated after tracheostomy. The right internal carotid 
artery was cannulated with a catheter for continuous measurement 
of the arterial pressure and heart rate. The right femoral vein was 
cannulated with a catheter for infusion of saline (10 ml/kg/hour) during 
the study period. The rats were randomized into three experimental 
groups: cecal ligation and puncture (CLP) + dummy column (Dummy-
DHP) group (n = 10), CLP + PMX-DHP group (n = 10), and sham group 
(n = 4). Four hours after CLP, Dummy-DHP or PMX-DHP was performed 
for 1  hour. Blood was drawn from the right internal carotid artery, 
perfused through PMX column or dummy column, and returned 
to the right femoral vein. The heart rate, mean arterial pressure, arterial 
blood gases, and plasma concentrations of creatinine, lactate, potassium, 
and cytokines (IL-6 and IL-10) were measured at baseline and at 4, 5, and 
8 hours after CLP. At the completion of the experiment, the rats were killed 
overdose of pentobarbital. The kidney, liver, and lung were harvested, and 
histopathologic examinations of these organs were performed.
Results Hypotension and metabolic acidosis occurred in the CLP  + 
Dummy-DHP group, whereas hemodynamics and acid–base balance 
were better maintained in the CLP  + PMX-DHP group. Plasma 
concentrations of lactate, creatinine, potassium, and cytokines were 
signifi cantly higher in the CLP + Dummy-DHP group than in the CLP + 
PMX-DHP group at 8 hours. Renal tubular cell death was observed in 
the CLP + Dummy-DHP group, but not in the CLP + PMX-DHP group.
Conclusion PMX-DHP improved hemodynamics, acid–base balance, 
and creatinine levels through reducing cytokines and renal tubular 
cell death in a rat model of cecal ligation and puncture. These fi ndings 
suggest the preventive role of PMX-DHP in the development of sepsis-
related acute kidney injury.
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Introduction The mortality rate of severe sepsis and septic shock 
is varied and high (25 to 70%). In our institute, the indication for 
polymyxin-B immobilized fi ber with direct hemoperfusion (PMX-DHP) 
has been that circulatory failure (systolic blood pressure <90  mmHg 
or required catecholamines and high lactacidemia) continued despite 
following early goal-directed therapy by the Surviving Sepsis Campaign 
guidelines 2012.
Methods This study included 80 patients with severe sepsis or septic 
shock due to abdominal infection retrospectively. These subjects were 
divided into two groups: those with WBC counts <4,000 (L-group: 64 
patients) and those with WBC counts >12,000 (H-group: 16 patients). 
Mean arterial pressure, WBC counts, platelet counts, interleukin-6 
(IL-6), and plasminogen activator inhibitor-1 (PAI-1) were measured 
immediately before the initiation and after the completion of PMX-
DHP. Statistical analysis was performed using the chi-squared test for 
background factors, with Wilcoxon’s rank-sum test for comparison 
within a group, and Mann–Whitney’s U test for comparison between 
groups. The signifi cance level was set at P <0.05.
Results The mortality rate of 28 days in the L-group was 32.8%, and was 
18.8% in the H-group. Mean arterial pressure increased signifi cantly 
(P <0.01) in the H-group compared with the L-group. WBC counts in the 
L-group increased and in the H-group decreased (P <0.01) during PMX-
DHP treatment. Platelet counts in both groups decreased signifi cantly 
(P <0.01).There was no signifi cant diff erence between before and after 
PMX-DHP in IL-6 levels. On the other hand, IL-1ra decreased signifi cantly 
before and after PMX-DHP. Also, IL-6 and IL-1ra in the L-group were 
signifi cantly higher than those in the H-group at the start of PMX-
DHP. PCT values in the L-group were increased compared with the 
H-group at the start of PMX-DHP (P <0.01). PCT in the L-group increased 
signifi cantly (P <0.01), but no signifi cant changes in the H-group. PAI-
1 showed no signifi cant changes before and after PMX-DHP and no 
changes in both groups at the start of PMX-DHP.
Conclusion The mortality rate of the L-group tended to be higher than 
that of the H-group. Infl ammatory and anti-infl ammatory cytokines 
in the L-group were higher than those of the H-group. These results 
indicate that leukopenia (WBC <4,000) in severe sepsis patients leads to 
more severe outcome and hypercytokinemia than leukocytosis (WBC 
>12,000) in severe sepsis patients.
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Introduction Thrombocytopenia-associated multiple organ failure 
(TAMOF) can lead to high mortality in critically ill children, possibly 
related to consequences of thrombotic microangiopathy. Plasma 
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exchange therapy may improve thrombotic microangiopathy [1]. The 
purpose of this observational cohort study is to describe whether 
there is an association between use of plasma exchange therapy and 
outcome in the Turkish TAMOF network.
Methods We performed a retrospective cohort analysis in patients with 
TAMOF at three diff erent pediatric ICUs comparing those who received 
plasma exchange (+) plus standard therapies with those who did not 
receive plasma exchange (–) and only received standard therapies.
Results Among the 42 TAMOF patients enrolled, all had a primary or 
secondary sepsis diagnosis. Fifteen received plasma exchange therapy 
(PE(+) group) and 27 received standard medical treatment without 
plasma exchange (PE(–) group). The mean age was 17.69 months 
(8.24 to 54.22) in the PE(+) group, and 13.46 months (6.47 to 20.55) 
in the PE(–) group. Age (P  =  0.232), gender (P  =  0.206), thrombocyte 
count (P = 0.09), OFI score (P = 0.111) and Pelod score (P = 0.177) on 
admission were not statistically diff erent between groups. The overall 
28-day mortality was higher in the PE(–) group 70.37% compared with 
26.67% in the PE(+) group (univariate P =0.006; multivariate controlling 
for Pelod, OFI, PRISM scores and neurological failure P = 0.048). Length 
of stay was increased in the PE(+) group (P = 0.004).
Conclusion The positive association found between use of plasma 
exchange therapy and improved survival supports the potential of 
this therapy in Turkish children with TAMOF. The positive, although 
less so, associated treatment eff ect observed after controlling for 
illness severity provides further rationale for performing a randomized 
controlled trial in the pediatric Turkish TAMOF network. Sample size 
calculations call for a 100-patient trial with a pre hoc interim analysis 
after enrollment of 50 TAMOF patients.
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Introduction Severe sepsis and multiorgan failure (MOF) are major 
causes of death in the ICU. The extracorporeal cytokine adsorption 
column (ECAC; Cytosorb®, CytoSorbents Corporation, USA), a critical 
care focused therapeutic device, results in rapid in vitro and in vivo 
elimination of several key cytokines and prevents organ failure. Use of 
ECAC in patients with sepsis is a new area of research with insuffi  cient 
data to promote large prospective RCTs. Studies published to date 
have shown promising results. We report our clinical experience with 
ECAC for severe sepsis/septic shock/MOF patients.
Methods A retrospective evaluation of ECAC in patients admitted to a 
tertiary ICU from November 13 to October 14 to analyze: clinical safety; 
selection of a subgroup of patients where it could be used; selection of 
timing for initiation; number of device fi lters required per patient; and 
selective markers to identify above initiation. Patients were managed 
with standard of care (SOC; antibiotics, vasopressors, i.v. fl uids, sepsis 
dosed steroids) and ECAC as adjuvant therapy. Vitals, APACHE II and 
SOFA scores were measured.
Results Nineteen ICU patients (14 men, fi ve women; 24 to 72  years; 
average ICU stay 10 days; average ventilator days 9) with APACHE II >17 
(except one with dengue shock syndrome), SOFA score ≥11 (n  = 16) 
and the majority having infection largely in the lung (n = 8; alone or 
with UTI and blood infection) followed by the abdomen (n  = 4), UTI 
(n = 3) and others (n = 4) were given ECAC (total ECAC = 31). Predicted 
mortality (PM) was >40% in 16, >30% in two and <30% in two (tropical 
infections) patients. Duration of therapy was 6 hours (no. of ECAC = 18) 
and 8 hours (n = 4; no. of ECAC = 5) for the majority of patients. Overall, 
four patients (two with tropical infections and two with PM >40%) 
survived; three of them had were ECAC early (<24 hours of admission). 
The majority of patients (n = 11) who died could be given ECAC only 
once. Of patients who died, seven were given ECAC late (>24 hours). 
APACHE scores before and after ECAC therapy were available for eight 
patients who died; APACHE score decreased >5 points in fi ve patients 
after single application of ECAC.
Conclusion ECAC can be used as adjuvant therapy in treatment of 
severe sepsis/septic shock/MOF. Our patients had high PM and four 
could be saved with use of ECAC. We could expect a better outcome 
if ECAC was used early (<24 hours) during treatment. However, future 
well-designed studies are needed to clarify the role of ECAC in patients 
with MOF/septic shock.
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Introduction Mortality from septic shock in the ICU remains high, 
ranging from 30 to 50%. In particular, Gram-negative bacilli (GNB) 
account for 40% of the causative bacteria of severe sepsis, which 
progresses to multiorgan failure due to signifi cant infl ammation. 
Hemoperfusion with polymyxin B-immobilized fi ber (PMX) adsorbs 
endotoxin and can reduce the infl ammatory cascade of sepsis due 
to GNB. However, the clinical effi  cacy of this treatment has not been 
demonstrated. We aimed to verify the effi  cacy of endotoxin adsorption 
therapy by using PMX.
Methods We retrospectively evaluated 387 patients who received a 
broad-spectrum antimicrobial treatment for septic shock due to GNB 
between January 2009 and December 2012 in the ICU of 10 Japanese 
tertiary hospitals. After alignment of the treatment time phase for each 
patient, we divided the patients into two groups according to whether 
PMX treatment was performed within 24  hours after ICU admission 
(PMX group: n  = 129 and non-PMX group: n  = 258). The primary 
endpoint was 28-day mortality.
Results The mean (SD) age and SOFA scores on ICU admission were 
72.5 (12.5) years and 10.0 (3.4), respectively. The infection site was 
intra-abdominal (47.0%), pulmonary (17.6%), and urinary tract (27.8%). 
Two-thirds of all patients had bacteremia due to GNB. No diff erence in 
28-day mortality was observed between the two groups (PMX: 33.9% 
vs. non-PMX: 33.1%, P = 0.87). In the Cox regression analysis adjusted 
for age, sex and facilities, the PMX treatment (hazard ratio = 0.87; 95% 
confi dence interval, 0.53 to 1.43) did not improve the outcome.
Conclusion No diff erence in mortality rate was observed after 
adjustment for the endotoxin adsorption therapy with PMX in the 
patients with septic shock due to GNB.
P132
Impact of evolving cardiac catheterisation services on admissions 
to a regional ICU
EA Gorman, D Trainor
Royal Victoria Hospital, Belfast, UK
Critical Care 2015, 19(Suppl 1):P132 (doi: 10.1186/cc14212)
Introduction National UK audit data demonstrate cardiac 
catheterisation services, including percutaneous coronary intervention 
and noncoronary interventions, are increasing [1-3]. National mortality 
rates post cardiac catheterisation are also increasing, refl ecting an 
increasing proportion of sicker patients undergoing interventional 
procedures [3]. National audit procedures do not evaluate patients 
admitted to intensive care post cardiac catheterisation. We aimed to 
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evaluate the impact of an evolving regional cardiac catheterisation 
service on a regional intensive care unit (RICU) serving a population 
of 1.8 million.
Methods A retrospective review was carried out. Patients admitted 
from the regional cardiac catheterisation laboratory to the regional 
ICU, between September 2009 and September 2014, were identifi ed 
using validated RICU admission records. Clinical data were extracted 
from computerised patient records.
Results A total of 170 patients were identifi ed (representing 2.9% of 
critical care admissions during this time). Baseline characteristics: 
71.7% male, median age 66 (IQR 55 to 74), median APACHE score 18 
(IQR 15 to 23). Seventy-one patients (41.7%) had an APACHE score >20. 
Fifteen patients (8.8%) were aged >80  years. Admissions increased 
yearly – 20 in 2010, 26 in 2011, 35 in 2012, 47 in 2013, 37 at the end of 
the third quarter of 2014 (projected 59 admissions by year end 2014). 
Median length of stay was 3.5 days (IQR 1.8 to 7.2). Average length of 
stay reduced yearly (9.14 days in 2010 to 5.01 days in 2014). ICU bed-
days per year remained static over the 5-year period. Critical care and 
hospital mortality rates were 33% and 39% respectively. There was a 
trend towards increasing mortality yearly, and with increasing age and 
APACHE score.
Conclusion An evolving cardiac catheterisation service is having a 
signifi cant impact on intensive care services within a regional centre. 
Increasing mortality trends in this critical care population refl ects post-
cardiac catheterisation mortality trends nationally. We suggest intensive 
care admissions post cardiac catheterisation should be included in the 
national audit, to allow forward planning of intensive care services and 
to promote quality improvement within this population.
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Introduction Focused Intensive Care Echo accreditation is a nationally 
approved pathway for training and accreditation in basic transthoracic 
echocardiography (TTE) in the UK. Recently, an e-learning module, the 
Intensive Care Echo and Basic Lung Ultrasound (ICE-BLU), has been 
introduced to facilitate TTE learning [1]. Previous work from our group 
has shown that incorporating simulation-based teaching elements into 
a basic TTE course improves candidates’ satisfaction [2]. We assessed 
the impact of introducing the ICE-BLU e-learning programme prior to 
our simulation-based basic TTE course.
Methods Prior to the August 2014 course, all candidates were required 
to complete the ICE-BLU e-learning module. On the morning of the 
course, the candidates completed a questionnaire to assess the impact 
of the e-learning module. The survey included questions on the quality 
of content, user friendliness, whether the content was pitched at the 
right level and any problems faced whilst accessing the e-learning 
module. We also analysed candidates’ feedback from our January and 
August 2014 courses (Figure 1).
Results The response rate of the survey was 100%. Eighty per cent of 
candidates completed the e-learning module. The e-learning module 
was rated high by most candidates (80%). However, nearly one-half of 
the candidates faced problems accessing the module, online. Analysis 
of candidates’ feedback (from the January and August 2014 courses) 
revealed that candidates’ overall impression was better with the 
introduction of e-learning prior to the course.
Conclusion Our survey has shown that the e-learning initiative 
was welcome by the candidates. We conclude that introduction of 
e-learning prior to a simulation-based basic TTE course enhances 
candidates’ satisfaction and feedback.
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Introduction Deep venous thrombosis (DVT) is an increasing major 
cause of mortality and morbidity. There is a need for quick, easy, 
cheap, convenient and reliable diagnostic tools. The objectives 
were to ascertain the diagnostic concordance of emergency doctor-
performed ultrasound (EDUS) of the lower extremities with specialist 
doctor-performed (radiologist or vascular surgeon) echo-Doppler 
(SDED), in the diagnosis of DVT, and to identify possible causes of 
nonconcordance.
Methods A prospective, multicentre study. Adult patients (>18  years 
old) with clinical suspicion of DVT, with high or moderate risk (on Wells 
scoring), or low risk with increased D-dimer levels, were eligible for 
the study. Emergency doctors performed two EDUS in femoral and 
popliteal areas (these results were blinded). After this, echo-Doppler 
was performed by specialist doctors. Both procedures were done within 
24 hours of each other. The fi nal result was considered nonconcordant 
if one or both of the EDUS did not match with the SDED. These SDED 
were used as reference (as standard clinical practice).
Results From September 2013 to September 2014, a total of 328 
patients were enrolled. Fifty-one investigators from seven hospitals 
performed the EDUS. Each patient had the EDUS (femoral and popliteal 
areas) and SDED (also in femoral and popliteal areas). Of 328 pairs of US 
studies, 37 were nonconcordant between EDUS and SDED. Two EDUS 
were incomplete, so the concordance analysis was performed with 326 
US studies, with 35 discordant. The percentage of agreement between 
EDUS and SDED was 89.26%. The kappa index was 0.76 (95% CI = 0.69 
to 0.84), and this means a substantial agreement.
Conclusion There is substantial agreement between EDUS and SDED 
in the diagnosis of DVT, in routine clinical practice. This confi rms the 
results of previous papers. The largest nondiagnostic concordance in 
thrombus occurs in the early performances of emergency doctors, 
Figure 1 (abstract P133).
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especially until the fi fth performance. After the sixth one, the incidence 
of mismatches falls dramatically. It seems advisable to mentor the 
training programmes with at least fi ve shadowed performances in 
order to lower the incidence of mistakes.
P135
Cardiac abnormalities in patients with septic shock detected by 
speckle tracking echocardiography
PY Ng1, WC Sin1, AK Ng2, WM Chan1
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Introduction Sepsis-induced myocardial dysfunction is a well-
recognized condition and confers worse outcomes in septic 
patients. However, the diagnostic criteria remain poorly described. 
Echocardiographic assessment by conventional parameters such as 
left ventricular ejection fraction (LVEF) is often aff ected by ongoing 
changes in preload and afterload conditions. Novel echocardiographic 
technologies such as speckle tracking imaging have evolved for direct 
assessment of the myocardial function. In this study, we investigate the 
measurement of myocardial strain by speckle tracking imaging for the 
diagnosis of sepsis-induced myocardial dysfunction.
Methods This is a prospective, case–control study at a university-
affi  liated tertiary care adult medical ICU. Consecutive patients admitted 
with a diagnosis of septic shock meeting the international consensus 
criteria were included. Patients with other causes of myocardial 
dysfunction were excluded. They are compared with age-matched, 
gender-matched, and cardiovascular risk factor-matched controls, 
who were admitted to hospital for sepsis but did not develop septic 
shock. Conventional echocardiographic parameters, as well as speckle 
tracking imaging of myocardial function, were obtained within 
24  hours of diagnosis. Offl  ine analyses of endocardial tracings were 
performed by two independent operators.
Results From January 2014 to December 2014, 32 patients with septic 
shock (study group) and 20 patients with sepsis but no septic shock 
(control group) were recruited. The baseline characteristics were similar. 
Conventional echocardiographic measurements, including LVEF (59.53% 
vs. 60.67% in the control group, P  =  0.450) and fractional shortening 
(31.98% vs. 32.98%, P = 0.323), did not diff er between the two groups. The 
study group had a greater degree of myocardial dysfunction measured 
by left ventricular global longitudinal strain (–14.6 vs. –17.6, P = 0.005, 
with a less negative value implying worse myocardial contractility). The 
hemodynamic profi les (cardiac index 3.49 l/minute/m2 vs. 3.41 l/minute/
m2 respectively, P = 0.764) were not statistically diff erent.
Conclusion This is a fi rst study in the adult population to show that 
the use of speckle tracking imaging can diagnose signifi cant sepsis-
induced myocardial dysfunction, which was not otherwise detectable 
by conventional echocardiography.
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peripheral veins and coronary sinus
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Introduction Sepsis is a leading cause of death in critically ill patients 
despite the use of modern antibiotics and resuscitation therapies. 
Biomarkers and cardiovascular changes have an important place in this 
process. Myocardial depression occurs in 40% of septic patients.
Methods Twenty patients (group I) with sepsis or septic shock were 
included and 10 patients (group II) served as the nonseptic group. 
Group I morbidity and mortality at day 28 in the ICU were targeted as 
the endpoint. Laboratory investigations, APACHE IV, SAPS II and SOFA 
scores were calculated. Biomarkers IL-1α, IL-1β, IL-6, IL-10, TNFα, CRP, 
NT-proBNP and troponin level were estimated on admission and day 
7 in the peripheral vein (PV) and coronary sinus (CS). Transthoracic 
echocardiography and tissue Doppler imaging was done on admission 
and on day 7.
Results Comparing group I versus group II, the mortality rate was 45%, 
and there was a statistically signifi cant diff erence for temperature 
(P  =  0.001), HR (P  =  0.001) and WBC count (P  =  0.01) on admission. 
Upon comparing survivors versus nonsurvivors in group I there was a 
statistical diff erence in HR on day 7 (P = 0.02), successful vasopressor 
withdrawal (P = 0.02), P/F ratio (P = 0.02) and ScVO2 on day 7 (P = 0.03). 
Regarding IL-1α, IL-1β, TNFα and troponin I there was no statistical 
signifi cant diff erence between groups I and II but IL-6, IL-10 and CRP 
showed statistically signifi cant diff erence on admission PV and CS. Pro-
BNP shows statistically signifi cant diff erence in all CS samples between 
septic and nonseptic groups. Regarding echo upon comparing the 
survivors versus nonsurvivors, E’d/t on day 0 shows a statistically 
signifi cant diff erence between both groups. SAPS II and seventh-day 
SOFA are good predictive scores for mortality in sepsis.
Conclusion Diastolic dysfunction was seen in 90% of patients. Fever, 
HR, and WBC counts are still good early indicators for diagnosis 
of sepsis. Vasopressor withdrawal on the seventh day was a good 
predictor for survival. Admission serum IL-6, IL-10 and CRP from PV 
were better indicators for sepsis than IL-1, pro-BNP and troponin I. 
Admission TNFα and seventh-day IL-6 levels were highly prognostic 
for mortality. CS samples proved that NT pro-BNP is a good indicator 
for sepsis diagnosis and a good predictor for survival. TNFα from CS 
samples was also a good predictor of mortality. SAPS II and a slower 
E’d/t on admission was a good predictor of mortality.
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Introduction Myocardial depression is common among septic 
patients [1]. The aim of this study was to assess whether the values 
of cardiac index (CI) and velocity–time integral (VTI) calculated by 
echocardiography diff er between survivors and nonsurvivors of sepsis.
Methods This was a prospective observational study. We included 
adult newly admitted septic patients, regardless of disease severity. 
Exclusion criteria were concomitant pregnancy or obstetric/gyne-
co logical sepsis and co-existing or terminal diseases that may limit 
life expectancy. At the moment of recruitment, additional exclusion 
criteria included: concomitant pulmonary embolism, trauma or 
acute ischemic coronary disease; pericardial tamponade; aortic valve 
disease; tachyarrhythmias and absence of adequate echocardiographic 
windows. Echocardiographic evaluations were made within the fi rst 
10  minutes of initiation of fl uid therapy in the emergency room. All 
measurements and images were obtained with a 1.5 to 3.5 MHz phased 
array transducer using a standard cardiac preset. CI is the quotient of 
the cardiac output (CO) divided by the body surface area. The CO is 
the product of the stroke volume by the heart rate. Stroke volume is 
calculated as the product between aortic VTI (measured using pulsed-
wave Doppler) and aortic cross-sectional area. The latter is calculated 
in the long axis parasternal window using the left ventricular outfl ow 
tract diameter measurement.
Results In 3 months, 58 patients were included. The average age was 
46.6 years, and 36 were male. Overall mortality was 14%. We included 
16 patients with sepsis syndrome, 27 patients with severe sepsis and 
15 patients with septic shock. Severe sepsis patients presented with 
higher values of CI, when compared with sepsis syndrome and septic 
shock patients (3.46, 3.08 and 2.92 l/minute/m2, respectively, P = NS). 
The same occurred with VTI (19.27, 18.81 and 16.74 cm for severe 
sepsis, sepsis syndrome and septic shock, respectively; P = NS). Mean 
values of CI were lower in nonsurvivors of sepsis (2.51 vs. 3.35 l/minute/
m2, P  =  0.018). Mean values of VTI were also lower in nonsurvivors 
(14.83 vs. 19.01 cm, P = 0.022). 
Conclusion In our study, nonsurvivors of sepsis presented with lower 
values of both CI and VTI in the emergency department. Therefore, CI 
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and VTI may be good markers of sepsis severity and mortality in newly 
admitted patients. In addition, further studies are warranted to assess 
the role of CI and VTI as therapeutic targets.
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Introduction Positive end-expiratory pressure (PEEP) is commonly 
used to correct hypoxemia in the ICU. However, PEEP may impair 
right ventricular functions by increasing its afterload. Speckle tracking 
imaging (STI) is a new echocardiography strain analysis technique 
that provides direct assessment of myocardial contractility during 
systole and diastole. The aim of this study was to evaluate the eff ects 
of diff erent PEEP levels on right ventricular functions by using STI in 
patients undergoing coronary artery bypass grafting surgery.
Methods After ethics committee approval and patients’ written 
consent, we prospectively analyzed 20 CABG surgery patients. After 
initiation of mechanical ventilation and before sternotomy, 5, 10, and 
20 cmH2O PEEP were applied in 5-minute intervals consequently. After 
stabilization at each PEEP level, four-chamber and two-chamber images 
of the right ventricle were recorded using TEE. The right ventricle 
diameter, velocity, longitudinal strain, SR, and fractional area change 
(RVFAC) were calculated and evaluated from the recorded images.
Results The mean age of study patients (85% male) was 59.7 ± 10.5 years. 
Intraoperative mean, systolic, and diastolic arterial blood pressures and 
heart rate were similar at the three PEEP levels. Compared with 5 and 
10 cmH2O PEEP, mean RVFAC signifi cantly decreased at 20 cmH2O PEEP 
(P  =  0.001). Right ventricle velocity reduced with incremental PEEP 
increases (P <0.05). Mean SR values decreased at 20 cmH2O PEEP when 
compared with 5 cmH2O PEEP (P = 0.03). Mean right ventricle diameter 
measurements decreased with incremental PEEP increases; however, 
this decrease was signifi cantly diff erent between 20 cmH2O PEEP and 
other two PEEP levels (P = 0.01). The mean right ventricle strain value 
signifi cantly decreased at 20 cmH2O PEEP when compared with other 
two PEEP levels (P <0.001 for both).
Conclusion Compared with 5 and 10 cmH2O PEEP levels, right ventricle 
functions in terms of strain, SR, right ventricle diameter, and RVFAC 
were signifi cantly impaired at 20 cmH2O PEEP level.
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Absence of lung sliding is not a reliable indicator of pneumothorax 
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Introduction The objective of our study was to estimate correlation 
between PEEP and disappearance of lung sliding (LS) due to lung 
overdistension in the absence of pneumothorax.
Methods We performed a prospective study from September 2013 
to May 2014 in adult patients with respiratory failure who required 
mechanical ventilation, lung CT and recruitment manoeuvre. Lung CT 
was used as the gold standard to exclude pneumothorax. A staircase 
recruitment manoeuvre was used with 5 cmH2O increases of PEEP from 
baseline to 35 cmH2O and decreases in reverse order. The duration of 
each step was 1 minute. Lung ultrasound was performed to evaluate 
LS at each step in one intercostal window in the highest point of left 
and right hemithoraces by physicians trained in lung ultrasound and 
blinded to changes in PEEP.
Results In all, eight patients were included; fi ve (62.5%) males, mean 
age 70.1 ± 7.4 years. Mean auto-PEEP was 0.7 ± 0.4 cmH2O. The values of 
PEEP at which LS disappeared or reappeared were compared using the 
Wilcoxon signed-rank test to assess the infl uences of anatomical side 
and PEEP increase or decrease. The values of PEEP at disappearance of 
LS for the right lung were not statistically signifi cantly diff erent from 
the left lung (P  =  0.844 for increases, P  =  0.938 for decreases). The 
values of PEEP at which LS disappeared obtained during increases were 
not statistically signifi cantly diff erent from values obtained during 
decreases (P  =  1.000 for left lung, P  =  0.875 for right lung; Figure  1). 
From data pooled from both sides and protocols, the median value of 
PEEP at which LS disappeared as a false positive sign of pneumothorax 
was 25 cmH2O (interquartile range  = 20 to 30 cmH2O). At PEEP  =  10 
cmH2O, no patient showed absence of LS, whereas at PEEP = 35 cmH2O, 
all patients showed absence of LS (Figure 2).
Conclusion According to this study, higher PEEP levels correlate with 
disappearance of LS without pneumothorax. Absence of LS in patients 
with high PEEP should be interpreted with caution and other signs of 
pneumothorax should be sought before therapeutic interventions are 
attempted.
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Introduction Quantifi cation of lung ultrasound (LUS) artifacts (B-lines) 
is used to assess pulmonary congestion in emergency medicine and 
cardiology [1,2]. We investigated B-lines in relation to extravascular 
lung-water index (EVLWI) from invasive transpulmonary thermodilution 
in septic shock patients. Our aim was to evaluate the role of LUS in an 
intensive care setting.
Methods Twenty-one patients admitted with septic shock to a general 
ICU underwent LUS of eight zones, four per hemithorax, within 
24  hours after ICU admission. EVLWI was calculated simultaneously 
by transpulmonary thermodilution using a pulse-contour continuous 
cardiac output system, and NT-proBNP and clinical data were collected. 
Two physicians blinded to other data independently quantifi ed the 
number of B-lines. Spearman’s rho was used to test the correlation of 
B-lines to EVLWI and clinical data, and linear regression and Bland–
Altman analysis were used to assess the agreement between B-lines 
and EVLWI. Interobserver variability was tested using Bland–Altman 
analysis and intraclass correlation coeffi  cient (ICC).
Results Fourteen patients (67%) were male, the median age was 62 years 
(IQR 55 to 68) and eight (38%) patients had cardiac comorbidities. In 
median, SAPS 3 was 64 (IQR 60 to 74), ICU length of stay was 3 days (IQR 
2 to 8) and seven patients (33%) died within 30 days of ICU admission. 
All patients were mechanically ventilated and treated according to 
Figure 1 (abstract P139). Absence of LS during increasing and 
decreasing PEEP.
Figure 2 (abstract P139). Values of PEEP above which LS was not 
present.
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guidelines [3]. The median number of B-lines was 15 (IQR 10 to 30) 
and the median (IQR) NT-proBNP, EVLWI and oxygenation index (OI) 
were 7,800 ng/l (3,690 to 15,050), 11 ml/kg (IQR 8 to 18) and 9.2 (5.7 
to 15.7), respectively. None of the characteristics diff ered signifi cantly 
between survivors and nonsurvivors. The number of B-lines correlated 
to EVLWI (ρ = 0.45, P = 0.04; r2 = 0.20, P = 0.04), but not to NT-proBNP 
(ρ = –0.42, P = 0.06), OI (ρ = 0.25, P = 0.31) or ICU length of stay (ρ = 0.14, 
P = 0.57). On Bland–Altman analysis, mean diff erences and 95% limits 
of agreements between B-lines and EVLWI was 4.9 (–14.5 to 24.5), and 
5.9 (–3.5 to 15.3) when assessing observer agreement. The ICC between 
methods was 0.52 (95% CI = –0.17 to 0.81) and 0.90 (95% CI = 0.73 to 
0.92) between observers.
Conclusion LUS non-invasively and user-independently quantifi es 
lung water in concordance with, but does not replace, invasive 
measurements. Further studies are needed establish the role of LUS as 
a monitoring and diagnostic tool in septic shock patients.
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Introduction Near-infrared spectroscopy (NIRS) with a vascular 
occlusion test (VOT) can be used to extrapolate information regarding 
the tissue oxygen extraction rate. We explored the meaning of 
variations in tissue oxygen saturation downslope (StO2down) during a 
VOT in critically ill patients.
Methods In this prospective observational study, NIRS (thenar 
eminence) was applied every day in 93 patients admitted to the 
ICU. A VOT was performed using a 40% StO2 target. The slope of the 
desaturation curve was assessed separately for the fi rst part (StO2 
Down1) and the last part (StO2 Down2) of the curve and the diff erence 
between Down2 – Down1 was calculated.
Results No signifi cant diff erences were seen in StO2 Down1 or Down2 
between ICU survivors (n  = 76) and ICU nonsurvivors (n  = 17) over 
the fi rst 10 days in the ICU, while Down2 – Down1 was higher in ICU 
nonsurvivors (Figure 1). Patients in the upper quartile of mean Down2 – 
Down1 showed the highest 90-day mortality (P = 0.014).
Conclusion ICU nonsurvivors tended to show a fl attening in the last 
part of the desaturation curve during a VOT, suggesting a reduced tissue 
oxygen extraction. This may depend on microvascular dysfunction 
and/or cellular hypometabolic status.
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Normobaric hyperoxia and the microcirculation in critically ill 
patients: a prospective observational study
S Zuccari, A Donati, E Damiani, E Montesi, S Ciucani, M Rogani, P Pelaia
Università Politecnica delle Marche, Ancona, Italy
Critical Care 2015, 19(Suppl 1):P142 (doi: 10.1186/cc14222)
Introduction It is well known that oxygen acts as a vasoconstrictor. 
We evaluated the impact of normobaric hyperoxia on the sublingual 
microcirculation in critically ill patients.
Methods Forty mechanically ventilated (FiO2 ≤50%) patients with 
hemodynamic stability were enrolled in a prospective observational 
study. The fi rst 20 patients underwent a 2-hour period of hyperoxia 
(FiO2  = 100%), and 20 patients were studied as controls (no FiO2 
variations). The sublingual microcirculation (three sites) was evaluated 
with sidestream dark-fi eld imaging at baseline (t0), after 2  hours of 
hyperoxia (t1), and 2  hours after return to baseline (t2). Continuous 
video recording was also performed during FiO2 variations on one and 
the same area (2-minute video).
Results No changes in mean arterial pressure were observed. The 
perfused small vessel density tended to decrease at t1 and normalize 
at t2 (Figure 1) in the hyperoxia group. These variations appeared early 
after 2 minutes of FiO2 changes. A signifi cant increase in lactate levels 
over time (from 1.1 (0.9 to 1.7) at t0 to 1.4 (1.1 to 1.9)  mmol/l at t2, 
P = 0.01) was seen in the hyperoxia group.
Conclusion Hyperoxia induces an early decrease in microvascular 
perfusion, which appears to go back to normality at return to normoxia.
P143
Near-infrared spectroscopy for assessing the tissue oxygen 
extraction rate during sepsis: relationship with outcome
A Donati, E Damiani, C Scorcella, S Tondi, S Ciucani, P Pelaia
Università Politecnica delle Marche, Ancona, Italy
Critical Care 2015, 19(Suppl 1):P143 (doi: 10.1186/cc14223)
Introduction Microcirculatory dysfunction impairs tissue oxygenation 
during sepsis. We applied near-infrared spectroscopy (NIRS) to evaluate 
the tissue oxygen extraction rate in sepsis and its relationship with 
outcome.
Methods A prospective observational study; 14 septic patients 
underwent NIRS monitoring (thenar eminence) with a vascular 
occlusion test (using a 40% StO2 target) at admission to the ICU. 
Figure 1 (abstract P141).
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Healthy volunteers (n = 27) were studied as controls. The slope of the 
desaturation curve was assessed separately for the fi rst (StO2 Down1) 
and the last part (StO2 Down2) of the curve and the diff erence between, 
Down2 – Down1, was calculated.
Results StO2 Down1 was lower in healthy volunteers as compared 
with septic patients (P  <0.05); no diff erence was seen between ICU 
survivors (n  = 7) and nonsurvivors (n  = 7). StO2 Down2 was similar 
between healthy volunteers and ICU survivors, while it was higher in 
nonsurvivors (P  <0.01 vs. healthy). ICU nonsurvivors showed higher 
Down2 – Down1 as compared with ICU survivors (P <0.01, Figure 1).
Conclusion Tissue oxygen extraction was reduced in septic patients. 
Nonsurvivors showed a fl attening in the last part of the desaturation 
curve during a VOT, while the fi rst part of the StO2 downslope did not 
show any diff erence between survivors and nonsurvivors. This may 
refl ect a tissue hypometabolic status, which may be better elicited in 
the fi nal part of the ischemic challenge.
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Prospective nonrandomized observational study of the use of 
an impedance threshold device in patients with spontaneous 
respiration and hemodynamic instability
C Pantazopoulos1, I Floros1, N Archontoulis1, D Xanthis1, D Barouxis2, 
N Iacovidou2, T Xanthos2
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Introduction The use of an impedance threshold device (ITD) in 
cardiac arrest victims has been shown to increase the systolic arterial 
pressure (SAP) by increasing venous return [1]. There are limited studies 
concerning the use of ITD in patients with spontaneous respiration 
and hemodynamic instability. The purpose of this study is to evaluate 
changes of hemodynamic parameters with the use of ITD in patients 
with spontaneous respiration and hemodynamic instability.
Methods A 5-month prospective nonrandomized observational 
study that included 50 adult patients with spontaneous respiration 
and hypotension in the emergency room and the wards of multiple 
causes except trauma. After measurement of the SAP and verifi cation 
of hypotension (SAP ≤90  mmHg), a mask-style ITD was added. 
Hemodynamic parameters were evaluated every 1  minute and for 
10 minutes after the intervention. Endpoint of the study was a change 
of patient’s SAP after application of ITD.
Results The SAP of patients that were included in the study increased 
15 to 22  mmHg (P  <0.05). Heart rate remained unchanged. Eighty 
percent of patients declared good to very good tolerance from ITD 
application.
Conclusion In this observational study of patients with spontaneous 
respiration and hypotension, ITD increased the SAP, while it seems that 
it was well tolerated by patients. Additional and larger studies will be 
needed in the future in order to investigate the benefi ts of ITD when 
used to patients with spontaneous respiration and hemodynamic 
instability.
Reference
1. Pirrallo RG, et al. Eff ect of an inspiratory impedance threshold device on 
hemodynamics during conventional manual cardiopulmonary resuscitation. 
Resuscitation. 2005;66:13-20.
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Introduction Severe burns result in rapid loss of intravascular volume 
due to development of a severe capillary leak and hypovolemic shock. 
It is widely accepted that traditional markers, such as blood pressure 
and urinary output, are useful but do not suffi  ciently refl ect global 
perfusion, regional microcirculation or reversal shock. Blood lactate 
concentration is widely used in ICUs as a reliable prognostic marker of 
global tissue hypoxia. Our aim is to determine whether the percentage 
of lactate clarifi ed in the fi rst 24 hours is valid as a guide for resuscitation.
Methods We prospectively studied 143 consecutive burn patients 
admitted to our Burn Unit. Sociodemographics and comorbidities 
data were recorded. Clinical data were collected to calculate the Acute 
Burn Severity Index. Resuscitation according to the Parkland formula 
was guided by a urinary output of 0.5 to 1 ml/hour and the results of 
monitoring the blood pressure. Crystalloid solution (Ringer´s acetate) 
was given exclusively during the fi rst 24 hours. Early surgical excision 
of burn eschar and early coverage of excised burn wounds with 
autografts was performed. Initial and subsequent serum lactate levels 
were measured to calculate lactate clearance according to the formula: 
lactate basal  – lactate at 24  hours / lactate basal  ×  100. The primary 
outcome was mortality.
Results During a period of 2  years we studied 143 patients; their 
mean age was 46.98  ±  19.38 years, mean TBSA burn injury of the 
study population was 22.82 ± 20.25. The fl ame was the most frequent 
mechanism. A total of 83 patients were in mechanical ventilation and 
13.6% of them developed ARDS. The mortality range in the study group 
was 17%. Serum lactate at admission ≥2 mmol/l was associated with 
31.3% mortality versus 6% in patients with a serum lactate at admission 
<2 mmol/l (P <0.05). Length of time to lactate normalization variable is 
associated with mortality (P <0.02). The average lactate normalization 
time was 4.6 days in nonsurvivors while in survivors it was 2.02 days. A 
relation does not exist between the lactate clearance and mortality in 
all patients.
Conclusion The length of time to lactate normalization in the severe 
burn patient is a marker of survival and a simple parameter to guide the 
endpoint of resuscitation; however, the percentage of lactate clarifi ed 
in the fi rst 24 hours is not valid.
P146
Blood lactate normalization following venoarterial ECMO 
institution for refractory cardiogenic shock
M Bottiroli, D Decaria, T Maraffi  , S Nonini, F Milazzo, R Paino
Anestesia Rianimazione 3, A.O. Niguarda, Milan, Italy
Critical Care 2015, 19(Suppl 1):P146 (doi: 10.1186/cc14226)
Introduction Venoarterial (VA) ECMO is used to support patients with 
refractory cardiogenic shock (CS). Elevated lactate level (>2  mmol/l) 
Figure 1 (abstract P143).
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is an indicator of end-organ hypoperfusion. We hypothesize that the 
lactate (LAC) normalization had prognostic value in this cohort of 
patients.
Methods We performed a retrospective observational study on patients 
admitted to the ICU for refractory CS from January 2010 to November 
2014. Patients with postcardiotomy and/or post-transplant CS were 
excluded. Demographics, clinical, hemodynamic and biochemical 
values were collected. LAC was measured on arterial blood before 
ECMO institution (LAC0) and after 48 hours (LAC48). Lactate clearance 
was calculated as follows: (LAC0  – LAC48) / LAC0  ×  100. Data were 
analyzed by comparative statistic; sensibility and specifi city were 
tested with ROC.
Results Twenty-three patients underwent VA ECMO for refractory CS 
in the study period. Etiologies of CS were: 11 acute myocarditis, fi ve 
acute myocardial infarction and seven acute decompensation of 
chronic cardiomyopathy. The median time of ECMO was 10 days (4 to 
15). Thirteen patients died during hospital stay and 10 survived. Three 
patients were bridged to LVAD and two to heart transplant; eight were 
bridged to recovery. The main cause of ICU death was multiple organ 
dysfunction (12/13). Nonsurvivors showed signifi cantly higher LAC0 (5 
(2 to 6) vs. 8 (5 to 11), P  =  0.021). Lactate clearance at 48  hours was 
not signifi cantly diff erent between survivors and nonsurvivors (79%, 
95% CI  = 67 to 86 vs. 60%, 95% CI  = 32 to 72, P  =  0.08). However, 
LAC48 was predictive for ICU mortality (AUC 0.82; 95% CI = 0.64 to 1.0; 
P = 0.011). ROC curve analysis identifi ed the accuracy was highest by 
setting the lactate <2 mmol/l. Patients that did not normalize lactate 
(LAC <2 mmol/l) after 48 hours despite hemodynamic restoration had 
poorer outcome at 30 days, as is shown in the Kaplan–Meier curve (log-
rank P = 0.006) (Figure 1).
Conclusion Failing to normalize patient’s LAC in the fi rst 48 hours of 
VA ECMO assistance for CS is a predictor of ICU mortality. Targeting 
LAC level <2  mmol/l at 48  hours post ECMO institution might be a 
reasonable goal for these patients.
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Introduction Inotropes and vasoactive drugs in septic shock are 
commonly used to maintain cardiac output, tissue perfusion and 
oxygenation. We undertook this study with the purpose of evaluating 
an inotropic score as a predictor of mortality and morbidity among 
children who diagnosed septic shock.
Methods A multicenter retrospective chart review was performed in two 
pediatric ICUs. A total of 93 children with septic shock were recruited. 
Hourly doses of following inotropes were recorded for the fi rst 48 hours 
after admission: dopamine, dobutamine, adrenaline and noradrenaline. 
The inotrope score for every hour, minimum, maximum and mean 
values for the fi rst 24 hours, and subsequent 24 hours were calculated. 
In our analysis, the inotrope score was calculated as described by 
Wernovsky. We expanded this formula to include norephinephrine as 
follows: Wernovsky Inotrope Score = dopamine dose (μg/kg/minute) + 
dobutamine dose (μg/kg/minute)  + 100  ×  epinephrine dose (μg/kg/
minute). Our adjusted inotrope score  = Wernovsky Inotrope Score  + 
100 × norepinephrine dose (μg/kg/minute).
Results Forty-two of 93 patients died. Age and sex were not diff erent 
between survivors and nonsurvivors. Signifi cantly higher mean and 
maximum inotropic score for the fi rst 24 hours and fi rst 48 hours were 
found in nonsurvivors than those of survivors (P <0.05). Using 15 as a 
cutoff  point for predicting mortality, the sensitivity and specifi city were 
69.76% and 50.98% respectively. The association between Prism scores 
and minimum, mean and maximum inotrope scores were statistically 
signifi cant for 0 to 24 hours, 25 to 48 hours and 0 to 48 hours. Mean 0 
to 24 hours and maximum 0 to 48 hours inotrope scores were weakly 
associated with prolonged ICU stay (P = 0.047, P = 0.042 respectively). 
There were no signifi cant relationships between inotrope scores and 
receiving mechanical ventilation.
Conclusion The mean and maximum inotropic scores in the fi rst 
24 hours and 0 to 48 hours are an independent predictor of mortality in 
critically ill children with septic shock.
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Introduction The shock index (SI; heart rate/systolic blood pressure) is a 
widely reported tool to identify acutely ill patients at risk for circulatory 
collapse in the emergency department (ED). Because old age, diabetes, 
essential hypertension, and β-/Ca2+ channel-blockers might reduce 
the compensatory increase in heart rate and mask blood pressure 
reductions in shock or pre-shock states, we hypothesized that these 
factors weaken the association between SI and mortality, reducing the 
utility of SI to identify patients at risk.
Methods This was a cohort study from Odense University Hospital of 
all fi rst-time visits to the ED between 1995 and 2011 (n = 111,019). The 
outcome was 30-day mortality. We examined whether age ≥65 years, 
diabetes, essential hypertension, and use of β-/Ca2+ channel-blockers 
modifi ed the association between SI and mortality. The prognostic 
value of SI ≥1 was evaluated with diagnostic likelihood ratios.
Results We observed a 30-day mortality of 3%. With SI <0.7 as reference, 
a SI of 0.7 to 1 was associated with an adjusted OR of 2.9 (CI 2.7 to 3.2) for 
30-day mortality while the adjusted OR for SI ≥1 was 10.3 (CI 9.2 to 11.5). 
ORs for SI ≥1 were reduced (but still signifi cant) in patients who were 
older, hypertensive, or on β-/Ca2+ channel-blockers, whereas diabetes 
had no eff ect. The OR for SI ≥1 in patients ≥65 years was 8.2 (CI 7.2 to 
9.4) compared with 18.9 (CI 15.6 to 23.0) in younger patients. β-/Ca2+ 
channel-blocked patients had an OR of 6.4 (CI 4.9 to 8.3) versus 12.3 (CI 
11.0 to 13.8) in nonusers, and the OR for hypertensive patients was 8.0 
(CI 6.6 to 9.4) versus 12.9 (CI 11.1 to 14.9) in nonhypertensive patients. 
The OR for SI ≥1 of 9.3 (CI 6.7 to 12.9) in diabetics did not diff er from the 
OR of 10.8 (CI 9.6 to 12.0) in nondiabetic patients. A SI of 0.7 to 1 was 
associated with ORs signifi cantly greater than 1 (range: 2.2 to 3.1) with 
no evident diff erences within the subgroups. A SI measurement ≥1 was 
associated with lower positive likelihood ratios in patients ≥65 years, 
with hypertension, diabetes or using β-/Ca2+ channel-blockers (range 
4.9 to 6.5) compared with patients not exposed to these factors (range 
7.6 to 11.6).
Figure 1 (abstract P146).
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Conclusion SI is independently associated with 30-day mortality in a 
broad population of ED patients. Old age, hypertension and β-/Ca2+ 
channel-blockers weaken this association, but the association remains 
prognostic. SI ≥1 suggests substantial risk of 30-day mortality in all ED 
patients.
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Risk factors for severe vasodilatory shock after cardiac surgery
J Almeida, F Galas, J Fukushima, E Almeida, A Gerent, E Osawa, C Park, 
R Nakamura, A Leme, M Sundin, R Kalil Filho, F Jatene, L Hajjar
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Introduction Vasodilatory shock is a well-known complication in 
patients who undergo cardiac surgery with cardiopulmonary bypass 
(CPB) and its occurrence is associated with higher morbidity and 
mortality. Despite that, clinical characteristics of vasoplegic shock and 
its spectrum of severity are poorly described. The aim of this study 
was to compare patients who developed mild to moderate vasoplegic 
shock with patients who developed a severe form and to identify 
predictive factors for the severe form of vasoplegic shock.
Methods We performed an observational study in 300 patients 
who underwent cardiac surgery with CPB and presented within 
the fi rst 24  hours after surgery with refractory hypotension and 
used a vasopressor agent. Severe vasoplegic shock was defi ned as a 
requirement of norepinephrine higher than 1  μg/kg/minute or the 
use of two or more vasopressors. Baseline characteristics, laboratorial, 
clinical and intraoperative data, such as amount of fl uids, bleeding, 
blood transfusion, inotropes and length of CPB were collected at ICU 
admission. Logistic regression was performed using severe vasodilatory 
shock as the outcome.
Results There were 46 (15%) patients who develop the severe form 
of vasodilatory shock within 24  hours after cardiac surgery. In a 
univariate analysis, patients with the severe form were more likely to 
be older, to receive more blood transfusion and inotropic agents, to 
have higher levels of serum lactate, lower hemoglobin concentration 
and lower SvO2 at the end of the procedure, lower cardiac output 
index, higher heart rate and higher levels of reactive C protein at ICU 
admission. These patients also experienced more postoperative organ 
dysfunction, had a longer length of ICU stay and higher mortality. There 
were no diff erences between patients regarding amount of fl uids and 
length of CPB. In a multivariate analysis we identify age (OR  = 1.04, 
95% CI  = 1.01 to 1.08, P  =  0.016), intraoperative use of epinephrine 
(OR = 5.49, 95% CI = 2.42 to 12.43, P <0.001), higher serum lactate at 
the end of the procedure (OR = 1.04, 95% CI = 1.01 to 1.06, P = 0.001) 
and intraoperative blood transfusion (OR = 5.06, 95% CI = 2.19 to 11.69, 
P <0.001).
Conclusion This study demonstrated that older patients, intraoperative 
blood transfusion and utilization of epinephrine were independently 
associated with a more severe form of vasodilatory shock after cardiac 
surgery with CPB. Also, we identifi ed that a higher lactate at the end 
of the procedure was an independent predictive factor for this severe 
form of shock.
Reference
1. Jochberger S, et al. Intensive Care Med. 2009;35:489-97.
P150
Preoperative treatment with levosimendan helps to evaluate 
myocardial reserves in cardiosurgical patients with chronic heart 
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Introduction The aim of the study was to assess the possibility of 
preoperative levosimendan (LS) administration in myocardial reserve 
evaluation and choice of the method of surgical treatment in patients 
with chronic heart failure (CHF).
Methods LS was used in 107 (female and male) patients (mean 
age 53  ±  3  years) as a component of CHF therapy to prepare them 
for the surgical intervention (2 to 4  days before surgery). In total, 
44.9% of the patients had CHF caused by noncoronarogenic dilated 
cardiomyopathy and 55.1% by ischemic cardiomyopathy. Indication for 
LS therapy was left ventricular ejection fraction (EF) <35% (28 ± 6%). 
Seventy percent of patients had mitral insuffi  ciency (MI), grades II to 
IV, 63% tricuspid insuffi  ciency (TrI), grades II to III, 84% pulmonary 
hypertension (PH), 47% arterial hypertension, grades II to III, and 27% 
of the patients had left ventricular aneurysm. Mean level of BNP was 
1,803 ± 124 pg/ml. LS was administered as i.v. infusion in doses of 0.025 
to 0.1 μg/kg/minute without previous bolus injection. Mean duration 
of infusion was 27.5 ± 5.3 hours. After infusion all patients underwent 
control assessment of values. All patients were operated: 25 (23.3%) 
underwent reverse cardiac remodeling, 63 (58.9%) myocardium 
revascularization (MR) with mitral or aortic valve replacement, 17 
(15.9%) MR and/or resection of left ventricular aneurism and two (1.9%) 
heart transplantation.
Results Heterogeneity of LS eff ects was registered in a number of values. 
The most signifi cant positive eff ect which allowed one to evaluate 
myocardial reserve was demonstrated by decrease of PPA (93.5% of 
patients) and increase of EF (77.6% of patients). The most signifi cant 
changes were also noted in decrease of TrI, PH and MI (in 53.2%, 
36.6% and 36% of patients, respectively). In 69.2% of patients with 
noncoronarogenic dilated cardiomyopathy the eff ect of LS exposure 
was marked. In the majority of patients with ischemic cardiomyopathy 
the eff ect was moderate. In case of the absence of LS-positive eff ect, 
perioperative use of mechanical circulatory support was considered.
Conclusion Preoperative use of LS allows one to evaluate myocardial 
reserves and prepare high-risk patients with CHF for surgery. Our 
fi ndings may serve as one of the additional criteria to choose the 
type of surgical treatment: reconstructive surgery (with or without 
perioperative mechanical circulatory support) or heart transplantation.
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Introduction Early studies suggested a signifi cant increase in survival 
in patients treated with levosimendan compared with dobutamine or 
placebo (LIDO, RUSSLAN and CASINO trials). However, two subsequent 
studies (SURVIVE and REVIVE II) have not confi rmed these fi ndings.
Methods A prospective observational study of all patients undergoing 
cardiac surgery at Malaga’s Regional Hospital from March 2009 to 
March 2013. We analyzed patients who used levosimendan compared 
with those that used dobutamine in the fi rst  hours after cardiac 
surgery, discarding patients in which neither of these two drugs were 
used or surgical cases that arrived at the ICU with both inotropics. We 
analyzed demographic variables as well as clinical complications in the 
ICU and overall perioperative mortality of patients. We performed a 
second analysis using the propensity score, obtaining the probability 
of patients being treated with either drug, pairing each patient who 
received levosimendan with its nearest neighbor receiving dobutamine.
Results We collected 875 patients: 331 received one of the two drugs, 50 
received both drugs and 494 did not receive any drug. ICU mortality was 
7.2% (levosimendan group) and 12.5% (dobutamine group), P = 0.1. After 
adjustment for severity and type of surgery, the use of levosimendan in 
the postoperative period was not a protective factor for ICU mortality 
(P = 0.18, OR = 0.5, 95% CI = 0.18 to 1.3). In the matched sample, mortality 
was 7.4% (levosimendan group) and 5.9% (dobutamine), P = 0.73. After 
logistic regression adjusted for severity, measured with EuroSCORE 
and type of surgery, levosimendan was not a protective factor for ICU 
mortality (P = 0.8, OR = 1.2, 95% CI = 0.26 to 5.45).
Conclusion In our environment, we have observed diff erences in 
the use of levosimendan compared with dobutamine (higher rate of 
men undergoing CABG, diabetes and worse EF). After homogenizing 
the sample of patients by propensity score, an eff ect on mortality is 
discarded and we observed a signifi cant need for use of norepinephrine 
and a nonsignifi cant trend for prolonged mechanical ventilation 
and renal failure requiring renal replacement therapy, both probably 
related with the greatest need for vasopressors observed.




Levosimendan: use, cost-eff ectiveness and outcome in a tertiary 
cardiothoracic centre
A Ranjan, N Bhudia, I McGovern, C Walker, L Kuppurao
Royal Brompton & Harefi eld NHS Foundation Trust, Harefi eld, London, UK
Critical Care 2015, 19(Suppl 1):P152 (doi: 10.1186/cc14232)
Introduction Levosimendan was originally developed for the 
treat ment of decompensated heart failure in situations for which 
conventional therapy is not suffi  cient. It is an eff ective calcium-
sensitising drug with vasodilatory and inotropic eff ects and improves 
cardiac contractility. Trials have shown positive outcome benefi t with 
the use of levosimendan [1]. We reviewed the usage levosimendan at 
our institution and outcome of these patients.
Methods We reviewed the use of levosimendan at Harefi eld from 
January 2013 through December 2013. Patient demographics, logistic 
EuroSCORE (Figure  1), diagnosis, surgical or intervention details, 
inotropic support, dosage and duration of levosimendan use, length 
of stay in the ICU, cost (Table 1) and patient outcome were collected.
Results Levosimendan was used in 30 patients, 23 (77%) male and 
seven (23%) female. Median age was 69 (59 to 72.8). Levosimendan 
was used post cardiac surgery, post angioplasty and in patients 
with ventricular assist devices (VAD) and extracorporeal membrane 
oxygenator (ECMO). Most of the patients received a standard regimen 
of 12.5 mg administered at a dose of 0.1 μg/kg/minute for 24 hours. 
Concurrent noradrenaline was used in most of the patients ranging 
from 0.02 to 0.2 μg/kg/minute. The median length of stay in the ICU 
was nine (6 to 14.5) days for survivors and 23.5 (7.5 to 36) days in 
nonsurvivors. Sixteen patients (55%) survived and were discharged 
from the hospital.
Table 1 (abstract P152). Cost of levosimendan based on a 70 kg patient
 Levosimendan Adrenaline Milrinone
Maximum dose (μg/kg/minute) 0.2 1 0.7
Cost per vial (£) 894 2.30 16
Cost per 24 hours (£) 894 7 112
Conclusion We have successfully used this drug in high-risk patients 
during the perioperative period with good results without major 
complications. Levosimendan seems to reduce catecholamine 
requirement, the need for mechanical circulatory support, and the 
duration of critical care, which can justify the cost of this drug. It can be 
also useful in weaning patients from short-term VAD and ECMO. Larger 
studies are required in this area.
Reference
1. Follath F, et al. Lancet. 2002;360:196-202.
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Introduction Levosimendan is an inotropic seldom used in emergency 
departments (EDs). It has shown improved mortality in patients with 
shock [1] with few adverse eff ects [2]. This work denotes the experience 
of levosimendan use in the ED of Hospital Universitario Mayor between 
2012 and 2014.
Methods We present a retrospective study which analyzes the 
eff ect, after 24  hours, of levosimendan administration on perfusion 
parameters of 166 ED patients. Patients had to have shock diagnosis of 
any cause. Diff erences between the initial and fi nal mean value of the 
following parameters were evaluated: lactate, central venous oxygen 
saturation (ScvO2) and venoarterial diff erence of CO2 (DvaCO2). Data 
were stratifi ed according to levosimendan categories (initial or rescue). 
In addition, association between diff erent variables with mortality 
was sought. Diff erences were considered statistically signifi cant at 
probability levels below 0.05.
Results There were no diff erences in APACHE II values between 
patients who received levosimendan as initial therapy from those who 
received it as a rescue measure. A total of 41 patients fulfi lled lactate 
normalization requirements (lactate <2.0 or clearance >50%) (Table 1). 
Forty-four patients reached normal values of SvcO2 and 37 patients 
of DavCO2 after levosimendan initiation. There were no associations 
between the normalization of lactate, SvO2 and DvaCO2 and diff erent 
types of shock. Twenty-nine patients who received initial therapy with 
levosimendan normalized their lactate values and 12 who received it as 
a rescue therapy (P <0.05). Sixty-three patients developed hypotension, 
and none had adverse eff ects requiring discontinuation of the drug. 
Hospital mortality was 47.7%. Variables associated with mortality in the 
study group were lactate value at admission (OR = 1.3, 95% CI = 1.0 to 
1.7), the use of vasopressin after start levosimendan (OR = 7.5, 95% CI = 
1.9 to 28.6) and the use of norepinephrine before starting (OR = 10.8, 
95% CI = 1.9 to 60.7).
Table 1 (abstract P153). Perfusion variables before and after levosimendan
Variable Initial Final
Lactate (mmol/l) 3.3 (0.5 to 18) 2.38 (0.4 to 17)*
SvcO2 (%) 56.3 (23 to 85) 65.2 (37 to 91)*
DvaCO2 (mmHg) 8.2 (–16 to 26) 7.3 (–2 to 21)
*P <0.01. McNemar test.
Conclusion Levosimendan use in the ED, as initial or rescue therapy, 
normalizes lactate values and improves the SvcO2 after 24  hours, 
without an increase in adverse eff ects.
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Introduction The inotropic agents used in the ICU are dobutamine and 
milrinone; unfortunately, they have shown signifi cant side eff ects when 
used for myocardial depression during septic shock. Our objective is to 
describe Mn behavior in septic shock.
Figure 1 (abstract P152). Logistic EuroSCORE of all patients.
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Methods We reviewed 72 clinical records of patients with diagnosis 
of septic and mixed shock who received Mn through January to 
December 2013. Demographic, hemodynamic, metabolic and 
gasometric data were recorded before and after Mn infusion. The 
PiCCO monitoring system was used. Data were expressed as mean and 
standard deviation. The statistical analysis used Student’s t test. P <0.05 
was considered signifi cant.
Results Seventy-two patients were studied: 36.5% were women, mean 
and SD of age, APACHE II, mechanical ventilation days and long ICU stay 
were: 67 ± 16 years, 18.5 ± 5.9 points, 14.9 ± 12.9 and 24.5 ± 21.9 days, 
respectively. A total 20.3% of the patients received dobutamine. Thirty-
nine percent presented mixed shock. Global mortality was 23%. After 
Mn infusion: cardiac index (CI) increased: 3.1 ± 1 to 3.3 ± 1.1, cardiac 
rate increased: 82.4 ± 14.4 to 88.3 ± 18 and ScvO2 increased: 71.1 ± 10.3 
to 76.1 ± 7.3 (P <0.05). PaCO2 arteriovenous diff erence and lactate were 
reduced: 7.36 ± 3.3 to 6.04 ± 3.6 and 18.7 ± 14.9 to 13.1 ± 9.1 (P <0.05). 
CVP, MAP, RVSI, VSTI, EVLWI and base excess showed no signifi cant 
diff erence. Mn initial average dose was 0.35  ±  0.13. NE before and 
after Mn infusion showed no signifi cant diff erence: 0.11 ± 0.20 versus 
0.12 ± 0.22.
Conclusion Mn optimizes cardiovascular performance in septic shock 
and mixed shock, without aff ecting hemodynamic variables and global 
tissue perfusion. In addition, we observed that the IC, ScvO2, PaCO2 
arteriovenous diff erence and lactate are related variables.
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Introduction The ECRI Institute has identifi ed alarm fatigue as the 
number one health technology hazard [1]. A recent study on 461 
ICU patients investigated 2,558,760 alarms [2]. In total, 88.8% of the 
annotated 12,671 arrhythmia alarms were false positives (FPs). It was 
concluded that the excessive number of alarms is ‘a complex interplay 
of inappropriate user settings, patient conditions, and algorithm 
defi ciencies’. Nine conditions causing alarms, four of which were ECG 
algorithm related, were reported [2]. In this study, we investigated a 
new algorithm in which improvements targeting three of the reported 
four ECG-related conditions were implemented: low amplitude QRS; 
wide QRS; nonactionable ventricular tachycardia (VT).
Methods The false alarm rate of the new algorithm (GE Carescape, 
2012) was compared with that of the algorithm evaluated in the study 
(GE Solar, 2003) [2] on the collected ECG waveform data. User settings 
such as QRS detection sensitivity (high/normal) were not available. 
Therefore, normal sensitivity was assumed for both versions. With the 
old algorithm, 10 patients with low QRS amplitudes gave a signifi cantly 
higher number of FPs than were reported [2]. For those patients, 
both sensitivity modes were tested with the old algorithm. Sixty-six 
percent of patients with a pacemaker did not have the pacemaker 
mode selected [2]. Outlier patients in which false alarms were due to 
user settings (20 patients with a pacemaker) or patient condition (four 
patients with a bundle branch block) rather than algorithm defi ciency 
were excluded.
Results Improved algorithm resulted in 66% reduction of FP alarms. 
When using the high-sensitivity mode for the 10 patients with low QRS, 
FP reduction was 18%. No compromises regarding detection of true 
events were found. The 24 outlier patients contributed to 81.3% of FP 
alarms. The algorithm changes responsible for the reduced FPs were: 
adaptive threshold for low amplitude QRS detection; QRS fi lter with an 
extended frequency range; management of VT alarm priorities.
Conclusion A majority of the FPs was linked to user settings and patient 
conditions. The algorithm changes resulted in a clear reduction of ECG 
algorithm-related FP alarms, while the magnitude of the reduction 
depends strongly on the settings at the bedside.
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Introduction Cardiac arrhythmias may be observed at any time during 
the ICU stay. The prognosis may suff er due to these arrhythmias. In our 
study, we aimed to evaluate incidence and risk factors of arrhythmias 
occurring in patients in the ICU.
Methods Patients treated in the ICU were included in the study if 
they fulfi lled the following: age >18, no cardiac valvular disease, no 
cardiac surgery in the recent 6-month period, no history of myocardial 
infarction (MI), need for mechanical ventilation, and one or more 
organ failure. Demographic, hemodynamic and laboratory parameters, 
APACHE II score, presence of sepsis, acute renal failure, MI, and VIP 
during the ICU stay were recorded. Therapies used for arrhythmia and 
response to therapies were also recorded.
Results Two hundred and fourteen patients were included in the study. 
Twenty-six percent (n = 56) of patients had arrhythmias. Incidence was 
higher in females (P = 0.045). Average age of arrhythmic patients was 69 
(19 to 86), and they were older than nonarrhythmic patients (P <0.001). 
APACHE II scores were higher in arrhythmic patients (P = 0.001).
Admission to the ICU with cerebrovascular event (CVE) and trauma was 
related to arrhythmia (P = 0.021, P = 0.032, respectively). There was a 
signifi cant relationship between VIP and sepsis presence (P  <0.001, 
P <0.001). Atrial fi brillation was the most frequent type of arrhythmia 
(53%), and the most frequently used medication was diltiazem (28.5%). 
The patients who had arrhythmias had a longer ICU stay (P = 0.021). 
The mortality rate for all patients was 48.1%. There was no statistically 
signifi cant relationship between arrhythmia and mortality (P >0.05).
Conclusion Older age, higher APACHE II scores, trauma, CVE, VIP and 
sepsis increases arrhythmia risk in critically ill patients. Atrial fi brillation 
is most common and the most preferred treatment for all arrhythmias 
is diltiazem.
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Introduction Pulmonary hypertension and right ventricular dysfunc-
tion (RVD) are frequently encountered in patients with acute heart 
failure. We sought a better understanding of the coupling between RVD 
and pulmonary hypertension in the setting of acute decompensated 
heart failure (ADHF) as it might improve the prognostic stratifi cation 
and infl uence the survival rates.
Methods Echocardiography was performed in 329 patients with ADHF 
and right ventricular function was assessed by measuring the right 
ventricular fractional area, and a right ventricular ejection fraction 
(RVEF) <35% was taken as the cutoff  value for RV systolic dysfunction. 
The systolic pulmonary pressure (PASP) was calculated from the 
tricuspid regurgitation signal applying the modifi ed Bernoulli equation, 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S54
and pulmonary hypertension was considered as PASP >35  mmHg. 
Based on the values of PASP and RVEF the study group was classifi ed 
into four subgroups: group 1, normal PASP/preserved RVEF; group 2, 
high PASP/preserved RVEF; group 3, normal PASP/ low RVEF; group 4, 
high PASP/low RVEF. The primary endpoint was all-cause mortality. The 
median follow-up was 18 months. Survival analysis was performed 
according to the Cox regression method, adjusted for age, gender, LV 
function, estimated glomerular fi ltration rate, troponin I, hemoglobin, 
serum sodium and BNP levels.
Results Pulmonary hypertension was found in 78% of the patients 
(median PASP: 53 mmHg). As compared with the patients with normal 
PASP the patients with pulmonary hypertension were more likely to be 
in New York Heart Association functional class (NYHA) III or IV (86% vs. 
49%, P <0.001), had a lower RVEF (23 ± 9% vs. 32 ± 8%, P <0.001), and 
had signifi cantly higher BNP levels (280 ± 107 pg/ml vs. 540 ± 320 pg/
ml, P  <0.001). In a Cox model, compared with patients with normal 
right ventricular function and without pulmonary hypertension (group 
1), the adjusted hazard ratio for mortality was 3.1 (95% CI: 1.6 to 4.2, 
P <0.01) in group 2, 0.3 (95% CI: 0.2 to 1.9, P = 0.3) in group 3 and 4.2 
(95% CI: 1.9 to 6.1, P <0.001) in group 4.
Conclusion Among ADHF patients, the coupling of pulmonary 
hypertension and RVD carries an incremental risk, having a portentous 
impact on the survival rate.
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Introduction Hs-cTn is the new standard cardiac biomarker for the 
diagnosis of myocardial necrosis. We conducted a prospective study 
to compare the course and values of Hs-cTn and CK-MB after CABG 
and OPCAB. We also evaluated the relationship between values 
>10 × 99th percentile URL of CK-MB and Hs-cTn as a possible marker 
for perioperative myocardial infarction.
Methods All adult patients undergoing cardiac surgery between 
February and August 2014 were included. Exclusion criteria were 
urgent surgery, GFR <60  ml/minute/1.73 m2, CK-MB >4  μg/l and/or 
Hs-cTn >14 ng/l at baseline (BL). Hs-cTn and CK-MB were measured 
before induction (BL), upon arrival in the ICU and at fi xed times after 
arrival. Patients with perioperative AMI as defi ned by the third universal 
defi nition of AMI were excluded for post hoc analysis [1].
Results Of the 93 patients admissible for inclusion, 40 in the CABG and 
14 in the OPCAB group met all inclusion criteria in this preliminary 
dataset. CK-MB values are higher from ICU arrival up to T24 versus 
baseline in both CABG and OPCAB (P <0.0001) with a peak at T3. For 
Hs-cTn, ICU up to T48 values are higher (P <0.01) in CABG with a peak 
at T6, and from T3 to T48 in OPCAB (P <0.05) versus baseline (Figure 1). 
In CABG patients CK-MB levels are higher versus OPCAB from ICU up to 
T12 (P <0.03), and from ICU to T48 for Hs-cTn levels (P <0.02). In 39 CABG 
patients (97.5%) and 10 OPCAB patients (71.4%) all individual Hs-cTn 
values are above 140 ng/l (= 10 × 99th percentile of URL).
Conclusion Both CK-MB and Hs-cTn levels increase signifi cantly after 
cardiac surgery. Postoperative Hs-cTn levels exceed the 10  ×  99th 
percentile of URL in nearly all CABG patients. Our data show an 
important discrepancy between the 10  ×  99th percentile for both 
biomarkers, and suggest that a diff erent defi nition for postoperative 
AMI may be needed when Hs-cTn is used.
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Introduction The POC PATHFAST cTnI assay (Mitsubishi Medience, 
Japan) has shown promising analytical validity. We thought to evaluate 
whether the assay could be classifi ed ‘highly-sensitive’.
Methods cTnI was determined using PATHFAST in 120 healthy 
individuals (60 men and 59 women, 21 to 69  years old, median 
42  years). Cardiac disorders were excluded by cardiac magnetic 
resonance imaging. The diagnostic characteristics were investigated 
by determination of cTnI and cTnT (Roche hs-cTnT) in 181 patients 
admitted to the chest pain unit at presentation, and 3 and 6 hours later. 
The results were related to the discharge diagnoses.
Results The cTnI concentrations measured in the control group 
ranged from 0.4 to 17.2, mean 2.1 (95% CI: 1.6 to 2.6) ng/l, without age 
dependency. Men revealed higher levels than women, means (IQR) 
were 2.8 (1.2 to 2.6) and 1.1 (0.7 to 1.3) ng/l. The CLSI nonparametric 
method revealed a 99th percentile value of 16 ng/l. The quantifi cation 
of cTnI above the LoD (1.0 ng/l) and below the 99th percentile was 
possible in 79 of 120 individuals. The imprecision profi le according to 
NCCLS revealed 20%, 10% and 5% CVs at concentrations of 2, 3 and at 20 
ng/l, respectively. The discharge diagnosis was NSTEMI in 71 patients. 
The cTnI median values at 0, 3 and 6 hours were 46, 166 and 399 ng/l, 
respectively. AUC values at 0, 3 and 6  hours were 0.923, 0.964 and 
0.969 for hs-cTnT and 0.919, 0.962 and 0.958 for cTnI, respectively. cTnI 
revealed AUC values of absolute changes from admission to 3  hours 
and from admission to 6 hours were 0.920 and 0.931, respectively.
Conclusion The PATHFAST cTnI demonstrated complete fulfi llment of 
the analytical criteria for high-sensitive cTn assays: The imprecision (CV) 
at the manufacturer-recommended 99th percentile value was 5%. The 
quantifi cation of cTnI in was possible in 65.8% of healthy individuals. 
The examination of the diagnostic characteristics revealed complete 
concordance with the hscTnT assay for detection of NSTEMI and 
for assessment of absolute changes of cTn values (rise and/or fall) in 
NSTEMI patients. PATHFAST cTnI showed highly sensitive detection of 
NSTEMI with increasing sensitivity at admission and after 3 to 6 hours, 
not going along with decreased specifi city. The PATHFAST cTnI might 
be useful at the point-of-care setting for early rule-in and rule-out 
diagnosis of NSTEMI.
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Introduction Primary percutaneous coronary intervention (PPCI) is 
the preferred reperfusion strategy for ST-elevation acute myocardial 
infarction (STEMI). In comatose survivors of cardiac arrest, mild induced 
hypothermia (MIH) improves neurological recovery.
Figure 1 (abstract P158).
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Methods A total of 112 patients undergoing PPCI and MIH were 
compared with 32 comparable consecutive patients who underwent 
PPCI but no MIH. We hypothesized that combining both methods lead 
to better survival rate. MIH was induced (propofol, fentanyl, saline 
4  ml/kg BW, 2°C) and maintained for 24  hours, targeting 32 to 34°C. 
Spontaneous rewarming was allowed (0.5°C).
Results There were no signifi cant diff erences between the MIH and 
Control group in general characteristics, cardiac arrest circumstances 
and angiographic features. Except for decreases in heart rate during 
MIH, there was no diff erence between MIH and no MIH groups in 
arterial pressure, peak lactate (7.7 vs. 6.2  mmol/l; P  =  0.36), need for 
vasopressors (57% vs. 41%; P = 0.09), aortic balloon counterpulsation 
(13% vs. 22%; P  =  0.19), repeat cardioversion/defi brillation (17% vs. 
25%; P = 0.30). There was lower incidence of inotropic use (36% vs. 59%; 
P  =  0.01) and use of antiarrhythmics (11% vs. 53%; P  =  0.002). There 
was no diff erence in FiO2 during mechanical ventilation and in renal 
function. See Table 1.
Table 1 (abstract P160). Survival after 12 months
 MIH Control P
CPC 1/2 50 (45%) 5 (15%)  0.002
CPC 3/4 0 0 NS
Cardio 20 (18%) 6 (19%) 0.95
CNS 18 (16%) 17 (53%) 0.00001
Conclusion Hospital survival with CPC 1/2 was signifi cantly better in 
the MIH group (45% vs. 15%; P = 0.01). Our study clearly demonstrates 
that PPCI and MIH are feasible and may be combined safely in comatose 
survivors of ventricular fi brillation in STEMI setting. Such strategy 
improves survival with good neurological recovery.
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Introduction Standard 12-lead electrocardiogram (ECG) is, with 
biomarkers, the most accurate method in the diagnosis of acute 
coronary syndrome (ACS). However, posterior (V7-V8-V9) and right 
(V3R-V4R-V5R) derivations are not systematically performed due to 
the time-consuming procedure involved, despite major therapeutic 
implications (fl uid loading instead of nitrates use in right ventricular 
involvement) and published guidelines [1]. Recently, an 18-lead ECG 
system, standard 12-lead ECG and six additional synthesized leads 
(assessing posterior and right ventricular areas) in only one recording 
procedure has been developed. The reliability of this material (ECG 
2550; Nihon Kohden Co. Ltd, Japan) was already validated in this 
indication in an Asian population [2,3].
Methods We conducted a prospective, observational study with 
patients admitted to our emergency department (ED), during a 6-month 
period. Requirement for ECG was guided by physician’s discretion 
according to patient’s history. All patients with chest pain, dyspnea, 
palpitations, disturbance of consciousness, malaise or abdominal 
complaint underwent synthesized 18-lead ECG within 10  minutes of 
ED arrival. The aim of the study was to evaluate the eff ectiveness of 
the synthesized 18-lead ECG as an ischemia triage tool in the ED, and 
particularly the ability to early detect a right ventricular involvement.
Results Of the 3,835 nontraumatic patients treated in the ED, 3,196 
were adults. In this adult population, 500 ECGs were performed in 
patients whose symptoms suggest ACS. The median age was 62.3 years 
and the sex ratio was 1.16. Clinical presentation was chest pain (31%), 
dyspnea (14%), palpitations (5%), disturbance of consciousness (3%) 
or others (47%). Fifty-six (11.2%) were diagnosed as ACS, including 20 
ST-elevation myocardial infarction (STEMI), 28 non-STEMI and eight 
unstable angina. Of the 20 STEMI patients, eight (40%) and fi ve (25%) 
were diagnosed as STEMI complicated by right ventricular and posterior 
wall ischemia respectively, which means that these complications 
could have been missed by standard 12-lead ECG.
Conclusion Eighteen-lead ECG with synthesized right-sided and 
posterior precordial leads was an effi  cient method to diagnose ACS in 
a Caucasian population within 10 minutes of ED arrival. It is particularly 
performant to detect right ventricular ischemia early, which can modify 
acute therapeutic strategy.
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Introduction After an acute myocardial infarction with ST-segment 
elevation (STEMI) treated with percutaneous coronary intervention 
(PCI), the left ventricle (LV) can undergo negative remodeling (R–). We 
aimed to investigate whether global longitudinal strain (SGL) of the left 
ventricle (LV) predicts remodeling.
Methods Transthoracic echocardiography with speckle tracking 
imaging (TTE-STI) was performed 2 to 3 days after primary PCI and 6 
months later in patients with diagnosis of STEMI. LV R– criteria were: 
LVEF increase ≤5% and end-diastolic volume increase ≥15%. Logistic 
regression and ROC curve analysis was used for the statistical analysis.
Results Eighty-three patients (56  ±  11  years) with STEMI at any LV 
localization and subjected to primary PCI were studied during 2012: LV 
Figure 1 (abstract P162).
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R– patients (n = 35, 42%) and no LV R– patients (n = 48, 58%). Diabetes 
mellitus (41% vs. 19%; P  <0.001) and TnI levels (1.2  ±  2.1  μg/l vs. 0.4 
±0.3 μg/l; P = 0.005) showed higher incidence in LV R– patients. SGL 
was –12.5 ± 5.6% in no LV R– patients and –6.5 ± 3.4 in LV R– patients. 
In the regression analysis just LV SGL and SL in left anterior descending 
territory remained signifi cant, OR: 1.85 (1.24 to 2.76) (P <0.001) and OR: 
1.63 (1.15 to 2.31) (P <0.001), respectively. The analysis of ROC curves 
revealed that at the cutoff  level of –12.46%, SGL identifi es LV R– with a 
sensibility of 81% and a specifi city of 86% (AUC = 0.88: 95% CI: 0.79 to 
0.96; P <0.001) (Figure 1).
Conclusion SGL assessment in the fi rst days after primary PCI is useful 
in the prediction of LV R– independently of the myocardial infarction 
localization.
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Introduction The aim was to analyze the related assistance times to 
transfer patients with ST-elevation acute coronary syndrome (STEMI) 
referred to another hospital with a hemodynamics unit (HU) for 
performing emergency catheterization (primary or rescue PCI).
Methods A consecutive registry of patients seen in 2013 (January to 
October) in the ICU of a hospital without a HU. The total transfer time 
is considered from the call to the Emergency Coordination Center until 
arrival at the HU. In turn, this time is divided into activation time, arrival 
time of the relocation team, patient preparation time and transfer time. 
In the case of primary PCI, the door-to-balloon time was estimated by 
adding to the total transfer time the initial assessment and completion 
time of catheterization and balloon infl ation. The times are expressed 
in minutes, as the median and interquartile range.
Results During 10 months of 2013, we treated 162 STEMI. Of these, 
104 had evidence of reperfusion (64%). Primary PCI was performed 
in 24 patients (23%), of which 10 were transferred from the hospital 
to the HU. Fibrinolytic therapy was used in 62 patients (59%), of these 
20 (32.2%) required rescue PCI. The transfer time for primary PCI was 
0:39:44 (0:31:41 to 0:44:32) minutes. The transfer time for rescue PCI 
was 0:38:56 (0:37:25 to 0:51:29) minutes. The door-to-balloon time 
estimated for primary PCI was 80 minutes.
Conclusion Times for interhospital transfer of patients with STEMI who 
had undergone urgent catheterization are within the range considered 
optimal. In the case of primary PCI, times are lower than the 90 to 
120 minutes recommended practice guidelines.
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Introduction The goal of the study was to analyse cerebral blood fl ow 
in pregnancy complicated by preeclampsia.
Methods This was a prospective study. I group: 45 patients, 17 to 
38 years (mean age 27.5 ± 5.3 years) with verifi ed diagnosis of severe 
preeclampsia; control group: 72 healthy women with normal pregnancy, 
third trimester, 19 to 34  years (mean age 24.5± 4.3  years). Exclusion 
criteria: potentially haemodynamically signifi cant stenosis; congestive 
heart disease; arrhythmia; large changes in haemorheology; diabetes 
mellitus; and craniospinal trauma and syncope. Study of cerebral 
fl ow was improved by the method of transcranial dopplerography 
(TCD). All patients underwent duplex scan of extracranial portions of 
brachiocephalic arteries and transcranial duplex scan in the area of 
middle cerebral artery (MCA) (segment M1). During duplex scan of 
brachiocephalic arteries lumen, the presence of extravasal causes for 
basic blood fl ow disturbances was estimated. We determined lumen 
of large basilar arteries and quantitative features of blood fl ow in MCA. 
By the transtemporal approach in the MCA M1 segment, peak systolic 
fl ow velocity (Vps), maximal end-diastolic velocity (Ved), time-adjusted 
maximal velocity (TAMX), resistance index (RI), pulsative index (PI), and 
systolic/diastolic ratio (S/D) were determined. Signifi cance of mean 
value diff erences were calculated using the STATISTICA 6.0 program 
with determination of Student’s t criteria with normal spread in the 
group.
Results All haemodynamic values in the M1 segment of MCA in 
preeclamptic patients were decreased in comparison with the same 
values in healthy pregnant women with diff erent signifi cance: PI (mean 
0.77 vs. 0.84, P <0.01); RI (mean 0.52 vs. 0.54, P <0.05); Vps (mean 90.22 
vs. 104.74 cm/second, P <0.001); Ved (mean 43.25 vs. 48.53 cm/second, 
P  <0.001); TAMX (mean 61.48 vs. 67.30 cm/second, P  <0.01); and S/D 
(mean 2.02 vs. 2.06, P  <0.05). Found pathophysiological changes of 
cerebral haemodynamics were consistent with a dopplerographic 
pattern of diminished perfusion and are typical for vascular segments, 
which are located proximally to the zone of abnormally high 
haemodynamic resistance: prestenotic arterial segments, episodes of 
arterial hypertension and distal vasoconstriction.
Conclusion With TCD we obtained a possibility to determine and 
estimate changes in cerebrovascular fl ow in pregnant patients with 
severe preeclampsia. This enhances diagnostic possibilities of some 
serious pregnancy complications, and gives us deep understanding of 
some components of pathogenesis and increased treatment effi  cacy.
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Introduction Diastolic dysfunction as evaluated by tissue Doppler 
imaging (TDI), particularly by E/E’ ratio (peak early diastolic transmitral 
velocity/peak early diastolic mitral annular velocity) and mitral annular 
E’-wave, is common and crucial in critical illness. Our prospective 
observational study assessed the prognostic signifi cance of TDI 
variables versus cardiac biomarkers, B-type natriuretic peptide (BNP), 
troponin-T (TnT) and investigated determinants of plasma BNP rise, in 
septic shock.
Methods Twenty-seven mechanically ventilated adult patients 
admitted to our ICU were evaluated within 72 hours of evolving septic 
shock. Patients underwent two transthoracic echocardiographies 
within 72  hours of the onset of septic shock: shortly after diagnosis 
and 24  hours later (confi rmatory), alongside relevant measurements 
of cardiac biomarkers. Peak mitral infl ow E and A velocity waves were 
recorded using pulsed-wave Doppler at the mitral valve tips from 
the apical four-chamber view, peak early (E’) and late (A’) diastolic 
myocardial velocities were obtained by TDI at the septal mitral annulus 
in the apical four-chamber view. E/E’ was calculated. P ≤0.01 was 
reported as statistically signifi cant.
Results Mean  ±  SD APACHE II score was 21.22  ±  7.28, mean  ±  SD 
admission SOFA score was 10.25  ±  2.76. Hospital mortality was 55%. 
Nonsurvivors had increased E/E’ (15.56  ±  1.48; P  <<0.00001) and 
reduced E’ 6.32  ±  0.68 cm/second (P  <<0.00001) compared with 
survivors, who exhibited inverse correlations with an E/E’ signifi cantly 
lower (9.30 ± 2.88) and higher E’ (9.01 ± 0.85 cm/second). In contrast, 
BNP and TnT levels displayed remarkably lower statistical signifi cance 
in nonsurvivors (P  =  0.005, P  =  0.007 respectively). The ROC curves 
had an area under the curve of 0.98 for the E’, and 0.92 for the E/E’. 
Vasopressor management (noradrenaline dose) (P  =  0.0001), fl uid 
balance (P <0.001) and E/E’ (P = 0.00004) were independent predictors 
of plasma BNP concentration.
Conclusion Diastolic dysfunction as evaluated by E/E’ and E’ constitutes 
a major independent predictor of outcome in septic shock, compared 
with cardiac biomarkers, suggesting that echocardiographic 
techniques assessing diastolic dysfunction in sepsis may replace 
cardiac biomarkers for mortality prediction. Fluid balance, vasopressor 
management and diastolic dysfunction are independent predictors of 
BNP elevation in septic shock. Our fi ndings should be confi rmed by an 
extended prospective study.
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Introduction Depending upon the medication administered, 
accidental administration of medication into the arterial line can cause 
devastating complications. This wrong-route injection is a never event 
in the UK but may be under-reported especially when occurring in the 
unconscious patient who may not notice associated pain temporally. 
Under-reporting may occur because resultant complications may be 
delayed a number of hours and the accountable healthcare worker may 
not recognise or choose not to report the error. In 2008 the UK National 
Patient Safety Agency (NPSA) reported only 76 incidents related to 
poor sampling technique but few wrong route arterial injections. Of 
these 21% suff ered moderate to severe harm [1]. The NPSA suggests 
that training and the use of clear labelling alongside red arterial tubing 
and standard red lock caps be used to prevent arterial sampling errors.
Methods In 2014, we conducted a national postal survey of ICUs in 
the UK to attempt to determine the rate of accidental intra-arterial 
injections. The survey was sent to the clinical director of every ICU and 
they were asked whether they were aware of any unintentional arterial 
line injection having occurred in their hospital in the last 5 years.
Results Of the 56 ICUs that responded, 16 (28.5%) reported that they 
had personally seen an accidental injection into the arterial line.
Conclusion Despite the arterial line safety recommendations made by 
the NPSA in 2008, we demonstrate that intra-arterial injection is still a 
problem and that it remains under-reported. Our incidence is likely to 
be an underestimate as it relies on the recollections of a single individual 
in each institution. Medical errors can be mitigated by consideration 
of human factors and system engineering to improve patient safety. 
A focus on clinical awareness, colour coding and training may lead to 
improvements; however, institutions and clinical directors also bear 
a responsibility to prevent never events and a number of engineered 
solutions are now available such as needle-free non-injectable arterial 
sampling devices to protect the healthcare environment and make this 
error impossible [2,3].
Acknowledgement Funding from Eastern Academic Health Science 
Network, UK.
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Introduction Use of ice-cold saline is assumed to provide best accuracy 
of TPTD to obtain the cardiac index (CI), global end-diastolic volume 
(GEDVI) and extravascular lung-water (EVLWI). However, room-
temperature injectate might facilitate TPTD outside the ICU. A recent 
study [1] showed acceptable bias and percentage error (PE) for CI-room 
derived from TPTD with 15  ml room temperature saline compared 
with CI-cold using 15  ml iced saline for TPTD. However, GEDVI-room 
and EVLWI-room had borderline PE values close to 30%, and the bias 
of GEDVI-room markedly increased with higher values of GEDVI and in 
case of femoral CVC. Since imprecision of TPTD-room might be reduced 
by a larger volume of injectate, it was the aim of our study to compare 
CI, GEDVI and EVLWI derived from TPDT using 20 ml room temperature 
injectate with standard TPTD with 15 ml iced saline.
Methods In 31 patients 236 sets with two 20 ml TPTDs with 21°C and 
subsequently two standard TPTDs with 4°C saline were obtained using 
the PiCCO-2 device with the latest algorithm correcting GEDVI for 
femoral TPTD (Pulsion Medical Systems, Germany).
Results Fifteen female and 16 male patients, APACHE II score 21 ± 7. 
Mean values of CI (4.02 ± 0.98 vs. 3.96 ± 0.91 l/minute*m2; P <0.001), 
GEDVI (800 ± 166 vs. 796 ± 163 ml/m2; P = 0.011) and EVLWI (10.3 ± 3.7 
vs. 9.7 ± 3.6 ml/kg; P <0.001) were slightly higher when measured at 
room temperature compared with cold saline. Mean bias and PE values 
were 0.06  ±  0.37 l/minute*m2 and 18.6% for CI, 4  ±  81  ml/m2 and 
20.2% for GEDVI and 0.5 ± 1.1 ml/kg and 22.7% for EVLWI. Bias values 
in case of femoral compared with jugular indicator injection were not 
signifi cantly diff erent for CI (0.04  ±  0.41 vs. 0.11  ±  0.30 l/minute*m2; 
P = 0.161) and EVLWI (0.56 ± 1.19 vs. 0.42 ± 1.07 ml/kg; P = 0.492). Bias 
for GEDVI-room was signifi cantly lower for femoral CVC compared with 
jugular indicator injection (–6.0 ± 81.1 vs. 18.9 ± 78.3 ml/m2; P = 0.008).
Conclusion Compared with previous data using 15  ml room-
temperature injectate, our data with 20 ml room-temperature injectate 
in general provide acceptable bias and percentage error when 
compared with standard TPTD with 15 ml iced saline. This also applies 
for femoral CVC room-temperature TPTD which might also be related 
to a new PiCCO-2 algorithm correcting for femoral CVC site.
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Introduction Patients with acute or chronic liver failure are considered 
to have an altered pattern of haemodynamics. Nevertheless, there is a 
lack of studies systematically investigating haemodynamics in patients 
with liver failure. Therefore, it was the aim of this study to compare 
transpulmonary thermodilution (TPTD)-derived haemodynamics 
of 112 patients with acute or chronic liver failure with 239 patients 
without liver failure.
Methods We analyzed a prospectively maintained database 
including 6,016 TPTD measurements in 351 patients. To account 
for diff erent numbers of TPTDs in diff erent patients, comparison of 
fi rst measurements of patients with and without liver failure was the 
primary endpoint. Statistics: Wilcoxon test for unpaired samples; IBM 
SPSS Statistics 22.
Results A total of 207 male and 144 female patients, APACHE II score 
21  ±  7, 62  ±  14  years old, one to 126 TPTDs per patient. Diagnosis: 
cirrhosis/liver failure n = 112 patients (31.9%), sepsis 55 (15.7%), ARDS 
46 (13.1%), GI aff ection 21 (6.0%), cardiogenic shock 19 (5.4%), various 
98 (27.9%). Patients with liver failure were slightly younger than the 
other patients (58 ± 11 vs. 64 ± 15 years; P <0.001). All other baseline 
characteristics were comparable including APACHE II (20 ± 7 vs. 21 ± 8; 
NS), SAPS (39 ± 12 vs. 41 ± 14; NS), height (172 ± 9 vs. 170 ± 9 cm; NS) and 
weight (76 ± 20 vs. 73 ± 17 kg; NS). Among haemodynamic parameters, 
preload markers GEDVI (753  ±  168 vs. 790  ±  226  ml/m2; P  =  0.182) 
and CVP (14.4 ± 8.8 vs. 14.9 ± 7.1 mmHg; P = 0.250) were comparable. 
Despite comparable preload parameters, the following parameters 
were signifi cantly diff erent: patients with acute or chronic liver failure 
had signifi cantly higher cardiac index (4.3 ± 1.3 vs. 3.3 ± 1.3 l/minute/
m2; P <0.001), stroke volume index (50 ± 15 vs. 37 ± 15; P <0.001), pulse 
pressure (75 ± 19 vs. 65 ± 21 mmHg; P = 0.021) and cardiac power index 
(0.7 ± 0.24 vs. 0.60 ± 0.28 W/m2; P <0.001). By contrast, MAP (77 ± 15 
vs. 80 ± 15 mmHg; P = 0.045), SVRI (1,305 ± 638 vs. 1,877 ± 898 dyn*s/
cm5*m2; P <0.001) and heart rate (84 ± 19 vs. 92 ± 22/minute; P <0.001) 
were signifi cantly lower in patients with liver failure.
Conclusion Our data derived from a large TPTD database demonstrate 
markedly diff erent haemodynamics in patients with cirrhosis or acute 
liver failure with the only exception of static preload markers GEDVI 
and CVP. These fi ndings should be considered in instable patients with 
liver failure.
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Introduction There are few methods of cardiac output (CO) estimation 
validated in children. The aim of this study is to investigate the 
reliability of an uncalibrated pulse contour method of CO estimation, 
the pressure recording analytical method (PRAM), in pediatric patients 
scheduled for diagnostic right and left heart catheterization, compared 
with the oxygen-direct Fick method.
Methods Cardiac index (CI) was simultaneously estimated by Fick, and 
PRAM applied to pressure signals recorded invasively from a femoral 
catheter. All measurements were performed in steady-state condition. 
PRAM CI measurements were obtained for 10 consecutive beats 
simultaneously during the Fick CI estimation. Agreement between Fick 
and PRAM was assessed using the Bland–Altman method. Correlation 
coeffi  cient, bias, and percentage of error were calculated.
Results Forty-three CI measurements were performed in 43 patients. 
The data showed good agreement between CIFick and CIPRAM: r2  = 
0.98; bias –0.0074 l/minute/m2; limits of agreement from –0.22 to 
0.22  l/minute/m2. The percentage error was 8%. Figure  1 shows the 
Bland–Altman plot.
Conclusion PRAM provides reliable estimates of cardiac output in 
hemodynamically stable pediatric cardiac patients compared with the 
Fick method.
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Introduction Although recognized as a questionable indicator of 
the intravascular volume, central venous pressure (CVP) is integrated 
in many therapeutic algorithms for hemodynamic resuscitation of 
critically ill patients [1]. In an attempt to simplify CVP estimation, several 
clinical and ultrasonographic approaches have been suggested [2-5]. 
Nonetheless, the external jugular vein (EJV) circumference and area 
have not been evaluated. Considering the role of EJV visual assessment 
in the clinical estimation of CVP, we hypothesized that EJV ultrasound 
evaluation could be used to reliably estimate CVP.
Methods Patients with a CVC placed as part of clinical management 
were evaluated. EJV and internal jugular vein (IJV) measurements 
were performed at the left cricoid level. IJV and EJV were visualized in 
short axis view; diameters, circumferences and areas were obtained at 
end expiration with simultaneous CVP measurement. Measures were 
performed by a single trained operator, who was blind to CVP values.
Results Forty-eight patients were included. A poor correlation was found 
between CVP and IJV and EJV circumference and area in mechanically 
ventilated patients. A strong correlation was found between CVP and 
EJV circumference (r: 0.74; P = 0.0004; 95% CI: 0.421 to 0.897) and area 
(r: 0.702; P = 0.0012; 95% CI: 0.35 to 0.88) in spontaneously breathing 
patients. Conventional receiver-operating characteristic curves were 
generated to assess the utility of EJV circumference and area to predict 
low (≤8  mmHg) versus high (>8  mmHg) CVP values. AUC for EJV 
circumference and area was 0.935 (P <0.0001; 95% CI: 0.714 to 0.997) 
and 0.87 (P <0.0001; 95% CI: 0.63 to 0.98) respectively (Figure 1).
Conclusion These results highlight a potentially evolving role of 
EJV circumference and area in the hemodynamic management 
Figure 1 (abstract P170). Bland–Altman plot of the cardiac index 
measured with Fick versus PRAM.
Figure 1 (abstract P171).
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of spontaneously breathing patients. An important aspect of the 
suggested approach is its simplicity, requiring basic technical skills 
and making it suitable in any scenario where an ultrasound machine 
is available.
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Introduction Hypovolaemia is generally believed to induce centrali sa-
tion of blood volume. Therefore, we evaluated whether hypovolaemia 
and hypervolaemia result in a change in central blood volume (that is, 
pulmonary blood volume (PBV)) and we explored the eff ects on the 
distribution between PBV and circulating blood volume (Vd circ).
Methods After local District Governmental Animal Investigation 
Committee approval, blood volume was altered in both directions 
randomly in steps of 150  ml (mild) to 450  ml (moderate) either by 
haemorrhage, retransfusion of blood, or infusion of colloids in six 
Foxhound dogs. The anaesthetised dogs were allowed to breathe 
spontaneously. Blood volumes were measured using the dye dilution 
technique: PBV was measured as the volume of blood between the 
pulmonary and aortic valve, and Vd circ by two-compartmental curve 
fi tting [1,2]. The PBV/Vd circ ratio was used as a measure of blood 
volume distribution. A linear mixed model was used for analysing the 
infl uence of blood volume alterations on the measured haemodynamic 
variables and blood volumes.
Results A total of 68 alterations in blood volume resulted in changes in 
Vd circ ranging from –33 to +31% (Figure 1). PBV decreased during mild 
and moderate haemorrhage, while during retransfusion PBV increased 
during moderate hypervolaemia only. The PBV/Vd circ ratio remained 
constant during all stages of hypovolaemia and hypervolaemia 
(Figure 1).
Conclusion Mild to moderate alterations of blood volume result in 
changes of PBV and Vd circ. However, against the traditional belief of 
centralisation we could show that the cardiovascular system preserves 
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Introduction Permissive hypotension, which results in avoidance 
of intravascular overpressure and thereby avoidance of platelet 
plug dislodgement early in the clotting mechanism, improves the 
results after trauma and hemorrhage. The research hypothesis is 
that augmentation of negative intrathoracic pressure with the use 
of an impedance threshold device (ITD) will improve hemodynamic 
parameters, without aff ecting permissive hypotension or causing 
hemodilution. On the other hand, aggressive resuscitation with 
Ringer lactate will cause hemodilution and intravascular pressures 
that are very high for permissive hypotension, capable of platelet plug 
dislodgement.
Methods Twenty anesthetized Landrace/Large-White pigs (19 ± 2 kg, 
10 to 15 weeks) were subjected to a fi xed hemorrhage (50% over 
30  minutes). The pigs were randomly allocated into two groups (n  = 
10 per group). In group A, ITD was the only treatment for hypotension, 
while in group B, an intravenous administration of 1 l Ringer lactate was 
applied for treatment of hypotension. Hemodynamic parameters were 
continuously assessed for the fi rst 30 minutes after blood loss.
Results Mean systolic arterial pressures (SAPs) 30  minutes after the 
intervention in each group were as follows: group A 80 ± 5 mmHg and 
group B 90 ± 4 mmHg. Maximum SAPs during the assessment period 
were: group A 89 ± 2 mmHg and group B 128 ± 5 mmHg. Mean pulse 
pressure was higher in the ITD group versus the fl uid resuscitation 
group (P  <0.05). After the assessment period, mean hematocrit in 
group A was 24 ± 2%, while in group B it was 18 ± 1% (P <0.001).
Conclusion In our study, the ITD increased SAP and pulse pressure 
without overcompensation. On the other hand, aggressive fl uid 
resuscitation led to a signifi cant increase of SAP >100 mmHg capable 
of clot dislodgement and in addition led to hemodilution.
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Introduction Measurement of global end-diastolic volume (GEDV) is 
provided by cardiovascular monitoring devices using thermodilution 
procedures. The aim of this study was to assess the relation between 
this clinically available index and left ventricular end-diastolic volume 
(LVEDV), which is typically not available at the patient bedside.
Methods Measurements were performed on six anaesthetised and 
mechanically ventilated pigs. Volume loading via successive infusions 
of saline solution was fi rst performed and was followed by dobutamine 
infusion. These two procedures provided a wide range of LVEDV values. 
During these experiments, GEDV was intermittently measured using 
the PiCCO monitor (Pulsion AG, Germany) during thermodilutions 
and LVEDV was continuously measured using an admittance catheter 
(Transonic, NY, USA) inserted in the left ventricle.
Results Table  1 presents the linear correlations obtained between 
LVEDV and GEDV. These correlations are good to excellent, with 
r2 values from 0.59 to 0.85. However, the coeffi  cients of the linear 
regressions present a large intersubject variability, which prevents the 
precise estimation of LVEDV using GEDV. Nevertheless, variations in 
LVEDV are well reproduced by the GEDV index. The variations in LVEDV 
actually equal 21 to 48% of those in GEDV. The coeffi  cient b is always 
nonzero, indicating that some proportion of the GEDV index is actually 
not linked to LVEDV.
Figure 1 (abstract P172).
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Table 1 (abstract P175). Linear regressions between LVEDV and GEDV
Subject a b (ml) r2
1 0.26 7.64 0.82
2 0.43 –47.10 0.66
3 0.21 –12.99 0.75
4 0.25 –11.42 0.59
5 0.41 –65.42 0.85
6 0.48 –65.75 0.68
LVEDV = a × GEDV + b.
Conclusion The results show that GEDV and LVEDV are generally 
well correlated, but the correlation coeffi  cients are subject specifi c. A 
preliminary calibration step (for instance using echocardiography) is 
thus necessary to infer LVEDV from GEDV.
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Introduction We performed an evaluation of three devices used for 
assessment of volume status in critically ill patients in our institution: 
transthoracic echocardiography (TTE) (CX50; Philips Ultrasound), 
bio reactance (NICOM; Cheetah Medical) and pulse contour-based 
thermodilution (PiCCO; Pulsion Medical).
Methods Ten mechanically ventilated critically ill patients with PiCCO 
monitoring in situ and a good quality of images on transthoracic view 
were included. All study measurements were made in triplicate. A single 
trained cardiologist, blinded to the results from the other monitors, 
performed the TTE study. Diff erences among the three methods were 
assessed for signifi cance using one-way ANOVA, Spearman’s coeffi  cient 
and Bland–Altman analysis. All statistical analyses were performed 
using Graph-pad Prism 5 and P <0.05 was taken as signifi cant.
Results Ninety measurements were obtained. NICOM and TTE-derived 
stroke volume appeared well matched but PICCO-derived values 
showed signifi cant variation (F = 2.4, P = 0.09). There was no correlation 
between TTE velocity time integer (VTI) and NICOM stroke volume 
variation (SVV) (r  = 0.24, P  =  0.20; Figure  1A) but a good correlation 
and small bias between TTE-VTI and PiCCO-SVV (r  = 0.76, P  <0.0001; 
Figure  1B). Applying the following indications for volume expansion 
(PiCCO and NICOM SVV >15% and TTE VTI variability >15%) we found 
an agreement in 71% of cases between TTE and PiCCO and in 42% of 
cases between echocardiography and NICOM.
Conclusion Stroke volume produced by bioreactance appeared to be 
comparable with that measured by echocardiography but not with 
PiCCO. There was a good agreement between decision-making as 
regards fl uid administration between PiCCO and echocardiography. 
NICOM appeared unreliable in this setting.
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Introduction Fluid administration is always important and diffi  cult 
during the therapy of patients with sepsis. Accurately predicting fl uid 
responsiveness and thus estimating whether the patient will benefi t 
from fl uid therapy seems particularly important. The present study 
intended to predict fl uid responsiveness in patients with sepsis using 
a bioreactance-based passive leg raising test, and to compare this 
approach with the commonly used central venous pressure (CVP) 
approach.
Methods This prospective, single-center study included 80 patients 
with sepsis from the Department of Critical Care Medicine of Zhejiang 
Hospital. Patients were randomly assigned to either Group A or Group 
B, with patients of in Group A fi rst taking the passive leg raising test and 
then taking the fl uid infusion test, while patients in Group B followed 
the opposite protocol. NICOM was used to continuously record 
hemodynamic parameters such as cardiac output (CO), heart rate 
(HR) and central venous pressure (CVP), at baseline1, PLR, baseline2, 
and volume expansion (VE). Fluid responsiveness was defi ned as the 
change in CO (ΔCO) ≥10% after VE.
Results CO increased during PLR (from 5.21  ±  2.34 to 6.03  ±  2.73 l/
minute, P <0.05); and after VE (from 5.09 ± 1.99 to 5.60 ± 2.11 l/minute, 
P <0.05). The PLR-induced change in CO (ΔCOPLR) and the VE-induced 
change in CO (ΔCOVE) were highly correlated (r = 0.80 (0.64 to 0.90)), 
while the CVP and ΔCOVE were uncorrelated (r = 0.12 (–0.16 to 0.32)). 
The areas under the ROC curves of ΔCOPLR and ΔCVP for predicting 
fl uid responsiveness were 0.868 and 0.514 respectively. ΔCOPLR ≥10% 
was found to predict fl uid responsiveness with a sensitivity of 86% and 
a specifi city of 79%.
Conclusion Bioreactance-based PLR could predict fl uid responsiveness 
in patients with sepsis, while CVP could not.
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Figure 1 (abstract P176).




Acute changes of metabolic parameters after fl uid challenge
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Introduction The detection of heart response to fl uid administration is 
still a challenge in clinical practice. Changes in metabolic parameters 
may be useful to detect changes in cardiac output (CO) after fl uid 
expansion.
Methods This is a prospective observational study in adult critically 
ill patients. CO was measured either by echocardiography or by a 
thermodilution method (PiCCO, Swan–Ganz catheter). Hemodynamic 
measurements and blood gas analysis were obtained before and after a 
fl uid challenge with either 1,000 ml crystalloid or 500 ml colloid. Arterial 
and central venous blood gas samples were taken simultaneously. 
Oxygen delivery (DO2), oxygen consumption (VO2) and carbon 
dioxide production (VCO2) were calculated according to well-known 
formulas. Patients were divided into three groups (high responders, 
mild responders and nonresponders) according to their change in CO 
(>20%, 10 to 20%, <10%, respectively).
Results We evaluated 27 patients, age 68 (95% CI: 61 to 74) and APACHE 
II score 22 (95% CI: 18 to 26). Seven patients were high responders, 
eight patients were moderate responders and 12 were nonresponders. 
DO2 was signifi cantly increased in high responders (37  ±  35%, 
P  <0.01) as compared with moderate responders or nonresponders. 
Furthermore, nonresponders had a decrease in their DO2 (–10  ±  7%, 
P <0.01), while moderate responders showed no change in their DO2 
(1.6% ± 10, P = 0.73) after fl uid challenge. We found no diff erences in 
changes in lactate levels and central venous oxygen saturation (ScvO2) 
between high responders, moderate responders and nonresponders. 
No diff erences in the changes of VCO2 or VO2/VCO2 ratio were found 
between high responders, mild responders and nonresponders too. 
Changes in DO2/VCO2 ratio were found to be signifi cantly increased 
only in high responders (47 ± 73% vs. –14 ± 31%, P = 0.02) and not in 
mild responders (15 ± 54% vs. –14 ± 31%, P = 0.15) as compared with 
nonresponders.
Conclusion Only signifi cant increases of CO (>20%), after fl uid 
administration, lead to improved oxygen delivery; DO2 may be 
decreased in nonresponders. The changes of ScvO2 and lactate levels 
do not track the changes of CO after fl uid challenge. The DO2/VCO2 ratio 
may be a useful index to identify signifi cant increases of CO after fl uid 
challenge in cases where CO measurement is not feasible.
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Global end-diastolic volume: a better indicator of cardiac preload in 
patients with septic shock
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Introduction The aim of the study was to assess the value of the 
global end-diastolic volume (GEDV) evaluated by transpulmonary 
thermodilution as an indicator of cardiac preload comparing with 
stroke volume variation (SVV) in patients with septic shock.
Methods A prospective, observational study performed in an 
interdisciplinary ICU including 91 patients with septic shock. 
Hemodynamic monitoring was performed with a new calibrated pulse 
wave analysis method (VolumeView/EV1000; Edwards Lifesciences) in 
37 patients (group EV1000) or with an uncalibrated method (FloTrac/
Vigileo; Edwards Lifesciences) in 54 patients (group Vigileo) during the 
fi rst 72  hours. All patients were receiving mechanical ventilation and 
vasopressors. Measurements were performed before and immediately 
after volume loading using 500 ml Ringer solution over a short period 
(<30 minutes).
Results A total of 211 fl uid challenges were studied in 91 patients. 
We observed a signifi cant relationship between the GEDV index 
before volume loading and the percentage increase in GEDV index 
in the EV1000 group and changes in GEDV index were signifi cantly 
correlated with changes in stroke volume index (r = 0.75, P <0.001), but 
an insignifi cant relationship between SVV variation and cardiac index 
variation (P >0.05) in the Vigileo group.
Conclusion The transpulmonary thermodilution GEDV is a better 
indicator of cardiac preload than SVV in patients with septic shock.
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Introduction Dynamic parameters are becoming standard for fl uid 
responsiveness assessment. Cutoff  values are diff erent in the literature. 
The aim was to assess the accuracy of diff erent preload parameters 
to predict fl uid responsiveness using pulse power analysis and to 
compare diff erent levels of hemodynamic response due to passive leg 
raising (PLR) against the eff ect of a fl uid challenge (FC).
Methods A prospective study in a 17-bed mixed ICU. Patients were fully 
ventilated and CO monitored with LiDCOplus® and underwent a FC due 
to hypotension and/or hypoperfusion and preload dependence (SVV 
and/or PPV >10%). PLR was performed before FC. Hemodynamic data 
were recorded prePLR, postPLR and postFC with 0.5 l crystalloids. We 
compared diff erent cutoff  values of increase in CO and SV (10 to 15%) 
to assess the ability of PLR, SVV, PPV and CVP to predict the response 
to FC. Statistical analysis: continuous variables expressed as mean ± SD. 
Comparison before and after was done using a paired Student’s t test, 
and receiver operating characteristic (ROC) curves were generated by 
varying the discriminating threshold of each variable.
Results Thirty-one patients were included. Baseline parameters: MAP 
70.5 mmHg (SD 13.3) 87% under catecholamine, SV 55.32 ml (SD 20.2), 
CO 5.2 l (SD 2), SVV 16.8% (SD 12), PPV 19.1% (SD 14), HR 96 bpm (SD 18) 
and CVP 9.2 mmHg (SD 2.5). In total, 41.9% of patients increased 15% 
CO after FC (selected as responders), 38.7% after the PLR. Diff erences in 
responders versus nonresponder patients were: baseline SVV (23.9 vs. 
11.6; P = 0.02) and PPV (28.4 vs. 12.4; P = 0.01). Diff erences in SV and CO 
were not statistically signifi cant. The best parameter to predict positive 
response to FC was PLR with cutoff  12.6% for CO increase: sensitivity 
84.6% (95% CI = 65 to 104), specifi city 94.4% (95% CI = 84 to 105) and 
AU ROC 0.94 (95% CI = 0.86 to 1.0). ROC was also good for SVV 0.835 
(95% CI = 0.66 to 1.0; P = 0.002) and PPV 0.833 (95% CI = 0.681 to 0.985; 
P  =  0.002) in this cutoff  value. In SV increase, PLR, SVV and PPV had 
P <0.05, but with worse ROC. In addition, SVV <13% identifi ed patients 
who will not increase MAP with FC: sensitivity 91.7% (95% CI = 76 to 
107.3%), negative predictive value 93.5 (95% CI  = 80.7 to 106). CVP 
failed to distinguish responders from nonresponders.
Conclusion Our results support the idea that a reversible FC (PLR; CO 
cutoff  12.6%) is best at identifying responder patients to a FC. Dynamic 
parameters (SVV/PPV) are also eff ective when appropriate. Beat-to-
beat SV and CO using pulse power analysis is a valid tool for these tests.
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Introduction Volume expansion remains the fi rst treatment step for 
most children with acute circulatory failure in order to assess blood 
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volume status. In this way, dynamic echocardiographic parameters 
have been proposed in mechanically ventilated children [1,2], using 
the heart–lung interactions. This study aimed to investigate whether 
respiratory variations of aortic blood fl ow velocity (DELTA Vpeak 
ao) and inferior vena cava diameter (DELTA IVC) by transthoracic 
echocardiography (TTE) could accurately predict fl uid responsiveness 
in ventilated children.
Methods A prospective observational and interventional study 
conducted in a pediatric ICU investigated 40 mechanically ventilated 
children with preserved left ventricular (LV) function using TTE. Each 
patient had tachycardia, hypotension, oliguria, delayed capillary 
refi lling or hemodynamic instability despite vasopressor drugs. 
Intervention: standardized volume expansion (VE).
Results The VE-induced increase in LV stroke volume was ≥10% in 28 
patients (responders) and <10% in 12 patients (nonresponders). Before 
VE, the DELTA Vpeak ao and DELTA IVC in responders was respectively 
higher than that in nonresponders (18.75% (12 to 32) vs. 13.5% (6 to 
16) and 31% (18 to 57) vs. 17.5% (14 to 25)). The prediction of fl uid 
responsiveness was higher with DELTA Vpeak ao (ROC curve area 0.894 
(95% CI = 0.756 to 0.969), P = 0.0001) and DELTA IVC (ROC curve area 
0.869 (95% CI = 0.717 to 0.957), P = 0.0001). The best cutoff  value for 
DELTA Vpeak ao was 16% with sensitivity and specifi city predictive 
values of 71.6% and 83.3%, respectively, and DELTA IVC was 20% 
with sensitivity and specifi city predictive values of 88.5% and 90.9%, 
respectively.
Conclusion In this study, DELTA Vpeak and DELTA IVC were appropriate 
variables to predict fl uid responsiveness by TTE in ventilated children.
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Introduction Prediction of fl uid responsiveness is defi ned by an 
increase in stroke volume (SV) of at least 10% after volume expansion. 
Dynamic [1] and static [2] esophageal Doppler (OD) parameters have 
been proposed in mechanically ventilated children to guide fl uid 
therapy. This study aimed to compare dynamic parameters using the 
respiratory variation in aortic blood fl ow with static parameters using 
Doppler corrected fl ow times (FTc) obtained by OD.
Methods A prospective, observational and interventional study was 
conducted in our pediatric ICU from March 2012 to September 2014. We 
investigated 18 mechanically ventilated children with acute circulatory 
failure (ACF)  – tachycardia, hypotension, oliguria, delayed capillary 
refi lling or hemodynamic instability despite vasopressor drugs – using 
OD for each patient. Intervention: standardized volume expansion (VE).
Results The VE-induced increase in stroke volume was ≥10% in 14 
patients (responders) and <10% in four patients (nonresponders). 
Before VE, the DELTA Vpeak ao in responders was higher than in 
nonresponders (19.5% (12 to 29) vs. 11.5% (7 to 13)), whereas FTc 
was lower in responders than in nonresponders (262.5 milliseconds 
(180 to 340) vs. 285 milliseconds (205 to 300)). The prediction of fl uid 
responsiveness was higher with DELTA Vpeak ao (ROC curve area 0.964 
(95% CI = 0.756 to 1.000); P = 0.0001) than with FTc (ROC curve area 
0.562 (95% CI = 0.314 to 0.790); P = 0.7203). The best cutoff  value for 
DELTA Vpeak ao was 13% with sensitivity and specifi city predictive 
values of 85.7% and 100%, respectively; and the best cutoff  value for 
FTc was 265 milliseconds with sensitivity and specifi city predictive 
values of 57.1% and 75%, respectively.
Conclusion In our study, DELTA Vpeak was the most appropriate variable 
to predict fl uid responsiveness by OD in ventilated children with ACF.
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Introduction The pleth variability index (PVI) is a new dynamic index 
obtained by automatic estimation of respiratory variations in the 
pulse oximeter waveform amplitude. This noninvasive and continuous 
hemodynamic monitoring has been recently proposed in mechanically 
ventilated patients to guide fl uid therapy. We recently acquired a PVI 
monitor in 2014. PVI is calculated by measuring changes in perfusion 
index (PI) during the respiratory cycle as follows: PVI = ((PImax – Pimin) / 
PImax) × 100. This study aimed to investigate whether PVI at baseline 
can predict fl uid responsiveness.
Methods In our pediatric ICU we started a prospective and 
observational study. Between January and November 2014, nine 
mechanically ventilated children were investigated using PVI and 
transthoracic echocardiography for each patient with acute circulatory 
failure (ACF): tachycardia, hypotension, oliguria, delayed capillary 
refi lling or hemodynamic instability despite vasopressor drugs. 
Intervention: standardized volume expansion.
Results Signifi cant changes in stroke volume were observed after 
volume loading (VL) ≥10% in eight patients (responders (R)) and <10% 
in one patient (nonresponder (NR)). Before VL, PVI was signifi cantly 
higher in R than NR at baseline ((19.75  ±  3.15%) vs. (9%  ±  0.00%), 
P <0.0001), and decreased signifi cantly in R from baseline to after VL 
((19.75% ± 3.15) vs. (12.5% ± 2.828), P <0.0001).
Conclusion In this study, PVI seems to predict fl uid responsiveness in 
ventilated children with ACF.
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Introduction The accuracy of predicting fl uid responsiveness (FR) 
using IVC collapsibility is high in patients on controlled mechanical 
ventilation, but remains unknown in spontaneously breathing patients 
with mechanical ventilation. Also, adequate ultrasound images of IVC 
are diffi  cult to obtain in a substantial number of patients. The aim of the 
current study is to evaluate utility of collapsibility of jugular veins (IJV) 
and subclavian veins (SCV) in comparison with collapsibility of IVC in 
patients on pressure support ventilation.
Methods Patients on pressure support ventilation were prospectively 
included when fl uid challenges were clinically indicated. Bilateral IJV 
were examined at the level of cricoid cartilage. Bilateral SCV were 
measured where the veins crossed the clavicle. Anteroposterior 
diameter, cross-sectional area (CSA) of IJV and SCV were measured 
using frame by frame analysis. IVC was measured 2 cm from the right 
atrial border in a long axis view. Fluid responsiveness was defi ned as 
8% increase of stroke volume calculated by the Vigileo monitor (Vigileo, 
FloTrac; Edwards Lifesciences) after passive leg raising (started from 
supine position). Receiver operating characteristic (ROC) curves were 
generated using EZR.
Results Twenty-nine patients (35 measurements) were included. 
Nineteen measurements had fl uid responsiveness. The mean tidal 
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volume was 9.8  ml/predicted body weight. The area under the ROC 
curve of IVC collapsibility was 0.576 (95% confi dence interval (CI): 
0.38 to 0.77), while the area under the ROC curves of right IJV, left IJV, 
right SCV and left SCV collapsibility were 0.870 (95% CI: 074 to 1.0), 
0.54 (95% CI: 0.34 to 0.74), 0.62 (95% CI: 0.43 to 0.81) and 0.54 (95% 
CI: 0.34 to 0.74), respectively. Greater than 11% of right jugular vein 
collapsibility predicted fl uid responsiveness with a sensitivity of 79% 
and a specifi city of 94%.
Conclusion Our results suggest collapsibility of the right jugular 
vein can be a useful predictor of fl uid responsiveness in patients on 
pressure support ventilation, compared with other central large veins. 
Collapsibility of IVC does not predict FR in those patients.
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Introduction The passive leg raising test (PLRT) is a self-volume challenge 
used in order to predict volume responsiveness (VR) in both spontaneous 
and mechanically ventilated critically ill patients. However, there were 
small numbers of arrhythmic patients included in previous studies. 
Therefore, the accuracy of the PLRT for prediction of VR in arrhythmic 
patient is still inconclusive. We hypothesized that the PLRT can predict 
VR in mechanically ventilated patients having cardiac arrhythmia.
Methods Mechanically ventilated patients having cardiac arrhythmia 
who have been considered for volume expansion were recruited in this 
prospective study. Each patient was sedated, paralyzed and monitored 
with a central venous catheter and a thermistor-tipped femoral arterial 
VolumeView catheter connected to the EV1000 monitor. We assessed 
hemodynamic changes after PLRT via a pulse wave contour analysis 
method. Then we compared it with hemodynamic changes after 
volume expansion (NSS 500 ml in 15 minutes) via the transpulmonary 
thermodilution (TPTD) method.
Results A total of 17 patients were included in this study. Six patients 
were volume responders (TPTD cardiac index change ≥15%). A PLRT 
change cardiac index ≥10% from the pulse wave contour analysis 
method had predicted VR with a sensitivity of 50%, a specifi city of 
72.7% and an area under the ROC curve of 0.591 (P = 0.546).
Conclusion The PLRT may not be used for prediction of VR in 
mechanically ventilated patients having cardiac arrhythmia; however, 
further and larger studies are needed to confi rm this fi nding.
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Introduction Preventable postsurgical complications are increasingly 
recognized as a major healthcare burden. A recent meta-analysis 
showed a 17 to 29% decrease in complications after major surgery with 
perioperative goal-directed therapy (PGDT) [1]. We assessed the fi nancial 
consequences of postsurgical complications in a large population from 
541 US hospitals in order to predict potential savings with PGDT.
Methods Data from adults who had any one of 10 major noncardiac 
surgical procedures between January 2011 and June 2013 were 
selected from the Premier research database. Twenty-six postsurgical 
complications were tabulated. Hospital costs, length of stay, and 
readmission rates were compared in patients with and without 
complications. Risk ratios reported by Pearse’s meta-analysis were 
used to estimate the expected reduction in postsurgical morbidity 
with PGDT. Potential cost-savings were calculated from the actual and 
anticipated morbidity rates using the mean diff erence in total costs.
Results A total of 204,680 patients met the search criteria, and 76,807 
patients developed one or more postsurgical complications (morbidity 
rate 37.5%). In patients with and without complications, hospital costs 
(including 30  days readmission costs) were $27,607  ±  32.788 and 
$15.783  ±  12,282 (P  <0.0001), median (interquartile range) hospital 
lengths of stay (fi rst stay) were 7 (4 to 10) days and 4 (3 to 5) days 
(P  <0.0001), and 30-day readmission rates were 17.2% and 11.9% 
(P <0.0001), respectively. With PGDT, the morbidity rate was anticipated 
to decrease from 26.6 to 31.1%, yielding gross cost savings of $153 
million to 263 million for the study period, $61 million to 105 million 
per year, or $754 to 1,286 per patient.
Conclusion Postsurgical complications occurred in more than one-
third of our study population and had a dramatic impact on hospital 
costs, length of stay, and readmission rates. Potential cost savings with 
PGDT were $754 to 1,286 per patient. These projections should help 
hospitals estimate the return on investment for implementation of 
PGDT.
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Introduction This study attempts to determine a vascular pedicle 
width (VPW) cutoff  value that identifi es a fl uid replete state defi ned as 
an IVC diameter ≥2 cm and ≤15% respiratory variation.
Methods In a cross-sectional design, consecutive, critically ill patients 
underwent simultaneous chest radiographs and ultrasounds. The 
Research Ethics Committee approved the study.
Results Eighty-four data points on 43 patients were collected. VPW 
correlated with IVC diameter (r  = 0.64, P ≤0.001) and IVC variation 
(r = –0.55, P ≤0.001). No correlation was observed between VPW and 
number of lung comets (r  = 0.12, P  =  0.26) or positive fl uid balance 
(r  = 0.3, P  =  0.058). On multivariate linear regression, standardized 
coeffi  cients demonstrated that a 1 mm increase in IVC diameter 
corresponded to a 0.28 mm (Beta) increase in VPW. ROC curve analysis 
yielded an AUC of 0.843 (95% CI = 0.75 to 0.93), P ≤0.001 and provided 
the best accuracy with a cutoff  VPW value of 64 mm (sensitivity 81%, 
specifi city 78%, PPV = 88.5%, NPV = 66%, correct classifi cation rate = 
79.6%). See Figure 1.
Figure 1 (abstract P187). ROC curve for VPW discriminating fl uid 
repletion by IVC ultrasound.
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Conclusion A VPW value of 64 mm accurately identifi es a fl uid replete 
state. Increased extravascular lung water, however, was not relatable 
to the VPW measurements. The VPW can be confi dently used to 
discriminate fl uid repletion from fl uid responsiveness.
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Introduction Fluid overload is associated with adverse outcomes 
in critical illness; however, better methodology is required for its 
quantifi cation. Bioelectrical impedance analysis (BIA) represents a non-
invasive method for quantifi cation of fl uid overload [1], but has not 
been widely taken up in the ICU.
Methods We assessed changes in fl uid balance and performed daily 
BIA (using a Maltron BioScan 920-II; Maltron International Ltd, UK) over 
3 days in consecutive ICU admissions with LOS >72 hours.
Results Of 24 patients 71% were male, median age was 65 years and 
APACHE II score was 15. Eleven patients had a medical diagnosis and 13 
a surgical or trauma reason for admission. Seventy-one percent were 
mechanically ventilated and 67% were on vasopressors or inotropes. 
Median BIA-estimated extracellular water was 25.2 l (IQR 22 to 28) on 
day 1, equating to excess fl uid of 7.2 l (IQR 5 to 13.9). Median right 
body resistance normalized to height at 50 kHz (R50/h) on day 1 was 
214 Ω/m (IQR 187 to 256). Daily change in ECW and R50/h correlated 
with daily fl uid balance between BIA measurements (R2 = 0.48 and 0.37 
respectively) (Figure 1).
Conclusion BIA suggests many patients already have signifi cant 
fl uid overload on the fi rst day of ICU admission. Overall, changes 
in device-specifi c algorithms for ECW estimation and measured 
resistances correlated with recorded fl uid balance; however, there 
were inconsistencies in the number of individual patients. Prospective 
assessment is required to establish whether BIA measurements can be 
used to assist fl uid management in the ICU.
Reference
1. Earthman C, et al. Bioimpedance spectroscopy for clinical assessment of fl uid 
distribution and body cell mass. Nutr Clin Pract. 2007;22:389.
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Introduction An eff ective fl uid challenge should increase the mean 
systemic fi lling pressure (Pmsf ) in order to increase the venous return. 
The objective of this study was to determine the minimum volume of 
intravenous fl uid required to signifi cantly increase the Pmsf.
Methods Patients following cardiac surgery were randomly allocated 
to receive 1, 2, 3 or 4 ml/kg (body weight) of crystalloid over 5 minutes 
using a 60 ml syringe. Pmsf was measured using the arterial pressure 
after stopping blood fl ow in the arm with a pneumatic tourniquet 
infl ated for 1 minute. Cardiac output (CO) was also recorded at baseline 
and immediately after the fl uid infusion. CO was measured with LiDCO 
or pulmonary artery catheter, and a positive response was considered 
an increase of 10% from baseline. From previous data, the least 
signifi cant change for Pmsf was 15%. Medians were compared using 
the independent samples media test, and proportions were compared 
using a chi-square test. Statistical signifi cance was considered when 
P <0.05.
Results Fifty patients were included, 40.8% of them were responders. 
The proportion of responders increases with the increase of dose of 
fl uids (Table 1). The regression equation was: change of Pmsf (%) = 4.4 
(dose of fl uids ml/kg, 95% CI 2.3 to 6.5) – 1.6 (95% CI 7.4 to 4.3, R2 = 
0.28, F(1.47) = 17.8, P <0.001). The predicted dose of fl uids required to 
achieve a change in Pmsf of 15% is 3.7 ml/kg crystalloids.
Table 1 (abstract P189). Change of Pmsf-arm and CO
 1 ml/kg 2 ml/kg 3 ml/kg 4 ml/kg 
 (n = 12) (n = 12) (n = 13) (n = 13) P
ΔPmsf-arm (%) 0.0  6.5 9.0 18 0.05
 (–4 to 9) (3 to 21) (8 to 16) (9 to 21)
ΔCO (%) 3.9 6 9.9 12.9 0.1
 (0.4 to 10) (2.1 to 9.1) (–1.6 to 14.3) (2.6 to 23.5) 
Responders (%) 25.0 18.2 46.2 69.2 0.04
Values are median (interquartile range).
Conclusion The minimum volume required to perform an eff ective 
fl uid challenge is 4 ml/kg infused in 5 minutes. However, only 30% of 
the variation of change in Pmsf can be explained by the dose of i.v. 
fl uid given. The proportion of responders increases with the volume of 
fl uids.
P190
Positive fl uid balance is an independent risk factor for acute 
kidney injury in critically ill patients: results of a prospective, 
cross-sectional study
N Salahuddin, M Sammani, A Hamdan, M Joseph, Y AlNemary, R Alquaiz, 
K Maghrabi
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
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Introduction In critical illness, fl uid overload may predispose to acute 
renal dysfunction by a number of mechanisms. Once acute kidney 
Figure 1 (abstract P188). Change in BIA-measured ECW (a) or R/h at 50 kHz (b) versus daily fl uid balance.
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injury (AKI) develops, positive fl uid balance has been described as 
a risk factor for overall mortality and delayed renal recovery. We 
hypothesized that fl uid overload may be an independent risk factor for 
AKI in the critically ill.
Methods In a cross-sectional design, we collected data on consecutive, 
critically ill, adult patients admitted over a 5-month period to the 
medical and surgical ICUs of a single center. AKI was defi ned according 
to the RIFLE Classifi cation. Logistic regression analysis was performed 
to determine the predictive ability of variables for AKI. The institutional 
Research Ethics Committee approved the study.
Results Three hundred and thirty-nine patients were included; mean 
age was 51 ± 20.4 years, 167 (49%) patients were male. Mean APACHE 
II score was 22 ± 12.8 and SAPS II score was 35.4 ± 18.9. Severe sepsis/
septic shock was the admitting diagnosis in 129 (38%) patients, 108 
(32%) patients were postoperative. AKI developed in 148 (44%) patients; 
Risk 29 (9%); Injury 26 (8%); Failure 89 (26%) by the RIFLE criteria. On 
univariate regression analysis; positive fl uid balance >2 l on the fi rst ICU 
admission day, OR 2 (95% CI = 1.3, 3.3, P = 0.002); age, OR 2.7 (95% CI = 
1.7, 4.2, P = 0.000); CHF, OR 3.1 (95% CI = 1.2, 7.9, P = 0.013); APACHE 
II score, OR 1.02 (95% CI = 1.0, 1.04, P = 0.006); SAPS II score, OR 1.04 
(95% CI = 1.02, 1.05, P = 0.000); mean MAP on admission, OR 0.98 (95% 
CI = 0.96, 0.99, P = 0.033); need for vasopressors on admission, OR 2.7 
(95% CI = 1.7, 4.2, P <0.001) and for >24 hours, OR 2.7 (95% CI = 1.7, 2.5, 
P <0.001); and vancomycin use, OR 1.5 (95% CI = 1.02, 2.53, P = 0.04) 
signifi cantly predicted the development of AKI. On multivariate 
regression, CHF, OR 3.8 (95% CI = 1.4, 10, P = 0.007); age, OR 1.02 (95% 
CI = 1.01, 1.03, P = 0.001); vasopressors for >24 hours, OR 2.6 (95% CI = 
1.6, 4.2, P <0.001) and a >2 l positive fl uid balance on the fi rst ICU day, 
OR 1.6 (95% CI = 1.02, 2.7, P = 0.04) remained signifi cant predictors.
Conclusion Fluid overload, defi ned as a >2 l positive fl uid balance on 
the fi rst day of ICU admission, is an independent risk factor for the 
development of AKI in the general ICU population.
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Introduction After cardiac surgery, about 15% of patients develop 
vasoplegic shock, characterized by systemic vasodilation, increased 
capillary permeability and edema. We hypothesized that large-volume 
resuscitation, resulting in positive fl uid balances in the fi rst 24 hours of 
ICU admission, would be associated with mortality and would not be 
protective against AKI in this subset of patients.
Methods This is a retrospective analysis of 362 patients submitted to 
cardiac surgery at the Heart Institute of University of São Paulo in a 
period of 2 years. Of a total of 2,383 patients, we enrolled 362 patients. 
Vasoplegic shock was diagnosed if in the 24  hours of ICU admission 
patients had hypotension, need of vasoactive drugs after fl uid 
replacement and cardiac index ≥2.2 l/minute/m2. Data were analyzed 
in logistic regression models for 30-day mortality and acute kidney 
injury through Acute Kidney Injury Network (AKIN) score as outcomes.
Results The mean age of patients was 57  years. Of 362 patients, 53 
died at 30 days (14.6%). Nonsurvivors as compared with survivors were 
slightly older (59 ± 12 vs. 55 ± 13, P = 0.063), had a higher prevalence 
of AKI through AKIN score ((0) 6.9%, (1) 11.1%, (2) 28.9%, (3) 31.9%, 
P  <0.001), a higher 24-hour fl uid balance (421  ml (–55 to 695) vs. 
2,686  ml (1,321 to 2,856), P  <0.001), and higher lactate levels at the 
intraoperative and at 48  hours (5  mmol/l (4.0 to 7.6) vs. 4.4 (3.33 to 
6.55), P <0.001; and 8.11 (5.49 to 12.3) vs. 1.5 (1.33 to 1.88), P <0.001). 
In the multivariate analysis, positive fl uid balance in the fi rst 24 hours 
(OR = 1.006, 95% CI = 1.003 to 1.008, P <0.001) and higher lactate after 
48 hours (OR = 1.204, 95% CI = 1.072 to 1.353, P = 0.002) were predictors 
of 30-day mortality. Forty-three percent of patients developed AKI 
during 30 days. In the multivariate analysis, positive fl uid balance in the 
fi rst 24 hours (OR = 1.001, 95% CI = 1.000 to1.001, P <0.001) and higher 
lactate at 48 hours (OR = 1.011, 95% CI = 1.000 to 1.021, P = 0.0043) 
were predictors of 30-day AKI.
Conclusion Positive fl uid balance after cardiac surgery is an 
independent risk factor for mortality and for acute kidney injury in 
patients presenting vasoplegic shock.
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Impact of postsurgical complications on hospital costs and margins
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Introduction The impact of postsurgical complications (PSC) on 
hospital cost has been studied but the impact on margins remains 
controversial [1]. We assessed economic consequences of PSC in US 
Medicare patients, and benefi ts expected from reducing PSC by 14% to 
40% with Enhanced Recovery Programs [2].
Methods Data from patients with ≥1 comorbidity and major cardiac, 
vascular, gastrointestinal and orthopedic surgeries in 2011 were 
extracted from Medicare Standard Analytic Files. Hospital margin was 
calculated as payment minus cost. Patients with and without PSC were 
compared, and the economic impact of a 14 to 40% relative reduction 
in PSC was calculated.
Results Of 303,432 patients, 37% had ≥1 PSC. Median length of stay 
was 10  days for patients with ≥1 PSC and 6  days without (P  <0.0001 
with vs. without PSC), with readmissions for 21% and 16%, respectively 
(P <0.0001 with vs. without PSC). Average margins for cases with PSC 
converted into without PSC would be $1,870 higher. A 14 to 40% 
reduction in patients with PSC (from 37% to 32% to 22%) would result 
in saving $153 million to $438 million, and increase hospital margins 
overall by $28 million to $79 million. See Table 1.
Table 1 (abstract P192)
                               With PSC                           Without PSC
Mean 2011 
US$/patient Cost ($) Margin ($) Cost ($) Margin ($)
Cardiac 46,535 –2,286 32,887* –778*
Gastrointestinal 33,280 –3,088 18,942* –752*
Orthopedic 20,798 –3,567 15,194* –1,872*
Vascular 31,042 –4,782 17,667* –2,267*
*P <0.0001 with versus without PSC.
Conclusion Postsurgical complications have a signifi cant impact on 
hospital margins. Enhanced Recovery Programs have the potential not 
only to improve quality of care but also to improve hospital margins.
References
1. Eappen S, et al. JAMA. 2013;309:1599-606.
2. Nicholson A, et al. Br J Surg. 2014;101:172-88.
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Lactate levels after major cardiac surgery are associated with 
hospital length of stay
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Introduction The objective of the study was to evaluate whether 
postoperative lactate values are associated with hospital length of 
stay in patients undergoing major cardiac surgery. Previous studies 
have shown an association between postoperative lactate levels 
and increased morbidity and mortality after major cardiac surgery. 
However, the association between lactate and hospital length of stay 
has not been adequately characterized.
Methods We performed a retrospective analysis of all patients 
presenting for coronary artery bypass grafting and/or valve surgery 
between 2002 and 2014 at a tertiary care center in Boston, who had 
a lactate level measured within 3 hours of skin closure. Lactate values 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S66
were categorized into clinical meaningful categories: 0 to 2  mmol/l 
(normal), 2 to 4  mmol/l (elevated) and ≥4  mmol/l (high) to allow for 
nonlinear eff ects. The unadjusted association between lactate group 
and length of stay was assessed with the Kruskal–Wallis test and 
post hoc Wilcoxon rank-sum tests. To assess the association between 
postoperative lactate levels and hospital length of stay we performed 
multivariable Poisson regression with robust variance estimates. We 
adjusted for more than 30 variables including patient demographics, 
comorbidities, cardiac characteristics (for example, New York Heart 
Association class and ejection fraction), and surgical characteristics (for 
example, year, status (elective, urgent, emergent), type of procedure, 
perfusion time, and cross clamp time).
Results We included a total of 1,267 patients. The median age was 68 
(quartiles: 59, 76), 32% were female, 68% underwent coronary artery 
bypass grafting and 59% underwent valve surgery. Median length 
of hospital stay was 6  days (quartiles: 5, 9). Median length of stay in 
the normal, elevated and high lactate groups were 5  days (quartiles: 
4, 7), 6 days (quartiles: 5, 9) and 9 days (quartiles: 6, 17), P <0.001 for 
comparison. In multivariable analysis, patients with an elevated lactate 
had a 1.12 times (95% CI: 1.02 to 1.23, P = 0.02) longer length of stay 
compared with those with normal lactate. Patients with a high lactate 
had a 1.30 times (95% CI: 1.10 to 1.53, P = 0.002) longer length of stay 
compared with those with normal lactate.
Conclusion Postoperative lactate levels are associated with increased 
length of hospital stay in patients undergoing major cardiac surgery. 
Interventions aimed at decreasing postoperative lactate levels may 
decrease hospital length of stay.
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Introduction The potential benefi ts of a protocol of intensive 
alveolar recruitment may be outweighed by its detrimental eff ects in 
hemodynamic stability after cardiac surgery. The aim of this study was 
to analyze the hemodynamic behavior of patients included in a trial of 
intensive alveolar recruitment after cardiac surgery.
Methods In this randomized trial, we assigned adult patients with PaO2/
FIO2 <250 at a PEEP of 5 cmH2O to either intensive alveolar recruitment 
or a standard protocol, both using low-tidal volume ventilation (6 ml/
kg/ibw) after adequate volemia status. Our hypothesis was that an 
intensive alveolar recruitment protocol with controlled pressure of 
15 cmH2O and PEEP of 30 cmH2O during 1  minute, repeated three 
times at 1-minute intervals between each maneuver, would not cause 
hemodynamic instability.
Results In total, 163 patients were included in the standard and 157 in 
the intensive group. Patients of the intensive group had a signifi cant 
reduction of the MAP at T1, T2 and T3 (1 hour, 2 hours and 3 hours of 
the protocol), returning to baseline after T4 (Figure 1). No patients had 
severe hypotension (MAP <65 mmHg) and the study was not stopped 
in any case. The length of the hospital stay was shorter among patients 
in the intensive group (10.9 (9.9 to 11.9) vs. 12.4  days (11.3 to 13.6); 
P = 0.045).
Conclusion An intensive alveolar recruitment protocol did not result in 
hemodynamic instability in hypoxemic patients after cardiac surgery 
(NCT01502332).
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Introduction National University Hospital, Singapore, recently 
formed a Division of Critical Care  – Respiratory Therapy. This service 
rapidly expanded to provide 24/7 Respiratory Therapy Services in 
the cardiothoracic intensive care unit (CTICU). One goal of service 
expansion was a reduction in duration of mechanical ventilation 
after cardiac surgery. We hypothesized that introduction of a team-
based extubation protocol would reduce the duration of mechanical 
ventilation and ultimately aff ect ICU length of stay.
Methods A multidisciplinary group created a team-based extubation 
protocol. The protocol was applied to all elective postoperative cardiac 
surgery patients. To assess the protocol’s impact, data were collected 
in a registry 3 months before and 3 months after protocol initiation. 
Data collection included cardiopulmonary bypass time, McCormack 
airway assessment, ICU admission time, initial pH, lactate, inotropes 
upon arrival at the CTICU, blood gas analysis prior to extubation, time 
of extubation and length of stay. Patients were excluded from data 
analysis if they experienced events which contraindicated application 
of the protocol, such as signifi cant intraoperative or postoperative 
complications. These events were explicitly stated in the extubation 
protocol. Singapore’s Domain-specifi c review board granted waiver of 
patient consent to analyze and present these data.
Results A total of 201 patients undergoing elective open cardiac 
surgery were included; 99 patients before protocol implementation 
(pre-protocol) and 102 patients after implementation (post-protocol). 
There was no signifi cant diff erence in mean age (60 vs. 61 P = 0.823), 
gender (79.8% vs. 79.4% P  =  1.00), EuroSCORE (26 vs. 32 P  =  0.576) 
and proportion receiving bypass surgery (72% vs. 80% P  =  0.206) or 
valve surgery (21% vs. 19% P = 0.722) between the two groups. Median 
extubation time was reduced by 3.5 hours (620 minutes vs. 408 minutes 
P <0.001). ICU length of stay was also reduced following introduction of 
the pre-protocol 48 hours versus 24 hours post protocol (P <0.05).
Conclusion A team-based extubation protocol signifi cantly reduced 
the duration of mechanical ventilation and this translated to reduced 
ICU length of stay in patients undergoing elective open-heart surgery.
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Introduction Frailty is defi ned as a multidimensional syndrome 
involving loss of physical and cognitive reserve leading to greater 
vulnerability to adverse events [1]. Such events include susceptibility 
to unplanned hospital admissions, and death [1-3]. Frailty is associated 
with increased ICU and 6-month mortality, and reduced quality of life 
[4]. The aim of this study is to investigate the impact of baseline frailty 
on postoperative quality of life indicators and postoperative frailty 
following cardiothoracic surgery.
Methods Adult patients undergoing cardiac surgery or thoracic surgery 
(involving thoracotomy) were included in this study. Baseline measures 
of frailty [4] and performance status were prospectively recorded using 
validated tools. Informed consent was obtained prior to inclusion. 
Outcome measures of APACHE II scores, duration of ventilation, length 
Figure 1 (abstract P194).
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of ICU stay and mortality were recorded. Follow-up at 6 months was 
conducted by telephone to assess recovery patterns.
Results A total of 120 patients were included in this study, including 
100 patients who underwent cardiac surgery and 20 patients who 
underwent thoracic surgery. Eighty-fi ve patients (70.8%) were male. 
The mean age was 65.4 years (range 25 to 89 years). The mean baseline 
frailty score also varied widely within our cohort. Four patients died in 
the ICU following their surgery (3% ICU mortality rate). Mean length 
of ICU stay was 2.7  days (range 0 to 20  days), with a mean duration 
of ventilation of 20  hours (range 0 to 264  hours). Follow-up of these 
patients at 6 months following their surgery is currently underway.
Conclusion Owing to advances in life expectancy, health and 
perioperative medicine, it has become more diffi  cult to determine 
fi tness for major surgery. Our data suggest that frailty may be a useful 
prognostic measure to help inform such decisions.
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Introduction The aim of our study was to assess whether the 
preoperative use of IABP is benefi cial in patients undergoing cardiac 
surgery of any kind.
Methods An observational, retrospective, multicenter study of all 
patients undergoing cardiac surgery and included in the ARIAM-
ANDALUCIA Registry of Cardiac Surgery from March 2008 to July 2012. 
The probability of placing IABP in the preoperative period has been 
calculated, making a propensity analysis to obtain two homogeneous 
groups treated with or without the IABP, based on personal history, 
functional status and type of surgery. Seventy-seven patients with 
preoperative IABP were matched with 77 patients without BCIAO with 
the nearest propensity score. We used the chi-square test or Student t 
test as needed and binary logistic regression for multivariate analysis so 
we can rule out possible confounding variables. We used the statistical 
package R v2.12 for MAC.
Results A total of 8,026 were recorded, in 77 of them an IABP was 
inserted before the surgery. We performed a propensity score analysis by 
pairing 72 patients with and without BCIAO based on epidemiological 
factors and type of surgery. In the analysis of all-cause 30-day mortality, 
27% of patients in whom IABP was inserted prior surgery died versus 
13.1% of patients without IABP preoperative implantation (P = 0.043). 
A combined endpoint that included need for prolonged mechanical 
ventilation over 24 hours or reoperation or mediastinitis or stroke after 
surgery or 30-day mortality was performed and occurred in 58.3% of 
patients with preoperative IABP versus 41.7% without it (P  =  0.046). 
When stratifi ed by preoperative risk (analyzed with EuroSCORE), no 
diff erence between groups was observed (P  =  0.62, OR 0.75 (0.23 to 
2.35)) for mortality rate and (P  =  0.11, OR 0.47 (0.19 to 1.18)) for the 
combined endpoint. The patients with preoperative IABP implantation 
had a higher ICU length of stay (10.6  ±  7.7 vs. 4.6  ±  6.7, P  =  0.046) 
with no diff erences in terms of overall hospital stay (21.8  ±  18.7 vs. 
18.9 ± 22.08, NS).
Conclusion The use of IABP prior to cardiac surgery in patients at high 
risk does not reduce the mortality rate nor the combined endpoint 
described above. ICU length of stay was greater in those patients in 
whom IABP was implanted prior to surgery; there were no diff erences 
in overall hospital stay.
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Introduction The aim of the study is to analyze IABP use in patients 
undergoing cardiac surgery included in the ARIAM Registry of Cardiac 
Surgery.
Methods An observational, retrospective, multicenter study of 
all patients undergoing cardiac surgery included in the ARIAM-
ANDALUCIA database of Cardiac Surgery from March 2008 to July 2012. 
We used the chi-square test and Student t test as needed, establishing 
the level of statistical signifi cance at 95%.
Results Of the 8,026 patients who underwent cardiac surgery during 
the study period, BCIAO was implemented in 358 (4.5%) of them. 
In total, 65.4% were male. Surgical times in those patients where 
IABP was implanted were 146  ±  81  minutes and 90  ±  66  minutes 
(cardiopulmonary and aortic clamping times, respectively). The in-
surgery room mortality was 4.7%, 30-day mortality in these patients 
was 40.2%. Patients in whom IABP was implanted had a mortality rate 
eight times higher than those who did not require it during surgery or 
postoperatively (40.2% vs. 8.4%, P = 0.0001. OR 8.1, 95% CI (6.4 to 10.3)). 
Besides mortality was higher, the later IABP was implanted the higher 
the mortality rate was (29.6% of the preoperative, 44.2% of surgical 
and 54.4% of those starting in ICU, P = 0.015). The ICU length of stay 
was 9 ± 22 days while the hospital length of stay was 21 ± 28 days. In 
patients who needed IABP, the ICU stay was higher than for those who 
did not need it (9 ± 22 vs. 5 ± 10 days, P = 0.002) whereas there was no 
diff erence in hospital stay (21 ± 28 vs. 20 ± 24 days, P = 0.054).
Conclusion The intra-aortic balloon pump was used by 4.5% of 
surgeries performed during the study period and in patients with an 
increased risk of perioperative complications, estimated by EuroSCORE. 
ICU length of stay was higher in patients requiring IABP, with no 
diff erences in overall hospital stay. Mortality rate was 40% higher, and 
increases with the delay in the implantation.
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Introduction Cardiopulmonary bypass can lead to postoperative 
hemodynamic disorders. Several genetic polymorphisms have 
been studied in this setting. We investigated the possible existence 
of a synergism between polymorphisms of plasminogen activator 
inhibitor type 1 (PAI-1) and tumoral necrosis factor beta (TNF-B) on 
hemodynamic response after cardiac surgery.
Methods We prospectively studied the association between 
hemodynamic response and polymorphisms of TNF-B and PAI-1 in 563 
patients undergoing elective cardiac surgery during the years 2008 to 
2011. We tested the Hardy–Weinberg equilibrium in the sample. V18 
SPSS was used.
Results We studied 563 patients. We found signifi cant diff erences in 
TNF-B polymorphisms regarding norepinephrine requirements at 
4  hours (F: 15.9; P  <0.001), post hoc Scheff é (GG vs. AA, 0.32 (0.11 to 
0.65) vs. 0.06 (0.04 to 0.09) μg/kg/minute, P <0.001; GG vs. AG, 0.32 (0.11 
to 0.65) vs. 0.06 (0.03 to 0.08), P <0.001)) and at 24 hours (F: 8; P = 0.005), 
post hoc Scheff é (GG vs. AA, 0.27 (0.01 to 0.52) vs. 0.10 (0.06 to 0.14), 
P = 0.019; GG vs. AG, 0.27 (0.01 to 0.52) vs. 0.07 (0.04 to 0.09), P = 0.003)). 
Unfavorable TNF-B (G homozygous vs. allele A) and PAI-1 unfavorable 
(4G homozygous vs. allele 5G) were grouped, after adjusting for 
perioperative signifi cant variables. The homozygous GG and 4G alleles 
were signifi cant for NA 4  hours (F: 5.5; P  =  0.02 and F: 4.1; P  =  0.04, 
respectively) and GG–4G allele interaction (F: 6; P  =  0.01) (Figure  1), 
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while for NA at 24 hours statistics showed GG (F: 3.2; P = 0.07), 4G allele 
(F: 2; P = 0.15) and interaction (F: 3.6, P = 0.05).
Conclusion GG homozygous polymorphism TNF-B is associated with 
an increased dependence on norepinephrine after cardiopulmonary 
bypass, showing a synergistic action with the 4G allele of PAI-1.
P200
Pharyngeal oxygenation during apnoea following conventional 
pre-oxygenation and high-fl ow nasal oxygenation
D Stolady, M Mariyaselvam, H Young, E Fawzy, M Blunt, P Young
Queen Elizabeth Hospital, King’s Lynn, UK
Critical Care 2015, 19(Suppl 1):P200 (doi: 10.1186/cc14280)
Introduction We hypothesised that pharyngeal oxygen concentrations 
would be maintained higher and for longer with transnasal humidifi ed 
rapid insuffl  ation ventilatory exchange (THRIVE) than conventional 
bag-mask pre-oxygenation (CPO). CPO requires the mask to be 
removed during laryngoscopy; this means that air may enter the 
mouth so subsequent apnoeic oxygenation will be less eff ective. Oral 
suctioning could exacerbate this process. However, if high pharyngeal 
oxygen concentrations and an open airway are maintained, apnoeic 
oxygenation could be substantially improved. Methods used have 
included NO-DESAT [1] and recently THRIVE [2], which has been shown 
to extend apnoea times for up to 1 hour.
Methods A volunteer with a nasopharyngeal sampling catheter 
underwent simulated emergency airway management (EAM), using 
both CPO and THRIVE, with and without suction. Following 3 minutes of 
pre-oxygenation with CPO (FiO2 = 1, FEO2 >0.8) or THRIVE (60 l/minute; 
Optifl ow, Fisher and Paykel), EAM was simulated by voluntary apnoea 
and pharyngoscopy with the laryngoscope blade tip placed 2 cm from 
the posterior pharyngeal wall. Capnography at the laryngoscope tip 
confi rmed apnoea. Pharyngeal gas samples (20  ml) were collected 
during apnoea, and after 5 seconds of oropharyngeal suctioning. Pre-
oxygenation was repeated between sampling. Samples (n = 100) were 
analysed using calibrated fuel cells.
Results Pharyngeal oxygen concentrations (mean and SEM) are shown 
in Figure 1 (all points are signifi cant P <0.05).
Conclusion Pharyngeal oxygen concentration rapidly falls following 
CPO. This may be detrimental for apnoeic oxygenation during con ven-
tional laryngoscopy. Conversely, THRIVE maintains high pharyngeal 
oxygen concentrations over time. Suction has an immediate negative 
eff ect on pharyngeal oxygen concentration that is attenuated by 
THRIVE. Assessment of NO-DESAT (15 l/minute) was abandoned due to 
discomfort.
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Eff ects of high-fl ow nasal cannula therapy on oxygenation, lung 
volumes and CO2 removal in critically ill hypoxemic patients: 
preliminary results
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Introduction High-fl ow nasal cannula (HFNC) is increasingly proposed 
as respiratory support for hypoxemic non-intubated acute respiratory 
failure patients. Clinically, HFNC therapy decreases dyspnea, improves 
patient’s comfort, improves oxygenation and enhances clearance 
of upper airway secretions [1]. We present preliminary results from a 
clinical study aimed at measuring the eff ects of HFNC on gas exchange, 
lung volumes and inspiratory eff ort in hypoxemic non-intubated 
critically ill patients.
Methods We performed a prospective randomized cross-over study on 
hypoxemic non-intubated patients (PaO2/FiO2 ≤300 mmHg) admitted 
to the ICU of the San Gerardo Hospital and prescribed to receive 
oxygen by facial mask. We delivered the same air/oxygen mix by HFNC 
(Optifl ow; Fisher & Paykel Healthcare, Auckland, New Zealand) and 
facial mask (20  minutes per step). Continuous recordings of regional 
lung volumes by EIT (Pulmovista 500; Drager Medical GmbH, Lubeck, 
Germany) and of inspiratory eff ort by esophageal pressure (Pes) were 
obtained and analyzed offl  ine by dedicated software.
Results We enrolled 15 patients (10 male), age 57 ± 16 years. Compared 
with standard facial mask, HFNC signifi cantly improved PaO2/FiO2 
(199 ± 60 vs. 150 ± 46, P <0.001) and end-expiratory lung impedance 
(corresponding to aeration) (866  ± 568 au vs. baseline, P  <0.001). 
Moreover, HFNC decreased the respiratory rate (22 ± 5 bpm vs. 20 ± 
5 bpm, P <0.001), as well as negative Pes swings (ΔPes 8.3 ± 5 mmHg vs. 
6.6 ± 1 mmHg, P <0.01) and corrected minute ventilation (that is, actual 
MV × actual PaCO2 / 40 mmHg) (49,887 ± 16,176 au vs. 41,811 ± 14,042 
au, P <0.001). Finally, central venous pressure increased (6 ± 5 mmHg 
vs. 4 ± 5 mmHg, P <0.01), possibly indicating positive end-expiratory 
pressure eff ect.
Conclusion In non-intubated hypoxemic critically ill patients, HFNC 
improves oxygenation and end-expiratory aeration; moreover, HFNC 
reduces the inspiratory eff ort and the minute ventilation needed to 
maintain normal arterial CO2 tension.
Reference
1. Sotello D, Rivas M, Mulkey Z, Nugent K. High-fl ow nasal cannula oxygen in 
adult patients: a narrative review. Am J Med Sci. 2015;349:179-85.
P202
New assembled video laryngoscope: a study on effi  cacy and 
cost-eff ectiveness
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Introduction Video laryngoscopes have been introduced in recent 
years as an alternative choice to facilitate tracheal intubation. 
Diffi  culties with tracheal intubation are mostly caused by diffi  cult direct 
laryngoscopy with impaired view to the vocal cords. Many endoscopic 
intubation laryngoscopes have been designed to visualize the vocal 
cords around the corner looking through a proximal viewfi nder. 
Although they are useful devices, they have limitations for doing direct 
laryngoscopy and are very expensive, hence they are not used for 
routine tracheal intubation.
Methods A Macintosh intubating laryngoscope has been modifi ed by 
attaching a waterproof USB camera with a inbuilt light source, which 
Figure 1 (abstract P199).
Figure 1 (abstract P200). Pharyngeal oxygen concentration.
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is located in the same position as the light source on the standard 
Macintosh blade thus providing a view angle of up to 290° and the 
USB camera is connected to a laptop. A total of the fi rst 50  patients 
who presented to the emergency department over a period of 
6 months in need of intubation were included in the study and every 
alternate patient participated in the evaluation of the assembled video 
laryngoscope (VAL). Information about patient demographics and 
airway characteristics, Cormack-Lehane (C/L) views and the ease of 
intubation using the VAL was collected. Failure was defi ned as more 
than one attempt at intubation.
Results Excellent (C/L1) or good (C/L2) laryngeal exposure was 
obtained in 92% and 8% of patients respectively. In 25 patients in 
whom VAL was performed, there was a comparable or superior view. 
Intubation with direct laryngoscopy was successful in 95.2% of patients 
and VAL was successful in 95.4% of patients. Three patients from the 
VAL group and four patients from the direct laryngoscopy group were 
excluded. See Figure 1.
Conclusion This new assembled VAL is the cheapest video-assisted 
laryngoscope available costing around $60, which can even be 
introduced into primary healthcare setup in developing countries. VAL 
consistently yielded a comparable or superior glottic view compared 
with direct laryngoscopy despite the limited or lack of prior experience 
with the device. Because the device can be used for both routine as well 
diffi  cult tracheal intubation, it may be a helpful tool to intubate trauma 
cases where C-spine immobilization is unavoidable. The presented 
video-assisted laryngoscope is a useful tool for documentation, 
teaching and monitoring tracheal intubation.
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cardiac arrest
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Introduction Airway complications are more common outside the 
operating theatre and in emergency situations. Capnography remains 
the gold standard of confi rming correct endotracheal tube (ETT) 
placement, retaining high sensitivity and specifi city in cardiac arrest 
[1]. The 2010 European Resuscitation Council guidelines for adult 
advanced life support recommended waveform capnography in this 
setting [2]. Failure to use capnography was also identifi ed as a major 
contributor to airway-related morbidity and mortality in a national 
UK audit [3]. We sought to investigate current practice relating to the 
availability and use of capnography equipment cardiac arrest within UK 
hospitals.
Methods Between June and November 2014, a telephone survey was 
conducted of all UK acute hospitals with adult level 3 ICUs and an 
emergency department (ED). Hospitals were identifi ed using nationally 
available data. A standardised telephone questionnaire was developed 
examining practice regarding intubation for cardiac arrest and the 
availability and utilisation of capnography within the ED, ICU and 
general wards. Questions were directed at the anaesthetist or intensive 
care doctor ‘responding to cardiac arrest calls’. The respondent was 
given the option to decline participation. All data were anonymised.
Results A total of 211 hospitals met the inclusion criteria. The response 
rate was 100%. Arrest calls were mainly attended by anaesthesia 
(47.8%) and ICU doctors (38.3%) with around 2% physicians only. 
Most were a registrar grade (56.3%). The ability to measure ETCO2 was 
available in all but four EDs; most used waveform capnography. A 
similar pattern was seen was seen in the vast majority of ICUs: a single 
institution reported no capnography available. However, in 141 (66.8%) 
of the hospitals surveyed, no facility to measure ETCO2 was present 
on the general wards. Where available, 86.7% used capnography to 
confi rm ETT placement. Less than 50% used ETCO2 to determine CPR 
eff ectiveness and 8% to prognosticate.
Conclusion We believe this is the fi rst study of its kind to follow NAP4 
and investigate the availability of capnography throughout for use 
during cardiac arrest. Whilst equipment levels appear adequate (albeit 
not perfect) in resuscitation areas, there appears a lack of availability of 
suitable devices on general wards.
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Using a laryngoscope and endotracheal tube succeeds in a diffi  cult 
case of nasogastric tube insertion
J Park, Y Lee
Ewha Womans Unversity Hospital, Seoul, South Korea
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Introduction Nasogastric (NG) tube insertion is necessary in a variety of 
critically ill patients for intra-abdominal decompression, prevention of 
aspiration, route of medication administration and nutrition. However, 
it often fails in patients who showed sedated or comatose mentality 
with poor cooperation during the procedure. Although there are many 
reports inserting a NG tube in diffi  cult cases, most methods need a 
special guide wire, tube or nasoendoscope. We report a case of NG tube 
insertion in a comatose patient using a laryngoscope and endotracheal 
tube which are easily available.
Figure 1 (abstract P202). New video laryngoscope connected to laptop.
Figure 1 (abstract P204). Insertion of a nasogastric tube through an 
endotracheal tube in the esophagus.
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Methods A NG tube was inserted using a laryngoscope and 
endotracheal tube.
Results A 15-year-old male patient admitted due to abrupt mental 
change and brain imaging showed severe subdural hemorrhage. 
NG tube insertion was done for enteral feeding but failed several 
times though changing position. As we had no guide wire and no 
nasoendoscope, an endotracheal tube was used as guidance for the NG 
tube. After making a longitudinal midline cut on the endotracheal tube, 
it was inserted into the esophagus under a laryngoscope. The NG tube 
was pushed into the endotracheal tube, and then the endotracheal 
tube was removed through the cut, reserving the NG tube. We checked 
the position of the NG tube by air sound and X-ray, and started enteral 
feeding without complication, such as nasal bleeding, emphysema, 
and gastric perforation. See Figure 1.
Conclusion We report a new method of NG tube insertion using a 
laryngoscope and endotracheal tube.
P205
Admissions with airway emergencies in the ICU at a tertiary referral 
centre
M Gresoiu, M Singer
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Introduction As a tertiary referral centre for ENT and maxillo-facial 
surgery, our ICU receives complex elective and emergency cases. 
The frequency, aetiology and outcomes of airway emergencies are 
poorly described. Understanding these factors is key to improving 
management.
Methods We conducted a retrospective review of the ICU electronic 
patient database examining unplanned admissions with airway 
emergencies between December 13 and November 14. Data 
on demographics, aetiology of airway obstruction (including 
postprocedural), APACHE II score, therapeutic intervention(s) 
administered, and outcomes were collected.
Results Of 1,516 unplanned admissions, airway emergencies 
represented 6.3% (96 patients) of whom 40 (41.7%) had malignancy 
(26 maxillo-facial/trachea, three pulmonary, four haematological, 
seven other) and 24 infection (abscesses, epiglottitis, Ludwig’s angina). 
Referring specialties were maxillo-facial surgery (n  = 34), internal 
medicine (n = 25), ENT (n = 21) and other surgical specialties (n = 16). 
Thirteen patients had complications post bronchoscopy (vocal cord 
palsy, need for NIV or intubation), one post microlaryngoscopy, and 20 
were admitted after diffi  cult intubation. Eighteen were admitted post 
drainage of abscess (dental, retropharyngeal) and seven for observation 
for epiglottitis. Thirteen patients had stridor (three tracheal stenosis, 
one vocal cord cyst, one post CVA, four post vocal cord palsy, one post 
oesophagoscopy, one post thyroidectomy, two post decannulation). 
Seven were admitted after emergency tracheostomy, one after blocked 
tracheostomy, one after emergency laryngectomy, six post bleeding 
(epistaxis, haemoptysis, bleed form laryngectomy site), and four post 
evacuation haematoma. Three were admitted following anaphylaxis/
angioedema and one after laryngospasm. Twenty-nine patients 
required medical management only (for example, steroids, nebulisers, 
and so forth), 25 were extubated post diffi  cult intubation and six 
needed haemostasis control. Ten (nine surgical) tracheostomies were 
performed during their ICU stay. Sixteen patients died in hospital, of 
whom fi ve were in the ICU at the time; 14 of these had an underlying 
malignancy. Twenty-three patients deteriorated during their ICU stay 
including HAP (n = 3), bleeding from airway (n = 3), PEA arrest (n = 1), 
airway swelling (n = 2), blocked laryngectomy (n = 1), and tracheostomy 
dislodgement (n = 1).
Conclusion Marked variation was seen in the type and aetiology of 
airway emergencies admitted to the ICU. A broad training programme 
is thus required to off er wide-ranging awareness of potential problems, 
communication (including an emergency airway plan), and acute 
management.
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rural Irish hospital
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Introduction Bantry General Hospital (BGH) is a small rural hospital 
serving a large, geographically isolated part of southwest Ireland. 
Following an infl uential national review of adult critical care services 
[1], a protocol was introduced in late 2010 mandating the immediate 
transfer of all medical patients intubated on an emergency basis to 
a large critical care centre 100 km away. Similar mandatory transfer 
protocols were introduced at the same time throughout the island 
of Ireland but few data are available regarding patient outcomes. We 
designed a study to look at the outcomes of all patients encompassed 
by the protocol at BGH.
Methods We retrospectively reviewed the charts and electronic data 
of medical patients requiring emergency intubation at BGH from 
November 2010 to December 2013. We recorded the following data: 
age, sex, admission diagnosis, comorbidities, time delay to transfer, in-
transit mortality, length of stay, survival to discharge and 1-month and 
6-month mortality.
Results Forty-fi ve patients (31 male) were included with a mean age 
of 67  ± 15  years. The commonest admission diagnoses were sepsis 
(10), cardiogenic shock (10), primary respiratory failure (nine) and 
intracranial haemorrhage (eight). The median transfer delay time was 
47 minutes. Only 27 (60%) patients were actually transferred and they 
were signifi cantly younger than nontransferred patients (62 vs. 73 years, 
P = 0.02). In-transit mortality was zero. Mean length of stay in the critical 
care centre was 14.8 ± 16.8 days. Survival to discharge was signifi cantly 
higher in transferred (14/27) compared with nontransferred (3/18) 
patients (52% vs. 17%, P = 0.017). Overall mortality rates were 62% and 
69% at 1 and 6 months respectively and were signifi cantly lower in the 
transferred group (P = 0.02).
Conclusion Overall mortality rates of medical patients intubated 
urgently at BGH were high. Forty per cent of intubated patients were 
not transferred, indicating signifi cant modifi cation of the protocol over 
time. Patients transferred to the critical care centre were younger and 
had signifi cantly better outcomes than patients remaining in BGH, 
probably due to decisions not to transfer patients with poor prognoses. 
Most patients who survived to discharge were still alive 6 months later.
Reference
1. Towards Excellence in Critical Care. Review of adult critical care services in the 
Republic of Ireland fi nal report. Submitted to the Health Service Executive; 
September 2009.
P207
Comparison of video laryngoscopy with direct laryngoscopy in 
patients with good glottic visualization: an observational study of 
348 emergency intubations
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Introduction Video laryngoscopy (VL) is known to improve glottic 
visualization and the fi rst-attempt success rate compared with direct 
laryngoscopy (DL) in emergency tracheal intubations (ETIs). Since VL 
does not align the oral, pharyngeal, and laryngeal axes of the upper 
airway, it sometimes leads to failed intubation despite good glottic 
visualization. We tested the hypothesis that VL has a lower fi rst-
attempt success rate of ETI than DL among patients with good glottic 
visualization.
Methods We performed a prospective observational study examining 
ETIs at our tertiary care institution from July 2012 to June 2014. 
All consecutive patients who underwent ETIs in the emergency 
department and ICU were included. Patients under 18  years of age, 
intubated with VL not using C-MAC, were excluded. After each ETI 
eff ort, the operator completed a standardized data collection form. We 
classifi ed glottic visualization as good (C-L grade 1 or 2), and poor (C-L 
grade 3 or 4). The primary outcome was the fi rst-attempt success rate. 
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The primary exposure was use of VL. Potential confounders of success 
rate examined were age, sex, primary indication of intubation, methods 
of intubation, and operator level of training and specialty. Among 
patients with good glottic visualization, we conducted a multivariable 
logistic regression adjusted for potential confounders.
Results A total of 348 patients were included. VL attained better glottic 
visualization than DL (92.3% vs. 82.6%, respectively: P <0.001). In total, 
299 patients with good glottic visualization were included in the 
analysis. Of these patients, 185 (61.9%) were male, median age and body 
mass index were 69 (interquartile range (IQR), 51 to 77) and 22 (IQR, 20 
to 24) respectively. In univariate analysis, VL group had less respiratory 
failure (18.3% vs. 46.8%: P <0.001) and included more trauma patients 
(21.1% vs. 7.9%: P <0.001). The fi rst-attempt success rates were similar 
between two groups (82.6% vs. 77.4%: P = 0.286). Multivariable logistic 
regression analysis adjusted for potential confounders showed that 
the success rate of VL was similar to that of DL (odds ratio, 1.17; 95% 
confi dence interval, 0.57 to 2.39).
Conclusion Despite the possible poor alignment of airway, the fi rst-
attempt success rate of VL is similar to that of DL among patients with 
good glottic visualization.
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pre-oxygenation and apnoeic oxygenation during rapid sequence 
induction
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Introduction Rapid sequence induction (RSI) in the ICU, emergency 
department (ED) and operating room (OR) carries the risk of hypoxemia 
if laryngoscopy is prolonged especially in high-risk patients. Bag and 
mask pre-oxygenation is normally used to extend the apnoea time; 
however, arterial desaturation may still rapidly occur. Transnasal 
humidifi ed rapid insuffl  ation ventilatory exchange (THRIVE) is a 
new technique that provides modest CPAP during pre-oxygenation 
and crucially also continuous oxygenation of the pharyngeal space 
throughout the apnoeic period. In elective surgery, THRIVE provides 
apnoea times as long as 60 minutes due to apnoeic oxygenation [1]. 
We report the fi rst implementation of THRIVE with emergency patients 
into the ICU, ED and OR.
Methods Following training a THRIVE system was installed in each 
location either as a fi xed system on the anaesthetic machine (OR) or 
a mobile solution on a wheeled stand (ICU, ER). This was a simplifi ed 
Optifl ow system (Fisher and Paykel, New Zealand) consisting of a 
high-fl ow rotameter, a reusable humidifi er, a reusable circuit and a 
disposable nasal interface. Anaesthetists of all grades were encouraged 
to use THRIVE (60 l/minute) prior to and during all high-risk intubations. 
Prospective data of pre and post intubation SpO2 and time to intubate 
were collected. Anaesthetists were interviewed on acceptability of the 
technique.
Results There were 62 RSI intubations using THRIVE (ICU and ED = 30; 
OR = 33). Diffi  cult airway equipment used in 36 cases (videolaryngoscopy 
in 23). Mean apnoea time was 118 seconds (30 to 480 seconds), with a 
median SpO2 fall of 1% (0 to 33%). There was no correlation between 
arterial desaturation and apnoeic time. OR cases had a mean apnoea 
of 113 seconds with a median SpO2 fall of 0% (0 to 13%). ICU and ED 
cases had a mean apnoea time of 119 seconds and median SpO2 fall of 
1% (0 to 33%). THRIVE was universally readily accepted. Reasons cited 
included: simplifi cation of pre-oxygenation (hands free) and increased 
confi dence. Six outlying arterial desaturation events suggested poor 
airway maintenance at induction or use in particularly high-risk 
patients. Many anaesthetists reinstituted THRIVE following extubation 
in selected patients (for example, obesity). No complications occurred 
during implementation.
Conclusion We conclude that THRIVE provides a convenient, safe 
and easy to implement technique for pre-oxygenation and apnoeic 
oxygenation during laryngoscopy.
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Introduction β-Adrenergic agonists increase the ciliary beat frequency 
in experimental models, raising the possibility that they may be useful 
for airway hygiene [1]. Salbutamol increases large airway mucociliary 
clearance [2], although this may not be true for smaller airways 
[3]. There are no data from ICU patients, so we decided to test the 
eff ectiveness of transtracheal instillation of a mixture of ipratropium 
and salbutamol, assessing the reduction of the number of aspirations 
and hours of ventilation.
Methods An open randomized prospective study was held during 
2014. All admitted patients were alternately selected as the study or 
control group and included if submitted to invasive ventilation for at 
least for 24  hours. Four patients who had secondary cardiac rhythm 
eff ects attributable to β-adrenergic agonists were excluded. In the 
study group, 3  ml of a dilution of 2.5  ml ipratropium (0.52  mg) plus 
salbutamol (2.5 mg) with 2.5 ml distilled water was instilled after the 
aspiration of secretions. During the ventilation period we noted for 
both groups, in addition to the demographic data, the number of 
tracheal aspirations by day and hours of ventilation. The statistical 
analysis was done with XLSTAT 2014 and we used the Kolmogorov–
Smirnov test to compare the normal distribution of the groups.
Results These preliminary results included 107 patients. The only 
normal distribution, according to the Kolmogorov–Smirnov test, was 
for the number of hours of ventilation: 76.3 ± 100 (24; 478) in the study 
group versus 111 ± 167 (24; 780) in the control group.
Conclusion The preliminary analysis, referring to the fi rst 6 months of 
study, showed a tendency in the reduction of both ventilation hours 
and length of stay in the study group. No signifi cant diff erence was 
found in the number of aspirations, which may be explained by ICU 
nursing routines. Further studies will try to fi nd whether signifi cant 
diff erences in the incidence of VAP exist, allowing this procedure to be 
implemented in ICU routines.
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Introduction We hypothesised that the simultaneous use of a heat 
and moisture exchanger (HME) and a heated humidifi er (HH) would 
increase the incidence of airway occlusion over a 24-hour period in 
comparison with each device in isolation. This bench study compares 
the incidence of airway occlusion when using (group 1) no airway 
humidifi cation, (group 2) a HME alone, (group 3) a HH alone and (group 
4) both a HME and a HH in combination. Tracheal intubation requires 
the use of artifi cial humidifi cation systems. HMEs are less effi  cient 
but convenient especially for a short period of intubation and HHs 
are commonly more expensive. Both devices are often used in close 
proximity on the ICU depending on the particular clinical scenario and/
or clinical practitioner. Following a critical incident of HME obstruction 
due to waterlogging on our ICU we realised that HH and HME may be 
used together inadvertently. This airway obstruction was only resolved 
by the removal of the HME from the patient’s breathing circuit.
Methods A lung simulator underwent pressure-controlled ventilation 
(Pinsp = 25 cmH2O; PEEP = 5 cmH2O; Vt = 500 ml) for 24 hours for seven 
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test periods for each group (n = 24). A HME (Filta-Therm; Intersurgical, 
Berkshire, UK) was placed between the breathing circuit and catheter 
mount or the HH (MR850; Fisher & Paykel, Auckland, New Zealand) was 
used, or both in combination. Circuit manipulation was performed 
4-hourly to simulate patient movement. Hourly Vt was recorded to 
determine airway occlusion. Critical airway occlusion (defi ned as a drop 
on the TV to <50 ml) was assessed using a Fisher’s exact test.
Results In all seven of the breathing circuits in group 4 (both a HME 
and a HH in combination), critical airway occlusion occurred suddenly 
between 19 and23  hours. No episodes occurred in the other three 
groups (P <0.0001).
Conclusion The combination of the use of HME and HH within a single 
ICU risks inadvertent dual use in a single patient and if uncorrected this 
is likely to result in a ventilator circuit obstruction. Medical errors can be 
mitigated by consideration of human factors and system engineering 
to improve patient safety. A focus on clinical awareness and training 
may lead to improvements; however, the numbers, experience and 
turnover of critical care staffi  ng would indicate that a systems approach 
is appropriate and either HME or HH should be used exclusively in an 
ICU.
P211
Endobronchial streptokinase for airway thrombus: a case series
D Lloyd, J Bomford, M Barry, W Berry, N Barrett, L Camporota, N Ioannou, 
B Lams, C Langrish, C Meadows, A Retter, D Wyncoll, G Glover
Guys and St Thomas’ NHS Trust, London, UK
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Introduction Pulmonary haemorrhage (PH) is common in patients 
receiving mechanical ventilation and especially during ECMO, due 
to severe lung pathology and systemic anticoagulation. Whilst PH 
manifests as worsening ventilation and gas exchange, in ECMO 
patients who already have low tidal volume and who do not rely on 
pulmonary gas exchange, deterioration may not be evident until 
extensive airway thrombus (AT) has developed. Management of AT 
is challenging, with lavage, suctioning, mechanical disruption and 
extraction of limited effi  cacy in severe cases. Limited reports suggest 
that topical thrombolytics may have a role in the management of AT 
[1]. We report the safety and effi  cacy of endobronchial streptokinase 
(EBSK) in patients with extensive AT.
Methods A retrospective case series in a UK ECMO centre. Patients who 
received EBSK between 2010 and 2014 were identifi ed from pharmacy 
records.
Results Five patients were identifi ed, 80% were male. Median age 
was 40 years, APACHE II score 36.5 and Murray score 3.75. Four were 
on ECMO with systemic heparin. All had ARDS secondary to lung 
infections (community-acquired pneumonia (two), lung abscess 
(one), TB (one) and PJP (one)). All had extensive AT, diagnosed on 
bronchoscopy, causing occlusion of the trachea or major bronchi, 
refractory to physiotherapy, lavage, suctioning ± rigid bronchoscopy. 
Patients received up to three administrations of EBSK, 1,000  u/ml in 
saline 0.9% under bronchoscopic guidance. Dose per administration 
was 30,000 to 80,000  u and total dose was 30,000 to 150,000  u (375 
to 1,500  u/kg), with interval bronchoscopy after several hours for 
lavage and suctioning of lysed clot. In all cases EBSK was well tolerated 
with no immediate complications and no clinically signifi cant change 
in systemic laboratory coagulation parameters at 12 or 24  hours 
compared with pretreatment baseline. In all cases, signifi cant clearance 
of airway thrombus was achieved. Median tidal volume increased from 
60 ml pre treatment to 170 ml at 24 hours. Median PaO2 during the ‘FiO2 
1.0 test’ improved from 9.0 to 17.6 kPa at 24 hours. No major bleeding, 
intracerebral haemorrhage or ECMO cannulae bleeding was seen up to 
7 days post treatment.
Conclusion In this series, the largest reported to date, and the fi rst 
on ECMO, EBSK was highly eff ective in achieving clearance of AT 
with subsequent improvements in pulmonary mechanics and gas 
exchange. No major disturbance of systemic coagulation parameters 
or major haemorrhagic complications occurred. The use of EBSK may 
be considered for refractory AT.
Reference
1. Keane et al. Chest. 1999;115:293-300.
P212
Reduction of ventilator-associated pneumonia using the 
AnapnoGuard system
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Introduction Ventilator-associated pneumonia (VAP) is a common 
complication in mechanically ventilated patients. Frequently the 
pathogens responsible derive from aspirated secretions of the upper 
respiratory tract or the stomach. In order to prevent aspiration, two 
missions should be attained: a good tracheal cuff  seal with a well-
tolerated pressure, together with continuous evacuation of secretions 
from the subglottic space. These two goals can be achieved using the 
AnapnoGuard system and its related endotracheal tube (ETT).
Methods A single-center, open-label study in a general ICU. Control 
group: (retrospective data) mechanically ventilated patients on 
standard of care regular ETT, manual suction of the trachea and oral–
pharyngeal space by nursing staff . Study group: (prospective data) 
connected at all times to the AnapnoGuard system: an ETT with two 
above-the-cuff  suction ports and a third port and lumen for rinsing 
and CO2 measurement. A triple lumen harness is connected to a control 
system designed to measure CO2 levels above the cuff  (to identify 
leaks), infl ate the cuff  accordingly, rinse and suction secretions above 
the cuff . To be included in the study patients had to have no pneumonia 
on admission and at least 3  days of mechanical ventilation. VAP was 
diagnosed for a new chest X-ray infi ltrate accompanied by fever, 
leucocytosis and positive sputum culture. The study was approved by 
the hospital IRB.
Results Control group: 100 patients who received standard intubation 
and treatment in 2009 to 2010. Of these, four dropped out due 
screening failure of pneumonia on the day of enrollment. Study group: 
in 2011 to 2014, 192 patients were screened. Of these, 49 were found 
eligible and were enrolled. Of these, 14 dropped out (four screening 
failures with pneumonia on day of enrollment and 10 withdrawals with 
MV of less than 24 hours). Mean age was 51 (control) and 49 (study). 
Males were 75% of both groups and mean weight was 81 kg in both. 
VAP was diagnosed in 26 (27%) of controls and only three (8.5%) of the 
study group (P  = 0.03). Mean time from admission to VAP diagnosis 
was 4.7 days in controls versus 5.12 in the study group (NS). No serious 
adverse events occurred.
Conclusion Patients connected to the AnapnoGuard system 
demonstrated a statistically signifi cant lower VAP rate compared with 
the control group (8.5% vs. 27% respectively, P = 0.03). The estimated 
relative risk of VAP occurring in the control group was more than three 
times higher than the study group. Rinsing and aspiration of subglottic 
secretions combined with cuff  pressure and seal management may be 
an eff ective method to prevent VAP.
P213
Risk factors for bleeding complications after percutaneous 
dilatational tracheostomy: a 10-year institutional analysis
K Pilarczyk1, G Marggraf1, M Dudasova1, E Demircioglu1, D Wendt1, 
B Huschens2, H Jakob1, F Dusse1
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Introduction Percutaneous dilatational tracheotomy (PDT) is the 
standard airway access in critically ill patients who require prolonged 
mechanical ventilation. Bleeding complications after PDT are 
infrequently observed but have a tremendous impact on further 
clinical course CFA risk stratifi cation for patients scheduled for PDT.
Methods We retrospectively reviewed the records of all patients who 
underwent PDT (using the Ciaglia technique with bronchoscopic 
guidance) on our cardiothoracic ICU between 2003 and 2013. Patients 
were stratifi ed into two groups: patients suff ering from acute moderate, 
severe or major bleeding (Group A) and patients who presented none 
or only mild bleeding (Group B).
Results A total of 1,001 patients (46% male, mean age 68.1  years) 
that underwent PDT were analyzed. In the majority of patients, no or 
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only mild bleeding during PDT occurred (none: 425 (42.5%), mild: 488 
(48.8%)). In 84 patients (8.4%), bleeding was classifi ed as moderate. 
Three patients suff ered from severe bleeding, only one major bleeding 
with need for emergency surgery was observed. Study groups showed 
signifi cant diff erences in Simplifi ed Acute Physiology Score (SAPS) on 
the day of PDT (Group A: 47.0 ± 13.1, Group B: 32.9 ± 11.2, P = 0.042), 
renal replacement therapy on the day of PDT (Group A: 53 (60.2%), 
Group B: 439 (48.1%), P  = 0.026), presence of coagulopathy (Group 
A: 48 (54.5%), Group B: 393 (43.0%), P = 0.043), platelet count (Group 
A: 91.6 ± 59.2, Group B: 111.5 ± 79.8 × 1,000/μl, P = 0.037), fi brinogen 
levels (Group A: 373.6 ± 159.1, Group B: 450.6 ± 259.0 mg/dl, P = 0.012), 
proportion of PDTs performed by residents (Group A: 72 (81.8%), Group 
B: 632 (69.2%), P = 0.034) and moderately to very diffi  cult PDT (Group 
A: 31 (35.2%), Group B: 141 (15.4%), P = 0.001). Using logistic regression 
analyses, diffi  cult PDT, low-experienced operator, SAPS >40 and low 
fi brinogen were independent predictors of relevant bleedings after 
PDT.
Conclusion Periprocedural bleeding complications during PDT are rare. 
However, low fi brinogen levels as well as diffi  cult PDT, low-experienced 
operator and SAPS >40 are associated with an increased risk for 
bleeding complications. Therefore, preprocedural risk evaluation 
for bleeding complications should include these factors and further 
studies are necessary to prove whether modifi cation of risk factors  – 
for example, substitution of fi brinogen prior to PDT – is able to reduce 
incidence of bleeding complications.
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Percutaneous dilatational tracheostomy: complications and safety 
without the use of bronchoscopic guidance
R Johnsen
Sygehus Lillebælt, Vejle, Denmark
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Introduction Since the introduction and development of percu-
taneous dilatational tracheostomy (PDT), this procedure is accepted 
and incorporated in ICUs worldwide. In spite of obvious benefi ts for 
the patients, who obtain more comfort and mobility and less use of 
sedatives, the procedure also implies the risk of several complications, 
some of which may be lethal. Severe complications include 
hemorrhage, displacement and pneumothorax. Diff erent methods 
of PDT are described in the literature, each with disadvantages and 
benefi ts. The aim of this study was to analyze complications due to 
PDTs performed without the use of bronchoscopic assistance.
Methods The study was conducted in a Danish eight-bed, non-
university ICU. Since 2007, all patients admitted to the ICU have been 
registered on an electronic patient record system, in which daily vital 
values, diagnoses, procedures and healthcare providers’ notes are 
entered. When searching for ‘percutaneous dilatation tracheostomy’ 
in the electronic system, we found all patients who had undergone 
this specifi c procedure. Afterwards we analyzed each of these patients’ 
hospital records, looking for any periprocedure or postprocedure 
complications noted within 7 days. In addition we registered patients’ 
age, sex, BMI, SOFA score, methods used in procedures and experience 
of operators.
Results A total of 136 patients admitted to the UCI had undergone 
a PDT between 2007 and 2014. Of these, two were excluded due to 
the PDT being performed in another hospital before admission to our 
ICU. All 134 PDTs were performed with the Ciaglia Blue Rhino Method. 
No PDTs were performed with bronchoscopic guidance. In 12 cases 
some kind of complication due to the PDT was registered: six cases 
with need of surgical hemostasis, three cases of bleeding with need 
of transfusion of blood products, one case of PDT displacement, one 
case of ventilation-related problems during procedure and, fi nally, 
one case of tracheal cartilage fracture. There were no incidents of 
pneumothorax. No PDTs had a lethal outcome due to the procedure 
itself. The total complication rate was 9.0%. Of the 12 cases, four (33%) 
complications occurred during the procedure, the rest (66%) occurred 
after the procedure. The overall periprocedure complication rate was 3%.
Conclusion In this study, PDTs without the use of bronchoscopic 
guidance were performed safely with a low rate of complications.
P215
Decision-making algorithm for TS in the ICU
L Marullo, A Tavano, P Fusco, F Ferraro
Second University of Naples, Italy
Critical Care 2015, 19(Suppl 1):P215 (doi: 10.1186/cc14295)
Introduction Nowadays more percutaneous dilatational tracheostomy 
(PDT) methods are in use, but there is no ideal risk-free technique. We 
Figure 1 (abstract P215).
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have outlined a decisional algorithm to choose the most appropriate 
technique in each case to reduce the incidence of complications.
Methods A retrospective review was performed using data from 
the last 14  years. Two hundred patients were selected. Patients were 
divided into two groups: one including the fi rst 100 PDTs treated 
without the algorithm (nA-group) and the other including the last 
100 patients treated with the algorithm (A-group). Valuation of 
clinical and anatomical features of the patients, neck ultrasound and 
fi brobronchoscopy came before the procedure [1]. The algorithm 
was formulated by our experience with PDT techniques, comparing 
the specifi c characteristics of each one with the physiopathological 
characteristics of each patient.
Results We recorded complications (bleeding, tracheoesophageal 
fi stula, subglottic stenosis, tracheal rings’ fracture, diffi  culty of 
placement, change of procedure) related to PDTs performed with and 
without applying the algorithm. We considered complications that 
occurred in our experience and we changed our modality in technique 
choice (Figure  1). Compared with the complications reported in the 
nA-group, use of the algorithm as a guide to choose the kind of PDT 
technique seems to reduce the incidence of complications (37% vs. 
19%; P = 0.001 chi-square test).
Conclusion In our experience the application of the proposed 
algorithm may reduce the incidence of complications related to PDT 
in the ICU. However, a randomized controlled multicenter study would 
be necessary in order to confi rm the effi  ciency and validity of the 
proposed algorithm.
Reference
1. Kollig E, et al. Injury. 2000;31:663-8.
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Introduction Percutaneous bedside tracheostomy (PBT) is a frequently 
done procedure in the ICU. PBT is a clean-contaminated procedure, 
and the duration of the procedure is 15 to 20 minutes depending on 
the physician’s procedural skills. The rate of infectious complications 
and effi  cacy of perioperative therapy in reducing infections after 
PBT is currently unknown. Currently there have been no defi nitive 
recommendations for prophylactic antibiotic therapy before PBT in the 
ICU.
Methods All clinical and microbiological data were retrospectively 
collected and analyzed during the ICU stay before PBT performance 
and 72  hours after the PBT procedure from 110 patients in our ICU. 
Controls were defi ned as patients in whom the PBT procedure was 
performed in the ICU, with antibiotics administered 72 hours prior to 
and during the procedure (Group 1, n  = 82). Cases were defi ned as 
patients in whom the PBT procedure was performed in the ICU without 
antibiotics administered 72  hours prior to and during the procedure 
(Group 2, n  = 28). Secondary bacteremia, line sepsis and VAP during 
the 72 hours after PBT were considered infectious complications. Two-
tailed P <0.05 was considered to be signifi cant.
Results No diff erences were found in age, gender, admission diagnoses, 
length of ICU stay and in-hospital mortality rate between the two study 
groups. Overall Gram-negative, Gram-positive and fungal fl ora were 
similar in both groups before and after PBT. Patients who received 
antibiotic therapy had a lower incidence of new ventilator-associated 
pneumonia (VAP) episodes (15/82 (18.2%) in Group 1 vs. 14/28 (50%) 
in Group 2, P  <0.001 (0.23, 0.87 to 0.13)) (Table  1). There were no 
diff erences in the incidence of bacteremia or line sepsis (Table 1).
Conclusion Our fi ndings highlight the importance of conducting a 
prospective randomized control trial to better understand the role of 
antibiotic prophylaxis in PBT.
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Introduction Patients with a tracheostomy (TQ) tube in place discharged 
from the ICU to a general ward (GW) are a fragile group and the TQ may 
be a risk factor for morbidity and mortality [1,2]. For this reason they 
need closer monitoring and more airway care. The Transitional Care Unit 
(TCU) assists patients with serious medical conditions and bridges the 
gap between the ICU and home or long-term care facilities providing 
the necessary medical, nursing, psychological and rehabilitative care. 
The purpose of this study was to evaluate the impact of the TCU on 
outcomes of tracheostomized patients discharged from the ICU.
Methods We retrospectively reviewed medical records of ICU adults 
patients who had TQ when discharged to a new TCU and to a GW. 
The study was carried out in two tertiary care university hospitals 
from January 2007 to November 2014. Study variables were age, sex, 
APACHE II score, principal diagnosis, associated major procedures, 
length of stay in ICU and out in hospital, TCU and GW, Sabadell score, 
in-hospital mortality, types of tracheotomy procedure, decision to 
decannulate and discharge to home or long-care facilities.
Results In total 12,839 records of patients discharged from the ICU 
were analyzed. Tracheostomy was present in 133 patients. Two groups 
were defi ned: (1) TCU (n = 56) and (2) GW (n = 77). Patients of the TCU 
group were older (60.1 ± 13.1 vs. 54.9 ± 15.8 years; P <0.05) with higher 
APACHE II score (23 (CI: 21.5 to 25.6) vs. 18.5 (CI: 17.1 to 19.9); P <0.001), 
and had longer stay in the ICU (45.8 (CI: 38.2 to 53.3) vs. 28.4 (CI: 24.2 
to 32.6) days; P <0.001) and on the ward (71.1 (CI: 57.4 to 84.8) vs. 46.1 
(CI: 33.7 to 58.2) days; P <0.001) than those of the GW group. The GW 
group had category 1 of Sabadell score more frequently than the TCU 
group (25.9% vs. 8.9%; P = 0.019). Rates of nosocomial infections were 
similar in both groups. No signifi cant diff erences on vasoactive use 
(50% vs. 40.2%), renal failure (23.2% vs. 20.7%), blood transfusions (25% 
vs. 23.2%), parenteral nutrition (10.7% vs. 12.9%), in-hospital deaths 
(14.3% vs. 24.6%), decannulation (55% vs. 50%), or discharge to home 
(53.6% vs. 37.7%) were found between groups 1 and 2, respectively.
Conclusion In our setting the TCU helps to care more safely for severe 
tracheostomized patients after ICU discharge, and furthermore 
facilitates discharge home.
References
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Introduction Incidence of obesity in developed countries is rising. 
Currently, Europe has a prevalence of 9 to 30% with signifi cant impact 
on public health systems. Obese patients in the ICU require special 
management and treatment. Altered anatomy in obese patients 
complicates procedures such as mechanical ventilation. Obesity 
aff ects cardiopulmonary physiology and requires elevated ventilation 
pressures. In our retrospective study, we determined the eff ect of early 
Table 1 (abstract P216). Clinical data of new infections 72 hours after the 
PBT procedure
Infection  Group 1 Group 2 P value OR
Bacteremia 21/82(25.6%) 11/28(39.3%) 0.149
Colonization 67/82(82.7%) 23/28(82.1%) 0.718
Line sepsis 10/82 (12%) 4/28 (14.3%) 0.39
New VAP (%) 15/82(18.2%) 14/28 (50%) 0.001
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percutaneous dilatational tracheotomy (PDT) and cessation of sedation 
on respiratory parameters in severely obese patients.
Methods From June 2010 to July 2014, we included all patients 
with a body weight of >130  kg, respiratory failure and PDT who 
were admitted to the ICU of the University Hospital of Muenster. We 
compared respirator parameters and blood gas analysis before and 
after PDT. Parameters were recorded on days –1, 0, 1, 3, 5, and 10, with 
day 0 describing the day of PDT.
Results Twenty-one patients were included in the study. Mean age 
was 56  ± 10.3  years and 14 (66.7%) of the patients were male. Body 
weight was 164.5 ± 39.4 kg, body height accounted for 176.8 ± 8.7 cm 
(n = 20) and body mass index was 49.7 ± 16.9 kg/m2. Patients stayed in 
the ICU for 18.4 ± 13.8 days. Mean time of mechanical ventilation by 
endotracheal tube was 2.4  ± 1.5  days (n  = 20) and via tracheostomy 
9.8  ± 7.0  days. After PDT, peak inspiratory pressure (P  <0.0001), 
positive end-expiratory pressure (P  <0.0001) and insuffl  ated oxygen 
concentration (P <0.0001) could signifi cantly and rapidly be reduced. 
Respiratory minute volume increased signifi cantly (P = 0.004). PDT was 
not associated with relevant complications.
Conclusion Early PDT rapidly improves respiratory distress in severely 
obese patients due enabling of spontaneous breathing and reduction 
of dead space ventilation.
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Early postoperative use of CPAP reduces need for unplanned IPPV 
in elective vascular patients
H Kennedy, J Navein, J Seidel
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Introduction Respiratory failure is a well-known complication of 
aortic aneurysm surgery. We describe the impact of a protocol, using 
CPAP after elective surgery to reduce the need for unplanned invasive 
ventilation.
Methods In 2012 we introduced a CPAP protocol for patients 
undergoing elective aortic aneurysm surgery, either open (AAA) or as 
an endovascular repair (EVAR). According to pre-existing risk factors 
(see Table 1) and arterial blood gas analysis in the anaesthetic room, 
they were assigned to two alternative options on the ITU: prophylactic 
CPAP for 9 hours in each of the fi rst two postoperative nights or oxygen 
via face mask. CPAP was applied at any time in the patients stay, if their 
P/F ratio dropped below 40. Criteria to stop CPAP were also predefi ned. 
Previously, CPAP was initiated at the discretion of nursing staff , P/F 
ratios were not utilised.
Table 1 (abstract P219). Criteria for the use of prophylactic CPAP
Current smoker
FEV1: <1.5 l/minute
Poor exercise tolerance (<100 yards) due to chest problems
SpO2 <92% on air
SpO2 <92% on FiO2 >0.4 in theatre
Results We compare patient cohorts in the years 2010 and 2011 (pre 
protocol) with 2013 and 2014 (post protocol). Results are reported 
as the split between open surgery and endovascular repair. Table  2 
presents requirements for invasive ventilation (IPPV) and length of stay 
(LOS) for both patient groups.
Table 2 (abstract P219). IPPV requirements and length of stay data
 2010 to 2011 2013 to 2014
 LOS LOS  LOS LOS 
 ITU hospital  ITU hospital 
IPPV (days)  (days) IPPV (days) (days) EVAR
2/67 (3%) 2 6 1/77 (1.3%) 2 5 AAA
10/46 (21.7%) 5 9 6/37 (16.2%) 5 12 
Conclusion There is a clear reduction in the need for unplanned IPPV 
in both patient groups. An audit in 2013 showed incomplete protocol 
adherence in the ITU, therefore benefi ts may be underestimated.
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Introduction The application of noninvasive ventilation (NIV) in ICUs 
has spread widely during the years. It is used in the treatment of 
diff erent forms of acute respiratory failure and COPD exacerbations. 
Although NIV is thought to be more comfortable for patients than 
invasive mechanical ventilation, its failure rates in the ICUs range 
between 10 and 40%. Except for the interface-related problems, there 
are some specifi c considerations for the patient–ventilator interaction 
and the applied mechanical forces. During NIV there is a predisposition 
for the stomach to be infl ated with gas, which could cause severe 
respiratory complications, especially in COPD patients, and thus 
prolong the mechanical ventilation and the weaning process. This 
remains one of the major causes for NIV failure. Although a lot of face 
masks with diff erent interfaces are available on the market, just a few 
have additional ports for a NGT. They are characterized by higher price 
and a complex setup. In order to perform NIV in patients, requiring NGT 
placement, without additional air leaks and to be able to ensure their 
enteral nutrition and/or stomach drainage, we installed a port for a 
NGT on a standard face mask.
Methods In this study, six of the COPD patients admitted to our ICU, 
who required NGT placement, were ventilated with the Draeger Evita 
2 dura through a modifi ed reusable silicone face mask (UMDNS code: 
12-453 with 22 mm ID connection; sizes 4 and 5) with silicone headgear 
and a hook ring. All of them had a NGT during their stay in the ICU. 
We evaluated the effi  cacy of our modifi cation comparing the achieved 
Vt with modifi ed and unmodifi ed face mask, during two periods of 
10 minutes. The mode and parameters of ventilation were not changed. 
We assessed patient comfort with a visual analogue scale.
Results The average duration of NIV was 3.5  days (SD  = 1.6). We 
examined two sets of 10 consequent breathing cycles for every 
patient. The mean Vt was 472 ml (SD = 76 ml) with standard face mask 
and 460 ml (SD = 86 ml) with the modifi ed one. There was statistically 
signifi cant correlation between the two datasets (P  <0.05). No 
additional leaks were detected. According to the VAS evaluation, fi ve of 
the patients (83%) had comfort improvement with the modifi ed mask.
Conclusion With this modifi cation of the face mask we achieved 
adequate drainage of the stomach and/or the enteral nutrition of the 
patients and improvement in their comfort during NIV, compared with 
the ventilation with a standard mask, without additional air leaks and 
at a low cost.
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Lung ultrasonography as a marker of pulmonary edema in cardiac 
surgery patients: visual versus quantitative evaluation
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Introduction Lung ultrasonography (LUS) has been used for non-
invasive detection of pulmonary edema. LUS visual scores (V-LUS) 
based on B-lines are poorly correlated with either pulmonary capillary 
wedge pressure (PCWP) or extravascular lung water (EVLW). A new 
quantitative LUS analysis (Q-LUS) has been recently proposed [1,2]. The 
aim of the study was to investigate whether Q-LUS is better correlated 
with PCWP and EVLW than V-LUS, and to what extent positive end-
expiratory pressure (PEEP) aff ects the assessment of pulmonary edema 
by Q-LUS and V-LUS.
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Methods Thirty-nine patients mechanically ventilated with PEEP of 
5 cmH2O (n = 47) or 10 cmH2O (n = 30) and PCWP (n = 77) or EVLW (n = 
38) monitored were studied.
Results PCWP was signifi cantly and strongly correlated with Q-LUS Grey 
Unit value (r2 = 0.64) but weakly with V-LUS B-line score (r2 = 0.19). EVLW 
was signifi cantly and strongly correlated with QLUS Grey Unit mean 
value (r2  = 0.65) more than with V-LUS B-line score (r2  = 0.42). Q-LUS 
showed a better diagnostic accuracy than V-LUS for the detection of 
PCWP  >15  mmHg or EVLW >10  ml/kg. With a PEEP of 5  cmH2O, the 
correlations with PCWP or EVLW were stronger with Q-LUS than V-LUS. 
With a PEEP of 10  cmH2O, the correlations with PCWP or EVLW were 
still signifi cant for Q-LUS but insignifi cant for V-LUS. Intraobserver 
repeatability and interobserver reproducibility were much better for 
Q-LUS than V-LUS.
Conclusion Both V-LUS and Q-LUS are acceptable indicators of 
pulmonary edema in patients mechanically ventilated with low 
PEEP but at high PEEP only Q-LUS provides data that are signifi cantly 
correlated. Computer-aided Q-LUS has the advantages of being not 
only independent of operator perception but also of PEEP.
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Introduction Lung ultrasound (LUS) allows semiquantifi cation of 
lung aeration in PEEP trials [1], pneumonia [2] and weaning [3]. LUS 
score is based on number/coalescence of vertical artifacts (B-lines) 
in longitudinal scan (LONG) [4]: the pleura is identifi ed between two 
ribs and its visualization limited by intercostal space (ICS) width. We 
hypothesized that a transversal scan (TRANSV) aligned with ICS would 
visualize longer pleura and a higher number of artifacts, with better 
assessment of loss of aeration (LoA).
Methods LONG and TRANSV were performed in six areas per lung 
(anterior, lateral and posterior, each divided into superior and inferior). 
Once LONG was performed, TRANSV was obtained by a probe rotation 
until the ribs disappeared. We considered pleural length, B-line 
number/coalescence, and subpleural/lobar consolidations. LUS score 
was assigned: 0 normal lung, 1 moderate LoA (≥3 well-spaced B-lines), 
2 severe LoA (coalescent B-lines), 3 complete LoA (tissue-like pattern).
Results We enrolled 38 patients (21 males, age 60 ± 16 years, BMI 24.7 ± 
4.7 kg/m2) corresponding to 456 ICSs. In 63 ICSs, a tissue-like pattern 
was visualized in both techniques. In the other 393, LONG versus 
TRANSV pleural length was 2.0 ± 0.6 cm (range 0.8 to 3.8; variance 0.31) 
versus 3.9 ± 0.1 cm (range 3.0 to 4.3; variance 0.1) (P <0.0001), B-lines per 
scan were 1.1 ± 1.6 versus 1.8 ± 2.5 (P <0.0001), coalescent B-lines were 
detected in 24 versus 30% (P <0.05) and subpleural consolidations in 16 
versus 22% (P <0.05), respectively. LUS scores’ prevalence signifi cantly 
diff ered in LONG versus TRANSV (Figure 1).
Conclusion TRANSV visualizes signifi cantly longer pleura and greater 
number of artifacts useful for lung disease assessment.
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Introduction Extravascular lung water (EVLW) refers to fl uid within the 
lung but outside the vascular compartment. Increment of EVLW was 
associated with mortality in critically ill patients. Extravascular lung 
water index (EVLWI) >10 ml/kg was found in patients with cardiogenic 
pulmonary edema and correlated with pulmonary capillary wedge 
pressure >20 mmHg. Measurement of EVLW needs sophisticated tools 
and an invasive method by transpulmonary thermodilution (TPTD) 
technique. In contrast, multiple B-lines by lung ultrasound (LUS) have 
been recently proposed to correlate with increased EVLW in patients 
with pulmonary edema. This study aims to compare three methods 
of LUS and EVLWI measured by TPTD to assess pulmonary edema in 
patients with septic shock.
Methods The authors prospectively enrolled 17 patients with septic 
shock who were admitted to the medical ICU, Phramongkutklao Hospital 
between September 2013 and June 2014. EVLWI was measured by TPTD 
(VolumeView Set, EV1000; Edwards Lifesciences) method. According 
to international evidence-based recommendations for point-of-care 
lung ultrasound 2012, three methods of LUS (LOGIQ e ultrasound; GE 
Healthcare) were compared to assess EVLW daily in each patient until 
no indication for invasive blood pressure monitoring [1]. Firstly, B-lines 
were measured in 28 lung zones. The total numbers of B-lines seen in 
each patient were counted as total B-line scores (TBS). Secondly, upper 
and lower BLUE points were anterior two-region scans each side marked 
by physician hands. Pulmonary edema was diagnosed if three or more 
B-lines were presented in all regions. Lastly, scanning eight regions, two 
anterior and two laterals per side, was considered abnormal if more than 
one scan per side had three or more B-lines.
Results A total of 40 comparisons were obtained. Signifi cant positive 
linear correlations were found between TBS and EVLWI determined 
by TPTD (r  = 0.637, P  <0.001). The TBS ≥39 has sensitivity of 91.7% 
and specifi city of 75.0% to defi ne EVLWI >10  ml/kg. There was low 
sensitivity (33.3% and 50.0% respectively) but high specifi city (100% 
and 96.0% respectively) of the positive BLUE points and eight regions 
to defi ne EVLWI >10 ml/kg.
Conclusion TBS is the best method for assessing EVLW compared with 
BLUE points and eight regions. These data support the benefi t of LUS 
with summation of B-line scores of 28 rib interspaces for assessment of 
the increment of EVLW in septic shock patients.
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Introduction Mechanical ventilation (MV) induces diaphragmatic 
muscle atrophy and contractile fi bre dysfunction, the so-called 
ventilator-induced diaphragm dysfunction (VIDD). Although 
Figure 1 (abstract P222). LUS scores. *P <0.01 TRANSV versus LONG.
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diaphragmatic atrophy can be assessed using ultrasound, the biggest 
trial in humans published so far included seven patients and only 
measuring the thickness at two moments during the disease process 
[1]. We aimed to assess the time course of diaphragm atrophy in a 
larger cohort of MV patients using ultrasound.
Methods A total of 54 patients from an adult ICU were included in this 
prospective single-centre cohort trial. Patients who needed <72 hours 
of MV or had been recently admitted to an ICU were excluded. Patients 
were ventilated in a controlled, assisted, and/or hybrid ventilation 
mode. The thickness of the diaphragm was assessed daily; the fi rst 
recording was within 24 hours after the start of mechanical ventilation 
and we continued the measurements until the patients were extubated 
or tracheotomised. We measured the diaphragm at the zone of 
apposition, as described by McCool and colleagues [2] using a linear 13 
MHz ultrasound probe. Figure 1 shows a sample measurement.
Results We were successfully able to record the diaphragm thickness 
in all included patients. Median time on the ventilator was 9 days (IQR 
4 to 15 days). Mean baseline thickness was 1.9 mm (SD ±0.4 mm), and 
mean nadir was 1.3  mm (SD  ±0.4 mm), corresponding with a mean 
change in thickness of 32% (SD ±18%). As early as after only 72 hours of 
MV, we already noted an average drop of diaphragm thickness of 20%, 
illustrating the rapid progression of the atrophy in VIDD.
Conclusion On average, diaphragm thickness decreased 32% in our 
cohort. The decrease occurred rapidly, with two-thirds of the maximal 
thinning already present after 72 hours of MV.
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Introduction Chest-X-ray is recommended for routine use in patients 
with suspected pneumonia, but its use in emergency settings is 
limited. In this study, the diagnostic performance of a new method 
for quantitative analysis of lung ultrasonography was compared with 
bedside chest X-ray and visual lung ultrasonography for detection 
of community-acquired pneumonia, using thoracic computed 
tomography as a gold standard.
Methods Thirty-two spontaneously breathing patients with suspected 
community-acquired pneumonia undergoing computed tomography 
examination were consecutively enrolled. Each hemithorax was 
evaluated for the presence or absence of abnormalities by chest X-ray 
and quantitative or visual ultrasonography.
Results Quantitative ultrasonography showed higher sensitivity (93%), 
specifi city (95%), and diagnostic accuracy (94%) than chest X-ray (64%, 
80%, and 69%, respectively), or visual ultrasonography (68%, 95%, 
and 77%, respectively), or their combination (77%, 75%, and 77%, 
respectively).
Conclusion Quantitative lung ultrasonography was considerably 
more accurate than either chest X-ray or visual ultrasonography in the 
diagnosis of community-acquired pneumonia and it may represent 
a useful fi rst-line approach for confi rmation of clinical diagnosis in 
emergency settings.
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Introduction One of the aims of lung recruitment is to improve 
oxygenation [1], but it has not yet been investigated in spontaneously 
breathing patients. Our objective was to evaluate the eff ects of 
recruitment maneuvers on oxygenation in patients ventilated in CPAP/
pressure support (CPAP/PS) mode.
Methods In a prospective, observational study, 30 patients with a Lung 
Injury Score ≥2 were recruited. Following baseline measurements (t0) 
PEEP was increased by 5 cmH2O (t1). Recruitment maneuver was applied 
for 40 seconds with 40 cmH2O PS. Measurements were taken immediately 
after recruitment (t2) then 15 minutes (t3) and 30 minutes later (t4).
Results According to the diff erence of PaO2/FiO2 between t2 and t0, 
three groups were defi ned: nonresponders (NR: diff erence of PaO2/FiO2 
≤0%, n = 8), low responders (LR: diff erence of PaO2/FiO2 = 0 to 50%, n = 
11) and high responders (HR: diff erence of PaO2/FiO2 >50%, n = 11). In 
the NR-group, PaO2/FiO2 decreased signifi cantly: median (interquartile), 
PaO2/FiO2 = 178 (159 to 240) versus 165 (118 to 210) mmHg; in the LR-
group and in the HR-group there was signifi cant improvement: 119 (98 
to 164) versus 161 (123 to 182) mmHg and 141 (130 to 183) versus 239 
(224 to 369)  mmHg, P  <0.05, respectively. Dynamic compliance (Cdyn) 
signifi cantly dropped at t2 as compared with t0 in the NR-group, Cdyn = 62 
(48 to 87) versus 53 (43 to 78) ml/cmH2O, while there was no signifi cant 
change in the LR- and HR-groups, P <0.05. At the same time points the 
dead space to tidal volume ratio (Vds/Vte) signifi cantly increased in the 
NR-group, Vds/Vte = 30 (23 to 37) versus 37 (26 to 42)%, but not in the 
LR- and HR-groups, P <0.05.
Conclusion Recruitment maneuvers improved PaO2/FiO2 in the 
majority of patients (73%) without aff ecting Cdyn or Vds/Vte; therefore it 
may be a safe approach to improve oxygenation in patients ventilated 
in CPAP/PS mode.
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Introduction Estimation of eff ective sample size (N/arm) is important 
to ensure power to detect signifi cant treatment eff ects. However, 
Figure 1 (abstract P224). Sample ultrasound recording. Lines 1 and 2 are 
diaphragm thickness measurements.
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traditional parametric sample size estimations depend upon restrictive 
assumptions that often do not hold in real data. This study estimates 
N to detect changes in length of mechanical ventilation (LoMV) using 
Monte-Carlo simulation (MCS) and mechanical ventilation (MV) data to 
better simulate the cohort.
Methods Data from 2,534 MV patients admitted to Christchurch Hospital 
ICU from 2011 to 2013 were used. N was estimated using MCS to determine 
a sample size with power of 80%, and compared with the Altman’s 
nomogram for two patients groups, (1)  all patients and (2)  targeted 
patients with 1 <LoMV ≤15  days. MCS allows any range of intervention 
eff ect to be simulated, where this study tested a 10 and 25% diff erence in 
LoMV (0.5 to 1.25 days for mean LoMV of 5 days). The simulated LoMV for 
the intervention group is compared with the LoMV in a control group using 
the one-sided Wilcoxon rank-sum test, Student t test, and Kolmogorov–
Smirnov test to assess central tendency and variation.
Results The distribution of LoMV is heavily skewed. Altman’s nomogram 
assumes a normal distribution and found N >1,000 to detect a 25% 
LoMV change. Figure 1 panels (1) and (2) show N for 80% power if all 
patients were included, and panels (3) and (4) for the targeted patient 
group. Panels (1) and (3) show that it is impossible to achieve 80% 
power for a 10% intervention eff ect. For 25% eff ect, MSC found N  = 
400/arm (all patients) and N = 150/arm (targeted cohort).
Conclusion Traditional parametric sample size estimation may 
overestimate the required patients. MCS can estimate eff ective N/arm 
and evaluate specifi c patient groups objectively, capturing local clinical 
practice and its impact on LoMV. It is important to consider targeting 
specifi c patient groups by applying patient selection criteria that can 
be easily translated into trial design.
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Introduction Benzodiazepines are used in many of settings to induce 
sedation, but can cause a reduction in respiratory drive. Objective 
monitoring of the eff ect of benzodiazepines on respiratory status in 
non-intubated patients has been diffi  cult, putting patient safety at 
risk. A non-invasive respiratory volume monitor (RVM) that provides 
continuous measurement of minute ventilation (MV), tidal volume (TV) 
and respiratory rate (RR) was used to quantify the eff ects of midazolam 
on respiratory status in spontaneously breathing patients.
Methods An impedance-based RVM (ExSpiron; Respiratory Motion 
Inc., Waltham, MA, USA) was used in 30  patients who received 2  mg 
midazolam prior to induction of anesthesia and were sedated but 
spontaneously breathing. Eleven of these patients (58  ± 19  years, 
average BMI 27.7) received midazolam at least 20  minutes prior 
to induction. Digital RVM data were collected and MV, TV and RR 
calculated and evaluated from 30-second segments 10 minutes before 
and after the fi rst dose of midazolam. Ten patients were analyzed as a 
group and one patient was analyzed separately (due to idiosyncratic 
reaction).
Results Following administration of midazolam, the group MV and TV 
decreased an average of 19 ± 7% and 16 ± 5%, respectively (mean ± 
SEM, P <0.01, both) while RR remained essentially unchanged (decrease 
of 3  ± 8%, P  >0.3). In the younger half of the cohort (45  ± 16  years), 
the decreases in MV and TV were not signifi cant, only 6 ± 3% and 8 ± 
5%, respectively. The older half of the cohort (72 ± 8 years) displayed 
fourfold greater MV and TV decreases (32 ± 11%, P <0.05 and 25 ± 6%, 
P <0.05), when compared with the younger cohort, P <0.01, Figure 1).
Conclusion Continuous monitoring with RVM provides a valuable 
depiction of hypoventilation from benzodiazepines, not demonstrated 
by other methodologies such as pulse oximetry and RR alone. 
RVM monitoring can help uncover potentially life-threatening 
hypoventilation in older patients. Further studies are ongoing to 
quantify hypoventilation after administration of other anesthetic 
medications.
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Introduction Mechanical ventilation has the potential to induce 
pulmonary coagulopathy. Local treatment by nebulization of heparin 
could be benefi cial in ventilated patients. The aim of this data meta-
analysis is to determine the association between nebulization of 
heparin and outcome of mechanically ventilated critically ill patients.
Methods PubMed, Scopus, EMBASE, and Web of Science were 
searched for relevant articles. Articles were selected if they compared 
Figure 1 (abstract P227).
Figure 1 (abstract P228).
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nebulization of heparin with standard care. The primary endpoint 
was overall mortality. Secondary endpoints included occurrence of 
pneumonia and number of ventilator-free days and alive at day 28.
Results Six articles were found: fi ve retrospective cohorts with historical 
controls, one randomized controlled trial, covering 423 patients. 
Dosages of nebulized heparin varied from 30,000 to 150,000  IU/day. 
Fifty out of 222 patients (22.5%) receiving nebulized heparin and 48 
out of 201 patients (23.9%) receiving standard care died (risk ratio (RR) 
0.79 (95% CI 0.47 to 1.35)) (see Figure 1). Occurrence of pneumonia (RR 
1.36 (95% CI 0.54 to 3.45); I2 = 59%), and number of ventilator-free days 
and alive at day 28 (standardized mean diff erence 0.11 (95% CI –0.14 to 
35); I2 = 0%), were not diff erent between the two groups.
Conclusion Nebulization of heparin is not associated with improved 
outcome in mechanically ventilated critically ill patients. This meta-
analysis is limited by methodological problems in most included 
studies. Only one randomized controlled trial could be included. Also, 
most patients in the meta-analyzed studies suff ered from inhalation 
trauma, and heparin dosages diff ered widely.
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Introduction The most frequent reasons for hypercapnic respiratory 
failure (HRF) in ICUs are COPD and in recent years obesity 
hypoventilation syndrome (OHS) and obstructive sleep apnea (OSA). 
Even 15 to 30% of COPD patients also have accompanying OSA. Due 
to increased upper airway resistance, those patients require higher 
expiratory pressures (EPAP) during noninvasive ventilation (NIV). In 
order to prescribe optimal mode and pressures during the ICU stay 
and at discharge, the intensivist should diagnose the underlying 
OSA. Portable recording devices have been developed and they were 
approved at least for the diagnosis in high pretest probability patients 
with results equal to in-laboratory polysomnography. The aim of this 
study is to assess whether respiratory polygraph (RPLG) can be used for 
obtaining diagnostic information of OSA in hypercapnic ICU patients.
Methods Patients, with HRF requiring NIV, were included in the study. 
RPLG studies were conducted under nasal oxygen before NIV, using the 
Philips Respironics Alice PDx® device, which provides the records of 
pulse oximetry with derived heart rate; snoring and nasal airfl ow with 
nasal pressure transducer and nasal thermistor; rib cage, abdominal 
motion and body position with abdominal and thoracic belts. American 
Academy of Sleep Medicine 2014 recommendations were used for the 
diagnosis of OSA and OHS. Because of the diagnostic diffi  culties of 
hypopnea in hypoxemic patients, we evaluated only the obstructive 
apnea index (OAI) instead of the apnea hypopnea index (AHI).
Results Thirty-one patients with the mean age of 67  ± 9  years were 
included in the study. Their mean APACHE II score was 16 ± 5 and BMI was 
33 ± 9 kg/m2. Admission arterial blood gases were as follows (mean ± 
SD); pH: 7.33 ± 0.07, PaO2: 74 ± 12 mmHg, PaCO2: 69 ± 11 mmHg, HCO3
–: 
31 ± 5, O2Sat%: 92 ± 4. Admission diagnoses of the patients were OHS 
(36%) and COPD (68%). Mean OAI was 13 ± 6 in patients with OAI >5. 
Eighty-one percent (n = 25) of the recordings were interpretable and 
clinical and RPLG data supported a new diagnosis of OSA in 14 (56%) 
patients, and EPAP levels were increased. Laboratory sleep study was 
recommended to 19% of the patients. At the end of the study 56% of 
the COPD and 72% of the OHS patients were identifi ed to have OSA.
Conclusion Although it underestimates AHI, RPLG is important and 
technically feasible in ICU patients in suggesting the presence of OSA 
and in providing information for appropriate NIV management.
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Introduction Respiratory muscle weakness is common in mechanically 
ventilated patients and impairs liberation from ventilation. Inspiratory 
muscle training (IMT) might accelerate liberation from mechanical 
ventilation. We undertook to summarize previously published IMT 
protocols and the impact of IMT on respiratory muscle function and 
clinical outcomes.
Methods We searched multiple databases using a sensitive search 
strategy combining MeSH headings and keywords for studies of IMT 
during MV. Studies were adjudicated for inclusion and data were 
abstracted independently and in duplicate. Methodological quality 
was assessed using the GRADE system.
Results Eleven studies met the inclusion criteria; of these, six were 
randomized controlled trials and fi ve were observational studies. 
Figure 1 (abstract P229). Eff ect of heparin nebulization on mortality.
Figure 1 (abstract P231). Eff ect of IMT on the rate of successful weaning from mechanical ventilation.
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A variety of IMT techniques were employed including inspiratory 
threshold loading (eight studies), biofeedback to increase inspiratory 
eff ort (one study), chair-sitting (one study) and diaphragmatic 
breathing pattern training (one study). Threshold loading was 
achieved by application of an external device (six studies) or increases 
in the inspiratory pressure trigger setting (two studies). Most studies 
implemented IMT in the weaning phase (n = 5) or after diffi  cult weaning 
(n = 5); one study implemented IMT within 24 hours of intubation. IMT 
was associated with greater increases in maximal inspiratory pressure 
compared with control (six studies, mean diff erence 7.6 cmH2O (95% CI 
5.8, 9.3), I2 = 0%). There were no signifi cant diff erences in the duration 
of MV (six studies, mean diff erence –1.1 days (95% CI –2.5, 0.3), I2 = 71%) 
or the rate of successful weaning (Figure 1; fi ve studies, risk ratio 1.13 
(95% CI 0.92, 1.40), I2 = 58%). The GRADE quality of evidence was low for 
all these outcomes; risk of bias was high for most studies and summary 
eff ects were imprecise and inconsistent. No serious adverse events 
related to IMT were reported.
Conclusion IMT in mechanically ventilated patients appears safe and 
well tolerated and improves respiratory muscle function. IMT was not 
associated with accelerated liberation from mechanical ventilation. 
However, because the included studies had important methodological 
limitations and employed varying methods of IMT, we cannot draw fi rm 
conclusions about the eff ect of IMT on clinical outcomes.
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Introduction As the objective clinical criteria [1] are imperfect to assess 
patients before extubation, simple physiological parameters are used 
to try to improve extubation failure (EF) prediction. The rapid shallow 
breathing index (RSBI) (respiratory rate (RR) over tidal volume (VT) 
ratio) recorded during a T-piece spontaneous breathing trial (SBT) 
is known as the most reliable physiologic predictor. However, RSBI 
is nowadays usually computed during a pressure support (PS) SBT 
using the values displayed on the ventilator screen and not based on 
spirometry measurements without any assist as initially published. 
The aim of the present study was to prospectively assess the ability of 
currently measured RSBI to predict EF.
Methods Retrospective analysis of prospectively collected data from 
patients intubated for more than 48  hours admitted in the medico-
surgical ICU of Lausanne, Switzerland, from January 2007 to December 
2008. EF was defi ned as the need for reintubation within 48 hours after 
extubation. Reintubations for a procedure requiring general anesthesia 
were not considered as EFs. RR and VT during the PS SBT were recorded 
from the ventilator and RSBI was computed accordingly. Baseline 
characteristics and currently measured RSBI were compared between 
patients who experienced EF versus success (t test or chi-square test as 
appropriate). The ability of currently measured RSBI to predict EF was 
assessed using ROC curve analysis.
Results A total of 478 extubated patients were included, 25 of whom 
(5.2%) were reintubated. ICU mortality (ICU-m) and in-hospital mortality 
(H-m) were higher in reintubated patients: ICU-m  = 6 (24) versus 22 
(5), P = 0.002 and H-m = 9 (36) versus 63 (15), P = 0.009. The reasons 
for EF were: acute lung failure (n = 15), congestive heart failure (n = 4) 
and aspiration/bronchial congestion (n = 6). Demographic data were 
similar between patients successfully and nonsuccessfully extubated: 
age: 58 ± 17 versus 58 ± 19 years, P = 0.85; male gender: 15 (60) versus 
263 (61), P  = 0.99. SAPS II score was higher in the EF group: 30  ± 22 
versus 42 ± 27, P = 0.04. RSBI were signifi cantly higher in patients who 
experienced EF: RSBI=59 ± 44 versus 43 ± 26, P = 0.04. The area under 
the ROC curve for currently measured RSBI was: 0.617 (95% CI = 0.571 
to 0.662), P = 0.035.
Conclusion In a cohort of 458 medico-surgical ICU patients, RSBI 
measured during a pressure support SBT was higher in patients 
experiencing EF but very imperfect to predict EF.
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Introduction Neutrophil extracellular traps (NETs) are fi brous 
structures that are produced extracellularly from activated neutrophil. 
They can trap and kill various pathogens, and their release is one of 
the fi rst lines of immune system. Meanwhile, recently it was reported 
that NETs also exert adverse eff ects in infl ammatory diseases. Acute 
respiratory distress syndrome (ARDS) and acute exacerbation of 
idiopathic pulmonary fi brosis is acute-onset respiratory failure. It is 
characterized by excessive neutrophil infi ltration into the alveolus, and 
great amounts of neutrophil elastase are released. The purpose of this 
study is to evaluate whether NETs are produced in bronchial aspirate 
of patients with ARDS or acute exacerbation of idiopathic pulmonary 
fi brosis, and to identify correlations with the respiratory function.
Methods This was a prospective observational study of seven patients 
admitted to the ICU of a large urban tertiary referral hospital. All patients 
were mechanically ventilated at the time of admission. The bronchial 
aspirates were collected serially from the patients by suction through 
a tracheal tube. To identify NETs, extracellular components including 
DNA, histone H3, and citrullinated histone H3 were simultaneously 
detected using immunohistochemistry. The respiratory function was 
evaluated by PaO2/FiO2 ratio (P/F ratio).
Results The study group was comprised of four men and three women. 
Median age was 69 (IQR: 61.0 to 72.5) years old. The reason for admission 
was ARDS (n  = 5) and acute exacerbation of idiopathic pulmonary 
fi brosis (n = 2). The reasons for ARDS are bacterial pneumonia (n = 3), 
necrotizing fasciitis (n  = 1) and extensive burn (n  = 1). We identifi ed 
NETs in the bronchial aspirates of all the patients. NET formation had 
persisted in four cases during the study period, their P/F ratio did not 
improve and all patients were dead due to respiratory failure. On the 
other hand, NETs decreased and vanished in three cases, their P/F ratio 
improved and all patients recovered from ARDS.
Conclusion NET formation was observed in bronchial aspirates of all 
the patients diagnosed with ARDS or acute exacerbation of idiopathic 
pulmonary fi brosis. It may be one of the prognostic factors of ARDS or 
acute exacerbation of idiopathic pulmonary fi brosis.
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Introduction Acute lung injury (ALI) and its hypoxemic form, acute 
respiratory distress syndrome (ARDS), has no approved pharma co-
logical treatment and is a condition with high mortality. Vascular 
leakage is one of the early events of ALI/ARDS. CD73 activity (ecto-
5’-nucleotidase) maintains the endothelial barrier function of lung 
capillaries via its enzymatic endproduct adenosine. Interferon-beta 
(IFNβ) increases synthesis of CD73 and has been eff ective in a mouse 
model of ALI [1].
Methods Therefore we conducted a phase I/II trial [2], in which 
intravenously administered human recombinant IFNβ1a (FP-1201) 
was used in the study, which consisted of dose escalation (phase I) and 
expansion (phase II) parts to test the FP-1201 safety, tolerability and 
effi  cacy in ALI/ARDS patients. CD73, MxA (a marker for IFN β response) 
and other biomarkers were measured to follow pharmacokinetics/
dynamics of the intravenously administered FP-1201 and therapeutic 
effi  cacy.
Results The optimal tolerated dose of FP-1201 (10 μg/day for 6 days) 
resulted in maximal MxA stimulation. Also soluble CD73 values 
increased, while IL-6 decreased in sera of the FP-1201-treated ALI/ARDS 
patients. The overall mortality of the 37 patients treated with FP-1201 
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was only 8.1%, fourfold to fi vefold less than the expected rate based on 
APACHE II score values of 21.9. The control group (n = 59), which was 
eligible for the trial but not possible to recruit, had mortality of 32.2% 
(P = 0.01) and APACHE II score 23.0.
Conclusion Restriction of vascular leakage with FP-1201 seems to 
signifi cantly benefi t ALI/ARDS patients. Our results suggest that FP-
1201 could be the fi rst eff ective, mechanistically targeted, disease-
specifi c pharmacotherapy for patients with ARDS. However, these 
fi ndings warrant conduction of a large multicenter study to establish 
safe and eff ective FP-1201 treatment of ARDS.
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Introduction Endocan (endothelial cell specifi c molecule-1), a 50 kDa 
dermatan sulfate proteoglycan, is expressed by endothelial cells in 
the lung and kidney. It was reported that the serum Endocan level 
is related to the severity of sepsis and positive correlation with the 
mortality rate. On the other hand, it was also reported that lower 
levels of serum Endocan are associated with subsequent development 
of chronic kidney disease, and chronic liver disease acute lung injury 
(ALI) in trauma patients. The aim of this study is confi rmation of the 
relationship between serum Endocan level and the severity of sepsis, 
and also the severity of acute respiratory distress syndrome (ARDS) in 
septic patients.
Methods This study was conducted as a single-center, retrospective, 
observational study in the emergency department of Fukuoka 
University Hospital from April 2010 to August 2013. Blood samples 
were collected within 2 hours when the patients were diagnosed with 
ARDS. In this time we adopted the Berlin defi nition as the categorized 
of ARDS severity. Furthermore, we evaluated the extravascular lung 
water index (EVLWi) and pulmonary vascular permeability index (PVPI) 
as a condition of ARDS using the transpulmonary thermodilution 
method. Additionally, 10 healthy donors were entered as a control. The 
patients were divided into nonsepsis, severe sepsis and septic shock 
using the ACCP/SCCM guidelines.
Results We enrolled 70 ARDS patients during the investigation periods. 
We met six patients with nonsepsis, 27 with severe sepsis and 37 with 
septic shock. The serum Endocan levels were signifi cantly higher in 
patients with septic shock (3.7 to 3.9 ng/ml) than in patients with severe 
sepsis (1.7 to 2.3 ng/ml, P <0.05), nonsepsis (0.6 to 0.3 ng/ml, P <0.05) 
and healthy donors (0.4 to 0.1 ng/ml, P <0.05). However, there was no 
signifi cant correlation between the Endocan level and the severity of 
ARDS. In addition, signifi cant correlation between the Endocan level 
and EVLWi and PVPI was not observed.
Conclusion These results suggested that there was good relationship 
between the Endocan level and the severity of sepsis. But unlike 
the trauma patients, correlation between the severity of ARDS and 
Endocan value was not recognized.
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Introduction Mesenchymal stem cells (MSCs) have potent stabilizing 
eff ects on the vascular endothelium injury, inhibiting endothelial 
permeability in lung injury via paracrine hepatocyte growth factor 
(HGF). Recently, it has been indicated that MSCs secreted more factors 
by MSC–endothelial cell (MSC-EC) interaction. We hypothesized that 
MSC-EC interaction restored endothelial permeability induced by 
lipopolysaccharide (LPS) via paracrine HGF.
Methods We investigated the endothelial permeability induced by 
LPS under two co-culture conditions in transwells. HPMECs were 
added into the upper chambers of cell-culture inserts, while there 
two diff erent co-culture conditions in the lower side of transwells as 
follows: MSC-EC interaction group: MSCs and HPMEC contact co-
culture in the lower chambers; and MSC groups: MSCs only in the lower 
chambers. The endothelial permeability in the upper side of transwells 
was detected. Then the concentration of HGF was measured in the 
culture medium using an enzyme-linked immunosorbent assay kit, 
following by neutralizing HGF with anti-HGF antibody in the co-culture 
medium. In addition, VE-cadherin protein expression were measured 
under the co-culture conditions by western blot, adherens junctions 
(AJs) protein including F-actin and VE-cadherin were detected by 
immunofl uorescence technique as well.
Results The permeability signifi cantly increased after LPS stimulation 
in a dose-dependent and time-dependent manner (P  <0.01). Mean-
while, MSC-EC interaction more signifi cantly decreased endothelial 
permeability induced by LPS (P  <0.05 or P  <0.01). Moreover, HGF 
levels in the MSC-EC interaction group were much higher than those 
of the MSC group (P  <0.01). However, neutralizing HGF with anti-
HGF antibody inhibited the role of MSC-EC interaction in improving 
endothelial permeability (P  <0.05). Compared with the MSC group, 
MSC-EC interaction increased VE-cadherin protein expression (P <0.01), 
and restored remodeling of F-actin and junctional localization of VE-
cadherin. However, the MSC eff ect was signifi cantly blocked by anti-
HGF antibody (P <0.05 or P <0.01).
Conclusion These data suggest that MSC-EC interaction decreased 
endothelial permeability induced by LPS, which was mainly attributed 
to HGF secreted by hMSCs. The main mechanisms of HGF restoring the 
integrity of EC monolayers are remodeling of endothelial intercellular 
AJs and decreasing caveolin-1 protein expression.
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Introduction Receptor for advanced glycation endproducts (RAGE) 
is a transmembrane receptor expressed in the lung and primarily 
located on alveolar type I cells. RAGE is implicated in acute respiratory 
distress syndrome to alveolar infl ammation and, when its soluble form 
sRAGE is assayed in plasma or pulmonary edema fl uid, as a marker 
of AT I cell injury. Functional activity of AT 1 cells can be assessed by 
the measurement of the alveolar fl uid clearance (AFC) rate [1], but the 
relationship between sRAGE plasma levels of sRAGE and AFC rates has 
never been investigated. Our objectives were to report plasma levels of 
sRAGE in a mouse model of direct acid-induced epithelial injury, and to 
test their correlation with AFC rates.
Methods Forty-one CD-1 mice were divided into two groups: an HCl 
group underwent orotracheal instillation of hydrochloric acid on day 0, 
and a group control. Mice were evaluated on days 0, 1, 2 and 4 after 
a 30-minute period of mechanical ventilation. Blood and lung edema 
fl uid (EF) were sampled. Before initiation of MV, all mice received a 
tracheal instillation of bovine serum albumin (5%) to detect changes 
in alveolar protein levels over 30 minutes. Plasma levels of sRAGE and 
total protein levels were measured. AFC rate values were corrected 
after measurement of mouse serum albumin in EF.
Results Basal AFC rate was 35% over 30 minutes in HCl-injured mice, 
but it was signifi cantly depressed on day 1 (16% over 30 minutes; P = 
0.02). Over time, AFC reached basal levels again. Plasma levels of sRAGE 
were higher in HCl-treated animals than in control animals on day 1 
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(P = 0.03) and day 2 (P = 0.02). The rate of AFC was inversely correlated 
with sRAGE levels in the plasma (Spearman’s ρ = –0.73, P <0.001). See 
Figure 1.
Conclusion The highest impairment in AFC is reported on day 1. sRAGE 
levels are also higher in injured mice and may be a good surrogate 
marker of AT I cell injury. This is a newly described relationship between 
AFC rates and sRAGE plasma level in a mouse model of direct epithelial 
injury. Our results support further translational investigation on the 
role of RAGE in alveolar injury and recovery.
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Introduction Cigarette smoking slowly and progressively damages the 
respiratory system [1]. In surgical critically ill patients, whether active 
cigarette smoking until admission to the surgical intensive care unit 
(SICU) is associated with increased risk of acute respiratory distress 
syndrome (ARDS) is not clearly identifi ed.
Methods We conducted a cohort study using the THAI-Surgical 
Intensive Care Unit (THAI-SICU) study databases [2], which recruited 
4,652 Thai patients admitted to the SICUs from nine university-based 
hospitals in Thailand (April 2011 to November 2012). The enrolled 
patients were divided into three groups (active smokers, exsmokers, 
and nonsmokers). Primary outcome was the incidence of patients 
diagnosed with ARDS and the secondary outcomes included 28-day 
mortality, incidence of systemic infl ammatory response syndrome 
(SIRS), SICU length of stay (LOS), and total SICU cost.
Results Of those 4,652 patients, there were 2,947 nonsmokers, 1,148 
exsmokers, and 557 active smokers. There was no diff erence of APACHE 
II score between three groups of patients. The active smokers exhibited 
the highest incidence of ARDS (active smokers 5.4%, exsmokers 4.8%, 
and nonsmokers 3%, P  = 0.003). There was no diff erence of 28-day 
mortality between the three groups of patients. Active smokers had 
the highest incidence of SIRS (active smokers 41%, exsmokers 37%, 
and nonsmokers 34%, P  = 0.006). Compared with nonsmokers and 
exsmokers, active smokers had a longer SICU LOS (P <0.01) and higher 
total SICU cost (P  = 0.02). Patients who smoked more than 15  pack-
years were 2.5 times more likely to develop ARDS than patients who 
smoked ≤15 pack-years (95% CI: 1.65 to 3.66, P <0.001). In multivariate 
analysis we found that every 1 pack-year of cigarette smoking before 
admission to the SICU is associated with increased risk of new ARDS 
with a hazard ratio of 1.02 (95% CI: 1.01 to 1.02, P  = 0.001) after 
adjustment for APACHE II score, age, gender, and chronic obstructive 
pulmonary disease.
Conclusion In surgical critically ill patients, active smokers are 
associated with increased risk of new ARDS, longer SICU LOS, and 
higher total ICU cost, compared with exsmokers and nonsmokers. 
Our fi ndings emphasize the essential need for a smoking cessation 
program.
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Introduction Traditionally, ARDS obese patients are ventilated with 
higher tidal volumes and higher PEEP due to expected increased 
in pleural pressure. However, data from the literature regarding the 
infl uence of body mass on lung mechanics and, particularly, on chest 
wall elastance are not univocal [1,2]. Failure to account for how the 
increase in body weight could aff ect the respiratory function can result 
in injurious mechanical ventilation and in the onset of VILI. The aim of 
this study was to evaluate the role of the body weight on respiratory 
mechanics in ARDS patients.
Methods A group of deeply sedated and paralyzed ARDS patients 
was divided into three classes according to the body mass index: 
normal weight (between 18.5 and 24.9 kg/m2), overweight (between 
25.0 and 29.9 kg/m2) and obese (between 30.0 and 39.9 kg/m2). They 
were mechanically ventilated in volume-controlled mode with a tidal 
volume of 6 to 8 ml/kg according to predicted body weight. Respiratory 
mechanics and gas exchange were assessed at PEEP levels of 5 and 
15 cmH2O.
Results A total of 101 ARDS patients was enrolled; 44 (43.6%) patients 
were normal weight, 36 (35.6%) overweight and 21 (20.8%) obese. 
Lung and chest wall elastance were not diff erent between groups, 
both at PEEP levels of 5  cmH2O and 15  cmH2O (P  = 0.580 and P  = 
0.113, respectively), and the end-inspiratory transpulmonary pressure 
was also similar. We did not observe any diff erence between groups 
regarding PaO2/FiO2 ratio (P = 0.178 at PEEP 5 cmH2O; P = 0.073 at PEEP 
15 cmH2O) and PaCO2 (P = 0.491 at PEEP 5 cmH2O; P = 0.237 at PEEP 
15 cmH2O).
Conclusion In ARDS obese patients the chest wall elastance and the 
end-inspiratory transpulmonary pressure are not aff ected by the body 
weight, suggesting that normal weight and obese patients present 
similar risks for lung stress and VILI onset. The severity of hypoxemia 
was not diff erent between groups.
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Introduction Acute respiratory distress syndrome (ARDS) develops 
on the basis of nosocomial pneumonia (NP) in 30 to 35% of cases. A 
complex clinical approach is required for diagnosing it. The aim of 
this study was to investigate into the role of the PaO2/FiO2 ratio (P/F), 
extravascular lung water index (EVLWI) and surfactant protein D (SPD) 
as a complex diagnostic tool for ARDS in NP.
Figure 1 (abstract P237). Relation between AFC rates and sRAGE plasma 
levels.
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Methods The observational study in ICU ventilated septic patients with 
peritonitis (70%), pancreonecrosis (25%) and mediastinitis (5%) was 
done in 2010 and 2014. ARDS was diagnosed and staged according to 
the V.A. Negovsky Research Institute criteria and the Berlin defi nition. 
Plasma SPD was measured on ARDS diagnosis (day 0) and days 3 and 
5 by the immunoenzyme essay (BioVendor, USA). Patients were treated 
according to the international guidelines. Data were statistically 
analyzed by STATISTICA 7.0, ANOVA and presented as median and 
25 to 75th percentiles (ng/ml); P  <0.05 was considered statistically 
signifi cant. Areas under the receiver operating curves were calculated.
Results Sixty-fi ve patients (out of 450 screened) were enrolled in the 
study according to the inclusion/exclusion criteria. Patients were 
assigned into groups: NP + ARDS (n = 43, 43 ± 4.9 years old, M/F 39/4, 
mortality 23%) and NP (n = 22, 40 ± 5.1 years old, M/F 20/2, mortality 
18%). Groups were comparable in APACHE II and SOFA scores on the 
baseline. In the NP + ARDS group SPD was higher at all points than in 
the NP group. Plasma SPD on day 0 >111.2 ng/ml yielded a sensitivity 
of 68.2% and specifi city of 92.3% (AUC 0.85; 95% CI 0.684 to 0.945; 
P <0.0001) for diagnosing ARDS in NP. P/F ratio on day 0 <280 yielded 
a sensitivity of 94.1% and specifi city of 76.9% (AUC 0.89; 95% CI 0.744 
to 0.952; P <0.0001) and EVLWI on day 0 >8.3 ml/kg yielded a sensitivity 
of 94.1% and specifi city of 92.3% (AUC 0.92; 95% CI 0.810 to 0.982; 
P <0.0001) for the diagnosis of ARDS in NP. A complex ROC analysis (for 
SPD in the group of patients with P/F <280 and EVLWI >8.3) yielded a 
much better diagnostic accuracy of SPD: cutoff  >93.7 ng/ml, sensitivity 
81.0%, specifi city 100.0% (AUC 0.96; 95% CI 0.817 to 0.998; P <0.0001).
Conclusion A complex approach (P/F <280, EVLWI >8.3, SPD >93.7) 
presents as a sensitive and highly specifi c method for diagnosing ARDS 
in NP patients.
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patients with diff use ARDS: a prospective randomized crossover 
study
M Jabaudon, N Hamroun, L Roszyk, R Blondonnet, R Guerin, JE Bazin, 
V Sapin, B Pereira, JM Constantin
CHU Clermont-Ferrand, France
Critical Care 2015, 19(Suppl 1):P241 (doi: 10.1186/cc14321)
Introduction The soluble form of the receptor for advanced glycation 
endproducts (sRAGE) is a promising marker for epithelial dysfunction, 
but it has not been fully characterized as a biomarker during ARDS. 
Whether sRAGE could inform on the response to ventilator settings 
has been poorly investigated, and whether recruitment maneuver (RM) 
may infl uence plasma sRAGE remains unknown.
Methods Twenty-four patients with moderate/severe, nonfocal ARDS 
were enrolled in this prospective monocentric crossover study and 
randomized into a ‘RM-SHAM’ group when a 6-hour-long RM sequence 
preceded a 6-hour-long sham evaluation period, or a ‘SHAM-RM’ 
group (inverted sequences). Protective ventilation was applied, and 
RM consisted of the application of 40  cmH2O airway pressure for 
40  seconds. Arterial blood was sampled for gas analyses and sRAGE 
measurements, 5  minutes pre RM (or 40-second-long sham period), 
5  minutes, 30  minutes, 1  hour, 4  hours and 6  hours after the RM (or 
40-second-long sham period).
Results Mean PaO2/FiO2, tidal volume, PEEP and plateau pressure 
were 125  mmHg, 6.8  ml/kg (ideal body weight), 13 and 26  cmH2O, 
respectively. Median baseline plasma sRAGE levels were 3,232 pg/ml. 
RM induced a signifi cant decrease in sRAGE (–1,598  ± 859  pg/ml) in 
1 hour (P = 0.043). At 4 and 6 hours post RM, sRAGE levels increased 
back toward baseline values. Pre-RM sRAGE was associated with RM-
induced oxygenation improvement (AUC 0.87). See Figure 1.
Conclusion We report the fi rst kinetics study of plasma sRAGE after RM 
in ARDS. Our fi ndings could help to design future studies of sRAGE as a 
marker of response to therapeutic interventions during ARDS.
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Introduction Oesophageal pressure is increasingly used to monitor 
and manage mechanically ventilated patients. Even if the oesophageal 
balloon catheter is correctly positioned, the measurement can be 
aff ected by inappropriate balloon fi lling and/or oesophageal reaction 
to balloon infl ation. We aimed to assess the oesophageal reaction to 
oesophageal balloon fi lling in mechanically ventilated patients.
Methods An oesophageal balloon catheter (NutriVent; Sidam, 
Mirandola, Italy) was introduced in mid/distal thoracic position in 31 
patients under invasive mechanical ventilation for acute respiratory 
failure. At ambient pressure, the balloon of the NutriVent catheter 
can be infl ated up to 6 ml without generation of recoil pressure. The 
balloon was progressively infl ated in 0.5  ml steps up to 9  ml and 
end-expiratory values of balloon pressure were used to assemble the 
balloon pressure–volume curve. The minimum slope section of the 
curve was graphically detected and infl ation volumes corresponding to 
this part of the curve were considered appropriate. Overdistension of 
the balloon being excluded by defi nition in this section of the curve, its 
slope was attributed to the oesophageal reaction to balloon infl ation.
Results Forty-fi ve oesophageal balloon pressure–volume curves were 
obtained in 31 patients undergoing controlled mechanical ventilation 
(PEEP 12  ± 5  cmH2O, FiO2 0.7  ± 0.2, tidal volume/ideal body weight 
8.0 ± 1.6 ml/kg). According to the graphically detected minimum slope 
section of the curve, the minimum and maximum appropriate balloon 
volumes were 1.5 ± 0.6 ml and 5.3 ± 0.9 ml, respectively. Between these 
two volumes, the slope of the curve was 1.1 ± 0.5 cmH2O/ml, ranging 
from 0.3 to 3.1 cmH2O/ml.
Conclusion The oesophageal artefact  – that is, the reaction of the 
oesophageal wall to balloon infl ation  – may be clinically signifi cant, 
being on average 1  cmH2O for each millilitre of volume injected in 
the catheter, but reaching values as high as 3 cmH2O/ml. The pressure 
generated by the oesophageal reaction leads to overestimation 
of pleural pressure. Therefore, the oesophageal artefact may 
signifi cantly aff ect clinical decision-making based on absolute values 
of oesophageal pressure.
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Introduction Prone positioning has been used for many years as an 
alveolar recruitment strategy in acute respiratory distress syndrome 
(ARDS). Prone positioning in ARDS improves oxygenation and 
Figure 1 (abstract P241). Evolution of plasma levels of sRAGE (pg/ml) in 
both randomization sequences.
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demonstrated recently its eff ectiveness on prognosis. Extrapulmonary 
etiologies of ARDS include abdominal emergencies. In cases of severe 
hypoxemia in the early postoperative period, intensivists discuss prone 
positioning based on the risk/benefi t ratio.
Methods We conducted a retrospective two-center study of 5  years. 
The aim was to compare the prevalence of surgical complication 
potentially related to prone positioning between patients who had 
at least one prone positioning session and patients that remained in 
a supine position after abdominal surgery. Patients with ARDS in a 
context of recent (<7  days) abdominal surgery (except laparoscopy) 
were included. The primary outcome was the number of patients who 
had at least one surgical complication potentially related to prone 
positioning. We defi ned a priori these complications: scar dehiscence, 
abdominal compartment syndrome, stoma leakage, stoma necrosis, 
scar necrosis, wound infection, displacing of a drainage system, removal 
of gastro- or jejunostomy feeding, digestive fi stula, evisceration.
Results We identifi ed 43 patients with postoperative ARDS (62  ± 
8 years, SAPS II 50 ± 13), among whom 34 (79%) had emergent surgery. 
Fifteen patients had at least one stoma after surgery. Nineteen patients 
(44%) had at least one prone positioning session (number of sessions: 
2 (1 to 3)). At baseline, prone group patients had minimum PaO2/FiO2 
ratio lower than the supine group (77  ± 23 vs. 110  ± 46  mmHg, P  = 
0.005). Plateau pressure was higher in the prone group (28 ± 4 vs. 23 ± 
5  cmH2O, P  = 0.002). The fi rst prone positioning session signifi cantly 
increased the PaO2/FiO2 ratio: 106  ± 52 vs. 192  ± 90  mmHg (P  = 
0.001). Mean duration of the fi rst prone positioning session was 20 ± 
10 hours. In the prone group, 11 patients (58%) had at least one surgical 
complication, in comparison with nine (38%) in the supine group (P = 
0.2). These complications resulted in revision surgery for two (10%) 
patients in the prone group and two (8%) in the supine group (P = 0.8). 
Mortality in the ICU was respectively 42% and 38% in prone group and 
supine group (P = 0.8).
Conclusion These preliminary results confi rm the eff ectiveness of prone 
positioning in terms of oxygenation in ARDS after abdominal surgery 
without signifi cant increase in surgical complications and no eff ect on 
the need for surgical revisions. Hence, if necessary, clinicians should not 
refrain from proning patients with postabdominal surgery ARDS.
P244
Regional distribution of excess tissue mass in ARDS lung
I Algieri1, D Massari1, A Colombo1, G Babini1, F Crimella1, M Brioni1, 
A Cammaroto1, K Nikolla1, C Montaruli1, M Guanziroli1, M Gotti1, 
C Chiurazzi1, M Amini1, M Chiodi1, M Cressoni1, D Chiumello2, L Gattinoni1
1Università degli Studi di Milano, Milan, Italy; 2Fondazione IRCCS, ‘Ospedale 
Maggiore Policlinico Mangiagalli Regina Elena’ di Milano, Milan, Italy
Critical Care 2015, 19(Suppl 1):P244 (doi: 10.1186/cc14324)
Introduction ARDS is characterized by edema diff use to all lung fi elds. 
Distribution of excess tissue mass had been studied with CT scan in a 
few patients on a single slice, comparing with data obtained in healthy 
controls.
Methods ARDS patients underwent CT scan imaging during their ICU 
stay at 45  cmH2O end-inspiratory pressure. After hospital discharge, 
patients underwent a follow-up CT scan performed at end inspiration. 
Each lung was divided into three sections along the apex–base axis 
and into three sections along the sternum–vertebral axis (nine regions 
per lung). Excess tissue mass in each lung region was defi ned as the 
diff erence in lung tissue (grams) between the CT scan performed 
during ARDS course and the follow-up CT scan. Results are presented 
as mean ± SD.
Results We studied eight ARDS patients (55  ± 18  years) with a BMI 
of 27 ± 6 kg/m2. At ICU admission, patients had the following clinical 
parameters: PaO2/FiO2 106 ± 33 with PEEP 15 ± 5 cmH2O; PaCO2 43 ± 
10 mmHg; pH 7.35 ± 0.05. The average increase in lung weight during 
ARDS compared with follow-up CT scan was 68 ± 40% (680 ± 320 g). 
Figure 1 presents the tissue volume during ARDS (white bars) and after 
ARDS resolution (black bars) and compares the ratio between the two 
(*P <0.01 vs. dependent region).
Conclusion The excess tissue mass was not diff erent between apex, 
hilum and base, but was increased in the dependent lung regions at 
apex and hilum, being uniformly distributed at the lung base.
P245
Functional respiratory imaging of airways in ventilated ARDS 
patients: revealing the regional relation between PEEP-induced 
airway opening and airway dilatation
T Schepens1, C Vanholsbeke2, W Vos2, J De Backer2, P Parizel1, PG Jorens1
1Antwerp University Hospital, Edegem, Belgium; 2FLUIDDA, Kontich, Belgium
Critical Care 2015, 19(Suppl 1):P245 (doi: 10.1186/cc14325)
Introduction ARDS has a wide variability of lung morphological charac-
teristics. Both alveolar collapse and airway narrowing or closing are 
present, often heterogeneously. Despite advances in ARDS imaging, we 
have thus far been unable to distinguish regional airway opening from 
airway dilatation in PEEP-induced lung recruitment. We demonstrate 
the technique of functional respiratory imaging (FRI) to diff erentiate 
these two entities.
Methods Six patients with early-stage ARDS were included in this 
prospective single-centre cohort trial. The lower infl iction point on a 
pressure–volume curve was considered as the clinically acceptable 
minimal PEEP value. Subsequently, four distinct PEEP levels were 
chosen to perform CT scans: at 20 cmH2O; median value between 1 and 
3; clinically acceptable minimal; and 0 cmH2O. FRI methods as described 
by De Backer and colleagues [1] were used to evaluate airway opening 
and airway dilatation.
Results Airway stretching (that is, bronchodilatation) could be 
quantifi ed and distinguished from airway recruitment with this 
technique. Higher PEEP pressures not only recruit, but also expand the 
bronchi. The ratio of dilation/recruitment of bronchi was higher in the 
upper lobes than in the lower lobes, as illustrated in Figure 1. We were 
able to phenotype each patient, allowing a prediction on when an 
increase in PEEP further recruits atelectasis/bronchi or distends certain 
airway regions.
Conclusion The novel technique of FRI can be used to visualise the 
airway structures in ARDS and distinguish airway stretching from 
Figure 1 (abstract P244).
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airway recruitment. This pilot study shows that, in ARDS, the upper lung 
regions are subject to airway dilation, whereas the lower (atelectatic) 
lung lobes have more airway opening with higher PEEP levels.
Reference
1. De Backer et al. Radiology. 2010;257:854-62.
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Effi  cacy and safety of open lung ventilation in patients with 
impaired peripheral chemorefl ex sensitivity
N Trembach, I Zabolotskikh
Kuban State Medical University, Krasnodar, Russia
Critical Care 2015, 19(Suppl 1):P246 (doi: 10.1186/cc14326)
Introduction Mechanical ventilation during anesthesia leads to the 
development of atelectasis, poor oxygenation and postoperative 
pulmonary complications. Application of PEEP and recruitment 
maneuver (RM) can signifi cantly reduce the severity of atelectasis and 
improve lung function. But the application of this strategy often leads 
to hemodynamic instability, which may be associated with impaired 
reactivity of the cardiovascular system. The purpose of this study was 
to evaluate the effi  cacy and safety of RM in patients with increased 
sensitivity of peripheral chemoreceptors (SPCR), which refl ects the 
decreasing reactivity of the cardiovascular system.
Methods We conducted a prospective study in 116 patients with high 
SPCR, evaluated using the breath-holding test. The test was performed 
by measuring of voluntary breath-holding duration (BHD) after two-
thirds of maximal inspiration. The end of breath-hold was determined 
by a palpation of contraction of the diaphragm. BHD <38 seconds was 
the marker of high SPCR [1]. All patients received a major abdominal 
surgery and were randomized into an open lung ventilation group or 
a PEEP group. The concept of open lung ventilation was performed 
as follows: PEEP was increased from 4 to 10 cmH2O for three breaths, 
from 10 to 15 cmH2O for three breaths, and from 15 to 20 cmH2O for 10 
breaths [2]. Then PEEP was reduced to 12 cmH2O. This RM was repeated 
every hour. In the PEEP group PEEP was maintained at 12 cmH2O during 
the whole anesthesia. Hemodynamics, blood gases and dynamic 
compliance were evaluated.
Results RM improved oxygenation compared with the PEEP group. 
The mean increase in the oxygenation index at the end of surgery was 
31% (from 340 to 445 mmHg, P <0.05), in the PEEP group the increase 
was less signifi cant and amounted to 12% (from 330 to 370  mmHg, 
P <0.05). Dynamic compliance increased by 35% in the RM group and 
did not change in the PEEP group. Hemodynamic changes at RM were 
more pronounced. So CI on average decreased by 34% (from 3.7 to 
2.5 l/minute/m2) compared with 10% with no RM (P  <0.05), and SVR 
decreased by 19% (from 1,310 to 1,150 dyn  × sec–1  × cm–5, P  <0.05), 
while in the PEEP group it did not change. No signifi cant diff erences 
between groups in the incidence of complications, length of stay in the 
ICU and in the hospital were noted.
Conclusion RM patients with high SPCR and with reduced reactivity of 
the cardiovascular system improve lung function, but this is associated 
with the risk of hemodynamic instability.
References
1. Zabolotskikh I, et al. Eur J Anesth. 2014;31:62.
2. Weingarten TN, et al. Br J Anesth. 2010;104:16-22.
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Determinants of energy dissipation in the respiratory system during 
mechanical ventilation
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M Cressoni, L Gattinoni
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Critical Care 2015, 19(Suppl 1):P247 (doi: 10.1186/cc14327)
Introduction Mechanical ventilation performs at each breath 
mechanical work on the lung parenchyma. Part of this energy is 
recovered and part is dissipated into the respiratory system. The 
purpose of this study is to assess the respective role of three known 
determinants of energy dissipation: lung opening and closing, strain 
and lung inhomogeneities [1].
Methods Thirteen female piglets (21  ± 2  kg) were ventilated with a 
strain (VT/FRC) greater than 2.5 (VT ~ 38 ± 3 ml/kg) for 54 hours or until 
massive lung edema developed. Piglets were divided into fi ve groups 
characterized by diff erent energy loads obtained varying the respiratory 
rate: 15 breaths/minute (n = 3), 12 (n = 3), 9 (n = 3), 6 (n = 2) and 3 (n = 2). 
Every 6 hours two CT scans were performed (end-expiration and end-
inspiration) and a static pressure–volume curve was obtained. A total 
of 51 CT scan couples and 51 corresponding pressure–volume curves 
was analyzed. The energy dissipated in the lung parenchyma at each 
breath was determined as the hysteresis area of the pressure–volume 
curve. CT scans were quantitatively analyzed with dedicated software. 
Data are presented as median (interquartile range).
Results Piglets ventilated with higher energy loads (RR 15 and 12) 
developed ventilator-induced lung injury (VILI), while piglets ventilated 
with lower energy loads (RR 9, 6 and 3) did not. The energy dissipated 
in the lung parenchyma at each breath was 0.56  J (0.52 to 0.62). 
Dissipated energy increased with time in piglets that developed VILI, 
while it remained near-constant in all the other piglets. Recruitability 
was 6% (3 to 8) of lung parenchyma, strain was 3.1 (2.6 to 3.5) and lung 
inhomogeneity extent (that is, the percentage of lung parenchyma that 
is inhomogeneous) was 10% (9 to 11). The energy dissipated in the lung 
parenchyma was well related to lung recruitability (r2 = 0.50, P <0.0001), 
strain (r2 = 0.57, P <0.0001) and lung inhomogeneity extent (r2 = 0.42, 
P  <0.0001). Multiple linear regression showed that dissipated energy 
was independently related to all of the three determinants of energy 
dissipation: lung opening and closing (P = 0.025), strain (P <0.0001) and 
lung inhomogeneities (P <0.01).
Conclusion Energy dissipation was largely dependent on strain, 
obtained with very high tidal volumes, but also lung inhomogeneities 
and lung opening and closing played a signifi cant role.
Reference
1. Cressoni M. et al. Am J Respir Crit Care Med. 2014;189:149-58.
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Immune response after prolonged hyperoxic mechanical ventilation
HJ Helmerhorst1, LR Schouten2, NP Juff ermans2, MJ Schultz2, E De Jonge1, 
DJ Van Westerloo1
1Leiden University Medical Center, Leiden, the Netherlands; 2Academic Medical 
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Critical Care 2015, 19(Suppl 1):P248 (doi: 10.1186/cc14328)
Introduction Mechanical ventilation and hyperoxia independently 
promote pulmonary injury and infl ammation. However, the time course 
of the immune response following concurrent exposure is unclear. The 
Figure 1 (abstract P245). Bronchodilation and bronchial recruitment 
split per lobe for one patient.
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aim of this preclinical study was to study both time-dependent and 
dose-dependent eff ects of supplemental oxygen during prolonged 
ventilatory support on pulmonary infl ammation in a well-established 
murine model of ventilation comparing low and high tidal volumes.
Methods Healthy male C57Bl/6J mice, aged 9 to 10  weeks, were 
randomly assigned to experimental groups (n = 8), in which the applied 
fractions of oxygen (FiO2) were 30%, 50% or 90% and tidal volumes 
were either 7.5 or 15 ml/kg. Anesthetized mice were tracheotomized 
and ventilated for 8 or 12 hours. Infl ammatory cells and mediators were 
measured in bronchoalveolar lavage fl uid (BALf ).
Results Mice exposed to higher FiO2 had signifi cantly higher PaO2 levels 
at the end of the experiment. The total number of infl ammatory cell in 
the BALf was not signifi cantly diff erent between the experimental groups 
(P = 0.28), yet an increasing trend in the percentage of neutrophils was 
observed with increasing FiO2 (P = 0.03). Cytokine and chemokine levels 
did not diff er between FiO2 groups at 8  hours of ventilation. In mice 
ventilated for 12 hours, a signifi cantly increasing trend in IFNγ, IL-1β, IL-
10, MCP-1 and TNFα (Fig. 1, P <0.01) was measured with increasing FiO2, 
whereas IL-6, KC, MIP-2, GM-CSF and VEGF remained virtually unchanged. 
Diff erences between the tidal volume groups were small and did not 
markedly infl uence the eff ects of hyperoxia. See Figure 1.
Conclusion Hyperoxia induced a time-dependent and diff erentiated 
immune response that was independent of tidal volumes in a model 
of mechanically ventilated mice. The presence of cytokines and 
chemokines in the pulmonary compartment was more pronounced 
with prolonged and severe hyperoxia.
P249
Perioperative assessment of regional ventilation during changing 
body positions and ventilation conditions by electrical impedance 
tomography with increased spatial resolution and signal quality
A März1, A Ukere1, K Wodack1, C Trepte1, A Waldmann2, S Böhm2, D Reuter1
1University Medical Center Hamburg-Eppendor, University Hamburg, 
Germany; 2Swisstom AG, Landquart, Switzerland
Critical Care 2015, 19(Suppl 1):P249 (doi: 10.1186/cc14329)
Introduction Electrical impedance tomography (EIT) is a functional 
imaging technology allowing one to regionally monitor aeration of the 
lungs. We used EIT with increased signal quality and spatial resolution 
to describe and quantify the regional changes in aeration caused by 
body position, both during spontaneous breathing and mechanical 
ventilation in pulmonary healthy patients undergoing laparoscopic 
prostatectomy.
Methods In 40 patients we performed EIT measurements at fi ve 
points of time (Table 1) with the Swisstom BB2 prototype. Thirty-two 
electrodes were used to apply weak alternating currents to the thorax 
and to measure the resulting voltages, from which tomographic 
images of the changes in regional impedance caused by ventilation 
were created. We describe the ventilation distribution using a novel EIT 
lung function parameter called Silent Spaces that provides information 
about areas that do not receive much or any air during tidal breathing 
and are divided into nondependent (NSS) and dependent Silent Spaces 
(DSS) using a reference line that runs perpendicular to the gravity vector 
right through the centre of ventilation. NSS and DSS are expressed as a 
percentage of the total lung area.
Results Perioperative changes of NSS and DSS are shown in Table  1 
as mean  ± SD. Statistically signifi cant diff erences marked by § when 
compared with 1 or by * when compared with 3 (P <0.05).
Conclusion We describe for the fi rst time the mapping of Silent 
Spaces during spontaneous breathing and changing ventilation 
conditions and body positions in patients with healthy lungs using 
EIT. This mapping of Silent Spaces might prove useful for developing 
perioperative protective ventilation strategies.
P250
Structural and functional eff ects of mechanical ventilation and 
aging on single rat diaphragm muscle fi bers
N Cacciani, H Ogilvie, L Larsson
Karolinska Institutet, Solna – Stockholm, Sweden
Critical Care 2015, 19(Suppl 1):P250 (doi: 10.1186/cc14330)
Introduction The still unclear mechanisms causing ventilator-
induced diaphragm dysfunction (VIDD) are considered intrinsic to the 
diaphragm muscle fi bers. VIDD delays and complicates weaning from 
mechanical ventilation (MV) and accordingly contributes to prolonged 
ICU stay by 50%, with older patients being more aff ected than the 
young. The main aim of this study was to measure the eff ects of aging 
and 5 days of MV on rat diaphragm muscle fi ber structure and function. 
We also aimed to investigate the biological age of the old rats to obtain 
data useful to design future experimental studies focusing on the 
eff ects of age in an ICU setting.
Methods We used a unique ICU rat model, which allows us to maintain 
the vital parameters stable under deep sedation and MV for long 
durations (several weeks). Diaphragm fi ber cross-sectional area (CSA) 
and force-generating capacity (specifi c force  = absolute force / CSA) 
were measured in young (6 months) and old (28 to 32 months) F344/
BN hybrid rats in response to 5  days of deep sedation and volume-
controlled MV. To investigate the biological age of the old rats, we 
performed a second set of experiments, comparing muscle fi ber CSA 
and specifi c force in fast and slow-twitch distal hind limb muscles in 
three diff erent age groups: young adults (6  months), middle aged 
(18 months) and old rats (28 months).
Results This study demonstrated an unexpected increase in CSA 
(P  <0.001) of the diaphragm fi bers in response to 5  days of MV in 
both young and old animals. Maximum force decreased 39.8 to 45.2% 
(P  <0.001) in both young and old animals compared with controls, 
resulting in a dramatic loss of specifi c force. This increase in CSA and 
the concomitant decrease in specifi c force observed in both young and 
old diaphragm fi bers are compatible with an ineff ective compensatory 
hypertrophy in response to the MV. The comparison of the limb muscles 
Figure 1 (abstract P248). Infl ammatory mediators independent of tidal 
volumes after 12 hours of MV.
Table 1 (abstract P249)
 1 2 3 4 5
 (sitting, (supine, (ventilated, (ventilated, (ventilated,
 spontaneous breathing) spontaneous breathing) supine position) 30° head down position) supine position)
NSS (%) 5.25 ± 2.9 4.12 ± 1.89§ 3.05 ± 1.9§ 2.8 ± 2.7§ 2.67 ± 1.9§
DSS (%) 0.07 ± 0.3 2.29 ± 2.3§ 9.23 ± 6.3§ 11.5 ± 8.9§* 8.5 ± 5.8§
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fi bers from young, middle aged and old animals confi rmed the 28 to 
32 month rats to be senescent from a skeletal muscle point of view.
Conclusion These results demonstrate intrinsic changes in diaphragm 
muscle fi bers of signifi cant importance for the prolonged and complicated 
weaning from MV. Moreover, the increased number of frail diaphragm 
muscle fi bers observed after MV in old age, both controls and mechanically 
ventilated, off ers a further age-related possible mechanism which may 
be of signifi cant clinical importance. These results also provided useful 
information to design future experimental studies focused on the eff ect 
of age in an ICU setting, pharmacological intervention strategies as well as 
mechanisms underlying rat strain diff erences.
P251
Does it make a diff erence to add automatic EPAP titration to the 
volume-targeted pressure support mode in noninvasive ventilation 
of hypercapnic ICU patients?
G Gursel, A Zerman, B Basarik, K Gonderen, M Aydogdu, S Memmedova
Gazi University Medical Faculty, Ankara, Turkey
Critical Care 2015, 19(Suppl 1):P251 (doi: 10.1186/cc14331)
Introduction Obese patients are increasing in number in ICUs and more 
than 90% of them also have sleep apnea syndrome. Variability in upper 
airway resistance during sleep and awakening periods makes it diffi  cult 
to set EPAP in these patients. A new mode that automatically titrates 
EPAP according to upper airway resistance and IPAP according to target 
tidal volume may be more eff ective. The aim of this study is to evaluate 
whether adding automatic EPAP titration to the volume-targeted 
pressure support mode will provide any therapeutic advantages in 
hypercapnic ICU patients.
Methods The hypercapnic patients treated with average volume-
assured pressure support-automatic EPAP (AVAPS-AE) mode (Group1 
(G1)) were compared with those treated with AVAPS mode (Group 2 
(G2)). G2 was recruited retrospectively and matched with G1 according 
to diagnoses, demographic characteristics, arterial blood gas values 
and daily noninvasive ventilation (NIV) usage times. Trilogy 100® 
devices and their software Directview® (Philips Respironics) were used 
to reveal the respiratory data such as pressures, volumes, and daily 
usage times. For statistical analyses, t test, chi-square test and repeated 
measures of ANOVA were used.
Results Twenty-eight patients were included in G1 and 22 patients in 
G2. There was no signifi cant diff erence between the patients’ admission 
parameters and daily NIV usage times. PaCO2 decreased >5 mmHg in 
93% of G1 patients and in 60% of G2 patients in the fi rst 6 hours (P = 
0.044). A 10 mmHg reduction in PaCO2 occurred in more patients (93% 
vs. 60%, P = 0.004) and in a shorter time (1.8 ± 1.2 vs. 3 ± 3 days, P = 0.044) 
in G1. At the time of discharge, PaCO2 levels were <50 mmHg in 79% of 
G1 and 41% of G2 patients (P = 0.006). Both groups showed similar and 
signifi cant improvements in PaO2, PaCO2 and HCO3
– levels within the 
fi rst 4 days but only in G1 patients were HCO3
– levels decreased more 
rapidly than G2 patients (P = 0.007). Duration of NIV (6 ± 2 vs. 8 ± 3 days, 
P = 0.002) and the number of mode and pressures changes (0.3 ± 1.8 
vs. 2  ± 2 times, P  >0.0001) were signifi cantly less in G1. While mean 
IPAP was similar in both groups, maximum and minimum EPAP titrated 
automatically in G1 were signifi cantly diff erent from G2. Mean tidal 
volume and amount of leakage were also signifi cantly higher in G1.
Conclusion These results suggest that the AVAPS-AE mode may 
provide some advantages in hypercapnic ICU patients such as rapid 
PaCO2 reduction, less NIV duration and workload.
P252
Retrospective study of patients receiving long-term mechanical 
ventilation
I Dunwoody, B Hopwood, R Sinclair
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Critical Care 2015, 19(Suppl 1):P252 (doi: 10.1186/cc14332)
Introduction This study analysed the practice of clinicians managing 
patients requiring long-term mechanical ventilation in the critical care 
unit (CCU) of the Royal Cornwall Hospital, Truro (RCHT), comparing 
outcomes of primary tracheostomy (TR) with trial of extubation (TOE).
Methods All 89 inpatients on the CCU who received mechanical 
ventilation continuously for 7  days or more between October 2012 
and December 2013 were initially included. Forty patients who were 
intubated prior to arrival at RCHT, had incomplete notes, or were 
extubated during end-of-life care were excluded. Patients were divided 
into groups by fi rst airway intervention; 31 TOE, 18 TR.
Results A total 52% (16/31) of patients had TOE, required no other 
airway intervention and survived to discharge from hospital, compared 
with 72% (13/18) of TR patients. Four patients from each group failed 
the fi rst intervention and died prior to a second intervention. In total, 
8/11 patients who had a second intervention after failed TOE survived 
to discharge from hospital. One patient had a second TR but died before 
discharge. This gave an in-hospital mortality rate of 19% for the TOE 
group and 28% for the TR group. TOE was performed earlier, all 31 on 
days 7 to 15. TR was performed later; 14/18 on days 7 to 15, and 4/18 on 
days 17 to 23. Early TR was more successful; 11/11 survived to discharge 
without a second intervention who had TR on days 7 to 12, compared 
with 29% (2/7) after day 12. TOE was more successful when performed 
later; 64% (7/11) survived to discharge without a second airway 
intervention when TOE was after day 10, 45% (9/20) between days 
7 and 10. After fi rst failed TOE, four patients had a successful second 
TOE; all four survived to discharge resulting in a median CCU stay of 
29 days and median hospital stay of 39 days (excluding prior to CCU 
admission). Seven patients had TR after the fi rst failed TOE, fi ve survived 
to discharge from the CCU and four to discharge from the hospital. This 
group had shorter median stays in both the CCU (27 days) and hospital 
(32 days). Overall, the median duration of time ventilated, in the CCU, and 
in hospital was shorter for the TOE group; 13, 17 and 24 days respectively, 
compared with 22, 27.5 and 34 days for the TR group.
Conclusion TOE is more common and is associated with shorter time 
spent ventilated, in the CCU and in hospital than TR. It is also associated 
with a lower in-hospital mortality rate. TOE is more successful when 
performed after day 10; TR is more successful when performed before 
day 13. After failed TOE, a second TOE is associated with longer time in 
hospital but a better mortality rate than secondary tracheostomy.
P253
Initial pH and mortality in patients with exacerbations of COPD and 
pneumonia treated with NIV in a teaching hospital critical care unit
IM Goodhart, MC Faulds, S Lobaz, AJ Glossop
Sheffi  eld Teaching Hospitals NHS FT, Sheffi  eld, UK
Critical Care 2015, 19(Suppl 1):P253 (doi: 10.1186/cc14333)
Introduction Bilevel non-invasive ventilation (NIV) is an established 
therapy in chronic obstructive pulmonary disease (COPD) but 
confl icting evidence exists for its use in patients with pneumonia. Initial 
arterial pH <7.25 is used as a marker of severity and need for admission 
to critical care (CC) [1]. We examined the impact of pH and condition 
on outcome in patients with acute respiratory failure (ARF) of mixed 
aetiology treated with NIV.
Methods Data were collected retrospectively for a 5-year period 
from 2008 to 2013 using the Metavision electronic patient record. 
We identifi ed all patients admitted with ARF treated with bilevel NIV. 
Patients who received continuous positive airway pressure or had a 
primary surgical problem were excluded. We recorded primary cause 
of respiratory failure, arterial blood gas values and mortality.
Results A total of 145 patients were identifi ed. Mean age was 64 and 
51% were male. The primary diagnosis was pneumonia in 69 patients 
and exacerbation of COPD in 57. The overall mortality was 19% on CC 
and 39% at 1 year. In patients with COPD, infective exacerbations had a 
higher CC mortality (17%) compared with non-infective (0%). However, 
by 1 year the mortality was 28% in infective and 29% in non-infective. 
Patients with pneumonia had a higher mortality on CC (25%) and at 
1 year (48%). Patients with an initial pH <7.25 were less likely to survive. 
The mortality at discharge from CC was 16% (pH ≥7.25) and 26% (pH 
<7.25) but narrowed to 38% and 39% by 1 year. When subdivided, it 
was found that patients with infective COPD and pH <7.25 had the 
lowest 1-year mortality (17%) while those with pneumonia and pH 
<7.25 had the highest mortality (67%).
Conclusion NIV is used in our unit with comparable success rates to 
published series [2,3]. COPD patients responded well to NIV, while 
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patients with pneumonia treated with NIV have the highest mortality. 
A low presenting pH is associated with a higher mortality in patients 
with pneumonia treated with NIV. However, in COPD patients, pH <7.25 
is not associated with higher mortality in CC or at 1 year. Further work 
defi ning the precise role of pH as a prognostic indicator is warranted.
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Introduction A large meta-analysis suggests that use of low tidal 
volumes benefi ts patients without ARDS [1] but most studies in this 
meta-analysis included patients receiving ventilation during general 
anesthesia for surgery. The aim of the present meta-analysis is to 
determine the association between tidal volume size and development 
of pulmonary complications in ICU patients.
Methods An individual patient data meta-analysis of studies of 
ventilation in ICU patients without ARDS. Corresponding authors 
of retrieved studies provided individual patient data. The primary 
outcome, pulmonary complications, was a composite of development 
of ARDS or pneumonia during hospital stay. Secondary outcomes 
included ICU and hospital length of stay, and in-hospital mortality. 
Patients were assigned to three groups based on tidal volume size 
(≤7 ml/kg predicted body weight (PBW), 7 to 10 ml/kg PBW, or ≥10 ml/
kg PBW).
Results Seven investigations (2,184 patients) were meta-analyzed. 
Pulmonary complications occurred in 23%, 28% and 31% respectively 
in the ≤7  ml/kg PBW, 7 to 10  ml/kg PBW and ≥10  ml/kg PBW group 
(adjusted RR, 0.72; 95% CI, 0.52 to 0.98; P  = 0.042). Occurrence of 
pulmonary complications was associated with a lower number of ICU-
free days and alive at day 28, a lower number of hospital-free days and 
alive at day 28 and increased in-hospital mortality.
Conclusion Ventilation with low tidal volumes is associated with a 
lower risk of development of pulmonary complications. Occurrence 
of pulmonary complications is associated with an increased ICU and 
hospital length of stay and in-hospital mortality in ICU patients without 
ARDS.
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Introduction The combination of a global demographic shift and 
increased survival following critical illness has led to an increasing 
number of patients requiring prolonged mechanical ventilation 
(PMV) and longer critical care stay. This is a prospective observational 
study evaluating the characteristics and speciality-based outcome of 
critically ill patients undergoing prolonged mechanical ventilation in 
the North of England Critical Care Network (NoECCN).
Methods A weekly survey was conducted over a 1-year period screening 
patients older than 16 years of age requiring PMV in all 18 adult critical 
care units within the NoECCN. Patient data collected included patient 
demographics, admission diagnosis and speciality, hospital length of 
stay (LOS) pre and post critical care admission, severity of illness scores, 
critical care LOS and status at hospital discharge.
Results During the study period 134 patients met the criteria for 
PMV representing 1% of annual admissions and 6.9% NoECCN bed-
days. The majority of patients receiving PMV were medical (50.7%), 
followed by emergency surgery (20.1%), elective surgery (16.4%) and 
specialist services such as spinal cord injury (8.2%) and cardiothoracic 
transplant (4.5%). The commonest admission diagnosis in the medical 
population was pulmonary infection followed by acute neurological 
disorders, while 89.4% of surgical patients were admitted to critical 
care during the perioperative period. At the end of the study period the 
highest hospital mortality was observed in the nonspecialist surgical 
population (26.5%). In contrast, the medical population had one of the 
lowest hospital mortality rates (11.8%), lower than predicted using the 
intensive care national audit research network illness severity score. 
Comparable rates of hospital discharge were found in both medical 
(85%) and nonspecialist surgical patients (88.9%).
Conclusion The results of this study highlight an expanding proportion 
of NoECCN critical care bed-days occupied by stable patients 
undergoing PMV. In keeping with published UK data, elevated hospital 
mortality was observed in the nonspecialist surgical subpopulation. 
Although the literature suggests the medical cohort of patients has 
poorer prognosis, within our region all were liberated from mechanical 
ventilation and over 80% were discharged from hospital.
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Introduction Positive end-expiratory pressure (PEEP) exerts multiple 
protective eff ects in hypoxemic critically ill patients: PEEP can increase 
end-expiratory lung volume (EELV) and induce recruitment, thus 
reducing lung strain and opening and closing of alveoli and potentially 
improving the ventilation/perfusion matching. In particular, estimation 
of PEEP-induced ventilation/perfusion matching might help identify 
the optimal PEEP setting, but bedside non-invasive methods are 
few and complex to be applied in daily clinical practice. Electrical 
impedance tomography (EIT) is a non-invasive bedside technique 
that claims to track global and regional changes in perfusion and 
ventilation over time. In the present study we aimed at verifying the 
eff ects of PEEP on ventilation/perfusion matching, as assessed by EIT, 
in acute respiratory failure patients.
Methods We enrolled 20 intubated critically ill patients undergoing 
controlled mechanical ventilation, sedated, paralyzed and with 
PaO2/FiO2 ≤300 at PEEP ≥5  cmH2O. We started EIT monitoring 
(Pulmovista500®; Dräger Medical GmbH, Lübeck, Germany) and 
applied two PEEP levels (clinical and clinical + 5 cmH2O) for 20 minutes 
each. We collected ventilatory and EIT parameters and, by offl  ine 
analysis, we calculated the increase of EELV at higher PEEP and the EIT-
based indexes of ventilation heterogeneity (VtHetend-insp) and of the 
regional homogeneity of ventilation/perfusion matching (HA/P).
Results Patients were 62  ± 12  years old, mean PaO2/FiO2 was 197  ± 
52, lower PEEP level was 7 (7 to 9) cmH2O, while higher PEEP was 12 
(12 to 14) cmH2O (P <0.001). At higher PEEP, EELV increased (391 (334 
to 555) ml vs. PEEP low, considered as baseline, P <0.001); VtHetend-
insp was reduced (1.8 (1.5 to 2.4) vs. 2.2 (1.8 to 2.6), P <0.001) and HA/P 
increased (0.29 ± 0.19 vs. 0.2 ± 0.15, P <0.05). Interestingly, the increase 
of HA/P was signifi cantly correlated with the decrease of VtHetend-
insp (r = –0.48, P <0.05). Moreover, patients with higher potential for 
improvement of ventilation/perfusion matching (that is, patients with 
increase of HA/P >16%) had higher baseline VtHetend-insp (2.6 (2.3 to 
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4.8) vs. 1.9 (1.5 to 2.1), P  <0.01) and lower compliance of dependent 
lung regions (Crsdep, 13 ± 3 ml/cmH2O vs. 18 ± 6 ml/cmH2O, P <0.05), 
as compared with patients with smaller improvement.
Conclusion EIT might represent a feasible, bedside method to estimate 
PEEP-induced improvement in ventilation/perfusion matching. 
Assessing regional ventilation and mechanical lung properties might 
help identify patients who would benefi t more from higher PEEP.
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Introduction Lung transplantation is associated with an infl ammatory 
reaction known as primary graft dysfunction. This clinical syndrome 
occurs within the fi rst 72  hours after transplantation and is 
characterized by hypoxemia (PaO2/FiO2 <300) and bilateral infi ltrates 
not secondary to cardiac dysfunction, viral or bacterial pneumonia and 
venous anastomotic obstruction.
Methods 18-FDG PET scan was used to study 15 lung transplantation 
patients. The rate of 18-FDG uptake (Ki) was computed voxel by voxel 
with the Patlak method. Patients were divided according to the median 
Ki (27.8 (20.3 to 34.6) ml/minute/ml × 104). Data are reported as median 
and interquartile range.
Results Five patients developed primary graft dysfunction; median 
Ki in these patients was not diff erent from patients who did not (24.5 
(18.2 to 33.6)  ml/minute/ml  × 104 vs. 29.1 (23 to 35.4)  ml/minute/
ml × 104 respectively, P = 0.64). Bilateral lung transplantation patients 
were characterized by a median Ki of 30.5 (22.9 to 34.5)  ml/minute/
ml  × 104, while patients undergoing single-lung transplantation 
presented a median Ki of 24.4 (21 to 34.1)  ml/minute/ml  × 104 (P  = 
0.61). Considering single-lung transplantation, graft and native lung 
had similar Ki: 24.4 (21 to 34.1) ml/minute/ml × 104 versus 24.2 (17.7 to 
30.1) ml/minute/ml × 104 respectively (P = 0.64). When patients were 
divided according to the median Ki value, higher Ki was associated with 
higher PaCO2 values (50 (46 to 53) mmHg vs. 37 (34 to 44) mmHg, P = 
0.01). See Table 1.
Table 1 (abstract P257)
 Ki <27.8 ml/ Ki ≥27.8 ml/
 minute/ml minute/ml 
 × 104 (n = 7) × 104 (n = 8) P value
PaO2/FiO2 280 (261 to 346) 239 (212 to 271) 0.31
pH 7.46 (7.43 to 7.48) 7.41 (7.39 to 7.44) 0.15
PaCO2 (mmHg) 37 (34 to 44) 50 (46 to 53) 0.01
WBCs (103 cell/mm3) 8 (8 to 9) 9 (9 to 16) 0.34
Total lung volume (ml) 1,298 (1,092 to 1,494) 1,516 (1,408 to 1,665) 0.18
Total lung weight (g) 592 (488 to 741) 732 (597 to 774) 0.39
Total lung gas (ml) 706 (551 to 843) 804 (755 to 1,080) 0.15
Not-infl ated lung tissue (%) 25 (12 to 30) 23 (17 to 30) 0.95
Poorly infl ated lung tissue (%) 34 (42 to 42) 31 (29 to 34) 0.39
Well-infl ated lung tissue (%) 36 (27 to 47) 47 (35 to 52) 0.53
Conclusion Patients clinically defi ned as having primary graft 
dysfunction did not have an increased rate of 18-FDG uptake. 18-FDG 
uptake was not diff erent in single-lung versus bilateral transplantation 
and, in single-lung procedures, the native lung showed elevated 
infl ammatory activity.
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Introduction Quantitative measurement of extravascular lung water 
(EVLW) would be extremely useful for clinical management, both as an 
index of severity and to guide treatment lung ultrasonography (LU) as 
a tool to quantify EVLW.
Methods Forty mechanically ventilated patients were examined for 
5  successive days after being eligible for weaning; counting B-lines 
(comets) in both lung fi elds by LU, peak airway pressure, plateau airway 
pressure, static compliance and ABG analysis every 6  hours. Patients 
were divided into two groups according to success of the weaning 
process: group A (weaned group), and group B (nonweaned group).
Results The median value of LU comets was signifi cantly lower in Group 
A compared with Group B. There was a signifi cant increase in hypoxic 
index in Group A compared with Group B. There was no signifi cant 
diff erence between both groups as regards PIP, while Pplat showed a 
signifi cant increase in Group B compared with Group A and Cs showed 
a signifi cant decrease in Group B.
Conclusion LU is a useful to quantify EVLW; it is a good predictor of 
weaning.
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Introduction Estimating respiratory mechanics of mechanically 
venti lated patients is unreliable when patients exhibit spontaneous 
breathing (SB) eff orts on top of ventilator support. This reverse 
triggering eff ect [1] results in an M-wave shaped pressure wave. A 
model-based method to reconstruct the aff ected airway pressure curve 
is presented to enable estimation of the true underlying respiratory 
mechanics of these patients.
Methods Airway pressure and fl ow data from 72  breaths of a pneu-
monia patient were used for proof of concept. A pressure wave 
reconstruction method fi lls parts of the missing area caused by SB 
eff orts and reverse triggering by connecting the peak pressure and 
end-inspiration slope (Figure  1). A time-varying elastance model [2] 
was then used to identify underlying respiratory elastance (AUCEdrs). 
The area of the unreconstructed M-wave has less pressure, resulting in 
a lower overall AUCEdrs without reconstruction. The missing area of the 
airway pressure or AUCEdrs is hypothesized to be a surrogate of patient-
specifi c inspiratory to assess the strength of SB eff orts. AUCEdrs and 
missing area A2 are compared with/without reconstruction.
Results Median AUCEdrs and breath-specifi c eff ort using reconstruction 
were 24.99 (IQR: 22.90 to 25.98) cmH2O/l and 3.64 (IQR: 0.00 to 3.87)% 
versus AUCEdrs of 20.87 (IQR: 15.24 to 27.48) cmH2O/l for unreconstructed 
M-wave data, indicating signifi cant patient and breath-specifi c SB 
eff ort, and the expected higher elastance (P <0.05).
Conclusion A simple reconstruction method enables the real-time 
measurement of respiratory system properties of a SB patient and 
measures the surrogate of the SB eff ort, that latter of which has clinical 
use in deciding whether to extubate or re-sedate the patient.
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Introduction Model-based respiratory mechanics can be used to 
guide mechanical ventilation therapy. However, identifi ed mechanical 
properties vary breath to breath, leading to potential treatment errors 
when using model-based care that requires accuracy. This study 
investigates and quantifi es this variability to improve its application in 
guiding clinical interventions.
Methods Retrospective data from 12 acute respiratory distress 
syndrome (ARDS) patients were used [1]. Each patient was sedated 
to prevent spontaneous breathing eff ort, and ventilated using 
the volume control mode with a square fl ow profi le. Varied PEEP 
levels were maintained for 30  minutes before 1  minute of data were 
collected for analysis. This dataset provides a wide range of respiratory 
mechanics values, and the clinical protocol detail is in [1]. A clinically 
proven, single compartment model respiratory system elastance (Ers) is 
identifi ed from data for every breathing cycle at each PEEP level using 
a linear regression method. The dynamic elastance (Edynamic = (peak 
airway pressure – positive end-expiratory pressure) / tidal volume) of 
the corresponding breathing cycle is calculated for comparison.
Results The coeffi  cient of variation (CV) of identifi ed Ers across all 
patients was low (<0.005), as expected, as the 30-minute period allows 
time-dependent alveolar recruitment to fully occur and stabilise. 
However, even with substantial stabilisation periods, there remains a 
diff erence between the minimum and maximum estimated Ers within 
each 1-minute period of analysed data. The diff erences were median 
2.8% (interquartile range (IQR): 1.5 to 4.6%, 90% range (90R): 0.8 to 
13.4) for Ers and 3.6% (IQR: 2.3 to 5.2, 90R: 0.9 to 10.8) for Edynamic, and 
in extreme cases, can be up to 16%.
Conclusion This study quantifi ed the variability (over short periods) 
of identifi ed and estimated respiratory mechanics properties used 
to (potentially) guide ventilation care in sedated patients. It is also 
important to note that this minimum level of variability occurs even 
when stabilisation is achieved. Thus, clinically, if this information was 
to be used to guide ventilation in real time, such as titrating PEEP to 
minimal elastance, larger errors, at least up to 15% variation in Ers, 
could be expected, which could well aff ect care. Such levels thus also 
begin to defi ne the minimum levels of change necessary to be larger 
than natural variation.
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Introduction Patient-dedicated arterial blood analysers off er the 
potential to allow close monitoring of critically ill patients without 
leaving the patient’s bedside or net loss of blood for the patient. A 
new patient-attached blood gas analyser was evaluated in a clinical 
environment to compare the results against the reference bench-top 
analyser.
Methods Twenty ICU patients with a range of clinical conditions, 
including trauma, head injury, post-surgical recovery and sepsis, were 
included in the study. The new analyser was operated by clinical staff  
at the Queen Elizabeth Hospital, Birmingham, who each underwent 
a 90-minute training programme. Patients were monitored using the 
patient-dedicated analyser (Proxima; Sphere Medical) for up to 3 days. 
Each time a sample was tested on the patient-dedicated analyser, 
a concurrent sample was drawn and tested on the hospital’s bench-
top analyser (Cobas b221; Roche Diagnostics). Samples were assessed 
using methods described by Bland and Altman for repeated measures. 
Performance of the novel device was analysed by calculating bias as the 
mean diff erence between the new analyser and the comparator device, 
imprecision as ±1 standard deviation (SD) from the mean and limits of 
agreement as ±1.96 SD from the mean. Percentage values for bias and 
precision were calculated from analysis of the percentage diff erence 
between the two methods of analysis. Intra-device imprecision for 
the haematocrit (Hct) sensor was calculated using a pooled variance 
calculation.
Results Over 275 paired samples were analysed over the following 
concentration ranges: pH 7.249 to 7.545; pCO2 3.32 to 11.01 kPa; pO2 
5.59 to 21.80 kPa; Hct 23.6 to 41.4%; K+ 3.3 to 4.79 mM. The imprecision 
for each sensor was calculated to be: pH  –0.00  ± 0.03; pCO2  –0.48  ± 
0.34 kPa; pO2 –0.85 ± 0.96 kPa; Hct –4.49 ± 3.42%; K+ 0.08 ± 0.15 mM, 
respectively. The data collected on the new analyser for Hct showed 
relative imprecision of 3.42%. The pooled SD was calculated to be 
1.21% and the mean SD of each of the novel devices used was 1.14%. 
This indicates that scatter observed on the Hct sensor was largely due 
to inter-device rather than intra-device factors.
Conclusion The patient-dedicated blood gas analysers demonstrated 
excellent agreement with the bench-top analyser for pH, pCO2, pO2 and 
K+, while Hct provides a reasonable trend monitor with variable bias. 
Proxima is well suited to enable staff  to more closely manage unstable 
and critically ill patients. This device may be of signifi cant benefi t to 
patients at risk of iatrogenic anaemia or those being treated in side 
rooms/isolation rooms.
Figure 1 (abstract P259). Edrs for M-wave and reconstructed airway pressure at PEEP = 15 cmH2O.
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Introduction Maintaining the appropriate tidal volume (VT) is 
important for success of lung protective ventilation. However, in 
neonates, the presence of airway leaks may increase the errors in the 
delivery of tiny VT, which raises a concern of ventilator-induced lung 
injury. This study is to investigate the accuracy of VT delivery during 
non-invasive ventilation (NIV) with modern neonatal ventilators.
Methods Using a lung simulator for a patient body weight of 3  kg, 
we measured the actual delivered VT in the lung and compared it 
with the value displayed on the ventilator in six ventilators. We tested 
18 conditions with various combinations of respiratory mechanics 
(normal, restrictive, obstructive), leak levels (0, 1.0, 1.5 l/minute), and 
PEEP settings (5, 10 cmH2O). All conditions were tested in NIV mode. 
The pressure level was set to achieve VT to the lung at 6 to 7 ml/kg. All 
other settings were: FIO2 0.21, Itime 0.6 seconds, f 25/minute, and default 
rise time. We calculated the mean errors of the ventilator-displayed VT 
at various levels of airway leak.
Results The VT mean error values are presented in Table 1. When no 
leak existed, the mean error was less than 5% in all ventilators except 
one (C3) which showed a mean error of 26%. As the leak level increased, 
three ventilators (C3, G5, and VN500) showed marked diff erences 
between the delivered and displayed VT. In particular, the VN500 could 
not operate in the large leak condition. The other three ventilators 
(PB840, PB980, Servo i) showed acceptable VT accuracy across all 
conditions tested.
Table 1 (abstract P262)
Leak      
amount Hamilton Hamilton    
(l/minute)  C3  G5  Servo i  PB840  PB980 VN500
0 26 (15) 4 (6) 3 (2) 2 (7) –4 (2) 2 (2)
1.0 –9 (5) 9 (5)  –2 (2) –5 (4) –2 (4) 20 (5)
1.5 16 (8) –14 (8) –2 (2) –6 (4) –2 (3) 33 (6)a
Data presented as mean (SD), %. aUnable to measure in one case.
Conclusion Tidal volume accuracy during neonatal NIV varies 
greatly among diff erent ventilators and leak conditions. This must 
be considered in neonatal ventilation management to avoid over-
ventilation or underventilation.
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Introduction Intentional early rehabilitation with mechanical 
ventilation in ICUs is performed in clinical settings. However, strict 
indexes for safe rehabilitation have not been fully elucidated. The 
purpose of this study is to analyze ventilator response (VR) between 
healthy volunteers and patients with mechanical ventilation.
Methods Sixteen healthy volunteers (Control group) and 13 patients 
on mechanical ventilation (MV group) were enrolled in this study. Both 
groups were positioned in a variety of postures (baseline in a supine 
position, settled back 30°, settled back 60°, and sitting position) and 
measured with an indirect calorimeter. The instantaneous energy 
expenditure (EE), tidal volume (TV), respiratory rate (RR) and minute 
expiratory volume (VE) were non-invasively measured in each posture. 
The VE was indexed by body weight and the EE was also indexed by 
the basal energy expenditure (BEE) estimated by the Harris–Benedict 
formula. VR was defi ned as the slope in the indexed VE–indexed EE 
plot with an assumption of those relationship in the linear manner. We 
examined the correlation between indexed EE and indexed VE in both 
groups, and the diff erences of the maximal indexed EE, the maximal 
indexed MV, and the others between both groups were investigated 
using the unpaired t test. For all the data, signifi cance was accepted at 
values of P <0.05.
Results There was a signifi cant correlation between the indexed EE and 
indexed VE in both groups (R = 0.51, P <0.0001 in the control group; R = 
0.63, P <0.0001 in the MV group). The VR was signifi cantly suppressed in 
the MV group compared with the control group (0.041 ± 0.003/minute/
BEE vs. 0.069 ± 0.003/minute/BEE, P = 0.012; respectively). Although the 
indexed VE was comparable in the MV and control groups (0.19 ± 0.07 l/
kg vs. 0.17 ± 0.04 l/kg, P = 0.23; respectively), the indexed EE was shifted 
to a higher range in the MV group than in the control group (maximal 
indexed EE; 2.26 ± 0.68 vs. 1.74 ± 0.20, P = 0.008; respectively). The TV 
was smaller (maximal TV; 985 ± 592 ml vs. 1,410 ± 299 ml, P = 0.018; 
respectively) and the RR was more frequent (maximal RR; 30 ± 8/minute 
vs. 16 ± 4/minute, P <0.0001; respectively) in the MV group than in the 
control group.
Conclusion The VR to external stress with mechanical ventilation is 
more suppressed than in healthy volunteers. The VE in the mechanical 
ventilation was earned by a higher RR rather than by increased TV. 
Careful monitoring of VE or RR would be benefi cial in early rehabilitation 
with mechanical ventilation.
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Introduction Failure to use or correctly interpret capnography in 
patients dependent on an artifi cial airway in ICUs was thought to 
have contributed to 74% of ICU airway-related deaths in the NAP4 
study [1]. However, capnography is only of value if those using it can 
interpret it correctly, with recommendations for training all ICU staff  in 
capnography [1,2]. A recent UK survey identifi ed that only 48% of ICUs 
have trained all staff  in capnography interpretation (TM Cook, personal 
communication). In this study, we used a capnography teaching aid 
(‘hats and caps’) to educate all ICU staff  during a 1-month period, and 
evaluated its eff ectiveness.
Figure 1 (abstract P264). ‘Hats and caps’ capnography training guide.
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Methods ‘Hats and caps’ was devised on our ICU [3] and used for the 
training: this teaches that capnography traces on the left signify the 
airway is functional, in contrast to the traces on the right which indicate 
immediate attention is required (Figure 1). This was presented to staff  
working on the ICU in individual bedside teaching sessions with 
feedback obtained and evaluated.
Results We delivered teaching sessions to 100% (9/9) of junior doctors, 
100% (71/71) of nursing staff  and other health professionals. We 
obtained feedback from 90% (76/84), showing an improvement in 
understanding of capnography from 73% of respondents to 100%, with 
87% reporting that the teaching aid made capnography interpretation 
much easier. All felt the training would improve patient safety, and 97% 
felt it would be worthwhile training in other ICUs.
Conclusion Use of ‘hats and caps’ enabled delivery of short bedside 
teaching sessions to clinical staff  in ICU during everyday work. 
Feedback shows a marked improvement in confi dence around 
capnography interpretation. It may have value in other ICUs to improve 
staff  understanding of capnography and improve patient safety.
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Introduction High fl ow nasal (HNF) requires precise control of the 
fraction of inspired oxygen (FiO2) and fl ow contributed as well as an 
adequate adjustment of temperature and humidity of the gas provided. 
There are several equipments for HNF. We evaluated the FiO2 and fl ow 
supplied with three diff erent systems
Methods There have been analyzed: (1)  ‘Oxygen Therapy’ from 
Dräger Evita-XL®; (2)  Fisher & Paykel Airvo® option; and (3)  pack of 
fl owmeters Debson®. Measurements were made in the distal part 
of the circuit that is used in clinical practice. Variables: programmed 
and measured FiO2, programmed and measured fl ow. We used the 
Oxygen Monitor Ohmeda 5120® and Flow Meter® Fisher-Porter. Before 
each measurement we checked and/or calibrated each of them. All 
measurements were performed at room temperature in the ICU of 
our hospital (23 to 26º).The data were processed using SPSS v.15.0.1, 
accepting a signifi cance level of 95%.
Results (1) FiO2 variation –0.001 ± 0.09 (–0.01 to 0.002); FiO2 percentage 
variation –0.012  ± 1.88 (–0.27 to 0.25); r2  = 0.999 and r  = 0.998 
(P  <0.000). Flow variation (l/minute) 5.45  ± 3.23 (4.94 to 5.96); fl ow 
percentage variation 19.59 ± 11.63 (17.75 to 21.43); r = 0. 997 and r2 = 
0.994 (P <0.000). (2) FiO2 variation –0.007 ± 0.26 (–0.011/–0.003); FiO2 
percentage variation –1.4040 ± 4.73 (–2.15 to –0.67); r = 0.996 and r2 = 
0.992 (P  <0.000). Flow variation (l/minute) 3.82  ± 3.85 (3.04 to 4.69); 
fl ow percentage variation 9.76  ± 8.08 (8.11 to 11.41); r  = 0.969 and 
r2 = 0.939 (P <0.000). (3) FiO2 variation –0.005 ± 0.26 (–0001 to 0009); 
FiO2 percentage variation –0.72  ± 5.2 (–1.5 to 0.1); r  = 0.996 and r
2  = 
0.992 (P  <0.000). Flow variation (l/minute) 3.91  ± 1.26 (3.69 to 4.13); 
fl ow percentage variation 12.77 ± 5.33 (11.84 to 13.7); r = 0.996 and r2 = 
0.992 (P <0.000). See Figure 1.
Conclusion The FiO2 percentage variation in the Airvo® is higher than 
the other two devices, with no clinical relevance. The fl ow percentage 
variation of Evita XL® is superior to the other two devices; this may have 
some clinical relevance.
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Introduction Weaning from mechanical ventilation is an important 
concern in ICU clinical practice. Surface electromyography (sEMG) [1] is 
a non-invasive tool to assess activity of diff erent muscles. We describe 
sEMG patterns of respiratory muscles during a CPAP trial [2] in patients 
undergoing pressure support ventilation.
Methods Twenty-one adult and clinically stable patients undergoing 
assisted mechanical ventilation for more than 48  hours were 
investigated during pressure support (baseline) and during a 2-hour 
CPAP trial. sEMG of diaphragm (costmar), intercostal and sternocleidal 
(accessory muscles) was recorded with a dedicated device (Dipha16; 
Inbiolab, Groningen, the Netherlands) simultaneously with airway 
waveforms and expressed as the ratio of the signal during baseline. 
Diaphragmatic electrical activity from a nasogastric tube (EAdi) of 14 of 
those patients was also measured.
Results The rapid shallow breathing index was lower than 105 in all 
patients and only one patient failed the trial. We observed that the 
mean inspiratory value of costmar increased immediately after switch 
to CPAP but did not signifi cantly vary during the CPAP trial (ANOVA, P = 
0.7). On the other hand, the activation of accessory muscles increased 
signifi cantly during the same period (P  = 0.01) and was strongly 
correlated with respiratory rate (r = 0.41, P <0.001) and inversely with 
Figure 1 (abstract P265). Programmed and measured fl ow. Figure 1 (abstract P266).
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tidal volume (r = –0.16, P = 0.02). In patients with EAdi we confi rmed 
a tight correlation between costmar and EAdi (r = 0.62, P <0.001). See 
Figure 1.
Conclusion sEMG indicated that while diaphragm activation remains 
constant during the CPAP period, accessory muscles were progressively 
recruited and particularly in the conditions of increased respiratory rate 
and lower tidal volumes.
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Introduction Mechanical ventilation is associated with increased risk 
of pneumonia, barotrauma, VILI, VAP, ARDS and mortality. From 2009 to 
2014 in the MICU/SICU of our facility, eff orts to reduce ventilator-days 
included: noninvasive ventilation, sedation reduction, daily sedation 
vacations and weaning protocols. In 2013, an early mobilization of 
ventilated patients in the SICU was initiated. Aggressive ventilator-day 
reduction eff orts may be expected to lead to premature extubations 
and reintubations.
Methods Ventilator-day data were compiled from 2009 to 2014 for 
MICU and SICU in our facility. Reintubation rates were calculated when 
intubations were required >1 day after an extubation.
Results Ventilator volume ranged from 639 to 766 distinct patients/
year in the MICU and from 555 to 687 for the SICU. Ventilator-day 
reduction was signifi cant (P  <0.01) for the MICU* (7.7 to 5.5,  –29%) 
and the SICU* (5.91 to 5.20,  –12%). Reduction patterns diff ered 
between the units as the SICU had a distinct reduction (**P = 0.007) 
between 2012 and 2013 coinciding with implementation of an early 
mobilization program. Reintubation rates diff ered between the units 
and rates did not increase with decreasing mean patient ventilator-
days. See Table 1.
Table 1 (abstract P267). Mean ventilator-days/reintubation rates
 2009 2010 2011 2012 2013 2014
MICU mean ventilator-days 7.71 6.81 5.90 5.88 5.50 5.50*
MICU reintubation rates 14.5% 9.8% 9.7% 9.8% 13.9% 8.3%
SICU mean ventilator-days 5.91 5.93 5.68 5.93 4.93** 5.20*
SICU reintubation rates 5.2% 3.0% 4.1% 4.3% 4.7% 7.5%
*, **Signifi cance as described in Results.
Conclusion Initiatives to reduce ventilator-days per patient realized 
signifi cant reductions from 2009 to 2014 while reintubation rates 
were unaff ected. One component of the bundle, early mobilization, 
introduced in the SICU in 2013 was associated with an additional 
reduction in mean ventilator-days.
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Introduction In routine practice for most surgical patients in Thailand, 
all appropriated patients with planned discontinuation of mechanical 
ventilator (MV) are routinely changed to T-piece before extubation. 
However, this method needs to alter the instrument for testing 
tolerability of the patient. The objective of this study was to compare 
continuous low pressure support (PSV) and the T-piece method (T) 
before discontinue mechanical ventilation and extubation in the 
surgical intensive care unit (SICU).
Methods We performed a prospective open-label randomized control 
study (non-inferiority trial) in SICU patients who were intubated and 
used mechanical ventilation, and appropriated discontinuation of 
the ventilator between June 2011 and November 2013. All patients 
underwent the same weaning protocol. The appropriated patients for 
discontinuation of MV were randomized into low pressure support 
up to 7  cmH2O and T-piece method. Reintubation within 72  hours, 
pneumonia after extubation, and hospital mortality were recorded. The 
statistical signifi cant diff erence was considered when P <0.05.
Results A total of 520 patients were randomized into two groups: low 
pressure support group (260 patients) and T-piece group (260 patients). 
There was no diff erence in age, gender, body mass index, comorbidity, 
site of surgery, Charlson Comorbidity Index and Acute Physiologic 
and Chronic Health II score between groups (P >0.05). Regarding the 
intention to treat analysis, there were no diff erences between groups 
in reintubation rate (PSV 10% vs. T 14.6%; P = 0.109), pneumonia after 
extubation (PSV 14.2% vs. T 11.9%; P  = 0.435) and hospital mortality 
rate (PSV 3.1% vs. T 3.5%; P = 0.805).
Conclusion The outcomes after discontinuation of the mechanical 
ventilator between low pressure support and T-piece was not 
diff erence in term of reintubation, pneumonia after extubation and 
hospital mortality.
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Introduction Postoperative morbidity after sleeve gastrectomy is 
decreasing, but remains signifi cant. Bleeding and surgical fi stules 
remain the leading causes of morbidity and mortality. In several studies 
in postoperative care of obese patients, non-invasive positive pressure 
ventilation (NPPV) reduced the risk of lower respiratory tract infection 
and pneumonia [1], thereby reducing in-hospital morbidity. The aim 
of study was to describe whether systematic use of NPPV improves 
morbidity in the postoperative care of sleeve gastrectomy.
Methods A 4-year before–after study was conducted in a 19-bed 
intermediate care unit of a private hospital. Before period: standard 
treatment – all patients received oxygen supplementation to achieve 
SaO2 above 90%. After period: standard treatment plus NPPV  – all 
patients were submitted to a systematic postoperative protocol: NPPV 
was provided using an oxygen CIPAP system with 5 cmH2O. Statistical 
analysis: complication rates were compared using the chi-square test. 
P <0.05 was considered statistically signifi cant.
Results A total of 857 patients were included. Inclusion characteristics 
were similar in the two groups: Before group – noNPPV: 352 patients, 
2010 to 2011. Age: 40.58 ± 10.94, BMI: 42.79 ± 5.51, sex ratio F/M: 0.81. 
After group  – NPPV: 504 patients, 2012 to 2013. Age: 40.81  ± 11.24, 
BMI: 42.92  ± 5.09, sex ratio F/M: 0.77. There is a signifi cant between-
group diff erence in the complication rate: Before group – noNPPV: 10 
surgical fi stula (2.84%) and six postoperative bleeding (1.70%); After 
group – NPPV: seven surgical fi stula (1.39%) and three postoperative 
bleeding (0.6%). The overall complication rate fell from 4.54% to 1.98%. 
The chi-square statistic = 4.58. The number of degrees of freedom is 1. 
The value returned from the chi-square statistic is P <5%.
Conclusion Systematic use of NPPV signifi cantly improves morbidity in 
the postoperative care of sleeve gastrectomy.
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Introduction The aim of this study was to determine the types, 
incidence, and risk factors for early postoperative pulmonary 
complications in heart transplantation recipients.
Methods We retrospectively collected data from the records of 
consecutive heart transplantations from January 2003 to December 
2013. A total of 83 patients underwent heart transplantation. Those 
patients younger than 10  years (n  = 9) and the patients who died 
intraoperatively (n = 1) or during the fi rst postoperative day (n = 1) were 
not included in the analyses. The data collected for each case were 
demographic features, duration of mechanical ventilation, respiratory 
problems that developed during the ICU stay, and early postoperative 
mortality (<30  days). The respiratory complications that we sought 
were pleural eff usion, pneumonia, pulmonary atelectasis, pulmonary 
edema, pneumothorax, and acute respiratory failure.
Results Of the 72 patients considered, 52 (72.2%) were male. The 
mean age at the time of transplantation was 32.1  ± 16.6  years. The 
mean duration of postoperative mechanical ventilation was 71.8  ± 
126.6  hours. The mean length of ICU stay was 13.5  ± 18.0  days. Two 
patients (2.8%) and one patient (1.4%) required extracorporeal 
membrane oxygenation support and intra-aortic balloon pump 
support, respectively, due to low cardiac output or primary graft 
failure postoperatively. Twenty-fi ve patients (34.7%) developed early 
postoperative respiratory complications. The most frequent problem 
was pleural eff usion (n = 19, 26.4%) followed by atelectasis (n = 6, 8.3%), 
acute respiratory distress syndrome (n  = 5, 6.9%), pulmonary edema 
(n = 4, 5.6%), and pneumonia (n = 3, 4.2%). Postoperative duration of 
mechanical ventilation (44.2 ± 59.2 hours vs. 123.8 ± 190.8 hours, P = 
0.005) and the length of ICU stay postoperatively (10.1  ± 5.8  hours 
vs. 19.8 ± 28.9 hours, P = 0.03) were longer among patients who had 
respiratory problems. Postoperative length of stay in the hospital 
(22.3 ± 12.5 days vs. 30.3 ± 38.3 days, P = 0.75) was similar in the two 
groups. The overall mortality rate was 12.5% (n  = 9 patients). The 
patients who had respiratory problems did not show higher mortality 
than those who did not have respiratory problems (16.0% vs. 10.6%, 
P = 0.71).
Conclusion Respiratory complications were relatively common in our 
cohort of heart transplant recipients. However, these complications 
were mostly self-limiting and did not result in increased mortality.
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Introduction We designed a pilot study to evaluate the interest of an 
early systematic acute recruitment maneuver (ARM) in postcardiac 
surgery hypoxemic patients in order to properly design a larger trial.
Methods This randomized controlled trial included consecutive 
patients operated on in our institution. Three hours after surgery, 
hypoxemic patients (PaO2 <300  mmHg, FIO2  = 1) were randomly 
assigned to ARM or control (H0). ARM was performed by applying once 
a positive end-expiratory pressure of 35  cmH2O during 45  seconds. 
Blood gases and hemodynamic variables were collected at H1, H8, 
H24 and H48. The primary endpoint was the duration of mechanical 
ventilation (MV). Secondary endpoints were survival rate, ICU length of 
stay and the occurrence of pneumonia.
Results We included 124 patients, age 67.5 ± 10.6 years, M/F sex ratio 
95/29, left ventricle ejection fraction 58.8  ± 10.6%, forced expiratory 
volume 94 ± 23% of the predicted value, bypass/valve ratio 82/53. The 
preoperative and postoperative PaO2/FIO2 were 401  ± 66 and 204  ± 
66 mmHg, respectively (P <0.0001). The hemodynamic and ventilation 
status as well as the fl uid and inotrope supports were comparable in 
the two groups. At H1, PaO2/FIO2 was 367 ± 15 in the recruited group 
versus 299 ± 15 mmHg in the control group, P = 0.002. At H8 and 24 
the diff erence was not signifi cant. At H48, the PaO2/FIO2 was lower in 
the recruited group (296 ± 10 vs. 343 ± 11 mmHg, P = 0.003) (Figure 1). 
The duration of mechanical ventilation (invasive + non-invasive) was 
lower in the recruited group (total 6.4 ± 1.4 vs. 8.4 ± 1.4 hours, P = 0.02). 
The survival rate, the length of stay in the ICU and the occurrence of 
pneumonia were similar in the two groups (P >0.2).
Conclusion We can speculate that the inverse evolution of the blood 
oxygenation between the ARM group versus control may be due to: 
barotraumatism of normal alveoli during the ARM and/or a higher de-
recruitment rate after ARM due to the shorter mechanical ventilation 
support. This pilot study shows that a unique ARM decreased 
the duration of MV in cardiac surgery patients but this may have 
subsequent detrimental eff ects on blood oxygenation.
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Introduction The aim of our study was to investigate the value of 
C-reactive protein (CRP) and procalcitonin (PCT) in identifi cation 
of the systemic infl ammatory response syndrome (SIRS) and other 
complications in the early postoperative period after cardiac surgery 
with cardiopulmonary bypass (CPB) [1].
Methods In 93 patients undergoing coronary artery bypass graft 
surgery with CPB, after Ethical Committee approval in a prospective 
study, serum PCT and CRP values were collected before operation and 
daily until postoperative day 5. All patients were divided post hoc into 
patients with SIRS (n = 42) and patients without SIRS (n = 51). Student’s 
t test, the Mann–Whitney U test and receiver operating characteristic 
(ROC) curves were used.
Results The comparison of serum CRP values in patients with or without 
SIRS on postoperative day 1 until postoperative day 5 demonstrated 
an increase in both groups without signifi cant diff erences (P  >0.05). 
The PCT levels increased more signifi cantly in SIRS patients (5.78  ± 
3.21 ng/ml vs. 1.23 ± 0.31 ng/ml) compared with patients without SIRS 
(P  = 0.0001) on postoperative day 1. In patients with postoperative 
complications (21/93, 22%) (circulatory failure  = 10, pneumonia  = 
2, respiratory insuffi  ciency  = 9, sepsis  = 0), PCT levels remained 
elevated until postoperative day 5 (6.11 ± 2.87 ng/ml) but diminished 
in patients with SIRS (0.96 ± 0.23 ng/ml) (P <0.0001). A PCT threshold 
value of 2.79  ng/ml was able to discriminate between postoperative 
complications in patients with or without SIRS with a sensitivity of 
Figure 1 (abstract P271).
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82.5% and a specifi city of 70% (area under the curve: 0.76  ± 0.05; 
P <0.01) on postoperative day 1.
Conclusion After cardiac surgery with CPB, PCT values increased 
signifi cantly in the SIRS group of patients compared with patients 
without SIRS on postoperative day 1 and remained elevated until 
postoperative day 5. In the early postoperative period, early rise of PCT 
values may help to discriminate the development of postoperative 
complications in patients with or without SIRS.
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Introduction Our goal was to investigate the incidence of postoperative 
jaundice in open heart surgery patients and to determine the risk 
factors associated with hepatic dysfunction.
Methods A total of 292 patients were included in a prospective 
study design. Patients undergoing on-pump coronary artery bypass 
graft surgery (CABG) (n = 154) and valve repair surgery (mitral, mitral 
and aortic valve and/or tricuspid valve) (n  = 138) were included. 
Postoperative hyperbilirubinemia was defi ned as occurrence of a 
plasma total bilirubin concentration of more than 34  μmol/l (2  mg/
dl) in any measurement during the postoperative period. All patients 
were divided into groups with or without hyperbilirubinemia. Liver 
enzymes were collected on postoperative days 1, 7, 14 and 30. The risk 
factors including age, cardiopulmonary bypass time, number of blood 
transfusions, inotropic support, use of intra-aortic balloon pump and 
ICU stay were evaluated with logistic regression.
Results Postoperative hyperbilirubinemia was observed in 27 of 292 
patients (9.3%). The numbers of valves replaced, preoperative total 
bilirubin concentration, increased cardiopulmonary bypass time, 
higher number of inotropic support agents, and use of intra-aortic 
balloon pump correlate with hyperbilirubinemia on postoperative 
day  7 (P  <0.05). Independent risk factors of early postoperative 
jaundice are; multiple valve replacement surgery, ejection fraction and 
use of intraaortic balloon pump (R = 0.58, R2 = 0.33, F = 26.44, P <0.001). 
The ICU stay was signifi cantly longer in group 2 (11.52 ± 3.76 days) as 
compared with group 1 (2.79 ± 1.36 days) (P <0.001).
Conclusion Patients undergoing multiple valve replacement 
procedures are at greater risk for the development of postoperative 
hyperbilirubinemia and an association with prolonged ICU stay was 
observed. Other risk factors including ejection fraction, increased 
cardiopulmonary bypass time and use of intra-aortic balloon pump are 
also important as they have been reported to increase postoperative 
complications [1].
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Introduction Pump-driven venovenous extracorporeal CO2 removal 
(ECCO2-R) increasingly takes root in hypercapnic lung failure to 
minimize ventilation invasiveness or to avoid intubation. A recently 
developed miniaturized device consisting of a centrifugal pump and 
a membrane ventilator (iLA Activve®; Novalung, Germany) allows 
eff ective decarboxylation via a jugular double lumen cannula. So far no 
data on gas exchange in this setting exist to date.
Methods We included 10 patients receiving iLA Activve® due to 
hypercapnic respiratory failure as bridge-to-transplant or obstructive 
lung disease. Sweep gas fl ow was increased in steps from 1 to 14  l/
minute at constant blood fl ow (phase 1). Similarly, blood fl ow was 
gradually increased at constant sweep gas fl ow (phase 2). At each step, 
gas transfer via the membrane as well as arterial blood gas samples 
were obtained.
Results During phase 1, we observed a signifi cant increase in CO2 
transfer together with a decrease in PaCO2 levels from a median 
of 66 mmHg (range 46 to 85) to 49 (31 to 65) mmHg from 1 to 14  l/
minute sweep gas fl ow, while arterial oxygenation deteriorated with 
high sweep gas fl ow rates. During phase 2, oxygen transfer signifi cantly 
increased leading to an increase in PaO2 from 67 (49 to 87) at 0.5 l/
minute to 117 (66 to 305)  mmHg at 2.0  l/minute. Higher blood fl ow 
rates also signifi cantly enhanced decarboxylation. Increasing blood 
fl ow to 2.0  l/minute led to negative suction pressures of more than 
–100 mmHg and signs of hemolysis. See Figure 1.
Conclusion Increasing sweep gas fl ow results in eff ective CO2 removal 
which can be further reinforced by raising blood fl ow. The clinically 
relevant oxygenation eff ect even in this setting of low invasivity could 
broaden the range of indications towards hypercapnic lung failure with 
mild to moderate hypoxia.
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Introduction Pulmonary overdistension has been observed in 33% of 
patients with acute respiratory distress syndrome (ARDS) despite low 
tidal volume (6 ml/kg ideal body weight) ventilation [1]. Tidal volume 
Figure 1 (abstract P274). PaO2 with increasing blood fl ow (*P <0.0001).
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(VT) reduction from 6 to 4  ml/kg attenuates overdistension but is 
associated with hypercarbia [2]. We thought to combine extracorporeal 
CO2 removal (ECCO2R) with continuous renal replacement therapy 
(CRRT) through the insertion of an oxygenator membrane within the 
hemofi ltration circuit in patients presenting both ARDS and acute 
kidney injury (AKI).
Methods A fi rst set of measurement was performed at 6 ml/kg before 
and after ECCO2R. Twenty minutes later, VT was reduced to 4 ml/kg for 
the remainder of the study period (72 hours). Ventilator settings were 
those of the ARMA trial. The CRRT mode was hemofi ltration with 33% of 
predilution. Ultrafi ltration was adjusted to achieve a fi ltration fraction of 
15%. Sweep gas fl ow was constant at 8 l/minute. The primary endpoint 
was a 20% reduction of PaCO2 at 20 minutes after initiation of ECCO2R.
Results Eight patients were studied. Age was 69 ± 11 years, SAPS II was 
68 ± 9 and SOFA score was 13 ± 4 at inclusion. Blood fl ow, at the inlet 
of the oxygenator membrane, was 400 ± 4 ml/minute. CO2 removal rate 
was 84 ± 4 ml/minute. Initiating ECCO2R, at 6 ml/kg, induced a mean 
PaCO2 reduction of 17% (41 ± 5.5 to 33.9 ± 5.6 mmHg, P <0.001). Then, 
lowering the VT to 4  ml/kg induced a mean PaCO2 increase of 25% 
(33.9 ± 5.6 to 42.6 ± 8 mmHg) and a mean PaO2/FIO2 ratio increase of 
8% (176 ± 63 to 190 ± 61). Minute ventilation decrease from 7.4 ± 1.6 to 
5 ± 1.2 l/minute. Respiratory system compliance did not vary. No major 
complications were observed.
Conclusion Combining ECCO2R and CRRT in patients with ARDS and AKI 
is safe and feasible through the insertion of an oxygenator membrane 
within a RRT circuit.
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Introduction The transfer of patients in extracorporeal membrane 
oxygenation (ECMO) from a peripheral hospital to a tertiary center 
represents a high-risk situation of adverse events [1]. The aim of 
this retrospective study is to determine the feasibility and safety of 
interhospital transfer for critically ill patients with ECMO support.
Methods We collected data for the ECMO Regional Reference Centre 
Careggi Hospital activity from September 2009 to June 2014. In this 
study, 57 transfers were examined. The ECMO service is activated by 
a telephone call from a peripheral hospital. The team is represented 
by an intensivist, a heart surgeon, a cardiologist, a perfusionist and 
an intensive care nurse, all previously trained in the management of 
patients with ECMO. Medical personnel and the necessary equipment 
are transported by an ambulance and a van, specially designed and 
equipped for the transfer of patients with ECMO.
Results In this study, 57 patients transferred from the peripheral hospital 
to the ECMO center were examined; in all cases the ECMO system was 
implanted in the peripheral hospital (54 venovenous ECMO and three 
venoarterious ECMO). On average, trails were 271  km  ± 304 (round 
trip) (minimum 14 km to maximum 939 km). The activation time from 
the call to the ambulance departure from our hospital was an average 
of 2  hours 27  minutes 13  seconds  ± 1  hour 25  minutes 35  seconds. 
Transfer duration (from activation to return to the ECMO center) was 
an average of 8  hours 25  minutes 6  seconds  ± 3  hours 27  minutes 
58 seconds (minimum 3 hours to maximum 16 hours 55 minutes). The 
stop time (necessary for evaluation of the patient and for placement of 
the ECMO system) was an average of 3 hours 53 minutes 40 seconds ± 
1 hour 6 minutes 35 seconds (minimum 2 hours 5 minutes to maximum 
7  hours 30  minutes). Major complications related to malfunctions of 
the devices during transport were not recorded; in some cases it was 
necessary to manage minor complications (circuit cavitation, minor 
vascula accesses bleeding).
Conclusion Some studies have found several complications during 
transfer of patients in ECMO [2]. In our experience, there were no 
complications during the transfer of ECMO patients, even for longer 
trips. A wide and thorough clinical evaluation and multidisciplinary 
ECMO team allowed the optimization of clinical parameters before 
transport and a safely transfer. The start of ECMO treatment at peripheral 
hospitals and the transfer of patients in ECMO may be a viable option 
compared with conventional ventilation. Our data suggest that ECMO 
can be set up safely in peripheral hospitals by a multidisciplinary highly 
specialized ECMO team [3].
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Introduction Cerebral microhemorrhages (MH) are diminutive focal 
bleedings which can be detected best by MRI using susceptibility-
weighted imaging sequences (SWI). They can be found in a variety 
of neurologic diseases. The pattern of distribution can lead to the 
underlying pathomechanism [1]. Survivors of high-altitude cerebral 
edema (HACE) showed multiple MH, predominantly in the splenium 
of the corpus callosum. Mountaineers with a lack of acclimatization to 
high altitudes tend to suff er from HACE. Hypoxemia in great heights 
is discussed to be the main trigger of HACE [2]. Acute respiratory 
distress syndrome (ADRS) is characterized by oxygenation failure 
in mechanically ventilated patients. The severity is classifi ed by the 
ratio of arterial oxygen tension to fraction of inspired oxygen [3]. In 
some patients suff ering from severe ARDS, refractory to conventional 
therapy, venovenous extracorporeal membrane oxygenation therapy 
is the therapeutic option to ensure oxygenation.
Methods Retrospectively, we examined 20 patients with cerebral MRI 
(including SWI) who had suff ered from severe ARDS and received 
ECMO therapy. The MRI slides were anonymized and analyzed by two 
experienced neuroradiologists. Based on the distribution pattern and 
characteristic, a modifi ed HACE score (mHCS) was surveyed [2].
Results Six of 20 patients (30%) showed multiple MH with emphasis 
in the splenium of the corpus callosum. Eight patients had sporadic 
MH in the parenchyma of the brain but not in the corpus callosum. The 
remaining six patients had no intracerebral alterations. The distribution 
of MH with involvement of the splenium resembled that seen in HACE 
survivors.
Conclusion Based on these results, we postulate that hypoxemia is 
one of the main players in the development of splenium-associated 
MH, not only in HACE but also in severe ARDS and other diseases 
accompanied with severe hypoxemia. Further investigations have to 
examine potential triggers and special circumstances concerning ARDS 
treatment which lead to MH in this distinctive pattern.
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Introduction Diff erential hypoxia is a pivotal problem in cardio-
pulmonary failure patients with femoral venoarterial extracorporeal 
membrane oxygenation (VA ECMO) support. Although there was some 
attempt to deliver more oxygenated blood to the upper body, the 
mechanism of diff erential hypoxia has not been well investigated.
Methods We used a sheep model of acute respiratory failure that was 
supported with femoral VA ECMO (from inferior vena cava to femoral 
artery (IVC-FA)), ECMO from superior vena cava to FA (SVC-FA), ECMO 
from IVC to carotid artery (IVC-CA) and ECMO adding an additional 
return cannula to internal jugular vein based on femoral VA ECMO (FA-
IJV). Angiography and blood gas analysis were performed.
Results Blood oxygen saturation (SO2) of IVC (83.6 ± 0.8%) was higher 
than that of SVC (40.3  ± 1.0%) in sheep with IVC-FA. Oxygen-rich 
blood was drained back to the ECMO circuit and poorly oxygenated 
blood in the SVC entered the right atrium (RA). SVC-FA achieved the 
oxygen-rich blood return from IVC to RA without shifting the arterial 
cannulation. SO2 of SVC and pulmonary artery increased (70.4 ± 1.0% 
and 73.4  ± 1.1%, respectively) subsequently. Compared with IVC-FA, 
less diff erences of venous oxygen return and attenuated diff erential 
hypoxia were also observed in IVC-CA and FA-IJV. See Figure 1.
Conclusion Diff erential venous oxygen return is a key factor of 
diff erential hypoxia in VA ECMO. We can take advantage of the 
notion of diff erential venous oxygen return to choose better cannula 
confi guration in clinical practice.
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Introduction The HELP-ECMO pilot study (Heparin low dose protocol 
versus standard care in critically ill patients undergoing ECMO; 
ACTRN12613001324707) is a randomised controlled phase II study 
evaluating two levels of heparin anticoagulation in patients with no 
requirement for full anticoagulation. This work is a substudy of the 
HELP-ECMO trial and describes the consent process of the parent 
study. At our site, consent for research is often obtained by the research 
coordinator with little involvement from investigators. However, the 
nature of the ECMO population required a modifi ed consent approach 
to be implemented given that ECMO is often inserted emergently. It 
required a model that would be successful out of hours and could be 
delivered by any member of the treating team.
Figure 1 (abstract P278). SO2 values from blood gas analysis and vena cava angiography.
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Methods The HELP-ECMO pilot study is enrolling patients admitted to 
a large metropolitan ICU who require ECMO. Education on eligibility 
criteria and study processes was given to all ICU senior medical 
staff . Consent must be performed prior to the commencement of 
anticoagulation, often only a short time after ECMO cannulation. To 
facilitate recruitment at all hours, a HELP-ECMO study box is located in 
the ICU. Within the box is an instruction page outlining the screening, 
consent and randomisation process, as well as administrative tasks. 
Plain language statements, randomisation envelopes and consent 
documentation stickers are provided. A consent script is provided 
to ensure consistency across consenting personnel. The process is 
reviewed by the research coordinator the following day to confi rm local 
governance compliance.
Results From April to December 2014, 30 patients were screened. 
Fourteen met the eligibility criteria and were approached for consent. 
Twelve patients were enrolled and randomised to receive either 
standard anticoagulation or low-dose heparin as per the study 
protocol. Consent was provided by the person responsible for 10 
patients. One patient was competent to consent for themselves and 
one was enrolled under legislation allowing enrolment into research in 
the absence of a person responsible. There were two refusals. Seventy-
one per cent of participants were approached out of hours. Eighty-six 
per cent were consented by clinicians. Twenty-one per cent of patients 
were consented by a non-investigator.
Conclusion The model of consent described has proven to be successful 
in this challenging patient population. The ability of all staff  to perform 
consent for the study has been a signifi cant factor in the success of 
the pilot. The review of study processes by research coordinators has 
supported this model.
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Introduction Harefi eld Hospital accepts patients as a tertiary centre 
for end-stage heart and respiratory failure for the south of England. 
Interventions include VA-ECMO, VV-ECMO as a bridge to lung 
transplantation, left ventricular assist devices (LVAD) as a bridge for 
heart transplantation, right ventricular assist devices (RVAD) and 
BIVADs. The aim of this review was to identify the total number of such 
patients, analyse the individual length of ITU stay and calculate survival 
and mortality rates for each intervention.
Methods Patients consisted of six groups: Group 1: VA ECMO, Group 
2: VV-ECMO, Group 3: LVAD, Group 4: RVAD, Group 5: BIVAD, Group 
6: combination of devices. Data were extracted from the Perfusion 
Department records and the intensive care dataset from 2011 to 
2013. Data included length of ITU stay, outcome, indication for device 
insertion and device-related major complications.
Results Forty patients were identifi ed. Twenty-nine were male and 11 
female. Group 1 included 22 patients, Group 2: two patients, Group 
3: four patients, Group 4: four patients, Group 5: zero, Group 6: eight 
patients treated with various combinations of ECMO or ventricular 
assist devices. ITU stay varied from 1 day to a maximum of 6 months 
intermittently for one patient. Duration of ITU stay for all 40 patients 
was 1,052  days with an average of 26.3  days per patient. Sixteen 
patients survived and were discharged to the Transplant Unit. Twenty-
four patients died, putting the survival rate at 40% for this group.
Conclusion This review demonstrates that the majority of these 
patients occupied intensive care beds for a prolonged period of time 
and despite the use of advanced support devices survival rates were 
signifi cantly lower than mortality rates.
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Introduction Venoarterial (VA) ECMO is used for mechanical support in 
patients with cardiogenic shock (CS) unresponsive to medical therapy. 
Long-term survival and quality of life after hospital discharge have not 
yet been well analyzed.
Methods We performed a retrospective observational study of patients 
admitted to the ICU for refractory CS from January 2010 to November 
2014. Patients with postcardiotomy and/or post-transplant CS were 
excluded. Demographic, clinical and biochemical variables were 
collected. Continuous variables are presented as mean (standard 
deviation) and categorical variables as percentage. Long-term 
outcome and quality of life were assessed during scheduled follow-up 
evaluations or telephonic interviews.
Results We analyzed 23 consecutive patients undergoing VA ECMO for 
refractory CS. Etiologies of cardiac collapse were: 11 acute myocarditis, 
fi ve acute myocardial infarctions and seven acute decompensation 
of chronic cardiomyopathies (CCM). Thirteen patients died during 
the hospital stay and 10 survived. The main cause of ICU death was 
progressive multiple organ dysfunction (12/13). Baseline variables are 
presented in Table 1. All patients discharged from the hospital are still 
alive at follow-up (median 27  months, range 4 to 56) with a median 
NYHA class of 1 (range 1 to 2). All patients except one returned to an 
active style of life. Multivariate analysis (Cox) revealed pre-ECMO SOFA 
score (HR = 2.18, 95% CI = 1.016 to 4.6) and history of CCM (HR = 19, 
95% CI = 2 to 178) and pre-ECMO lactate (HR = 1.2, 95% CI = 1.02 to 1.4) 
as independent risk factors for hospital mortality.
Table 1 (abstract P281)
 Alive Dead P value
Age (years) 30 ± 18 43 ± 14 0.012
CCM 0 (0%) 7 (100%) 0.014
SOFA 8 ± 1.4 10 ± 1.9 0.002
Creatinine (mg/dl) 1.1 ± 0.3 2.2 ± 0.7 0.001
Bilirubin (mg/dl) 1 ± 0.4 2 ± 1.8 0.09
Lactate (mmol/l) 5 ± 2.1 8 ± 5.3 0.021
Platelets (103/μl) 257 ± 79 162 ± 99 0.03
Conclusion VA-ECMO is an eff ective treatment tool for refractory CS in 
patients with acute life-threatening heart failure. Patients aff ected by 
acute decompensation of CCM had poorer outcomes characterized by 
multiple organ dysfunction, as already known in the literature.
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Introduction Rhabdomyolysis is a condition that results in the release 
of mainly creatine kinase (CK) and myoglobin from the breakdown of 
myocytes. Myoglobin has been known to cause renal failure (RF) and 
the CK level is routinely used as an indicator. A CK level >5,000  U/l 
was found to be associated with the risk of RF [1]. However, data are 
lacking on the level of CK to predict RF, especially in general trauma 
patients. The purpose of this study was to determine the initial CK level 
that predicts markedly elevated CK and the characteristics of trauma 
patients with elevated CK.
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Methods Data from the Songklanagarind Hospital trauma registry 
were reviewed over 1 year (January 2013 to December 2013). Patients 
with at least two records of CK and creatinine (Cr) levels were included. 
Creatine kinase levels were analyzed during the fi rst 3 days of hospital 
admission. RF was defi ned as a Cr increment >0.3 mg/dl within 48 hours.
Results Of the 1,491 patients admitted to the trauma service, 47 
patients had CK levels drawn twice. These patients had a mean 
age of 32  years and a median Injury Severity Score (ISS) of 14. The 
predominant mechanism of injury was motorcycle crash. Only three 
patients developed RF. The median CK during the fi rst 3  days after 
admission was 3,088 (IQR 1,327, 6,072) U/l. The CK peaked at 11 hours 
after admission at a mean value of 16,114.167 (SD 34,010.80) U/l. There 
were no signifi cant diff erences in demographic data, ISS scores and 
fl uid balance between the groups of CK level over or below 5,000 U/l. 
A mean positive fl uid balance observed; however, initial CK was 
signifi cantly diff erent between the two groups. None of the patients 
with initial CK of <900 U/l had a peak of CK >5,000 U/l.
Conclusion Trauma patients had varying levels of elevated CK. Initial 
CK shows a promising result as a predictor of high peak CK levels. A 
larger sample size is needed to demonstrate the predictors of RF in 
trauma patients with elevated CK levels.
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Introduction The clinical diagnosis of rhabdomyolysis is confi rmed by 
creatine kinase (CK) levels >1,000 IU/l [1]. A local therapeutic protocol 
triggers aggressive renoprotective treatment in all patients with CK 
>2,000 IU/l. To evaluate local practice and refi ne CK thresholds for the 
instigation of renoprotective treatment, we studied the correlation 
between CK time trends and adverse outcomes such as acute kidney 
injury (AKI), the need for emergency renal replacement therapy (RRT) 
and mortality. We also evaluated the McMahon Score, a risk prediction 
model based on demographic, clinical, and laboratory variables 
available on admission [2].
Methods A retrospective observational study of adults with confi rmed 
rhabdomyolysis admitted to the Neurosciences Critical Care Unit 
between 2002 and 2012. Data collection included APACHE score, daily 
CK (with PEAK CK defi ned as the maximum CK recorded throughout 
ICU stay), creatinine, calcium, phosphate and bicarbonate levels, AKI, 
RRT, ICU length of stay and mortality.
Results A total of 232 patients met the inclusion criteria. Rhabdo-
myolysis was associated with trauma (76%), medical (15%) and surgical 
(9%) admission diagnoses. Forty-fi ve (19%) patients developed AKI, 
with 29 (12.5%) requiring RRT. Mortality was signifi cantly higher in 
patients who developed AKI (62% vs. 18%, P <0.001). Average CK on 
admission was 5,009 IU/l (SD 12,403 IU/l). CK values remained greater 
than 2,000 IU/l for an average of 3.3 days (range 1 to 10 days). Although 
PEAK CK was greater in patients requiring RRT compared with those 
that did not (PEAK CK: 32,354 IU/l vs. 7,353  IU/l, P  = 0.001), receiver 
operator characteristic curves revealed that a threshold for PEAK CK 
>5,000 IU/l is only 55% specifi c and 83% sensitive for the prediction of 
need for RRT. CK peaks on the day of admission in 46% of patients, on 
day 2 in 37%, and on day 3 or later in 17% of cases. A McMahon Score 
>6 calculated on admission is 68% specifi c and 86% sensitive for RRT.
Conclusion Although higher CK levels are associated with adverse 
outcomes, instigation of renoprotective treatment should not be 
based solely on CK levels. A McMahon Score >6 on admission allows for 
a more sensitive, specifi c and timely identifi cation of patients at risk of 
renal failure requiring RRT.
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Introduction AKI has been poorly studied in surgical septic patients. 
The aim of our study was to determine the factors related to AKI in 
surgical septic patients with complicated intra-abdominal infection 
(CIAI) and mortality associated with AKI in this setting.
Methods An observational study was performed of all adult patients 
with CIAI requiring surgery and ICU admission from June 2011 to June 
2013. We recorded demographic data, SAPS II, SOFA score at admission, 
presence of septic shock, history of pre-existing comorbidities, 
angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor 
blocker (ARB), NSAIDs, statins or diuretics consumption, baseline 
creatinine and at admission, and standard biomarkers. Factors 
associated with developing AKI and renal replacement therapy (RRT) 
were studied using a multivariate analysis. Association between 
mortality and AKI and RRT need was also analyzed.
Results A total of 114 patients were included, with a mean SAPS II of 
42.14. Sixty-seven patients (58.8%) developed AKI and 33 (28.9%) 
required RRT. Development of AKI (R2 = 0.498; P <0.0001; AUC = 0.926) 
was independently associated with SOFA (OR  = 1.57; 95% CI  = 1.29, 
2.02) and creatinine at admission (OR for 0.1 units = 1.56; 95% CI = 1.30, 
1.99). RRT need (R2 = 0.382; P <0.0001; AUC = 0.892) was independently 
associated with arterial hypertension (HTN) (OR  = 4.90; 95% CI  = 
1.50, 15.97) and SOFA score (OR = 1.71). In another model with more 
predictive capacity (R2 = 0.433; P <0.0001; AUC = 0.918) the number of 
previous medications (OR = 3.73; 95% CI = 1.92, 8.38) and SOFA score 
(OR = 1.86; 95% CI = 1.47, 2.54) were related to RRT need. Both AKI and 
RRT need were related to ICU (RR = 8.41, 95% CI = 1.14, 62.5; and RR = 8, 
95% CI = 2.40, 27.85 respectively) and 28-day mortality (RR = 2.8, 95% 
CI = 1.00, 7.86; and RR = 4.65, 95% CI =1.99, 10.40 respectively).
Conclusion Severe AKI with RRT need is highly associated with 
previous HTN. The number of previous medications is related to severe 
AKI too. HTN has been described as a risk factor for developing AKI in 
critically ill patients [1]. ACEI and ARB use has been associated with AKI 
development in septic patients [2]. To our knowledge, this is the fi rst 
study that investigates risk factors associated with AKI in surgical septic 
patients with CIAI.
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Introduction Acute kidney injury (AKI) is associated with increased 
morbidity and mortality in critically ill patients [1]. Early detection and 
treatment may improve outcome.
Methods A retrospective analysis of prospectively collected data from 
2,158 patients without end-stage renal disease from the EPaNIC trial [2]. 
For early detection of AKI, defi ned according to the creatinine-based 
KDIGO guidelines [3], three multivariate logistic regression models 
(LR) were developed using data available at baseline (LR_B), upon ICU 
admission (LR_BA), and at the end of the fi rst day in the ICU (LR_BAD1). 
In a subpopulation (n  = 580) where plasma neutrophil gelatinase-
associated lipocalin (pNGAL), an early biomarker of AKI, was measured 
at ICU admission, the value of adding pNGAL to LR_BA and LR_BAD1 
was assessed. The models were evaluated via bootstrapping, by 
comparing receiver operator characteristic (ROC) and decision curves.
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Results Table 1 presents the performance of the models and admission 
pNGAL. Performance improved when predictions were made at a later 
time point, and was highest for LR_BAD1. Similar results were obtained 
in subgroups of septic and cardiac surgery patients. As an independent 
predictor, pNGAL alone did not perform better than a model using 
routine clinical data available upon admission. However, when 
combining pNGAL with LR_BA, predictive performance improved. The 
performance of LR_BAD1 was not improved by including pNGAL.
Conclusion This study shows the potential of data-driven models 
based on routinely collected patient information for early detection 
of AKI during the fi rst week of ICU stay. Although adding admission 
pNGAL to admission data improved early detection of AKI, this added 
value is lost upon inclusion of data from the fi rst day of ICU.
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Introduction This study tested the hypothesis that the cellular 
response in the kidney to sepsis is characterized by early activation 
of AMP activated protein kinase (AMPK), and that such activation is 
temporally associated with downregulation of the epithelial sodium 
channel (B-ENaC).
Methods Fifteen C57BL/6 wildtype (WT) mice were subjected to cecal 
ligation and puncture (CLP), and sacrifi ced at 2, 6, 18, 24, or 48 hours. In 
addition, we pretreated three WT and three AMPK Beta 1 knockout mice 
with the AMPK activator AICAR (100  mg/kg intraperitoneal, 24  hours 
before CLP), and sacrifi ced 24 hours after CLP. Blood and tissue samples 
were collected for all animals. AMPK activation (pThr172), B-ENaC, and 
mitophagy (LC3 II/I) were examined by western blot of kidney lysates. 
Plasma creatinine (Scr) was assessed using ELISA.
Results The acute response to sepsis was characterized by early 
activation of AMPK which increased from 6 to 18  hours, peaked at 
24 hours, and decreased by 48 hours (Figure 1A). This activation was 
associated with a consistent decrease in B-ENaC expression. In AICAR 
pretreated animals, AMPK was only activated in WT mice, which was 
associated with a decrease in the expression of B-ENaC as compared 
with AMPK KO mice (Figure 1B).
Conclusion AMPK was activated early after induction of sepsis, and 
was associated with a consistent decrease in Beta-ENaC expression in 
the apical membrane of tubular epithelial cells. In addition, absence of 
AMPK activation in KO animals was associated with increased expression 
of Beta-ENaC at 24 hours after CLP. These data support the hypothesis 
that early activation of AMPK decreases energy consumption through 
ion channel downregulation.
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Introduction Little is known about temporal changes in [TIMP-
2·IGFBP7] relative to injury in patients who develop AKI. In this analysis, 
we examined [TIMP-2·IGFBP7] in serial urine collections from the subset 
of Sapphire patients who were admitted to the ICU after major surgery.
Methods We stratifi ed 238 Sapphire patients into three groups by their 
maximum AKI stage within 48 hours of the start of surgery using KDIGO 
criteria (No AKI, KDIGO 1, and KDIGO 2 to 3). Median TIMP-2·IGFBP7 
values were calculated from all samples collected at 12 (±6)-hour 
intervals for 4 days following the start of surgery.
Table 1 (abstract P285). Area under ROC curves for the diff erent models
      LR_BA + 
    pNGAL on LR_BA on pNGAL on
    subpopulation subpopulation subpopulation
 LR_B LR_BA LR_BAD1 with pNGAL with pNGAL with pNGAL
 (n = 2,158) (n = 2,067) (n = 1,808) (n = 528) (n = 528) (n = 528)
 0.73 0.76 0.82 0.64 0.70 0.76
Figure 1 (abstract P286). (A) AMPK activation (p-Thr172) and Beta-ENAC 
expression during early CLP. (B) Diff erence in Beta-ENAC expression 
between AICAR pretreated WT versus KO at 24 hours after CLP. Figure 1 (abstract P287).
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Results There were 101 patients without AKI, 95 patients with KDIGO 1 
AKI, and 42 patients with KDIGO 2 to 3 AKI within 48 hours of the start 
of surgery. In patients without AKI, median TIMP-2·IGFBP7 values were 
less than 0.3 (ng/ml)2/1,000 (dashed line in Figure 1) for all time points. 
In patients with KDIGO 1 AKI, median [TIMP-2·IGFBP7] signifi cantly 
exceeded this cutoff  at 24 and 36 hours following the start of surgery 
(*one-sided P  <0.025). Median [TIMP-2·IGFBP7] increased earlier in 
KDIGO 2 to 3 AKI patients, remaining signifi cantly elevated relative to 
the cutoff  from 12 to 60 hours after the start of surgery. The highest 
median [TIMP-2·IGFBP7] was observed at 24 hours for KDIGO 2 to 3 AKI 
patients and was nearly fi ve times the 0.3 (ng/ml)2/1,000 cutoff .
Conclusion Urinary [TIMP-2·IGFBP7] was signifi cantly elevated as early 
as 12 to 24 hours from the start of surgery in patients who developed 
AKI within 48 hours. Monitoring of these biomarkers in the immediate 
postsurgical period might enable improved management of patients 
at risk for AKI.
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Introduction Sepsis and acute kidney injury (AKI) have a high 
prevalence in the ICU population. The aim of this study is to describe 
the composite of tissue inhibitor of metalloproteinases-2 (TIMP2) and 
insulin-like growth factor-binding protein-7 (IGFBP7) as novel urinary 
renal biomarkers in both septic and nonseptic patients.
Methods We conducted a prospective, observational study in two 
university hospitals. Patients were admitted in ICU either from the 
emergency department or after undergoing an acute surgery at hospital 
admission. Two months prior to the admission, recruited patients had 
not been admitted to hospital. We collected epidemiological, clinical 
and laboratory data at admission, 24 and 48 hours. TIMP2*IGFBP7 was 
analysed in urine samples by a point-of-care device (Nephrocheck®; 
Astute Medical).
Results The sample included 98 patients (65 men) with mean age 
55 ± 17.3 years, length of ICU stay 11.1 ± 14.6 days. In total, 41.4% had 
sepsis at ICU admission; 59.2% were diagnosed of sepsis within the 
fi rst 48 hours of stay. We stratifi ed patients based on the presence of 
AKI as per the AKIN KDIGO defi nition, as well as their worst level of 
TIMP2*IGFBP7 during their fi rst 2-day stay. Values of mean and 25th 
to 75th percentile for the worst value of TIMP2*IGFBP7 were 0.24 (0.11 
to 0.46), 0.50 (0.28 to 1.24), 0.94 (0.34 to 3.28) and 3.34 (1.47 to 6.22) 
for no AKI, AKIN I, II and II respectively (P  <0.0001). The worst values 
for no AKI/no sepsis, no AKI/sepsis, AKI/no sepsis and AKI/sepsis were 
0.21 (0.10 to 0.4), 0.32 (0.15 to 0.63), 1.05 (0.41 to 2.31) and 0.98 (0.36 
to 3.94) respectively, with P  <0.05 for AKI and P  = NS for sepsis. The 
AUC ROC curve for prediction of AKI of the worst value was 0.80 with 
sensitivity of 73.5% and specifi city of 71.4% (P  <0.0001). In contrast 
to the Sapphire study, in our population cutoff  values of 0.4 and 0.8 
(ng/ml)2/1,000 predict AKI and AKIN ≥II respectively, regardless of the 
presence of sepsis. See Figure 1.
Conclusion TIMP-2 and IGFBP-7 can predict AKI in both septic 
and nonseptic critically ill patients. Further pragmatic randomised 
controlled trials are needed to prove their role on clinical basis.
Reference
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Introduction The gold standard for routine evaluation of kidney 
function is measurement of serum creatinine concentration (Scr). 
In ICU patients, muscle loss and dilution leads to decreased Scr. Scr 
is distributed in total body water, resulting in delay of Scr changes 
when the glomerular fi ltration rate (GFR) changes (lag time). Cystatin 
C (CysC) is a protein produced by all cells with a nucleus and therefore 
less aff ected by muscle mass. Also, the lag time may be shorter as the 
volume of distribution is only extracellular fl uid. The objective of this 
study was to evaluate whether single point measurement of CysC 
is more adequate than Scr for monitoring of kidney function in ICU 
patients.
Methods Data were collected in two prospective single-center studies 
on a convenience sample of ICU patients. During the 24-hour study 
period, we measured CysC, Scr, and urinary inulin clearance (Cinu) as a 
Figure 1 (abstract P288). ROC curve and area under the curve (AUC) for the worst [TIMP2]*[IGFBP7] value within the fi rst 48 hours of ICU admission to 
predict (a) AKI and (b) AKIN KDIGO ≥2.
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gold standard for assessment of GFR. We compared Scr and CysC, with 
Cinu. Also, we assessed Cinu in patients who had CysC and Scr within 
the normal sex and age corrected limits. Finally, we determined the 
ability of CysC and Scr to detect normal range and decreased GFR (80 
to 120 ml/minute/1.73m2 resp. <60).
Results We included 68 patients, with median age 58  years (IQR 
29 years), length of stay in the hospital before study 11 days (IQR 16), 
and APACHE II score 19 (IQR 9). Scr was 1.12 (IQR 1.55), CysC 0.64 (IQR 
0.73), and Cinu 80  ml/minute/1.73 m2 (IQR 82). Cinu was markedly 
decreased in patients with Scr in normal range (n  = 12) compared 
with patients with CysC in normal range (n = 22) (55 ml/minute/1.73 
m2 (IQR 57.4) vs. 100 (IQR 42.2), P <0.001). Patients with normal range 
Scr had similar proportion of patients with Cinu in the normal range 
compared with normal range CysC patients (33.3% vs. 45.5%, P = 0.23). 
ROC analysis showed that Scr and CysC had similar performance for 
detection of normal range Cinu (AUC: 0.66; 95% CI  = 0.53 to 0.77 vs. 
0.77; 95% CI = 0.65 to 0.87; P = 0.118), and decreased Cinu (AUC: 0.86; 
95% CI = 0.76 to 0.97 vs. 0.94; 95% CI = 0.88 to 1; P = 0.113).
Conclusion Single point measurement of Scr and CysC has similar 
performance for detection of normal and decreased GFR in this cohort 
of ICU patients. Performance was weak for detection of normal GFR, 
but both biomarkers had moderate good performance for detection 
of decreased GFR.
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Introduction Acute kidney injury (AKI) is a common complication 
following transcatheter aortic valve implantation (TAVI) and has 
been shown to increase mortality. The concentration of the G1 cell 
cycle arrest proteins TIMP-2 and IGFBP7 in the urine have recently 
been suggested as sensitive biomarkers for early detection of AKI in 
critically ill patients. Whether postoperatively elevated levels of urinary 
[TIMP-2][IGFBP7] (UTI) predict the development of an AKI in patients 
undergoing TAVI is currently unknown.
Methods In a prospective cohort study, 40 patients undergoing 
TAVI, either trans-apical (TA) or trans-aortic (TAo), were enrolled. 
Serial measurements of UTI were performed every 12  hours in the 
postoperative course. Results were calculated for their multiplication 
and presented as arbitrary values. Urinary output and serum creatinine 
were recorded simultaneously. The primary clinical endpoint was the 
occurrence of AKI according to the AKI Network.
Results Mean age was 81  ± 5.6  years (16 male, 40.0%). Thirty-fi ve 
patients underwent TA-TAVI and fi ve patients TAo-TAVI. AKI developed 
in 17 patients (42.5%); seven patients (17.5%) suff ered from AKI 3 and 
required renal replacement therapy (RRT). Mean maximum value of 
UTI within 24 hours after TAVI was signifi cantly higher in patients with 
AKI compared with patients without renal impairment (2.19 ± 3.11 vs. 
0.67 ± 0.816, P = 0.037) and higher in patients with AKI 3 compared with 
patients with AKI 2 (4.73 ± 3.58 vs. 0.59 ± 0.71, P = 0.022). In contrast, 
preoperative creatinine (AKI (mg/dl) 1.22 ± 0.41 vs. no AKI 1.30 ± 0.59; 
AKI 3 1.32 ± 0.49 vs. AKI 2 1.26 ± 0.53, P = NS) and early postoperative 
serum creatinine levels (maximum within 24 hours after TAVI: AKI 1.41 ± 
0.50 vs. no AKI 1.34 ± 0.60; AKI 3 1.69 ± 0.56 vs. AKI 2 1.32 ± 0.54, P = 
NS) did not show any association with the development of AKI. ROC 
analyses revealed a very good predictive value of early UTI levels for 
the development of AKI 3 within the next 72  hours after TAVI with a 
sensitivity of 100% and a specifi city of 80% for a cutoff  value of 0.815 
(AUC = 0.919, 95% CI = 0.824 to 1.0, SE 0.048, P = 0.001).
Conclusion Early elevation of urinary [TIMP-2][IGFBP7] after TAVI 
is associated with the development of postoperative AKI. These 
biomarkers have an excellent diagnostic accuracy in the prediction of 
severe AKI requiring RRT that is superior to that of serum creatinine. 
Further studies are necessary to prove whether UTI-guided therapy of 
patients with AKI can reduce morbidity and mortality.
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Introduction Patients undergoing elective liver surgery have an 
increased risk for developing AKI [1]. This study was intended to assess 
[TIMP-2]*[IGFBP7] and its possible association with urine output (UO) 
in this population. Secondly we sought to compare [TIMP-2]*[IGFBP7] 
with serum creatinine concentration (Scr).
Methods A prospective single-center pilot study performed on 12 
patients undergoing elective liver surgery. Serial urine samples were 
analyzed for [TIMP-2]*[IGFBP7] measured with the Nephrocheck device 
(Astute Medical, San Diego, CA, USA). Serial Scr was analyzed, UO, 
blood losses, and mean arterial pressure (MAP) were recorded. Fluid 
management was standardized, oliguria defi ned as a UO <0.5 ml/kg/
hour. [TIMP-2]*[IGFBP7] values of >0.3 identify patients at high risk and 
>2 at highest risk for AKI [2].
Results Males comprised 66.7%, median age was 72  years. Median 
surgical time was 195  minutes. Peroperative median MAP was 
71  mmHg (IQR 69; 77). Baseline median GFR was normal in eight 
patients and decreased in four patients (eGFR >90 and 66.5  ml/
minute/1.73 m2 respectively). Median baseline Scr was 0.75 mg/dl (IQR 
0.61; 1.10), 0.74 mg/dl (IQR 0.64; 1.04) at ICU admission and 0.74 mg/
dl (0.64; 1.04) on day 1 postoperatively. No diff erence in Scr and 
eGFR was seen between these time points (P  = 0.457 and P  = 0.517 
respectively; repeated-measures ANOVA). Median peroperative and 
postoperative UO was 0.18 ml/kg/hour (IQR 0.13; 0.23) and 0.93 ml/kg/
hour (IQR 0.79; 1.49) respectively. Median baseline [TIMP-2]*[IGFBP7] 
was 0.10 (IQR 0.04; 0.34), 2.02 (1.44; 6.23) during surgery, 0.61 (IQR 0.27; 
1.22) at ICU admission and 0.74 (0.67; 0.97) on day 1 postoperatively. 
[TIMP-2]*[IGFBP7] diff ered at these time points (P <0.0001; repeated-
measures ANOVA). Peroperative oliguria was associated with increased 
[TIMP-2]*[IGFBP7] (P = 0.018, chi-squared test).
Conclusion This pilot study demonstrated the association between 
[TIMP-2]*[IGFBP7] increase and oliguria and may therefore indicate 
kidney damage during liver surgery. As Scr could not diff erentiate for 
these changes, patients did not meet the classical biomarker criteria 
for AKI.
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Introduction There is currently no accurate method of measuring the 
glomerular fi ltration rate (GFR) during acute kidney injury (AKI). Four-
hour creatinine clearance (4-CrCl) is often used. We have previously 
validated a method of measuring the GFR using a continuous infusion 
of low-dose iohexol (CILDI) in patients with stable renal function (GFR 
from normal to <30  ml/minute/1.73  m2). Steady state was achieved 
in <10  hours in all subjects and we calculate that variations >10.3% 
suggest an AKI. In this study we compare GFR measured by CILDI with 
4-CrCl and 1-hour creatinine clearance (1-CrCl).
Methods Critically ill patients with evolving AKI and patients following 
nephrectomy were recruited. Demographics were compared using 
the t test. CIDLI was connected for up to 72  hours. Plasma and renal 
iohexol and creatinine concentrations were measured by tandem 
mass spectrometry four times daily. Iohexol renal clearance (IRC) and 
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1-CrCl and 4-CrCl were calculated and compared using Bland–Altman 
analysis.
Results Baseline estimated GFR was similar in the postnephrectomy 
(88 ± 28) to the evolving AKI group (92 ± 23), P = 0.70. The evolving AKI 
group had a higher APACHE score (17.8 ± 5.1 vs. 10.6 ± 3.9; P <0.001). 
When 1-CrCl was compared with IRC, a bias of 0.8% (SD 26%, limits of 
agreement –52 to 50%; Pearson’s r = 0.90) was observed in the evolving 
AKI group, whereas bias was –3.3% (SD 16, limits of agreement –35 to 
29%; Pearson’s r = 0.95) in the postnephrectomy group. When 4-CrCl 
was compared with IRC, bias was 5.1% (SD 54, limits of agreement 
–102 to 112%, Pearson’s r = 0.45) in the established AKI group and bias 
was –4.5% (SD 38, limits of agreement –79 to 70%; Pearson’s r = 0.78) in 
the postnephrectomy group.
Conclusion Our data suggest that 4-CrCl is not as accurate and precise 
as 1-CrCl in patients with AKI and following nephrectomy. IRC appears 
to be more accurate and precise in patients with a predicted AKI risk 
and outcome (post nephrectomy) than in patients with evolving AKI. 
We hypothesise that IRC will be useful alternative to creatinine-based 
measures of AKI.
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Introduction Acute kidney injury (AKI) following coronary artery 
bypass grafting (CABG) results in signifi cant morbidity, mortality and 
prolonged stay on the cardiothoracic ICU. We sought to determine the 
incidence of AKI in our cardiothoracic centre, hypothesizing a higher 
occurrence in patients undergoing CABG using cardiopulmonary 
bypass (ONCAB) compared with off -pump (OPCAB) surgery [1].
Methods Retrospective data from all nondialysed patients undergoing 
isolated CABG at our institution were collected for the year 2013. 
Propensity scoring using the software platform MatchIt® was used 
to match subjects from ONCAB and OPCAB groups with regard to 
preoperative variables: logistic EuroSCORE, creatinine clearance (CrCl), 
gender and operative urgency. Postoperative AKI was defi ned as a rise 
of 50% or more in baseline serum creatinine [2]. Chi-square analysis 
was used to determine statistically signifi cant diff erences.
Results From 500 cases (369 OPCAB, 131 ONCAB), 262 subjects were 
included in the fi nal analysis, with 131 in each group. There was a higher 
incidence of AKI and renal replacement therapy (RRT) in the ONCAB 
group, although this was not signifi cantly greater than in the OPCAB 
group (Table 1). The mortality rate was identical with three deaths in 
each group. The average length of ICU stay for the OPCAB group was 
1.96 days versus 2.49 days for the ONCAB group.
Table 1 (abstract P293)
 OPCAB ONCAB P value
AKI 14 (10.69%) 19 (14.50%) 0.35
RRT 6 (4.58%) 9 (6.87%) 0.43
Conclusion Our study is limited by its size and the use of logistic 
EuroSCORE as a composite measure of risk factors. However, it has 
demonstrated that in our predominantly off -pump cardiac unit, 
OPCAB conferred no statistically signifi cant advantage over ONCAB 
with regard to postoperative AKI. Studies to date have standardised 
patient-specifi c variables, but not the conduct of the procedure itself; 
for example, minimising renal hypoperfusion during OPCAB. This may 
be a reason for the lack of clear superiority in the continuing debate 
over choice of CABG procedure and reducing the risk of AKI.
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Introduction Severity of acute kidney injury (AKI) and fl uid overload 
(FO) are not incorporated into current severity of illness measures and 
are invisible to the practitioner. The causal relationship and timing 
between AKI and FO and oxygenation is not clear. The Fluid Overload 
Kidney Injury Score (FOKIS) is a daily score incorporating subscores for 
AKI (pRIFLE (creatinine (Cr) and urine output (UOP))), FO (total fl uid 
(in – out) / ICU admission weight) >15% in fi ve percentile increments, 
and exposure to nephrotoxic medications. We previously reported 
that FOKIS outperforms PRISM in mortality prediction in our pediatric 
intensive care unit (PICU). We hypothesized that patients with AKI on 
admission to the PICU developed worse fl uid overload and in turn 
worse oxygenation.
Methods We prospectively calculated daily FOKIS scores and subscores 
(Cr, UOP, FO) in PICU patients. We excluded patients with <7 day stays 
in order to properly explore the association between timing of AKI and 
FO and oxygenation by oxygenation index (OI).
Results Over 18 months, there were 2,830 patients, 436 patients with 
PICU stay >7  days, 361 patients had complete data for all 7  days. 
Mortality was 4.5% overall and 11% cohort. A total of 246 patients 
(68%) had AKI (by FOKISCr or FOKISuop); 205 patients (57%) on day 
1, 85 patients (24%) on day 3. Admission or day 3 AKI by either FOKIS 
subscore (FOKISCr or FOKISuop) did not predict maxFO or mortality. 
Increasing total FOKIS score was associated with increasing mortality 
and increasing OI (Table  1). FOKIS, controlled for PRISM, was an 
independent predictor of OI (P = 0.03).
Table 1 (abstract P294)
     P
FOKIS 0 <4 4 to 7 >7 value
maxOI, median (IQR) 7.4 11.1 16.4 14.2 0.03
 (5.9 to 16.4) (6.2 to 23.6) (7.3 to 29.6) (10 to 38.7) 
Mortality, % 3.6 7.7 13 38 <0.001
Conclusion In PICU patients, admission or day 3 AKI alone did not 
predict maxFO. A composite score that includes both AKI and FO 
parameters correlated with OI and discriminated survivors from 
nonsurvivors. FO seems to result from combination of increased fl uid 
exposure with underlying AKI but cannot fully be explained by oliguria 
in pediatric patients.
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Introduction Tissue inhibitor of metalloproteinase-2 (TIMP-2) and 
insulin-like growth factor binding protein 7 (IGFBP7) are specifi c 
urinary biomarkers which can predict acute kidney injury (AKI) in 
critically ill patients within 12 hours [1]. A [TIMP-2]·[IGFBP7] result >0.3 
(ng/ml)2/1,000 is associated with seven times the risk of AKI compared 
with a test result ≤0.3 [2]. The aim of our study was to explore the use 
of potentially nephrotoxic medications within the window between a 
positive biomarker test and the diagnosis of AKI stage 2 or 3.
Methods We identifi ed all patients enrolled into the Sapphire study [1] 
who received at least one potentially nephrotoxic drug on the day of AKI 
(defi ned by stage 2 or 3 as per KDIGO classifi cation). We subsequently 
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determined the proportion of patients who had a [TIMP-2]·[IGFBP7] 
result >0.3 (ng/ml)2/1,000 before meeting the criteria for AKI.
Results Of 184 patients who developed AKI, 58% received one or more 
potentially nephrotoxic drug on the day of AKI. Eighty-nine percent 
of these patients had a positive biomarker test ≥12  hours earlier. In 
41% of patients receiving one or more nephrotoxic drug on the day of 
AKI, at least one nephrotoxic medication was stopped within 1 day of 
AKI, and in 24% of patients all nephrotoxic drugs were stopped within 
1 day of AKI, which implies that these medications were not absolutely 
necessary.
Conclusion Nephrotoxic medications are commonly used in patients 
who develop moderate or severe AKI. The [TIMP-2]·[IGFBP7] test could 
have identifi ed many of these patients earlier and would have off ered 
an opportunity to reduce exposure to non-essential nephrotoxic drugs.
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Introduction This study investigated renal outcomes following radio-
contrast (RC) administration in patients from two intensive care units 
(ITUs), where one gave RC-induced nephropathy (RCIN) prophylaxis, 
while the other did not. Acute kidney injury (AKI) during critical 
illness increases morbidity and mortality. ITU patients, who already 
suff er a variety of renal insults, often require RC, increasing their risk 
of developing AKI, and requiring renal replacement therapy (RRT). 
Evidence suggests that hydration alone is inadequate for the prevention 
of RCIN in ITU patients, and is contraindicated in some disease states 
[1]. The European Society of Intensive Care Medicine (ESICM) provides 
recommendations for prophylaxis [2]. The current study aimed to 
establish the effi  cacy of the ESICM recommended prophylaxis.
Methods Retrospective data from 140 Maidstone (M) ITU patients 
(men 101, women 39, mean age 63.5, mean APACHE 15.3) and 73 
Tunbridge Wells (T) ITU patients (men 41, women 32, mean age 60.2, 
mean APACHE 20.2) admitted between 22 September 2011 and 22 
September 2013, who underwent RC-enhanced CT, were collected. 
Patients on MITU received ESICM-recommended RCIN prophylaxis: 
200 mg aminophylline i.v. over 30 minutes prior to RC, 1.26% sodium 
bicarbonate 3 ml/kg/hour for 1 hour prior to RC and 1 ml/kg/hour for 
6  hours post RC. TITU patients received standard critical care alone. 
Exclusion criteria were: those undergoing RRT prior to CT, >1 CT in 
48  hours, no creatinine (Cr) data available post scan. The Cr prior to 
CT (baseline), at 24, 48 and 72 hours post CT scan were identifi ed. The 
RIFLE criteria was used to classify the changes of Cr from baseline into 
low risk (% change >1.25), risk (% change >1.5), injury (% change >2) or 
failure (% change >3, or Cr>355 and increase of >44).
Results The total number of patients developing renal injury falling into 
any RIFLE category for MITU at 24, 28 and 72 hours was eight (0.06%), 
12 (0.09%) and 14 (0.1%), while for TITU it was fi ve (0.07%), six (0.08%), 
and four (0.05%) respectively. A repeated-measures ANOVA revealed 
no signifi cant diff erences in outcomes between the two groups overall 
(F = 2.35, P = 0.127) or at each time point (F = 1.93, P = 0.123).
Conclusion While RCIN is a recognised problem within the critical care 
population, there is little clear evidence for any prophylactic strategy to 
reduce this risk. This study suggests that a RCIN prophylaxis protocol 
based on the ESICM recommendations has no eff ect on the incidence 
of RCIN. However, further studies are needed.
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Introduction Patients who undergo major oncology surgery are under 
high risk to develop postoperative acute kidney injury (AKI), mainly 
due to infl ammatory and ischemic insults. This complication results in 
worse outcomes. The aim of this study is to identify predictive factors 
of AKI in this population.
Methods We performed an observational study in 285 consecutive 
patients admitted to a surgical ICU after major abdominal oncology 
surgery. Baseline characteristics, laboratorial, clinical and intraoperative 
data, such as type of fl uids, blood transfusion, bleeding and use of 
vasopressor, were collected at ICU admission. Early acute kidney injury 
was defi ned according to the Acute Kidney Injury Network classifi cation 
at 48 hours of ICU admission. Logistic regression model was performed 
using AKI as the outcome.
Results There were 76 (26.7%) patients who developed AKI within the 
fi rst 48 hours after ICU admission. In a univariate analysis, patients with 
AKI were more likely to be male, had higher Sequential Organ Failure 
Assessment (SOFA) score, higher baseline serum creatinine and urea 
levels, higher serum lactate levels and had more metabolic academia 
at admission. These patients also had a higher 24-hour Simplifi ed Acute 
Physiology III score and higher length of mechanical ventilation as 
compared with non-AKI patients. There were no diff erences between 
patients regarding intraoperative vasopressors, type and amount of 
fl uids, diuresis and blood transfusion. In a multivariate analysis we 
identifi ed admission base defi cit (BD) (OR = 1.13, 95% CI = 1.02 to 1.24, 
P = 0.017) and SOFA score (OR = 1.35, 95% CI = 1.2 to 1.51, P <0.001) as 
independent predictive factors of early AKI.
Conclusion Both SOFA score and BD may be used to predict AKI in 
surgical oncology patients at ICU admission. These variables allow 
physicians to recognize early patients who might be under risk, and 
anticipate measures to avoid further renal impairment.
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Introduction The predictive value of NGAL for renal recovery is not 
established.
Methods Data from the fi rst 19 patients were assessed during a 
multicentre low molecular weight heparin trial (FBI, EudraCT Number: 
2012-004368-23). Critically ill patients with AKI are randomly assigned 
into either a treatment arm (1  mg/kg enoxaparin) or a control arm 
(40  mg enoxaparin) upon commencement of CRRT. The primary 
outcome is the occurrence of venous thromboembolism. NGAL was 
measured at baseline and during CRRT-free intervals.
Results Patients were comparable at baseline with respects to 
demographics, APACHE II, creatinine, NGAL, start of dialysis, and the 
duration of dialysis. The main cause of AKI was sepsis (42%). In 63% 
of the patients, the reason for starting dialysis was a combination of 
anuria and electrolyte disturbances. Twenty-six percent of patients 
were dialysis dependent after the fi rst CRRT-free interval. Plasma NGAL 
levels were higher in nonrenal recovery patients (1,074 (±694) ng/ml) 
compared with renal recovery patients (296 (±197)  ng/ml; P  = 0.01). 
Urine NGAL levels were higher in nonrenal recovery patients (3,885 
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(±2,722) ng/ml) compared with renal recovery patients (597 (±565) ng/ml; 
P = 0.006). See Figures 1 and 2. Infl ammatory parameters (WBCs, CRP, 
and procalcitonin) did not diff er signifi cantly between the groups.
Conclusion NGAL may be able to predict renal recovery, and allow 
proper utilization of resources.
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Introduction There is currently no validated strategy for the timing of 
renal replacement therapy (RRT) for acute kidney injury (AKI) in the ICU 
when short-term life-threatening metabolic abnormalities are absent. 
No adequately powered prospective randomized study has to date 
addressed this issue. As a result, signifi cant practice heterogeneity 
exists and may expose patients either to unnecessary hazardous 
procedures or to undue delay in RRT.
Methods This is a multicenter, prospective, randomized, open-
label parallel-group clinical trial that compares the eff ect of two RRT 
initiation strategies on overall survival of critically ill patients receiving 
intravenous catecholamines and/or invasive mechanical ventilation 
and presenting with RIFLE F stage of AKI. In the early strategy, RRT is 
initiated immediately. In the delayed strategy, clinical and metabolic 
conditions are closely monitored and RRT is initiated only when one 
or more events (severity criteria) occur, including: oliguria or anuria for 
more than 72  hours after randomization, serum urea concentration 
>40  mmol/l, serum potassium concentration >6  mmol/l, serum 
potassium concentration >5.5  mmol/l persisting despite medical 
treatment, arterial blood pH <7.15 in a context of pure metabolic 
acidosis (PaCO2 <35  mmHg) or in a context of mixed acidosis with a 
PaCO2 >50 mmHg without possibility of increasing alveolar ventilation, 
acute pulmonary edema due to fl uid overload despite diuretic therapy 
leading to severe hypoxemia requiring oxygen fl ow rate >5  l/minute 
to maintain SpO2 >95% or FiO2 >50% under invasive or non-invasive 
mechanical ventilation. The primary endpoint is overall survival, 
measured from randomization (D0) until death, regardless of the cause. 
The minimum follow-up duration for each patient will be 60 days. To 
demonstrate a 14% decrease in mortality, a total of 546 subjects (273 
per group) should be randomized.
Results Enrollment is ongoing. After the fi rst interim analysis, the 
DSMB recommended to continue the study. On 5 December 2014, 318 
patients were included in the trial.
Conclusion The AKIKI study will be one of the very few large randomized 
controlled trials evaluating mortality according to the timing of RRT 
in critically ill patients with RIFLE F stage of AKI. Results should help 
clinicians better decide when to initiate RRT.
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Introduction The prevalence of malnutrition in acute kidney injury 
(AKI) is high. Patients with AKI may require renal replacement therapy 
(RRT), which could result in loss of water-soluble micronutrients. 
Little is known about these losses in RRT and whether they diff er 
between types of RRT. This study aims to quantify micronutrient 
losses during RRT in patients with AKI and to compare them in three 
diff erent RRT modalities: continuous venovenous haemofi ltration 
(CVVH), intermittent haemodialysis (IHD) and sustained low-effi  ciency 
diafi ltration (SLEDf).
Methods A prospective observational study is being conducted at 
NUH. Thirty-three adult patients with AKI requiring RRT (13 IHD, 10 
SLEDf, 10 CVVH) have been recruited. Samples of blood and RRT 
effl  uent were obtained at baseline, mid and end-session from each 
participant during their fi rst RRT treatment. Samples were processed 
and stored at –80°C for subsequent analysis of amino acids by high-
performance liquid chromatography and trace elements by inductively 
coupled mass spectrometry after derivatization from physiological 
fl uids. Micronutrient losses were calculated by multiplying mass-
corrected concentrations by total volume of RRT effl  uent, adjusted for 
baseline plasma concentrations and RRT dose. Data were analysed by 
restricted maximum likelihood estimating equations.
Results The total baseline plasma concentration of all standard 
amino acids was similar between IHD versus SLEDf groups (1,812  ± 
517 vs. 2,675 ± 527 μmol/l, respectively) but were higher in the CVVH 
group (3,194  ± 564  μmol/l). RRT reduced the plasma concentration 
of amino acids in the SLEDf group (to 1,732  ± 529  μmol/l; P  = 0.02), 
but had no eff ect in the IHD or CVVH groups (IHD; 1,853 ± 523, CVVH; 
2,845 ± 512 μmol/l). The average, unadjusted loss of amino acids was 
signifi cantly infl uenced by mode of RRT (IHD, 5.13  ± 3.1 vs. SLEDf, 
8.21 ± 4.07 vs. CVVH, 18.69 ± 3.04 g; P <0.01). The total baseline plasma 
concentration of trace elements was similar in the IHD, SLEDf and CVVH 
groups (3,797 ± 827, 3,667 ± 791, 3,642 ± 481 μg/l, respectively). By the 
end of the RRT session, the plasma concentration of trace elements had 
reduced (IHD, to 3,103 ± 827; SLEDf, to 2,805 ± 797; CVVH, to 3,433 ± 
481 μg/l; P = 0.01). By the end of each RRT session, total losses of trace 
elements were estimated at IHD, 5,051 ± 2,312; SLEDf, 8,751 ± 2,421; 
CVVH, 11,258 ± 2,547 μg/l; P = 0.02 for treatment.
Conclusion Micronutrients are lost during RRT in AKI. The degree of 
micronutrient loss is infl uenced by the type of RRT used.
Figure 2 (abstract P298). Urine neutrophil gelatinase-associated 
lipocalin concentration by recovery.
Figure 1 (abstract P298). Plasma neutrophil gelatinase-associated 
lipocalin concentration by recovery.
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Introduction Conventional membranes used for CRRT have a limited 
middle molecule clearance. New membranes called super high-fl ux 
(SHF) or high cutoff  membranes have been investigated. The loss of 
albumin with hemofi ltration is a major drawback, but these membranes 
can be used in CVVHD with regional citrate anticoagulation (Ci-Ca® 
CVVHD), which may limit albumin loss, and contribute to a prolonged 
fi lter patency and an improved and stable middle molecule clearance. 
We evaluated saturation coeffi  cients (SC), plasma clearances (PCL) and 
serum levels of eight small and middle molecules during 72 hours of 
Ci-Ca® CVVHD with a SHF membrane (Ultrafl ux®EMiC®2).
Methods After approval of the local committee of medical ethics 
and written informed consent we enrolled patients on a surgical ICU 
with AKI RIFLE-F who were treated with a Ci-Ca® CVVHD with a SHF 
membrane for 72  hours. We measured urea (0.006  kDa), creatinine 
(0.113  kDa), osteocalcin (5.8  kDa), B2MG (12  kDa), myoglobin 
(17.2 kDa), FreeLightChains (FLC) kappa (25 kDa) and lambda (50 kDa) 
and albumin (66 kDa) at 0 hours, 1 hour, 6 hours, 12 hours, 24 hours, 
48 hours, and 72 hours. PCL, SC and serum levels during 72 hours were 
compared, using the Wilcoxon signed-rank test with P <0.05.
Results Four females and 10 males (mean age 68.1 ±15.1 years; mean 
APACHE II score 13.7 ± 14.7; mean SAPS II 38.7 ± 12.7) were included. 
The SC and the PCL (ml/minute) of small solutes like creatinine at 1 hour 
(1.0 ± 0.0/23.72 ± 1.04) and 72 hours (0.95 ± 0.16/22.19 ± 3.99) were not 
statistically signifi cantly diff erent (P = 0.5/P = 0.42), the PCL was slightly 
reduced by 6%. The creatinine serum level was reduced by 42%. The 
SC and PCL of B2MG from 1 hour (0.61 ± 0.09/14.49 ± 2.5) to 72 hours 
(0.48 ± 0.13/11.6 ± 2.96) were signifi cantly decreased (P = 0.0024/P = 
0.0061). The reduction was 23% only; the overall clearance still was 
high. There was almost no reduction in SC or PCL for FLC kappa from 
1 hour (0.176 ± 0.047/4.14 ± 1.08) to 72 hours (0.164 ± 0.078/3.854 ± 
1.87), not reaching statistical signifi cance (P = 0.94/P = 0.81). The serum 
levels of B2MG and FLC kappa were decreased by 39% and 23%. The SC 
of albumin was low (1 hour: 0.0009 ± 0.0004) and clearance decreased 
rapidly within the fi rst 6  hours from 0.021  ± 0.01 to 0.011  ± 0.009. 
Serum levels of albumin did not decrease (1 hour: 2.64 ± 0.51; 72 hours: 
2.63 ± 0.25).
Conclusion This study shows high middle molecular clearances using a 
SHF membrane with Ci-Ca® CVVHD for 72 hours with no loss of albumin. 
This set-up may improve blood purifi cation in critically ill patients with 
acute kidney injury.
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Introduction Citrate has been used to anticoagulate extracorporeal 
haemofi ltration circuits since the 1960s, and has been used as the 
fi rst-line anticoagulant for continuous venovenous haemodiafi ltration 
(CVVHDF) at Conquest Hospital since 2009. Benefi ts of citrate 
demonstrated in clinical trials include increased fi lter life and increased 
bicarbonate formation from metabolism of the citrate complex; citrate 
also lacks the increased bleeding risk associated with unfractionated 
heparin use. One of the main issues with new renal replacement 
therapies is the development of ideal dialysate fl uids. During the initial 
period of citrate use at Conquest, hyponatraemia was identifi ed as an 
issue, with off -license supplementation of dialysate fl uid with sodium 
bicarbonate often necessary to prevent this. New protocols were 
therefore developed, designed to maximise the fi ltration dose and 
maintain normal electrolyte balance.
Methods A comparison of patients receiving CVVHDF on the 11-bed 
critical care unit at Conquest Hospital, Hastings was undertaken, 
before and after the implementation of new CVVHDF protocols. All 
patients receiving CVVHDF were identifi ed from the electronic patient 
record system between March 2012 to 2013 and September 2013 to 
2014. Patient demographics, the duration of CVVHDF and sodium 
bicarbonate supplementation were analysed between the groups to 
assess the impact of the new protocols.
Results Sixty-four patients received CVVHDF in 2012 to 2013, 61 
receiving citrate and three receiving unfractionated heparin due to 
fulminant liver failure. Forty-seven patients received CVVHDF in 2013 
to 2014, two receiving no anticoagulation due to severe coagulopathy 
and one receiving unfractionated heparin. The two patient cohorts 
assessed were similar in age (median 65.5 for March 2012 to 2013 
cohort vs. 66 for September 2013 to 2014 cohort), gender mix (64% 
male vs. 57% male) and severity of illness as assessed by APACHE II 
score (23 vs. 24). Mean duration of CVVHDF was also similar (71.5 hours 
vs. 75 hours). A total 30/64 of 2012 to 2013 patients did not require a 
fi lter change prior to completion of RRT, compared with 23/47 of 2013 
to 2014 patients. Sodium bicarbonate was added to the dialysate fl uid 
in 29/64 2012 to 2013 patients, compared with just 2/47 2013 to 2014 
patients.
Conclusion Changing protocols resulted in a signifi cant reduction in 
off -license addition of sodium bicarbonate to dialysate bags without 
impacting on fi lter life, thus reducing nursing workload and removing 
a potential source of adverse events in this high-risk group of patients.
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Introduction Venovenous extracorporeal membrane oxygenation 
(VV-ECMO) is a novel therapy for severe respiratory failure (SRF). 
Its introduction has reduced mortality; however, patients require 
substantial blood product support and between 10 and 20% of cases 
develop a life-threatening haemorrhage.
Methods We contacted 336 practitioners at 135 centres, examining 
their haematological management.
Results In total 25% of practitioners contacted responded; 85% were 
attending physicians, predominantly based in North America and 
Europe, 41 and 32% respectively. Ninety-six per cent of units used a 
polymethylpentene membrane oxygenator and all used a centrifugal 
pump. Thirty-four per cent of responders managed <10 cases a 
year and 60% worked in units handling <20 annually, 6% saw >50 
patients. One centre did not use unfractionated heparin. Monitoring 
of anticoagulation varied; 52% used the APTT, 43% the ACT and 5% 
the APTTr. Sixty per cent did not routinely measure antithrombin. 
Scenario 1 was based on a patient with H1N1. Practitioners targeted a 
haemoglobin (Hb) of 80 to 100 g/l; however, 20% targeted a Hb outside 
this range; 38% favouring a transfusion threshold of <80  g/l when 
the patient was improving compared with 32% when the patient had 
just started on ECMO. Seventeen per cent of practitioners transfused 
platelets when the count was <30 × 109/l whilst 21% maintained the 
platelet count >100  × 109/l. Scenario 2 described a patient with SRF 
secondary to a hospital-acquired pneumonia. The patient developed a 
haemothorax, with persistent blood loss of 200 ml/hour. Practitioners 
targeted a higher haemoglobin concentration of 100 g/l and targeted 
a higher platelet count of >100 × 109/l when compared with the patient 
in scenario 1, neither of these diff erences was statistically signifi cant. 
Seventy-one per cent stated they would manage the patient off 
anticoagulation. There was no agreement as to the length of time 
off  anticoagulation; 26% restarted anticoagulation in <12  hours, 
compared with 22% who advised no anticoagulation for >5  days. 
Scenario 3 examined the management of an incidental intracranial 
haemorrhage. There was a lack of consensus regarding the duration off  
anticoagulation; 14% of responders held anticoagulation for less than 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S107
12 hours whilst 37% held anticoagulation for >5 days and tranexamic 
was considered useful by 25%.
Conclusion There was wide variation in the use of blood products and 
the intensity of anticoagulation. This is not surprising given the current 
lack of evidence. Further work is required to provide a standardised 
approach.
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Introduction For continuous renal replacement therapy (CRRT), 
continuous administration of anticoagulant would be necessary to 
prevent the circuit clotting. Nafamostat mesilate (NM) is commonly 
used as its anticoagulant in Japan, although unfractionated heparin 
(UFH) is the most frequently used anticoagulant internationally. There 
is little study to compare the risk and benefi t of NM with UFH as an 
anticoagulant during CRRT.
Methods We conducted a single-center retrospective observational 
study to compare NM with UFH as anticoagulant during CRRT. We 
screened subsequent critically ill patients requiring CRRT in our ICU from 
January 2011 to December 2013. We excluded patients who required 
any other extracorporeal circuit including extracorporeal membrane 
oxygenation, who used both NM and UFH simultaneously, or who were 
administered any other anticoagulant including gabexate mesilate 
or urokinase. The primary outcome of this analysis was fi lter life, and 
the secondary outcome was the incidence of bleeding complications 
during CRRT. As an initial dose, NM and UFH were given pre fi lter at 
15 to 25  mg/hour and 1,500 to 3,000  IU/hour, respectively. The dose 
of both drugs was adjusted to maintain activated clotting time at post 
fi lter between 150 and 200 seconds. Filter life was assessed using the 
Kaplan–Meier method and the incident of bleeding complications 
was compared using the chi-square test. P <0.05 was considered to be 
statically signifi cant.
Results We included 101 patients in this study. Among them, 76 patients 
were with NM and 25 patients were with UFH. They used 239 fi lters in 
total; 173 with NM, 66 with UFH. There were signifi cantly more post-
surgical patients in the NM group (P = 0.001). There was no diff erence 
in age, APACHE II score, days from ICU admission to commencement of 
CRRT, length of ICU stay and mortality between two groups. There was 
no diff erence in median number of fi lters used by one patient (NM vs. 
heparin; median of 1.5 (IQR) vs. 2 (IQR), P = 0.27). Filter life in the UFH 
group was signifi cantly longer than those in the NM group (NM vs. UFH; 
median of 24 hours vs. 36 hours; P = 0.01). The incidence of bleeding 
complications was not signifi cantly diff erent between two groups (P = 
0.15).
Conclusion In our retrospective analysis with 101 patients, fi lter life 
with UFH was signifi cantly longer than those with NM. The incidence of 
bleeding complications was not signifi cantly diff ered between patients 
with NM and UFH.
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Introduction Acute kidney injury (AKI) aff ects 40% of critically ill 
patients, with UK data reporting 5% needing renal replacement 
therapy (RRT). Hospital mortality is reported as being up to 60%. We 
sought to evaluate renal and long-term patient survival outcomes in 
AKI patients receiving RRT on our ICU.
Methods Data were collected from our computerised information 
system on all AKI patients receiving RRT on our ICU, between October 
2008 and October 2013. This included demographics, APACHE II and 
SOFA scores, modality and dose of RRT and ICU length of stay (LOS). 
Renal and patient survival at ICU discharge was collected, in addition to 
outcome data at 28 and 90 days and 12 months. Data were examined 
using Cox proportional hazard multivariate analysis, with Stata 10.1.
Results A total of 620 patients with AKI received RRT on our ICU 
between October 2008 and October 2013. Sixty-one per cent were 
males. Median age was 65 years (IQR 54 to 74). Median APACHE II score 
was 23 (IQR 18 to 27). Median SOFA score was 11 (IQR 8 to 13). Fifty-fi ve 
per cent were mechanically ventilated. A total of 96.7% received CVVH 
as the principal RRT modality. Twenty-one per cent received a period of 
high-volume haemofi ltration (HVHF) (80 ml/kg/hour), median LOS was 
6 days (IQR 3 to 14). In total, 331 (53.4%) patients recovered their renal 
function at ICU discharge, whilst 237 (38.2%), 220 (35.4%), and 220 
(35.4%) patients did not at 28 and 90 days and 12 months respectively. 
A total of 414 (66.7%) patients survived to ICU discharge, with 368 
(59.3%), 341 (55%) and 308 (49.6%) patients being alive at 28 and 
90 days and 12 months respectively. Overall patient survival at the end 
of follow-up was 43%. Adjusting for age and sex; APACHE II score, SOFA 
score and use of HVHF were associated with worse patient survival at 
ICU discharge (HR: 1.07, 95% CI: 1.03 to 1.11, P <0.001, HR: 1.11, 95% 
CI: 1.03 to 1.19, P = 0.006 and HR: 2.27, 95% CI: 1.4 to 3.66, P = 0.001, 
respectively). Adjusting for age and sex; APACHE II score and use of 
HVHF were associated with worse renal recovery at ICU discharge (HR: 
1.06, 95% CI: 1.03 to 1.09, P <0.001 and HR: 1.55, 95% CI: 1.03 to 2.3, P = 
0.032 respectively). SOFA score did not appear to signifi cantly impact 
renal recovery (HR: 0.99, 95% CI: 0.94 to 1.04, P = 0.81).
Conclusion Results from our cohort suggest that, in patients with AKI 
presenting to ICU for RRT, long-term patient survival is signifi cantly 
impaired. Renal outcomes are poor with 35% being either dialysis 
dependent or having severe chronic kidney disease (eGFR <15  ml/
minute), at 1 year from ICU discharge. Our data do not suggest a benefi t 
of using HVHF in AKI patients presenting to ICU for RRT.
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Introduction Oxidative stress (OS) has been invoked as a relevant 
factor in the evolution and outcome of critical care patients. Indeed, 
antioxidant therapies have been used in critical care patients, but 
with controversial results. This may be explained by assuming OS as a 
homeostatically regulated parameter and both its excess and its defi cit 
infl uencing severity progression. Nonetheless, antioxidant agents could 
mask an OS signaling role, blocking otherwise physiological responses 
aimed at recovery of homeostasis. We have evaluated plasma total 
antioxidant capacity (TAC) in traumatized patients in the emergency 
department (ED) and we determined its potential relationship with 
severity and trauma location.
Methods In a prospective observational study of ED polytraumatized 
patients (n = 23, mean Acute Physiology and Chronic Health Evaluation 
II (APACHE II) score of 11 ± 6) we measured (in the fi rst 24 hours) plasma 
TAC by the ferric reducing activity/antioxidant power (FRAP). For control 
subjects, we used age-matched and gender-matched volunteers (n = 
32). We also evaluated the contribution of antioxidant molecules (uric 
acid, bilirubin, and albumin) to these values.
Results Polytraumatized patients show diff erences in TAC with 
reference to control subjects. ED polytraumatized patients show high 
FRAP values. We found that FRAP values were inversely correlated 
with APACHE II score (r = –0.266, P <0.01) suggesting that, in trauma 
patients, increased antioxidant response, as measured by FRAP assay, 
could be a pathophysiological response to stress. Albumin and uric 
acid concentrations reproduced the FRAP trend with severity.
Conclusion FRAP values in trauma ED patients are independently 
infl uenced by age (β = 0.271, P <0.021), APACHE II score (β = –0.356, 
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P  <0.002) and head trauma (β  = –0.219, P  <0.045). These results 
accentuate the infl uence of trauma location and severity in TAC 
changes. TAC response in ED patients reinforces the need for an 
adequate tailoring of treatments aimed at their recovery, such as 
antioxidant therapies.
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Introduction Previous studies reported hypothermia as an independent 
predictor for mortality. However, diff erent cutoff  points were used in 
these studies and external validation has never been applied. The aim 
of this study was to quantify the net eff ect of hypothermia on admission 
to the ICU on the 28-day mortality and to test the predictors from the 
developed model in another level 1 trauma center with a comparable 
patient population to validate the model.
Methods A retrospective cohort study was performed in adult 
trauma patients admitted to a level 1 trauma center and who were 
transferred to the ICU between 2007 and 2012. Diff erent cutoff 
points for hypothermia were compared to fi nd the best defi nition for 
hypothermia. Logistic regression analysis was performed to quantify 
the net eff ect of hypothermia on admission to the ICU on 28-day 
mortality and to develop a model with predictors. The developed 
model was externally validated in data from another level 1 trauma 
center with a comparable patient population.
Results In total, 722 trauma patients were included, of which 
300  patients were hypothermic. The mortality in the hypothermia 
group was signifi cantly higher than in normotherm patients (OR = 3.73, 
95% CI = 2.02 to 7.13, P <0.001). A cutoff  point of 36°C was observed as 
the best threshold for hypothermia (sensitivity 74%, specifi city 56%). 
Besides hypothermia, other predictors found for 28-day mortality were 
APACHE II score corrected for temperature, minimum thrombocytes in 
fi rst 24  hours and urea and included in the fi nal model with an AUC 
of 0.89 (95% CI  = 0.85 to 0.92). External validation of the model was 
associated with a predicted probability of an AUC of 0.64 (95% CI = 0.51 
to 0.77).
Conclusion Hypothermia, defi ned as <36°C, is associated with an 
increased 28-day mortality. The discriminative ability of the developed 
model for predicting mortality in a new patient population is moderate.
P308
Near-infrared spectroscopy to assess tissue oxygenation in patients 
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Introduction We evaluated tissue oxygenation by means of near-
infrared spectroscopy (NIRS) and explored its relationship with 
outcome in polytrauma patients.
Methods A prospective observational study; 37 polytrauma patients 
underwent NIRS monitoring (thenar eminence) every day during 
their stay in the ICU. A VOT was performed with a 40% tissue oxygen 
saturation (StO2) target. Healthy volunteers (n  = 27) were studied as 
controls.
Results StO2 increased over the fi rst 7 days only in hospital survivors (n = 
29), who showed higher values as compared with healthy volunteers 
at days 5 and 7 (Figure 1). StO2 downslope and upslope tended to be 
lower in H-nonsurvivors (n = 8) (P <0.05 at days 2 and 4) as compared 
with H-survivors. Tissue hemoglobin index was lower in H-no survivors 
over the fi rst 7  days and tended to normalize only in H-survivors 
(P >0.05 vs. healthy at day 7). Five patients were discharged from the 
ICU but did not survive until H-discharge. At discharge from the ICU, 
these patients were similar to H-survivors in SOFA score, heart rate, 
mean arterial pressure and lactate, but showed lower StO2 downslope 
(–13 (–16.5, –11.7)%/minute vs. –8.6 (–11.7, –6.5)%/minute, P = 0.01).
Conclusion An increase in StO2 and lower tissue oxygen extraction 
rates were associated with H-survival in polytrauma patients.
P309
Features and treatment of surviving casualties in the Kunshan 
‘August 2’ Explosion Accident: 40 case reports and literature review
J Liu, WU Wu
Suzhou Municipal Hospital, Nanjing Medical University, Suzhou, China
Critical Care 2015, 19(Suppl 1):P309 (doi: 10.1186/cc14389)
Introduction The aim was to analyze the injury features and treatment 
strategies of surviving casualties in the explosion accident on 2 August 
2014 in Kunshan city (Kunshan ‘August 2’ Explosion Accident).
Methods We retrospectively studied 40 cases of surviving casualties in 
the Kunshan ‘August 2’ Explosion Accident, and systemically reviewed 
the relevant literature.
Results A total of 40  cases were admitted to our hospital within 
6.3  ± 0.8  hours after the explosion accident on 2 August 2014 in 
Kunshan city, including 28 males and 12 females. The major injury 
types included burn injury, inhalation injury, blast injury (lung, eye, 
eardrum, and so forth), traumatic brain injury and bone fractures. 
All cases suff ered from burn injury caused by the explosion. The 
mean burned area in the surviving casualties accounted for 92  ± 
14% total body surface area (TBSA) and those with third-degree 
burns for 77  ± 19% TBSA. Additionally, incidence rate of inhalation 
injuries was 97.5%. There were 34 cases complicated by multiple 
organ dysfunction syndrome, which accounted for 85.0%. The 
common organ dysfunction of surviving casualties included the 
lungs, circulation, liver, gastrointestinal tract, kidney, brain, and 
coagulation. During hospitalization, the most common infectious 
site in surviving casualties was a burn wound, followed by blood 
and lung. The most common infectious strain of bacteria was Gram-
negative bacteria, which accounted for 91.3%. Further analysis 
showed that Proteus mirabilis ranked fi rst in occurrence, followed by 
Acinetobacter baumannii and Pesudomonas aeruginosa, and Klebsiella 
pneumonia and Enterobacter cloacae ranked fourth and fi fth. After 
intensive treatment, the mean 28-day mortality was 20.0% and 90-
day mortality was 62.5%, mainly due to septic shock and multiple 
organ dysfunction syndrome.
Conclusion During the Kunshan ‘August 2’ Explosion Accident, burn 
injury was the leading cause of injuries. Most surviving casualties are 
accompanied by multiple organ dysfunction syndrome and infection.
P310
Duration of mechanical ventilation in trauma patients: risk factor 
for VAP?
I Turriziani, A Cecchi, A Giugni, L Copertino
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Introduction In the literature, duration of mechanical ventilation 
(DMV) is often considered an important risk factor (RF) [1] for VAP [2] 
in critical patients; generally the whole duration of MV is taken into 
Figure 1 (abstract P308).
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account, including days before and after infection onset. We tried to 
assess whether, counting only MV days prior to VAP development 
(MVp), something would change.
Methods We considered, in a 10-year period, data prospectively collected 
in our database (4D solution, V11) on trauma patients admitted to the 
ICU directly from the emergency department. Inclusion criteria were: 
age ≥16 years, ICU length of stay (ICUlos) ≥4 days, DMV ≥48 hours; we 
excluded patients who received antibiotics before VAP (or during the 
whole stay, for patients without VAP) and with incomplete data. Data 
were: age, sex, prehospital GCS <9, prehospital intubation (preHTI), 
admission base excess (BE), Injury Severity Score (ISS), surgery, massive 
transfusion, feeding, antacids, nursing, DMV, ICUlos and MVp. MVp was 
calculated as the diff erence between the fi rst day of VAP and the fi rst 
day of MV in patients who developed VAP (vapY) and whole DMV in 
patients that did not (vapN). We only considered the fi rst infectious 
episode. The outcome was VAP onset. Group comparison was made 
with Fisher’s exact test and Student’s t test. Signifi cant variables were 
evaluated in a logistic regression (LR) model; the Hosmer–Lemeshow 
test (HL) was used as the post-estimation test. Odds ratio (OR) and 95% 
confi dence interval (95% CI) were calculated. Statistical signifi cance for 
P <0.05. We used Stata/IC 10.1 for analysis.
Results A total of 541 patients met the inclusion criteria, 378 (69.9%) 
developed VAP. MVp does not seem to be a RF for VAP because they are 
longer in vapN than in vapY (mean MVp 5.5 vs. 4.41, P = 0.001). PreHTI 
(vapY/N: 49.74%/38.65%; OR: 1.57; 95% CI: 1.08 to 2.28), ISS (mean 
vapY/N: 28.4/25.55; P = 0.0018), BE (mean vapY/N: –3.76/–3.04; P = 0.03) 
were signifi cantly diff erent between the two groups. In LR only preHTI 
(OR: 1.47; 95% CI: 1.01 to 2.15) and ISS (OR: 1.03; 95% CI: 1.01 to 1.05) are 
RF for VAP (HL: P = 0.133).
Conclusion In our study MVp are not a RF for VAP in trauma patients, 
although the whole DMV is longer in patients with VAP (mean DMV 
vapY/N: 13.57/6.09; P = 0.0001). Further studies could confi rm whether 
the whole DMV in trauma patients with VAP is a consequence of 
infection.
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Introduction Road accidents are the leading cause of death for 
young people, 50% being represented by vulnerable road users 
(VRU) (pedestrians, cyclists). In-depth accident studies assess the 
consequences of lack of use of safety devices and the need to develop 
new ones. Since 2009 a permanent team (physicians and engineers) 
has performed in-depth studies on road trauma admitted to our ICU 
[1].
Methods The team studied 52 VRU crashes that occurred in an urban 
area. The clinical data included an injury assessment using total body 
CT scan, Injury Severity Score (ISS), Abbreviated Injury Score (AIS), ICU 
and hospital length of stay and outcome score. Engineers collect data 
onsite with the partnership of the police, and assess the dynamics 
of the vehicles with the most advanced reconstruction techniques. 
Medical and engineering data were cross-matched during the 
correlation process. Injuries suff ered by each person were related to 
specifi c impact objects.
Results The average ISS is 21.5 (SD 10.9). Cars are the most involved 
in serious urban VRU crashes. Car-to-pedestrian crashes are the most 
frequent (50%). The impact speed is always over 40 km/hour (Table 1). 
The head and face are the most frequently injured part (48% of the 
571 injuries collected), followed by lower extremities (15%). In terms of 
maximum AIS (MAIS), the head is the most severely injured region with 
42% of MAIS 3+ (Figure 1).
Table 1 (abstract P311). Accident dynamics: medium speed (km/hour)
Dynamic N injured Speed (SD)
Car vs. pedestrian 29 41.1 (13.9)
Motorcycle vs. pedestrian 7 40.6 (4.3)
Car vs. cyclist 10 40.7 (15.9)
Other  6 49.0 (5.4)
Conclusion The head is still the most frequently and severely injured 
region. The severity of injuries increases in the most rigid part of the car. 
Improving VRUs’ safety devices (active and passive) to reduce impact 
speed and severity of the primary impact has to be the next step.
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Introduction The purpose of this study is to analyze anatomic 
distributions, diagnostic methods, and prognosis of missed fractures in 
patients with severe injury.
Methods A review of single-institutional medical records between 
January 2001 and May 2012 identifi ed 58 patients with 62 delayed 
diagnoses of fractures among 4,643 severely injured patients older 
than 20 years with Injury Severity Scores higher than 16. We evaluated 
combined injuries, location of fractures, diagnostic methods, and 
reasons for missed diagnosis at initial examination.
Results Among 62 missed fractures, there were eight cases of spine 
fracture, 10 cases of peri-shoulder joint fracture, eight cases of upper 
extremity fracture, 10  cases of pelvis of acetabulum fracture, and 26 
cases of lower extremity fracture. Head injury was the most common 
concomitant injury (23 cases). Initially missed fractures were most 
commonly discovered by offi  cial reading by radiologists. The most 
common reasons for misdiagnosis were the use of improper radiologic 
study and missed-reading of proper radiologic studies.
Conclusion In order to prevent misdiagnosis of fractures in patients 
with severe injury, meticulous physical examination with suspicion of 
fractures should come fi rst. In addition, obtaining proper radiologic 
study and thorough evaluation of radiologic images are important to 
decreasing the rates of missed fracture diagnoses. In addition, thorough 
surveillance for ipsilateral fractures is important in extremities with 
identifi ed fractures.
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Introduction Severe trauma aff ects the immune system, which in 
its turn is associated with poor outcome. The mediators driving the 
immune responses in trauma are largely unknown. The aim of this 
study was to investigate the role of endogenous microparticles (MPs) 
in mediating the immune response following severe trauma.
Methods A prospective, observational substudy of the Acute 
Coagulopathy and Infl ammation in Trauma (ACIT) II study was 
performed at our academic level 1 trauma center. Adult multiple 
trauma patients with an Injury Severity Score of 15 or higher were 
included between May 2012 and June 2013. Ex vivo whole blood 
stimulation with lipopolysaccharide was performed on aseptically 
collected patient plasma containing MPs and in plasma depleted of 
MPs. Flow cytometry and transmission electronic microscopy were 
performed on plasma samples to investigate the numbers and cellular 
origin of MPs. Healthy individuals served as a control group.
Results Ten trauma patients and 10 healthy individuals were included. 
Trauma patients were signifi cantly injured with a median ISS of 19 (17 
to 45). On admission to the hospital, the host response to bacterial 
stimulation was blunted in trauma patients compared with healthy 
individuals, as refl ected by decreased production of IL-6, IL-10 and TNFα 
(P <0.001). In trauma patients, MP-positive plasma was associated with 
a signifi cantly higher synthesis of IL-6 and TNFα compared with plasma 
depleted from MPs (P = 0.047 and 0.002 respectively). Compared with 
healthy individuals the number of circulating MPs was signifi cantly 
decreased in trauma patients (P  = 0.009). Most MPs originated from 
platelets. Multiple cellular protrusions, which result in MP formation, 
were observed in plasma from trauma patients, but not in healthy 
controls.
Conclusion On admission, trauma patients have a reduced immune 
response towards endotoxin challenge which is, at least in part, 
mediated by MPs, which circulate in low numbers and in early stages. 
Most MPs originate from platelets, which indicates that these cells 
may be the most important source of MPs involved in initiating an 
infl ammatory host response post injury.
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Introduction Various DAMPS, alarmins are released after trauma. The 
soluble receptor for advanced glycation endproducts (sRAGE) was 
reported to be associated with acute renal failure and duration of 
ventilation [1]. Cell-free DNA (cfDNA) has been associated with prognosis 
in trauma patients [2]. We studied the kinetics of these two biomarkers 
over the fi rst 5 days, in a cohort of severely ill trauma patients.
Methods Patients who had sustained serious traumatic injury, within 
24  hours of trauma, were recruited in a level I trauma center. We 
collected ISS, baseline demographic characteristics, resuscitation 
information and daily organ dysfunction (MOD) scores, over 10 days. 
Blood samples were collected within 24 hours of trauma (day 0) and 
on days 1, 3 and 5. sRAGE was measured by ELISA and cfDNA was 
measured by UV absorbance after plasma isolation.
Results Median ISS was 39 and mortality was 21% (8/38). During the 
fi rst 5 days after trauma, the median concentration of sRAGE (Figure 1) 
decreased signifi cantly over time (P  <0.0001) while median levels of 
DNA did not (P = 0.73), and remained elevated compared with normal 
control. No correlation was found with ISS. Patients initially in shock had 
lower levels of sRAGE or cfDNA (P <0.05) and had received more fl uid 
(10.6 l vs. 5.25 l) or blood (6 l vs. 0.5 l). Day 3 and day 5 sRAGE levels were 
inversely correlated with PRBC received. Medians of sRAGE on days 0 
(1,301 vs. 730 pg/ml) and day 1 (925 vs. 760 pg/ml) were signifi cantly 
higher in nonsurvivors (P  <0.01). Finally, day 0 sRAGE was correlated 
with the maximal (r = 0.44; P = 0.007) and the cumulative renal failure 
component of the MODS, over the 10 days (r = 0.48; P = 0.005).
Conclusion DNA and sRAGE kinetics diff er following trauma. Early 
elevation of sRAGE predicts mortality in univariate analysis and 
correlates with subsequent renal failure.
References
1. Cohen MJ. J Trauma. 2010;68:1273-8.
2. Simmons JD. Ann Surg. 2013;258:591-6.
P315
Clinical decision rule for cervical magnetic resonance imaging in 
suspected cervical spinal cord injury without bony injury is useful in 
predicting severity of cervical stenosis
T Inagaki1, A Kimura1, A Hagiwara1, R Sasaki1, K Kobayashi1, A Inaka1, 
G Makishi2
1National Center for Global Health and Medicine Hospital, Tokyo, Japan; 
2Seirei Hamamatsu General Hospital, Shizuoka, Japan
Critical Care 2015, 19(Suppl 1):P315 (doi: 10.1186/cc14395)
Introduction Cervical spinal cord injury (CCI) without bony injury 
(CCIWOBI) is more frequent among Asian than among Caucasian 
populations and shows various extents of severity. Cervical magnetic 
resonance imaging (MRI) is useful for detecting intramedullary lesions, 
ligament injuries and intervertebral disk hernias, but some patients 
with mild CCIWOBI do not show clinically signifi cant abnormalities on 
MRI. To date, the cost–benefi t ratio of performing MRI in addition to 
computed tomography (CT) is unclear. We have developed a clinical 
decision rule for cervical MRI (MR-CDR), indicating MRI for patients 
>70 years old with ossifi cation of the posterior longitudinal ligament 
on CT or injury in a ground-level fall or a fall down stairs. The objective 
of the present study was to prospectively validate this MR-CDR for 
cervical MRI in patients with suspected mild CCIWOBI.
Methods We have been conducting a prospective observational study 
in two institutions in Japan since September 2012, enrolling patients 
with CCIWOBI among head or neck trauma patients >16  years old 
brought in by ambulance. We collect data about patient characteristics, 
injury profi les, neurological fi ndings, results of radiological 
examinations, and medical courses. We then analyze the sensitivity and 
specifi city of MR-CDR for detecting intramedullary lesions on MRI and 
conduct further analysis.
Figure 1 (abstract P314). sRAGE kinetics (days).
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Results During the study period, 63 patients were brought in with 
CCIWOBI. Mean age was 60.6  years (standard deviation, 17.9  years) 
and 76% were male. Forty-fi ve patients presented with mild symptoms 
(Frankel Grade D). Cervical MRI was performed for 23 patients. Sensitivity 
and specifi city of MR-CDR in detecting intramedullary lesions on T2-
weighted imaging among cases of suspected mild CCIWOBI were 
85.7% (95% confi dence interval (CI), 60.1 to 96.0%) and 33.3% (95% 
CI, 12.1 to 35.4%). Further analysis showed a signifi cant diff erence in 
minimal spinal canal diameter as measured on sagittal T2-weighted 
imaging between the MR-CDR-positive and MR-CDR-negative groups 
(5.0 mm vs. 8.3 mm, P = 0.0003). One patient underwent surgery during 
hospitalization and no patients experienced exacerbated neurological 
fi ndings. No signifi cant diff erences were evident between groups in 
discharge status, duration of hospitalization, or neurological fi ndings 
at discharge.
Conclusion MR-CDR was not validated for predicting the existence of 
intramedullary lesions on cervical MRI. MR-CDR is useful in predicting 
the severity of cervical stenosis.
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Introduction Chest tube malfunction, after the tube thoracostomy, is 
often the result of an inappropriate chest tube tip position. The aim of 
this study was to analyze the precision of chest tube placement using 
the targeted wire guide technique (TWG technique) with a curve dilator 
and to compare it with the classical surgical technique (CS technique).
Methods In this clinical study 80 patients with an indication for thoracic 
drainage due to pneumothorax or pleural eff usion were included. The 
experimental group contained 39 patients whose chest tube was 
placed using the TWG technique. The control group contained 41 
patients whose chest tube was placed using the CS technique.
Results The comparison of the outcomes of the two techniques applied 
suggests that the TWG technique was signifi cantly more successful, 
irrespective of patient diagnosis (TWG vs. CS in all patients, 78.4% vs. 
36.6%, P <0.001). See Table 1.
Table 1 (abstract P316)
  CS technique TWG technique 
Diagnosis N (% of success) (% of success) P value
Pleural eff usion 47 37.5 78.2 0.005
Pneumothorax 31 35.3 78.6 0.029
Total 78 36.6 78.4 <0.001
Conclusion Using a curved dilator and the TWG technique for 
the thoracic drainage procedure we found statistically signifi cant 
advantage to the TWG technique in comparison with the CS technique 
regarding precise chest tube placement within the pleural cavity.
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Introduction In the surgical ICU, bedside tracheostomy (T) is one of 
the most frequently applied surgical techniques for multi-injured 
patients mainly with TBI [1]. The optimum surgical time decision for 
T still remains a contradiction in trauma. This retrospective study was 
designed to register all trauma patients who underwent T, during 
60 months of observation (2009 to 2013), in order to identify factors 
associated with their ICU outcome on the basis of the T day (A <10th 
day >B) after tracheal intubation.
Methods Seventy-eight injured patients in the SICU underwent T, 
from a total of 403 issues; 58 male and 20 female, with mean age 59.3 
and 74.7 years respectively. The total length of ICU stay recorded was 
2,098 days, nursing time 26.55 (4/93), whereas the T time was adjusted 
between the 6th and 16th day (mean 11th). Mean ISS score was 22.59 (9 
to 50). Classifi cation according to trauma type was TBI (n = 44) followed 
by thoracic trauma. Thirty-one male survivors were discharged from 
the ICU, to the ward. The mortality rate amounts to 47 cases due to 
infectious/non-infectious nosocomial complications and multiorgan 
dysfunction syndrome. Clinical ISS, the type of injury, ICU length of stay 
(LOS), T day, demographic (gender, age) data and ICU outcome were 
registered. Statistical analysis was performed with GraphPad 5.0.
Results There is positive signifi cant correlation between T day and LOS 
of injured patients (P <0.001, Spearman coeffi  cient = 0.1672). Statistical 
analysis by Mann–Whitney test, between groups A and B, showed 
signifi cant diff erences in ICU LOS (P <0.001); no signifi cant diff erences 
(P <0.05) were found for age, ISS and outcome (Table 1).
Conclusion The optimum and early time point of tracheostomy seems 
to be directly related with LOS in the ICU, independently of the rate 
of ISS, patient’s age and outcome. These results could account for ICU 
cost-eff ectiveness, as diminished LOS decreased the overall cost.
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Introduction The outcome of multiple trauma patients is related to a 
number of diagnostic and therapeutic interventions during hospitali-
zation. ICU patients with severe trauma are susceptible to sepsis 
leading to poor outcome. Factors associated with the occurrence of 
sepsis and the outcome of these patients were investigated.
Methods We studied retrospectively all trauma patients admitted to 
the A’ ICU of KAT General Hospital in Athens during the last 3  years 
and were treated for more than 5 days. Age, gender, the type of injury, 
the severity of injury (Injury Severity Score), the length of ICU stay, 
severe sepsis, coexisting diseases, the outcome and the cause of death 
were recorded. Logistic regression and chi-square tests were used for 
statistical analysis.
Table 1 (abstract P317). SICU data
 Outcome
ICU data ISS Age ICU LOS (days) Tracheostomy day Survival Mortality
A <10 16 ± 87 (16/45) 66 ± 94 (28/87) 602 17.2 ± 21.5 (4/47) 5.5 ± 6.5 (1/10) n = 13 (43.3%) n = 17 (57.7%)
B >10 16 ± 25 (9/50) 64 ± 87 (23/93) 1,496 25 ± 34 (9/95) 15 ± 26 (11/23) n = 18 (40%) n = 27 (60%)
t test NS NS <0.001 <0.001 NS NS
Data presented as median ± IQR.
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Results A total of 106 multiple trauma patients, 85 men and 21 women, 
met the inclusion criteria. Depending on their age, patients were 
divided into two groups: <60  years old and >60  years old. In both 
groups, gender, the type and severity of injuries and the length of ICU 
stay were not associated with outcome. The length of ICU stay was 
correlated with severe sepsis and coexisting diseases (P <0.01) in both 
groups. Mortality was not diff erent in the two groups. The presence 
of at least one coexisting disease was signifi cantly associated with 
mortality (P  <0.007). Sepsis was signifi cant cause of death in trauma 
patients >60 years (P <0.05).
Conclusion In multiple trauma patients, the length of ICU stay and 
comorbidities infl uence the occurrence of severe sepsis, comorbidities 
increase mortality, and sepsis is the leading cause of death in trauma 
patients >60 years old.
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Introduction Ventilator-associated pneumonia (VAP) is associated with 
increased length of ventilation, ICU stay, mortality, cost and antibiotic 
burden [1]. There is a large variation in reported rates of VAP, partly as a 
result of inconsistencies in defi nition [2]. We explored a more pragmatic 
defi nition to describe the VAP rate, antibiotic burden and outcome of 
VAP in a 44-bed adult critical care unit in a level 1 trauma centre.
Methods A retrospective review of all adult patients admitted to the 
ICU at The Royal London Hospital over a 6-month period (February to 
August 2014). The diagnosis of VAP was based on the Clinical Pulmonary 
Infection Score. Patients were identifi ed with VAP if they were started 
on antibiotics for chest sepsis 48  hours after start of mechanical 
ventilation. Demographic, clinical, microbiological and radiological 
data were collected to identify risk factors, and compare VAP and non-
VAP groups. Chi-squared and ANOVA tests were performed using the 
SOFA statistics package.
Results A total of 535 mechanically ventilated patients were admitted 
in the study period, with 281 ventilated for more than 48  hours. The 
incidence of VAP was 11% in all ventilated patients and 19.6% in those 
ventilated more than 48 hours. VAP rates were 31% in polytrauma, 25% 
in neurotrauma and 18% in the neuromedical/surgical cohort. Early 
and late onset VAP were equal in number. Patients with VAP spent 
longer on mechanical ventilation (9 ± 9 in no VAP vs. 18 ± 18 days in 
VAP patients; P  <0.001), and had longer ICU and hospital LOS (11  ± 
10 vs. 22 ± 20 days; P <0.001). However, APACHE II scores and hospital 
mortality were unaff ected (VAP 33.3% vs. no VAP 37.6%; P  = 0.173). 
Despite rising infl ammatory markers and secretion load, many patients 
did not exhibit oxygenation defi cits. Sputum microbiology showed 
S. aureus, H. Infl uenza, Klebsiella and Enterobacter as predominant 
pathogens with low rates of Pseudomonas, Acinectobacter and other 
resistant organisms. Average length of antibiotic use was 6 (3 to 18) days.
Conclusion Chest sepsis after 48  hours of mechanical ventilation 
commonly complicates neurocritical illness and polytrauma requiring 
signifi cant ICU resources and antibiotic burden. However, it does not 
aff ect mortality. Further research should focus on pathophysiology and 
new preventative measures to reduce VAP in the at-risk population.
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Introduction The normobaric oxygen paradox (NOP) postulates 
that a period of normobaric hyperoxia followed by a rapid return to 
normoxia will create a condition of relative hypoxia, which acts in turn 
as a stimulus for erythropoietin (EPO) production [1]. Variations in GSH 
and oxygen free radical (ROS) levels may be involved in this process. We 
tested the NOP in critically ill patients.
Methods A prospective observational study on 38 mechanically 
ventilated (FiO2 <50%) patients with no active bleeding, no blood 
transfusion needed, and no kidney failure. Eighteen patients 
underwent a 2-hour period of normobaric hyperoxia (FiO2  = 100%), 
20  patients were evaluated as controls (no FiO2 variations). EPO was 
assayed at baseline (t0), 24 hours (D1) and 48 hours (D2). Serum GSH 
and ROS were assayed at t0 (baseline), t1 (2-hour FiO2 100%) and t2 (2-
hour return to normoxia) in 12 patients in the hyperoxia group.
Results EPO tended to increase in the hyperoxia group over time (P = 
0.05), while it remained stable in the control group (P = 0.53) (Figure 1). 
ROS levels increased at t1 and decreased at t2, GSH tended to decrease 
at t1 and increased at t2 in the hyperoxia group.
Conclusion Relative hypoxia after a transient period of normobaric 
hyperoxia induces an increase in GSH levels, thus enhancing ROS 
scavenging. This may act as a stimulus for EPO production.
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Introduction The early exclusion of PE is a major precondition for goal-
oriented diagnostic and therapeutic measures. The aim of the study 
was to evaluate the new point-of-care assay PATHFAST D-dimer in 
comparison with VIDAS D-Dimer Exclusion and STRATUS CS D-dimer.
Methods A total of 272 patients with symptoms of PE and VTE were 
included. The diagnoses of VTE and PE were established by duplex 
ultrasound, venography and spiral CT. D-dimer values were determined 
in the patients and in plasma samples obtained from 102 healthy 
individuals who served as the control group.
Results Mean D-dimer concentration of the control group and of 
the patient group with PE was 0.28 (95% CI: 0.25 to 0.31)  mg/l and 
1.45 (95% CI: 1.23 to 1.72)  mg/l, respectively. Receiver operator 
characteristics analysis revealed an optimized cutoff  value of 
0.466 mg/l for the PATHFAST D-dimer assay (AUC = 0.975 (95% CI: 0.938 
to 0.993); sensitivity: 95% (95% CI: 86 to 99%); specifi city: 89% (95% CI: 
82 to 95%)). Therefore we used a rounded up cutoff  value of 0.5 mg/l to 
examine the diagnostic accuracy of PATHFAST D-dimer to exclude PE. 
The correlation between PATHFAST and VIDAS results was particularly 
close for concentrations at or around the critical cutoff  value of 
Figure 1 (abstract P320).
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0.5 mg/l. The correlation between PATHFAST and STRATUS results was 
particularly close in the patient group with VTE (r = 0.9694), whereas 
slightly lower results were obtained with STRATUS in the control group. 
With the widely used cutoff  value 0.5  mg/l, PATHFAST demonstrated 
suitable sensitivity but not STRATUS. ROC analysis indicated that 
optimal cutoff  values could be set at either 0.5 or 0.6 mg/l and at 0.3 or 
0.4 mg/l for PATHFAST and STRATUS, respectively.
Conclusion By use of the PATHFAST D-dimer assay only six of diagnoses 
were missed at the time of fi rst presentation compared with 10 diagnoses 
missed by the VIDAS D-dimer Exclusion assay, yielding higher sensitivity 
of the PATHFAST D-dimer assay compared with the VIDAS assay (90% 
vs. 83%). The STRATUS assays showed comparable performance and 
appeared to be suitable for the exclusion of VTE in the emergency room 
setting, whereas PATHFAST demonstrated superior sensitivity. Moreover, 
the PATHFAST analyzer allows simultaneous determination of D-dimer 
and cardiac troponin I within 16  minutes from whole blood samples. 
Therefore, this method might be useful at the point of care for early 
diagnostic assessment of patients with symptoms of PE or chest pain 
admitted to the ER or to the chest pain unit.
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Introduction A prospective study was conducted in patients for 
treatment of venous thromboembolism (VTE) to compare the eff ect 
of enoxaparin and rivaroxaban using the method of low-frequency 
piezoelectric thromboelastography (LPTEG) for checking coagulation 
activation markers.
Methods A total of 60  patients entered the Odessa Clinical Regional 
Hospital for treatment venous thromboembolism. Patients were 
divided into two groups. The fi rst group (n  = 30) were receiving 
enoxaparin in dosage 1.5 mg/kg subcutaneously per day. The second 
group (n  = 30) were receiving rivaroxaban orally 15  mg/day. For 
checking the coagulation state we were using such indicators of LPTEG 
as constant thrombin activity (CTA), intensity of coagulation drive (ICD) 
and gel point (GP). We performed LPTEG three times per day: 4, 12 and 
24 hours after taking the drug to check for changes in the coagulation 
state in both groups of patients.
Results The peak action of enoxaparin and rivaroxaban was observed 
at 4  hours post administration. LPTEG indicators that determine the 
coagulation state after 4 hours in the fi rst group: CTA was decreased 
by 72.12% (P <0.05), ICD was decreased by 68.44% (P <0.05), GP was 
increased by 17.9%; in the second group: CTA was decreased by 76.24% 
(P <0.05), ICD was decreased by 74.52% (P <0.05), GP was increased by 
23.34%. After 12  hours, CTA in the fi rst group decreased by 22.41%, 
ICD decreased by 5.3%, GP increased by 8.12%, indicating reduction of 
hypocoagulation eff ect; in the second group, CTA decreased by 39.35% 
(P <0.05), ICD decreased by 40.24% (P <0.05), GP increased by 18.25%. 
After 24  hours in the fi rst group LPTEG indicators returned to the 
original value, and in the second group of patients CTA was decreased 
by 15.14%, ICD was decreased by 6.62%, GP increased by 14.22%.
Conclusion Using LPTEG showed the hypocoagulation eff ect of 
continuous rivaroxaban 24  hours after oral administration compared 
with enoxaparin, which retains less hypocoagulation eff ect 12 hours after 
administration. LPTEG indicators in the second group were bigger than 
in the fi rst group after 12 hours: CTA 43.07%, ICD 69.72%, GP 54.12%.
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Introduction Thromboembolic complications (TEC) are very common 
and lethal in patients suff ering from traumatic injury [1]. The trauma 
clinical guidelines recommend the administration of pharmacological 
thromboprophylaxis (PTP) to reduce the risk of developing TEC [2]. 
However, it is unknown whether delayed PTP initiation increases risk 
of TEC. We hypothesize that delayed PTP initiation is associated with 
increased TEC rates.
Methods A retrospective chart review (2010 to 2013) was conducted 
on adult trauma patients that were admitted into a level 1 trauma 
centre in Toronto. Demographics, date of PTP initiation, date of TEC 
diagnosis (CT-PE/US Doppler), injury type and severity were collected. 
A comparison between early and late PTP initiation has been made 
with regards to TEC development. Student’s t test, univariate and 
multivariate logistic regression analyses were performed.
Results A total of 1,312 patients received PTP, 821 (62.5%) initiated 
early PTP (within 48 hours) while 491 (37.5%) initiated after 48 hours. 
The group that initiated early prophylaxis was younger (mean: 46 vs. 
55, P <0.0005), had lower ISS (mean: 17 vs. 24, P <0.0005), shorter length 
of stay (LOS) (mean: 11 vs. 23, P <0.0005), more pelvic fractures (19% 
vs. 13%, P = 0.0058), more head injury (AIS Head ≥3, P <0.0005), less 
blunt trauma (85% vs. 95%, P <0.0005), lower incidence of TEC (5.3% 
(44) vs. 8.5% (42), P = 0.023), and lower mortality rate (1.5% vs. 7.5%). 
Univariate analysis showed LOS (P  <0.0005), ISS (P  <0.0005), time to 
PTP initiation (P  = 0.0018) and blunt MOI (P  = 0.0099) signifi cantly 
associated with TEC events. Multivariate analysis, however, showed TEC 
events correlated only to LOS (P = 0.0001). Stepwise multiple logistic 
regression confi rmed LOS as independently associated with TEC events 
(95% CI = 0.003, 0.006, P <0.0005).
Conclusion Mortality rates in patients with delayed PTP are higher. Our 
study shows LOS as the only independent predictor for TEC. However, 
this might not necessarily refl ect causation. Delayed PTP appears not to 
be an independent predictor to TEC events in trauma patients, which 
favours current clinical trends when it comes to contraindicating early 
PTP initiation.
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Introduction Pulmonary embolism (PE) is a signifi cant cause of death 
with 10% of patients dying within 3 months [1]. Multiple studies now 
advocate the use of thrombolysis (TPA) in both massive and submassive 
PE [1,2]. This audit assessed the impact of introducing a guideline 
allowing for thrombolysis of submassive and massive PE at a large UK 
teaching hospital.
Methods Retrospective data collection using notes and imaging to 
risk-stratify patients. First audit ran from January to June 2012. New 
guidance was introduced in March 2013 (Figure 1) after which a second 
cycle ran for a further 6 months.
Results Re-audit revealed 46 patients with radiological evidence of 
massive or submassive PE on CTPA (32% of all PEs). Ten patients had 
clinical features of submassive PE and nine presented as massive PE. 
Previous guidelines suggested consideration of TPA in only seven 
patients in 6  months. TPA was given to two patients; however, six 
patients had no contraindications to treatment (Table  1). Limitations 
to TPA administration were late recognition of submassive PE and 
inadequate knowledge of changes to guidelines.
Conclusion Delivering a service that off ers TPA to patients with 
submassive PE signifi cantly increases the need to consider this therapy. 
Introducing this service is only eff ective if doctors initially assessing 
these patients are aware of recent changes to guidelines for PE.
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Table 1 (abstract P324). TPA decisions
  High Intermediate
 Total risk risk
Considered TPA and given 2 2 0
Considered TPA but contraindications 1 1 0
Considered TPA and not given on balance 3 0 3
Considered TPA and not given but fi t  3 2 1
criteria
Not considered TPA but contraindicated  4 1 3
anyway
Not considered TPA and on balance  5 1 4
would not be given
Not considered TPA but fi t criteria 1 0 1
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Introduction Despite preventive anticoagulation therapy measures, 
venous thromboembolic disease is a major cause of morbidity and 
mortality among patients hospitalized in ICUs. In fact, pulmonary 
embolism is not only the most serious manifestation of the disease, but 
also one of the primary causes of sudden death. The aim of this study 
is to investigate the frequency of thromboembolism and pulmonary 
embolism in ICU hospitalized trauma and neurosurgical patients.
Methods One hundred ICU patients, 51 postoperative neurosurgical 
and 49 trauma, were included in the study. Patients’ demographic data 
as well as medical history, temperature, white blood cells and platelets 
counts were recorded on admission, the day of thrombosis diagnosis 
and the fi nal outcome of their treatment. Statistics were performed 
with SPSS-19. P <0.05 was considered signifi cant.
Results Thirty-eight out of 100  patients presented thrombosis, 
14 trauma and 24 neurosurgical. We examined the correlation of 
thrombosis development during hospitalization with diagnosis, 
treatment allocated time and overall patient outcome. It was found 
that neurosurgical patients developed thrombosis more frequently 
than trauma patients (P <0.05). In relation to diagnosis, thrombosis was 
prevalent among patients with brain lesions (P = 0.018). Regarding the 
type of thrombosis, pulmonary embolism was also commonly apparent 
among individuals with brain lesion (P = 0.020). In addition, there was 
a statistically signifi cant correlation in thrombosis occurrence between 
hospitalization day (P  <0.01) and patients’ outcome on discharge 
(P  <0.001). The type of thrombosis was directly associated with poor 
outcome, especially one that resulted from central catheters (P <0.001) 
and pulmonary embolism (P  <0.001). However, no correlations were 
found with temperature, white blood cells and platelet counts on 
admission (P > 0.05).
Conclusion Thrombosis aff ects the ICU patient’s fi nal outcome. 
The type of thrombosis contributes to a poor outcome and mainly 
the occurrence of pulmonary embolism signifi cantly increases the 
mortality rate.
P326
Incidence and outcome of asymptomatic deep vein thrombosis in 
critically ill patients: a prospective cohort study
R Echigoya, H Okamoto, H Uchino, A Kuriyama, N Tamura, K Sato, T Fukuoka
Kurashiki Central Hospital, Okayama, Japan
Critical Care 2015, 19(Suppl 1):P326 (doi: 10.1186/cc14406)
Introduction Asymptomatic deep vein thrombosis (DVT) including 
catheter-related thrombosis (CRT) is an increasingly recognized disease 
entity in critically ill patients. However, the reported rate and outcome 
of DVT vary widely depending on study design, patient background 
and detecting method. The objective of this study is to evaluate the 
incidence and outcome of DVT in adult critically ill patients.
Methods This study is a prospective cohort study of patients admitted 
to a medical and surgical ICU from 1 July 2014 to 15 October 2014. All 
consecutive patients over 18 years of age and with expected ICU stay 
over 72 hours were included. Patients who had previous history of DVTs 
were excluded. We examined internal jugular vein, subclavian vein, 
axillary vein, brachial vein, femoral vein, superfi cial femoral vein, and 
popliteal vein, on ICU admission and within 48 hours after ICU discharge. 
The DVT was diagnosed using compression ultrasonography with color 
Doppler. Images were interpreted by two independent investigators 
trained in ultrasonography. All patients received intermittent 
pneumatic compression and unfractionated heparin twice daily during 
their IUC stay. Once the DVT was detected, therapeutic anticoagulation 
was initiated. Contrast-enhanced CT was performed when the patients 
were suspected to have pulmonary embolism. The primary outcome 
was the incidence of DVT during the ICU stay. Patients were followed 
until their hospital discharge.
Results A total of 51 patients were included. The median age and BMI 
were 73 years and 23 kg/m2, respectively; 31% were female and 69% 
were surgical critical care patients. The median APACHE II and SOFA 
scores were 20 and 8, respectively. Risk factors associated with DVT 
were presence of central venous catheter 63%, malignancy 9% and 
hemodialysis 14%. The rate of DVT was 18.6% and the rate of CRT was 
13.7%. All of these were asymptomatic and seen in neck and upper 
extremities. There was no DVT-associated adverse event (pulmonary 
embolism, bleeding) during hospital stay. The 28-day all-cause 
mortality rate was 3.4%.
Conclusion While incidence of asymptomatic DVT is relatively high in 
adult critically ill patients, they were found only in the neck and upper 
extremities without any adverse event. Further research is needed to 
evaluate the clinical signifi cance of this type of DVT.
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Introduction Computed tomographic pulmonary angiography (CTPA) 
has been used as a standard tool for diagnosing an acute pulmonary 
embolism (APE). The right ventricular (RV) strain signs may be used to 
predict adverse outcomes. However, the results are still controversial. 
The primary objective of our study was to evaluate the relationship 
between the RV strain signs and respiratory failure requiring 
mechanical ventilation or death in APE. The secondary objective was to 
identify clinical factors which related to those outcomes.
Figure 1 (abstract P324). New local guidelines.
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Methods CTPA and the medical records of patients with suspected 
APE on admission from June 2011 to March 2013 were reviewed. RV 
dysfunction signs included right ventricular to left ventricular (RV/LV) 
diameter ratio, interventricular septal shift, main pulmonary artery 
to ascending aorta (mPA/AA) diameter ratio, IVC contrast refl ux, SVC 
diameter, IVC diameter, PA diameter and azygos vein diameter. Clinical 
factors included cardiovascular, respiratory parameter and also time to 
diagnosis and treatment.
Results There were total of 36 cases with suspected APE on admission. 
Ten patients required mechanical ventilation (27.8%) and seven 
patients died (19.4%). Interventricular septal (IVS) shift was a signifi cant 
risk factor of in-hospital death (85.7% vs. 27.6%, P  = 0.008) and 
respiratory failure (70% vs. 26.9%, P = 0.026). The sensitivity, specifi city, 
positive predictive and negative predictive values of IVS shift to predict 
in-hospital death were 85.7%, 70%, 42.8% and 95.5%, respectively. 
The sensitivity, specifi city, positive predictive and negative predictive 
values of IVS shift to predict respiratory failure were 70%, 73.1%, 50% 
and 86.4%, respectively. The ratios of RV to LV diameter and the ratio 
of main pulmonary artery to ascending aorta diameter tended to be 
higher in the nonsurvivor group. The clinical factor that predicted 
mortality was the PaO2 to FiO2 ratio (P/F ratio). Mean P/F ratio in survivor 
and nonsurvivor groups was 246.1 ± 94.1 vs. 132.2 ± 78.1, respectively 
(P = 0.011). P/F ratio ≤150 was the best predictor of mortality (66.7% vs. 
8.7%, P = 0.008).
Conclusion The IVS shifting from CTPA and P/F ratio ≤150 helps predict 
poor outcomes in APE.
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Introduction Recently, mean platelet volume (MPV) was reported to 
predict early death in acute pulmonary embolism (PE). The aim of this 
study was to investigate the role of MPV and MPV/platelet count ratio 
(MPV/P) in risk stratifi cation of patients with acute PE.
Methods We retrospectively reviewed the medical records of patients 
with acute PE admitted to the emergency department. In addition 
to the clinical evaluation, platelet count and MPV were measured on 
admission.
Results One hundred and fi fty-two patients were included. Patients 
with right ventricular (RV) dysfunction had signifi cantly higher MPV 
levels and MPV/P than patients without RV dysfunction. Receiver 
operating characteristic analysis revealed that a MPV cutoff  of 7.85 fl  
provided 53.3% sensitivity and 68.5% specifi city, and a MPV/P cutoff  
of 0.0339 fl /(109/l) provided 69.6% sensitivity and 65% specifi city for 
prediction of RV dysfunction. There was a positive correlation between 
MPV and systolic pulmonary artery pressure (SPAP) and between MPV 
and RV diameter. There was a positive correlation between MPV/P and 
SPAP and between MPV/P and RV diameter. The low-risk PE group had 
lower MPV and MPV/P than the massive PE and submassive PE groups.
Conclusion MPV and MPV/P are associated with RV dysfunction and 
clinical severity in acute PE. Low MPV and MPV/P levels may be an 
indicator of low risk in patients with acute PE.
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Introduction Atypical haemolytic uraemic syndrome (aHUS) is 
associated with severe kidney damage; almost one-half of adults 
with aHUS progress to end-stage renal disease (ESRD) after the fi rst 
episode [1]. Two prospective clinical trials have assessed the effi  cacy of 
eculizumab (Ecu) in patients with aHUS [2]. We now evaluate data on 
progression to ESRD before and during Ecu treatment.
Methods Patients with chronic kidney disease (CKD) stage 1 to 4 
were analysed for progression to an ESRD event (two consecutive 
glomerular fi ltration rate measurements <15  ml/minute/1.73m2 (CKD 
stage 5)). ESRD incidence rate ratios during supportive care (SC) and 
Ecu treatment phases were calculated using a negative binomial 
regression analysis. Kaplan–Meier analyses were calculated for all 
patients and stratifi ed by CKD stages 2 to 4 at baseline. Hazard ratios 
(HR) were calculated from Cox proportional hazard models.
Results The SC and Ecu treatment phases included 32 and 33 patients, 
respectively. With SC, during a median (range) of 211 (7 to 745) days, 13 
(41%) patients had a total of 16 ESRD events. On Ecu treatment, during 
a median (range) of 924 (73 to 1,254) days, three (9%) patients had a 
total of fi ve ESRD events. The ESRD event rate was 92% lower during Ecu 
treatment versus the SC phase (0.36 vs. 0.07; P = 0.001); the incidence 
rate ratio was 0.08 (95% CI = 0.02 to 0.37; P = 0.001). HR for progression 
to ESRD for patients on Ecu versus SC was 0.03 (95% CI <0.01 to 0.34), a 
97% reduction (Figure 1). Stratifi cation by baseline CKD stage showed 
no patients with CKD stage 2 or 3 at baseline progressed to ESRD over 
3 years of Ecu treatment.
Conclusion Ecu treatment reduces the number of ESRD events and 
the rate of progression to ESRD; thus initiation of Ecu early after aHUS 
diagnosis may prevent cumulative kidney damage and progression to 
ESRD.
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Introduction Atypical haemolytic uraemic syndrome (aHUS) is a 
severe, life-threatening disease requiring rapid treatment to inhibit 
complement-mediated thrombotic microangiopathy (TMA) and 
avoid irreversible organ damage. Four prospective clinical trials have 
reported the safety and effi  cacy of eculizumab (Ecu) in the treatment 
of aHUS [1,2]. We report data from a pooled analysis of these trials on 
renal function in patients starting Ecu within ≤7 days or >7 days after 
the current aHUS manifestation.
Methods Data from four phase 2, open-label, single-arm trials including 
both paediatric and adult patients with aHUS were pooled. Patients 
with a documented date of onset of current TMA manifestation and 
a baseline estimated glomerular fi ltration rate (eGFR) of <90  ml/
Figure 1 (abstract P329). Kaplan–Meier analysis of ESRD progression for 
SC and Ecu treatment for all patients.
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minute/1.73  m2 were included. Changes from baseline in eGFR were 
analysed at study visits using a one-sample t test.
Results Data from 97 patients were analysed: median (range) age at 
enrolment was 29 (0 to 80) years; 62% of patients were females; median 
(range) duration of current manifestation to start of Ecu treatment 
was 23 (1 to 1,447) days; median (range) baseline eGFR was 15.9 (5.6 
to 76.1) ml/minute/1.73 m2. Ecu treatment was started in 21 patients 
in ≤7  days and 76 patients in >7  days after presentation with TMA. 
Median eGFR was 11 ml/minute/1.73 m2 for the patients started within 
7 days and 16 ml/minute/1.73 m2 for those initiating >7 days. The mean 
change from baseline in eGFR for patients starting Ecu in ≤7 days and in 
>7 days after presentation with TMA were 57 and 23 ml/minute/1.73 m2 
at 1 year, respectively (Figure 1).
Conclusion This pooled analysis indicates that patients treated with 
Ecu within 7 days of a TMA manifestation had a greater improvement 
in eGFR over time than patients in whom treatment was delayed. These 
data show the importance of rapid diagnosis and treatment of aHUS for 
recovery of renal function.
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Introduction Hemoglobin as the main trigger parameter for blood 
transfusion usually gives diminutive information about oxygen delivery 
and consumption. Although central venous oxygen saturation (ScvO2) 
is an alternative parameter, its changes are unable to detect regional 
hypoxia. Our aim was to evaluate the quotient of the central venous-to-
arterial carbon dioxide gradient (δPCO2) and the arteriovenous oxygen 
content diff erence (Ca-cvO2) as a valid transfusion trigger parameter 
in hemodynamically stable anemic patients to reduce the amount of 
potentially counterproductive erythrocyte transfusions [1].
Methods Forty-fi ve postoperative patients admitted to our cardiac 
ICU were enrolled between January 2013 and September 2014. 
Three groups were defi ned according to the trend of blood loss over 
the surgical drains in the fi rst 24 postoperative hours. Mild blood 
loss was defi ned as 500 to 1,000  ml/24  hours, moderate (1,000 to 
1,500/24  hours) and severe (>1,500  ml/24  hours). In addition to the 
δPCO2 the following parameters were monitored: CI, CO, SVR, serum 
lactate, ScvO2 and hemoglobin. Ca-cvO2 was calculated and the δPCO2/
Ca-cvO2 quotient was assessed for a total of 400 paired blood samples. 
All enrolled patients were hemodynamically stable. A retrospective 
analysis of this data was performed.
Results δPCO2/Ca-cvO2 showed signifi cant correlation with the 
moderate and severe blood loss groups (P <0.01), while no signifi cant 
correlation was detected in the mild blood loss group. The abnormality 
of the δPCO2/Ca-cvO2 was easy detectable and refl ected intracapillary 
hemoglobin capacity decline and signifi cantly improved after 
erythrocyte transfusions (P <0.005).
Conclusion Blood transfusions carry risks of adverse eff ects and should 
be carried out responsibly. Our fi ndings suggest an additive and easy 
detectable transfusion trigger parameter (δPCO2/Ca-cvO2) providing 
physiological information on anemia-related altered oxygen extraction 
conditions and hence the indication for erythrocyte transfusions. 
However, additional studies are warranted to confi rm these fi ndings.
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Introduction We aimed to evaluate the frequency of red blood cell (RBC) 
transfusion in patients with traumatic brain injury (TBI) as well as determinants 
and outcomes associated with RBC transfusion in this population.
Methods We conducted a systematic review of cohort studies and 
trials of patients with TBI. We searched Medline, Embase, The Cochrane 
Library and BIOSIS databases from their inception up to 30 June 2014. 
We selected cohort studies and RCTs of adult patients with TBI reporting 
data on RBC transfusions. We extracted data related to demographics, 
baseline characteristics, blood product use and any relevant clinical 
patient-oriented outcome. Cumulative incidences of transfusion were 
pooled through random eff ect models with a DerSimonian approach, 
after a Freeman–Tukey transformation to stabilize variances. To evaluate 
the association between RBC transfusion and potential determinants 
as well as outcomes, we pooled risk ratios or mean diff erences with 
random eff ect models and the Mantel–Haenszel method. Sensitivity 
and subgroup analysis were planned a priori.
Results We identifi ed 21 eligible studies (16,951 patients). After 
pooling data from the 20 included cohort studies (16,884 patients), 
at least around 33% (95% CI: 27 to 39; I2: 97.8%) of patients with TBI 
in published reports received transfusions at some point during their 
hospital stay. In a post hoc analysis of one RCT comparing transfusion 
strategies, 82% of patients were transfused RBCs. Thresholds for 
transfusion were rarely available and varied from 6 to 10  g/dl. From 
raw data, Glasgow Coma Scale scores were lower in patients who were 
transfused than those who were not (three cohort studies; n = 1,371; 
mean diff erence of 1.38 points (95% CI: 0.86 to 1.89); I2 = 12%). Mortality 
was not signifi cantly diff erent among transfused and nontransfused 
patients both in univariate and multivariate analyses. Hospital length 
of stay was longer among patients who were transfused (three studies; 
n = 455; mean diff erence 9.58 days (95% CI: 3.94 to 15.22); I2 = 74%). 
Due to the observational nature of included studies, results should be 
considered cautiously due to the high risk of confounding.
Conclusion RBC transfusion is frequent in patients with TBI, but 
practices varied widely in cohort studies in this population. The paucity 
of data precludes defi nitive conclusions and highlights the lack of 
clinical evidence guiding transfusion strategies in TBI.
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Introduction The aim of this study is to explore the association between 
red blood cell transfusion (RBCT) and mortality in Thai critically ill 
surgical patients.
Figure 1 (abstract P330). Mean change in eGFR from baseline over 
1 year (standard error).
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S117
Methods This study was a part of the multicenter, prospective, 
observational study performed in nine surgical intensive care units 
(SICUs) across the nation between April 2011 and November 2012 [1]. 
This study included adult patients admitted to the SICUs after surgery. 
Patients were categorized into transfusion and no transfusion groups 
according to whether or not they received RBCT at any time during 
SICU stay. Demographic data, clinical outcomes as well as SICU and 
hospital length of stay (LOS) and SICU and hospital mortality were 
collected. Patients were followed for up to 28 days or until discharge 
from the SICUs. The primary endpoint was hospital mortality. Data 
were compared between groups and logistic regression analysis was 
performed to determine whether RBCT was an independent risk factor 
of hospital mortality. In addition, patients were matched between 
groups based on the propensity score of the requirement of RBCT and 
were then compared.
Results Overall, 968 of 2,374 (40.8%) patients received RBCT. Trans-
fused patients, when compared with those without RBCT, had more 
frequency of admission after emergency surgery, higher APACHE II 
score, higher SOFA score, higher number of organ dysfunctions and 
lower hemoglobin level at admission. When compared with patients 
without RBCT, those with RBCT had more frequency of all adverse 
events including infection, AKI, ALI/ARDS and MI, and longer SICU 
and hospital LOS. Both SICU and hospital mortality were also higher in 
the transfusion group compared with the no transfusion group (9.4% 
vs. 1.6% and 13.7% vs. 3.6%, both P <0.001, respectively). The logistic 
regression analysis showed that RBCT was an independent risk factor 
of hospital mortality with odds ratio of 1.60 (95% CI 1.05 to 2.45). In 
the propensity-score matched cohort of 852 patients, when compared 
with patients without RBCT, transfused patients had more frequency of 
adverse events including infection and AKI, longer SICU and hospital 
LOS and higher hospital mortality (7.5% vs. 4.0%, P = 0.027).
Conclusion This study showed that RBCT was associated with increased 
morbidity and mortality in critically ill surgical patients. These results 
supported the restrictive strategy of RBCT suggested by more recent 
studies.
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Introduction Anaemia in patients with severe traumatic brain injury 
(TBI) may worsen neurologic outcome. The aim of this study was to 
determine the association of haemoglobin level (Hb) with neurologic 
outcome and to determine a transfusion threshold which may be used 
in future transfusion trials aimed at improving neurologic outcome in 
TBI patients.
Methods A substudy of the prospective multicentre Activation of 
Coagulation and Infl ammation in Trauma (ACIT) II study was performed 
on subjects recruited between January 2008 and December 2014. All 
adult trauma patients admitted to a level 1 trauma centre with severe 
traumatic brain injury (AIS head ≥3), ICU admission and available Hb 
levels on admission were selected for analysis. The primary outcome 
was the cognitive functioning of patients as determined by an 
estimated Glasgow Outcome Scale (GOS) on discharge. Anaemia 
was defi ned as a Hb level of ≤9  g/dl (severe anaemia) or ≤10  g/dl 
(moderate anaemia) within the fi rst 24 hours post injury. Multivariate 
logistic regression models were used to determine the association 
between anaemia and neurologic outcome. The receiver operating 
characteristic curve and the Youden Index were used to determine an 
optimal transfusion threshold.
Results Of a total of 261 TBI patients, 61 patients (23%) fell below the 
threshold for severe anaemia and 101 patients (39%) had moderate 
anaemia within the fi rst 24 hours. In a model adjusted for all relevant 
confounders, a Hb level of ≤9 g/dl was associated with a poor neurologic 
outcome (OR = 2.572, 95% CI = 1.058 to 6.250), whereas an Hb level of 
≤10 g/dl was not. A Hb level of ≤10.3 g/dl had a sensitivity of 82% and 
a specifi city of 62% to predict poor neurologic outcome in TBI patients.
Conclusion In TBI patients a Hb level of ≤9 g/dl is associated with poor 
neurologic outcome. A transfusion threshold of ≤10.3  g/dl may be 
a reasonable target to be tested in future transfusion trials aimed at 
improving neurologic outcome of TBI patients.
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Introduction Red blood cell (RBC) transfusion is associated with 
increased morbidity and mortality in the critically ill. Adverse eff ects 
of transfusion may be mediated by red blood cell storage lesion. In this 
study, we hypothesized that MPs from stored RBC bags would induce 
a more pronounced host response than MPs from fresh RBC bags and 
that this response is dose dependent.
Methods MPs were isolated by high-speed centrifugation from red blood 
cell transfusion bags stored for 2 to 7 (fresh) or 25 to 35 (stored) days. 
Whole blood from healthy volunteers was incubated with supernatant 
from the bags either containing MPs or depleted from MPs (n = 12 bags 
per group). Controls were incubated with PBS as a negative and LPS 
(10 ng/ml) as a positive control. Cytokines in supernatant were measured 
by ELISA. Data are expressed as medians and interquartile ranges.
Results Supernatant from blood bags containing MPs strongly induced 
production of all cytokines compared with supernatant without MPs, a 
reaction which equaled that of LPS stimulation. MPs from stored RBC 
bags induced higher production of TNF (868 (263 to 1,625) vs. 2,596 
(407 to 3,040)  pg/ml, P  = 0.049), IL-6 (1,088 (234 to 3,716) vs. 6,952 
(1,507 to 21,990), P = 0.042) and IL-8 (1,333 (535 to 3,569) vs. 5,562 (833 
to 13,904), P = 0.081) compared with MPs from fresh RBC bags. There 
was no diff erence in IL-10 responses between groups (8.0 (3.9 to 32.1) 
vs. 3.9 (3.9 to 22.2), P = 0.390). The host response was dose dependent 
both for fresh and stored MPs. In addition, the same amount of older 
MPs induced a stronger host response compared with fresh MPs.
Conclusion MPs from RBC transfusion bags induce a strong 
proinfl ammatory response, which is largely negated when MPs are 
removed. This MP-mediated response depends both on the amount of 
MPs as well as on alterations in MPs as a result of storage.
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Introduction Sub-Saharan Africa suff ers from more acute life-
threatening indications for blood transfusion compared with high-
income countries [1]. The commonest ‘systems failure’ contributing to 
perioperative death in low-resource settings is the timely availability of 
correctly cross-matched blood products [2]. Often this is not the result 
of an absolute shortage of blood products, but failure in the chain of 
supply and distribution. We audited an early step in this chain, the 
quality of blood requests, at the University Teaching Hospital (UTH) 
in Lusaka, Zambia. UTH does not have a formal blood request form, 
and only the cancer diseases hospital (CDH) has a blood request form 
developed by the blood bank.
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Methods We performed a 1-day retrospective review in June of blood 
request forms submitted to the cross-match laboratory, followed 
by a 14-day prospective review in September 2014. Group and save 
requests were excluded. Each form was audited against the American 
Association of Blood Banks (AABB) minimum standards for content of a 
blood request form. Analysis was performed with Fisher’s exact test for 
nominal data and t test for continuous data.
Results A total of 1,163 blood requests were reviewed, 51 from CDH 
and 1,112 from other wards. Eighteen forms from CDH (35%) and 22 
from other wards (2%) met all minimum AABB standards (P <0.0001). 
The mean number of standards met on the requests from CDH and the 
rest were 11.25 (SD 0.93) and 8.87 (SD 1.75) respectively (P <0.0001). 
Considering all blood requests, the standards met in order from least 
to most were: signature of requesting doctor (36%), urgency of request 
(43%), hospital number (59%), indication for transfusion (62%), type of 
product requested (72%), requesting doctor’s name (78%), age or date 
of birth of patient (84%), gender of patient (89%), quantity of products 
requested (90%), date form was completed (90%), patient’s ward (95%), 
and patient’s full name (100%).
Conclusion The audit revealed an important system failure impacting 
on effi  cacy and safety of transfusion practice at UTH. Full patient 
identifi ers, as well as vital information such as the indication and 
urgency, were rarely fi lled in, which are crucial for the blood bank to 
prioritise the release of blood products. The audit shows that practice 
may be signifi cantly improved by a cheap intervention such as a 
standardised blood request form meeting international standards.
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Introduction In Zambia, supply of blood is insuffi  cient to meet 
clinical need, on a national level. Paradoxically, blood is also more 
often transfused unnecessarily in this setting. The Zambian National 
Blood Transfusion Service is currently scaling up voluntary blood 
donation and supply systems, and requires hospitals to improve blood 
transfusion safety. At a rural district hospital in Zambia, we audited 
practice and surveyed knowledge amongst staff  using standards 
established in national guidelines.
Methods A retrospective audit over 2 months of all blood transfusion 
forms at St Francis Hospital, Eastern Province, Zambia. Respective 
patients’ notes were reviewed for: record of observations during 
transfusion; patient demographics; and length of stay. We surveyed 
nurses’ attitudes, confi dence and knowledge in relation to blood 
transfusion standards.
Results In May and June 2014, 457 requests were made for blood, 
of which 157 (34%) received blood transfusion, of which 108 (69%) 
had records of observations available. The audit demonstrated that 
requests were mostly complete (90%), but urgency was indicated in 
only 32%. The matching of blood to patient by more than one nurse 
was recorded amongst 66% of cases. Only 2% of transfusions met 
minimal requirements for transfusion reaction monitoring. Of nurses 
surveyed (n = 20), most were experienced in their post (mean 7.3 years, 
range 2 weeks to 20 years). Nurses rated themselves as highly confi dent 
in handling blood transfusions and identifying and dealing with 
transfusion reactions. However, 90% believed they could identify all 
transfusion reactions by measuring temperature alone, and 25% would 
measure temperature only as a parameter to monitor the transfusion, 
even in ideal settings. Most knew to check observations before, 
15  minutes after the start of transfusion and then hourly thereafter 
(88%); but only 10% would check at the start, at completion and 4 hours 
after completing transfusion. The most frequently reported reason for 
not doing observations was time pressure on the ward (85%).
Conclusion In this setting, current practice is evidently inadequate to 
identify and prevent blood transfusion reactions. The survey revealed 
high confi dence but patchy knowledge amongst nurses of the 
requirements for safe blood transfusion. Better timing to transfuse at 
times when nursing staff  numbers are higher, alongside compulsory 
training, may together represent potential low-cost interventions to 
improve blood transfusion safety.
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Introduction Critically ill patients often need blood transfusion, but 
no reliable predictors of transfusion requirements are available at 
ICU admission. We hypothesized that ICU patients admitted with iron 
defi ciency may be at higher risk for developing anemia, requiring blood 
transfusion. The aims of this study were to determine the frequency 
of iron defi ciency in ICU patients at admission and to investigate its 
relationship with transfusion requirements in ICU patients.
Methods Eighty-fi ve patients admitted to the general ICU were enrolled 
in the prospective observational study. We studied 58 patients, after 
excluding those transfused on or before ICU admission. The patients’ 
age, gender, APACHE II score, diagnosis, severity score, presence of 
sepsis, ICU complications, ICU treatments, and transfusion-free interval 
were recorded. Iron defi ciency was assessed on the basis of several 
parameters, including hemoglobin, hematocrit, levels of serum iron, 
iron-binding capacity, transferrin saturation, levels of ferritin, soluble 
transferrin receptor, hepcidin, C-reactive protein, and peripheral blood 
smear.
Results The mean age was 43.5 ± 5.7 years. Of 58 patients (38 male/20 
female), 25 (43.1%) had iron defi ciency with outcomes of blood 
samples used at ICU admission. The overall transfusion rate was 32.8%, 
being higher in iron-defi ciency patients than in normal iron profi le 
patients (42.3 vs. 14.9%, P = 0.001). After adjusting for severity of illness 
and hemoglobin level, iron-defi ciency patients remained signifi cantly 
associated with transfusion, with a hazard ratio of 4.2 (95% CI, 1.3 to 
12.9; P = 0.001).
Conclusion Iron defi ciency is common at ICU admission and is 
associated with higher transfusion requirements. These fi ndings have 
important implications for transfusion practices in ICU patients.
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Introduction This aim of this analysis is to explore the use of 
thromboelastography (TEG) in the management of hypercoagulation 
in the ICU. TEG allows the assessment of whole blood coagulation and 
fi brinolysis and hence can identify patients who are hypercoagulable.
Methods A prospective audit of TEG tests performed on patients being 
treated on a general surgical and medical ICU was conducted over a 
2-month period.
Results Twenty-one out of 78 patients (26.9%) had one or more TEG 
criteria consistent with hypercoagulopathy. Admission diagnoses 
included trauma (37%), haemorrhage (23%), postoperative (23%) and 
sepsis (14.3%). Sixty-two per cent of patients with a primary diagnosis 
of trauma were in a hypercoaguable state. Hypercoagulopathy was 
suggested by an abnormally short R time in 16 patients (76%), an 
abnormal alpha angle in 17 cases (81%), a maximum amplitude 
>74 mm in nine cases (43%) and a high LY30 in one case. Procoagulant 
treatment was given to seven patients and fi ve patients had received 
no coagulation modifi cation prior to testing (Figure 1). Eight patients 
were receiving prophylactic anticoagulation and only one was 
receiving treatment-dose anticoagulation. A change in management 
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as a result of performing TEG was documented in 14 of these 21 
patients. No further blood products were administered in all cases and 
anticoagulation was commenced or increased in four cases.
Conclusion Hypercoagulopathy was present in 27% of patients. One-
third of these patients had recently received prothrombotic therapy 
indicating a possible iatrogenic aetiology. TEG analysis resulted in 
cessation of prothrombotic drug and blood product administration 
in all cases. Further research is required to determine whether titrated 
anticoagulation treatment to normalise the TEG profi le in these 
patients would be benefi cial.
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and improve anticoagulation during extracorporeal treatments
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Introduction During early sepsis, activation of the infl ammatory 
response and coagulation occurs. Extracorporeal therapies are used to 
adsorb mediators, but the coagulation of fi lters is a drawback [1,2]. The 
aim of this study is to evaluate whether thromboelastography (TEG) 
may detect hypercoagulation and may improve anticoagulation during 
extracorporeal treatments.
Methods Twenty-four patients with early severe sepsis had a TEG 
monitoring at basal time (T0) and during three diff erent extracorporeal 
treatments (T1): coupled plasma fi ltration (CPFA) with heparin infusion 
(Group A), CPFA with citrate infusion (Group B) and RRT with oXiris 
fi lter – heparin coated – and no heparin infusion (Group C). ANOVA test 
was used for the statistical analysis.
Results Table 1 presents the TEG values in early septic patients at T0. At 
T1, angle and MA decreased and r increased in Group A at diff erence 
with Group B and Group C (P <0.01). In group C, LY 30 was higher than 
in Group A and B (P <0.01).
Table 1 (abstract P341)
 Control Sepsis
r 8 ± 2 6 ± 3
k 4 ± 2 1.7 ± 0.5*
Angle 47 ± 15 67 ± 7*
MA 55 ± 8 72 ± 5*
LYS 30 1.8 ± 1 0.95 ± 0.9
*P <0.01.
Conclusion In early sepsis, TEG monitoring may detect hyper coagu la-
bility. CPFA with heparin, but not CPFA with citrate and oXiris, is able to 
reverse hypercoagulability. OXiris may induce fi brinolysis. TEG detects 
alterations of coagulation during early sepsis and extracorporeal 
treatments.
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hemostatic tests decrease mortality? A systematic review
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Introduction This systematic review done in March and updated in 
November 2014 has been conducted in accordance with the STARD, 
PRISMA and STROBE recommendations. Retrospective and prospective 
studies with a comparison group published in English were kept.
Methods Two reviewers (JC and ÉN) and two librarians (MC and DR) 
independently conducted a systematic review and identifi ed abstracts. 
Full texts were read by two authors (ÉN and ÉP), and data were 
extracted. The following databases were searched: Cochrane CENTRAL, 
Medline, Embase, LILACS, Web of Science, Science.gov, SciFinder 
Scholar, WorldCat, the Transf Evid Lib Database, and proceedings 
of the congresses of the International Society on Thrombosis and 
Haemostosis and the American Society of Hematology.
Results We initially kept 2,870 references. In total, 453 articles had 
mortality in their keywords. After reading the abstracts, 37 papers 
were analysed, and three articles evaluating mortality in two groups of 
patients (using and not using a VHT) were identifi ed. Among these three 
studies, only one had raw data available. We did not succeed in getting 
this information from the two other authors. We asked the main authors 
of the 37 selected papers, and renowned authors in the fi eld, if they had 
studies with new data that could be included in our review. The answers 
were negative. The three studies were: Johansson and Stensballe, total 
832 cases, 121 traumas, raw data unavailable for trauma [1]; Messenger 
and colleagues, prospective study, 50 cases, mortality similar, raw data 
unavailable [2]; and Kashuk and colleagues, prospective study, 68 cases, 
mortality 59% control group, 28% VHT group [3].
Conclusion With the studies available as of the end of 2014, it is 
impossible to conclude whether the use of a VHT in the emergency 
department decreases mortality. Other studies are needed.
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Role of thromboelastography in the management of haemorrhage: 
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Introduction The aim of this analysis is to explore and evaluate the 
role of thromboelastography (TEG) in aiding the management of 
patients admitted with haemorrhage to the ICU. TEG has been shown 
to rationalise and reduce transfusion requirements [1] but the precise 
role of TEG in the assessment and management of haemostasis 
in the bleeding patient is uncertain and has not been previously 
demonstrated.
Methods A prospective audit of TEG analyses performed on patients 
in the general medical and surgical ICU was recorded over a 2-month 
period. Operators documented the reason for admission, demographic 
data, indication for TEG, laboratory results, blood gas analysis, TEG 
results, diagnosis and subsequent action from the TEG result. Only 
patients who had been admitted with haemorrhage were included in 
this analysis.
Figure 1 (abstract P340). Coagulation modifi cation prior to TEG analysis 
in hypercoagulable patients.
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Results Seventy-eight audit sheets were completed, of which 31 
identifi ed haemorrhage as the reason for admission. The mean age was 
59.3 (range 21 to 90) and the mean APACHE II score was 18.23 (range 
11 to 37). The main indications for TEG analysis included coagulopathy 
(64%) and ongoing haemorrhage (45%). As a result of performing 
TEG analysis, 23 (74%) patients had a documented change in their 
management. Ten patients did not require any further administration 
of blood products, which they would have received based on 
conventional laboratory results. The information gained from TEG also 
resulted in the omission of anticoagulation in three patients, and with a 
further two patients anticoagulation increased.
Conclusion TEG aids prompt rationalisation of blood products and 
titration of anticoagulation in the bleeding patient. TEG identifi es a 
number of patients who required administration of platelets and other 
procoagulants which would not have been identifi ed by conventional 
methods. Several patients would have also received inappropriate 
transfusions which has both cost and resource implications, alongside 
the potential adverse eff ects on patients. We recognise that further 
research is needed to clarify the overall effi  cacy of TEG in the bleeding 
patient.
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Introduction This review aims to assess the value of thrombo-
elastography (TEG) on the general ICU, which has not been previously 
demonstrated. TEG is a near-patient assessment of whole blood 
coagulation and fi brinolysis, which reduces transfusion requirements 
during cardiothoracic surgery and liver transplantation.
Methods A prospective audit of TEG tests performed on patients being 
treated on a general ICU was conducted over 2 months.
Results A total of 332 TEG tests were performed with a failure rate of 
29.8%. Seventy-eight audit sheets were collected. Mean patient age 
was 68.9 years and mean APACHE II score was 18.1. Admissions included 
trauma (33.0%), perioperative (43.6%), haemorrhage (42.3%) and 
sepsis (21%). Standard tests of coagulation demonstrated 22 defi cits in 
coagulation which were not identifi ed as functionally signifi cant with 
TEG. Of these, 20 had abnormal clotting factor activity as measured 
by the INR/APTTr and 13 patients were thrombocytopenic. In total, 
52.6% documented that the TEG result changed the management of 
the patient. In 46.8% of these cases no further blood products were 
required. In 41% there was no documentation. See Table 1 and Figure 1.
Table 1 (abstract P344). Summary of concordance with standard tests versus 
TEG analysis
 Both TEG normal/ Standard normal/
 abnormal  standard abnormal TEG abnormal
Clot factor defi cit 9 (11.5) 20 (25.6) 3 (3.8)
Platelet defi cit 11 (14.1) 13 (16.6) 2 (2.6)
Fibrinogen defi cit 5 (6.4) 4 (5.1) 5 (6.4)
Data presented as n (%).
Conclusion TEG analysis suggested that 22 patients who were identifi ed 
as coagulopathic with traditional measures of coagulation did not 
have a functional defi ciency. Over one-half of TEG studies resulted in 
a change in management and in 46.8% no further transfusions were 
required. There was a high technical failure rate and a low audit return 
rate, which may indicate the need for further training.
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Introduction Our aim was to assess hemostasis, using ROTEM, 
in patients with end-stage liver disease (ESLD) undergoing liver 
transplantation (LT) and to develop a predictive model for patients 
prone to high intraoperative blood loss.
Methods We retrospectively analyzed 122 patients who underwent 
LT between January and December 2013 in a single national center. 
Patients with acute liver failure or incomplete data were excluded. 
Demographic data, severity of liver disease assessed by MELD score 
(model for ESLD), presence of portal vein thrombosis, and laboratory 
data were recorded preoperatively. We performed concomitant 
ROTEM assay and standard coagulation tests (prothrombin time (PT), 
International Normalized Ratio (INR), fi brinogen) 1 hour before surgery 
and 15  minutes after the neohepatic phase. Intraoperative blood 
loss was recorded. High blood loss was defi ned as loss of one blood 
volume during surgery. Correlation between recorded data standard 
ROTEM parameters and derived thrombodynamic ROTEM parameters 
(potential index (TPI), maximum velocity of clot formation (MaxV), time 
to MaxV (MaxVt), AUC) were analyzed using SPSS 19.0.
Results After applying exclusion criteria, 72 patients were analyzed 
with mean age of 54.5  years (SD 11.6) and a median MELD score of 
17.4 (7 to 34). Preoperative MCE correlated with age (P  = 0.044, 95% 
CI (–7.50, –0.12)) and MELD score (P  = 0.009, 95% CI (–37.21, –6.69)), 
but not with PT (P  = 0.557) or INR (P  = 0.623). MaxV correlated with 
fi brinogen level (P = 0.005, 95% CI (0.01, 0.05)) and AUC correlated with 
age (P = 0.034, 95% CI (–257.74, –11.91)) and MELD score (P = 0.01, 95% 
CI (–1,233.14, –215.33)). Patients with portal vein thrombosis had an 
increase in InTEM CFT (P  = 0.002, 95% CI (77.98, 317.97)) and MaxVt 
(P  = 0.03, 95% CI (5.53, 105.63)). No correlation was found between 
preoperative ROTEM parameters and intraoperative blood loss. We 
calculated ΔMaxV, ΔMaxVt and ΔAUC as the mathematical diff erence 
between preoperative and intraoperative MaxV, MaxVt and AUC. High 
blood loss correlated with ΔAUC (P  = 0.005, 95% CI (15.69, 61.03)), 
ΔMaxV (P = 9=0.002, 95% CI (–20,413, 6,392)) and ΔMaxVt (P = 0.008, 
95% CI (15.69, 61.07)).
Conclusion MELD score correlated with a decrease in MaxV and AUC 
on preoperative ROTEM but not with INR. Patients with portal vein 
thrombosis have increased InTEM CFT and MaxVt. High blood loss 
was associated with a decrease in thrombodynamic parameters, but 
no correlations were found between blood loss and standard ROTEM 
parameters.
Figure 1 (abstract P344). Change in management due to TEG results.




Evaluation of fi xed dose four-factor prothrombin complex 
concentrate for warfarin reversal at a level 1 trauma center
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Introduction FDA-approved dosing of four-factor prothrombin 
complex concentrate (4F-PCC) in the USA is based on an INR and 
weight; however, there are data suggesting that a fi xed dose of 4F-PCC 
may be suffi  cient for INR reversal and hemostasis [1,2]. The objective of 
this study was to assess the effi  cacy and safety of a fi xed dose of 1,500 
units of 4F-PCC. Historically, warfarin reversal included a combination 
of factor IX complex, vitamin K, and fresh frozen plasma (FFP). Using a 
fi xed dose of 4F-PCC may also provide signifi cant cost savings when 
compared with traditional dosing.
Methods This retrospective chart review compared 26 admitted adults 
who received a fi xed dose of 1,500 units 4F-PCC with 26 patients who 
received a combination of factor IX complex and vitamin K, with or 
without FFP, for warfarin reversal from 1 January 2012 to 1 November 
2014. Primary outcomes included reversal to an INR of <2 and reversal 
to an INR of <1.6. Secondary outcomes included ICU and hospital 
length of stay (LOS), change in INR, INR nadir, potential cost savings 
from 4F-PCC versus traditional dosing, and major adverse eff ects.
Results The INR was reduced to <2 in 100% of patients in the 4F-PCC 
group versus 84.6% of patients in the factor IX group (P <0.05). The INR 
was reduced to <1.6 in 90.8% of patients in the 4F-PCC group versus 
50% in the factor IX group (P <0.05). Mean pre-reversal INRs were 3.5 
and 4 and ranged from 1.1 to 10 and from 1.3 to 10 in the 4F-PCC and 
factor IX group respectively (P = 0.29). On average, a medication cost 
savings of US$802.63 dollars per patient was calculated from using a 
fi xed 1,500 unit dose over traditional dosing of 4F-PCC. There was a 
trend toward a shorter mean ICU LOS in the PCC group when compared 
with the factor IX group (5.8 vs. 2.8  days) and shorter mean hospital 
LOS (10.7 vs. 5.7  days), although neither outcome was statistically 
signifi cant. No diff erence in adverse event rates was observed.
Conclusion A fi xed dose of 1,500 units of 4F-PCC was signifi cantly more 
eff ective at lowering the INR to a threshold of less than either 2 or 1.6 
when compared with a combination of factor IX complex and vitamin 
K with or without FFP. Further research is needed to investigate clinical 
outcomes and a possible reduction in ICU and hospital LOS.
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Four-factor prothrombin complex concentrate (Beriplex® P/N) is 
superior to three-factor prothrombin complex concentrate for 
reversal of coumarin anticoagulation
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Introduction The study was conducted as a head-to-head comparison 
of a four-factor prothrombin complex concentrate (4F-PCC) and two 
diff erent three-factor PCCs (3F-PCC) for eff ective reversal of vitamin 
K antagonist (VKA)-induced anticoagulation using an established 
rat model of acute bleeding [1]. The 4F-PCC (containing the human 
coagulation factors II, VII, IX and X) is indicated for the urgent reversal 
of acquired coagulation factor defi ciency induced by VKA therapy in 
adult patients with acute major bleeding. In contrast, the 3F-PCCs 
(containing factors II, IX, X and only minimal VII) are indicated for the 
prevention and control of hemorrhagic episodes in hemophilia B 
patients. Nevertheless, the use of 3F-PCC for correcting hemostasis 
following warfarin overdose has been discussed but the lack of factor 
VII in these 3F-PCC products has raised questions about effi  cacy.
Methods Rats received an oral dose of 2.5 mg/kg phenprocoumon. At 
15.75 hours post dosing, animals were treated with a single intravenous 
dose of saline, 4F-PCC (Beriplex® P/N, Kcentra®; CSL Behring) or 3F-PCC 
(Bebulin® VH; Baxter and Profi lnine® SD; Grifols). Study endpoints 
included bleeding following tail clip, activated partial thromboplastin 
time (aPTT), and prothrombin time (PT). In addition, the plasma levels 
of vitamin K-dependent coagulation factors were determined.
Results Acute coumarin anticoagulation of rats induced a rise in median 
bleeding time by ≥2-fold from an average of 823 to 1,800  seconds 
(maximum observation period) compared with untreated animals. In 
parallel, PT and aPTT were prolonged from 8.9 to 29.9  seconds and 
from 14.5 to 25.5  seconds, respectively. Treatment with 4F-PCC was 
able to fully and statistically signifi cantly reverse bleeding, achieving 
average bleeding times of 676 seconds. In parallel, the elevation in PT 
was reduced to 15.1 seconds. In contrast, the two 3F-PCC products were 
not or only partially able to reduce coumarin-induced bleeding with 
average bleeding times of 1,398 and 1,708  seconds post treatment, 
respectively. This also correlated with inferior reductions in PT which 
achieved minimum levels of 23.8 and 29.5 seconds, respectively. There 
was no reduction in aPTT seen for any treatment option.
Conclusion In conclusion, this fi rst direct comparison of 4F-PCC and 
3F-PCCs for the reversal of VKA anticoagulation in a rat model of acute 
bleeding suggests that replenishment of all four vitamin K-dependent 
coagulation factors including factor VII as achieved using a 4F-PCC may 
result in superior effi  cacy compared with the use of 3F-PCCs.
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Introduction This study assessed whether a four-factor prothrombin 
complex concentrate (4F-PCC; Beriplex®/Kcentra®; CSL Behring) can 
eff ectively reverse bleeding associated with the direct oral factor Xa 
inhibitor apixaban in an established in vivo rabbit model [1,2].
Methods For dose-fi nding purposes, anesthetized rabbits were treated 
with a single intravenous dose of apixaban (800 to 1,600  μg/kg). In 
a subsequent study phase, anesthetized rabbits were treated with 
apixaban (1,200 μg/kg) followed by 4F-PCC (6.25 to 100 IU/kg). Bleeding 
signals were quantifi ed following a standardized kidney incision by 
measurement of the volume of blood loss and time to hemostasis over 
an observation period of 30 minutes. Blood samples were collected for 
monitoring of coagulation parameters.
Results Dose-dependent increases in time to hemostasis and total 
blood loss were observed post apixaban administration with maximum 
bleeding signals seen at 1,200 μg/kg. Treatment with 4F-PCC resulted in 
a statistically signifi cant reversal in apixaban-induced bleeding time (all 
doses) and volume (doses ≥12.5 IU/kg). Of the coagulation parameters 
measured, thrombin generation initiated using phospholipids only was 
the in vitro coagulation parameter most sensitive to 4F-PCC-mediated 
bleeding reversal, although statistically signifi cant 4F-PCC-mediated 
reductions in the prothrombin time and whole blood clotting time 
were also observed.
Conclusion In conclusion, 4F-PCC treatment eff ectively decreased 
apixaban-induced hemorrhage at a clinically relevant dose range.
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Introduction Acute trauma coagulopathy (ATC) is seen in 30 to 40% 
of severely injured trauma casualties. Early use of blood products is 
thought to attenuate ATC. This study determined the potential impact 
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of prehospital versus immediate in-hospital packed red blood cells 
and fresh frozen plasma (PRBC:FFP) in two models of severe battlefi eld 
injury.
Methods This is a prospective randomised controlled trial using in 
vivo models of injury conducted in accordance with the Animals 
(Scientifi c Procedures) Act, 1986. Two injury strands were investigated 
in 43 terminally anaesthetised Large White pigs: whole body blast 
exposure (Bl) or no blast (ShBl) plus soft tissue injury and haemorrhage. 
Thirty minutes later animals were randomly allocated to a 60-minute 
simulated prehospital hypotensive resuscitation with either PRBC:FFP 
(1:1 ratio) or 0.9% saline (Early and Late groups respectively). This was 
followed by 150 minutes of simulated in-hospital resuscitation with a 
revised normotensive target whereby PRBC:FFP was initiated in the 
Late group and continued in the Early group.
Results In the ShBl injury strand there was a signifi cant reduction in ATC 
in Early compared with Late PRBC:FFP treatment (TEG R and K times) in 
both the prehospital (P = 0.004 and P = 0.003 respectively, ANOVA) and 
early in-hospital (P  = 0.002 and P  = 0.005) phases, although clotting 
was normalised in the Late group within 60  minutes of initiating 
PRBC:FFP. Prehospital base defi cit (BD) was signifi cantly attenuated 
in ShBl Early versus Late (9.0 ± 2.1 vs. 14.4 ± 2.2 mM). BD improved in 
both Early and Late treatment groups during the in-hospital phase but 
remained greater in the Late group throughout (P  <0.001). In the Bl 
injury strand the trend in coagulation was similar to that seen in the 
ShBl injury strand (but the diff erences between Early and Late did not 
attain statistical signifi cance). By contrast, Early versus Late PRBC:FFP 
treatment did not result in a diff erence in BD in the Bl strand. Finally, 
there was no diff erence in the total amount of PRBC:FFP used between 
the two treatments in either injury strand, but in both injury strands 
the Early treatment groups required signifi cantly less saline (P <0.001).
Conclusion Prehospital use of PRBC:FFP may attenuate ATC and 
improve physiological status. Furthermore the amount of crystalloid 
may be reduced with potential benefi t of reducing the third-space 
eff ect and later tissue oedema.
Acknowledgements © Crown copyright 2014. Published with the 
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Introduction To compare the eff ectiveness of prothrombin complex 
concentrate and fresh frozen plasma (FFP) in patients with multiple 
injuries, complicated with coagulopathy bleeding.
Methods The study involved 51 patients who entered Odessa Regional 
Hospital with traumatic injuries (concomitant skeletal trauma) 
complicated with hypocoagulation. Patients were divided into two 
groups: in the fi rst group (26 patients), as a treatment for coagulopathy, 
was administered PCC in a dose of 1 ml/kg (25  IU/kg); in the second 
group (25 patients) was administered FFP in a dose of 15  ml/kg. 
Evaluation of the functional state of the hemostasis system was carried 
out using low-frequency thromboelastography (LFTEG) on admission 
to hospital and 24 hours after the patient’s admission to the ICU.
Results According to LFTEG, polytrauma patients had statistically 
signifi cant abnormalities in platelet aggregation (intensity of contact 
coagulation (ICC)), in coagulation (intensity of coagulation drive 
(ICD), clot maximum density (MA)) and in fi brinolytic activity (index of 
retraction and clot lysis (IRCL)). ICC in patients with multiple injuries was 
decreased by 27.51%, ICD was decreased by 34.68%, MA was decreased 
by 75.16%, IRCL was 91.06% above the norm. Patients of group 1 
according to LFTEG had signifi cant changes in all parts of coagulation 
24  hours after intensive care. Indicators of platelet hemostasis 
characterized by persistence of hypoaggregation: ICC was decreased 
by 24.51%, compared with the norm; parameters of coagulation 
and fi brinolysis had a reliable trend toward normal and decreasing 
the activity, the fi brinolysis index reached normal reference values. 
Patients in group 2 had hypoaggregation and hypocoagulation state 
with increased activity of fi brinolysis: ICC was reduced by 25.62%, ICD 
decreased by 19.76%, MA was decreased by 22.34%, IRCL was increased 
by 24.52%. Clinically, patients of group 1 had reduced indicators for 
infectious complications, reducing the term of mechanical ventilation 
and reducing the volume of blood transfusions.
Conclusion Patients with multiple injuries have violation in all parts of 
blood coagulation. The use of prothrombin complex concentrate can 
reduce the severity of pathological changes in the hemostatic system 
in patients with polytrauma.
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Introduction The anticoagulant eff ect of dabigatran can be reversed 
with idarucizumab or PCCs in porcine blood in vitro [1]. However, the 
impact on clinical parameters such as blood loss is not known. Thus, this 
study assessed the effi  cacy of idarucizumab in comparison with PCC 
and aPCC in dabigatran-anticoagulated swine following polytrauma on 
clinically relevant endpoints.
Methods After ethical approval, 28 male pigs were administered 
dabigatran etexilate (30 mg/kg twice daily p.o.) for 3 days. Dabigatran 
was administered intravenously in anaesthetised animals on day 4 to 
achieve consistent high concentrations. Animals were randomised to 
receive idarucizumab (60 mg/kg, n = 7), PCC (50 U/kg; n = 7), aPCC (50 
U/kg; n = 7) or placebo (n = 7). Intervention started 12 minutes after 
bilateral femur fractures and a standardised blunt liver injury. The 
primary endpoint was blood loss (observation period 300  minutes). 
Further, histopathology, haemodynamics and several coagulation 
variables were also assessed. Data were analysed by repeated-measures 
ANOVA (mean ± SD).
Results Dabigatran levels were comparable between groups (571  ± 
174  ng/ml) and resulted in altered coagulation variables. Blood loss 
was comparable 12 minutes post trauma between groups (801 ± 49 ml) 
and increased to 3,816 ± 236 ml in anticoagulated control animals post 
injury. Idarucizumab treatment reduced total blood loss to 1,086  ± 
55  ml (P  <0.005 vs. all), aPCC to 1,639  ± 104  ml (P  <0.05 vs. control) 
and PCC to 1,797 ± 80 ml (P <0.05 vs. control) after 5 hours. All animals 
in the intervention groups survived, whereas control animals died 
within the observation period (mean survival: 89 minutes, range: 62 to 
145  minutes). In histopathology no signs of thromboembolic events 
were present. Altered coagulation variables returned to baseline levels 
after idarucizumab application and were also signifi cantly, although 
inconsistently and to a lesser extent, ameliorated following PCCs.
Conclusion All medical interventions were associated with reduced 
blood loss and increased survival. However, idarucizumab, a specifi c 
antidote to dabigatran, reduced total blood loss more prominently and 
normalised coagulation parameters to a greater degree as compared 
with either PCC or aPCC.
Reference
1. Grottke O, et al. Crit Care. 2014;18:R27.
P352
Coagulation support algorithm with rapid TEG and functional 
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Introduction Early coagulation support is essential in massively 
bleeding patients. A Coagulation Support Algorithm (CSA), integrating 
rapid TEG (r-TEG) and functional fi brinogen TEG (ff -TEG) could shorten 
the time to a tailored treatment (Figure 1).
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Table 1 (abstract P352). Comparison of time to results
Test k-TEG r-TEG r-TEG + ff -TEF SCT
r (minutes) 13.8 ± 7.1 2.6 ± 2 – 
ACT (seconds)  265.7 ± 171.9 – 105.2 ± 46.3
TMA (minutes) 42.6 ± 12.4 25.4 ± 14.1 – 
CSAT (minutes)   21 ± 7.4 
Data presented as mean ± SD. ACT, activated clotting time; CSAT, Coagulation 
Support Algorithm total time; SCT, standard coagulation tests; TMA, time to 
maximum amplitude. r: r-TEG versus k-TEG, P = 0.0000003; r-TEG versus SCT, 
P = 0.000000001; k-TEG versus SCT, P = 0.000000009; TMA: r-TEG versus k-TEG, 
P = 0.0001; r-TEG versus SCT, P = 0.00000004; k-TEG versus SCT, P = 0.000002; ACT 
versus r of k-TEG (seconds), P = 0.000004; CSAT versus k-TMA, P = 0.00000005.
Methods A retrospective comparison of the time to available TEG and 
Standard Coagulation Tests (SCT: INR, aPTTr, fi brinogen level) results 
in two groups of bleeding and coagulopathic patients using citrate 
kaolin-TEG (k-TEG) or the CSA protocol (r-TEG/ff -TEG). Statistical analysis 
was performed with Student’s t test for unpaired samples.
Results Twenty-three patients for each k-TEG and CSA group were 
compared. The time to available results was shorter using the CSA 
protocol in comparison with k-TEG (Table  1). The diff erences were 
both statistically (P  <0.00001) and clinically (mean reduction time 
21 minutes) signifi cant. SCT needed the longest time to obtain the fi nal 
results.
Conclusion The implementation of a CSA, including r-TEG and ff -TEG, 
could shorten the time to a targeted treatment in critically bleeding 
patients.
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Introduction Assessing the cost-eff ectiveness of therapeutic interven-
tions is increasingly crucial for health decision-making. Spontaneous 
bacterial peritonitis (SBP) is one of the major complications of liver 
cirrhosis. The use of albumin in conjunction with antibiotics has been 
shown to be eff ective through clinical trials [1].
Methods A decision tree (TreeAge®) (Figure  1) was populated from 
published sources for clinical, cost and epidemiologic variables. The 
perspective taken was that of the US payer. The robustness of the model 
was checked using one-way and probabilistic sensitivity analyses. The 
clinical course was followed for 3 months or until death. Total medical 
costs and quality-adjusted life years (QALYs) [2] were calculated.
Table 1 (abstract P353). Results of the cost-eff ectiveness model
  Total medical Total costs/
Treatment QALYs costs ($) QALY ($)
Antibiotics + albumin 2.45 7,628 3,111
Antibiotics 1.48 7,682 5,182
Results Total costs were decreased when using albumin, and the 
improved survival resulted in an additional QALY for patients on 
albumin, decreasing the cost per QALY. See Table 1 and Figure 2.
Conclusion The use of albumin in the treatment of SPB is cost-eff ective.
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Introduction The use of albumin in therapeutics is controversial in 
several areas and requires assessment based on evidence for eff ective 
resource allocation. Supported indications include sepsis, areas of 
hepatic diseases and coronary artery bypass grafts (CABG). Latent 
therapeutic demand (LTD) [1] is the underlying evidence-based 
demand ensuring ample supplies of drugs are available and aff ordable. 
Estimating the LTD would assist decision-making and resource 
Figure 1 (abstract P352). Coagulation Support Algorithm.
Figure 1 (abstract P353). Structure of decision tree for patients with SBP.
Figure 2 (abstract P353). Cost-eff ectiveness acceptability across range 
of WTP.
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S124
allocation, but many of the clinical and epidemiologic variables are 
subject to uncertainty. Decision analysis [2] may assist in generating an 
assessment of the demand for albumin.
Methods A decision analysis model was constructed using Excel. The 
model is based on the relationships of the epidemiological and clinical 
factors shown in the infl uence diagram (exemplifi ed in Figure  1 for 
sepsis). Data for the individual factors were obtained from the literature. 
One-way sensitivity analysis was used to generate Tornado diagrams 
(exemplifi ed in Figure  2 for albumin use in sepsis) to determine the 
relative contribution of diff erent factors to the LTD. Probabilistic 
sensitivity analysis was used to generate a probability distribution and 
calculate a mean level for the LTD of each indication.
Results On average, albumin use was calculated as 104  g per 1,000 
inhabitants in severe sepsis, 157 g per 1,000 inhabitants in liver diseases 
and 61 g per 1,000 inhabitants in CABG. This shows a total LTD of 322 g 
per 1,000 use of albumin in the US annually.
Conclusion Albumin consumption in the USA currently averages 479 g 
per 1,000 population [3]. Hence, the LTD of these three evidence-based 
indications represents 67% of current usage. Further work is needed to 
assess the LTD for albumin in other, less well-defi ned areas.
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Introduction Adequate fl uid therapy is essential to the care of septic 
patients, aiming to optimize oxygen delivery without compromising 
microcirculation. In recent years, a few studies have suggested that 
albumin may be superior when compared with crystalloids in severe 
cases of septic shock. However, there are no data in the fi rst hours of 
resuscitation. The aim of this study is to evaluate whether albumin 4% 
solution compared with lactated Ringer decreases 30-day mortality in 
cancer patients with septic shock.
Methods The Lactated Ringer Versus Albumin in Early Sepsis Therapy 
(RASP) study is a prospective, randomized, double-blind and controlled 
trial, with 360 patients. Until November 2014, at the Cancer Institute of 
University of São Paulo, we enrolled 110 patients with cancer and septic 
shock to receive as resuscitation fl uid in the fi rst 12  hours of ICU an 
admission bolus of albumin 4% solution or lactated Ringer. The primary 
outcome was 30-day mortality. Secondary outcomes include ICU 
mortality, ICU and hospital length of stay, 90-day mortality, daily SOFA 
score, rates and length of mechanical ventilation, renal replacement, 
needing of vasopressor drugs, status performance and fl uid balance.
Results From 650 eligible patients, 110 patients were included in the 
study – 50 patients in the albumin group and 60 in the Ringer group. 
The mean age was 63 (57 to 70) years in the albumin group and 61 (51 
to 71) in the Ringer group, P = 0.508. Most patients were male (58% in 
the albumin group vs. 56.1% in the Ringer group, P = 0.846). The ECOG 
was similar between the albumin and Ringer groups ((0) 26% vs. 8%, 
(1) 38% vs. 36.8%, (2) 20% vs. 38.6%, (3) 16% vs. 15.8%, P = 0.05). The 
SAPS 3 admission score was 51 ± 13 in the albumin group and 49 ± 10 
in the Ringer group, P = 0.492. The total amount of administered fl uid 
in the fi rst 12  hours of resuscitation was 1,000  ml (1,000 to 1,500) in 
the albumin group and 1,000 ml (1,000 to 1,000) in the Ringer group, 
P = 0.59. The 12-hour fl uid balance was 1,053 ml (385 to 1,700) in the 
albumin group and 990 ml (200 to 1,525) in the Ringer group. The 30-
day mortality was similar in both groups (60% in the albumin group 
and 50.9% in the Ringer group, P  = 0.34). No signifi cant diff erences 
in the other secondary outcomes were observed between the two 
groups.
Conclusion In cancer patients with septic shock, resuscitation with 
albumin 4% as compared with lactated Ringer did not improve the rate 
of survival at 30 days.
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Introduction The induction of ECMO may result in metabolic acidosis 
[1] due to circuit priming with chloride-rich fl uids, and the sudden 
decrease in plasma strong ion diff erence (SID). This eff ect can be 
attenuated using balanced solutions with a SID equal to the patient’s 
plasma bicarbonate concentration (HCO3
–) [2]. We aimed to compare 
the eff ects of a novel balanced solution (SID equal to patients’ HCO3
–) 
with those of commonly employed crystalloids for circuit priming in 
patients undergoing venovenous ECMO.
Methods We randomly assigned patients with acute respiratory failure 
in need of ECMO to receive either NaCl 0.9% (NS, SID = 0), Ringer lactate 
(RL, SID  = 28), or a novel balanced solution (Solution X, SID equal to 
the patient’s HCO3
–) for circuit priming solution. Arterial blood gases 
and laboratory parameters were collected at 0, 5, 30, 60, 90, and 
Figure 1 (abstract P354). Variables used to construct the LTD model in 
sepsis.
Figure 2 (abstract P354). Relative importance of inputs into the LTD 
model for sepsis.
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120 minutes after pump start. SID, base excess (BE) and total weak acids 
(Atot) were calculated.
Results We enrolled 20 patients (23 priming procedures  – RL, n  = 8; 
NS, n = 8; Solution X, n = 7). ECMO was initiated for ARDS (45%), bridge 
to lung transplant (25%), acute graft failure after transplant (15%), and 
acute on chronic respiratory failure (15%). Average priming volume was 
10 ± 5 ml/kg; patients’ baseline HCO3
– was 28 ± 6 mEq/l. During the fi rst 
2 hours after ECMO initiation, arterial pH raised similarly in all groups 
(P = 0.39) due to CO2 removal. In contrast, BE decreased starting after 
5 minutes in both the NS and RL groups (BE variation, –2.2 ± 1.7 and 
–1.9 ± 1.3 mEq/l, P <0.001 vs. baseline; P = 0.04 for interaction, two-way 
ANOVA, 2-hour period). No BE changes were observed in the Solution 
X group (0.3 ± 0.8 mEq/l). In the NS group, BE reduction was associated 
with a reduction in SID (from 39 ± 8 to 34 ± 6 mEq/l at 5 minutes, P = 
0.008), entirely due to an increase in Cl (103 ± 7 vs. 108 ± 6 mEq/l, P = 
0.001). In the RL group, BE and SID reductions (40 ± 8 vs. 36 ± 8 mEq/l, 
P  = 0.008) were associated with an increase in both Cl (105  ± 7 vs. 
107 ± 7 mEq/l, P = 0.01) and lactate (1.4 ± 0.6 vs. 2.2 ± 1.0 mEq/l, P = 
0.008). No changes were observed in other electrolyte concentrations. 
Dilution did not diff er between groups (P = 0.25 for Atot variation). The 
acidifying eff ect of NS and RL was amplifi ed in patients with higher 
baseline HCO3
–.
Conclusion As compared with NS and RL, the use of a novel balanced 
solution with a SID equal to the patient HCO3
– level for ECMO priming 
uniquely avoids the addition of metabolic acidosis to patients with 
uncompensated hypercapnia.
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Introduction The aim of our study is to investigate the eff ect of 
intraoperative use of gelatin in living donor liver transplantation on 
postoperative acute kidney injury (AKI). It has been demonstrated 
that ischemia and chloride-liberal fl uid management cause AKI in liver 
transplantation [1]. Gelatin has minimal side eff ects on renal functions 
[2]; however, it might be a reason for postoperative AKI.
Methods A total of 154 liver transplantation patients were retrospectively 
evaluated between September 2011 and September 2013, and among 
these, 128 patients were included in the study. The patients who were 
under 18  years old, transplanted from cadaveric donors and needed 
preoperative renal replacement therapy were excluded. The patients 
were divided into two groups as GI (without gelatin administration) 
and GII (with gelatin administration). The patient’s age, gender, actual 
body weight, diagnoses, MELD score, APACHE II score, duration of 
operation, total clamping time, noradrenalin infusion rate, amount of 
erythrocyte suspension, fresh frozen plasma (FFP) and thrombocyte 
suspension used, intraoperative fl uid balance, intraoperative and total 
clamping diuresis, serum creatinine levels on the postoperative 1st, 
2nd, 4th and 7th days, duration of mechanical ventilation, length of 
ICU and hospital stay, hospital and 1-year mortality rate were recorded. 
The changes in creatinine levels on the 1st, 2nd, 4th and 7th days were 
evaluated according to the KDIGO guideline for AKI [3].
Results In total, 128 patients were categorized as GI (58, 45%) or GII 
(70, 55%). Total clamping time, intraoperative diuresis, intraoperative 
crystalloid use, intraoperative fl uid balance, operation bleeding, 
erythrocyte suspension, FFP and thrombocyte suspension use and 
postoperative lactate levels of GII were statistically signifi cantly higher 
than GI (P <0.001 for each). According to the KDIGO guideline, AKI in 
GII on the 1st, 2nd, 4th and 7th days (11.4%; 20%; 24.3%; 17.1%) was 
statistically signifi cantly higher than GI (P <0.001 for each).
Conclusion In patients who received gelatin, kidney dysfunction in the 
postoperative period was observed more frequently. Also in this group, 
total clamping time was longer and amount of blood products used 
during surgery was more than the other group. Which of these factors 
is associated with AKI has to be revealed with further studies.
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Introduction The purpose was to study the incidence of acute kidney 
injury (AKI) according to RIFLE and AKIN criteria in critically ill burn 
patients resuscitated with Ringer’s solution and supplements of 
lower molecular weight hydroxyethyl starch (HES)130/0.4/6%, and to 
determine the relationship between RRT indication and mortality.
Methods We studied 165 consecutive patients admitted to the critical 
care burn unit. Resuscitation was performed using lactated Ringer’s 
solution and HES at a low dose to achieve urine output, lactate levels, 
and transpulmonary thermodilution parameters. The contributions 
of colloids and crystalloids were measured, and renal function was 
evaluated. Statistical analysis was performed using the Spearman test.
Results The average total body surface area (TBSA) burned was 30 ± 
15%, and the median of the total volume needed in the fi rst 24 hours 
was 4.01  ml/kg/% TBSA burned. According to the RIFLE criteria, 10 
(6.1%) patients presented with risk, 11 (6.7%) presented with injury, and 
11 (6.7%) presented with failure. According to the AKIN criteria: 9.7% 
presented stage I, 3% stage II and 10.3% stage III. Replacement therapy 
(RRT) was performed in 15 patients (9.1%). In six of these patients RRT 
was employed in the fi nal stages of multiorgan failure. In the remaining 
nine patients, for various reasons only one survived.
Conclusion During the resuscitation phase of the burn patients, the 
use of HES (130/0.4/6%) at low doses does not seem to cause more 
risk or injury according to RIFLE or AKIN criteria than those reported by 
studies in burn patients resuscitated without HES. However, the need 
for RRT is associated with a high mortality, although in many cases the 
display is terminal.
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Introduction Graft failure is a major cause of morbidity in patients 
with burns, resulting in increased length of hospital stay and increased 
number of operations. At our regional burns unit we collated the data 
from anaesthetic charts of patients admitted to our burns ICU who 
required skin grafting. The aim was to analyse whether any anaesthetic 
variables contribute to graft failure.
Methods Thirty-fi ve patients were included in the analysis with a total 
of 191 operations. These were a combination of debridement, split 
skin grafts (SSG) and change of dressings. All patients were admitted 
to our burns ICU between January 2009 and October 2013. Exclusion 
criteria were death prior to discharge and initial surgery at a diff erent 
hospital. Sixteen patients had good graft viability (Group A) and 19 
patients had poor graft viability (Group B). Logistical regression was 
performed using SPSS (Version 22.0). Hosmer and Lemeshow testing 
was used to confi rm goodness of fi t. Independent variables were age, 
sex, preoperative haemoglobin, intraoperative fl uid resuscitation, 
blood products, inotropes, volatile agents and temperature. Poor graft 
viability was defi ned as requiring at least one additional skin graft. 
Analysis was performed on all operations and then by subtype of 
operation (that is, SSG and debridement, SSG only).
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Results There was no signifi cant diff erence in age, %total burn surface 
area or Belgian Outcome Burns Injury score between the groups. For 
all operation data, use of colloids was found to signifi cantly contribute 
towards poor graft viability (P  = 0.035, 95% CI). When analysis was 
performed on only SSG and debridement operations, colloids 
remained signifi cant (P = 0.034, 95% CI) and metarminol use was found 
to signifi cantly contribute (P  = 0.028, 95% CI) to poor graft viability. 
Overall use of inotropes was not signifi cant between the two groups. 
Other variables including minimum and maximum temperature, 
preoperative haemoglobin and blood transfusion were not found to 
be signifi cant.
Conclusion Our results suggest that the use of colloids is a contributor 
to poor graft viability in burns. This was found to be independent of 
temperature and overall inotrope use; however, the use of metarminol 
may be a contributing factor.
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Introduction For a long time, many investigators have tried to demon-
strate increased mortality associated with acid–base distur bances. In 
this study, we sought to determine the association of hyperchloremia 
measured at ICU admission and whether this electrolyte disturbance is 
associated with an increase in morbidity and mortality.
Methods Data were retrospectively collected for consecutive adult 
patients admitted to Agustin O’Horan Hospital ICU, between January 
2011 and July 2014, who underwent inpatient medical treatment using 
electronic fi les.
Results The dataset consisted of 936 medical fi les and serum chloride 
concentration values on admission, 853 being eligible. Hyperchloremia 
(serum chloride >110 mmol/l) is quite common, with an incidence of 
47.71%. Patients were propensity matched based on their association 
with death and hyperchloremia. Of the 853 patients collected, patients 
with hyperchloremia after admission (n  = 446, 52.3%), patients were 
matched to patients who had normal serum chloride levels after 
admission. These two groups were well balanced with respect to all 
variables collected. The hyperchloremic group was at increased risk 
of mortality at ICU discharge, relative risk ratio = 1.81; 95% confi dence 
interval, 1.41 to 2.51 risk increase of 25.31%. Admission hyperchloremia 
was associated with increased morbidity, mortality and higher scores in 
severity scales; this association was statistically important. See Figure 1.
Conclusion This retrospective cohort trial demonstrates an association 
between hyperchloremia and poor ICU admission outcome (death). 
Additional studies are required to demonstrate a causal relationship 
between these variables.
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Introduction Kidneys play a crucial role in the regulation of electrolytes 
and acid–base homeostasis. Impaired renal function is associated with 
greater urinary strong ion diff erence (SIDu) in patients with metabolic 
acidosis [1]. In critically ill patients, several factors, such as infused fl uids 
and acid endogenous production, would lead to changes in plasma 
SID and acid–base homeostasis without renal regulation of urinary 
electrolytes and SIDu [2]. Hence, AKI can be highlighted as an inability 
to address acid–base metabolic disturbances, which may be detected 
before major increases in creatinine or decreases in urine output. We 
evaluated the eff ects of renal function on urinary strong ion excretion 
using the Stewart approach to acid–base in critically ill patients with 
AKI.
Methods A retrospective study was conducted. Patients with a 
diagnosis of AKI according to KDIGO creatinine criteria and available 
urinary chemistry at one point during their ICU stay were evaluated. 
Day 0 was defi ned as the day when SIDu was calculated from urinary 
spot analysis (SIDu = Na+U + K+U – Cl–U). Patients were followed and 
staged for AKI in the next 3 days. AKI reversibility was defi ned according 
to the lack of criteria for AKI.
Results In total, 143 critically ill patients with a diagnosis of AKI were 
included. SIDu at day 0 did not diff er between diff erent AKI stages at 
day 0. SIDu at day 0 was statistically diff erent between diff erent AKI 
stages at days 1, 2, 3 (Table 1). SIDu at day 0 was statistically diff erent 
between reversible and not reversible AKI at days 1, 2, 3 (Table  2). A 
conventional receiver-operating curve was generated to assess the 
accuracy of SIDu to predict AKI reversibility at day 1. AUC for SIDu was 
0.82 (P <0.0001; 95% CI: 0.75 to 0.88).
Table 1 (abstract P361). SIDu (mEq/l) between diff erent AKI stages at days 1, 
2, 3 post admission
 AKI stage
 3 2 1 0 P value
Day 1 48.1 (21) 46 (22) 37.9 (20) 17.3 (22) <0.001
Day 2 40.2 (23) 45.9 (20) 45 (23) 29 (22) 0.004
Day 3 40.3 (26) 47.2 (18) 53.2 (23) 31 (23) 0.006
Table 2 (abstract P361). SIDu (mEq/l) between reversible versus not 
reversible AKI at days 1, 2, 3
 Reversible Not reversible  P value
Day1 16.8 (23) 43.9 (21) 0.0001
Day2 28.5 (24) 45.3 (22) 0.0001
Day3 30 (24) 47.3 (21) 0.0001
Conclusion SIDu identifi ed patients with reversible AKI with good 
accuracy. SIDu can be a promising, simple and cost-eff ective tool in AKI 
patient evaluation. Further research is needed to assess SIDu capability 
to early detect patients with renal dysfunction before increases in 
creatinine or decreases in urine output.
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Figure 1 (abstract P360). Group mortality, high and low chlorine.
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Introduction The aim was to evaluate whether guidelines for intra-
venous (i.v.) potassium replacement improved plasma potassium 
homeostasis in ICU patients. Prompt and eff ective treatment of 
hypokalaemia is an important intervention in the ICU, but concentrated 
i.v. potassium solutions may cause serious harm if used inappropriately 
[1]. There were previously no formalised guidelines on i.v. potassium 
supplementation in the ICU at Sheffi  eld Teaching Hospitals. Practice 
was reviewed and guidelines were introduced to improve patient 
safety, plasma potassium homeostasis and reduce i.v. potassium 
supplementation requirements.
Methods A before and after evaluation of plasma potassium homeo-
stasis in ICU patients requiring i.v. potassium supplementation was 
conducted over a period of 8 months (August 2013 to May 2014). Patient 
data on plasma potassium levels, i.v. and oral potassium supplements 
administered were obtained from the clinical information system. 
Clinical appropriateness of i.v. potassium acetate prescriptions, fl uid 
and chloride intake related to potassium infusions and cost linked to 
the guidelines were also compared pre/post implementation. Impact 
of the guidelines on nurses’ practice was assessed using questionnaires.
Results Median i.v. potassium replacement dose per patient was 
signifi cantly reduced in the post-guidelines group from 215 (IQR: 94; 
485) to 80 (IQR: 40; 160) mmol; P <0.001. Although the percentage time 
per group for patients who were hypokalaemic was less in the post 
group (18.2% vs. 14.8%), there was no diff erence in mean patient values 
(24.2 (20.3)% vs. 22.1 (17.5)%; P = 0.228). The duration of hyperkalaemia 
was increased. Prescribing of i.v. potassium acetate was not always 
appropriate. Median patient fl uid-related dose was increased (107.5 
(IQR: 47.1; 242.4) vs. 250 (IQR: 100; 600) ml; P <0.001), whilst chloride 
doses were reduced (170.7 (IQR: 91.3; 438.3) vs. 110 (IQR: 55; 250) mmol; 
P <0.009). Nurses were satisfi ed with the new practice, reporting it was 
safe, eff ective and clinically useful. However, compared with baseline 
practice, they perceived the guidelines as less eff ective and felt the 
workload was higher.
Conclusion Implementation of i.v. potassium replacement guidelines 
improved the use of i.v. potassium in the ICU by reducing the 
requirement for i.v. potassium supplementation and increasing the 
overall time patients spent without hypokalaemia. Whilst nursing 
staff  found the guideline useful and felt it increased safe use of i.v. 
potassium, more work is needed to ensure nurse workload is not 
increased signifi cantly.
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Marked exposure to the endocrine-disrupting chemicals phthalates 
and bisphenol A in the ICU
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Introduction Care for ICU patients has benefi ted from medical devices. 
Bisphenol A (BPA) and phthalates can leach from the plastic matrix. 
We hypothesized that ICU patients are exposed to BPA and phthalates 
through medical devices.
Methods Serum (n = 118) and urinary (n = 102) samples of adult (n = 35) 
ICU patients were analyzed for total BPA and di(2-ethylhexyl)phthalate 
(DEHP) and other phthalate metabolites (PMs). We also enrolled 
patients preoperatively before scheduled thoracic surgery and repeat 
samples were taken on days 1 to 4 during the ICU stay. Control data 
came from 44 healthy controls or from referenced literature.
Results Our results show that adult ICU patients are continuously 
exposed to phthalates (that is, DEHP) as well as to BPA, albeit to a 
lesser extent, resulting in detectable serum and urinary levels in 
almost every patient and at every studied time point. Moreover, these 
levels were signifi cantly higher than in controls or compared with 
referenced literature. The chronology of exposure was demonstrated: 
the preoperative urine and serum levels of the DEHP metabolites were 
often below the detection limit. Medical devices are the source of 
these chemicals: patients on hemofi ltration, extracorporeal membrane 
oxygenation or both showed serum levels 100-fold or 1,000-fold 
higher than the general population or workers in plastic industry. The 
serum and some of the urinary levels of the DEHP metabolites are the 
highest ever reported in humans; some at biologically highly relevant 
concentrations of even ≥10 to 50 μM.
Conclusion Adult ICU patients are exposed to plastic softeners, in 
particular PMs. Despite the continuously tightening regulations, BPA 
and DEHP are still present in medical devices. Because patient safety 
is a concern in the ICU, further research into the (possibly toxic and 
clinical) eff ects of chemicals released from medical devices should be 
undertaken.
P365
Low serum 25-hydroxyvitamin D at critical care initiation is 
associated with sepsis and morbidity in Dutch critically ill patients
K De Haan
Erasmus MC, Rotterdam, the Netherlands
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Introduction Vitamin D defi ciency may frequently occur in critically ill 
patients and may be associated with sepsis and increased mortality. We 
therefore evaluated the prevalence of 25-hydroxyvitamin D defi ciency 
in a Dutch ICU, and its relationship with sepsis, morbidity and mortality.
Methods We conducted a prospective observational study in a 10-bed 
mixed ICU. A total of 1,372 patients were admitted between July 2011 
and June 2013 including 198 readmissions, of which 940 patients were 
studied. 25-Hydroxyvitamin D levels were determined within 24 hours 
after admission. 25-Hydroxyvitamin D levels were judged as suffi  ciency 
(>50 nmol/l), insuffi  ciency (30 to 50 nmol/l) and defi ciency (<30 nmol/l).
Results The prevalence of defi ciency and insuffi  ciency was 36% and 
38%, respectively. Only 26% of the patients had suffi  cient vitamin D 
levels. Vitamin D defi ciency is associated with sepsis (P <0.001) at ICU 
admission. Patients with defi cient levels had higher mean APACHE IV 
scores, 64 versus 52 (P <0.001), and longer length of hospital stay, 12 
versus 9 days (P <0.001), respectively, as compared with patients with 
suffi  cient levels. Patients with defi cient vitamin D levels had an odds 
ratio for in-hospital mortality of 1.4 (95% confi dence interval of 0.84 to 
2.29, P = 0.2) relative to patients with suffi  cient vitamin D levels.
Conclusion 25-Hydroxyvitamin D defi ciency frequently occurs in 
Dutch critically ill patients. Although relating to sepsis, disease severity 
and morbidity, vitamin D defi ciency is not an independent predictor of 
mortality in these patients, which was otherwise relatively low.
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Incidence and predisposing factors for the development of 
disturbed glucose metabolism and diabetes mellitus after intensive 
care admission: the DIAFIC study
S Van Ackerbroeck, K Janssens, P Jorens, T Schepens, W Verbrugghe, 
V Van Hoof, L Van Gaal, C De Block
University Hospital Antwerp, Edegem, Belgium
Critical Care 2015, 19(Suppl 1):P366 (doi: 10.1186/cc14446)
Introduction Stress hyperglycaemia (SH) is commonly observed 
during hospitalisation in the ICU and adversely infl uences outcome [1]. 
When SH occurs in previously nondiabetic patients, this might refl ect 
a latent disturbance of glucose metabolism and predict future risk 
of diabetes. We wanted to assess the incidence of disturbed glucose 
metabolism (DGM) and identify predictors for future diabetes risk. This 
could support timely diagnosis, prevention, and early treatment of 
impending diabetes mellitus (DM).
Methods In this prospective observational study, we enrolled 338 
patients without known DM, who were admitted for at least 36 hours to 
the ICU of the Antwerp University Hospital between September 2011 
and March 2013. A 75  g oral glucose tolerance test was performed 
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6 to 9  months post ICU admission to screen for disturbed glucose 
metabolism. Furthermore, we examined whether post-discharge 
glucose disturbances could be predicted by the FINDRISC questionnaire 
[2], patient demographics, comorbidities, HbA1c at ICU admission, and 
by parameters related to ICU stay (glucose parameters, insulin need, 
caloric intake, disease severity).
Results In total, 246 patients (73%) experienced SH during their ICU 
stay. Eight months post ICU admission, glucose metabolism was 
disturbed in 119 (35%) subjects. Of these, 27 (8%) had impaired 
fasting glucose, 43 (13%) had impaired glucose tolerance, 25 (7%) had 
impaired fasting glucose and impaired glucose tolerance, and 24 (7%) 
were diagnosed with DM. A disturbed glucose metabolism tended to 
be more prevalent in subjects who experienced SH during ICU stay as 
compared with those without SH (38% vs. 28%, P = 0.065). HbA1c on 
admission correlated with the degree of SH (r = 0.308, P <0.001). The 
FINDRISC score (9.5 vs. 11, P  = 0.001), SAPS 3 score (median of 42 in 
both groups, P = 0.003) and daily caloric intake during ICU stay (222 vs. 
197, P = 0.011) were associated with a DGM.
Conclusion Stress hyperglycaemia is frequent in nondiabetic patients 
and has a tendency towards future disturbances in glucose metabolism 
and DM. Glucose metabolism was disturbed in 35% of subjects 8 months 
post ICU admission, of whom 7% was diagnosed with diabetes mellitus. 
Predictors of elevated risk included a high FINDRISC score, high SAPS 3 
score, and a lower daily caloric intake during ICU stay.
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Introduction It is conjectured that transition of hypoglycemia to 
hyperglycemia may be more harmful than hypoglycemia itself. We 
investigated the association between the degree of correction of 
hypoglycemia and ICU mortality in patients under moderately strict to 
strict glycemic control.
Methods This is a retrospective analysis from a pooled cohort from 
seven ICUs in the Netherlands over 6 years. ICU patients who developed 
hypoglycemia (<70 mg/dl) were included. We excluded patients who 
were readmitted, and patients with hypoglycemia in whom no follow-
up blood glucose measurement was performed within 8  hours. We 
determined the association between three measures of correction of 
hypoglycemia within 8  hours after hypoglycemia and ICU mortality: 
predefi ned ranges of the ‘highest blood glucose level’ (<80 mg/dl; 80 
to 110 mg/dl; 110 to 150 mg/dl (reference category); 150 to 180 mg/
dl; and >180  mg/dl); quartiles of the ‘delta glucose’, defi ned as the 
diff erence between minimum and maximum blood glucose level with 
the third quartile as reference category; and quartiles of the ‘standard 
deviation’ of the blood glucose level with the third quartile as reference 
category.
Results In total, 4,516 ICU patients developed at least one episode 
of hypoglycemia. In three separate multivariate analyses for each of 
the three measures we adjusted for the respective confounders. The 
category 80 to 110  mg/dl of the ‘highest blood glucose level’ was 
associated with increased mortality compared with the reference 
category (odds ratio (OR) = 1.31, 95% confi dence interval (CI) = 1.06 to 
1.61). The lowest quartile of the ‘delta glucose’ (OR = 1.32, 95% CI = 1.03 
to 1.69) and the lowest quartile of the ‘standard deviation’ (OR = 1.55, 
95% CI = 1.23 to 1.96) were associated with higher ICU mortality than 
their reference categories.
Conclusion Not the transition to hyperglycemia, but insuffi  cient 
recovery from hypoglycemia is associated with an increased ICU 
mortality in patients under moderately strict or strict glucose control 
with insulin.
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Computer versus paper insulin protocol for managing 
hyperglycemia in three ICUs
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Introduction The purpose of this study was to compare a computer 
protocol against a paper protocol in managing three domains of 
glucose control. Hyperglycemia is common in critically ill patients, and 
their risk of death is associated with hyperglycemia, hypoglycemia, 
and glucose variability. A safe and eff ective insulin protocol must 
minimize hyperglycemia and glucose variability while also avoiding 
hypoglycemia. Computer-based insulin protocols promise better 
performance by adjusting to each individual’s sensitivity to insulin.
Methods This is a historical cohort study with 759 patients admitted to 
three ICUs (medical/cardiac, trauma, and neuroscience) at an academic 
tertiary care hospital. All adult patients from January 2012 to October 
2013 on one of two continuous insulin protocols for at least 8 hours 
were included. At the start of the study period the paper protocol in use 
(Adult ICU) had a target glucose of 140 to 180 mg/dl and was used for 
any patient with a glucose higher than 180 mg/dl. In June 2013 this was 
replaced by a computer-based insulin protocol (EndoTool) that had the 
same criteria for initiation and had a target glucose of 150 mg/dl. The 
primary exposure was the insulin protocol, and the primary outcome 
was performance in maintaining glucose control.
Results The median glucose in the EndoTool group (141.5  mg/dl) 
was lower than in the Adult ICU group (159.9  mg/dl) (P  <0.0001). 
The standard deviation of glucose in the EndoTool group (32.3  mg/
dl) was lower than the Adult ICU group (39.5  mg/dl) (P  = 0.0001). 
The proportion of patients in each group with 10% or higher of 
measurements at a severe hyperglycemia level (≥200  mg/dl) in the 
EndoTool group (35.2%) was lower than the Adult ICU group (64.1%) 
(P <0.0001). The proportion of patients who had at least one moderate 
hypoglycemic measurement (<70 mg/dl) was not signifi cantly diff erent 
between the EndoTool group versus the Adult ICU group (11.73% 
vs. 9.3%, respectively; P  = 0.34). However, there was a higher overall 
incidence of hypoglycemia in the EndoTool group (5.65 hypoglycemic 
measurements/100 person-protocol days) compared with the Adult 
ICU group (3.43/100 person-protocol days) (RR  = 1.65, 95% CI  = 1.09 
to 2.45, P  = 0.014). Severe hypoglycemia (<40  mg/dl) was rare, only 
occurring in 1/179 (0.56%) in the EndoTool group and 4/580 (0.69%) in 
the Adult ICU group.
Conclusion Patients on the computer protocol had a lower median 
glucose, less variability, and less hyperglycemia than patients on the 
paper protocol. There was a higher risk of moderate but not severe 
hypoglycemia in the computer group.
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Continuous blood glucose monitoring reduces the risk to ICU 
patients
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Abingdon, UK
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Introduction GlySure Limited (Abingdon, UK) has developed a 
continuous intravascular glucose monitoring system (CIGMS) to 
simplify the application of hospital protocols for optimal glucose 
control at the point of care. We have previously reported on the early 
results achieved in cardiac patients [1] and MICU patients [2]. This 
initial success has been sustained and demonstrated in further patient 
groups. We have now reached the point where we can conjecture upon 
the regular application of the GlySure CIGMS in day-to-day ICU practice. 
This in turn prompts the question, ‘How eff ective will continuous blood 
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glucose data prove in such routine use?’ Using actual case data, we 
have shown how comparing the mean absolute relative diff erence 
(MARD) and integration of the area under the curve (AUC) from the 
continuous glucose monitoring and intermittent measurement can be 
used to measure patient risk.
Methods The analysis used aggregated case data generated from 
our recent clinical trials, where a GlySure sterile, single-use sensor 
and dedicated monitoring system was used to measure the blood 
glucose concentration in patients continuously and in real time. The 
measurement of risk was compared using the MARD, an accepted error 
calculation tool, and the AUC was calculated using an AUC analysis 
software program.
Results When MARD from the GlySure sensor and intermittent 
measurement using the hospital’s existing protocol was compared, 
the measure of risk to the patient (that is, the uncertainty regarding 
the patient’s absolute blood glucose status) for the GlySure sensor 
was 50.5% lower than the intermittent measurement. The results also 
showed that as the variability of the BG data increases, the benefi t of 
continuous monitoring increases by signifi cantly reducing patient risk. 
The continuous monitoring reduces the patient’s risk by 88%, 73%, and 
69% respectively in high, medium and low variability situations.
Conclusion It is more and more evident that continuous glucose 
technology will be instrumental in driving safe and eff ective glucose 
management protocols that will support more consistent glycemic 
management standards within ICUs and across institutions.
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Introduction There is a need for continuous glucose monitoring in 
critically ill patients. The objective of this trial was to determine the 
point accuracy and reliability of a device designed for continuous 
monitoring of interstitial glucose levels in ICU patients (Sentrino; 
Medtronic MiniMed, Northridge, CA, USA).
Methods Critically ill patients with an anticipated life expectancy 
>96 hours were eligible for participation, if the platelet count was >30 × 
1012 ml. Device readings were compared with glucose measurements in 
arterial blood using blood gas analyzers (RapidLab Siemens Healthcare 
Diagnostics, The Hague, the Netherlands). We used a linear mixed 
model to determine which factors aff ect point accuracy. In addition, 
we determined the reliability, including duration of device start-up and 
calibration, skips in data acquisition, and premature disconnections of 
sensors.
Results We included 50 patients, aged 65 (56 to 72) years with an 
APACHE II score of 23 (17 to 26). Admission types were medical (62%), 
elective surgery (22%) and emergency surgery (16%), and 22% had 
diabetes. For the accuracy analyses we had 929 comparative samples 
from 100 sensors in 45 patients (11 (7 to 28) samples per patient) during 
4,639 hours (46 (27 to 134) hours per patient and 46 (21 to 69) hours 
per sensor). The Bland–Altman plot showed a bias of –0.6 mg/dl with 
limit of agreement between –57.2 and 56  mg/dl. Glucose prediction 
error analysis showed 60% of the glucose values <75  mg/dl within 
±15 mg/dl and 75.8% of the glucose values ≥75 mg/dl within 20% of 
the comparative RapidLab results. Clarke error grid analysis showed 
75.3% in zones A and 23.5% of the paired measurements in zones B, 
0.3% of the paired measurements in zones C and 0.9% of the paired 
measurements in zones D. Point accuracy did not meet the ISO14971 
standard for dosing accuracy, but improved with increasing numbers 
of calibrations, and was better in patients who did not have diabetes 
mellitus. Sixty out of 105 sensors were removed prematurely for a 
variety of reasons. The device start-up time was 49 (43 to 58) minutes. 
The number of skips in data acquisition was low, resulting in availability 
of real-time data during 95 (89 to 98)% of the connection time per 
sensor.
Conclusion The point accuracy of the device was relatively low in 
critically ill patients. The device reliability was relatively good, although 
sensors were removed prematurely for a variety of reasons.
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Introduction Hyperglycemia is common and often multifactorial in 
critically ill patients. The association of hyperglycemia with adverse 
outcome has repeatedly been established in a variety of settings. The 
objective of this study was to investigate whether hyperglycemia on 
admission to the ICU impacts presentation and outcome of sepsis 
patients and whether this eff ect is diff erent for patients with a history 
of diabetes mellitus.
Methods A two-center, prospective observational cohort study was 
conducted including all consecutive critically ill patients admitted to 
the ICU between January 2011 and July 2013. Sepsis patients were 
identifi ed using strict clinical and diagnostic criteria. The fi rst glucose 
measurement within a time window of 4 hours before up to 4 hours after 
ICU admission was categorized into euglycemia (71 to 140 mg/dl), mild 
hyperglycemia (141 to 200 mg/dl) or severe hyperglycemia (>200 mg/
dl), patients with hypoglycemia were excluded. A multivariable Cox 
proportional hazard model was used to determine the eff ect of 
admission hyperglycemia on mortality corrected for covariates.
Results Of the 1,059 patients admitted with sepsis, 526 (55.8%) had 
admission glucose levels within the normal range, 270 (25.5%) had 
mild hyperglycemia and 202 (19.1%) severe hyperglycemia. Patients 
with severe hyperglycemia were older, had higher APACHE IV scores 
and were more often diabetics compared with euglycemic patients. 
Shock on admission was more common in patients admitted with 
euglycemia. Crude mortality increased with increased admission 
glucose and a Cox regression analysis showed increased risk for 30-
day (HR = 1.67, CI = 1.24 to 2.23), 60-day (HR = 1.42, CI = 1.08 to 1.87) 
and 90-day (1.31, CI = 1.02 to 1.70) mortality in patients admitted with 
severe hyperglycemia compared with euglycemia. The association 
between mortality and severe hyperglycemia on admission was only 
present in patients without known diabetes but not in patients with a 
history of diabetes (30-day mortality HR = 1.67, CI = 1.15 to 2.43 vs. 1.84, 
CI = 0.97 to 3.49). Severe hyperglycemia was associated with a blunted 
proinfl ammatory cytokine response (IL-6 and IL-8) on admission in 
patients without, but not in patients with diabetes.
Conclusion Severe hyperglycemia on admission is associated with 
increased 30-day, 60-day and 90-day mortality in sepsis patients 
without a history of diabetes mellitus.
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Introduction Insulin infusion in critically ill patients mandates frequent 
measurements of the blood glucose level [1]. Microdialysis is a well-
established technology that off ers the opportunity to sample blood 
analytes with high accuracy, without the need for drawing blood 
samples [2,3]. We aimed to determine point and trend accuracy of 
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microdialysis-based continuous glucose monitoring (CGM) (EIRUS®; 
Maquet Critical Care AB, Solna, Sweden).
Methods Patients with an expected stay in the ICU of >48  hours 
needing an arterial catheter and a central venous catheter (CVC) were 
eligible. For a maximum of 3 days, during 8 hours per day, 125 μl blood 
was drawn from the arterial line every 15 minutes. Point accuracy was 
expressed using Clarke error grids, Bland–Altman plots and glucose 
prediction error analysis [4,5]. Trend accuracy was expressed using 
continuous glucose error grid analysis [6].
Results Three-hundred and fi fty-four paired samples were obtained 
from seven patients (66 (59 to 79) years old, APACHE II score 23 (20 to 
28), 51 (19 to 77) samples per patient). Point accuracy: 91% of paired 
values were in zone A, with the remaining 9% of the values in zone B in 
the Clarke error grid. In the Bland–Altman, bias was 5.4 mg/dl with an 
upper limit of agreement of 32.5 mg/dl and a lower level of agreement 
of –21.8 mg/dl. Glucose prediction error analysis showed that 91% of 
the values ≥75 mg/dl within 20% of the values measured by the blood 
gas analyzer were within range. Trend accuracy: in the rate error grid 
of the continuous glucose error grid analysis, 96% of the paired values 
were in zone A, 3.7% were in zone B and 0.3% were in zone C.
Conclusion Point and trend accuracy of the tested microdialysis-based 
CGM are good in critically ill patients.
Acknowledgement Maquet Critical Care AB provided two CGM systems 
and disposables for the duration of the study, but had no infl uence on 
study design or study reporting.
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Introduction Hyperglycemia occurs in 50 to 85% of patients admitted to 
a medical ICU (MICU) and has been associated with poor prognosis [1,2]. 
Whether applying intensive insulin therapy to achieve tight glycemic 
control in critically ill patients is benefi cial remains controversial [2]. 
Another important observation is a link between glycemic variability 
and mortality [3]. We performed a pilot study hypothesizing that when 
implementing intensive insulin therapy, real-time continuous glucose 
monitoring (RT-CGM) may help to safely achieve tight glucose control, 
while avoiding hypoglycemia and reducing glycemic variability in 
MICU patients.
Methods This two-center randomized controlled pilot study was 
performed during a 3-year period. To be included, patients had to be 
severely ill (APACHE II score ≥20) and CGM monitoring had to be started 
within 48 hours after admission in the MICU. Thirty-fi ve patients (age 
66 ± 10 years; nondiabetic/diabetic patients 27/8; APACHE II score 28 ± 
6) were randomly assigned to RT-CGM (n = 16) or to blinded CGM. In 
both groups a microdialysis-based glucose sensor (GlucoDay®S) was 
used during a 96-hour period of glucose monitoring. Insulin infusion 
was performed using a modifi ed Yale protocol. Outcome measures 
were percentage of time in normoglycemia and in hypoglycemia, 
glycemic variability, and CGM accuracy.
Results In the RT-CGM group the percentage of time at the target 
glycemia (80 to 110 mg/dl) was 37 ± 12% versus 34 ± 10% in the control 
group (NS) and glycemia averaged 119 ± 17 mg/dl versus 122 ± 11 mg/
dl respectively (NS). Time spent in hypoglycemia (<60 mg/dl) was not 
statistically diff erent between the group assigned to RT-CGM (0.6  ± 
1.6% of the time) versus those with blinded CGM registration (2.4  ± 
4.3% of the time). Parameters of glucose variability (standard deviation 
of mean glucose value, coeffi  cient of variation, mean amplitude of 
glucose excursions) did not diff er between the groups. The GlucoDay®S 
values and arterial glycemia correlated well with 98.6% of data falling 
in regions A and B of error grid analysis.
Conclusion In our study, the use of RT-CGM neither improved glucose 
control and variability, nor did it reduce hypoglycemic events. On the 
other hand we can state that our insulin infusion protocol already led 
to overall tight glucose control without a signifi cant hypoglycemia risk, 
leaving little space for improvement.
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Introduction Faecal peritonitis (FP) is a common cause of sepsis and 
admission to the ICU [1]. We report a review of all patients admitted to our 
ICU over 5 years with FP. The aim was to defi ne the clinical characteristics, 
outcomes and risk factors for mortality in ICU patients with FP.
Methods Data were extracted retrospectively from electronic case 
fi les. The primary outcome was ICU mortality. Secondary outcomes 
were hospital, 28-day, 90-day and 1-year mortality. Logistic regression 
analysis was used to identify independent risk factors for mortality.
Results Ninety-nine FP patients were admitted between April 2008 
and January 2014. Median age was 73 (IQR 61 to 79), with a female 
preponderance (53.5%). The median ICU length of stay (LOS) was 5 days 
(IQR 2 to 16). On admission to critical care, clinical data included (all 
medians): temperature 36.6°C (IQR 36 to 37.2), systolic blood pressure 
(BP) 113 mmHg (IQR 104 to 136), diastolic BP 56 mmHg (IQR 49 to 67), 
lactate 2.3  mmol/l (IQR 1.5 to 3.7), bilirubin 12 μmol/l (IQR 9 to 20), 
haemoglobin 104  g/l (IQR 93 to 116), haematocrit 31 (IQR 28 to 36), 
creatinine 88 μmol/l (IQR 66 to 152), prothrombin time 13.1  seconds 
(IQR 11.9 to 14.4). In 86 patients the initial operation was an emergency 
laparotomy, with primary perforation in 53 cases. Subsequent 
anastomotic dehiscence and need for relaparotomy happened in 24 
and 33 cases respectively. Forty per cent of patients underwent more 
than one surgical abdominal intervention. The most common antibiotic 
used was tazobactam and fl uconazole was the commonest antifungal. 
The percentages of patients receiving mechanical ventilation, renal 
replacement therapy and inotropic/vasopressor support during ICU 
stay were 72.7%, 25.3% and 84.8% respectively. The ICU and hospital 
mortality rates were 23.5% and 26.1%, respectively, increasing to 26.7% 
at 28 days, 28.4% at 90 days and 32.2% at 1 year. None of the surgical 
factors or diabetes infl uenced survival. The strongest independent risk 
factors associated for ICU mortality were systolic BP on ICU admission 
(OR = 1.05, 95% CI = 1.01 to 1.09, P = 0.015), acute kidney injury (AKI) 
within the fi rst 24 hours of ICU admission (OR = 0.15, 95% CI = 0.03 to 
0.9, P = 0.026) and lactate on ICU admission (OR = 0.62, 95% CI = 0.39 
to 1, P = 0.05).
Conclusion In this cohort of critically ill FP patients the ICU and 
12-month mortality rates were 23.5% and 32.2%, respectively. The 
most consistent predictors of mortality across all time points were AKI 
within 24 hours of ICU admission and admission lactate.
Acknowledgement VP and AT are joint fi rst authors.
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Introduction Postoperative ileus appears to be underestimated after 
cardiac surgery. We conducted this study to analyse the incidence, risk 
factors and outcomes of postoperative ileus.
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Methods In this single-centre observational study we prospectively 
enrolled all patients undergoing elective cardiac surgery. The primary 
output was the time to faeces (TTFE) as representing the postoperative 
ileus. Secondary outputs were the occurrence of ischaemic colitis 
and pneumonia. Quantitative variables were compared by ANOVA or 
Wilcoxon tests, qualitative variables by chi-square tests. Multivariate 
analyses were performed by logistic regression, P  <0.1 for inputs 
P <0.05 for outputs.
Results We included 349 patients: age 67.5 ± 10.8 years, M/F sex ratio 
252/97, preoperative left ventricle ejection fraction 58.8  ± 10.6%, 
bypass/valve ratio 234/154, number of grafts 2.7 ± 0.9, mammal arteries 
1.8  ± 0.5. In univariate analyses, bypasses received more anaesthetic 
drugs (P <0.01), had shorter extracorporeal circulation duration, 67 ± 
27 versus 75 ± 24 minutes (P <0.01), and received less blood products 
(P <0.0001). Bypasses had lower postoperative levels of troponin (3.9 ± 
7.6 vs. 8.1 ± 21 pg/ml, P <0.01) and LDH (330 ± 162 vs. 420 ± 175 pg/
ml). In contrast, the intra-abdominal pressure (IAP) was higher and 
related to the number of grafts at day 0 (Figure 1) and day 1 (P = 0.01 
and 0.02 respectively), and to the number of mammal grafts at day 0 
and day 1 (P = 0.01 and 0.04 respectively). The TTFE was longer but did 
not reach signifi cance (P = 0.13) as well as the occurrence of abdominal 
ischaemia (P  = 0.22). The occurrence of pneumonia was higher (P  = 
0.01). In multivariate analysis, the IAP at day 0 and day 1 was related to 
propofol quantities only. The predictors of pneumonia were: duration 
of mechanical ventilation, peak lactate in the postoperative 24 hours, 
and coronary bypass: OR = 163, 2.6, and 4.2 respectively.
Conclusion The number of coronary grafts and of mammal artery 
used in cardiac surgery is associated with higher IAP and higher risk of 
pneumonia. However, whether this is due to direct bowel ischaemia or 
longer anaesthesia remains to be studied in larger trials.
P376
ICU outcome of patients undergoing cytoreductive surgery 
followed by hyperthermic intraperitoneal chemotherapy: 
a single-center study
A Nadeem, A Al-Tarifi 
King Faisal Specialist Hospital, Riyadh, Saudi Arabia
Critical Care 2015, 19(Suppl 1):P376 (doi: 10.1186/cc14456)
Introduction Peritoneal carcinomatosis (PC) is associated with poor 
prognosis. The advent of complete cytoreductive surgery (CRRS) 
followed by hyperthermic intraperitoneal chemotherapy (HIPEC) 
has shown promise in improved survival for locally advanced intra-
abdominal carcinomatosis. Such patients are routinely admitted to the 
ICU postoperatively. Little is known about the natural course of such 
patients while in the ICU.
Methods The procedure was introduced in our hospital in 2008 as the 
fi rst regional center performing such therapy. A retrospective chart 
review of 129 cases of CRS-HIPEC admitted to a 22-bed surgical ICU in 
a tertiary care academic center between November 2008 and March 
2014. Primary outcomes were ICU length of stay (LOS) and duration of 
mechanical ventilation (MV). Secondary outcomes were hospital LOS 
and hospital mortality.
Results Eighty-seven patients (69.9%) were females. Mean age was 
48.9  years. Primary cancer was colorectal in 42 patients (32.5%), 
ovarian in 39 (30%), appendiceal in 29 (22%), others in 15.5%. Average 
operative time was 11 ± 2.1 hours. Average intraoperative crystalloids 
given were 12,217 ± 4,359 ml, packed RBCs were 2 ± 2.3 units, colloids 
1,083  ± 898  ml, average blood loss was 1,108  ± 785  ml. All patients 
were admitted to the ICU post procedure. The average fl uid balance 
during the OR was 9,481 ± 4,694 ml. Patients stayed in the ICU for an 
average of 6 ± 5.3 days. All patients survived the ICU stay. The duration 
of mechanical ventilation was 57 ± 83 hours, total fl uid balance while 
in the ICU was 1,467  ± 3,399  ml. Hypomagnesemia was the most 
frequent electrolyte abnormalities in 79 (61%). Pleural eff usions in 48 
(37%), of which three patients only required drainage, Seven patients 
(5.6%) developed pneumonia, no patient required renal replacement 
therapy. Average hospital LOS was 33.7 ± 29 days. Only two patients 
died in the hospital. When the fi rst 65 patients were compared with the 
last 64 patients, the duration of MV, ICU LOS and hospital LOS were all 
signifi cantly shorter in the latter group (72 vs. 43 hours, 6.8 vs. 5.0 and 
40 vs. 27 days respectively; P <0.01 for all).
Conclusion With proper selection of patients, CRS with HIPEC can be 
done safely with no major complications. There is a signifi cant reduction 
in ICU utilization and shorter hospital LOS with more experience in such 
procedure, suggesting a learning curve as well as better utilization of 
resources by referring such patients to a high-volume center.
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Introduction The disseminated intravascular coagulation (DIC) score is 
a predictor of outcome in critically ill patients [1,2]. Yet disturbances 
of coagulation and hemostasis, as refl ected by the DIC score, are a 
common fi nding in patients with liver cirrhosis. Thus, it is unclear 
whether the DIC score has prognostic value in critically ill patients with 
liver cirrhosis. The aim of this study was to assess the applicability and 
prognostic impact of the DIC score in critically ill patients with liver 
cirrhosis.
Methods Patients with liver cirrhosis admitted to the medical ICU were 
analyzed for this study. Detailed laboratory analyses including platelet 
count, D-dimer, fi brinogen and prothrombin index were performed on 
admission and the DIC score was calculated. Survival was assessed on 
site or by contacting the patients or the attending physician.
Results In total, 150 admissions to the ICU with liver cirrhosis were 
analyzed. Thirty-nine percent were female. Median age was 56 (IQR 
49 to 63) years. The median SOFA score on admission was 9 (6 to 13), 
median MELD score 26 (IQR 18 to 36). Twenty-eight-day mortality was 
59%. Median DIC score on admission was 5 (IQR 4 to 6). Overt DIC 
(DIC score ≥5) was found in 65%. DIC score was signifi cantly higher in 
nonsurvivors compared with survivors (5 (IQR 4 to 7) vs. 4 (IQR 3 to 6); 
P <0.01). AUROC for the DIC score in prediction of 28-day mortality was 
0.68 (95% CI = 0.59 to 0.77). Overt DIC on admission was signifi cantly 
associated with 28-day mortality (OR  = 3.4 (95% CI  = 1.69 to 6.84), 
P  <0.01). The 28-day mortality rate in admissions with cirrhosis and 
overt DIC was 70% compared with 40% in those with a DIC score <5.
Conclusion Disturbances in coagulation and hemostasis are found in 
the majority of cirrhotic patients admitted to the ICU. The DIC score is a 
suitable predictor of 28-day mortality in critically ill patients with liver 
cirrhosis.
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Warm ischemia time, postreperfusion syndrome and initial poor 
function after liver transplantation: are they connected?
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Introduction Factors associated with initial poor graft function (IPGF) 
after liver transplantation are still under debate. Although the initial 
insult to the graft begins during the cold ischemia time (CIT), recent 
studies showed that most injuries occur during rewarming. Ischemic–
reperfusion (I/R) injuries are present in all grafts and may be responsible 
for postoperative graft dysfunction. Along with other factors, I/R injury 
may also play a role in the development of postreperfusion syndrome 
(PRS) after revascularization of the liver graft. The aim of this study 
was to assess whether longer warm ischemia time (WIT) is associated 
with PRS or with IPGF after liver transplant. The secondary aim was to 
investigate whether patients with intraoperative PRS have a higher risk 
for postoperative IPGF.
Methods This retrospective observational study included 60 liver 
transplant patients. We excluded from the study group patients with 
retransplant procedures, and the recipients of divided grafts and of 
grafts from extended criteria donors. We recorded: demographic data, 
intraoperative PRS, CIT, WIT, ALT, AST levels and standard coagulation 
tests on postoperative days (POD) 1 to 5. Statistical analysis was 
performed using SPSS Statistics v.19.1 with signifi cant P value under 0.05.
Results We used the criteria of Nanashima and colleagues for the 
diagnosis of IPGF (ALT and/or AST level above 1,500 IU/l within 72 hours 
after OLT). The study group included 33 men (55%) and 27 women. 
Mean (±SD) age was 50.56 (±13.26) years. WIT longer than 60 minutes 
correlated signifi cantly with ALT and AST levels in POD 1 to 3 (P <0.0001 
for ALT in POD 1 to 3, P = 0.001 for AST in POD 1, P = 0.007 and 0.013 for 
AST in POD 2 and 3) and with prothrombin time (P = 0.008 in POD 1, P = 
0.03 in POD 2 and P = 0.015 in POD 3). We could not fi nd a correlation 
between PRS and WIT (P = 0.566), CIT (P = 0.439) or transaminase levels 
on POD 1 to 3. The correlation between WIT >60 minutes and IPGF was 
confi rmed using the Pearson chi-square test (P <0.0001). The same test 
was used to correlate IPGF with PRS with nonsignifi cant results (P  = 
0.876).
Conclusion Our study showed that PRS is not a risk factor for 
IPGF after liver transplantation. WIT over 60  minutes does not 
infl uence the development of PRS, but is associated with IPGF after 
liver transplantation. Close monitoring of liver tests in the early 
postoperative period is very important especially in recipients of grafts 
with WIT over 60 minutes. Further eff orts to decrease WIT may prove 
useful for the reduction of IPGF in liver transplant patients.
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Introduction Healthcare workers are at risk for infections caused by 
hepatitis B (HBV), hepatitis C (HCV) and human immunodefi ciency 
(HIV) viruses that transmit via blood and body fl uids. In the present 
study, it was aimed to investigate the seroprevalences of HBsAg, anti-
HCV and anti-HIV in patients admitted to the ICU.
Methods HBsAg, anti-HCV and anti-HIV test results and demographical 
data of the patients admitted to the Reanimation ICU between January 
2012 and December 2014 were evaluated retrospectively. HBsAg, 
anti-HCV and anti-HIV tests were assayed with a macro-ELISA method 
(Axsym-Abbott, Architect i2000; Abbott, USA). Statistical analysis was 
performed with the chi-square test.
Results The records of 462 patients admitted to our ICU were reviewed. 
The results of 36 patients could not be reached, so 426 patients were 
evaluated in the study. Among 426 patients, 169 (39.7%) were female 
and 257 (60.3%) were male. The mean age was 63.7 ± 18.7. HBsAg was 
positive in nine (2.1%) patients; all of these nine were male. Anti-HCV 
was positive in four (0.9%) patients; among these, three were male and 
one was female. Only one patient was positive for anti-HIV.
Conclusion In the present study, it was observed that the sero-
prevalences of HBsAg, anti-HCV and anti-HIV were not higher than 
in our city population. However, taking the safety precautions of the 
healthcare workers during surgical or invasive procedures such as 
catheterization, intubation or tracheostomy without any information 
about the serological test results of the patients will reduce the 
contamination of these agents.
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Introduction Patients with decompensated cirrhosis admitted to the 
ICU have historically had a very high mortality rate [1]. It has been 
suggested that improving patient selection can improve ICU outcomes 
in patients with cirrhosis [2]. The aim of this study was to determine 
the mortality and evaluate the risk factors that may infl uence the 
outcome of this group of patients in a large UK district general hospital 
with a view to introducing selection criteria for future ICU admission of 
patients with decompensated liver disease.
Methods A retrospective analysis was performed of all adult patients 
with decompensated chronic liver disease admitted to a general 
(nontransplant) critical care unit between January 2012 and December 
2013. Data were collected regarding demographics, ICU mortality, 
hospital mortality, aetiology of chronic liver disease, severity scores, 
acute diagnoses, and organ support requirements.
Results Thirty-seven patients were identifi ed, with a median age 
of 57  years, predominantly male (62%). Seventy-six per cent had 
alcohol-related cirrhosis. Overall ICU mortality was 29.7% and hospital 
mortality was 48.6% – these values were higher in the alcoholic group 
(39.3% and 57.1% respectively). All ICU deaths were in those with 
alcoholic liver disease. Median scores were: APACHE III 93, SOFA (day 
1) 9, Child–Pugh 11, MELD 21. Seventy per cent were treated for sepsis, 
22% had a GI bleed, 57% had encephalopathy, 24% had suspected/
confi rmed spontaneous bacterial peritonitis, and 70% had an acute 
kidney injury. Organ support requirements were: 35% respiratory 
(non-invasive or invasive ventilation), 38% vasoactive agent support, 
24% renal replacement therapy (RRT). Alcoholic liver disease patients 
requiring respiratory or cardiovascular support had an ICU mortality of 
64%, and those requiring RRT had a mortality of 75%. Alcoholic liver 
disease patients requiring combined respiratory, cardiovascular, and 
RRT support had 100% mortality.
Conclusion Those with decompensated chronic liver disease admitted 
to the ICU have a signifi cant ICU/hospital mortality, which is increased 
in alcoholic liver disease. Sepsis and AKI were the most common acute 
diagnoses in this cohort. Alcoholic liver disease patients requiring organ 
support have a very high mortality, and the outlook for multiorgan 
failure requiring RRT in this group is dismal.
References
1. Olson JC, et al. Hepatology. 2011;54:1864-72.
2. Sauneuf B, et al. Crit Care. 2013;17:R78.
P381
Prometheus® liver therapy in children with acute liver failure
J Vande Walle, S Claus, E Snauwaert, J De Rudder, A Raes, M Dick, 
A Prytula, W Van Biesen, S Eloot
Ghent University Hospital, Gent, Belgium
Critical Care 2015, 19(Suppl 1):P381 (doi: 10.1186/cc14461)
Introduction The Fractionated Plasma Separation and Adsorption 
System Prometheus® (Fresenius Medical Care, Germany) aims at being 
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a supportive therapy as a bridge to transplantation or recovery in adults 
with liver failure. The system off ers specifi c challenges when applied 
in children due to the large extracorporeal volume (700 to 750 ml). We 
therefore developed an adapted protocol for the application in children.
Methods Priming of the blood circuit is performed using 2  l isotonic 
saline, whereas the plasma circuit, containing both adsorption devices, 
is fi lled with 2  U fresh frozen plasma or 400  ml stabilized solution of 
human plasma proteins. Next, for children with body weight (BW) 
<25 kg, a solution of 60 to 65% packed cells (PC) is infused in the inlet 
blood line at 40  ml/minute. The volume of PC needed is calculated 
based on the circuit priming volume and the maximum allowed 
extracorporeal blood volume of the child (= 8 ml/kg × BW). After the 
priming phase, blood and plasma fl ow are increased to at least 100 ml/
minute and 200  ml/minute, respectively, and dialysate fl ow is set at 
300 ml/minute. Regional citrate anticoagulation is done with a calcium-
free dialysate, while, eventually, heparin is added to the priming 
solution. Post treatment, the circuit volume is either not reinfused (BW 
<25 kg) or reinfused using isotonic saline (BW >25 kg), with a volume 
depending on the hydration status and the originally infused volume 
of PC. Reduction ratios (RRs, %) of urea, creatinine (Crea), bilirubin 
(bili), and ammonia (NH3) were calculated from pretreatment and 
posttreatment serum concentrations. Primary and secondary patient 
outcome was evaluated.
Results Eight children (fi ve male/three female), 8.6  ± 5.9  years old 
(range 2 to 15.6 years), BW 32 ± 21 kg, GFR 71 ± 20 ml/minute/1.73 m2, 
with an uncuff ed double lumen dialysis catheter (8 to 14 Fr Femoralis 
(n = 6) and 9 Fr Jugularis (n = 2)) were treated according to this protocol. 
In total, 19 sessions were executed using FX40 (n = 13), FX50 (n = 3), 
and FX60 (n = 3) dialysers during 6.5 ± 0.9 hours. Blood fl ow was 149 ± 
45  ml/minute, albumin fl ow 226  ± 49  ml/minute, and ultrafi ltration 
fl ow 432 ± 517 ml. RRs were 70 ± 15% (urea), 34 ± 14% (Crea), 44 ± 16% 
(bili), and 36 ± 10% (NH3). Primary survival rate was 100%. Four patients 
were transplanted (bridge to transplant) of which, however, one died 
within 30 days after discharge from the ICU. The fi fth patient died due 
to primary disease 9 months after treatment, and the remaining three 
patients fully recovered (bridge to recovery).
Conclusion This adapted Prometheus® protocol is promising for the 
treatment of children with liver failure.
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Introduction The molecular adsorbent recirculating system (MARS) 
is used to remove circulating albumin-bound toxins in patients with 
liver failure. However, the application of MARS has not demonstrated 
improved survival in randomized clinical trials and the clinical utility 
has not been fi nally established. In our department, the use of MARS is 
now restricted to the most critically ill patients with acute or acute on 
chronic liver failure. We aimed to explore MARS effi  cacy in removing 
toxicity parameters and the safety of the system.
Methods Since 2005, we have treated 69 patients (30 males/39 females 
with median age of 39 years ranging from 1 month to 70 years) listed 
for liver transplantation with MARS. The median Model of End Stage 
Liver Disease (MELD) score in patients older than 12 years of age (n = 
56) was 33 (interquartile range 26 to 39). The fl ow rate was 35 to 40 ml/
kg/hour and treatment kits were changed every 8 to 12  hours. The 
patients were treated for a median of 31 hours (range 1 to 240 hours).
Results Fifty-fi ve patients (79%) were successfully bridged to 
transplantation. Nine died before they could be transplanted, and 
fi ve patients recovered without liver transplantation. Forty-four (81%) 
of the transplanted patients were alive 30 days after transplantation. 
Ammonium decreased modestly from a median of 148 to 124 
μM (P  = 0.03) during MARS treatment. We detected worsening of 
coagulopathy with signifi cant decreases in platelet count and 
fi brinogen concentrations, and increase in International Normalized 
Ratio. Phosphate and magnesium decreased signifi cantly during MARS 
treatment.
Conclusion Close observation and treatment of coagulopathy and 
electrolyte disturbances is essential when treating patients with MARS. 
MARS can reduce and stabilize ammonium and other biomedical 
markers in patients listed for urgent liver transplantation with high 
MELD score and liver encephalopathy. It seems that, in some cases 
and with our settings, the detoxifi cation properties of MARS may be 
insuffi  cient.
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Introduction Liver failure (LF) is associated with prolonged hospital 
stay, increased cost and substantial mortality. With regard to a limited 
number of donor organs, extracorporeal liver support is an appealing 
concept to bridge to transplant or to avoid transplant in case of 
recovery. A new type of albumin dialysis, the HepaWash® system, 
was recently introduced. The HepaWash® system provides rapid re-
generation of toxin-binding albumin by secondary circuits altering 
binding capacities of albumin by biochemical (changing pH) and 
physical (changing temperature) modulation of the dialysate.
Methods We evaluated the fi rst 14 patients treated with the HepaWash® 
system with regard to safety and effi  cacy. Seven patients were treated 
in the context of the run-in phase of the studies (HEPATICUS 1 and 
HEPATICUS 2) and seven patients were treated since the HepaWash® 
system received the CE certifi cate in July 2013. Patients treated suff ered 
under acute on chronic LF (n  = 9) or secondary LF which resulted 
from nonhepatic diseases such as sepsis (n  = 5). Primary endpoint: 
comparison of serum bilirubin, creatinine and serum BUN before and 
after the fi rst treatment with the HepaWash® system. Statistics: IBM 
SPSS Statistics version 22. The Wilcoxon test for paired samples was 
used to detect signifi cant treatment eff ects.
Results A total of 254 treatments (1 to 101 per patient) were performed 
in 14 patients (six female, eight male). Mean age 54 ± 13. MELD score 
33.7 ± 7.0, CLIF-SOFA 14.6 ± 2.7. Main underlying disease: nine acute-
on-chronic LF; fi ve secondary LF. While bilirubin did not change 
signifi cantly on the day before HepaWash® treatment (26.2 ± 15.4 vs. 
26.0 ± 15.4 mg/dl; P = 0.116), serum bilirubin levels were signifi cantly 
decreased by the HepaWash® procedure (26.0 ± 15.4 vs. 17.7 ± 10.5 mg/
dl; P = 0.001). Similarly, serum creatinine (2.2 ± 0.8 vs. 1.6 ± 0.7 mg/dl; 
P = 0.005) and serum BUN (49.4 ± 23.3 vs. 31.1 ± 19.7 mg/dl; P = 0.003) 
were signifi cantly lowered by the HepaWash® procedure. There were no 
serious adverse events observed in conjunction with the HepaWash® 
treatment.
Conclusion So far the HepaWash® system has proven to be a safe and 
feasible procedure to eff ectively eliminate water and protein-bound 
toxins in humans with LF.
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Intensive care referral and admission: do the criteria for liver 
disease match?
J McPeake, CR Soulsby, T Quasim, J Kinsella
University of Glasgow, UK
Critical Care 2015, 19(Suppl 1):P384 (doi: 10.1186/cc14464)
Introduction Hospital admission and mortality rates for patients with 
cirrhosis in the UK are rising [1]. Cirrhotic patients are physiologically 
challenged and at increased risk of sepsis and death [2]. Mortality 
rates for cirrhosis in nontransplant ICUs are up to 37% [3]. Increased 
availability of medical therapies and public expectation places pressure 
on limited intensive care resources. There is a lack of research into 
factors used to decide which patients to admit or refer to the ICU.
Methods A prospective survey was sent to all consultant 
gastroenterologists and consultant intensivists in Scotland. Each 
recipient rated the signifi cance of 18 physiological and social criteria 
on their decision to refer or admit a patient to intensive care from 1 to 
5, with 1 being no infl uence and 5 denoting signifi cant impact on the 
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decision. Recipients listed additional criteria used in their own practice 
and asked whether they would admit or refer individual grades of 
Child–Pugh cirrhosis with either a gastrointestinal bleed or sepsis.
Results Thirty-fi ve consultant gastroenterologists and 65 intensive 
care consultants responded, representing a response rate of 34% and 
45% respectively. The only criterion given an average rating of 5 by 
both gastroenterologists and intensivists was Child–Pugh score when 
stable. Presence on the transplant list, referral secondary to bleeding 
varices, recent discharge from the ICU, abstinence from alcohol, 
nutritional status, age under 30 and more than one additional organ 
failure all scored 4 or 5 from both groups. Sex, employment, smoking 
or drug use, deprivation and positive virology status did not infl uence 
the decision to refer or admit patients. Clinicians reported compliance 
with medication and outpatient appointments plus an obvious 
precipitant factor as important features in their decision. The majority 
of respondents would refer or admit all grades of Child–Pugh cirrhosis 
with gastrointestinal bleeding. Most would refer or admit Child–Pugh 
A or B with sepsis. A total 76.5% of gastroenterologists would refer 
Child–Pugh C cirrhosis with sepsis but only 33.3% of intensivists would 
accept.
Conclusion Referral and admission decisions for patients with cirrhosis 
are multifactorial. Child–Pugh status when stable appears to be of 
greatest signifi cance. The diff erence in opinion of admission of patients 
with Child–Pugh C with sepsis requires further evaluation.
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Introduction Cirrhotic patients admitted to the ICU are usually regarded 
as having a particularly poor prognosis when compared with other 
groups of critically ill patients. The aim of our study was to evaluate the 
prevalence, case mix and outcomes of patients with cirrhosis admitted 
to the general ICU of a nontransplant center.
Methods Data were collected from a running ICU database. We studied 
cirrhotic patients admitted to the ICU between January 2013 and 
November 2014.
Results A total of 30 patients with cirrhosis were admitted, accounting 
for 3% of total ICU admissions. Mean age was 54.5 years, with a male 
preponderance (76.7%). The main cause for cirrhosis was alcohol 
(53.3%), followed by alcohol plus chronic hepatitis C virus (HCV) infection 
(20%) and HCV virus infection alone (13.3%). The most common causes 
for admission were sepsis/septic shock (26.7%), surgical (23.4%), 
gastrointestinal bleeding and hepatic encephalopathy (16.7% each). 
At admission, these patients presented an average Model for End-
Stage Liver Disease score of 23.5 ± 10.4 with 70% classifi ed as grade 
C in the Child–Pugh score; mean Acute Physiology and Chronic Health 
Evaluation (APACHE II) 29.2 ± 8.7 and new Simplifi ed Acute Physiology 
Score (SAPS II) 62.7  ± 29. Regarding organ failure at admission, the 
mean Sequential Organ Failure Assessment score was 12.8 ± 4.5. The 
ICU mortality of these patients was 43.3% and hospital mortality 
was 53.3%. The variables at admission that related signifi cantly with 
ICU mortality were: all scores described except for Child–Pugh score, 
bilirubin, the International Normalized Ratio, creatinine, bicarbonate, 
lactate, pH and the use of renal replacement therapy during the ICU 
stay (P  <0.05). The mortality rate of cirrhotic patients was superior 
to the general ICU mortality (43% vs. 26%). However, patients with 
cirrhosis presented signifi cantly higher severity scoring systems 
(APACHE II; SAPS II) at admission compared with noncirrhotics, with 
high prevalence of organ dysfunction as assessed by SOFA score.
Conclusion The high severity of disease in conjunction with the 
high mortality rate observed in this group of patients should make 
us consider the possible benefi ts of earlier referring/admission to 
the ICU, ideally before multiorgan failure arises. On the other hand, 
in nontransplant centers where cirrhotic patients constitute a small 
percentage of total ICU admissions, the complexity and peculiarities of 
the management of these patients should prompt their early transfer 
to a specialized center.
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Introduction The aim was to study the evolution and incidence of 
intraabdominal hypertension in critical burn patients using a slightly 
restrictive fl uid therapy protocol based on monitoring transpulmonary 
thermodilution and lactic acid.
Methods A prospective study of 132 consecutive patients admitted 
to the Critical Burn Unit between October 2008 and October 2011. In 
all of them resuscitation was performed by objectives: blood pressure 
(>65  mmHg), hourly diuresis (0.5 to 1  cm3/kg), lactic acid clearance 
and thermodilution transpulmonary parameters (CI >2.5 l/minute/m2, 
ITBI: 600 ml/m2). We performed measurements of IAP with a bladder 
catheter every 8 hours in the fi rst 72 hours.
Results Ninety-eight men and 34 women were studied. Mean age 48 ± 
18 years and a TBSA of 35 ± 22%. The fl uid provided by %TBSA in the 
fi rst 8 hours was less than predicted by Parkland (4.05 ml/kg), although 
the total contribution in the fi rst 24  hours was similar. The evolution 
of the intra-abdominal pressure was: admission 9.7 mmHg, 8 hours 11, 
16 hours 10.5, 24 hours 12.1, 32 hours 12.0, 40 hours 12.0, 48 hours 11.1, 
56 hours 10.3, 64 hours 10.0 and 72 hours 10.0. A total of 44 patients 
(33.3%) had a determination higher than 12  mmHg, distributed: 15 
patients between 12 and 15 mmHg (IAHT I grade), 14 between 16 and 
20 mmHg (II), nine between 21 and 25 mmHg (III) and six >25 mmHg 
(IV). See Figures 1 and 2.
Conclusion IAH incidence when a slightly restrictive fl uid protocol used 
is less than expected.
Figure 1 (abstract P386). Intraabdominal pressure.
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Introduction Intra-abdominal hypertension (IAH) is frequent in the ICU 
and has been associated with adverse outcomes and worse prognosis. 
The purpose of our study was to assess risk factors for IAH and prognosis 
of major injured patients during burn resuscitation.
Methods Adult burned patients with a burn injury exceeding 20% 
of total body surface area, from 1 April to 30 November 2013, were 
included. IAP was measured when IAH was suspected, according to the 
Kron method via the Foley catheter. Monitoring of IAP was performed 
every 6 hours during 5 days until normalization.
Results Twenty patients were enrolled in the study. The mean age 
was 36 ± 13 years. There were 14 males and six females. The average 
TBSA was 44  ± 17%. Screening and monitoring of IAP were applied 
by: oliguria (42%), abdominal distension (31.5%) and gastrointestinal 
trouble (21%). IAH occurred between day 2 and day 3 after early 
burn resuscitation, respectively in 52% and 63%. IAH was observed in 
69% of cases in patients admitted to the ICU with a delay of 1.6 days 
post burn injury. IAH was noted in 13 patients; of these, fi ve patients 
developed an abdominal compartment syndrome. The mean IAP was 
16 ± 7 mmHg. Patients were assigned into two groups: G1 (IAH+; n = 
13) and G2 (IAH–; n = 7). Comparative study of the two groups shows 
that HIA increases signifi cantly body weight gain within the fi rst 5 days 
after injury: 8 kg for G1 versus 2 kg for G2 (P = 0.04), occurrence of ARDS 
(70% for G1 vs. 16.7% for G2, P = 0.02), respiratory failure (77% for G1 vs. 
28.5% for G2, P = 0.06), shock (70% for G1 vs. 16.7% for G2, P 0.02) and 
mortality (61.5% vs. 50%).
Conclusion IAH was frequent in early burn resuscitation of major 
injured patients. It seems to be associated with fl uid overload in burns 
and contributes to organ damage.
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Introduction The aim of our study was to investigate the eff ects of 
sepsis on respiratory mechanics in a porcine model of intra-abdominal 
hypertension (IAH).
Methods Sixteen pigs were divided into two groups of eight (G-A/
G-B). All animals received general anesthesia and were mechanically 
ventilated. Parameters recorded included respiratory system, chest 
wall and lung compliance (CRS, CCW, CL) and respiratory system and 
chest wall inspiratory and expiratory resistances (RRSisp, RRSexp, 
RCWisp, RCWexp). After baseline measurements (0  minutes), intra-
abdominal pressure IAP was raised by helium insuffl  ation to 25 mmHg 
in both groups and remained at that level for the whole study. In G-B, 
sepsis was induced 60 minutes after IAP increase, by i.v. administration 
of Escherichia coli endotoxin. Parameters were recorded every 
20 minutes. The last measurement was made at 180 minutes, right after 
deinsuffl  ation, and IAP return to baseline levels.
Results CRS decreased statistically signifi cantly in both groups after 
IAP increase and increased after deinsuffl  ation only in G-A. Similarly, 
CCW decreased in both groups but returned to baseline values in both 
groups after deinsuffl  ation. CL decreased more signifi cantly in G-B and 
returned to baseline values only in G-A. RRSisp increased only in G-B 
and did not decrease after deinsuffl  ation, whereas RRSexp increased 
in both groups, in a more signifi cant manner in G-B, and decreased 
only in G-A after deinsuffl  ation. RCWisp and RCSesp did not show 
any alterations during the study period. Results are depicted as mean 
values ± SD in Tables 1 and 2.
Conclusion Both sepsis and IAH have negative eff ects on respiratory 
mechanics. However, their combination has even more detrimental 
eff ects, which do not ameliorate after deinsuffl  ation.
Figure 2 (abstract P386). IAH classifi cation.
Table 1 (abstract P388). Compliance alterations during the study
  CRS (ml/cmH2O)   CCW (ml/cmH2O)   CL (ml/cmH2O)
Minutes A B P value A B P value A B P value
0 35 ± 8 31 ± 4 NS 58 ± 20 46.1 ± 11 NS 99 ± 22 98 ± 14 NS
20 14 ± 4** 12 ± 3** NS 20 ± 6** 17.7 ± 3** NS 52 ± 21** 35 ± 11** NS
40 13 ± 4** 12 ± 1** NS 19 ± 6** 16.8 ± 3** NS 47 ± 23** 36 ± 13** NS
60a 12 ± 3** 11 ± 2** NS 20 ± 5** 18.4 ± 4** NS 41 ± 20 28 ± 7** NS
80 13 ± 3** 10 ± 1** NS 20 ± 6 18.2 ± 44 NS 41 ± 21** 24 ± 6** <0.05
100 12 ± 3** 10 ± 2** NS 21 ± 8** 19.9 ± 5** NS 37 ± 20** 19 ± 4** <0.05
120 12 ± 3** 10 ± 1** NS 20 ± 6** 21.9 ± 7** NS 37 ± 20** 17 ± 3** <0.05
140 12 ± 3** 9 ± 1** NS 21 ± 7** 21.8 ± 6** NS 37 ± 20** 17 ± 5** <0.05
160 12 ± 3** 9 ± 1** NS 21 ± 7** 22.3 ± 7** NS 37 ± 19** 16 ± 4** <0.05
180 33 ± 7** 16 ± 5** <0.001 50 ± 18 77.0 ± 18** <0.05 81 ± 20* 21 ± 7** <0.001
aSepsis induction. Comparison with baseline: *P <0.05, ** P<0.01.
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Introduction CD73/ecto-5’-nucleotidase is an enzyme that generates 
adenosine, which dampens infl ammation and improves vascular 
barrier function in several disease models. CD73 also circulates in a 
soluble form in the blood [1]. We studied whether levels of soluble form 
of CD73 and cytokines/chemokines predict the development of organ 
failure in acute pancreatitis [2,3].
Methods Altogether, 161 patients with acute pancreatitis (107 were 
subclassifi ed according to the revised Atlanta criteria into mild, 29 
into moderately severe and 25 into severe forms) were studied. Serum 
and blood cell samples were collected at admission. Protein levels of 
soluble form of CD73 in serum were determined using a novel enzyme-
linked immunosorbent assay, activity of soluble form of CD73 using 
radioactive enzyme assays, and CD73 messenger RNA levels from 
leukocytes using quantitative PCR. Serum levels of 48 cytokines and 
growth factors were determined using Bio-Plex Pro Human Cytokine 
Assay 21-plex and 27-plex magnetic bead suspension panels.
Results Activity and protein concentration of soluble form of CD73 
and messenger RNA level of CD73 all decreased along with the 
disease severity (P ≤0.01 for all). The activity of soluble form of CD73 
at admission predicted the development of severe pancreatitis in 
diff erent groups of the patients. Especially, activity of soluble form of 
CD73 was better than C-reactive protein or creatinine in predicting 
the severity of pancreatitis in the group of patients without any signs 
of organ failure at admission. In subgroup analyses of patients with 
severe pancreatitis and without organ dysfunction upon admission, IL-
8, hepatocyte growth factor and granulocyte colony-stimulating factor 
(G-CSF) levels predicted the development of severe pancreatitis, with 
G-CSF being the most accurate cytokine.
Conclusion Activity of soluble form of CD73 and levels of certain 
cytokines at admission to the hospital have prognostic value in 
predicting the development of the severe form of acute pancreatitis. 
The possibility that combining them with other prognostic markers 
might improve prognostic accuracy requires further studies.
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Introduction Heterogeneous published results led us to conduct a 
clinical trial to assess the effi  cacy of a new formulation of four probiotics 
(P) as prophylaxis for complications after colorectal surgery.
Methods A double-blind, placebo-controlled randomized study was 
conducted enrolling patients undergoing colorectal cancer surgery. 
Placebo or a formulation of L. acidophilus, L. plantarum, B. lactis and 
S. boulardii was administered starting 1  day before operation and 
continuing for 15  days post operation. Patients were followed-up 
for 30  days with the development of postoperative complications as 
the primary outcome. PAXGene tubes and serum were collected on 
postoperative day 4 for measurement of gene expression and serum 
cytokines (ClinicalTrials.gov NCT02313519).
Results Administration of P signifi cantly decreased the rate of all 
postoperative major complications (28.6% vs. 48.8% of placebo, P  = 
0.010, odds ratio: 0.42). Major benefi t was found in the reduction of the 
postoperative pneumonia rate (2.4% vs. 11.3%, P  = 0.029), of wound 
infections (7.1% vs. 20.0%, P = 0.020), of anastomotic leakage (1.2% vs. 
8.8%, P = 0.031) and of the need for mechanical ventilation (20.2% vs. 
35.0%, P = 0.037). The time until hospital discharge was shortened as 
Figure 1 (abstract P390).
Table 2 (abstract P388). Respiratory system resistance alterations during the study
  RRSisp (cmH2O/l/minute)   RRSexp (cmH2O/l/minute)
Minutes A B P value A B P value
0 8.1 ± 0.8 8.3 ± 0.7 NS 13.6 ± 4.1 15.5 ± 3.7 NS
20 7.8 ± 0.6 8.1 ± 0.7 NS 17.1 ± 5.2** 19.3 ± 2.2** NS
40 7.8 ± 0.8 7.6 ± 0.9 NS 18.1 ± 5.4** 20.6 ± 3.1** NS
60a 7.6 ± 0.9 7.5 ± 1.1 NS 18.9 ± 4.4** 19.9 ± 4.7** NS
80 7.8 ± 1.2 8.2 ± 1.2 NS 18.6 ± 4.2** 21.1 ± 4.12** NS
100 7.8 ± 0.9 7.9 ± 0.9 NS 18.2 ± 4.5** 22.7 ± 4.5** NS
120 8 ± 0.6 9.1 ± 1.1 <0.05 18.6 ± 4.3** 20.9 ± 2.2** NS
140 7.7 ± 0.6 9.5 ± 1.2 <0.01 18.8 ± 3.5** 22.9 ± 3.2** <0.05
160 7.3 ± 0.7 9.6 ± 1.5* <0.01 17.7 ± 3.5** 22.2 ± 2.3** <0.01
180 8.1 ± 0.8 9.7 ± 1.2* <0.01 14.9 ± 3.3 18.9 ± 2.3* <0.05
aSepsis induction. Comparison with baseline: *P <0.05, **P <0.01.
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well. Gene expression of SOCS3 was positively related with circulating 
IL-6 in the P group but not in the placebo group (Figure 1).
Conclusion The studied P formulation signifi cantly decreased the 
risk of postoperative complications, namely mechanical ventilation, 
infections and anastomotic leakage. Modulation of the gene expression 
of SOCS3 is one suggested mechanism.
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Introduction In this study, we aimed to determine the success rate 
of nasoenteric tube (NET) insertion into the postpyloric area by 
ultrasonography (USG) and compare it with the commonly used 
method, direct abdominal radiography.
Methods Patients admitted to an adult ICU between April and July 2014 
with an indication for NET insertion for enteral feeding were included 
in the study after informed consent was given from patients’ relatives. 
Nasoenteric feeding tubes were placed using the blind bedside 
method by a single anesthesiologist. Any motility stimulant agent 
was not used. The outside of the polyurethrane 8 F with unweighted 
NET (Bexen, Spain) and its guiding wire were lubricated with gel. The 
NET was inserted into the nostril after determination of the mouth–
posterior ear–xiphoid distance and pushed on at least such a distance. 
Followed by auscultation of the gastric area and air infusion of 30 to 
50 ml into the tube, the patient was positioned on their right side and 
the tube was advanced 20 to 30 cm more. Then the guiding wire inside 
the NET was removed. The patient was then brought to the supine 
position and NET was visualized by two radiologists simultaneously by 
M5 portable USG (Mindray, PRC), with a 3.5 MHz convex probe whether 
it passes through the postpyloric area or not. Localization of the tube 
was confi rmed with abdominal radiography in all patients. During 
the fi rst insertion of the NET, the ratios for inaccurate localization and 
correct placements through the postpyloric area were recorded and 
results were compared with abdominal radiography.
Results In this study, the bedside blind method was used for NET 
insertion into 34 patients. Eleven of the tubes were detected passing 
through the postpyloric area by USG. In one case the NET could not 
be seen in the postpyloric area by USG, but it was detected in the 
postpyloric area by control abdominal radiography. In 22 patients, NETs 
were detected in the stomach with control abdominal radiography. 
Success for NET placement with the bedside blind method and USG 
imaging was 35% versus 91.6%, respectively.
Conclusion The success rate of the bedside blind method in the NET 
placement was low. It is clear that if any other placement techniques 
with high success rate will be applied, USG will be useful in a higher 
number of patients reducing the need for abdominal radiography.
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Introduction The objective was to determine whether the 
administration of thiamine mitigates elevated lactate levels in patients 
with septic shock. Thiamine is essential for aerobic metabolism and we 
have found that thiamine levels are low and inversely correlated with 
lactate levels in patients with sepsis.
Methods We performed a randomized, double-blind, placebo-
controlled, two-center trial from January 2010 to October 2014. We 
enrolled patients with septic shock, elevated lactate (≥3 mmol/l) and 
no obvious competing cause of lactate elevation. Patients received 
thiamine 200  mg or placebo i.v. twice/day for 7  days. The primary 
outcome was lactate levels at 24 hours. Secondary outcomes included 
the SOFA score at 24  hours and mortality. Lactate levels at 24  hours 
were compared between groups using the Wilcoxon rank-sum test 
and categorical variables were compared using the Fisher’s exact test. 
Lactate values at 24 hours, for those who died before 24 hours, were 
imputed according to a predefi ned plan. We performed a preplanned 
analysis in those with baseline thiamine defi ciency (≤7 nmol/l).
Results We enrolled 88 patients; 43 received thiamine and 45 placebo. 
Baseline characteristics were similar between groups. We found 
no overall statistical signifi cant diff erence in 24-hour lactate levels 
between thiamine and placebo groups (2.5 (IQR: 1.5 to 3.4) vs. 2.6 
(IQR: 1.6 to 5.1), P  = 0.40). Fewer patients in the thiamine group had 
lactate levels >4 mmol/l at 24 hours (21% vs. 38%, P = 0.10) and this was 
statistically signifi cant if only evaluating survivors at 24 hours (7% vs. 
33%, P = 0.03), although our preplanned analysis was to impute data. 
We found no diff erence in 24-hour SOFA score or mortality. A total of 28 
(35%) patients were thiamine defi cient. Of the defi cient patients, those 
receiving thiamine had statistically signifi cant lower lactate levels at 
24 hours (2.1 (IQR: 1.4 to 2.5) vs. 3.1 (IQR: 1.9 to 8.3), P = 0.03) and more 
patients in the placebo group had a lactate >4 mmol/l (38% vs. 7%, P = 
0.07). Mortality in the thiamine and placebo groups was 13% and 46%, 
respectively (P = 0.10).
Conclusion Thiamine defi ciency is prevalent in septic shock. Thiamine 
did not decrease overall median lactate levels at 24  hours. In the 
patients with thiamine defi ciency, there were statistically signifi cant 
lower lactate levels at 24  hours in the thiamine group and a large, 
although nonsignifi cant, diff erence in mortality.
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Introduction Malnutrition is common in hospitalized medical patients 
and is associated with poor clinical outcomes. Whether malnutrition 
has a direct link to adverse outcomes or is rather a mirror of the 
severe patient condition remains debated. Our aim was to study the 
association of acute and chronic malnutrition status with blood 
biomarkers from diff erent pathophysiological concepts to better 
understand the underlying mechanisms of malnutrition.
Methods We prospectively followed consecutive adult medical 
inpatients hospitalized between February 2013 and October 2013 in 
a tertiary care Swiss hospital. Nutritional risk was assessed using the 
Nutritional Risk Screening (NRS 2002) score, which incorporates acute 
and chronic measures of malnutrition. Multiadjusted regression models 
were used to investigate the associations between acute and chronic 
nutritional risk and biomarkers mirroring infl ammation (CRP, PCT, 
proADM, leucocytes), stress (copeptin), renal dysfunction (creatinine, 
urea), nutritional status (vitamin D25, albumin, calcium, glucose), and 
hematological function (platelets, INR, Hb, RDW). Biomarker levels were 
transformed into deciles due to skewed distributions.
Results A total of 529 patients (mean age 72 years, 57.1% male) were 
included. Overall, there was a signifi cant association of NRS and 
most biomarkers of infl ammation, stress, renal function, nutrition 
and the hematological system (coeffi  cient and 95% CI): CRP 0.021, 
P = 0.0021, PCT 0.28, P = 0.003, proADM 0.4, P <0.001, copeptin 0.44, 
P <0.001, urea 0.28, P = 0.002, vitamin D25 –0.23, P = 0.012, albumin 
–0.6, P <0.001, hemoglobin –0.5, P <0.001, RDW 0.46, P <0.001. These 
associations remained robust after adjustment for sociodemographics 
(model 1), comorbidities (model 2) and main medical diagnosis 
(model 3). Subgroup analysis suggested that mainly the acute part 
of malnutrition and not chronic malnutrition was associated with an 
increase in biomarker levels.
Conclusion Acute malnutrition was associated with a pronounced 
infl ammatory response and an increase in biomarkers from diff erent 
pathophysiological systems which may partly explain the link between 
malnutrition and adverse medical outcomes. However, interventional 
trials are needed to prove causal relationships.
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Introduction The provision of nutrition in the critical care unit (CCU) has 
shifted from nutrition support to nutrition therapy, and the potential 
benefi ts derived from this in the recovery of the critically ill is being 
explored [1]. We audited the management of nutrition in the CCU in a 
South African Hospital against the American Society of Parenteral and 
Enteral Nutrition Guidelines. Furthermore, we reviewed the knowledge 
and confi dence of healthcare providers in the management of nutrition 
in the CCU.
Methods Retrospective data collection of patients admitted to a four-
bed CCU over a 4-month period in 2013. A survey was distributed to 
diff erent disciplines involved in patient nutrition in the CCU.
Results Seventy-two patients were admitted to the CCU during this 
time period, and notes were able for 44. Three paediatric patients were 
excluded. Twenty-nine patients stayed for 2 or more days (the audit 
population). The median age of the audit population was 38, 19 were 
female. Sixteen were postoperative admissions. The median APACHE II 
score of the patients with suffi  cient available data (n = 16) was 14 (range 
6 to 34). The audit found that 21 of the patients had nutrition started 
in the CCU, with 15 having nutrition started within 48 hours. Only eight 
patients had a nutritional assessment done. A total of 45 responded to 
the survey: eight anaesthetists, 25 from surgical disciplines, seven CCU 
nurses, and fi ve dieticians. All agreed that nutrition should be started 
in the fi rst 48 hours, except from the surgeons only 14 (56%) agreed. 
The average self-rating of knowledge of nutrition management in 
the CCU (1 = lowest, 5 = highest) was 2.1 with the dieticians and CCU 
nurses showing the highest confi dence with 3.4 and 2.6, respectively. 
The anaesthetists rated their knowledge at 1.9 and the surgeons rated 
themselves at 1.8.
Conclusion We found that there is poor management of nutrition in 
the CCU. This is paired with limited knowledge and low confi dence in 
management amongst the attending staff . Evidence would suggest that 
the development and dissemination of clear hospital guidelines could 
improve rates of correct management [2]. However, the lack of uniform 
guidance based on strong evidence from the leading global authorities 
on nutrition suggests that, in order to improve implementation of 
adequate nutrition, more research is urgently required.
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Introduction Optimizing enteral nutrition early has been shown to 
be benefi cial in critically ill patients. However, underfeeding is still a 
common problem. The critically ill surgical patient often presents with 
additional challenges to optimal enteral feeding. The objective of this 
study was to improve enteral feeding practices in a surgical ICU.
Methods The Clinical Practice Improvement Programme is a local 
quality improvement initiative involving a multidisciplinary team aimed 
at identifying and improving defi ciencies in the process of delivery of 
care. A team led by an intensivist, consisting of doctors, surgeons, nurses 
and a pharmacist, was formed to improve enteral feeding practices in 
a surgical ICU. The quality improvement methodology was employed. 
An audit was carried out to determine the problem of underfeeding 
in the unit. Root cause analyses were conducted and team members 
identifi ed key barriers to optimal feeding and areas for improvement. 
Protocols were developed to standardize and encourage early enteral 
feeding as well as to reduce the time feeds are interrupted for patients 
who were going for surgeries or for various other reasons. Educational 
interventions were conducted with lectures to physicians and nurses. 
Visual aids in the form of screensavers at each bedside computer 
served as reminders to the team to optimize feeding. A subsequent 
audit was then conducted to determine the improvement in achieving 
the desired outcomes, namely the amount of calories and proteins 
received as well as the proportion of patients who achieved >70% of 
their target calories and proteins. We considered target calories to be 
25 kcal/kg/day and target proteins to be 1.5 g/kg/day.
Results Patients received more calories (78.3% vs. 59.1%) and more 
proteins (70.2% vs. 54.6%) post implementation. The mean percentage 
of patients in the post group who achieved >70% of required calories 
was 80.1% versus 30.9% in the pre group. The mean percentage of 
patients who achieved >70% of required proteins was 58.3% versus 
32.1% in the pre group.
Conclusion The multipronged approach of the quality improvement 
methodology helped to increase the provision of calories and proteins 
in our population of critically ill surgical patients. However, there is still 
room for improvement in terms of achieving optimal enteral nutrition 
targets early in our population. There is also a need to look into 
sustaining such results.
P396
Could preoperative and postoperative optimal nutrition support 
modulate the infl ammatory response and clinical outcome of 
severe malnourished surgical patients with gastrointestinal 
neoplasia?
L Mirea, D Pavelescu, I Grintescu
Emergency Hospital Floreasca, Bucharest, Romania
Critical Care 2015, 19(Suppl 1):P396 (doi: 10.1186/cc14476)
Introduction Our aim was to assess whether perioperative and 
postoperative optimal 7-day nutrition support could modulate the 
infl ammatory status and clinical outcome of severe malnourished 
patients with surgery for gastrointestinal neoplasia.
Methods A prospective randomized study of 64 patients with 
gastrointestinal neoplasia, severe malnourished BMI <18.5, albumin 
level <3 g/dl, BW loss >10%, NRS >3, scheduled for surgery, allocated 
into two groups. Group A: 32 patients, minimal enteral nutrition in the 
postoperative period according to tolerance, medium 500  kcal/day. 
Group B: 32 patients received optimal parenteral nutrition support (25 
kcal/kg/day) 3  days before surgery and continued for at least 4  days 
postoperatively. We measured CRP, fi brinogen, IL-6, TNF, albumin level 
preoperative and at 96 hours, the incidence of complications, and the 
length of ICU stay.
Results There was a signifi cant decrease in the values of CRP, IL-6, 
TNF, albumin at 96  hours in group B. No diff erence in fi brinogen. A 
signifi cantly lower rate of complications and a shorter time of ICU stay 
were observed in group B. See Figures 1 and 2 (overleaf ).
Conclusion Perioperative optimal nutrition support for at least 7 days 
could modulate the infl ammatory status and clinical outcome of severe 
malnourished surgical neoplasic patients.
P397
Does discontinuation of the use of hydroxyethyl starches in the 
critically ill cardiac surgery patient have an impact on caloric 
intake?
E De Waele, K De Bondt, S Mattens, J Czapla, J Nijs, M La Meir, D Nguyen, 
PM Honoré, H Spapen
Universitair Ziekenhuis Brussel, Brussels, Belgium
Critical Care 2015, 19(Suppl 1):P397 (doi: 10.1186/cc14477)
Introduction After research revealed unwanted eff ects of the use of 
starches in critically ill patients, its use in the immediate postoperative 
period of cardiac surgery patients came to an abrupt ending. However, 
they constitute an important source of non-intended calories, providing 
4 calories per gram. We investigated whether this phenomenon 
(involuntary) attributed to an increase in caloric debt for this critically 
ill patient population.
Methods We retrospectively searched a database of 417 elective 
cardiac surgery patients, representing 5,004 observation-days. Caloric 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S139
intake was evaluated in the group of patients before and after the 
cessation of starch use.
Results Patient characteristics and caloric needs were comparable: 
2,054 ± 395 kcal/day and 2,056 ± 347 kcal/day. The 140 patients who in 
the immediate postoperative period had volume resuscitation without 
the use of starches had a mean non-intended fl uid caloric intake of 69 
(± 36.3) kcal/day. The group of 277 patients who received starches in 
the postoperative period had a mean non-intended fl uid caloric intake 
of 105 (± 100.2) kcal/day.
Conclusion Withdrawal of the use of starches resulted in a 34% 
decrease of non-intended caloric intake by fl uids, contributing to 
caloric debt. Whether outcome is infl uenced and/or whether these 
fi ndings are clinically relevant needs further research.
P398
NUTRIC score in oncologic patients
A Patrão, L Bei, F Coelho
Instituto Português de Oncologia – Porto, Portugal
Critical Care 2015, 19(Suppl 1):P398 (doi: 10.1186/cc14478)
Introduction The NUTRIC score is a tool designed to quantify the risk of 
critically ill patients developing adverse events that may be modifi ed 
by aggressive nutrition therapy, in the general population of an ICU. 
Cancer patients are more prone to be at nutritional risk due to the 
disease and treatment complications. Our aim was to characterize 
NUTRIC score behavior in the population of patients admitted to an 
oncologic ICU.
Methods Between January and June 2014 we applied the NUTRIC score 
to all patients, age >18 years, without cerebral death criteria and with 
a length of stay (LOS) >72  hours. Data were collected and analyzed 
using SPSS v20.0. To evaluate the impact on mortality we used logistic 
regression.
Results Sixty-nine patients were included, 23 women (33.3%) and 
46 men (66.7%). Most patients were aged between 50 and 75  years 
(72.5%) and had normal range weight 58% (n = 40). The mean LOS was 
11.56 (minimum: 3 to maximum: 69). The most common motive for 
admission was sepsis (7.7%, n = 26). APACHE II score was above 15 in 
77% of the patients (n = 53) and SOFA score was superior to 6 in 56.5% 
(n = 30). The NUTRIC score was low risk in 42% (n = 29) of the patients 
and high in 58% (n = 40). Twenty-eight-day mortality was 26.1% (n = 
18). A high NUTRIC score corresponded to a 22-fold increased odds of 
dying in the fi rst 28  days (P  <0.001). Both APACHE II and SOFA were 
mortality predictors alone, with an increase of 1 point in APACHE score 
corresponding to an increase of 14% (P  = 0.002) and an increase of 
Figure 1 (abstract P396). Results 1.
Figure 2 (abstract P396). Results 2.
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1 point in SOFA corresponding to an increase in the odds of being dead 
at 28 days (P = 0.002). Body mass index, age, number of comorbidities, 
and days in the ICU did not correlate with mortality.
Conclusion The NUTRIC score is a good tool in cancer patients to 
predict 28-day mortality. Nevertheless, the only compounds of the 
NUTRIC score that correlated independently with mortality were 
APACHE II and SOFA scores. Further investigation towards the inclusion 
of other categories such as tumor staging and the type of tumor could 
be useful to develop a specifi c prognostic tool for this population.
P399
Early calorie-dense immune nutrition in haemodynamically 
compromised cardiac patients
S Efremov, V Lomivorotov
Research Institute of Circulation Pathology, Novosibirsk, Russia
Critical Care 2015, 19(Suppl 1):P399 (doi: 10.1186/cc14479)
Introduction The aims of present study were to test the hypothesis that 
early enteral nutrition (EN) with calorie-dense food supplemented with 
glutamine improves recovery of nutritional status in critically ill cardiac 
patients and to evaluate their resting energy expenditure (REE).
Methods A prospective randomised study of 40 adult cardiac patients 
undergoing elective cardiopulmonary bypass surgery no more 
than 24  hours before eligibility assessment, complicated with acute 
heart failure syndrome. Patients were randomised to receive either 
standard isocaloric isonitrogenic early EN (standard group, n  = 20) 
or immunomodulating early EN (immune group, n  = 20). The daily 
energy target was set using REE measured by indirect calorimetry 
(CCM Express; Medgraphics, St. Paul, MN, USA). Serum prealbumin, 
transferrin, C-reactive protein, blood lactate and clinical characteristics 
were analysed.
Results The actual REE was an average of 6.8 and 7.5  kcal/kg/day 
higher than the REE calculated using the Harris–Benedict equation 
and empiric approach (25 kcal/kg/day), respectively (Figure 1). Early EN 
with immune formula was associated with higher levels of prealbumin 
concentration on the 14th day (0.13 ± 0.01 g/l and 0.21 ± 0.1 g/l; P = 
0.04) and transferrin on the 3rd, 5th, 7th, and 14th day (P <0.05) after 
surgery.
Conclusion Haemodynamically compromised cardiac patients have 
increased REE, which in the absence of indirect calorimetry should be 
set at 30 kcal/kg/day. Early EN using a calorie-dense immune formula 
leads to better recovery of nutritional status as assessed by serum 
protein levels.
P400
Measurement of skeletal muscle glycogen status in critically ill 
patients: a new approach in critical care monitoring
I San Millan, J Hill, P Wischmeyer
University of Colorado, Aurora, CO, USA
Critical Care 2015, 19(Suppl 1):P400 (doi: 10.1186/cc14480)
Introduction Critically ill patients experience hypermetabolism in-
creas ing substrate utilization, especially glucose oxidation. Glycogen is 
the main source of glucose in the body, being 85% and 15% stored in 
skeletal muscle and liver respectively. Since glycogen stores are limited 
we evaluated the hypothesis that critical illness could be associated 
with glycogen depletion leading to skeletal muscle catabolism for 
gluconeogenesis and eventually resulting in cachexia, an important 
determinant of future ICU survival and ICU-acquired weakness.
Methods Nine critically ill patients (58.75  ± 25 to 75  years old) 
with an ICU stay from 1  day to 5  weeks were evaluated for skeletal 
muscle glycogen content using a rapid, non-invasive high-frequency 
ultrasound methodology (MuscleSound®, Denver, CO, USA). Scans 
were obtained from the rectus femoris and vastus lateralis muscles. 
Glycogen content was measured with a score from 0 to 100 according 
to the MuscleSound® scale. Patients had a variety of primary diagnoses 
including septic shock (n  = 3), hemorrhagic shock/abdominal 
hypertension (n = 1), hypovolemic shock/post major oncologic surgery 
(n = 1), trauma (n = 3), and burn injury (n = 1).
Results Six out of nine patients had no glycogen present in the muscle 
(score  = 0). The other three patients had glycogen scores between 5 
and 15 which are well below scores of healthy individuals (reference 
50 to 70). As a comparison we collected post-competition levels in 
competitive athletes, which decrease their glycogen stores (score 15 
to 25) but are well above those of most critically ill patients we have 
studied.
Conclusion This is the fi rst time that muscle glycogen stores have been 
evaluated in critical illness. Our data show severe glycogen depletion 
in ICU patients which probably leads to muscle catabolism necessary 
for gluconeogenesis, eventually resulting in cachexia. This fi nding 
poses severe metabolic challenges for ICU patients in which interfering 
with recovery can contribute to poor survival. In light of our fi ndings, 
re-evaluation of nutritional protocols and potential anabolic/anti-
catabolic therapy to decrease muscle catabolism may improve survival. 
Diff erent therapeutics that may prevent hypermetabolism (such as 
beta-blockers) should be re-evaluated along with anabolic agents (that 
is, oxandrolone) which could counteract the severe catabolic response 
in critical illness. Monitoring of muscle glycogen repletion could signal 
the transition from the catabolic to anabolic phase.
P402
Plasma glutamine after acute or elective admission on the ICU
H Buter, M Koopmans
MCL, Leeuwarden, the Netherlands
Critical Care 2015, 19(Suppl 1):P402 (doi: 10.1186/cc14482)
Introduction Low plasma glutamine concentrations are associated 
with unfavourable outcome at acute ICU admission. We questioned 
whether there is a diff erence in plasma glutamine level after acute or 
elective ICU admission.
Methods We performed a single-centre prospective observational 
study in a 22-bed mixed ICU. Exclusion criteria were age <18 years and 
total parental nutrition at admission. Patients were divided into two 
groups: elective surgery and acute admissions. Blood samples were 
taken at ICU admission and daily at 6.00  a.m. Glutamine levels were 
measured using the Bioprofi le 100 plus analyser (Nova Biomedical UK, 
Cheshire, UK). A Mann–Whitney U test was used to detect diff erences 
between groups and a Bonferroni method to correct for multiple 
comparisons.
Results We included 88 patients after elective surgery (76 cardiac and 
12 general surgery) and 90 patients after acute admission (27 sepsis, 
17 acute surgery, two trauma and 44 medical). Baseline characteristics 
are presented in Table  1. Plasma glutamine levels at admission were 
signifi cantly lower in acute patients compared with elective surgery, 
0.25  mmol/l (IQR 0.09 to 0.37) versus 0.43 mol/l (IQR 0.33 to 0.55) 
Figure 1 (abstract P399). Indirect calorimetry measured signifi cantly 
higher resting energy expenditures.
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(P <0.001). There appeared to be a signifi cant correlation between the 
APACHE IV score and glutamine levels (R = 0.52, P <0.001). Moreover, in a 
backward linear regression analysis this correlation was independently 
associated with APACHE IV scores and the presence of infection, but 
not with the type of admission.
Conclusion Plasma glutamine levels were signifi cantly lower after 
acute admission compared with elective surgery. In both groups a 
considerable amount of patients had decreased glutamine levels, but 
this was not independently associated with the type of admission. 
In contrast to previous studies we found that glutamine levels were 
determined by severity of illness and the presence of an infection.
P403
Intravenous fi sh oil lipid emulsions in ICU patients: an updated 
systematic review and meta-analysis
P Langlois1, R Dhaliwal2, M Lemieux2, D Heyland3, W Manzanares4
1Hospital Fleurimont, Sherbrooke, QC, Canada; 2Kingston General Hospital, 
Kingston, ON, Canada; 3Queen´s University, Kingston, ON, Canada; 4University 
Hospital, Montevideo, Uruguay
Critical Care 2015, 19(Suppl 1):P403 (doi: 10.1186/cc14483)
Introduction Intravenous fi sh oil (FO) lipid emulsions (LEs) are rich in 
ω-3 polyunsaturated fatty acids, which exhibit anti-infl ammatory and 
immunomodulatory eff ects. We previously demonstrated that FO-
containing emulsions may be able to decrease mortality and ventilation 
days in the critically ill. Over the last year, several additional randomized 
controlled trials (RCTs) of FO-based LEs have been published. Therefore, 
the purpose of this meta-analysis was to update our systematic review 
aimed to elucidate the effi  cacy of FO-based LEs on clinical outcomes in 
the critically ill.
Methods We searched computerized databases from 1980 to 2014. 
Overall mortality was the primary outcome and secondary outcomes 
were infections, ICU and hospital length of stay (LOS), and mechanical 
ventilation (MV) days. We included RCTs conducted in critically ill adult 
patients that evaluated FO-based LEs in parenteral nutrition (PN) or 
enterally fed patients. We analyzed data using RevMan 5.1 (Cochrane 
IMS, Oxford, UK) with a random eff ects model.
Results A total of 10 RCTs (n  = 733), including four trials published 
over the last year, met inclusion criteria. There was considerable 
heterogeneity in interventions tested in these trials. No eff ect on 
overall mortality was found. When the results of fi ve RCTs that reported 
infections were aggregated, FO-containing emulsions signifi cantly 
reduced infections (RR 0.64; 95% CI, 0.44 to 0.92; P = 0.02, heterogeneity 
I2  = 0%). Furthermore, FO-based LEs were associated with a trend 
toward a reduction in MV days (WMD, –1.41; 95% CI, –3.43 to 0.61; P = 
0.17, heterogeneity I2  = 0%), and hospital LOS (WMD –4.06; 95% CI, 
–10.14 to 2.03; P = 0.19, I2 = 89%, P <0.00001), without eff ect on ICU 
LOS. See Figure 1.
Conclusion FO-based LEs may be associated with a reduction in 
infections, as well as clinically important reductions in duration of 
ventilation, and hospital LOS. Nevertheless, according to current 
literature there is inadequate evidence to give a fi nal recommendation 
on the routine use of FO-containing emulsions in PN and/or as a 
pharmaconutrient strategy in enterally fed critically ill patients. Further 
large-scale RCTs which should aim to consolidate potential positive 
treatment eff ects are warranted.
P404
Glutamine administration in sepsis: enteral, parenteral or both? 
Experimental study in swine
G Stavrou1, E Filidou2, K Arvanitidis2, K Fotiadis1, V Grosomanidis1, 
A Ioannidis1, G Tsaousi1, A Michalopoulos1, G Kolios2, K Kotzampassi1
1Aristotle University of Thessaloniki, Greece; 2Democritus University of Thrace, 
Alexandroupolis, Greece
Critical Care 2015, 19(Suppl 1):P404 (doi: 10.1186/cc14484)
Introduction Glutamine (GLN) is recommended in the critically ill for 
i.v. administration but enteral use is not quite clarifi ed. We decided to 
measure GLN plasma levels in healthy and septic swine after GLN given 
by i.v., enteral or both routes, over a 3-hour period.
Methods Sepsis was induced by E. coli LPS. GLN was infused: i.v. 
through the femoral vein (0.5 g/kg); enterally (E) through jejunostomy 
(0.5 g/kg); and i.v. + E. Blood was drawn continuously from the femoral 
artery and the portal vein for GLN plasma levels in systemic-S and 
portal-P circulation.
Results In healthy swine, GLN levels remained stable, both in S and P; 
i.v. infusion, and even more i.v. + E signifi cantly increased GLN in the S 
circulation (P <0.001), whereas E infusion failed to do so (P = 0.4). On the 
contrary, GLN P levels were signifi cantly increased after i.v. + E infusion, 
as well as after E infusion (P  <0.001) and to a lesser extent, after i.v. 
(P <0.001). In sepsis, both S and P GLN levels decreased signifi cantly. 
Table 1 (abstract P402)
 Elective Acute
Age (years) 68 ± 10 59 ± 17*
APACHE IV 46 ± 14 67 ± 29*
LOS ICU 2 (2 to 2) 4 (2 to 7)*
Survival (n) 88 85*
Mean ± SD or median (IQR). *P <0.01.
Figure 1 (abstract P403). Eff ects of parenteral fi sh oil lipid emulsions on infections.
Figure 1 (abstract P404).
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As previously, i.v. (P = 0.001) and even more i.v. + E (P <0.001) infusion 
signifi cantly increased S GLN levels, while E infusion failed to have 
any eff ect. In the P vein, both i.v. (P = 0.02) and i.v. + E (P <0.001) GLN 
increased signifi cantly, whereas the E had no eff ect (P  = 0.08). See 
Figures 1 and 2.
Conclusion In our experimental early sepsis model, a combination of 
E and i.v. GLN seems to be the most appropriate; this results in high 
GLN levels for the functional needs, including those of the gut mucosa.
Reference
1. Crit Care. 2014;18:R76.
P405
Prehospital factors associated with an ICU admission from the 
emergency department
TA Williams1, J Finn1, D Fatovich2, D Brink3, KM Ho2, H Tohira4
1Curtin University, Bentley, Australia; 2Royal Perth Hospital, Perth, Australia; 
3St John Ambulance – WA, Belmont, Australia; 4 Curtin University Health 
Sciences, Bentley, Australia
Critical Care 2015, 19(Suppl 1):P405 (doi: 10.1186/cc14485)
Introduction This study aimed to describe the patient characteristics 
and prehospital factors associated with an ICU admission from the ED. 
There is a paucity of information about the early recognition of critical 
illness by paramedics; especially in the Australian prehospital setting.
Methods A retrospective cohort study, July 2012 to June 2014, 
conducted in the Perth metropolitan area, which is served by a single 
ambulance service. Adult patients were included if transported to a 
public hospital ED that used the ED information system (EDIS) (seven 
of eight EDs) and were admitted to the ICU from the ED (ED-ICU 
group). Patients aged <16  years, those from rural areas or transfers 
were excluded. We used existing ambulance clinical data linked to 
EDIS data. Prehospital cohort characteristics are described using 
univariate statistical techniques. Logistic regression was conducted 
with admission to the ICU from the ED (critical illness surrogate) as the 
outcome variable. Variables included in regression models were age, 
sex, paramedic-identifi ed urgency, that is the time patients should be 
seen by a doctor based on the Australasian Triage Scale, paramedic-
identifi ed patient problem and the time taken from the ambulance 
service receiving the call to hospital arrival. Physiological variables: 
systolic blood pressure (SBP), heart rate (HR), respiratory rate (RR), 
temperature, oxygen saturation, and GCS were included in the logistic 
models.
Results Of the 142,448 eligible patients transported by ambulance, 
1,076 (0.75%) were admitted to the ICU from the ED: the ED-ICU group 
was younger (mean 53 vs. 61 years, P <0.001). Seventeen percent of ICU 
patients were transported as Urgency 1 (resuscitation/immediate) and 
58% as Urgency 2 (within 10 minutes) while 70% of non-ICU patients 
were transported as Urgency 3 to 5 (P <0.001). Thirteen percent of ICU 
patients had a SBP <90 mmHg, 15% had a HR ≥130 and 19% had a RR 
>30. Drug overdose (21%) and respiratory conditions (18%) were the 
most common ICU conditions identifi ed by paramedics for the ED-ICU 
group. All variables entered into the logistic models were signifi cant 
(all P <0.001) except the time taken from receiving the call to hospital 
arrival (P = 0.48).
Conclusion Three-quarters of the ED-ICU patients were transported to 
the ED with high urgency. Currently no prehospital severity of illness 
or early warning system (EWS) is used in our ambulance service. Given 
the small proportion of ED-ICU patients who presented with abnormal 
observations, it is unlikely that introducing an EWS would alter practice 
or patient outcome.
P406
Reliability of a new French-language triage algorithm for out-of-
hours primary care calls: the SALOMON rule
E Brasseur1, A Ghuysen1, AF Donneau2, V D’Orio1
1C.H.U. of Liège, Belgium; 2University of Liège, Belgium
Critical Care 2015, 19(Suppl 1):P406 (doi: 10.1186/cc14486)
Introduction Because of increased workloads associated with primary 
care physician (PCP) shortage, many western countries have been 
facing the diffi  cult challenge of optimizing their out-of-hours primary 
care services. PCPs initially gathered in small rotation groups, and then 
further collaborations led to larger-scale cooperatives. In such models, 
implementation of patient call triage is mandatory to increase the 
effi  ciency, quality and safety of care [1]. Organization models diff er, 
from the PCP performing all patient calls to nurses and nurse assistants 
answering calls and performing triage, but no validated triage 
algorithm has been reported to date. We developed a specifi c French-
language triage algorithm called SALOMON (Système Algorithmique 
Liégeois d’Orientation pour la Médecine Omnipraticienne Nocturne) in 
order to guide nurse triage PCP out-of-hours calls. The present study 
tested this algorithm reliability.
Methods The SALOMON algorithm is based on 53 common 
presentation fl owcharts using specifi c discriminators to triage calls 
into four categories according to the level of care required: emergency 
medical services, nonemergent visit to local emergency department, 
PCP home visit or PCP delayed consultation. Using an appropriate 
statistical test, we assessed the accuracy of presentation fl owchart 
and triage category selections attributed to 130 clinical scenarios, by 
10 diff erent nurses, in comparison with references established by a 
local team of experts, at two diff erent time periods: immediately after 
training (T0) and 3 to 6 months after algorithm practice (T1).
Results Overall selection of fl owcharts was accurate for 94.1% of 
scenarios at T0 and 98.7% at T1. Triage category selection was correct 
for 93.3% of scenarios at T0 and 98.4% at T1. Both fl owchart selection 
and triage category were correct in of 89.5% case in T0 and at 97.5% 
T1. When an incorrect fl owchart was used, triage category remained 
accurate in 64.9% and 70.5% respectively. Both fl owchart and triage 
selection accuracy improved signifi cantly from T0 to T1 (P <0.0001).
Conclusion The results of the present study revealed that using the 
SALOMON algorithm is reliable for out-of-hours PCP call triage by 
nurses. Validity of this rule may be further evaluated through its actual 
implementation in real-life conditions.
Reference
1. Huibers L, et al. Scand J Prim Health Care. 2011;29:198-209.
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Adequacy of trained assistance, emergency equipment and drugs 
at emergency calls in the ICU and in remote areas of the hospital
I Kolic1, S Unell2, A Watts2, A Barry2, J Short2
1South London Healthcare NHS Trust, London, UK; 2Lewisham and Greenwich 
NHS Trust, London, UK
Critical Care 2015, 19(Suppl 1):P407 (doi: 10.1186/cc14487)
Introduction We aimed to identify the adequacy of assistance provided 
and to assess correct anaesthetic equipment and drug availability at 
emergency calls made in the ICU and in remote areas of the hospital. 
Emergency calls often involve managing critically ill patients with the 
highest mortality results. The importance of a clinical team with the 
necessary competencies and the right level of resources are paramount.
Methods We undertook a prospective survey of all adult patients with 
emergency calls put out to the anaesthetic team in a London district 
Figure 2 (abstract P404).
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general hospital over a 6-week period. We performed a snapshot 
audit of equipment in resuscitation trolleys across each ward and 
in the radiology department. We compared the data collected on 
available equipment with the standard set by the Resuscitation 
Council (UK) Recommended Minimum Equipment Checklist [1]. The 
survey addressed the availability, clinical competency and appropriate 
duration of stay of the anaesthetic assistant at the emergency calls. 
Further qualitative data were collected on the availability of required 
emergency drugs.
Results During the study period 44 emergency calls were attended. 
Twenty-three (52%) of these calls were in the accident and emergency 
department, and four (9%) in the ICU. Survey results demonstrated 
two cases where no anaesthetic assistant arrived at the emergency 
call put out to them. In cases where timely assistance was available, 
the assistant did not have the adequate clinical and anaesthetic skills 
required by the attending physician. In 6% of cases where skilled 
assistance was required (n = 2), it was felt that the assistant did not stay 
for the clinically required length of time. Emergency drugs required 
were found to not be available in 11% of cases (n = 5) and in 17% of 
cases (n = 6) the necessary emergency equipment was not available. 
Data were collected on equipment from 17 resuscitation trolleys. The 
inadequacies identifi ed were the oxygen cylinders were fi lled less than 
75% full in 41% cases (n = 7) and end-tidal capnography was identifi ed 
to be absent.
Conclusion Emergency calls require standards to be met involving the 
competency of responding team members and adequate resources. 
This leads us to question whether guidelines should exist regarding 
the clinical competency and timeliness of the assistant available to the 
physician at emergency calls.
Reference
1. Resuscitation Council (UK). Recommended minimum equipment for in 
hospital adult resuscitation (October 2004). https://www.resus.org.uk/pages/
eqipIHAR.html.
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Use of an electronic early warning score and mortality for patients 
admitted out of hours to a large teaching hospital
J Bannard-Smith, S Abbas, S Ingleby, C Fullwood, S Jones, J Eddleston
Manchester Royal Infi rmary, Manchester, UK
Critical Care 2015, 19(Suppl 1):P408 (doi: 10.1186/cc14488)
Introduction There is widespread concern regarding excess mortality 
for patients admitted to hospital out of hours. We introduced an 
electronic track and trigger system (Patientrack) with automated alerts 
in a large university teaching hospital between 2010 and 2012. The 
system computes the patient’s early warning score and alerts medical 
staff  via a pager. It is operational 24  hours a day, 7  days a week and 
could be an eff ective tool to reduce variations in mortality throughout 
the working week.
Methods We extracted hospital outcome data for all admissions during 
the fi nancial years between 2007 and 2014. We identifi ed variables 
that predicted mortality and incorporated them into a multivariate 
logistic regression model to assess risk of death for admissions in hours 
(9:00 am to 5:00 pm, Monday to Friday) versus out of hours (all other 
times).
Results Data were available for 1,180,268 hospital admissions, of which 
7,264 (0.6%) died. Predictors for hospital mortality included: age, male 
sex, unplanned admission and admission from supportive care. Risk of 
death for out-of-hours admissions was not signifi cantly diff erent to in-
hours for any year (1.01 (0.92 to 1.11), P = 0.784). There was a signifi cant 
fall in risk of death over the 7-year period compared with baseline 
values in 2007/08 (Table 1).
Conclusion In our cohort there was no evidence of increased mortality 
for patients admitted out of hours compared with in hours. This 
remained true after adjustment for age, sex, emergency admissions 
and admission source. Our data demonstrated an overall fall in risk of 
death over the study period. The introduction of Patientrack could have 
contributed to this reduction in mortality.
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Introduction Medical emergency team (MET) calls are quickly 
becoming an integral part of the response to a deteriorating patient in 
Australia. Conceptually the MET call response incorporates a structured 
approach, but in practice this can quickly disintegrate. This collapse 
of method can leave patients without clear treatment plans and staff  
disenfranchised. We sought to improve the process of the MET call 
response at our regional hospital by introducing targeted interventions 
focused on teamwork, communication, leadership and role allocation.
Methods We invited junior doctors and nurses to complete a survey 
designed by a multidisciplinary MET Call Working Group; 138 staff  (40% 
of population) completed the survey. Based on analysis of responses, a 
focused three-pronged intervention was formulated and implemented 
hospital wide. The arms of the intervention were: identifi cation of the 
name and role of each staff  member using highly visible labels; role 
allocation according to policy written through a multidisciplinary 
working group; and a time out during the response allowing a structured 
synopsis of the patient’s current status to be communicated to the team. 
The intervention was preceded by extensive staff  education, and 175 
staff  (50%) completed the survey 6 months later to assess its success.
Results The intervention signifi cantly increased satisfaction amongst 
staff  regarding: identifi cation of the team leader and other key staff  
members at the response; and time out eff ectiveness in reducing 
repetition and improving staff  understanding of the patient’s status 
and medical issues. We found no signifi cant change in staff  perceptions 
regarding the clarity of the ongoing treatment plan at the end of the 
MET call response.
Conclusion Utilising a low-cost intervention in a regional setting, we 
were successful in improving staff  perceptions of role allocation and 
communication within our MET call responses. The intervention also 
led to signifi cantly increased overall satisfaction with the MET call 
system. Through our surveys we have identifi ed other facets of the MET 
call response that also require attention. Given our encouraging results 
we are designing a follow-up intervention incorporating structured 
multidisciplinary training in MET call scenarios.
P410
Successful implementation of a medical emergency team: 
2-year experience in a teaching hospital
A Tridente, J Elmore, R Varia, T Mahambrey
St Helens and Knowsley, Liverpool, UK
Critical Care 2015, 19(Suppl 1):P410 (doi: 10.1186/cc14490)
Introduction A medical emergency team (MET) was introduced in our 
institution in January 2012 to provide timely response to the needs 
of acutely ill inpatients and cardiac arrest calls. The MET assesses the 
patient and prescribes a management plan for the responsible team to 
follow; promptly stabilising and transferring patients to a place of safety 
where required. We aimed at evaluating the eff ects of introducing the 
MET on clinically relevant processes and outcomes.
Methods Prospective data were analysed using STATA 10.1. The primary 
outcome measure was immediate mortality (defi ned as mortality at 
Table 1 (abstract P408). Overall risk of death ratios compared to 2007/08
Year ROD 95% CI
2008/09 1.01 0.73 to 1.5
2009/10 1.03 0.74 to 1.5
2010/11 0.46* 0.33 to 0.7
2011/12 0.31* 0.22 to 0.4
2012/13 0.27* 0.2 to 0.39
2013/14 0.26* 0.2 to 0.37
*P <0.001.
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conclusion of the MET intervention); the secondary outcome measures 
were admission to critical care after a MET call and cardiac arrest.
Results A total of 5,763 MET calls were made between 9 January 2012 
and 4 March 2014, of which 5,310 (92.1%) were MET calls, 349 (6.1%) 
cardiac arrest calls, 36 (0.6%) false alarms and 68 (1.2%) unclassifi ed. 
The number of calls increased by 32.7% from 2,255 in 2012 to 2,993 
in 2013, with all month-specifi c comparisons showing signifi cant 
increases in MET activity (ranging from 0.5% to 103.6% increases). 
MET activity displayed cyclical yearly changes, with the winter months 
and the month of August (junior doctors’ changeover period) being 
particularly busy. Median response time (interquartile range) was 1 (1 
to 2) minutes, with 99.1% calls attended to within 3 minutes. There were 
210 (3.64%) immediate deaths (with no signifi cant diff erences between 
years), 112 (1.9%) patient transfers to critical care, 233 (4%) patients 
were transferred to other locations (other than critical care) while 
4,697 (81.5%) patients remained on the ward of origin. In 408 cases 
(7.1%) a do-not-resuscitate order was instituted. On multiple logistic 
regression analyses, when the type of call was taken into consideration, 
the response time had no infl uence on primary (mortality OR = 0.83, 
95% CI = 0.63 to 1.09, P = 0.18) and secondary outcomes (admission 
to critical care OR = 0.85, 95% CI = 0.62 to 1.17, P = 0.33; subsequent 
cardiac arrest OR = 0.57, 95% CI = 0.27 to 1.2, P = 0.14).
Conclusion The MET has been successfully implemented, with demand 
for its services having increased by 32.7% in 1  year. The unadjusted 
immediate mortality rate of patients for whom a MET/cardiac arrest 
call is activated is 3.64%. Response time had no infl uence on mortality, 
most probably due to the rapid response time. Immediate mortality 
was low, probably as a result of early adequate intervention. Further 
evaluation of overall hospital mortality is warranted for future studies.
P411
Evaluation of emergency call Code Blue over a 5-year period
N Bakan, G Karaoren, S Tomrk, S Keskin
Istanbul Umraniye Training and Research Hospital, Istanbul, Turkey
Critical Care 2015, 19(Suppl 1):P411 (doi: 10.1186/cc14491)
Introduction Code systems are the emergency call and management 
systems for rapid response in healthcare institutions. The main aim 
of these systems is to provide common institutional understanding 
of what is necessary to be done immediately at the time of an event. 
Code Blue (CB), which is used throughout the world and was described 
in the 2008 service quality standards of Turkey, defi nes the necessary 
emergency intervention in cases of respiratory or cardiac arrest. This 
study aimed to evaluate the clinical and application data of patients for 
whom a CB call was made between 2009 and 2013.
Methods After approval of local ethics committee, retrospective 
examination was made of CB forms. The age and gender of the patient, 
diagnosis, department to which admitted, time of CB call, reason for CB, 
whether or not CB was appropriate, whether or not CPR was applied, 
duration of CPR if applied, APACHE II and PRISM scores and predicted 
mortality were recorded from the hospital automated record system 
and the CB form. Patients who refused treatment or who could not 
reach the necessary parameters for the calculation of APACHE II and 
PRISM scores were excluded.
Results From CB calls for a total of 1,195 patients over the 5-year 
period, 1,035 (86.6%) were evaluated. The rate of erroneous CB was 
36.9%. Patients comprised 413 (39.9%) females and 622 (60.1%) males 
with a mean age of 59.73 ± 23.13 years (range, 0.1 to 102 years). The 
distribution of total cases over the 5 years (2009 to 2013) was 15.5%, 
25.2%, 26.5%, 19% and 13.8% respectively. Distribution according to 
clinic was emergency internal (37.5%), internal (16.5%) and emergency 
surgical (9.5%). Clinical diagnosis was cardiac 28.8%, neurological 
15.6% and end-stage cancer 13.5%. A total 19.9% of the patients 
were those discharged from intensive care. The total survival rate was 
59.6%. The duration of CPR in survivors was statistically longer than in 
nonsurvivors (P <0.01). There was no statistically signifi cant relationship 
between the duration of CPR and age (P >0.05). The overall mean time 
taken to reach the patient was 102.71 ± 22.47 seconds, which reduced 
to 93.64  ± 19.91  seconds in 2013. The APACHE II–PRISM scores and 
mortality rates were low in the cases of erroneous CB (P <0.05).
Conclusion The time taken to reach patients conformed with the 
global standard mean 2 to 3  minutes [1]. The rates of erroneous 
CB and time to reach patients reduced each year due to more staff  
experienced and knowledgeable in CB and the structuring of the 
emergency clinic.
Reference
1. Nolan JP, et al. European Resuscitation Council guidelines for resuscitation 
2010 section 1. Executive summary. Resuscitation. 2010;81:1219-76.
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Attention Code Blue: a comprehension of in-hospital cardiac arrest 
from a multispeciality hospital in South India
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Introduction Numerous American and European studies have 
associated survival rates of in-hospital cardiac arrest (IHCA) with 
diff erent quality markers. There has been a paucity of studies that 
explain IHCA in Asian populations. This study was conducted to assess 
the characteristics and survival among patients suff ering from IHCA.
Methods All Code Blue activations from 1 January 2012 to 31 December 
2012 were analyzed retrospectively. Data were gathered from the Code 
Blue form and fi ner details of individual patients were linked through 
their medical records. Code Blue was activated only for events that 
happened outside the medical and surgical ICUs.
Results A total of 260 Code Blue activations were made, out of which 
there were 203 true cardiac arrest events among 40,168 in-patients; the 
cumulative incidence of the same was 0.51%. Mean (SD) duration of 
arrival of the Code Blue Team (CBT) to the scene was 64.5 (27.7) seconds. 
Cardiovascular illness was the predominant baseline morbidity but 
none of the baseline illness showed increased risk of mortality in this 
group. Among true cardiac arrest events, 92.6% was due to pulseless 
electrical activity/asystole and 7.7% was due to ventricular fi brillation 
(VF)/pulseless ventricular tachycardia (VT); both of these did not have 
any diff erence on the initial outcome. But having an initial rhythm of 
VF/pulseless VT had 90% more chance for discharge from the hospital, 
with P  = 0.04. Although arrival time of the CBT did not have any 
infl uence on the fi nal outcome, duration of resuscitation ≤20 minutes 
had an odds ratio of 10.6 with P <0.001 favoring return of spontaneous 
circulation over death after controlling for age. Of the 203 patients who 
had true cardiac arrest events, 43 (21.2%) were discharged from the 
hospital. Good neurological outcome at discharge was seen among 22 
(10.8%) of the patients based on Cerebral Performance Category Score.
Conclusion Our experience shows that out of every 1,000 patients 
admitted to our hospital, about fi ve sustained cardiac arrest, of whom 
only 11.3% survived to hospital discharge with good neurological 
recovery. Variation in the eff ectiveness of the cardiopulmonary 
resuscitation quality in comparison with world data could be due to the 
inherent diff erence in the severity of the primary illness in the patients 
and diversity in the reported data.
References
1. Abella BS, et al. JAMA. 2005;293:305-10.
2. Merchant RM, et al. Crit Care Med. 2011;39:2401-6.
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Are we failing to teach cardiopulmonary resuscitation (CPR) in 
schools? A pilot study to assess CPR and automated external 
defi brillator training in London schools
J Salciccioli, D Marshall, M Sykes, A Wood, S Joppa, M Sinha, PB Lim
Imperial College London, UK
Critical Care 2015, 19(Suppl 1):P413 (doi: 10.1186/cc14493)
Introduction Mortality from cardiac arrest remains high [1]. Bystander 
cardiopulmonary resuscitation (CPR) and the use of automated 
external defi brillators (AED) are two of the most important factors 
favouring survival [2]. CPR/AED training in schools is a recommended 
intervention for signifi cantly improving training rates across a large 
population [3]. The current practice for CPR/AED training in London 
schools is unknown. The primary aim of this study was to assess current 
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practices relating to CPR and AED training in London secondary 
schools.
Methods We conducted a registered audit of CPR and AED training 
in London schools. Secondary schools were identifi ed via web links 
for each of the London Borough Councils. Telephone interviews 
with school staff  familiar with CPR and AED training practices were 
conducted prospectively using a standardized web-based survey. 
All survey response data were captured electronically. We defi ned 
universal training as any programme which delivers CPR and AED 
training to all students in the school. We used simple descriptive 
statistics to summarise the results.
Results A total of 51 schools completed the survey covering an 
estimated student population of 54,037. There were four (8%) schools 
that provide universal training programmes and an additional 23 (45%) 
off er optional training programmes for students. There were 16 (31%) 
schools which have an AED available on the school premises. The most 
common reasons for not having a universal CPR training programme is 
the requirement for additional class time (15/51; 29%) and that funding 
is unavailable for such a programme (12/51; 24%). There were three 
students who died from sudden cardiac arrest over the period of the 
past 10 years.
Conclusion CPR and AED training rates in London secondary schools 
are low. The majority of schools do not have an AED available on 
premises. The most common reason for not providing CPR training 
is the requirement for additional class time. These data highlight an 
opportunity to vastly improve CPR training rates in a large population. 
Future studies should assess programmes which are cost-eff ective and 
which do not require signifi cant amounts of additional class time.
References
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Introduction Adequate chest compression (CC) depth is crucial for 
resuscitation outcomes. Lightweight rescuers, particularly women, 
are often unable to achieve the required 5 to 6  cm CC depth. This 
nonrandomised cohort study investigated new strategies to improve 
CC performance.
Methods Data were prospectively collected from January 2011 to 
January 2012 from 336 female medical and pharmacy students 
undergoing CPR training at the Lithuanian University of Health Sciences. 
During the training process, the instructors performed a simple 
5-second intervention (Andrew’s manoeuvre) with all of the rescuers 
in the study group. The instructor pushed 10 times on the shoulders of 
each trainee while she performed CCs to achieve the maximal required 
compression depth. Immediately after training, the participants were 
asked to perform a 6-minute BLS test on a manikin that was connected 
to a PC with SkillReporter™ System software (Laerdal, Norway); the 
quality of the participants’ CPR skills was then evaluated.
Results The CC depth in the study group increased by 6.4 mm (P <0.001) 
compared with the control group (52.9 vs. 46.6 mm). A regression 
analysis showed that Andrew’s manoeuvre increased the depth of the 
CCs among women by 14.87 × (1 – 0.01 × weight) mm.
Conclusion Andrew’s manoeuvre during CPR training signifi cantly 
improved the performance of the female rescuers and helped them 
achieve the CC depth required by 2010 resuscitation guidelines. It is 
most eff ective among the women with the lowest body weight.
Reference
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Introduction Implementation of point-of-care ultrasound examination 
into cardiopulmonary resuscitation (CPR) may increase diagnostic 
accuracy for determining the cause of cardiac arrest. However, current 
protocols either do not refl ect all causes detectable by ultrasound or are 
too complicated for prehospital use. Thus, we decided to construct and 
validate a new protocol TRACE (ThoRacic and Abdominal sonography 
in Cardiac arrEst) for ultrasound examination during out-of-hospital 
cardiac arrest (OHCA).
Methods We designed a new protocol for ultrasound examination 
during OHCA to increase the success rate for the establishment of 
OHCA cause. The subcostal view was performed during planned 
rhythm check to assess the presence of cardiac tamponade and size 
of the right and left ventricle and inferior caval vein. Thereafter, during 
ongoing cardiac compressions, Morrison’s pouch and right pleural 
space were investigated to exclude intraperitoneal and inrapleural 
free fl uid. The same procedure was applied on the left side of the body. 
Finally, the anterior thoracic view was done to exclude pneumothorax. 
Working diagnosis was compared with the fi nal in-hospital diagnosis 
or autopsy.
Results We examined 40 consecutive OHCA patients. Correct cause 
of OHCA during CPR was recognised in 38 patients (95%). Leading 
causes were acute coronary syndrome (55.0%), pulmonary embolism 
(15.0%) and complication of chronic heart failure (10.0%). Incorrect 
recognition was performed in one patient with respiratory cause, 
originally considered as pulmonary embolism, and in another with 
pulmonary embolism, considered as respiratory cause. One rhythm 
check was suffi  cient to perform TRACE in 31 patients, in the other 
two interruptions of cardiac compressions were required. Return 
of spontaneous circulation was achieved in 15 (37.5%) patients, 
favourable neurological outcome at hospital discharge in eight (20%) 
patients. Specifi c therapy to aff ect the cause of OHCA was applied 
during OHCA in 12 (30%) patients.
Conclusion Implementation of the TRACE protocol to the CPR process 
was feasible, required minimal interruption of cardiac compressions 
and resulted in a high recognition rate for the cause of OHCA.
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Introduction Cardiac arrest patients are not transported only supine. 
The eff ect of body position on resuscitability and cerebral perfusion in 
a 30° and 60° incline is not known.
Methods Twenty-fi ve female pigs were subjected to a simulated 
cardiac arrest (3  minutes no fl ow, 5  minutes mechanical CPR). Next, 
animals were randomly assigned to one of the three groups: GROUP 
60 (n  = 8), 60° incline for 3  minutes to simulate transport in space 
restricted elevator; GROUP 30 (n  = 8), 30° incline for 8  minutes to 
simulate staircase transport; and GROUP 0, with no incline. During 
subsequent standard CPR including rescue ECMO, resuscitability and 
cerebral perfusion were assessed.
Results Attainment of ROSC (3, 5, 5 in respective groups, P = 0.021), time 
to ROSC (15:24 (13:26; 16:02) vs. 19:19 (18:28; 19:37) vs. 9:10 minutes 
(8:28; 9:41), respectively, P  = 0.005) signifi cantly diff ered. Changes in 
carotid blood fl ow according to the respective periods of the protocol 
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(baseline, cardiac arrest, initial supine CPR and 30° vs. 60° CPR) are 
depicted in Figure 1.
Conclusion Positional changes during simulated refractory cardiac 
arrest in this experimental model signifi cantly aff ect resuscitability and 
brain perfusion. Animals subjected to shorter time in a more inclined 
(GROUP 60) position were more easily resuscitated; however, cerebral 
blood fl ow was better preserved in GROUP 30.
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hospital cardiac arrest: a retrospective study in a single institution
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Introduction Despite several large studies concerning out-of-hospital 
cardiac arrests in recent years, it is not clear whether their in-hospital 
counterparts have benefi ted from advances in resuscitation as well as 
post-resuscitation care.
Methods We identifi ed all cases of in-hospital cardiac arrest (IHCA) 
occurring in the National University Hospital in Singapore from 1 June 
2008 to 31 May 2009. Patients for which IHCA occurred but where 
no resuscitation was attempted were excluded. Key outcomes were 
classifi ed as primary (survival to discharge) and secondary (return of 
spontaneous circulation). Additionally, various arrest characteristics 
were analysed to identify predictive factors for survival to discharge 
with level of signifi cant set at P <0.05.
Results Among 353 unique cases of IHCA analysed, 63 patients 
(17.8%) had a shockable rhythm (ventricular fi brillation and pulseless 
ventricular tachycardia) of which 17 (27.0%) survived to discharge. 
While 290 (82.2%) patients presented with nonshockable rhythm 
(asystole or pulseless electrical activity), only 32 patients (11%) 
survived to discharge. For patients who survived to discharge, 
univariate analysis showed that event location (P = 0.016), nationality 
(P = 0.035), paying class (P = 0.038), use of ECG monitoring (P = 0.048), 
initial cardiac rhythm (P = 0.000) and presence of a house offi  cer (P = 
0.005) were statistically signifi cant. Multivariate analysis showed that 
patients with shockable rhythms were 2.52 times more likely to survive 
but other factors were not signifi cant. For patients who attained ROSC, 
univariate analysis showed that time of day (P = 0.006), event location 
(P = 0.000), and number of adrenaline doses administered (P = 0.000) 
were statistically signifi cant. Multivariate analysis showed that an arrest 
occurring in the ICU setting was 2.9 times more likely to attain ROSC 
(95% CI: 1.02 to 5.59, P = 0.044).
Conclusion The results of this study have described some key 
predictive factors regarding positive outcomes in IHCA in Singapore. 
These are vital in understanding important features regarding IHCAs 
and will aid in developing policies to help improve care and survival in 
this group of patients.
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Comparison of complications secondary to cardiopulmonary 
resuscitation between out-of-hospital cardiac arrest and in-hospital 
cardiac arrest
M Seung, Y Park
Yonsei University Severance Hospital/Yonsei University College of Medicine, 
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Introduction Chest compression during cardiopulmonary resuscitation 
(CPR) could bring out unintended complications which are mainly 
composed of chest injuries. The aim of this study was to assess whether 
there was a signifi cant diff erence in the complications of CPR between 
out-of-hospital cardiac arrest (OHCA) and in-hospital cardiac arrest 
(IHCA) survivors using multidetector computed tomography (MDCT).
Methods We performed a retrospective cohort study in the emergency 
departments of two academic tertiary care centres from January 
2009 to May 2014. We enrolled both OHCA and IHCA patients who 
underwent successful CPR. The enrolled patients had undergone a 
chest CT within 48 hours after ROSC. We evaluated the MDCT fi ndings 
of the CPR-related chest injuries and compared complications between 
OHCA and IHCA patients.
Results A total of 148 patients were fi nally enrolled in this study, OHCA 
were 89 (60.1%) and IHCA were 59 (39.8%). The mean CPR time, both 
in-hospital and total, was longer in OHCA survivors. Rib fractures were 
Figure 1 (abstract P417).
Figure 1 (abstract P419). Patient demographics and clinical fi ndings.
Figure 2 (abstract P419). Comparison complications of CPR between 
the OHCA group and the IHCA group.
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detected more in OHCA survivors. Frequency of multiple rib fractures 
was higher in OHCA survivors. Frequency of sternum fractures was 
higher in OHCA survivors, showing no signifi cant diff erence. In lung 
injuries, lung contusion and pneumothorax account for the large part, 
and OHCA survivors had higher incidence in both complications but 
statistically insignifi cant. Major complications occurred in eight cases 
in OHCA survivors and three cases in IHCA survivors during the study 
period. After adjusting for the time factor in multiple logistic regression 
analysis, rib fractures and multiple rib fractures became statistically 
signifi cant in OHCA survivors. See Figures 1 and 2.
Conclusion Frequency of rib fractures and multiple rib fractures were 
higher in OHCA survivors. Further investigation is needed into the 
relation between the location of CPR and the CPR-related injuries, 
eff orts to reduce the complications after CPR.
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Introduction Fluid loading during cardiopulmonary resuscitation 
for nonhypovolemic cardiac arrest remains controversial. Thus, we 
conducted an experimental study comparing the impact of two 
diff erent doses of balanced crystalloid infusion on hemodynamics in a 
porcine model of ventricular fi brillation.
Methods Ventricular fi brillation was induced for 15  minutes in 19 
anesthetized domestic pigs. Before induction, the animals were 
randomized to receive either 1,000  ml (34  ± 3  ml/kg, group A, n  = 
7) or 500  ml (16  ± 2  ml/kg, group B, n  = 7) of balanced crystalloid 
solution or to undergo no fl uid loading during CPR (group C, n  = 5). 
After spontaneous circulation (ROSC) was restored, the animals were 
observed for 90 minutes.
Results In all groups, signifi cant increase of intracranial pressure 
followed by its decrease after ROSC was observed. While in groups 
B (from 12 ± 2 to 18 ± 2 mmHg, P <0.05) and C (from 13 ± 1 to 18 ± 
3 mmHg, P <0.05) it was comparable (P >0.05), the rise of intracranial 
pressure in group A was signifi cantly higher (from 12  ± 3 to 23  ± 
3 mmHg, P <0.05). Whereas coronary perfusion pressure was lower in 
group A than in control group C during volume loading, fl uid infusion 
induced its mild increase in group B (group A: 12.1  ± 2.4, group B: 
16.0 ± 2.6, group C: 13.6 ± 2.8 mmHg, P = 0.043). Decrease of cerebral 
perfusion pressure was equal in all groups. Cardiac index 10 minutes 
after ROSC signifi cantly diff ered among all groups (group A: 8.9 ± 2.2, 
group B: 7.1 ± 1.3, group C: 4.9 ± 1.9 l/minute/m2, P = 0.007) and the 
dose of crystalloid infusion during cardiac arrest positively correlated 
with cardiac index increase (r = 0.815, P <0.001).
Conclusion Fluid loading during CPR had signifi cant impact on 
hemodynamics in our experimental model. While a high dose led 
to unintentional increase of intracranial pressure and decrease of 
coronary perfusion pressure, a low dose did not aff ect intracranial 
pressure and was associated with mild increase of coronary perfusion 
pressure during cardiac arrest.
P421
Near-death experiences in survivors of cardiac arrest: a study about 
demographic, medical, pharmacological and psychological context
F Lallier, G Velly, A Leon
Centre Hospitalier Universitaire, Reims Cedex, France
Critical Care 2015, 19(Suppl 1):P421 (doi: 10.1186/cc14501)
Introduction Near-death experiences (NDEs) are increasingly being 
reported as a clear reality of clinical signifi cance. Previous studies, 
essentially, have been trying to estimate their incidence in various 
populations, notably after cardiac arrest resuscitation, and to 
understand the implication of resuscitation characteristics [1,2]. Using 
the Greyson NDE scale [3], the present retrospective study aimed 
at exploring cardiac arrest survivors and the correlations between 
NDE and physiological, medical, psychological and pharmacological 
context.
Methods In a retrospective study from 2005 to 2012, 295 consecutive 
cardiac patients who were successfully resuscitated after cardiac arrest 
were enrolled. In total, 204 (69%) were alive during the research period 
(mean delay: 55 months). A total of 118 (40%), over 18 years, able to 
answer a short standardized interview were included in the study when 
they accepted to participate. Demographic, medical, pharmacological 
and psychological data were recorded and we used the Greyson NDEs 
scale to identify and characterize NDEs. Descriptive and unifactorial 
analysis was performed using the Jacknife method and Wald test 
according to low event frequency.
Results From our 118 reports, 20 described a core experience and 18 
(15.3%) met the criteria for NDEs (Greyson NDEs total score >6/32 (7 
to 19)). Only one patient recounted a negative experience. Regarding 
the risk factors for NDEs, using univariate analysis, we found for 
demographic data: woman (CI: 1.11 (1.10 to 1.12), P  <0.0001), age 
under 60 (CI: 1.23 (1.21 to 1.24), P <0.0001), prior knowledge of NDEs 
(CI: 1.97 (1.95 to 1.99)) and previous NDE (CI: 5.82 (4.19 to 8.08)). 
According to the history of previous disease, we found an increased 
risk for pulmonary disease (CI: 1.75 (1.73 to 1.77)), rheumatic disease 
(CI: 3.79 (3.75 to 3.84)), endocrine disease (CI: 1.45 (1.43 to 1.46)), and a 
decrease for cardiac disease (CI: 0.65 (0.64 to 0.66)), psychiatric disease 
(CI: 0.71 (0.69 to 0.72)) and digestive tract disease (CI: 0.71 (0.69 to 
0.72)). For previous pharmacological treatment we found a decrease of 
risk for all classes and particularly when two drugs were simultaneously 
given (CI: 0.37 (0.36 to 0.38)).
Conclusion Although our study has a number of methodological 
limitations, these results about incidence in cardiac arrest survivors 
corroborate previous retrospective reports. It is possible that every 
cardiac arrest survivor has had to live a NDE, regardless of brain 
mechanisms associated with experience, but only some patients 
remember it. If some chronic medications, such as benzodiazepine, 
may decrease memorization, the role of the elements of the clinical 
context about NDE during resuscitation is speculative
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Utilisation and prognostic impact of cathlab investigation prior 
to intensive care admission for patients following out-of-hospital 
cardiac arrest
L Eveson, S Shrestha, V Achan, M Davies, M Peck
Frimley Park Hospital, Frimley, UK
Critical Care 2015, 19(Suppl 1):P422 (doi: 10.1186/cc14502)
Introduction Our 700-bed hospital has a 24–7 cathlab service that 
routinely investigates patients with indications prior to ICU admission 
following out-of-hospital cardiac arrest (OOHCA). Our aim was to 
compare survivors and nonsurvivors and evaluate utilisation and 
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prognostic impact of angiography and primary percutaneous coronary 
intervention (PPCI) in this patient group.
Methods A retrospective analysis using Trust electronic databases 
(Symphony, WardWatcher, PICIS, PRISM) of all OOHCA patients 
admitted to our ICU over 3 consecutive years between 1 November 
2011 and 31 October 2014.
Results A total of 351 patients presented to our emergency department 
(ED) following OOHCA in this period, and of these 50% died in the ED, 
37% were admitted to the ICU and 13% were admitted elsewhere. Of 
the 129 patients admitted to the ICU, median age was 66 (range 18 to 
93), 71% were male, 68% had a shockable presenting rhythm, median 
ICU LOS was 3.75 (range 1 to 34 days) and ICU and hospital mortalities 
were 50% and 60% respectively. Eighty-nine percent (n = 48) of OOHCA 
survivors admitted to the ICU had a shockable rhythm compared with 
55% (n = 41) of nonsurvivors. Eighty-three percent (n = 45) of survivors 
admitted to the ICU went to the cardiac cathlab before ICU admission 
compared with 53% (n  = 39) of nonsurvivors. Forty-three percent 
of survivors had PPCI compared with 26% of nonsurvivors. Eighty-
one percent (n  = 44) of survivors received therapeutic hypothermia 
compared with 62% (n = 48) of nonsurvivors.
Conclusion Over 3 consecutive years our annual case mix, ICU and 
hospital mortalities for OOHCA patients admitted to the ICU have 
remained stable, while our annual pre-ICU cathlab and PPCI utilisation 
have risen consistently in both survivors and nonsurvivors. ICU survivors 
were more likely to have had a shockable rhythm, been to the cathlab, 
and received PPCI and TH, but all may simply refl ect selection bias. 
Any benefi t these conferred to cardiac patients may have been off set 
by our liberal ICU admission policy to OOHCAs with nonshockable 
rhythms. Access to 24–7 PPCI in this group may determine survival and 
we suggest that OOHCA patients should be taken directly to regional 
heart attack centres.
P423
Utilisation and prognostic impact of angiography and primary 
percutaneous coronary intervention prior to intensive care 
admission for patients following out-of-hospital cardiac arrest
L Eveson, S Shrestha, M Davies, V Achan, M Peck
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Critical Care 2015, 19(Suppl 1):P423 (doi: 10.1186/cc14503)
Introduction Our 700-bed hospital has a 24–7 cathlab service that 
routinely investigates patients with indications prior to ICU admission 
following out-of-hospital cardiac arrest (OHCA). Our aim was to 
compare ICU survivors and nonsurvivors and evaluate the utilisation 
and prognostic impact of angiography and primary percutaneous 
coronary intervention (PPCI) in this patient group.
Methods A retrospective analysis using Trust electronic databases 
(Symphony, WardWatcher, PICIS, PRISM) of all OHCA patients admitted 
to our ICU over 3 consecutive years between 1 November 2011 and 31 
October 2014.
Results A total of 351 patients presented to our hospital following 
OHCA in this period, and of these 50% died in the ED, 37% were 
admitted to the ICU and 13% elsewhere. Of the 129 patients admitted 
to the ICU, median age was 66 (range 18 to 93), 71% were male, 68% 
had a shockable presenting rhythm, median ICNARC score was 31 
(range 10 to 66), median ICU LOS was 3.75 (range 1 to 34  days) and 
ICU and hospital mortality were 50% and 60% respectively. ICU 
survivors were more likely to have had a shockable rhythm (89 vs. 
55%), been to the cathlab (83 vs. 53%), received PPCI (43 vs. 26%) and 
TH (82 vs. 62%) and had lower median ICNARC scores (26 vs. 35) than 
nonsurvivors. Over the 3 consecutive years, pre-ICU cathlab and PPCI 
utilisation increased annually in ICU survivors (73 vs. 86 vs. 89% and 
45 vs. 54 vs. 59% respectively) and nonsurvivors (40 vs. 38 vs. 50% and 
20 vs. 27 vs. 31% respectively). However, our annual ICU and hospital 
mortality remained unchanged (46 vs. 51 vs. 51% and 60 vs. 57 vs. 62% 
respectively).
Conclusion ICU survivors were more likely to have had a shockable 
rhythm, been to the cathlab, received PPCI and TH and been less sick 
than nonsurvivors, but these may simply refl ect selection and other 
biases. Any benefi t these factors did confer to cardiac patients may 
have been off set by our liberal ICU admission policy to OHCAs with 
nonshockable rhythms. However, access to 24–7 PPCI may determine 
survival and we suggest that all OHCA patients should be taken directly 
to regional heart attack centres.
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Targeted temperature management after cardiac arrest and fever 
control with an esophageal cooling device
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Introduction Mild hypothermia and fever control have been shown to 
improve neurological outcomes post cardiac arrest. Common methods 
to induce hypothermia include body surface cooling and intravascular 
cooling; however, a new approach using a catheter placed into the 
esophagus has recently become available.
Methods We report the fi rst three cases of temperature control using an 
esophageal cooling device (ECD). The ECD was placed orally in a similar 
fashion to orogastric tubes. Temperature reduction was achieved by 
connecting the ECD to a commercially available heat exchange unit 
(Blanketrol II or III).
Results The fi rst patient, a 59-year-old male (73 kg), was admitted after 
successful resuscitation from a protracted out-of hospital cardiac arrest. 
His initial temperature was 35°C, which is within our current institutional 
protocol of 34 to 36°C. Several hours after arrival, his temperature 
slowly increased to 35.8°C despite application of a cooling blanket and 
ice packs to the groin and axilla. The ECD was inserted and a reduction 
of temperature to 34.8°C was achieved within 3  hours. The patient 
expired on day 3. The second patient, a 54-year-old female (95 kg), was 
admitted after resuscitation from an out-of-hospital PEA arrest. Despite 
initiating our cooling protocol with surface-cooling blankets and cold 
intravenous saline, she mounted a fever peaking at 38.3°C shortly 
after admission. After ECD insertion and confi rming the external 
heat exchanger connection, her temperature gradually dropped to 
35.7°C over a period of 4  hours. She subsequently made a favorable 
neurological recovery and was discharged home at day 23. The third 
patient, a 47-year-old male patient (86 kg) presented with an ongoing 
fever secondary to necrotizing pneumonia in the postoperative period 
after coronary artery bypass grafting. His fever was unresponsive to 
empiric antibiotic therapy, antipyretics, cooling blankets, and ice packs. 
ECD insertion resulted in a decrease in temperature from 39.5°C to 
36.5°C in less than 5 hours. The patient eventually made a full recovery 
and was discharged home after 59 days. In all three patients, placement 
of the device occurred in less than 3  minutes and ease of use was 
reported as excellent by nursing staff  and physicians.
Conclusion The ECD is a novel technology that can be used for 
temperature management post cardiac arrest and for fever control 
in critically ill patients. Despite patients mounting a febrile response, 
temperature control was achieved and maintained successfully. The 
device was reported as being easy to use, by both physicians and 
nurses.
P425
Is selective nasopharyngeal brain cooling detrimental to 
neuroprotection?
M Kumar, L Johnson, A Goldberg, M Kashiouris, L Keenan, A Rabinstein
Mayo Clinic, Rochester, MN, USA
Critical Care 2015, 19(Suppl 1):P425 (doi: 10.1186/cc14505)
Introduction Clinical outcomes vary depending on the method used 
to induce therapeutic hypothermia following stroke or cardiac arrest. 
In swine, we tested the hypothesis that selective nasopharyngeal brain 
cooling (SNBC), in contrast to systemic hypothermia, adversely impacts 
cerebral perfusion.
Methods In two groups of animals (34 to 35  kg), blood fl ow in the 
right middle cerebral artery (MCA) was measured using transcranial 
Doppler (TCD). In group 1, SNBC was initiated using perfl uorohexane 
aerosol (1  ml/kg/minute) and oxygen (1  l/kg/minute) through a 
nasopharyngeal catheter atomizer. In group 2, the animals were body 
surface cooled using water-circulating blankets (4°C). In both groups, 
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brain temperature, intracranial pressure (ICP), core temperatures and 
vital signs were continuously recorded. Cooling was terminated once 
the brain reached 32°C and the animals were allowed to passively 
rewarm.
Results In the SNBC group, the brain target temperature was reached 
in 54 ± 11 minutes. The mean ICP dropped precipitously to a nadir of 
–15 mmHg. TCD showed signifi cant vasospasm in the MCA, compared 
with the internal carotid artery (ICA), during the entire cooling 
phase (Table  1). Upon termination of cooling, the brain temperature 
spontaneously rewarmed to core temperature in 13  ± 4  minutes. 
Rewarming was associated with hyperemia and elevation of ICP. In 
group 2, there was no cerebral vasospasm or hyperemia during cooling 
and rewarming respectively.
Conclusion SNBC is associated with signifi cant vasospasm of the MCA. 
In addition, spontaneous and rapid rewarming of the brain, vasodilation, 
rapid reperfusion, and rebound elevation of ICP, all occurring minutes 
after termination of SNBC, are likely to be detrimental to an already 
ischemic brain.
P426
Hemodynamic targets during therapeutic hypothermia after 
cardiac arrest: a prospective observational study
K Ameloot, I Meex, C Genbrugge, W Boer, F Jans, B Ferdinande, W Mullens, 
M Dupont, C Dedeyne, J Dens
ZOL Genk, Belgium
Critical Care 2015, 19(Suppl 1):P426 (doi: 10.1186/cc14506)
Introduction In analogy with sepsis, current postcardiac arrest (post-
CA) guidelines recommend to target mean arterial pressure (MAP) 
above 65 mmHg and SVO2 above 70%. This is unsupported by mortality 
or cerebral perfusion data. The aim of this study was to explore the 
associations between MAP, SVO2, cerebral oxygenation and survival.
Methods A prospective, observational study during therapeutic 
hypothermia (24 hours –33°C) in 82 post-CA patients monitored with 
near-infrared spectroscopy.
Results Forty-three patients (52%) survived in CPC 1 to 2 until 180 days 
post CA. The mean MAP range associated with maximal survival was 
76 to 86  mmHg (OR  = 2.63, 95% CI (1.01; 6.88), P  = 0.04). The mean 
SVO2 range associated with maximal survival was 67 to 72% (OR  = 
8.23, 95% CI (2.07; 32.68), P  = 0.001). In two separate multivariate 
models, a mean MAP (OR = 3.88, 95% CI (1.22; 12.33), P = 0.02) and a 
mean SVO2 (OR  = 8.79, 95% CI (1.69; 18.36), P  = 0.01) in the optimal 
range persisted as independently associated with increased survival 
after correction for presence of early bystander CPR and presenting 
shockable rhythm. Based on more than 1,625,000 data points, we found 
a strong linear relation between SVO2 (range 40 to 90%) and average 
cerebral saturation (R2 = 0.86) and between MAP and average cerebral 
saturation for MAPs between 40 and 87 mmHg (R2 = 0.70). Based on our 
hemodynamic model, the optimal MAP and SVO2 were determined to 
be 87 mmHg and 72%.
Conclusion The optimal SVO2 (72%) and MAP (87  mmHg) derived 
from our hemodynamic model matched with the observed SVO2 (67 
to 72%) and MAP (76 to 86 mmHg) associated with maximal survival. 
Prospective interventional studies to reach or maintain these targets 
are needed to confi rm these fi ndings.
P427
Pharmacologic evaluation of shivering management in 
neurologically injured patients utilizing therapeutic normothermia
T Lam, B Heather, J Jancik
Hennepin County Medical Center, Minneapolis, MN, USA
Critical Care 2015, 19(Suppl 1):P427 (doi: 10.1186/cc14507)
Introduction Uncontrolled shivering may have negative consequences 
by increasing metabolic demand and subsequently neutralize the 
benefi ts of therapeutic normothermia [1]. Previous anti-shivering 
protocols that utilize the least sedation have been described in 
therapeutic temperature modulation (TTM) [2]. Our aim is to describe 
and evaluate an anti-shivering protocol that emphasizes the least 
sedating regimen with the least number of pharmacologic agents for 
patients undergoing therapeutic normothermia.
Methods This retrospective chart review includes patients with 
neurologic injury who underwent TTM from March 2013 to November 
2014 and were evaluated for the following outcomes: percentage of 
total patient hours in each score of the Bedside Shivering Assessment 
Scale (BSAS) at 72  hours, 168  hours, and total duration of TTM; 
percentage of total patient days in each tier of the anti-shivering 
protocol at 72  hours, 168  hours, and total duration of TTM; de-
escalation of anti-shivering agents with or without the necessary need 
for re-escalation; ICU and hospital length of stay (LOS); rescue agents 
utilized; and hospital mortality.
Results Evaluation of 47 patients who underwent TTM resulted in 
a total of 505 patient-days of TTM with 6,967 BSAS hours. Overall, 
patients spent 85.5% of total hours at BSAS 0, 11.4% of total hours at 
BSAS 1, 2.5% of total hours at BSAS 2, and 0.6% of total hours at BSAS 3. 
Patients were in tier 0 of the anti-shivering protocol 33.1% of the time, 
in tier 1 of the anti-shivering protocol 20.6% of the time, in tier 2 of 
the anti-shivering protocol 43.6% of the time, and in tier 3 of the anti-
shivering protocol 2.8% of the total duration of TTM. There were 487 
rescue doses of fentanyl and 243 rescue doses of meperidine that were 
required for shivering. Patients had a mean ICU LOS of 19 days, mean 
hospital LOS of 21 days, and a mortality rate of 23.4%.
Conclusion This study demonstrates a high level of effi  cacy of our 
protocol and the feasibility of de-escalation to limit the number of 
pharmacologic interventions. With our patient population spending 
a large percentage of time without shivering, it would suggest that 
this protocol could be revised further by utilizing rescue agents more 
frequently in order to prevent escalation of therapy to the next tier.
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Introduction Therapeutic hypothermia (TH) is the international 
standard of care for all comatose patients after cardiac arrest, but 
criticism focuses on poor outcomes. We sought to develop criteria to 
identify American urban patients more likely to benefi t from TH.
Methods A retrospective chart review of 107 consecutive adults under-
going TH in downtown New Orleans from 2010 to 2014 yielded records 
for 99 patients with all 44 survivors or families contacted up to 4 years.
Results Sixty-nine males and 38 females with a mean age of 60.2 years 
showed 63 dead (58%) and 44 survivors (42%). Presenting cardiac 
rhythm was divided into shockable (pulseless ventricular tachycardia, 
ventricular fi brillation) and nonshockable (pulseless electrical activity, 
asystole). Presenting in shockable rhythms with ROSC <20  minutes 
were 21 patients with 15 (71%) survivors (P = 0.001). Time >20 minutes 
until ROSC in shockable rhythms had fi ve patients with three survivors 
(78%, P  = 0.001). Presenting in nonshockable rhythms with ROSC 
<20  minutes were 54 patients with 18 survivors (33%, P  = 0.001). 
ROSC >20 minutes in nonshockable rhythms had 19 patients with two 
survivors (8%, P = 0.001). Survivors of shockable rhythms showed 19 
(100%) living post TH. Fifteen survivors (79%, n = 19, P = 0.001) had CPC 
Table 1 (abstract P425). Cerebral vasospasm during SNBC
 MCA fl ow ICA fl ow   
 velocity velocity Lindegaard Pulsatility ICP
Intervention (cm/second)  (cm/second) ratio ratio (mmHg)
Baseline 62 41 1.51 0.77 13
SNBC cooling 128 52 2.46 0.48 –15
SNBC rewarming 96 44 1.74 1.12 21
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score 1 or 2 with four survivors (21%, n = 19) having a CPC score of 3. 
A total of 25 survived nonshockable rhythm. Acute survival of patients 
with nonshockable rhythm showed 18 expired <72 hours (72%, n = 25) 
with long-term survival of four patients (5%, n = 74) and CPC scores of 
1 or 2 (P = 0.001). Interestingly, patients with time to ROSC <20 minutes 
exhibiting more than one loss of sustained ROSC showed 100% 
mortality (P = 0.001). Patients presenting with shockable >20 minutes 
ROSC had overall survival of 70% (P = 0.001), but those undergoing >3 
cardiac rhythm changes had 100% mortality (P = 0.001).
Conclusion Patients presenting with shockable rhythms undergoing 
TH had overall acute survival of 70% followed by long-term survival of 
100% after 4 years. In contrast, patients presenting with nonshockable 
rhythm had long-term survival of 5%. TH is not recommended.
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Diff erence in cerebral saturation during cardiopulmonary 
resuscitation between survivors with favorable neurological outcome 
and compromised neurological outcome at hospital discharge
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Introduction During out-of-hospital cardiac arrest (OHCA) monitoring 
possibilities are limited. Recently, the role of cerebral oximetry, using 
near-infrared spectroscopy, during ALS was investigated. In this 
study we determined whether the magnitude of increase in cerebral 
saturation (rSO2) or mean rSO2 during prehospital ALS was associated 
with good neurological outcome at hospital discharge (Cerebral 
Performance Category (CPC) 1 or 2).
Methods With IRB approval, we prospectively measured rSO2 during 
ALS in consecutive OHCA patients. One sensor of the Equanox™ 7600 
(NONIN) was applied on the patient’s forehead’s right side when the 
medical emergency team arrived in an OHCA. ROSC was defi ned as 
ROSC >20 minutes.
Results We included 88 prehospital cardiac arrest patients between 
December 2011 and October 2014 with eight (9%) patients with CPC 1 
or 2. Twenty-seven patients of the nonsurvivors had ROSC >20 minutes 
and one patient had CPC 3 at hospital discharge. We observed no 
signifi cant diff erence between both groups in age (P  = 0.161), time 
between emergency call and start of ALS (P  = 0.788) and duration 
of basic life support performed by bystanders, general practitioners 
or paramedics (P  = 0.649). The initial rhythm was asystole in one 
(12.5%) survivor and in 50 (62.5%) nonsurvivors (P = 0.009), ventricular 
fi brillation in six (75%) survivors and 13 (16%) nonsurvivors (P = 0.001), 
and pulseless electrical activity in one (12.5%) survivor and 17 (21%) 
nonsurvivors (P = 1.00). The cardiac arrest was witnessed in all survivors 
(100%) and in 49 (61%) nonsurvivors (P = 0.046). First measured rSO2 
was 38% (27 to 67) in the survivor group compared with 22% (8 to 32) 
in the nonsurvivor group (P = 0.004). Also a signifi cant diff erence was 
found in mean rSO2 until 1  minute before ROSC between survivors 
and nonsurvivors, respectively 46% (40 to 74) and 34% (22 to 42). We 
observed no signifi cant diff erence in increase of rSO2 until 1  minute 
before ROSC between survivors 12.5% (5 to 21) and nonsurvivors 11% 
(5 to 18) (P = 0.719).
Conclusion We observed a signifi cant diff erence in fi rst measured rSO2 
and mean rSO2 until 1 minute before ROSC between patients with good 
neurological outcome (CPC 1 or 2) at hospital discharge and patients 
with worse neurological outcome or nonsurvivors (CPC 3 or 4 or 5). 
However, no signifi cant diff erence was observed in the increase between 
both groups. Larger studies are necessary to confi rm these results.
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Association between hemoglobin, cerebral oxygenation and 
neurologic outcome in postcardiac arrest patients
I Meex, K Ameloot, C Genbrugge, M Dupont, B Ferdinande, J Dens, 
C Dedeyne
ZOL Genk, Belgium
Critical Care 2015, 19(Suppl 1):P430 (doi: 10.1186/cc14510)
Introduction The safety of a restrictive transfusion threshold of 7 g/dl 
applied in all critically ill patients can be questioned in postcardiac arrest 
(post-CA) patients since these are phenotypically clearly distinct. The aims 
of this study were to investigate the association between hemoglobin, 
cerebral oxygenation (SctO2) and outcome in post-CA patients.
Methods A prospective observational study in 82 post-CA patients 
during hypothermia in the fi rst 24 hours of ICU stay. Hemoglobin was 
determined hourly together with a corresponding SctO2 by NIRS and 
SVO2 in patients with a pulmonary artery catheter (n = 62).
Results Based on 2,099 paired data, we found a strong linear relationship 
between hemoglobin and average SctO2 (SctO2 = 0.70 × hemoglobin + 
56 (R2 = 20.84, P = 10–6)). Given the previously suggested SctO2 target 
between 66 and 68%, hemoglobin levels below 10  g/dl generally 
resulted in suboptimal brain oxygenation. Forty-three patients (52%) 
had a good neurological outcome (CPC 1 to 3) at 180  days post CA. 
There was a signifi cant association between average hemoglobin 
above 12.3 g/dl and good neurological outcome (OR = 2.88, 95% CI = 
1.02; 8.16, P = 0.04). In a multivariate model, this association persisted 
after correction for comorbidities and age by the modifi ed Charlson 
score (OR  = 2.99, 95% CI  = 1.05; 8.53, P  = 0.03). This association was 
entirely driven by results obtained in patients with an average SVO2 
below 70% (OR = 17.55, 95% CI = 1.67; 184.41, P = 0.01).
Conclusion There is a steep linear relationship between hemoglobin and 
SctO2 in post-CA patients with hemoglobin levels below 10 g/dl generally 
resulting in cerebral desaturation. Average hemoglobin below 12.3  g/
dl was independently associated with worse neurological outcome 
180  days post CA. An interventional trial is necessary to investigate 
whether maintaining higher hemoglobin would improve outcome.
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Somatosensory evoked high-frequency oscillations and 
prognostication after cardiac arrest
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Introduction Electrical median nerve stimulation elicits a burst of 
high-frequency oscillations (HFOs) superimposing onto the cortical 
short-latency potential. Digital fi ltering of somatosensory evoked 
potentials (SSEPs) enables non-invasive analysis of these HFOs. The late 
HFO component following the cortical N2O peak is ascribed to spiking 
activity of cortical neurons.
Methods We retrospectively studied late HFO components of median 
nerve SSEPs obtained 24  hours to 4  days after cardiac arrest in 
patients treated with mild hypothermia (33°C for 24  hours). Cortical 
average recordings were digitally fi ltered at 450 to 750 Hz and noise-
corrected maximum peak-to-peak amplitudes of the cortical late HFO 
bursts determined. Outcome upon ICU discharge was dichotomized 
according to the Cerebral Performance Category (CPC) scale. CPC 1 to 3 
was classifi ed as good outcome, CPC 4 to 5 (unresponsive wakefulness 
syndrome and death) as poor outcome.
Results Of 307 consecutive patients, 153 (50%) achieved good outcome 
(CPC 1 to 3) and 154 (50%) had poor outcome. Late HFO bursts were 
present in 102 (33%) recordings. Among patients with late HFO amplitudes 
above 0.1 μV, 26 had CPC 1 to 3, none had CPC 4 and eight died. Case 
review indicated causes of death other than hypoxic encephalopathy in all 
patients who died despite HFO amplitudes above 0.1 μV.
Conclusion We found cortical late HFO bursts, obtained by digital 
fi ltering of standard SSEP recordings, in a signifi cant proportion of 
patients after cardiac arrest treated with mild hypothermia. Our data 
indicate that the presence of late HFO bursts with amplitudes above 
0.1 μV may confi rm absence of severe hypoxic encephalopathy early 
after cardiac arrest with high specifi city.
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One-size-fi ts-all or patient-tailored hemodynamic targets in 
post-cardiac arrest patients: an observational near-infrared 
spectroscopy study on cerebral autoregulation
C Genbrugge, K Ameloot, I Meex, W Boer, F Jans, W Mullens, M Dupont, 
B Ferdinande, J Dens, C Dedeyne
ZOL Genk, Belgium
Critical Care 2015, 19(Suppl 1):P432 (doi: 10.1186/cc14512)
Introduction A subgroup of post-CA patients with disturbed cerebral 
autoregulation might benefi t from higher mean arterial pressures 
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(MAPs). We aimed to (1) investigate whether patients with disturbed 
autoregulation have a worse prognosis, (2) phenotype these patients, 
(3) defi ne an individual optimal MAP and (4) investigate whether time 
under this individual optimal MAP is associated with outcome.
Methods A prospective observational study in 51 post-CA patients 
monitored with near-infrared spectroscopy.
Results (1)  In multivariate analysis, patients with preserved auto-
regulation (33.65%) had a signifi cant higher 180-day survival rate 
(OR = 4.62, 95% CI (1.06; 20.06), P = 0.04). (2) Phenotypically, a higher 
proportion of patients with disturbed autoregulation had pre-
CA hypertension (31  ± 47 vs. 65  ± 49%, P  = 0.02) suggesting that 
right shifting of autoregulation is caused by chronic adaptation of 
cerebral blood fl ow to higher blood pressures. Based on an index of 
autoregulation (COX), the average COX-predicted optimal MAP was 
85 mmHg in patients with preserved and 100 mmHg in patients with 
disturbed autoregulation. (3)  An individual optimal MAP could be 
determined in 33/51 patients. (4) The time under the individual optimal 
MAP was negatively associated with survival (OR = 0.97, 95% CI (0.96; 
0.99), P = 0.02). The time under previously proposed fi xed targets (65, 
70, 75, 80 mmHg) was not associated with a diff erential survival rate.
Conclusion Cerebral autoregulation was shown to be disturbed in 
35% of post-CA patients of which a majority had pre-CA hypertension. 
Disturbed cerebral autoregulation within the fi rst 24 hours after CA is 
associated with a worse outcome. In contrast to uniform MAP goals, the 
time spent under a patient-tailored optimal MAP, based on an index of 
autoregulation, was negatively associated with survival.
P433
Response of regional oxygen saturation technologies during 
hypoxia
UB Borg, AM Neitembach
Covidien, Boulder, CO, USA
Critical Care 2015, 19(Suppl 1):P433 (doi: 10.1186/cc14513)
Introduction The purpose of this study was to determine the rate and 
magnitude of response to hypoxia for three diff erent regional oxygen 
saturation (rSO2) devices. rSO2 technologies are focused on absolute 
accuracy without consideration of response characteristics. Current 
rSO2 technologies assume that the oxygen saturation is a fi xed ratio 
of arterial and venous blood. Cerebral arteries have an oxygenation-
related vasoactivity that may change the arterial/venous ratio during 
hypoxia. Thus, absolute rSO2 accuracy may be less important compared 
with sensitivity to changes in cerebral rSO2.
Methods Ten subjects completed the study and are included in the 
analysis. One INVOS sensor (SAFB-SM) was placed on the left side 
and one Equanox (8000CA) or Foresight (1 July 2007 or 1 July 2005) 
sensor (alternated between subjects) was placed on the right side 
of the forehead for bilateral monitoring. Desaturation was induced 
by adjusting the inspiratory gas mixture of O2/N2. Desaturation was 
titrated from room air to achieve a plateau of 70% arterial oxygen 
saturation (SpO2). Resaturation was induced by rapid change in FiO2 
to 1.0. After 5  minutes of SpO2 100%, the process was repeated by 
desaturation to SpO2 70% and rapid return to SpO2 100%. Cerebral and 
pulse oximetry data were recorded during the study and the time of 
each FiO2 change and plateau was recorded. rSO2 levels at 10, 20, 40, 60 
and 80% of the total SpO2 response were calculated for each device to 
assess the rate of rSO2 change. The rate of rSO2 change in seconds and 
total rSO2 change were compared.
Results The rate of rSO2 change during desaturation was similar for 
all devices with an average slope factor of 0.17 for Foresight, 0.16 for 
Equanox and 0.21 for INVOS. The rate of rSO2 change in seconds during 
resaturation from SaO2 70% to SaO2 100% was signifi cantly faster for 
INVOS (42 ± 16) compared with Foresight (57 ± 20) (P <0.05). There was 
signifi cant diff erence in total rSO2 change between INVOS (23  ± 4%) 
and Equanox (15 ± 4%) during desaturation and resaturation (P <0.005) 
and between INVOS compared with Foresight (20 ± 5%) (P <0.05).
Conclusion All rSO2 devices followed the SpO2 slope during 
desaturation as expected. The diff erences between the devices in terms 
of total rSO2 change reached statistical signifi cance. There were also 
signifi cant diff erences in the rate of rSO2 change in seconds between 
INVOS and Foresight during resaturation. The rate of absolute change 
in seconds and the magnitude of absolute change may result in better 
resolution to detect physiological changes. Clinical studies are required 
to elucidate the clinical relevance of the diff erences.
P434
Use of bispectral index EEG monitoring for a fast and reliable 
detection of epileptic activity in postcardiac arrest patients
J Haesen1, L Desteghe1, I Meex2, C Genbrugge2, J Demeestere2, J Dens2, 
L Ernon2, C De Deyne2
1Universiteit Hasselt, Belgium; 2Ziekenhuis Oost-Limburg, Genk, Belgium
Critical Care 2015, 19(Suppl 1):P434 (doi: 10.1186/cc14514)
Introduction Assessment of prognosis in postcardiac arrest (post-
CA) patients became very challenging since the introduction of 
therapeutic hypothermia (TH). Continuous EEG monitoring has been 
proposed to improve prognostication; however, its use is limited due to 
diffi  culties in ready interpretation. Thus emerges the need for a simple 
EEG montage. The bispectral index (BIS) monitor is a simplifi ed EEG 
system, mainly calculating an index ranging from 0 (isoelectric EEG) 
to 100 (full consciousness) to provide information on hypnotic depth 
of anaesthesia. The aim of the study was to validate the accuracy of 
simplifi ed EEG monitoring in a CA setting.
Methods BIS monitoring (BIS VISTATM) was applied to collect 
frontotemporal data in TH-treated CA patients. A standard 19-channel 
EEG was performed after return to normothermia. Afterwards, small 
EEG frames coincident with the time of full EEG registration were 
extracted from the BIS monitor. We asked two neurophysiologists to 
indicate the presence of status epilepticus (SE), cerebral inactivity (CI), 
burst suppression (BS), periodic epileptiformic discharges (PEDs) or a 
diff use slowing pattern (DS). In addition, these samples were analysed 
by two inexperienced physicians, who were asked to indicate the 
presence of SE.
Results Thirty-four simplifi ed EEG samples were analysed. According 
to standard EEG, 11 patients showed a DS pattern, three had CI, six 
showed BS, four showed PEDs and 10 had an SE. Neurophysiologists 
interpreted all samples with a high accuracy. Mean sensitivity was 
82.12% and mean specifi city was 91.88%. Only one SE was missed by 
one neurophysiologist. Unfortunately, only one PED was confi rmed 
by both neurophysiologists. Interobserver reliability was high (κ  = 
0.843). High correlations were found for the comparison of full and 
simplifi ed EEG for both neurophysiologists (r = 0.809). Further, the two 
inexperienced physicians identifi ed SE with a sensitivity of 85% and 
specifi city of 98%.
Conclusion Simplifi ed EEG monitoring, using BIS, resulted in high 
accuracy of a simple classifi cation system in post-CA patients. Not 
only neurophysiologists, but also treating physicians were capable to 
identify SE, which may play an important role in the early detection of 
SE. We suggest using BIS as a screening tool in post-CA patients to save 
valuable time in the detection of SE, without replacing the need for full 
EEG monitoring for confi rmation.
P435
Diff erences in cerebral saturation measured during prehospital 
advanced life support, between patients with presumed cardiac 
origin and noncardiac origin of cardiac arrest
C Genbrugge1, W Boer1, K Anseeuw2, I Meex3, F Jans1, J Dens1, 
C De Deyne1
1ZOL, Genk, Belgium; 2ZNA Stuivenberg Belgium; 3Hasselt University, Hasselt, 
Belgium
Critical Care 2015, 19(Suppl 1):P435 (doi: 10.1186/cc14515)
Introduction During out-of hospital cardiac arrest (OHCA) cerebral 
saturation may provide relevant information on cerebral oxygenation. 
In this study we examined the time course in cerebral saturation (rSO2) 
during prehospital ALS comparing patients with a presumed cardiac 
origin (survivor = Sc, nonsurvivor = NSc) of arrest and noncardiac origin 
(survivor = Snc, nonsurvivor = NSnc) of arrest.
Methods With IRB approval, we prospectively measured rSO2 from 
the start of ALS in consecutive OHCA patients. One sensor (Equanox™ 
7600; Nonin) was applied on the patient’s forehead’s right side when 
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the medical emergency team arrived at the OHCA setting. ROSC was 
defi ned as ROSC >20 minutes. Retrospectively, included patients were 
divided into two groups with respect to their presumed origin of arrest.
Results Between December 2011 and October 2014, 113 OHCA patients 
were included. We observed a signifi cant diff erence in asystole and VF 
as initial rhythm between NSc and NSnc, respectively (P  = 0.035 and 
P = 0.001). In both groups of NS, duration of ALS was signifi cant longer 
compared with the two S groups (P  = 0.001 in both comparisons). 
We observed no signifi cant diff erence in fi rst measured rSO2, mean 
rSO2 until 1  minute before ROSC and increase in rSO2 until 1  minute 
before ROSC (respectively P = 0.123, P = 0.501, P = 0.265) between Sc 
and Snc. However, when we compare the nonsurvivors of cardiac with 
noncardiac origin, we observed a signifi cant diff erence in mean rSO2 
until 1 minute before ROSC, 35% (27 to 44) in the NSc group and 27 (21 
to 34) in the NSnc group (P = 0.026). First measured rSO2 was 24.5% (13 
to 34) in the NSc group and 14 (4 to 28) in the NSnc group (P = 0.069) 
trending to be signifi cantly diff erent. No signifi cant diff erence was 
observed in increase until 1 minute before ROSC between both groups 
of NS (P  = 0.920). Signifi cant diff erences was observed in mean rSO2 
until 1 minute before ROSC and increase in rSO2 between Snc and NSnc 
(P = 0.033; P <0.001) and between Sc and NSc (P = 0.001; P <0.001).
Conclusion We can conclude that NSc have a signifi cant higher mean 
rSO2 and trend to have a signifi cant diff erence in fi rst measured rSO2 
compared with NSnc. However, no signifi cant diff erence was observed 
between Sc and Snc.
P436
Amplitudes of cortical somatosensory evoked potentials and 
outcome prediction after cardiac arrest
C Storm, CJ Ploner, C Leithner
Charite Universitaetsmedizin, Berlin, Germany
Critical Care 2015, 19(Suppl 1):P436 (doi: 10.1186/cc14516)
Introduction Bilaterally absent cortical somatosensory evoked 
potentials (SSEPs) predict poor outcome after cardiac arrest. A 
threshold for the amplitude of early cortical SSEPs above which patients 
may survive with good outcome has not been determined. Thus, 
tolerable noise levels for the interpretation of cortical SSEPs are poorly 
defi ned. Furthermore, it has not been systematically investigated 
whether high amplitudes of cortical SSEPs may exclude severe hypoxic 
encephalopathy incompatible with re-awakening.
Methods We prospectively studied SSEPs after median nerve 
stimulation obtained 24 hours to 4 days after cardiac arrest in patients 
treated with targeted temperature management at 33°C for 24 hours. 
Amplitudes of cortical SSEPs were determined, if at least two peripheral, 
spinal and cortical recordings per side were available, spinal potentials 
were bilaterally reproducible and cortical noise level was below 
0.25 μV. Cortical SSEP amplitude was defi ned as largest amplitude of 
a reproducible cortical SSEP of four cortical recordings (two per side) 
within 50 milliseconds after stimulation. Outcome was assessed upon 
ICU discharge using the Cerebral Performance Category (CPC) scale. 
CPC 1 to 3 was defi ned as good outcome, CPC 4 to 5 as poor outcome.
Results Of 318 consecutive patients examined, 293 had complete SSEP 
recordings with reproducible spinal potentials and cortical noise levels 
below 0.25 μV. Of those, 137 (47%) had good outcome and 156 (53%) 
had poor outcome. The lowest amplitude of the early cortical SSEPs in a 
survivor with good outcome was 0.62 μV. All 79 patients with amplitudes 
below this threshold had poor outcome. None of 27 patients who 
survived with CPC 4 (unresponsive wakefulness syndrome) had cortical 
SSEP amplitudes above 2.5 μV. Twenty-four patients with amplitudes 
above this limit died. Detailed case review indicated a cause of death 
other than hypoxic encephalopathy in these patients.
Conclusion Our data indicate that the prognostic value of SSEP after 
cardiac arrest extends beyond a mere absent–present dichotomy. 
Bilaterally absent as well as very low amplitude SSEPs predict poor 
outcome with high positive predictive value. SSEPs should not be used 
for prognostication, if noise in cortical recordings could mask critically 
low amplitudes. High amplitudes of early cortical SSEPs strongly 
argue against severe hypoxic encephalopathy incompatible with 
re-awakening.
P437
Prognostic value of neuron-specifi c enolase after cardiac arrest and 
targeted temperature management
K Streitberger, C Leithner, CJ Ploner, C Storm
Charité Universitätsmedizin, Berlin, Germany
Critical Care 2015, 19(Suppl 1):P437 (doi: 10.1186/cc14517)
Introduction The serum concentration of neuron-specifi c enolase (NSE) 
has been established as a highly specifi c predictor of poor outcome 
after cardiac arrest. Recent studies have indicated that patients treated 
with targeted temperature management at 33°C for 24 hours may have 
good outcome despite NSE serum concentrations considerably higher 
than the cutoff  established for normothermic patients. The threshold 
above which survival with good outcome becomes very unlikely, 
its positive predictive value and sensitivity for prediction of poor 
outcome have not been established in this patient group. Furthermore, 
a threshold below which hypoxic encephalopathy may be largely 
excluded has not been determined.
Methods From 2006 through 2014 we prospectively included in-
hospital and out-of-hospital cardiac arrest patients treated with 
targeted temperature management at 33°C for 24  hours. The NSE 
serum concentration was determined 3  days after cardiac arrest and 
the outcome was assessed according to the Cerebral Performance 
Category (CPC) upon ICU discharge. CPC 1 to 3 was defi ned as good 
outcome and CPC 4 to 5 as poor outcome. Individual case review was 
performed in patients with good outcome despite very high NSE serum 
concentration and in patients with poor outcome despite very low NSE 
serum concentration.
Results Of 601 included patients, 309 (51%) had good outcome. 
An NSE serum concentration threshold of 90  μg/l predicted poor 
outcome with a positive predictive value of 0.98 and a sensitivity 
of 0.51. Three patients survived with good outcome despite an NSE 
serum concentration >90 μg/l. In two of these patients NSE elevations 
had been documented prior to cardiac arrest. One patient had a 
neuroendocrine tumor of the pancreas, the other patient suff ered from 
encephalitis of unknown etiology and an osteomyelofi brosis. Potential 
confounders in the third patient were an ovarian carcinoma, the use 
of an intra-aortic balloon pump and blood transfusions shortly after 
cardiac arrest. Only 16 of 205 patients with NSE <17  μg/l had poor 
outcome, the majority of these patients died from causes other than 
hypoxic encephalopathy.
Conclusion In patients with cardiac arrest and targeted temperature 
management at 33°C, an NSE serum concentration of >90 μg/l strongly 
indicates poor outcome. NSE producing tumors, acute brain diseases, 
severe hematologic diseases, use of an intra-aortic balloon pump and 
blood transfusions need to be considered as potential confounders. 
An NSE serum concentration of <17  μg/l largely excludes hypoxic 
encephalopathy incompatible with re-awakening.
P438
Resuscitated cardiac arrest in patients admitted with acute heart 
failure: analysis of a large prospective AHEAD network registry
J Parenica1, J Belohlavek2, J Spinar1, G Dostalova2, S Havranek2, A Linhart2, 
R Miklik1, L Dusek3, J Jarkovsky3
1University Hospital Brno, Czech Republic; 2General University Hospital, 
Prague, Czech Republic; 3Masaryk University, Brno, Czech Republic
Critical Care 2015, 19(Suppl 1):P438 (doi: 10.1186/cc14518)
Introduction Heart failure is a frequent cause of cardiac arrest and 
vice versa, cardiac arrest frequently complicates acute heart failure 
episodes. We aimed to characterize the infl uence of cardiac arrest on 
outcome of acute heart failure patients admitted to hospital.
Methods The AHEAD registry includes patients hospitalized for acute 
heart failure from 10 PCI and fi ve non-PCI centers in the Czech Republic. 
The data were collected from September 2006 to October 2012.
Results In the respective period, a total of 6,242 patients were 
enrolled into the registry. Resuscitated cardiac arrest occurred in 313 
patients prehospitally and in 484 after admission; the remaining 5,445 
patients were not resuscitated during their index hospitalization. 
Patients resuscitated after admission in comparison with prehospitally 
resuscitated were older, had lower left ventricle ejection fraction, more 
Critical Care 2015, Volume 19 Suppl 1 
http://ccforum.com/supplements/19/S1
S153
frequently suff ered cardiogenic shock, had more organ dysfunctions 
and died more frequently, respectively, with hospital mortality of 
79.5% versus 29.1%, P <0.001; see also Figure 1.
Conclusion In patients hospitalized for acute heart failure, both 
prehospital and postadmission resuscitated cardiac arrest is a severe 
complication associated with signifi cantly morbidity and mortality.
P439
Outcome of cardiopulmonary resuscitation in cancer patients in an 
Indian tertiary cancer center
SN Myatra, N Prabhu, JV Divatia
Tata Memorial Hospital, Mumbai, India
Critical Care 2015, 19(Suppl 1):P439 (doi: 10.1186/cc14519)
Introduction Cardiopulmonary resuscitation (CPR) after cardiac arrest 
in cancer patients is often discouraged as it is associated with poor 
outcome. In our 700-bed tertiary cancer hospital in Mumbai, India, 
the ICU runs an in-hospital cardiac arrest team (CAT). We reviewed our 
data to determine outcome from CPR, identify factors associated with 
improved outcomes and justify the presence of a CAT in our cancer 
hospital.
Methods All in-hospital patients from November 2012 to November 
2014 (2-year period) with unanticipated cardiorespiratory arrests were 
included. Data were recorded prospectively using the Utstein template. 
Only patients with cardiac arrest rhythms were included. Patients 
with anticipated progression towards arrest, those with seizures, 
hypotension without dysarrythmias or other medical emergencies 
were excluded. The outcomes studied were return of spontaneous 
circulation (ROSC) and survival on hospital discharge (SOHD). Binary 
logistic regression analysis was performed to determine factors 
associated with ROSC and SOHD.
Results One hundred and ninety-three patients (110 males, 83 females, 
mean age 48.2  ± 18.3  years) were studied. The mean time interval 
between collapse and onset of resuscitation was 2.3  ± 2.1  minutes. 
A total of 65.3% arrests were witnessed. Sustained ROSC occurred in 
36.8% patients and the SOHD was 24.9%. The initial rhythm recorded 
during CPR was asystole in 133 patients, pulseless electrical activity 
in 21 patients and ventricular fi brillation/tachycardia (VF/VT) in 
39 patients. SOHD for these rhythms was 8.3%, 33.3% and 76.9%, 
respectively. On univariate analysis, type of rhythm, witnessed arrests 
and time to resuscitation were associated with sustained ROSC and 
SOHD. On multivariate analysis, only type of rhythm, VF/VT (P = 0.000) 
and PEA (P  = 0.017), were signifi cantly associated with SOHD, while 
witnessed arrest and time to resuscitation were not.
Conclusion Sustained ROSC occurred in 36.8% patients and the SOHD 
was 24.9%. A reduced response time, witnessed arrest and type of 
rhythm are associated with ROSC and improved SOHD. The type of 
rhythm was independently associated with SOHD, with VF/VT and PEA 
having improved survival while asystolic patients had a poor outcome. 
These considerations justify the presence of a CAT in our cancer 
hospital.
P440
Outcome after CPR: when we cannot save lives, we can save organs
C Caestecker, J Froyman, P Lormans, W Stockman
AZ Delta, Roeselare, Belgium
Critical Care 2015, 19(Suppl 1):P440 (doi: 10.1186/cc14520)
Introduction Patients resuscitated after cardiac arrest (CA) who suff er 
bad neurologic outcome or become brain dead might become organ 
donors (OD) when well managed and identifi ed. We report on the 
cohort of patients resuscitated after in-hospital or out-of-hospital CA 
becoming OD in a tertiary community hospital with an intensive donor 
identifi cation program.
Methods Data from our 28-bed mixed medical/surgical adult ICU in a 
900-bed tertiary hospital were analyzed from 2010 to 2014.
Results Our ICU admitted 2,320 patients/year. Overall ICU mortality in 
this period was 7.4%. A summary of the results is presented in Table 1. 
Of the 219 patients admitted after CA, 21 (10%) became OD. This 
resulted in 55 successfully transplanted organs (28 kidneys, 17 livers, 
seven lung pairs, three hearts). Of note, good outcome (CPC 1 and 2) 
was achieved in 55 patients (25%).
Table 1 (abstract P440)
 Organ Donors  ICU admission
Year donors after CA  DCD/DBD after CA
2010 11 3 0/3 40
2011 9 5 3/2 41
2012 18 4 3/1 47
2013 17 5 4/1 53
2014 13 4 1/3 38
Total 68 21 (31%)  11/10 219
Conclusion Ten percent of patients resuscitated after CA and admitted 
to the ICU become OD, consisting of up to 31% of the total number 
of OD in our center. Patients resuscitated after CA who suff er severe 
irreversible brain damage or are brain dead can thus substantially 
expand the donor pool. This justifi es extensive resuscitation eff orts, 
if not to save lives, then to save organs. This might be reassuring for 
families, staff  and the community.
P442
Eff ect of alcohol in blood on neurological outcome and survival of 
patients with combination of polytrauma and head injury
S Pristovnik1, M Strnad2, V Vujanoviæ1, T Pelcl1, V Borovnik-Lesjak1
1Health Center Dr. Adolf Drolc, Maribor, Slovenia; 2Medical Faculty Maribor, 
Slovenia
Critical Care 2015, 19(Suppl 1):P442 (doi: 10.1186/cc14522)
Introduction The association between blood alcohol level (BAL) on 
mortality and neurologic outcome in patients with polytrauma and 
head injury is not clear and the data in the literature are sometimes 
confl icting. Some studies suggest a possible neuroprotective eff ect 
of alcohol and increased survival while others show the opposite. The 
rationale for this study was to investigate whether BAL has any impact 
on presentation, neurologic outcome and survival in patients with 
combination of polytrauma and head injury.
Methods This is a retrospective study of 43 polytraumatized patients 
with head injury who were intubated and treated by the prehospital 
unit and transported to the trauma center. Patients were grouped 
according to their BAL into BAL+ (>0.5  mg/l) and BAL– (≤0.5  mg/l). 
Inclusion criteria were age ≥18, Injury Severity Score ≥16 and head 
Abbreviated Injury Scale (AIS) ≥3. Physiological parameters and 
outcome with respect to survival to hospital discharge (STHD) and 
functional outcomes were analyzed. Severity of injuries was measured 
using the Trauma–Injury Severity Score (TRISS) and head injury using 
AIS. Functional outcome was measured using the Glasgow Outcome 
Scale (GOS), Cerebral Performance Category (CPC) and Glasgow Coma 
Figure 1 (abstract P438). Overall mortality (including hospitalization). 
Total n = 6,242.
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Scale (GCS) at discharge. Diff erences among groups were analyzed 
using Student’s t test, the Mann–Whitney U test and the chi-square test.
Results BAL did not have a signifi cant eff ect on presenting 
physiological parameters. There was a signifi cant diff erence in the age 
of the groups, showing that patients in the BAL+ group were younger 
(32.6 vs. 56.8 years; 95% confi dence level; P = 0.000). BAL had a lasting 
eff ect on functional measures of neurological outcome which showed 
better results in the BAL+ group; it had signifi cantly better GOS (4.7 vs. 
3.9; 95% confi dence level; P = 0.027), and GCS at discharge was on the 
border of statistical signifi cance (15 vs. 14; 95% confi dence level; P = 
0.05). Other variables (TRISS, AIS, STHD, CPC) did not show statistically 
signifi cant diff erences among groups.
Conclusion Presence of alcohol in the blood had a positive eff ect 
on neurological outcome but there was no signifi cant diff erence in 
survival. However, the positive results in neurologic outcome in the 
BAL+ group may also be due to the fact that this group was younger. 
The small number of patients in the study is another limiting factor of 
the interpretation. Therefore, the neuroprotective role of alcohol needs 
further clarifi cation.
P443
Endothelial dysfunction in acute brain injury and the development 
of cerebral ischemia
S Van Ierssel1, VM Conraads1, EM Van Craenenbroeck1, Y Liu2, AI Maas1, 
PM Parizel1, VY Hoymans1, CJ Vrints1, PG Jorens1
1University Hospital Antwerp, Edegem, Belgium; 2The Third Xiangya Hospital, 
Changsha, China
Critical Care 2015, 19(Suppl 1):P443 (doi: 10.1186/cc14523)
Introduction Cerebral ischemia (CeI) is a major complicating event 
after acute brain injury (ABI) in which endothelial dysfunction is a key 
player.
Methods We studied cellular markers of endothelial dysfunction and 
peripheral reactive hyperemia index (RHI) in 26 patients with ABI at 
admission and after 6 and 12 days, and compared these with healthy 
volunteers (n  = 15). CeI was determined clinically or using computer 
tomography.
Results In patients with ABI, RHI at admission was signifi cantly 
reduced compared with healthy subjects (P = 0.003), coinciding with 
a decrease in circulating endothelial progenitor cells (EPC) (P = 0.002) 
(Table 1). The RHI recovered in eight patients without development of 
CeI (Figure 1, black), but failed to fully recover by day 12 in three out 
of four patients that developed CeI (Figure  1, red). Despite recovery 
of the RHI within 12 days in these patients (P = 0.003), the EPC count 
remained signifi cantly lower after 12  days in patients with ABI (P  = 
0.022) (Table 1). CD31+ T cells and endothelial microparticles were not 
diff erent between controls and patients. No diff erences were noted in 
cellular markers of endothelial dysfunction in patients developing CeI 
and those not.
Conclusion Patients with ABI exhibit impaired microvascular endo thelial 
function measured as RHI and a decreased circulating level of EPC.
P444
Survey on ICP, target CPP and MAP measurement level in patients 
with severe acute brain injury in diff erent ICUs
M Van Laer1, K Deschilder2, W Stockman2
1UZ Brussel, Brussels, Belgium; 2AZ Delta, Roeselare, Belgium
Critical Care 2015, 19(Suppl 1):P444 (doi: 10.1186/cc14524)
Introduction Since most patients with acute brain injury are treated 
head-up at 30 to 45°, there can be a height diff erence of up to 15 cm 
between the heart and the ear canal. This causes a diff erence between 
mathematical CPP and true CPP of up to 11 mmHg depending on the 
zero reference level used and the body length of the patient (Figure 1). 
We conducted a survey to analyze the current practice on CPP targets 
and zero reference levels in diff erent ICUs.
Methods Neuro-ICU physicians were invited to participate in a survey 
on ICP and CPP targets and the level of measurement.
Results The results of 30 centers are summarized in Table 1. Most centers 
(83.3%) use head-up elevation of 30 to 45° and consider an ICP of 
20 mmHg as the threshold to start treating ICP (80%). More variation is 
noted in minimal and maximal CPP threshold. All centers measure ICP 
at the ear canal. Twenty-seven centers (90%) measure MAP at the heart, 
three centers measure MAP at the ear canal. These three centers use >50, 
60 and 65 mmHg as minimal CPP and raise the bed to 30 to 45°. The two 
centers using minimal CPP >60 mmHg do not apply an upper limit.
Conclusion Considering the infl uence of position on CPP, the variations 
among centers and the narrow range of CPP thresholds, future studies 
and guidelines should describe where MAP is measured. Alternatively, 
we propose a new formula for CPP: true CPP = MAP(heart) – ICP(ear) – 
height diff erence (heart to ear canal (cm)) × 0.73.
Figure 1 (abstract P443). Figure 1 (abstract P444).
Table 1 (abstract P444)
ICP threshold (mmHg); n (%) >15; 2 (6.7%) >18; 1 (3.3%) >20; 24 (80%) >25; 3 (10%)
Minimal CPP (mmHg); n (%) >50; 6 (20%) >55; 4 (13.3%) >60; 16 (53.3%) >65 to 70; 4 (13.3%)
Maximal CPP (mmHg); n (%) <70 to 75; 8 (26.7%) <80; 8 (26.7%) <85; 2 (6.7%) No limit; 12 (40%)
Table 1 (abstract P443). Evolution in time of markers of endothelial 
dysfunction after acute brain injury
 Healthy volunteers
 (n = 15) D0 D6 D12
EPC/105 PBMC 24.1 ± 6.3 11.9 ± 2.2 11.0 ± 1.8 12.6 ± 2.3
%CD31+ of T cells 43.1 ± 2.6 42.4 ± 2.4 40.1 ± 3.0 43.4 ± 2.8
RHI (n = 12) 2.41 ± 0.14  1.68 ± 0.12 2.14 ± 0.15 2.46 ± 0.21
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Introduction The gold standard technique for imaging cerebral blood 
fl ow (CBF) and metabolism is 15oxygen positron emission tomography 
(15O PET). Continuous near-infrared spectroscopy (NIRS) has been used 
to assess adequacy of cerebral oxygenation following stroke, traumatic 
brain injury and subarachnoid haemorrhage [1], and measurements 
have been compared with jugular oxygen saturation. In this study we 
compared NIRS with 15O PET within healthy volunteers.
Methods Fifteen healthy subjects were recruited (12 male, average age 
38 years); PET precluded females of reproductive age. Steady-state 15O 
PET with arterial sampling was performed to measure CBF, cerebral 
metabolic rate of oxygen (CMRO2), oxygen extraction ratio (OEF) and 
cerebral blood volume (CBV) [2]. Simultaneously, NIRS data were 
collected using a Hamamatsu NIRO 200 with sensors on either side of 
the forehead. NIRS OEF was calculated from tissue oxygen saturation, 
SaO2 and an assumed arterial/venous blood volume ratio of 30/70 [3].
Results The frontal region 15O PET CBF, CMRO2, OEF and CBV were mean 
(SD) 44.9 (10) ml/100 ml/minute, 158.7 (24.7) μmol/100 ml/minute, 45.8 
(7.3)%, and 2.8 (0.8)  ml respectively, and there was no relationship 
between NIRS and 15O PET (Figure 1).
Conclusion We found no relationship between NIRS and baseline 
physiology as determined by 15O PET. Further studies should assess 
the dynamic response of NIRS to a measured change in physiology in 
patients. Further confi nes of NIRS include its limited and focal brain 
coverage.
References
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Introduction The purpose of this study is to assess the rate of 
confi rmed infections, antibiotic exposure, and monitoring practices 
with normothermia protocol utilization for traumatic brain injury 
patients. Treatment and prevention of fever is a focus of therapy for 
patients with severe neurological injury as fever has been identifi ed as 
an independent risk factor for morbidity and mortality [1].
Methods The retrospective chart review analyzed outcomes of 
maintaining normothermia at 36.5°C versus a similar population 
without temperature control as a standard of care in patients admitted 
with traumatic brain injuries defi ned as a Glasgow Coma Score <8 
upon admission. Patients included were 18 to 59  years of age and 
were mechanically ventilated with intracranial pressure monitoring for 
greater than 72 hours. The primary outcome evaluated was the number 
of patients treated for confi rmed infections. Secondary outcomes 
included the antibiotic length of therapy (LOT), antibiotic days of 
therapy (DOT), number of cultures, and ICU and hospital length of stay 
(LOS). DOT was defi ned as the sum of days on which each antibacterial 
drug was administered.
Results A total of 23 patients treated with normothermia and 119 
patients in the control group were evaluated between January 2009 
and September 2014. The number of patients treated for confi rmed 
infections was similar between groups (normothermia: 73.9%, control: 
80%, P  = 0.803). Empiric antibiotic therapy was more commonly 
utilized in the normothermia group at 34% versus 20.5% (P = 0.173). 
Antibiotic LOT and DOT were 13.8 versus 10.8 days (P = 0.157) and 18.3 
versus 16.2 days (P = 0.575) in the normothermia versus control groups, 
respectively. Total culture rate was lower in the normothermia group 
with 13.2 versus 8.78 (P = 0.0002) cultures per patient. No signifi cant 
diff erence in hospital LOS (normothermia: 23 days, control: 18 days, P = 
0.158) or ICU LOS (normothermia: 17 days, control: 15 days, P = 0.185) 
was demonstrated.
Conclusion Rates of confi rmed infections and number of antibiotic 
days were similar between the normothermia and control groups, 
suggesting that normothermia does not increase infection risk. 
However, the number of cultures obtained in the control group was 
signifi cantly greater than the normothermia group with a trend toward 
increased empiric antibiotic use.
Reference
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Introduction Osmotherapy with mannitol (Man) or hypertonic saline 
(HTS) is currently used to treat elevated intracranial pressure after 
severe acute brain injury (sABI); however, their eff ect on cerebral 
oxygenation and metabolism has not been extensively evaluated.
Methods A retrospective analysis of a cohort of patients with sABI 
after traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) 
monitored with cerebral microdialysis (CMD), brain oxygen (PbtO2) and 
ICP, who were treated with Man (20%, 0.5 g/kg) or HTS (7.5%, 100 ml) 
for ICP >25  mmHg. Osmotherapy was administered over 20  minutes 
and each patient’s individual response to intervention was analyzed 
up to 120 minutes following infusion. Only episodes where no other 
hypertonic solute was administered within 2  hours before or after 
treatment were selected. Variables analyzed included CMD lactate, 
pyruvate, glucose, glutamate, lactate/pyruvate ratio, and main brain 
physiologic variables ICP, PbtO2, CPP. Analysis was conducted using 
mixed-eff ects multilevel regression.
Results Sixty-four treatments (32 HTS, 32 Man) were studied among 
26 patients (19 TBI, seven SAH; age 42  ± 17  years, time from injury 
to treatment 2.6  ± 1.9  days). Man and HTS eff ectively decreased ICP 
(coeffi  cient = –2.5 mmHg, 95% CI = –3.2 to –1.8 mmHg and –2.9 (–3.8 
to –2.0) respectively; both P  < 0.0001). No signifi cant diff erence was 
found in CMD lactate, pyruvate, glucose and PbtO2 after HTS or Man 
treatment. CMD glutamate decreased signifi cantly after Man (–0.73 
( –1.41 to –0.052); P <0.05), but not after HTS.
Conclusion Osmotherapy with Man and HTS treatment had no eff ect 
on cerebral oxygenation and metabolism. Man, but not HTS, favorably 
reduced brain glutamate. These fi ndings support further investigation 
to test the value of alternative osmotic agents (such as hypertonic 
lactate) that may reduce ICP and at the same time improve cerebral 
metabolism after sABI.
Acknowledgements Supported by grants from the Swiss National 
Science Foundation and the Novartis Foundation for Biomedical 
Research.
Figure 1 (abstract P445). Linear correlation between NIRS and PET OEF.
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Introduction In patients with acute brain injury (ABI), increased 
cerebral energy demand is frequent, potentially leading to cerebral 
glucose depletion (GD) and poor outcome. In this setting, lactate may 
act as supplemental fuel. We examined dynamics of cerebral lactate 
supply during prolonged GD in ABI.
Methods We retrospectively analyzed severe ABI (18 TBI, eight SAH) 
monitored with brain oxygen and cerebral microdialysis (CMD) 
to measure hourly levels of cerebral extracellular glucose, lactate, 
pyruvate and lactate/pyruvate ratio (LPR). Variations of CMD variables 
were analyzed as a function of GD (defi ned as spontaneous decreases 
of CMD glucose from normal to low (<1.0 mM), at least 2 hours) and 
increased cerebral energy demand (LPR >25).
Results During GD (60 episodes; 26 patients), we found an increase 
of CMD lactate (4 ± 2.3 vs. 5.4 ± 2.9 mM) and LPR (27 ± 6 vs. 35 ± 9; 
all P <0.005) while brain oxygen and blood lactate remained normal. 
Dynamics of lactate and glucose supply were studied by analyzing 
the relationship between blood and CMD samples. No correlation 
between blood and brain lactate was found when brain glucose and 
LPR were normal (r = –0.12, P = 0.48; Figure 1), while this correlation 
became linear during GD, progressively rising to r  = 0.53 (P  <0.0001) 
when energy demand increased, suggesting increased cerebral lactate 
availability. The correlation between blood and brain glucose changed 
in the opposite direction, decreasing from r = 0.78 to 0.37 (P <0.0001) 
during GD and at LPR >25.
Conclusion Energy dysfunction is associated with increased supply 
of nonhypoxic cerebral lactate. Our data suggest lactate may act as 
alternative substrate after ABI when availability of cerebral glucose is 
reduced.
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measured by transcranial Doppler in children with severe trauma 
brain injury
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Introduction This study was designed to see whether there is a 
correlation between the transcranial Doppler (TCD) parameters and 
the CCP and intracranial pressure (ICP) monitoring during the cerebral 
hemodynamic changes and to evaluate ICP indirectly by TCD.
Methods A prospective and descriptive study conducted in our PICU 
from June 2011 to December 2013. We investigated 51 children with 
severe trauma brain injury (TBI). The TCD measurements were routinely 
performed bilaterally on the middle cerebral artery parallel to the 
ICP registration. The ICP and CPP data were correlated to PI and the 
correlation coeffi  cient calculated. To control the linear correlation, the 
residuals were tested for normal distribution around the regression 
line.
Results ICP registrations were made parallel with all TCD measurements 
in 51 patients. Intraparenchymal ICP monitoring was inserted within 
the fi rst 3 hours after trauma and there was no complication (infections, 
intracranial hemorrhage, or technical failure) related to invasive ICP 
monitoring. Increased ICP was noted upon transducer insertion in 38 
children with male prevalence (10 girls, 28 boys). Median GCS was 6, 
indicating the magnitude of injury in this group of patients. The overall 
results of the 38 patients showed a strong correlation between the 
ICP and PI and during outbursts of ICP with a correlation coeffi  cient 
of r = 0.89 (ICP >20 mmHg) and r = 0.90 (ICP <20 mmHg). The relation 
between ICP and PI was estimated by the linear regression equation: 
ICP = 22,299 × PI – 10,705 (ICP >20 mmHg) and ICP = 38,592 × PI – 16,972 
(ICP <20 mmHg). The CPP and PI were correlated signifi cantly during 
the changes in intracranial pressure. However, a better correlation was 
found when ICP >20  mmHg and PPC <50  mmHg (PI was 2.4  ± 0.89 
when CPP was 35.96 ± 4.48 with a correlation coeffi  cient of Pearson r = 
0.80) than when ICP <20 mmHg and CPP >50 mmHg (PI was 0.78 ± 0.14 
when CPP was 57.11  ± 9.62 with a correlation coeffi  cient of Pearson 
r =0.76).
Conclusion The absolute value of the PI is a reliable noninvasive 
indicator of ICP in pediatric severe TBI. A strong correlation between 
PI and ICP was demonstrated. Therefore, PI may be of guiding value in 
the invasive ICP placement decision in the neurointensive care patient 
when ICP monitoring is not systematically performed. In particular, ICP 
monitoring remains as grade C in the latest guidelines of management 
of STBI in children published in 2012.
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Introduction The aim was to evaluate the accuracy of bispectral index 
(BIS) monitoring for the diagnosis of brain death in severely comatose 
patients. We aimed to determine the utility of the BIS as a tool for 
clinical evaluation of the moment of brain death.
Methods A prospective observational study with waiver of consent 
was conducted in the trauma ICU for 2  years from October 2012 to 
September 2014. Monitoring of BIS occurred during patient stay in 
the ICU. Population: 62 severely comatose patients (Glasgow Coma 
Score less than 6) admitted to the ICU mainly because of intracerebral 
hemorrhage, head injury, or postanoxic coma. BIS was recorded 
continuously during the hospitalization in the ICU. Where necessary, 
clinical brain death was confi rmed by EEG or brain stem test.
Results Twenty-nine patients were already clinically brain dead at the 
time of admission, and their individual BIS values were 0. Twenty-four 
patients were not clinically brain dead at the time of admission, and their 
individual BIS values were between 20 and 30. These patients became 
brain dead, and their individual BIS values dropped to 0 in a few hours to 
a few days. Seventeen patients who did not become brain dead during 
their hospitalization in the ICU had persistent electrocerebral activity on 
EEG, and their average BIS values remained above 31.
Conclusion The BIS is a noninvasive, simple, and easy to interpret 
method, showing a perfect correlation with the other diagnostic 
methods. BIS can be used in severely comatose patients as an 
assessment of brain death.
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Figure 1 (abstract P448). Correlations between blood and brain lactate.
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Introduction Measurement of intracranial pressure (ICP) and arterial 
blood pressure is used to derive cerebral perfusion pressure (CPP) 
and to guide targeted therapy of severe traumatic brain injury (TBI) 
necessitating ICU admission. In this review we discuss the evidence 
for ICP monitoring, CPP calculation, and ICP/CPP-guided therapy after 
severe TBI. Despite its widespread use, there is currently no class I 
evidence that ICP/CPP-guided therapy improves outcomes. Similarly, 
no class I evidence can currently advise the ideal CPP.
Methods A review of current literature with special focus on 
autoregulation (PRx)-guided CPP treatment in TBI patients.
Results Optimal CPP is probably patient, time, and pathology specifi c 
and related to cerebral autoregulation status. The fact that optimal 
CPP and autoregulation status varies between individual patients and 
over time makes it an attractive bedside tool to serve as a (simplifi ed) 
model to investigate the use of autoregulation (PRx) status to fi ne 
tune or feedback clinical treatments in individual sedated TBI patients 
(optimal CPP concept) [1]. Evidence is emerging for the role of other 
monitors (representing (local) metabolism, oxygen supply/use, 
perfusion, neuronal functioning) that enable the intensivist to employ 
an individualized multimodality monitoring approach in TBI [2].
Conclusion The management of TBI is likely to become increasingly 
based on a more comprehensive monitoring and management 
approach rather than relying on absolute numbers of ICP and CPP 
in isolation. This will allow individual optimization of perfusion 
and therefore of oxygen and energy substrate delivery. We await 
further robust, high-quality evidence to support the benefi ts of 
using more sophisticated monitoring tools like the autoregulation-
guided CPP concept during the ICU management of TBI. For the near 
future, more important is a greater understanding of the underlying 
pathophysiology.
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Introduction In the present experimental study we explore whether 
cerebral venous lactate/pyruvate ratio (LP ratio) measured by intra-
vascular microdialysis during induced hemorrhagic shock may be used 
as a surrogate marker for compromised cerebral oxidative metabolism.
Methods Six female pigs were anesthetized and vital parameters was 
recorded. Microdialysis catheters were placed in cerebral hemisphere 
parenchyma, the superior sagittal sinus and femoral artery. Brain tissue 
oxygenation (PbtO2) and intracranial pressure (ICP) was recorded. 
Hemorrhagic shock was achieved by bleeding the animals to a mean 
arterial pressure (MAP) of approximately 35 mmHg. Animals were kept at a 
MAP of about 30 to 40 mmHg for 90 minutes. The animals were resuscitated 
with reinfusion of shed blood followed by 3 hours of observation.
Results In the cerebral hemisphere, hemorrhagic shock caused a 
marked increase in the LP ratio, while a signifi cant but minor increase 
was observed in the sagittal sinus. The LP ratio increased and continued 
doing so to a very high level. In the femoral artery, the shock period was 
associated with a slight increase of the LP ratio. The increase in the LP 
ratio in the sagittal sinus was markedly and signifi cantly higher than in 
the arterial blood. Further, the dynamic changes in the LP ratio in the 
sagittal sinus followed that of the parenchyma, not the arterial blood. 
After infusion of blood ICP increased, cerebral perfusion pressure and 
PbtO2 decreased and the microdialysis showed continuous signs of 
ischemia and cellular degradation.
Conclusion This experimental study documents that during protracted 
pronounced hemorrhagic shock, cerebral energy metabolism was 
severely compromised and exhibited a biochemical pattern typical 
of ischemia and cellular degradation. After retransfusion this pattern 
continued. From intravenous microdialysis in the sagittal sinus, it is 
possible to achieve semiquantitative information of the intracerebral 
redox state. Accordingly, it might be possible to monitor the global 
cerebral energy state continuously with a strictly extracerebral 
technique. This technique might be valuable in various severe 
conditions during critical care when cerebral energy metabolism may 
be compromised; for example, resuscitation after cardiac standstill, 
open heart surgery, multitrauma and so forth. Interestingly the study 
also showed that after reinfusion of blood other parts of the body 
recovered, evaluated by microdialysis, but the brain showed signs of 
damage, making the brain the limiting organ in hemorrhagic shock.
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Introduction Improvement of recovery is a challenging process in cases 
with varying degrees of severe brain injury (BI) requiring intensive care. 
Amantadine sulfate (AS) is recommended for use in cases with brain 
injury. The Coma Remission Scale (JFK-CRS) consists of auditory–visual–
motor–mouth–tongue functions, communication and awareness 
scales; provides a score between 0 and 23; and shows numeric recovery 
from coma. The aim of this study was to evaluate outcomes and eff ects 
of AS used for neurorecovery on the Glasgow Coma Scale (GCS) and 
JFK-CRS in our ICUs during the last 5 months.
Methods After approval of the Ethics Committee, we recruited 12 
patients with brain injury resulted from trauma or hemorrhage who 
had initial GCS of ≤9 and received AS (500 mg, twice daily over 10 days) 
during the recovery period. In all subjects, age, gender, diagnosis, initial 
APACHE II score, time of initiation of AS therapy, JFK-CRS and GCS scores, 
aspartate aminotransferase, alanine aminotransferase, BUN, creatinine, 
platelet count, electrocardiography fi ndings, electrolyte values and 
arterial blood gas values on days 1, 6, 10 and 14 were recorded.
Results The patients’ diagnoses included two post-CPR, fi ve intracranial 
and one subdural hematoma, one CVA, one postoperative aneurysm, 
one subarachnoid hemorrhage and one brain contusion. Table  1 
(overleaf) presents the fi ndings. The AS therapy was initiated between 
days 3 and 33 of admission in all patients other than Patients 2 and 8. A 
dramatic improvement was observed in a patient with both GCS and JFK-
CRS score of 5 when AS therapy was initiated in month 5 and the patient 
was discharged for home care. In Patient 9, AS therapy was withdrawn 
on day 5 due to persistent thrombocytopenia (TP) despite exclusion 
of other reasons; subsequently, improvement was observed in TP. The 
complications were relatively less severe with average acceptability.
Conclusion We suggest that an AS dose of 1,000 mg/day (over 10 days) 
seems to improve neurorecovery in BI patients with good tolerability. 
Prospective controlled studies with large, homogeneous BI populations 
will better defi ne the role of AS for recovery and complications.
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Introduction Traumatic brain injury (TBI) prognostication is a 
developing fi eld striving to identify indicators, notably neurochemical 
Critical Care 2015, Volume 19 Suppl 1 
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biomarkers, of long-term outcomes. Among these, ubiquitin carboxy-
terminal hydrolase L1 (UCH-L1) is currently being investigated to defi ne 
its potential prognostic value. The objective of this systematic review 
is to determine the ability of UCH-L1 to predict prognosis following a 
moderate or severe TBI.
Methods The MEDLINE, Embase, The Cochrane Library and BIOSIS 
electronic databases, conference abstracts and existing narrative 
reviews were searched from their inception to July 2013. Cohort studies 
including patients with moderate or severe TBI having evaluated the 
prognostic value of UCHL-1 according to mortality or the Glasgow 
Outcome Scale (GOS) were considered. Data concerning patients, 
outcomes, study methods, and laboratory methods were abstracted. 
Pooled results were planned to be presented using mean diff erences 
and analyzed using random eff ect models, as well as sensitivity 
analyses to explain potential heterogeneity.
Results Our search strategy yielded 2,257 articles, of which fi ve studies 
corresponded to our inclusion criteria (n  = 730). All studies were 
performed by the same group of researchers. Five studies reported 
mortality (n  = 515), two studies reported GOS (n  = 58). Results from 
all included studies observed that UCHL-1 was a signifi cant predictor 
of mortality. However, only two studies represented a unique study 
population, thus precluding a meta-analysis.
Conclusion In this systematic review, we observed that all published 
studies on UCHL-1 were conducted by the same group of investigators 
and presented results from an intersecting cohort of patients. Due 
to the paucity of data, we could not perform a pooled analysis and 
conclude on the association of this biomarker with long-term prognosis. 
Assays using UCHL-1 were only recently developed and further studies 
done by diff erent research teams will be needed to determine the 
reproducibility and validity of UCH-L1 as a potential prognostic tool.
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Introduction Central nervous system (CNS) injury, such as stroke, is 
known to increase susceptibility to infections that adversely aff ect 
clinical outcome. This impaired immune response to infection is 
termed CNS injury-induced immune defi ciency syndrome (CIDS). 
Activation of the cannabinoid 2 receptor (CB2R) suppresses immune 
function suggesting that antagonism of this receptor may overcome 
CIDS. The main purpose of this study was to determine the impact of 
CB2R inhibition on leukocyte activation within the microcirculation 
following endotoxin challenge in an experimental stroke model.
Methods This was a prospective, randomized animal study. Five 
experimental groups (male C57BL/6 mice, age: 6 to 8  weeks) were 
subjected to the following treatments: control; endotoxemia (LPS 
5 mg/kg, i.v.); transient cerebral hypoxia–ischemia (HI) + endotoxemia; 
HI + endotoxemia + CB2R antagonist (AM630 2.5 mg/kg, i.v.). HI was 
induced by unilateral carotid artery occlusion, followed by 50-minute 
exposure to a low oxygen atmosphere (8% O2). The CB2R antagonist 
was given 15 minutes prior to LPS administration. Intravital microscopy 
was carried out 2  hours after LPS administration. Brains were then 
extracted and stained with tetrazolium chloride to calculate the infarct 
volume. The primary outcome measurement in this study regarding 
the immune response after stroke was the quantifi cation of leukocyte 
adhesion following endotoxin challenge in submucosal venules of the 
gut – an important organ in the development of multiorgan failure in 
endotoxemia and sepsis.
Results Compared with endotoxemic animals without CNS injury, mice 
subjected to HI displayed reduced leukocyte activation in intestinal 
submucosal venules indicative of CIDS. Administration of the CB2R 
antagonist in animals with CIDS challenged with endotoxin restored 
peripheral leukocyte recruitment without a detrimental impact on 
infarct size.
Conclusion CB2R-related modulation of leukocyte activation is 
involved in the impaired immune response following CNS injury. 
Future studies will explore the CB2R pathway in order to develop novel 
therapies to improve the immune response in CIDS.
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Introduction Our purpose was to evaluate the time from shipping of 
the study start-up package to study screening, as well as conditions that 
may impact this process, in the context of a large-scale multifaceted 
and multicenter clinical study in trauma.
Methods We designed a survey questionnaire based on four domains: 
REB characteristics and process, centers’ characteristics, experience 
of the study and clinical teams, and center-specifi c implementation 
approaches. The questionnaire was self-administered to all lead 
research coordinators of the 17 level 1 participating trauma centers in 
Table 1 (abstract P453). Findings of 12 patients receiving amantadine sulfate
    Initiation of  
Patient number Sex/age (years) APACHE II GCS A/B/C AS therapy (day) CRS score D/E/F/G Complications Outcome
1 M/14 24 3/5/7 6 0/4/5/6 H, J Still in ICU
2 F/78 33 8/8/10 84 0/0/0/0 K Ex
3 F/75 35 5/6/4 4 1/1/0/Ex K, L Ex
4 M/24 29 3/3/3 6 0/0/Ex K, L Ex
5 M/27 27 4/4/15 6 1/13/18/22 L, M, J Discharged
6 F/70 45 3/3/3 20 0/0/0/0 – Ex
7 F/72 22 5/5/12 3 4/7/11/17 K, L, I Discharged
8 F/53 27 3/5/10 150 5/7/10/14 K Discharged
9 F/38 34 4/4/4 33 0/0/1/1 H, J Still in ICU
10 M/50 26 4/6/13 8 0/7/18/19 L, J Discharged
11 M/63 24 8/10/12 14 6/8/8/12 – Discharged
12 M/50 31 4/6/11 6 2/5/7/9 L, J Still in ICU
F, female; M, male. GCS, Glasgow Coma Scale: A, at admission to ICU; B, at initiation of AS therapy; C, outcome value. CRS: D, value on day 1; E, value on day 6; F, 
value on day 10; G, value on day 14. Complications observed: H, low platelet; J, ALT increase by twofold; K, BUN increase by twofold; L, AST increase by twofold; M, 
convulsion.
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the ongoing Pan-Canadian TBI-Prognosis Study. Descriptive statistics 
were used.
Results Overall, 33.4  weeks (95% CI  = 24.8 to 42.1) were required 
on average from the start-up package mailing to centers and the 
start of the screening process. Data sharing and fi nancial agreement 
were mainly responsible for this delay with an average of 28.6 weeks 
(95% CI  = 20.4 to 36.7) needed to complete the agreement with the 
coordinating center. REB approval was obtained on average 17.5 weeks 
(95% CI = 13.8 to 21.2) from the shipping of the study package to the 
participating centers. Eighty percent of the REBs had members with 
prior experience in multicenter clinical research, and more than half 
with specifi c clinical expertise in critical care medicine or neurology/
neurosurgery. A standardized electronic REB submission process was 
used in most REBs (60%). All centers had experience in implementing 
multicenter clinical studies. PIs had experience conducting from 
zero to 40 prior clinical studies and from 3 to 24  years of research 
experience with protected research time ranging from 5 to 75%. RCs 
had managed from zero to more than 50 clinical studies. Most centers 
(87%) organized specifi c presentation of the study to the critical care 
medical staff  (93%), while some (60%) presented the study to other 
medical teams. Agreements from other departments such as radiology 
(87% of centers), electrophysiology (80%) and clinical imaging (73%) 
were requested in most centers.
Conclusion The implementation of a large Canadian multicenter 
and multifaceted clinical study in the trauma population involved a 
signifi cant amount of time and energy from both the coordinating and 
the participating sites. The variable experience of participating sites 
and teams, as well as the involvement of diff erent medical disciplines, 
may have had an impact on study implementation time. Delays for 
REB approval but also for data sharing and fi nancial agreement must 
be taken into consideration in the timeline for implementing large 
multicenter clinical studies in trauma.
P457
Optic nerve sheath diameter by bedside ultrasound is a reliable 
screening test for cerebral edema in the comatose ICU patient
A Mohamed, N Alharbi, N Salahuddin, I Hussain, O Solaiman
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
Critical Care 2015, 19(Suppl 1):P457 (doi: 10.1186/cc14537)
Introduction ICU patients may remain comatose after resolution of 
critical illness. Frequently this is due to delayed sedative clearance but 
may also result from increases in intracranial pressure (ICP) and cerebral 
edema. We proposed that measurement of the optic nerve sheath 
diameter (ONSD) is a rapid, bedside screening test that can be used to 
quickly identify patients with cerebral edema and increased ICP.
Methods This was a prospective, observational study carried on 
consecutive patients admitted to a multidisciplinary medical and 
surgical ICU. Stable patients with unexplained coma and scheduled 
for brain imaging were included. Patients with obvious ocular trauma 
or on sedative, narcotic infusions were excluded. ONSD was measured 
using a 7.5 to 10 MHz linear array ultrasound transducer probe placed 
on the closed eye in the transverse axis. The ONSD was measured 
at a predefi ned point 3 mm posterior to the globe. Both eyes were 
measured and the mean value used. The study protocol was approved 
by the Hospital Research Ethics Committee (RAC Prop No. 2141 103). 
Statistical analysis was carried out using SPSS version 20.0.
Results ONSD was measured in 43 patients; mean age was 62  ± 
19.2 years, 48% (n = 20) were female. Admitting diagnosis was sepsis 
in 24% (n = 10), intracranial vascular event in 21% (n = 9), cardiac arrest 
in 12% (n = 5), hepatic encephalopathy in 7% (n = 3), malignancy with 
metastases in 7% (n = 3) and other causes in 28% (n = 12). The ONSD 
measured correlated highly between eyes, Spearman’s ρ  = 0.799, 
P ≤0.001. The area under the ROC curve for detecting cerebral edema 
was 0.812 (95% CI  = 0.667 to 0.957). Using a 0.58  cm cutoff  ONSD 
diameter, the sensitivity was 86%, specifi city 74%, negative predictive 
value 96% and the positive likelihood ratio = 3.3.
Conclusion This study suggests that bedside measurement of ONSD by 
ultrasound performs well as an initial screening test for cerebral edema. 
The identifi ed cutoff  value of 0.58 cm can be used to detect cerebral 
edema with reasonable accuracy.
P458
Levels of N-terminal pro-brain natriuretic peptide in brain injury 
patients
L Tsentsiper, E Kondratyeva, S Kondratyev, N Dryagina
Russian Polenov’s Neurosurgical Institute, Saint-Petersburg, Russia
Critical Care 2015, 19(Suppl 1):P458 (doi: 10.1186/cc14538)
Introduction Currently, the most common way to predict the outcome 
of acute brain damage is to study the level of protein S-100 in the 
serum. This method lacks specifi city as the concentration of protein 
S-100 signifi cantly increases with age, more for men than women, 
and there are no data on prognostically signifi cant changes in the 
level of S-100 after removal of the tumor and cerebral hemorrhages. 
Endothelins, vasopressin, some cytokines, excess sodium or calcium 
in serum, activation of the sympathoadrenal system, and tachycardia 
are the stimulants of brain natriuretic peptide production. The rise 
of the natriuretic peptide level in cases of acute brain damage has a 
functionally adaptive nature, based on vasodilation, diuretic action 
peptide and ability to reduce sympathoadrenal system activity. Thus, 
we can suppose that the more severe the damage, the higher the 
stimulation of natriuretic peptide. In this study we investigate the level 
of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients 
with severe brain damage and fi nd correlation between the level of 
peptide and outcome.
Methods We studied 110 patients having brain injuries of various 
origins. All patients were divided into four groups. All patients were 20 
to 72 years old, 58 men and 52 women. Group 1 (n = 17) – acute TBI, 
group 2 (n = 29) – patients operated on for the brain tumor, group 3 
(n = 36) – hemorrhagic stroke, group 4 (n = 28) – vegetative state. We 
measured the level of brain natriuretic peptide on days 1 to 3, and then 
every 7 days for 21 days.
Results All patients with severe acute brain damage (groups 1, 2, 3) 
had a level of NT-proBNP higher than normal (normal 0 to 125 pg/ml). 
Signifi cant diff erence in values between the groups was not observed. 
Level of NT-proBNP above 700  pg/ml and/or the absence of its 
reduction to normal dynamic indicators was marked by an unfavorable 
outcome of the disease – severe disability (n = 25) or death (n = 18). For 
patients from group 4 regardless of their age, sex, severity of condition 
and treatment results in a level of NT-proBNP below 250 pg/ml.
Conclusion In cases of acute severe brain damage the level of NT-
proBNP signifi cantly increased. Correlation between the level of 
NT-proBNP and etiology of acute brain damage was not observed. If 
the level of NT-proBNP is above 700  pg/ml and/or in the absence of 
its reduction to normal, then poor outcome of the disease  – severe 
disability or death  – can be predicted. Level of NT-proBNP cannot 
be used as an indicator for the severity of the status for patients in a 
vegetative state in contrast to patients with acute brain damage.
P459
Cerebral oximetry monitoring in pediatric seizure patients in the 
emergency department
T Abramo1, B Schnieder1, E Storm1, N Hobart-Porter1, Z Hu1, N Todd1, 
L Crawley1, M Meredith2, S Godbold1
1University of Arkansas School of Medicine, Little Rock, AR, USA; 2University of 
Tennessee School of Medicine, Memphis, TN, USA
Critical Care 2015, 19(Suppl 1):P459 (doi: 10.1186/cc14539)
Introduction During ictal/post-ictal events, altered cerebral physiology 
occurs: increased neuronal activity causes signifi cant increase in 
cerebral metabolism with changes in ipsilateral cerebral blood fl ow. 
Standard PED seizure monitoring is by O2SAT and ETCO2 which yield 
no direct data about regional cerebral oxygenation/physiology (rSO2). 
Signifi cant abnormal hemispheric cerebral physiology resulting in 
neurological injury can occur without knowing because the current 
monitoring system could not detect the abnormal hemispheric 
abnormality. Cerebral oximetry can provide a rapid, non-invasive 
detection of each hemisphere’s cerebral physiologic changes during 
ictal/post-ictal phases. The aim was to study left and right rSO2 values in 
patients in the pre and post seizure periods and in nonseizing controls.
Methods An observational study of seizing and nonseizing patient’s 
left and right rSO2 readings compared with nonseizure patients.
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Results No diff erence for ictal left and right rSO2 readings across ages. 
See Figure 1.
Conclusion We have demonstrated abnormal hemispheric cerebral 
physiology during focal or generalized ictal activity. In patients with 
generalized seizures, the left and right rSO2 values were signifi cantly 
decreased. In patients with focal seizures, the ipsilateral rSO2 values 
were signifi cantly diff erent from the contralateral rSO2 readings and 
correlated to the hemisphere experiencing the focal seizure. In certain 
patients, during the ictal phase their rSO2 readings rose and stayed 
or rose then dropped. Overall, cerebral oximetry has shown great 
monitoring potential for actively seizing patients in the emergency 
department.
P460
Neurophysiological tests in the neuro ICU
A Marudi1, Y Valzani2, F Valzania1, M Carpentiero1, C Parenti1, S Scacchetti1, 
S Baroni1, E Bertellini1
1Nuovo Ospedale Civile Sant’Agostino Estense, Modena, Italy; 2University of 
Modena and Reggio Emilia, Modena, Italy
Critical Care 2015, 19(Suppl 1):P460 (doi: 10.1186/cc14540)
Introduction Neurophysiological tests (NPTs) are important prog-
nostic and diagnostic tools for patients admitted to the modern 
neuro ICU (NICU) [1]. Electroencephalography (EEG), somasensorial 
evoked potentials (SSEP), auditory brainstem response (ABR) and 
electromyography (EMG) complete clinical examination and radio-
logical fi ndings in patients suff ering from post-traumatic brain injury, 
post-anoxic brain injury, refractory male epiletticus status, and 
neuromuscular illness. We evaluate the spread of NPTs in our NICU.
Methods We collected data from patients admitted to our NICU from 
January 2014 to November 2014. We recorded the admission diagnosis 
and the NPT applied.
Results From January 2014 to November 2014 we performed 521 EEG, 
45 SSEP/ABR and 10 EMG. In post-anoxic and post-traumatic brain-
injured comatose patients we performed EEG, SSEP and ABR 24 to 
48 hours after the admission to predict later prognosis and expected 
neurological defi cit [2]. In the presence of a benign pattern no further 
evaluation was performed; in the presence of a malignant pattern the 
NPTs were repeated every 48 to 72  hours according to the protocol 
of our institute. In post-anoxic comatose patients we recorded EEG 
during hypothermia to assure burst suppression. In post-traumatic 
brain-injured patients with a persistent comatose state we use EEG to 
detect nonconvulsive states which potentially can increase secondary 
brain injury if untreated. In malignant epilepticus status we use EEG 
to monitor the eff ect of therapy and to modify it. In patients who 
present profound weakness of legs and hands we performed EMG to 
distinguish primary peripheral myopolyneuropathy (Guillian Barrè, 
miastenia gravis) from secondary illness acquired in the ICU (critical 
polyneuropathy, critical myopathy) [3].
Conclusion NPT can improve management of patients admitted to the 
neuro ICU. The data provided can modify therapeutic strategies and 
improve outcome in these settings of patients.
References
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Goal-directed cerebral hemodynamic strategy decreases the 
incidence of postoperative delirium in patients with intracranial 
hypertension in major abdominal surgery
I Zabolotskikh, N Trembach
Kuban State Medical University, Krasnodar, Russia
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Introduction Increased intracranial pressure (ICP) adversely aff ects 
anesthesia due to a disturbed cerebral blood fl ow. In older patients 
this disturbance may increase the incidence of postoperative delirium 
(POD) and may lead to a poor outcome [1]. The standard hemodynamic 
protocol involves maintaining the mean arterial blood pressure (MAP), 
but in patients with intracranial hypertension it may not be enough to 
maintain adequate cerebral perfusion. The purpose of this study was 
to evaluate the protocol of maintaining cerebral perfusion pressure 
(CPP) in the prevention of postoperative delirium in older patients in 
abdominal surgery.
Methods A total of 132 ASA 3 patients, undergoing major abdominal 
surgery (duration 5.2 (4.3 to 6.5) hours) with ICP >12 mmHg evaluated 
by a venous ophthalmodynamometry [2], were included in our research. 
Patients were randomized into two groups: MAP group, in which MAP 
Figure 1 (abstract P459).
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was maintained above 70 mmHg or within 20% from baseline (n = 78); 
or CPP group, in which CPP was maintained above 60 mmHg or within 
20% from baseline (n = 54). ICP, MAP and CPP were assessed every hour 
of anesthesia. Time of recovery of consciousness, incidence of POD and 
length of stay in the ICU and in the hospital were also evaluated.
Results Initial ICP was 14 ± 3 mmHg in the MAP group and 15 ± 2 mmHg 
in the CPP group. During the anesthesia it was stable without any 
signifi cant change. Decreasing of MAP after induction of anesthesia 
was similar in two groups and it was stable during the anesthesia. The 
frequency of use of vasopressors and infusion rate was higher in the 
CPP group. Time of recovery of consciousness in the MAP group was 
higher (28 ± 7 minutes vs. 18 ± 5 minutes (P <0.05)). The incidence of 
postoperative delirium was higher in the MAP group (18% vs. 11% in 
the CPP group (P <0.05)). There were no signifi cant diff erences between 
two groups in other complications. Total length of stay in the ICU and in 
the hospital was higher in the MAP group (6 ± 2 days vs. 4 ± 2 (P <0.05) 
and 15 ± 3 days vs. 12 ± 2 in the N group (P <0.05)).
Conclusion A goal-directed hemodynamic protocol of maintaining CPP 
can decrease the incidence of POD in older patients with intracranial 
hypertension after major abdominal surgery compared with a protocol 
of maintaining MAP.
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Hydroquinone shows neuroprotective potential in an experimental 
ischemic stroke model via attenuation of blood–brain barrier 
disruption
JH Cho, CW Park, TG Ohk, MC Shin, MH Won
Kangwon National Univeristy, Chuncheon-si, Gangwondo, South Korea
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Introduction Hydroquinone (HQ), a major benzene metabolite, 
occurs naturally in various plants and food, and is also manufactured 
for commercial use. Although many studies have demonstrated the 
various biological eff ects of HQ, the neuroprotective eff ects of HQ 
following ischemic stroke have not been investigated. Therefore, in 
this study, we fi rst examined the neuroprotective eff ects of HQ against 
ischemic damage in a focal cerebral ischemia rat model.
Methods It was proven that pre and post treatment with 100  mg/
kg HQ protects from ischemia-induced cerebral damage, which was 
confi rmed by evaluation of neurological defi cit, positron-emission 
tomography and 2,3,5-triphenyltetrazoliumchloride staining.
Results In addition, pre and post treatment with 100  mg/kg HQ 
signifi cantly attenuated ischemia-induced Evans blue dye extra-
vasation, and signifi cantly increased the immunoreactivities and 
protein levels of SMI-71 and glucose transporter-1 (GLUT-1), which 
were well known as useful makers of endothelial cells, in ischemic 
cortex compared with a vehicle-treated group.
Conclusion Briefl y, these results indicate that pre and post treatment 
with HQ can protect from ischemic damage induced by transient 
focal cerebral ischemia, and the neuroprotective eff ects of HQ may be 
closely associated with the prevention of BBB disruption via increase of 
SMI-71 and GLUT-1 expressions.
P463
Impact of hyperthermia before and during ischemia reperfusion on 
neuronal damage and gliosis in the gerbil hippocampus induced by 
transient cerebral ischemia
CW Park, JH Cho, TG Ohk, MC Shin, MH Won
Kangwon National Univeristy, Chuncheon-si, Gangwondo, South Korea
Critical Care 2015, 19(Suppl 1):P463 (doi: 10.1186/cc14543)
Introduction Hyperthermia can exacerbate the brain damage pro-
duced by ischemia. In the present study, we investigated eff ects of 
hyperthermia before and during ischemia–reperfusion on neuronal 
damage and glial changes in the gerbil hippocampus following 
transient cerebral ischemia using cresyl violet staining, NeuN 
immunohistochemistry and Fluoro-Jade B histofl uorescence staining.
Methods The animals were randomly assigned to four groups: sham-
operated animals with normothermia (normothermia + sham group); 
ischemia-operated animals with normothermia (normothermia  + 
ischemia group); sham-operated animals with hyperthermia 
(hyperthermia  + sham group); and ischemia-operated animals with 
hyperthermia (hyperthermia  + ischemia group). Hyperthermia 
(39.5  ± 0.2°C) was induced by exposing the gerbils to a heating pad 
connected to a rectal thermistor for 30  minutes before and during 
ischemia–reperfusion.
Results In the normothermia + ischemia group, a signifi cant delayed 
neuronal death was observed in the stratum pyramidale (SP) of the 
hippocampal CA1 region (CA1) 5  days after ischemia–reperfusion. 
In the hyperthermia  + ischemia group, neuronal death in the SP of 
the CA1 occurred at 1  day post ischemia, and neuronal death was 
observed in the SP of the CA2/3 region at 2  days post ischemia. In 
addition, we examined activation of astrocytes and microglia using 
immunohistochemistry for anti-glial fi brillary acidic protein (GFAP) and 
anti-ionized calcium-binding adapter molecule 1 (Iba-1). GFAP-positive 
astrocytes and Iba-1-positive microglia in the ischemic hippocampus 
were activated much earlier and much more accelerated in the 
hyperthermia  + ischemia group than those in the normothermia  + 
ischemia group.
Conclusion Based on our fi ndings, we suggest that experimentally 
hyperthermic precondition before cerebral ischemic insult produces 
more extensive neuronal damage and glial activation in the ischemic 
hippocampus.
P464
Eff ects of long-term exercise on memory recovery in the aged gerbil 
hippocampus after transient cerebral ischemia
CW Park, JH Cho, TG Ohk, MC Shin, MH Won
Kangwon National Univeristy, Chuncheon-si, Gangwondo, South Korea
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Introduction Therapeutic exercise is an integral component of 
rehabilitation for patients with stroke. Despite the high prevalence 
of cerebral ischemia in the older population, the mechanisms linking 
restorative exercise to memory recovery from ischemic stroke have 
not been completely understood in aged animals. In this study, we 
investigated eff ects of long-term exercise on neuronal death and 
memory recovery in the aged gerbil hippocampus after transient 
cerebral ischemia. We also investigated changes in gliosis, ischemia-
induced myelin repair, microvessels, neurogenesis, and growth factor 
immunoreactivity in the hippocampus to study possible mechanisms 
of restorative exercise in memory recovery.
Methods The gerbils were divided into four groups (n  = 12 in each 
group): the sham-operated group (Sham), 4-week sedentary group 
following ischemia (SD4), 1-week treadmill group following ischemia 
(TR1) and 4-week treadmill group following ischemia (TR4). Treadmill 
exercise was stared at 5 days after ischemia/reperfusion (I/R) and lasted 
for 1 or 4 weeks, and the animals were sacrifi ced 31 days after ischemia.
Results In this study, 4 weeks of treadmill exercise facilitated memory 
recovery despite neuronal damage in the CA1 region after I/R. On the 
other hand, the long-term treadmill exercise alleviated the increased 
gliosis in the CA1 region, and increased the myelin repairing and 
microvessels in the CA1 region and DG, and enhanced the ischemia-
induced cell proliferation, neuroblast diff erentiation, neuronal 
maturation of the newly generated cells, and BDNF expression in the 
ischemic DG of the aged gerbil.
Conclusion These results suggest that, in the aged gerbil, long-term 
treadmill exercise after ischemic stroke could restore the impaired 
short-term memory function through the cumulative eff ects of 
multiple neurorestorative processes.
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Introduction Liberal use of oxygen after brain insults remains 
controversial [1,2]. We studied whether high arterial oxygen tension 
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(PaO2) is associated with decreased long-term survival in patients with 
spontaneous intracerebral hemorrhage (ICH) treated in the ICU.
Methods Data on primary admissions for adult patients (>18  years) 
treated for ICH in Finnish ICUs between 2003 and 2012 were collected 
from a nationwide ICU database. Patients were divided into three groups 
according to the PaO2 value associated with the lowest measured PaO2/
FIO2 ratio during the fi rst 24  hours after ICU admission. High arterial 
oxygen tension was defi ned as PaO2 >19.9 kPa; intermediate as PaO2 
13 to 19.9  kPa; and low as PaO2 <13  kPa. The primary outcome was 
6-month mortality.
Results Of the 3,033 patients, 63% (n = 1,923) had low PaO2, 29% (n = 
892) intermediate PaO2, and 7% (n = 218) high PaO2. Forty-nine percent 
of the patients died during the 6-month follow-up. Of these, 75% 
died before discharge from hospital. Univariate analysis showed that 
6-month mortality was higher in the high PaO2 group (61%) compared 
with the intermediate and low PaO2 groups (52% and 46% respectively, 
P  <0.001). Multivariate analysis, however, showed no statistically 
signifi cant correlation between high PaO2 and mortality (with the low 
PaO2 group as the reference category, odds ratio for death (OR) for 
high PaO2 = 1.10, 95% confi dence interval (CI) = 0.76 to 1.58 and for 
intermediate PaO2 = 0.96, 95% CI = 0.78 to 1.17).
Conclusion High PaO2 is not predictive of 6-month mortality in patients 
treated for spontaneous ICH in the ICU. Therefore, targeting higher 
PaO2 values appears to be a safe approach in order to avoid hypoxemia.
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aneurysmal subarachnoid hemorrhage
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Introduction In critically ill patients, blood lactate on admission 
is associated with outcome, but in patients with aneurysmal sub-
arachnoid hemorrhage (SAH) this has not been investigated. We 
studied the association of early circulating lactate and glucose with 
unfavorable disease course. The prognostic role of both lactate and 
glucose was studied, hypothesizing that both may be increased due to 
sympathetic activation after SAH [1].
Methods In this retrospective cohort study we included consecutive 
patients with aneurysmal SAH admitted to the ICUs of two university 
hospitals in the Netherlands between November 2006 and December 
2011. Exclusion criteria were: nonaneurysmal SAH, ICU admission 
>24 hours after ictus, death ≤48 hours after admission and no lactate 
measurement <24 hours after admission. Maximum blood lactate and 
glucose levels within the fi rst 24 hours after SAH were used for analyses. 
The outcomes were DCI, defi ned as a new hypodensity on brain CT due 
to DCI, and poor outcome, defi ned as a modifi ed Rankin Scale of 4, 
5 or death 3 to 6 months after the ictus. We performed proportional 
hazard analyses to assess the associations of lactate and glucose with 
DCI, and logistic regression was used to assess the associations with 
poor outcome. Multivariable analyses were adjusted for established 
predictors for DCI and poor outcome.
Results Two hundred and eighty-fi ve patients were included in the 
analyses. DCI occurred in 84 patients (29%) and 106 patients (39%) 
had poor outcome. Lactate was independently associated with DCI 
(adjusted HR = 1.16, 95% CI = 1.04 to 1.30) and poor outcome (adjusted 
OR = 1.53, 95% CI = 1.25 to 1.94). Maximum lactate and glucose were 
strongly related (Spearman’s ρ  = 0.55, P  <0.001). In multivariable 
analyses including both lactate and glucose as independent variables, 
only lactate was independently related to poor outcome (OR  = 1.42, 
95% CI = 1.11 to 1.81), and only glucose was independently associated 
with DCI (HR = 1.10, 95% CI = 1.02 to 1.19).
Conclusion Maximum lactate in the acute phase after aneurysmal 
SAH is associated with both DCI-related infarction and poor outcome. 
Once glucose was considered, early lactate remained independently 
associated with poor outcome, while glucose, instead of lactate, was 
associated with DCI. These routinely available laboratory measurements 
may improve identifi cation of patients at risk for complications or poor 
outcome after SAH. Confi rmation of the pathophysiological signifi cance 
of lactate and glucose in prospective research is warranted.
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Prediction of 60-day case fatality after aneurysmal subarachnoid 
hemorrhage: external validation of a prediction model
S Dijkland, B Roozenbeek, P Brouwer, H Lingsma, D Dippel, L Vergouw, 
M Vergouwen, M Van der Jagt
Erasmus MC – University Medical Center, Rotterdam, the Netherlands
Critical Care 2015, 19(Suppl 1):P467 (doi: 10.1186/cc14547)
Introduction Aneurysmal subarachnoid hemorrhage (SAH) is a 
devastating disease with substantial morbidity and mortality. 
Prognostic modeling is an important instrument to identify high-
risk patients in both clinical practice and research settings. Recently, 
a prognostic model to predict 60-day case fatality after aneurysmal 
SAH was developed with data from the International Subarachnoid 
Aneurysm Trial (ISAT) [1]. Our aim was to externally validate this model 
in a retrospective cohort of consecutive SAH patients.
Methods We included consecutive aneurysmal SAH patients admitted 
to one university hospital between October 2007 and October 2011. 
Exclusion criteria were: age <18  years, hospital admission >28  days 
after SAH, nonaneurysmal SAH, explicit objection by the patient to view 
the medical data and missing data on 60-day case fatality. The model’s 
predictors were age, maximum lumen size of the aneurysm, Fisher 
grade and World Federation of Neurological Surgeons (WFNS) grade. 
Two versions of the model were validated: one with WFNS grade scored 
on admission and the other with WFNS grade assessed at the time of 
treatment decision, as a proxy to WFNS grade at randomization used 
in the ISAT. The outcome was 60-day case fatality. Model performance 
was assessed by studying discrimination, expressed by the area under 
the receiver operating characteristic curve (AUC), and calibration.
Results A total of 307 patients were included in the validation cohort. 
The observed 60-day case fatality rate was 30.6%. Discrimination was 
good, and was considerably better for the model with WFNS grade at 
treatment decision (AUC = 0.89) compared with the model with WFNS 
grade on admission (AUC  = 0.82). Calibration was poor, with mean 
predicted probabilities of 17.0% for the model with WFNS grade on 
admission and 17.7% for the model with WFNS grade at the time of 
treatment decision.
Conclusion Our results indicate that the ISAT prediction model is 
generalizable, since the model showed adequate performance in 
an independent, unselected cohort of aneurysmal SAH patients. The 
model discriminated well between patients who died and those who 
survived the fi rst 60  days after SAH. Additionally, use of WFNS grade 
at the time of treatment decision of the ruptured aneurysm improved 
model performance. However, since predicted probabilities were lower 
than observed probabilities, the ISAT prediction model needs to be 
adapted before use in clinical practice.
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Introduction Perihematomal edema (PHE) expansion contributes to 
increased morbidity and mortality after spontaneous intracerebral 
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hemorrhage (ICH). Pathophysiology of PHE is incompletely understood. 
Recently, the role of cortical spreading depolarizations (CSDs) in 
secondary brain injury was established in subarachnoid and traumatic 
brain injury patients. However, the value of CSDs after ICH is not known.
Methods Patients with ICH fulfi lling the inclusion criteria were 
prospectively enrolled in the observational COSBID study (Co-operative 
Study on Brain Injury Depolarisations). g.BSamp (g.tec, Austria) 
connected to PowerLab and LabChart software (Adinstruments) was 
used for electrocorticography (EcoG). Electrocardiogram patches at 
the patient’s shoulder and bed served as groundings, and a surface 
reference electrode was glued on the mastoid. The duration of EcoG 
depressions was defi ned as the time between depression onset and 
start of EcoG recovery in the integral of power calculations (0.5 to 
45  Hz; 60 seconds time constant decay). Brain tissue oxygen tension 
(PbtO2), cerebral blood fl ow (CBF), cerebral metabolism and intracranial 
pressure were monitored in the PHE region. Data are presented as 
median and interquartile range.
Results Eighteen patients with ICH (ICH volume: 54 (33 to 69)  ml) 
were analyzed. Hematoma evacuation was performed in 17 patients, 
one subject underwent craniectomy only. Patients were 60 (55 to 
67) years old and 38% female. Monitoring time per patient was 10 (6 
to 14) days. A total of 129 CSDs with 16 (10 to 29) minutes of EcoG 
depression were observed. Eighty-four percent (n  = 15) of patients 
showed expansion of PHE by 25 (10 to 50) ml within 3 to 6 days after 
bleeding. Neuromonitoring probes were 35 (23 to 58) mm distant from 
the EcoG strip. CSDs occurred in 73% (n  = 11) of patients with PHE 
expansion. The interval between CSDs was 98  minutes (25 to 308). 
CSDs were associated with a signifi cant decrease of PbtO2 (–4 mmHg 
(–3; –7); duration 10 (5 to 23) minutes) in 68% (52/77), CBF changes in 
95% (19/20) and metabolic derangement in 80% (80/100) of CSDs. PHE 
expansion was observed in all patients with spreading convulsions (n = 
2) and patients with repetitive CSDs occurring as clusters (n = 3).
Conclusion CSDs are common in ICH patients and associated with 
perihematomal PbtO2 decreases and metabolic derangement. 
Especially, clusters of CSDs might be associated with detrimental 
metabolic changes of the perihematomal brain tissue.
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Introduction The aim of this study was to identify the association 
between troponin level and the outcome in patients with acute 
ischemic stroke.
Methods We retrospectively investigated 152 patients admitted to 
our reanimation ICU for cerebrovascular accident between 1 January 
2013 and 31 December 2013. Inclusion criteria were as follows: patients 
with acute ischemic stroke, measurement of serum troponin level 
and electrocardiography performed within 24  hours of admission. 
Not included were patients with intracerebral hemorrhage, no brain 
imaging or electrocardiography, previous myocardial infarction, stable 
or unstable angina pectoris before admission, previous coronary 
angioplasty or coronary bypass surgery.
Results Of 152 patients, 51 patients were excluded from the study 
because of the exclusion criteria. The serum troponin level was elevated 
in 81 patients. The patients were divided into two groups; patients in 
group 1 (n = 81) with serum troponin level >0.01, and those in group 2 
(n = 20) with serum troponin level ≤0.01. For 1-month follow-up results 
of patients, death had occurred in 50.6% (n = 41) of patients in group 
1 and in 25% (n  = 5) of patients in group 2. There was a signifi cant 
positive correlation between the increase in troponin level and death 
within 1  month (r  = 0.205; P  = 0.040). The best cutoff  point revealed 
by the ROC curve of troponin was 0.291 mg/l; at which the sensitivity 
was 73% and the specifi city was 79% when used for prediction of death 
within 1 month (area = 0.319, CI = 0.214 to 0.423, P = 0.021; Figure 1).
Conclusion These results suggest that increased serum troponin 
level at admission is associated with higher mortality rate. Troponin 
positivity on admission is an independent prognostic predictor in 
acute ischemic stroke.
Reference
1. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the 
prognosis of ischemic stroke: a systematic review. Stroke. 2009;40:e380-9.
P470
Increased risk of ischemic stroke in patients with burn injury: 
a nationwide cohort study in Taiwan
TY Hung1, YC Su2
1Zhongxing Branch of Taipei City Hospital, Taipei, Taiwan; 2Dalin Tzu Chi 
Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan
Critical Care 2015, 19(Suppl 1):P470 (doi: 10.1186/cc14550)
Introduction The results of studies attempting to assess the risks of 
ischemic stroke in patients with burn injury have been confl icting. We 
investigated the risks of ischemic stroke in hospitalized burn injury 
patients in Taiwan to evaluate whether the risk is higher compared with 
the general population.
Methods The data from 1 million National Health Insurance bene fi ciaries 
were utilized. All adult benefi ciaries were followed from 1 January 2005 
until 31  December 2012 to identify those who developed ischemic 
stroke. Meanwhile, each identifi ed patient with burn injury was 
matched with 100 unexposed patients based on the high-dimensional 
propensity score. Cox regression models were applied to compare the 
hazards of ischemic stroke in the matched cohorts.
Figure 1 (abstract P469).
Figure 1 (abstract P470). Patient fl owchart of enrollment.
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Results A total of 743,237 patients were enrolled. After matching, 1,763 
burn injury patients and 176,300 unexposed patients were selected. 
The adjusted hazard ratio of ischemic stroke was signifi cantly increased 
in burn injury patients (1.84; 95% CI, 1.43 to 2.36). Such phenomenon 
remained signifi cantly after 12 months (1.54; 95% CI, 1.11 to 2.13). See 
Figures 1 and 2.
Conclusion The risk of ischemic stroke is higher in patients hospitalized 
with burn injury than in the general population, and the eff ects may be 
extended longer than expected previously.
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Introduction Coronary artery bypass grafting (CABG) surgery usually 
improves myocardial contractility, reducing cardiovascular events. 
However, it is a high-risk procedure associated with signifi cant 
neurological complications, including stroke, delirium and cognitive 
impairment. The pathophysiology of these complications is not very 
well known, and may include low fl ow state after surgery, low cardiac 
output, embolism and reperfusion lesion. The aim of this study 
is to prospectively evaluate the cerebral hemodynamics through 
transcranial color and spectral Doppler sonography in high-risk 
patients undergoing cardiac surgery with a pump.
Methods This was a prospective, single-center study, performed at the 
Heart Institute from University of São Paulo. From May to November 
2014 we included 35 patients in the study, aged older than 18  years 
old, submitted to CABG with a pump, with EuroSCORE higher than 6 or 
left ventricular ejection fraction lower than 40%. Transcranial color and 
spectral Doppler sonography was performed 48 hours before surgery 
(T0), 7 days (T1) and 6 months after surgery (T2). We used a probe of 
2.5 to 2  MHz (Doppler Box DWL/Compumedics, Singen, Germany). 
All recordings were taken with the patient in a supine position. We 
measured the middle cerebral artery mean fl ow velocity and pulsatility 
index. The end-expiratory pressure of CO2 (PETCO2) was measured 
with infrared capnography attached to a face mask. Blood pressure, 
hematocrit and axillary temperature was also recorded.
Results The mean age of patients was 64  years; most patients were 
male (74%). Middle cerebral artery mean fl ow velocity increased 
signifi cantly after cardiac surgery. It was 53.89 ± 17.23 m/second at T0, 
61.48 ± 15.18 m/second at T1 and 59.27 ± 16.12 m/second at T2 (P = 
0.029). The pulsatility index was similar at all time points (0.88 ± 0.25 
at T0, 0.85 ± 0.24 at T1 and 0.91 ± 0.25 at T2, P = 0.146). There was a 
signifi cant diff erence in the levels of hemoglobin (13.19 ± g/dl 1.97 at 
T0 and 9.64 ± 1.48 g/dl at T1, P = 0.002). However, this diff erence was 
not maintained at T2 (12.7 ± 2.02 g/dl at T2, P = 0.252). There were no 
diff erences regarding PETCO2 at the time points.
Conclusion After cardiac surgery with a pump in high-risk patients, 
improvement of cerebral hemodynamic occurs, perhaps due to the 
optimization of cardiovascular function. These fi ndings must be better 
investigated.
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Introduction Infl ammation may be important in the pathogenesis of 
ICU-acquired weakness (ICU-AW) since SIRS, sepsis and multiple organ 
failure are the main risk factors. Local infl ammation has been found in 
muscle and nerve tissue of patients with ICU-AW, but little is known 
about the association with systemic infl ammation. We hypothesized 
that systemic infl ammation is increased in patients who develop ICU-
AW compared with patients who do not develop ICU-AW.
Methods Newly admitted ICU patients ≥48  hours on mechanical 
ventilation were included. Daily plasma samples were collected from 
leftover plasma. Muscle strength was evaluated as soon as patients were 
awake and attentive. ICU-AW was defi ned by a mean Medical Research 
Council score <4. IL-1β, IL-6, IL-8, IL-10, IL-13, TNFα, IFNγ, fractalkine, 
GM-CSF, sICAM-1, sE-selectin and sP-selectin were measured in plasma 
samples of days 0, 2 and 4 using cytometric bead arrays and FACS. 
Diff erences of maximum levels between patients with and without ICU-
AW were calculated using Mann–Whitney U tests. Principal component 
(PC) analysis was used to avoid multicollinearity and to reduce the set 
of mediators into a smaller set of PCs. To investigate whether diff erent 
infl ammatory profi les are associated with development of ICU-AW, we 
used multivariable logistic regression models of selected PCs, corrected 
for a priori selected variables, being age, gender, BMI, sepsis, SOFA 
score, APACHE IV score, immune insuffi  ciency and corticosteroids.
Results Ninety-nine of 204 included patients developed ICU-AW. 
Patients with ICU-AW had higher APACHE IV and SOFA scores, a longer 
duration of mechanical ventilation, longer ICU stay, and died more 
often on the ICU compared with ICU patients without ICU-AW. Maximal 
levels of IL-1β, IL-6, IL-8, IL-10, TNFα, IFNγ, fractalkine and sICAM-1 were 
higher in patients who developed ICU-AW compared with patients 
who did not develop ICU-AW (univariable analysis). PC 1 to 4 derived 
from maximal levels explained >69% of the total variance in the data. 
Multivariable logistic regression models showed that PC 1 (mainly 
loaded by IL-6, IL-8 and IL-10) and PC 4 (mainly loaded by sP-selectin) 
were signifi cantly higher in patients with ICU-AW compared with 
patients without ICU-AW (OR of 1.27 (95% CI = 1.02 to 1.60) and 1.55 
(1.06 to 2.27) respectively).
Conclusion Development of ICU-AW is associated with increased 
systemic infl ammation in the fi rst days after ICU admission.
Acknowledgement This research was supported by the Center for 
Translational Molecular Medicine (MARS).
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Introduction Muscle wasting is a common consequence of long-
term stay in the critical care environment, which may slow down 
the rehabilitation of survivors. Previous ultrasound studies have 
Figure 2 (abstract P470). Burn injury patients have higher adjusted 
hazard ratio of ischemic stroke.
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demonstrated a loss of cross-sectional area of lower limb muscles 
during a 10-day intensive care stay. In this study, we have looked at 
how markers of muscle architecture (muscle thickness, pennation 
angle and fascicle length) change in the lower limb, as well as looking 
at changes in muscle thickness in the upper limb.
Methods Following ethical approval, patients who were intubated and 
ventilated in one of two critical care departments were assented to take 
part in the study by their next of kin. B-mode ultrasound scans of the 
right biceps, vastus lateralis and the medial head of gastrocnemius were 
performed on days 1, 5 and 10. Scans were not performed in patients 
once they were free of sedation. Muscle thickness (MT) was measured 
in all three muscles, with pennation angle (PA) being measured in the 
lower limb muscles. Fascicle length (FL) was derived from PA and MT.
Results Twenty patients were recruited, of which 15 were scanned on 
day 5, and eight were scanned on day 10. In the biceps, there were no 
alterations in MT over 5 or 10 days. MT of the vastus lateralis signifi cantly 
decreased on day 5 (1.77 ± 0.06 mm muscle loss, P = 0.03) and day 10 
(5.58 ± 0.09 mm muscle loss, P = 0.01). There was also a signifi cant loss 
in PA over 5 days (1.48 ± 0.63°, P = 0.01) and 10 days (2.96 ± 0.72°, P = 
0.01). However, FL was unchanged over time. There was a signifi cant 
relationship between size of PA and percentage loss of PA and FL in 
over 5 days. Loss of MT and PA (MT: 3.21 ± 2.08 mm lost, PA: 2.19 ± 1.64°) 
was observed in the medial gastrocnemius over 10 days, but did not 
approach signifi cance. Large fascicles on day 1 were associated with 
greater percentage loss of FL on day 5 (P = 0.012).
Conclusion In the lower limb, we have shown that MT and PA alterations 
occur in the fi rst 10 days. Patients with larger PA and FL appear to lose 
a greater percentage of angle and fascicle length in the fi rst 5 days. In 
contrast, we have demonstrated a sparing eff ect on the muscles of the 
upper limb compared with the lower limb. These fi ndings may have 
implications for rehabilitation and interventions to preserve muscle 
mass.
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Introduction Muscle weakness in long-stay ICU patients contributes 
to 1-year mortality [1]. Whether electrophysiological screening is an 
alternative diagnostic tool also in unconscious/uncooperative patients 
remains unknown. The aims of this study were to determine the 
diagnostic properties of abnormal compound muscle action potential 
(CMAP), sensory nerve action potential (SNAP) and spontaneous 
electrical activity (SEA) for Medical Research Council (MRC)-sum score 
defi ned weakness and their predictive value for 1-year mortality.
Methods Data were prospectively collected during the EPaNIC 
trial (ClinicalTrials.gov NCT00512122) [2] from October 2008 to 
November 2010. From day 8 onwards, nerve conduction studies 
and electromyography were performed weekly in 642 long-stay 
and 88 randomly selected short-stay patients and muscle strength 
was assessed in cooperative patients using the MRC-sum score. The 
electrophysiologist was blinded for the clinical assessments of the 
physiotherapists and vice versa. The two primary outcomes were: 
sensitivity, specifi city, positive and negative predictive values of 
abnormal CMAP, SNAP and SEA for weakness (MRC-sum score <48); 
and the predictive value for 1-year mortality of abnormal fi ndings 
on fi rst electrophysiological screening. This association was assessed 
by univariate and multivariate analyses correcting for weakness and 
other risk factors, including baseline risk factors, comorbidities, illness 
severity and ICU exposures.
Results A total of 730 patients were electrophysiologically screened, 
of which 432 were tested for weakness. On day 8, only normal CMAP 
excluded weakness with a high negative predictive value (80.5%). 
By day 15, abnormal SNAP and the presence of SEA revealed a high 
positive predictive value (91.7% and 80.0%, respectively). On day 
8, only a reduced CMAP was associated with higher 1-year mortality 
(35.6% vs. 15.2%, P <0.001). This association remained signifi cant after 
correction for weakness and other risk factors (OR: 2.463 (95% CI: 
1.113 to 5.452), P = 0.026). Also among conscious/cooperative patients 
without weakness, reduced CMAP was independently associated with 
a higher likelihood of death within 1 year (HR: 2.818 (95% CI: 1.074 to 
7.391), P = 0.035).
Conclusion The diagnostic properties of electrophysiological screening 
vary over time. Abnormal CMAP documented early during critical 
illness carries information about longer-term outcome, which should 
be further investigated mechanistically.
Acknowledgement HVM and GH contributed equally.
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Introduction Many ICU patients develop ICU-acquired muscle weak-
ness (ICU-AW) due to inactivity and critical illness. ICU-AW is associated 
with short-term and long-term physical impairments and impaired 
functional status [1]. The de Morton Mobility Index (DEMMI) was 
developed to measure changes in mobility across clinical settings 
and proved to be reliable, feasible and sensitive to small but clinically 
relevant changes in functioning [2]. Our aim was to evaluate the 
psychometric properties of the DEMMI in ICU patients.
Methods The inter-rater reliability and validity were determined in a 
prospective observational study. Patients were included and assessed 
by two independent raters until hospital discharge. Reliability was 
expressed using the intraclass correlations (ICC). To evaluate the 
validity, the DEMMI scores were compared with the Barthel Index (BI), 
Katz-ADL and manual muscle testing (MMT).
Results A total of 115 ICU patients were included. The average age was 
61 years and 67% of the patients were male. ICU admission diagnoses 
were 53% acute surgery, 14% elective surgery and 33% were admitted 
for medical nonsurgical reasons. Inter-rater reliability of the DEMMI was 
high: intraclass correlation coeffi  cient (ICC) ranging from >0.91 (range 
0.85 to 0.94) at ICU admission, >0.98 (range 0.96 to 0.99) at the MICU 
and >0.97 (range 0.96 to 0.98) at the general ward. Internal consistency 
reliabilities (Cronbach α) of the DEMMI were 0.84, 0.87 and 0.98 at 
the ICU, MICU and hospital ward respectively. Validity coeffi  cients 
(Spearman’s rank correlations) with BI, Katz-ADL and MMT were 0.63, 
–0.45 and 0.62.
Conclusion The DEMMI is a reliable, responsive and feasible measure ment 
instrument for the assessment of mobility in critically ill ICU patients.
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Introduction Delirium in the ICU is a predictor of mortality and 
cognitive impairment at hospital discharge. Although several pathways 
for delirium have been described, it is very diffi  cult to predict the 
occurrence of delirium. In this study, we examined plasma biomarkers 
in delirious and nondelirious patients at admission and whether the 
biomarkers can predict onset of delirium.
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Methods We targeted 103 ICU patients in Okayama University Hospital 
between April 2013 and February 2014. Delirium was diagnosed using 
the Confusion Assessment Method  – ICU. On admission, blood was 
obtained for biomarker analysis. Patients with severe head injury and 
under 16 years old were excluded. P <0.05 was considered statistically 
signifi cant.
Results Thirty-seven delirious and 66 nondelirious patients were 
included. We found that delirious patients tented to have higher B-type 
natriuretic peptide (BNP) levels and to have lower estimated glomerular 
fi ltration rate (eGFR) (BNP: delirious patients 188.6 pg/ml, nondelirious 
patients 78.2  pg/ml (P  = 0.001); eGFR: delirious patients 58.6  ml/
minute/1.73  m2, nondelirious patients 81.3  ml/minute/1.73  m2 (P  = 
0.020)). Procalcitonin (PCT) and D-dimer were almost the same between 
delirious and nondelirious patients (PCT: delirious patients 0.202 ng/ml, 
nondelirious patients 0.150 ng/ml (P = 0.613); D-dimer: delirious patients 
5.25 ng/ml, nondelirious patients 5.35 ng/ml (P = 0.714)).
Conclusion BNP and eGFR in ICU admission was associated with 
delirium. PCT and D-dimer in ICU admission was not associated with 
delirium. BNP and eGFR might evaluate a predictor of delirium in ICU.
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Introduction Mental illness has been recognised as a potential risk factor 
both for intentional and unintentional injury. About 50% of patients 
presenting with self-infl icting injuries in emergency departments had 
previous known psychiatric disorder (PD) [1,2], whereas individuals 
with mental illness were admitted for unintentional injury twice as 
often as those without [3]. We aimed to assess the prevalence of PD in 
trauma patients being admitted to a major trauma ICU and compare it 
with the nontrauma population.
Methods We retrospectively reviewed all admissions from January 
2010 to December 2013 in a tertiary, mixed ICU that serves a London 
major trauma centre (MTC) hospital. Data obtained were age, APACHE 
II score, reason for admission, length of stay (LOS), mortality and a 
diagnosis of depression, bipolar, self-harm, psychosis, schizophrenia 
and suicide attempt.
Results Of 978 trauma patients admitted to the ICU, 68 (7%) had a 
known PD. Their diagnoses are shown in Figure 1. Median APACHE II 
score and unadjusted mortality were 13 and 18% respectively in the PD 
group (15 and 12% in the entire cohort, P >0.05). Patients suff ering from 
more than one diagnosis or self-harm alone had increased median LOS 
(6 vs. 4 days in the entire cohort, P >0.05).
Conclusion Trauma patients with PD have increased mortality and LOS. 
MTCs provide a unique opportunity to identify mental illness during 
hospitalisation through screening and intervention programmes. 
Integration of mental health services into ICU care should be examined, 
as it might provide an effi  cient and cost-eff ective way of decreasing the 
risk of reinjury.
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Introduction Delirium is associated with signifi cant morbidity and 
mortality in critically ill medical and surgical patients. However, patients 
suff ering from trauma are generally excluded from these studies. 
Our objectives were to assess the incidence of delirium and identify 
modifi able risk factors associated with delirium among critically ill 
trauma patients.
Methods This was a prospective observational study of trauma 
patients from two critical care trauma centers. We excluded patients 
who had ICU stay <48  hours and those with severe traumatic brain 
injury (TBI) (GCS ≤8). Patients were followed until ICU discharge, 
resolution of delirium, death or ICU length of stay >28 days. Delirium 
was assessed daily using the Confusion Assessment Method for the 
ICU until the end of the follow-up period. Demographic and admission 
data, daily consumption of medications, and environmental factors 
(that is, presence of clock, TV/radio, and so forth) were collected daily. 
Univariate analysis was performed using Cox regression analysis to 
identify risk factors for delirium. The independent eff ect of modifi able 
risk factors was assessed using multivariate Cox regression analysis 
adjusting for severity of illness and nonmodifi able risk factors.
Results We enrolled 150 trauma patients resulting mostly from falls 
(40%) and motor vehicle accidents (28.7%) over 14  months. Patients 
with TBI accounted for 56.7% while polytrauma patients without 
TBI accounted for 43.3%. Mean ICU length of stay was 8.1 ± 7.1 days, 
69.3% required mechanical ventilation, 14.7% required a tracheostomy. 
Delirium developed in 58 patients (38.7%) (mean age 62.9 ± 15.7, mean 
APACHE score 15.4 ± 6.1, mean ISS score 23.4 ± 9.1). Univariate analysis 
revealed that delirium was signifi cantly associated with the following 
nonmodifi able risk factors: age (per 10-year range), APACHE II score 
(per 10-point increase), need of mechanical ventilation, presence of 
TBI and pre-existing diabetes. In a multivariate analysis when adjusting 
for the nonmodifi able risk factors, opioids (adjusted HR = 0.37, 95% CI 
(0.14 to 1.0)), presence of a TV/radio in the room (adjusted HR = 0.28, 
95% CI (0.12 to 0.67)), and number of hours mobilized (adjusted HR = 
0.77, 95% CI (0.68 to 0.88)) had a protective eff ect on delirium; whereas 
use of physical restraints (adjusted HR = 2.20, 95% CI (1.11 to 4.35)) and 
active infection (adjusted HR  = 2.08, 95% CI (1.16 to 3.71)) remained 
strongly associated with delirium.
Conclusion Considering the long-term consequences of delirium, 
steps should be implemented to prevent its development in trauma 
and include optimizing opioids and mobilizing patients while limiting 
use of physical restraints.
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Evaluation of the PRE-DELIRIC delirium prediction tool on a general 
ICU
J Hanison, S Umar, K Acharya, D Conway
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Introduction Delirium is a frequently occurring complication of critical 
care, occurring in approximately 45% of unplanned UK ICU admissions 
Figure 1 (abstract P477).
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[1]. The presence of delirium in critical care is an independent risk 
factor for mortality; for every day of delirium, there is an additional 
10% relative risk of death at 1 year [2]. A delirium prediction tool PRE-
DELIRIC has been recently developed and calibrated in a multinational 
project [3]. This study aimed to determine the utility of PRE-DELIRIC on 
our ICU.
Methods This study prospectively investigated 41 patients. Medical and 
surgical general ICU patients were included after 24 hours of sedation 
and mechanical ventilation. The researchers calculated PRE-DELIRIC 
scores for each patient. PRE-DELIRIC involves recording 10 variables, 
submitted into an online algorithm that estimates the percentage 
risk of delirium. We diagnosed delirium with the CAM-ICU which was 
performed 12 hourly [4].
Results The PRE-DELIRIC scores predicted a mean rate of delirium of 
39%. PRE-DELIRIC risk scores ranged from 4 to 93% (Figure 1). Six (15%) 
patients developed delirium in the fi rst 24 hours following extubation. 
Fifteen (37%) of patients were predicted 20% or less probability of 
delirium. Twelve (29%) patients developed delirium at any point during 
their ICU stay. This resulted in 36 total delirium bed-days.
Conclusion Our observation that <30% of patients experienced 
delirium is less than the reported prevalence in similar settings and 
our own audits. This study demonstrates that there is some agreement 
between recorded rates of delirium and predicted rates using PRE-
DELIRIC. We suggest that PRE-DELIRIC can be used in quality/audit work 
on UK ICUs in order to assess attempts to improve the management of 
delirium. Further work is required to assess the utility of PRE-DELIRIC as 
a risk assessment tool in individual patients.
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Introduction Propofol infusion syndrome (PRIS) is a rare propofol 
complication, leading to cardiac failure. It was fi rst described in critically 
ill children and in adults with traumatic brain injury. Pathophysiology is 
unknown although common factors are the prolonged (>48 hours) use 
of high-dose (>5 mg/kg/hour) propofol combined with elevated levels 
of catecholamines and corticosteroids. Recently, case reports of early-
onset PRIS during anesthesia and in the early postoperative setting were 
published. In many of these, lactic acidosis is interpreted as onset of 
PRIS. Criticism off ers that it might concern a poor diff erential diagnostic 
approach or an observational bias. Also, lactic acidosis is not an obligate 
PRIS symptom and incidence of lactic acidosis during propofol sedation 
is unknown. To gain insight into the incidence and characteristics of early 
PRIS, we performed a systematic review on early PRIS cases.
Methods A literature study via MEDLINE and Embase search with 
keywords ‘PRIS’, ‘lactic acid’, ‘propofol’ and ‘sedation’. All cases in English, 
French and Spanish were indentifi ed. Exclusion criteria were onset 
>48 hours, unclear description of time pattern and dose.
Results Twenty-two cases of early PRIS were found. These concerned 
10 pediatric versus 12 adult patients. Eleven were identifi ed in the 
ICU versus 11 in the operating room. The survival rate of early PRIS 
was 95.5%, and morbidity was restricted to four patients. In the adult 
subgroup, the mean propofol dose was 4.9  mg/kg/hour. Triggering 
factors such as use of catecholamines and corticosteroids were found 
in 36.4% and 45% of patients. In total, 3/22 cases matched Bray’s 
defi nition of PRIS. In 14/22 cases, lactic acidosis was interpreted as 
onset of PRIS.
Conclusion Compared with a review by Fudickar [1], we found 
signifi cant diff erences in critical dose, risk factors, symptomatology and 
morbidity/mortality between PRIS and early PRIS cases. As criticisms 
are off ered, a question is whether these cases really are the onset of 
the fatal syndrome PRIS. Therefore, we completed diff erential diagnosis 
of lactic acidosis and found that not all possible causes (for example, 
hyperglycemia, ketonemia, pharmacologic confounders as biguanides, 
epinephrine) were ruled out in most cases. This is important since PRIS 
is an exclusion diagnosis. The existence of early PRIS should indeed be 
questioned and investigated by large, multicenter observational trials.
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Introduction Among drugs used for sedation, propofol has a primary 
role [1]. Despite propofol being described to exert a relaxant eff ect on 
skeletal muscle, no data showing its action on diaphragm are reported. 
The aim of this observational study on humans is to apply ultrasound 
to assess propofol’s eff ect on diaphragmatic contraction and motion 
during endoscopic procedures.
Methods We investigated seven consecutive patients undergoing 
gastroscopy or colonoscopy in the endoscopy unit of our hospital. 
Patients received propofol at a dose able to induce and maintain 
sedation to level 6 of the Ramsay Sedation Scale during the procedure. 
Measurements were obtained on right side of the thorax in millimeters; 
diaphragmatic motion (DM) and diaphragmatic motion at maximal 
inspiration (DM forced) were measured in M-Mode with a 3.5  MHz 
array convex probe placed on the midclavicular line using the liver 
acoustic window. Thickness at end inspiration (TEI) and thickness at 
end expiration (TEE) were measured in M-Mode with a 10 MHz vascular 
probe. The thickening fraction (TF) was calculated: (TEI – TEE) / TEE [2]. 
Time points of measurements were taken when the patient arrived 
in the surgery room (Baseline), 1  minute after level 6 of the Ramsey 
Sedation Scale was obtained (Sedation) and 5 minutes after the patient 
had a recovery to level 1 on the Ramsey Sedation Scale (Awakening). 
Figure 1 (abstract P479). Range of PRE-DELIRIC scores.
Table 1 (abstract P481)
Variable Baseline Sedation Awakening P value
Thickness end inspiration (mm) 3.25 (0.21) a2.66 (0.20) b,c3.22 (0.30) <0.001*
Thickness end expiration (mm) 2.11 (0.20) d2.00 (0.15) 2.07 (0.15) 0.112*
Thickening fraction 0.54 (0.07) e0.36 (0.10) f,g0.49 (0.11) <0.001*
Diaphragmatic motion (mm) 18.66 (2.23) h13.27 (4.93) 15.31 (0.40) 0.055
Diaphragmatic motion forced  54.61 (19.34) – 56.34 (13.75) 0.298
(mm)
aP <0.001 versus baseline. bP = 0.043 versus baseline. cP <0.001 versus sedation. 
dP = 0.030 versus baseline. eP =0.012 versus baseline. fP =0.353 versus baseline. 
gP = 0.041 versus sedation. hP = 0.022 versus baseline.
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Data analyzed are reported in Table  1 and expressed as mean (SD). 
*ANOVA was used to compare data for repeated measurements. Post 
hoc statistical comparison with Bonferroni’s test was used to identify 
signifi cant variations.
Results During propofol administration TEI reduced 19% whereas after 
awakening it increased 14.5% but did not reach baseline. Conversely 
TEE did not change during the study. During propofol sedation, TF 
decreased 34% and returned to baseline after recovery. DM showed 
29% reduction during propofol administration whereas the forced 
diaphragmatic motion tested when patients were conscious (forced 
DM) did not evidence any change.
Conclusion In this observational study, ultrasound assessed that 
propofol causes a reduction of diaphragmatic contraction and motion 
during endoscopic procedures.
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Introduction Delirium recognition in critically ill patients is considered 
to be important taking into account the poor outcomes associated with 
its occurrence. The purpose of this study was to evaluate knowledge 
pertaining to delirium as well as the implementation of screening 
practices. This study constituted a component of a survey that explored 
current sedation-related practices in South African ICUs.
Methods Following approval from the University Human Research 
ethics committee, a validated questionnaire was distributed 
electronically to physician members of various medical databases in 
South Africa as South Africa does not have a formal registry of critical 
care practitioners.
Results One hundred and twenty-six of 174 respondents indicated 
that they practice in the ICU setting. Sixty-six per cent were specialists 
and mainly anaesthesiologists (42%), whilst 32% were critical care 
subspecialists. The respondents indicated that on average 30 ± 20% of 
their patients experience delirium. Eighty per cent of the respondents 
indicated that delirium impacts signifi cantly negatively on patient 
outcomes whilst 1% indicated that there was no such association. 
Delirium screening is achieved mainly by clinical assessment (77%). 
Twenty-four per cent utilise an objective tool to screen for delirium 
and amongst them the CAM-ICU is utilised by 80%. Amongst delirious 
patients the sedative of choice is dexmedetomidine in the majority. 
However, 20% prescribe midazolam as a fi rst choice in this setting.
Conclusion The fi ndings are comparable with reports of similar 
surveys conducted in other regions. The delirium screening method 
is inadequate as the vast majority do not utilise an objective method.
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Introduction Weaning from prolonged mechanical ventilation (MV) 
in the ICU may be impeded by the occurrence of agitation. Loxapine 
had the ability to control agitation without aff ecting the effi  cacy of 
spontaneous ventilation in an observational study, justifying the 
implementation of a randomized controlled trial.
Methods We conducted a multicenter, placebo-controlled, parallel 
group, randomized trial at fi ve French ICUs between November 2011 
and November 2013. Patients (aged >18  years) under MV for more 
than 48  hours who were potential candidates for weaning from the 
ventilator and who exhibited agitation defi ned by a Richmond Agitation 
Sedation Scale (RASS) >2 after sedation withdrawal were randomly 
assigned to receive either loxapine or placebo. All participants were 
masked to group of allocation. After randomization, patients received 
150 mg loxapine or placebo by nasogastric tube. RASS was monitored 
every 4 hours. A second dose of loxapine or placebo was administered 
if agitation persisted or worsened. In case of severe agitation, usual 
sedation (benzodiazepines and morphinic agents) was immediately 
resumed. Extubation was contemplated when patients were conscious 
and calm. The primary endpoint was the time between the fi rst 
administration of loxapine or placebo and successful extubation (no 
reintubation in the following 48 hours). Three hundred patients were 
necessary to have 90% power to detect a 2-day reduction of weaning 
time in the loxapine group with a one-sided type I error rate of 5%.
Results The trial was discontinued after 101 patients had been 
randomized because of insuffi  cient enrollment. Fifteen patients 
withdrew consent, leaving 86 patients for analysis. Forty-seven patients 
were assigned to the loxapine group and 39 to the placebo group. 
Median time to successful extubation was 3.2  days in the loxapine 
group and 5  days in the placebo group (RR  = 1.2, 95% CI  = 0.75 to 
1.88; P = 0.45). During the fi rst 24 hours, sedation was more frequently 
resumed in the placebo group (44% vs. 17%, P = 0.01). One patient had 
a transient seizure in the loxapine group.
Conclusion These results are consistent with the hypothesis of 2 days 
reduction of the median weaning time in the loxapine group, but the 
diff erence was not statistically signifi cant. Loxapine reduces the need 
for resuming sedation during weaning from MV. Given the quality 
of the data and methodology, these results may be useful in future 
meta-analyses.
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Introduction We investigated the incidence, symptoms and risk factors 
for withdrawal associated with prolonged dexmedetomidine use. 
Dexmedetomidine is an α2-adrenergic receptor agonist, with anxiolytic, 
analgesic and sedative properties. Intended for short-term use, 
there is increasing literature describing prolonged use for sedation. 
However, this raises the potential of withdrawal syndrome and there 
is no recommendation for the discontinuation of dexmedetomidine. 
Other goals included determining the hemodynamic eff ects of 
discontinuation of dexmedetomidine and role of clonidine in patients 
with prolonged dexmedetomidine use.
Methods A retrospective review of patients admitted to the critical 
care unit who had exposure to dexmedetomidine for longer than 
48  hours, between 1 January 2014 and 15 July 2014. Data included 
patient demographics, dexmedetomidine exposure (bolus dose, total 
cumulative dose, duration), other sedative exposure, withdrawal 
symptoms measured by WAT-1 score, nursing subjective assessment 
and treatment given for withdrawal. Each potential withdrawal 
episode was reviewed by two reviewers. Hemodynamic parameters 
were analyzed to assess hemodynamic changes associated with 
discontinuation of dexmedetomidine. Descriptive statistics were used 
with t test and chi-square test. Median and interquartile range (IQR) are 
reported.
Results A total of 53 patients accounted for 69 unique dexmedetomidine 
treatment courses. Median age at the time of dexmedetomidine 
infusion was 5  months (range 1  day to 3  years). Dexmedetomidine 
dose ranged from 0.1 to 2  μg/kg/hour with a median cumulative 
dose of 87  μg/kg (IQR 53, 156). Median duration of exposure to 
dexmedetomidine was 124  hours (IQR 76, 178) with a maximum 
duration of 466 hours. We identifi ed 24 separate episodes of withdrawal 
(incidence 35%). Most common symptoms were agitation (100%), fever 
(67%), vomiting/retching (46%), loose stools (29%) and decreased sleep 
(20%). Statistical analysis showed that factors signifi cantly associated 
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with withdrawal were cumulative dose (P = 0.01) and duration of use 
of dexmedetomidine (P = 0.02). Duration of opioids exposure prior to 
dexmedetomidine wean was also a risk factor for withdrawal (P = 0.01). 
Use of clonidine as a transition from dexmedetomidine did not protect 
against withdrawal (P = 0.59).
Conclusion This study showed that withdrawal syndrome is associated 
with prolonged infusion of dexmedetomidine. Patients with higher 
cumulative doses and longer duration of exposure were more at 
risk. Our results suggested that clonidine use is not protective for 
withdrawal from dexmedetomidine.
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experience with dexmedetomidine in seven adult ARDS patients
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Introduction Sedation in the ICU is a basic therapeutic procedure 
to increase tolerance of invasive treatments and reduce discomfort. 
Extracorporeal membrane oxygenation (ECMO) is a highly invasive 
treatment and prolonged sedation may be required. Patients 
undergoing ECMO represent a challenge with respect to sedation. 
Initially, deep sedation may be required to optimize ventilation and 
circuit–patient fl ows and to minimize oxygen consumption. The other 
critical phase is represented by weaning from ECMO support. Optimal 
sedation is not clearly defi ned, moreover there are no data on sedation 
practices with dexmedetomidine (DEX) in adult patients undergoing 
ECMO. In contrast to other sedatives, DEX has analgosedative eff ects 
without respiratory depression, and could be useful to facilitate 
spontaneous respiratory activity during recovery from sedation.
Methods We investigate the role of DEX as a sedative agent used 
during recovery from deep sedation and weaning from extracorporeal 
support in patients on vv-ECMO. From May 2014 to October 2014 we 
prospectively enrolled seven patients aff ected by ARDS of diff erent 
etiologies treated with vv-ECMO. The mean age was 53.7 ± 7.9 years 
and the mean ICU stay was 21.4 ± 11.5 days. Initially, all patients were 
sedated with association of opioids and GABA receptor agonists, 
following the internal protocol. At the time of weaning from ECMO, 
ruled out cardiovascular instability, we started the administration of 
DEX (0.7 μg/kg/hour, without initial bolus) with progressive decrease of 
the dose of other sedative drugs.
Results The mean duration of DEX infusion was 6.1 ± 4.8 days. Except 
for one patient, who received DEX as a single drug after suspension 
of other sedatives, a low-dose infusion of another sedative (<50% 
compared with initial dose) was maintained. Three patients presented 
adverse events: two bradycardia and one hypotension. In four patients 
DEX was discontinued after recovery of respiratory function; in two 
patients deeper sedation for ventilatory dyssynchrony was needed so 
other sedative drugs were started. Only in one patient was the drug 
suspended for extreme bradycardia, resolved after suspension.
Conclusion In our study, DEX allowed the reduction of doses of other 
sedative drugs during weaning from vv-ECMO; this may lead to a 
cooperative sedation, promoting spontaneous breathing. Side eff ects 
described and the cost–benefi t ratio must still be verifi ed extensively in 
patients during weaning from ECMO.
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Introduction Sedation in the ICU is crucial in reduction of patients’ 
discomfort, in particular in patients undergoing mechanical ventilation 
to help tolerate intubation and reduce pain and anxiety. Propofol (Pr) 
is a widely used option, but other viable alternatives for short-term 
sedation (STS; that is, <24 hours) include benzodiazepines (BDZ) and 
dexmedetomidine (Dx). We aimed at pooling all available evidence on 
the comparative eff ects of Pr in terms of awakening and recovery times 
after STS in mechanically ventilated ICU patients.
Methods We planned a systematic literature review searching Medline 
and Scopus and performed a meta-analysis on direct comparisons 
reporting on weaning time (Tw), duration of mechanical ventilation 
(Tmv), time to extubation (Tex) and length of stay in the ICU (Ticu). The 
primary analysis considered only data from RCTs, while in a secondary 
analysis observational studies were also included.
Results The literature search identifi ed 15 relevant RCTs, of which 11 
versus BDZ, and a further fi ve observational studies, of which one 
versus BDZ. When compared with BDZ, Pr associated with signifi cantly 
reduced Tw (–1.6 hours, 95% CI: –2.5 to –0.8), Tmv (–2.0 hours, 95% CI: 
–3.7 to –0.2), and Ticu (–5.0 hours, 95% CI: –8.5 to –1.4); no statistically 
signifi cant diff erence resulted when comparing Pr and Dx. When 
nonrandomized evidence was included, results did not change 
signifi cantly.
Conclusion In conclusion, Pr is associated with shorter awakening and 
recovery times after STS than BDZ, while no diff erence could be shown 
when Pr was compared with Dx.
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Introduction Recently, several animal studies observed that 
dexmedetomidine (DEX), a new sedative and α2-adrenoceptor 
agonist, inhibited the infl ammatory responses [1-3]. Moreover, DEX 
was reported to have anti-infl ammatory eff ects in patients [4,5]. 
However, these studies were the small-sized studies and there are few 
studies about the eff ects of long-term administration of DEX in severe 
septic patients. The present study evaluated the eff ects of long-term 
administration of DEX on infl ammatory responses and severity in 
severe septic patients. We hypothesize that the administration of DEX 
has benefi cial eff ects for severe septic patients.
Methods In 66 patients (M/F 44/22, mean age 66  years) with severe 
sepsis, who were administered propofol (0.5 to 4.0  mg/kg/hour) 
only for sedation, 42 patients (M/F 28/14, mean age 67  years) were 
administered DEX (0.2 to 0.7  μg/kg/hour) for more than 24  hours 
in addition to propofol (DEX group). Twenty-four patients were not 
administered DEX (Control group). Primary outcome were changes in 
infl ammatory responses at 48 hours after the administration of DEX or 
none, and secondary outcomes were changes in APACHE II and SOFA 
scores at 48 hours after the administration of DEX or none.
Results The administration of DEX occurred for a mean 130 hours (24 
to 433  hours) in the DEX group. White blood cell counts, C-reactive 
protein (CRP) and procalcitonin (PCT) in both groups signifi cantly 
decreased after the administration of DEX or none. However, CRP and 
PCT in the DEX group were signifi cantly lower than those in the control 
group: CRP 7.7 (5.0) versus 13.6 (7.9)  mg/dl; P  <0.05, PCT 7.6 (11.7) 
versus 18.6 (11.6) ng/ml; P <0.05, mean (SD). APACHE II and SOFA scores 
in both groups decreased after the administration of DEX or none, but 
APACHE II and SOFA scores in the DEX group were lower than those in 
the control group: APACHE II 10.8 (4.8) versus 15.2 (5.1); P <0.05, SOFA 
3.6 (2.0) versus 5.8 (2.9); P <0.05, mean (SD).
Conclusion In the present study, the long-term administration of DEX 
has benefi cial eff ects of infl ammatory responses and severity for severe 
septic patients.
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Introduction To describe the main indications, doses, infusion length 
and side eff ects of dexmedetomidine (DEX) administered to children 
and adolescents admitted to the pediatric ICU (PICU).
Methods A retrospective observational study including children 
(<18  years) admitted to a Brazilian PICU who received DEX between 
November 2011 and June 2014. Demographic data, indications, initial 
dose, maximum dose and time of infusion of DEX, side eff ects and 
impact on heart rate (HR) and mean arterial pressure (MAP) 6 and 
24 hours after the start of infusion.
Results A total of 77 children with a median age of 15 (4 to 84) months, 
weight of 10 (5.7 to 20) kg and length of ICU stay of 8 (5 to 14) days 
received DEX, with a mortality rate of 9%. Indications were: weaning 
from mechanical ventilation (32.5%), neurosurgical postoperative (NCI) 
and upper airway surgery (VAS) (24.7%), non-invasive ventilation (13%), 
refractory tachycardia (6.5%) and other indications (23.3%). There was 
no diff erence between the initial and maximum doses and infusion 
length. There was a signifi cant decrease in MAP and HR after 6 hours 
infusion of DEX in the total group; however, no signifi cant diff erence 
occurred between groups when analyzing MAP and HR 24 hours after 
the start of infusion (P = 0.798 and 0.379, one-way ANOVA, respectively). 
In six patients (8%) DEX was suspended for possible side eff ects.
Conclusion Increased DEX indications have been observed in the 
pediatric population. In this study DEX was demonstrated to be a 
safe and tolerable drug with few side eff ects, especially related to the 
cardiovascular system.
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Introduction Pain assessment is associated with important out omes in 
ICU patients but remains challenging, particularly in non communicative 
patients. Use of a reliable tool is paramount to allow any implementation 
of sedation/analgesia protocols in a multidisciplinary team. This study 
compared psychometric properties (inter-rater agreement primarily; 
validity, responsiveness and feasibility secondarily) of three pain scales: 
Behavioural Pain Scale (BPS/BPS-NI, that is BPS for non-intubated 
patients), Critical Care Pain Observation Tool (CPOT) and Non-Verbal Pain 
Scale (NVPS), the pain tool routinely used in this 16-bed medical ICU.
Methods In a prospective observational study of ED polytraumatized 
patients (n = 23, mean Acute Physiology and Chronic Health Evaluation 
II (APACHE II) score of 11 ± 6) we measured (in the fi rst 24 hours) plasma 
TAC by the ferric reducing activity/antioxidant power (FRAP). For control 
subjects, we used age-matched and gender-matched volunteers (n = 
32). We also evaluated the contribution of antioxidant molecules (uric 
acid, bilirubin, and albumin) to these values.
Results Polytraumatized patients show diff erences in TAC with 
reference to control subjects. ED polytraumatized patients show high 
FRAP values. We found that FRAP values were inversely correlated 
with APACHE II score (r = –0.266, P <0.01) suggesting that, in trauma 
patients, increased antioxidant response, as measured by the FRAP 
assay, could be a pathophysiological response to stress. Albumin and 
uric acid concentrations reproduced the FRAP trend with severity.
Conclusion FRAP values in trauma ED patients are independently 
infl uenced by age (β = 0.271, P <0.021), APACHE II score (β = –0.356, 
P <0.002) and head trauma (β = –0.219, P <0.045). These results accen-
tuate the infl uence of trauma location and severity in TAC changes. The 
TAC response in ED patients reinforces the need for adequate tailoring 
of treatments aimed at their recovery, such as antioxidant therapies.
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Introduction To determine which of three methods of pain manage-
ment provided the best pain control in severe ASA III older patients in 
the surgical ICU (SICU). As technology improves, more older patients 
benefi t from surgery and need SICU care. Older surgery patients 
frequently present two medical problems. First is unspecifi c symptoms 
and decreased pain sensation resulting in delayed diagnosis. Second, 
they usually are not given enough perioperative pain relief. Optimal 
pain management results in perioperative stable hemodynamic status 
and decreased morbidity, mortality, length of stay and medical costs.
Methods A retrospective cohort study chart review of 1,872 all-cause 
patients in a 16-bed SICU during April 2011 to September 2012. Un-
consciousness, uncooperative, ASA <III and <65-year-old patients were 
excluded. The primary point was to compare eff ectiveness of three 
diff erent methods of pain management: P.R.N. i.v. Demerol/NSAID 
(D/N), i.v. patient-controlled analgesia (PCA) and patient-controlled 
epidural analgesia (PCEA), in three diff erent conditions: rest, movement 
and coughing, with visual analogue scales (VAS 0 to 100). Secondary 
point was patient satisfaction.
Results A total of 1,292 patients were excluded. VAS results are 
presented in Table  1 as mean  ± SD. At rest, the PCEA group is 
signifi cantly better than the other two groups. When at movement, 
there is no diff erence between the PCEA group and the D/N group but 
both are better than the PCA group. While coughing, the PCEA group is 
worse than the D/N group, although there is no diff erence between the 
PCEA group and the PCA group. The PCEA group gets the best grades 
in patient satisfaction.
Table 1 (abstract P490)
 Demerol/NSAID PCA PCEA
 (n = 449) (n = 62) (n = 69) P value
VAS (rest) 21 ± 14 * 19 ± 9* 12 ± 10 <0.001
VAS (movement) 35 ± 20 41 ± 12* 33 ± 11 0.02
VAS (coughing) 40 ± 24* 58 ± 14 51 ± 14 <0.001
*Signifi cant diff erence.
Conclusion PCEA provided better pain control at rest than the other 
two methods, whereas P.R.N. Demerol/NSAID and PCEA were somewhat 
better than PCA when patients were moving. While coughing, P.R.N. 
Demerol/NSAID provided the best pain control. However, patient 
satisfaction was signifi cantly better with PCEA.
P491
Subanesthetic xenon increases erythropoietin levels in humans and 
remains traceable in the fi rst 24 hours after exposure: a randomized 
controlled trial
J Ney, C Stoppe, M Brenke, A Goetzenich, S Kraemer, G Schaelte, 
A Fahlenkamp, R Rossaint, M Coburn
RWTH Aachen University, Aachen, Germany
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Introduction The noble gas xenon was recently amended to the 
list of prohibited substances by the World Anti-Doping Agency as 
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it is supposed to trigger the production of HIF-1α and subsequently 
erythropoietin. Subsequently, researchers and clinicians started a 
scientifi c discussion about the potential clinical benefi t in support of 
humans exposed to high demand, such as critically ill patients. The 
objective of this study was therefore to evaluate the eff ect of xenon on 
serum levels of erythropoietin in healthy volunteers.
Methods This is a monocenter, randomized, blinded, crossover trial, 
which was registered at ClinicalTrials.gov (NCT01285271). Healthy 
study test persons were spontaneously breathing randomly 1  hour 
of xenon 30% (Xe/O2 30%/65%) or control gas (N2/O2 30%/65%). The 
primary outcome parameter was the erythropoietin level 24  hours 
after exposure. Secondary outcome parameters are xenon’s elimination 
kinetics measured in blood and exhalation samples.
Results The application of xenon increases erythropoietin levels 
with a maximum 24  hours after exposure (1.32 (0.99 to 1.66) P  = 
0.033) compared with the baseline values and compared with 
control values (0.87 (0.68 to 1.05) P = 0.012, Figure 1). Xenon was gas 
chromatographically traceable in blood and exhalation probes up to 
24 hours after exposure.
Conclusion One hour of a subanesthetic level of xenon increases 
erythropoietin levels in healthy study test persons and remains 
gas chromatographically traceable in blood and exhalation probes 
24 hours after exposure. These fi ndings may stimulate larger studies to 
confi rm these results and to open new avenues for the therapeutic use 
of xenon in critically ill patients.
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MIRUS™, a new system for sedation with halogenates in the ICU: 
a preliminary study of feasibility in postsurgical patients
P Mancinelli, S Romagnoli, C Chelazzi, G Zagli, E Bonicolini, A Belardinelli, 
AR De Gaudio
Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
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Introduction Sedation is standard practice in the ICU [1]. The aim of 
this study was to investigate the effi  ciency and safety of the MIRUS™ 
system (Pall Medical), a new device for sedation in ICU patients [2]. The 
system delivers volatile anesthetics in mechanically ventilated patients. 
An open reservoir scavenger and a dedicated gas fi lter avoid residual 
volatile anesthetic halogenate escaping into the room air.
Methods Ten mechanically ventilated patients electively admitted 
for ICU postoperative monitoring were sedated with sevofl urane 
delivered with the MIRUS™ system. Two patients were excluded from 
the analysis because inclusion criteria had been lost during the study 
period. Analgesia was obtained with morphine sulfate: bolus 0.1 mg/
kg i.v. at the end of surgery and 0.2 to 0.4 mg/kg/24 hours. The primary 
endpoint was to achieve predefi nite levels of sedation (Riker scale 4). 
Secondary endpoints were the assessment of hemodynamic stability 
(MAP and HR), blood lactates, any type of side eff ects, and sevofl urane 
consumption. Data were collected at the following times: admission to 
the ICU (T1), 1 hour after initiation of sedation (T2), and 1 hour after 
sedation withdrawal (T3). Results were expressed as median (IQR) or 
mean (SD), where appropriate.
Results The local ethical board approved the protocol. Median duration 
of sedation was 4 (5.5 to 2) hours. Predefi nite levels of sedation were 
achieved in all patients with a median MAC of sevofl urane of 0.5 (0.5 to 
0.3)% and with a median gas consumption of 9.9 (14.3 to 5.3) ml/hour. 
MAP and HR values at T1 were 86.5 (97 to 80.8) mmHg and 81.5 (103.8 
to 65) bpm, respectively; at T2, 74.5 (89 to 69.5) mmHg and 74 (82 to 
58.3) bpm, respectively; and at T3 92.5 (101 to 76.8) mmHg and 74 (88.5 
to 66.3) bpm, respectively. Lactates were always normal. Mechanical 
ventilation was interrupted 5.4 (3.1) minutes after withdrawal of 
sevofl urane and respiratory parameters always were within normal 
values. Finally, no side eff ects were registered at any phase of the study.
Conclusion This pilot study shows that MIRUS™ is eff ective and safe 
in delivering sevofl urane for sedation at a predefi nite target level in 
postsurgical patients, without side eff ects. Further data with a larger 
number of patients and for a longer duration of sedation are required 
to confi rm these positive, preliminary observations.
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Introduction Electroencephalographic-based cerebral monitors 
such as the bispectral index (BIS) have been used for titration of both 
inhalational and intravenous anesthetics during general anesthesia. 
Titration of anesthetics using these monitors may facilitate an earlier 
recovery from general anesthesia and less consumption of anesthetics. 
The primary aim of this study was to investigate whether BIS-guided 
anesthesia would reduce time to tracheal extubation when compared 
with minimum alveolar concentration (MAC)-guided anesthesia in 
patients undergoing onpump cardiac surgery.
Methods Fifty patients undergoing elective coronary artery bypass 
grafting surgery from a single tertiary referral university hospital 
were randomized to BIS-guided anesthesia (Group BIS, n  = 25) and 
MAC-guided anesthesia (Group MAC, n = 25). The inspired desfl urane 
concentration was titrated to maintain a BIS value of 40 to 60 in Group 
BIS and an age adjusted minimum alveolar concentration of 0.7 to 1 was 
used in Group MAC. Time to tracheal extubation across the two groups 
was the primary outcome measure. Secondary outcomes included 
intraoperative desfl urane consumption, postoperative complications, 
and lengths of stay in the ICU and hospital.
Results Demographic features, logistic EuroSCOREs, duration of 
cardiopulmonary bypass and surgery were similar in both groups. 
Mean desfl urane consumption was signifi cantly lower in Group BIS 
(11.9 ± 1.7 ml/hour) compared with Group MAC (13.4 ± 3.0 ml/hour) 
(P = 0.031). Time to tracheal extubation was not signifi cantly diff erent 
between the groups (13.3 ± 9.6 hours vs. 17.0 ± 22.4 hours) (P = 0.68). 
Incidences of postoperative complications were similar and lengths of 
stay in the ICU and hospital were 2.4 ± 0.7 days versus 3.2 ± 2.7 days 
Figure 1 (abstract P491). Erythropoietin levels after 30% xenon exposure.
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and 5.3 ± 1.2 days versus 6.5 ± 3.1 days in Group BIS and Group MAC 
respectively (P >0.05 for all).
Conclusion Intraoperative use of BIS monitoring in patients undergoing 
onpump cardiac surgery reduced desfl urane requirement but BIS-
guided anesthesia did not facilitate time to extubation and lengths of 
stay in the ICU and hospital.
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Use of sevofl urane in the medical ICU: 2-year experience, patient 
and safety profi le
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Introduction The aim of this study is to present our experience with 
sevofl urane in the ICU, outline which patients were sedated with 
sevofl urane and present the safety profi le. Sevofl urane has some 
potential advantages over intravenous sedation: rapid elimination and 
few interactions. The optimal role of sevofl urane in ICU is not known.
Methods We performed a retrospective study on adult patients who 
were sedated with sevofl urane in the medical ICU. The decision to 
use sevofl urane was left to the attending physician. Institutional 
ethics committee approval was obtained. The target mean alveolar 
concentration in all patients was 0.5 to 1%. The AnaConDa® device 
(Sedana Medical, Uppsala, Sweden) was used along with the Anastasia® 
(Sedana Medical) gas monitor. Data were obtained from patients’ 
medical records.
Results We included 61 adult patients who were admitted from April 
2012 to November 2014. Mean age was 62.6 ± 14.9 years, 39 (63.9%) 
were male. ICU mortality was 41%, hospital mortality was 43%. Mean 
duration of sevofl urane use was 3.56 ± 2.31 days. Admission diagnoses 
were: successful resuscitation after cardiac arrest (44.2%), sepsis (37.7%), 
cardiogenic shock (4.9%), pancreatitis (3.3%) and liver failure, acute 
exacerbation of COPD, asthma, tetanus and intracerebral hemorrhage 
(1.6% each). During treatment with sevofl urane, no patients developed 
malignant hyperthermia, new hyperkalemia or QT prolongation. 
In three (4.9%) patients, worsening liver function tests prompted 
sevofl urane discontinuation. Ischemic hepatitis was considered an 
alternative in all three patients. Seven (11.4%) patients developed renal 
failure while receiving sevofl urane. Sevofl urane was continued in all 
patients and renal failure was attributed to alternative diagnoses. No 
self-extubations were recorded. In seven (11.4%) patients, sevofl urane 
was discontinued because of worsening ventilation. In six (9.8%) 
patients, unexpected awakening occurred. Eight patients (13.1%) had 
symptoms of delirium after sevofl urane inhalations were concluded.
Conclusion We identifi ed sevofl urane as an appropriate sedation agent 
in a diverse group of patients. Sevofl urane advantages over intravenous 
sedation could be more pronounced in some patient groups (for 
example, successful resuscitation after cardiac arrest). The safety profi le 
of sevofl urane sedation was comparable with intravenous sedation [1].
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Introduction The new MIRUS™ system as well as the established 
AnaConDa® system uses a refl ector to conserve volatile anaesthetics 
(VA) [1]. Both systems act with commercially available ICU ventilators. 
In contrast to AnaConDa®, MIRUS™ includes an automated control of 
end-tidal VA concentrations. In this study we compared feasibility, costs 
and recovery times after anaesthesia with isofl urane (ISO), sevofl urane 
(SEVO) or desfl urane (DES) in ventilated and spontaneously breathing 
patients.
Methods The study was approved by the appropriate institutional 
review board. After written informed consent, 63 ASA I to III patients 
undergoing elective hip or knee replacement surgery under general 
anaesthesia were included. Patients were randomly organised into 
three groups (20 to 22 each). Anaesthesia was induced with intravenous 
anaesthetics. After tracheal intubation MIRUS™ automatically adjusted 
the end-tidal VA concentration to 1.0 MAC. Patients were ventilated 
with the Puritan Bennett 840 ICU ventilator. After 1 hour of anaesthesia 
with 1.0 MAC the ventilator mode was switched from SIMV VC+ (totally 
controlled ventilation, passive patient, with a tidal volume of 8 ml/IBW) 
to proportional assist ventilation with 50% support (active patient). At 
the end of surgery the MIRUS™ system was stopped (MAC set to 0.0) 
and recovery times were measured.
Results Patients were comparable in age, height, weight and operation 
time. In 60/63 patients a MAC of 1.0 was reached by MIRUS™. Therefore, 
ISO 11.2 ± 3.3 ml/hour, SEVO 24.3 ± 4.8 ml/hour or DES 41.7 ± 7.9 ml/
hour (mean ± SD; t test: P <0.001) were used during passive ventilation. 
During patients’ active ventilation, mean VA consumptions of ISO 
9.6 ± 5.1 ml/hour, SEVO 19.4 ± 9.6 ml/hour or DES 35.5 ± 23.0 ml/hour 
were detected (NS between passive and active patients). ISO was the 
cheapest VA (€2.70  ± 3.10/hour passive patient, €1.90  ± 2.30 active 
patient), followed by SEVO (€8.40 ± 3.70 passive patient and €6.8 ± 3.8 
active patient) and DES (€9.6 ± 4.1 passive patient and €8.6 ± 6.5 active 
patient). Recovery times were signifi cantly shorter after SEVO and DES 
compared with ISO (minutes:seconds; ISO 9:31 ± 6:04, SEVO 6:19 ± 2:56, 
DES 5:27 ± 1:59).
Conclusion This study showed that MIRUS™ could automatically 
control end-tidal VA concentrations in ventilated and spontaneously 
breathing patients. Using ISO reduces costs. Further studies must be 
taken to analyse feasibility, costs and recovery times of ISO, SEVO and 
DES used for sedation in an ICU setting.
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Introduction The use of etomidate is a risk factor for relative adrenal 
insuffi  ciency in patients undergoing cardiopulmonary bypass (CPB) 
[1]. The objective was to determine the possible interaction between 
Figure 1 (abstract P496).
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etomidate and beta tumoral necrosis factor (TNFβ) polymorphism on 
hemodynamics after CPB.
Methods A prospective cohort study on CPB patients who received 
etomidate or not during anesthetic induction during 2008 to 2011. 
Demographic and postoperative variables were collected. We tested 
the Hardy–Weinberg equilibrium in order to avoid selection bias. V18 
SPSS was used.
Results We studied 433 patients undergoing CPB, 285 (65.8%) men and 
148 (34.2%) women, 66 ± 6 years, EuroSCORE I 5.3 ± 4%. TNFβ was in 
Hardy–Weinberg equilibrium (χ2: 0.6; P = 0.42). A total of 254 (58.7%) 
patients received etomidate, 152 out of them required vasoactive 
drugs. Homozygous G was defi ned as unfavorable TNFβ versus the A 
allele [2]. Using the general linear model after adjusting for sex and 
amines dose at 4  hours, an independent association was observed 
between the systemic vascular resistance index (SVRI) at 4 hours and 
the use of etomidate (F: 18; P  <0.001): 1,849 (95% CI: 1,673 to 2,024) 
versus 2,493 (95% CI: 2,258 to 2,729) dinas.seg/cm5.m2, the presence 
of homozygous G (F: 6.5; P  = 0.01), and also showed a signifi cant 
etomidate–homozygous G interaction (F: 22.8: P  <0.001): 1,687 (95% 
CI: 1,350 to 2,023) versus 3,041 (95% CI: 2,589 to 3,492) dinas seg/cm5.
m2 (Figure 1).
Conclusion Etomidate use is associated with lower postoperative 
SVRI which is increased in the presence of G homozygosity for TNFβ 
polymorphism.
References
1. Iribarren JL, et al. J Cardiothorac Surg. 2010;5:26.
2. Iribarren et al. Interact Cardiovasc Thorac Surg. 2008;7:1071-4.
P497
Sedation practices in South African ICUs: results of a national survey
F Paruk, S Chetty
University of Witwatersrand, Johannesburg, South Africa
Critical Care 2015, 19(Suppl 1):P497 (doi: 10.1186/cc14577)
Introduction There has been a paradigm shift in the approach to 
sedation of critically ill patients. The purpose of this study was to 
evaluate current sedation-related practices in South African ICUs.
Methods A validated questionnaire was distributed electronically to 
physician members of various medical databases in South Africa as 
South Africa does not have a formal registry of critical care practitioners.
Results One hundred and twenty-six of 174 respondents indicated 
that they practice in the ICU setting. Sixty-six per cent were specialists 
and mainly anaesthesiologists (42%), whilst 32% were critical care 
subspecialists. The public and private-sector representation was 64% 
and 46% respectively. A written sedation guideline is implemented 
by 42%. Forty-three per cent utilise a sedation scale, with the Ramsey 
Sedation Scale being the commonest in use. However, 38% of 
sedation scale users do so infrequently. Daily interruption of sedation 
is practiced by 75%. Light sedation is targeted by 42% and 14% do 
not follow any sedation targets. Upon admission and on subsequent 
days, sedation targets are achieved most of the time by 48% and 69% 
of the respondents respectively. Whilst a wide variety of sedatives are 
prescribed, midazolam constitutes the most commonly prescribed 
agent. Dexmedetomidine is the agent of choice for postcardiac surgery 
patients with cardiovascular comorbidities, delirious patients, during 
weaning and for non-invasive ventilation. Propofol is the agent of 
choice amongst neurological patients. The respondents indicated that 
there is a need for local sedation guidelines.
Conclusion The fi ndings are comparable with reports of sedation 
surveys conducted in other countries. There is an evidence–practice 
gap that needs to be addressed.
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Introduction Operation therapy is more invasive than medication 
therapy and then operation-related medical errors (MEs) might be 
of more signifi cant impact than medication errors. We assessed the 
incidence and characteristics of operation-related MEs to improve 
patient safety in such patients.
Methods The Japan Adverse Event (JET) study was a prospective cohort 
study which had evaluated AEs and MEs at two tertiary care hospitals. 
We included all adult patients aged ≥15 years old who had operations 
over a 2-month period. The primary outcome of this study was the 
operation-related MEs, defi ned as any deviation from appropriate 
process of an operation or perioperative care. Trained nurses placed 
at each participating hospital reviewed all charts daily on weekdays, 
along with laboratories, incident reports, and prescription queries to 
collect any potential event. They also collected the characteristics of 
the patients in the cohort. Some operation-related MEs are associated 
with operation-related AEs, which are operation-related preventable 
AEs. After those suspected events were collected, physician reviewers 
independently evaluated them and classifi ed them as operation-
related MEs, AEs, or rule violations. Physician reviewers assessed and 
rated operation-related AEs according to the symptom and the severity 
of injury.
Results This study included 389 patients with 6,624 patient-days. The 
median age of patients was 69 years and 224 (58%) were male. Among 
these 389 patients, 31 patients had 46 operation-related MEs during 
their hospital stay and the incidence of operation-related MEs was 12 
per 100 patients. Operation-related AEs occurred in 29 patients with 43 
events. The most frequent symptoms for operation-related MEs were 
skin (26%), bleeding (21%), and central nervous system (14%). Among 
46 operation-related MEs, 43 (93%) were not intercepted, and they 
resulted in operation-related AEs that were considered as preventable 
operation-related AEs. Nine of preventable operation-related AEs (21%) 
were fatal or life-threatening: fi ve were nerve injury during operation 
and stroke after neurosurgical operation, and one biliary peritonitis 
after gastrectomy and cholecystectomy, and tension pneumothorax 
after lung lobectomy, and two unexpected massive bleeding due to 
vessels injury.
Conclusion Ninety-three percent of operation-related MEs resulted 
in operation-related AEs and 21% of them resulted in life-threatening 
events. Prevention of operation-related MEs should improve the 
mortality of surgical patients.
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Introduction As informatisation of hospitals continues to spread, 
increasing amounts of healthcare related data are being collected, 
and the ICU is no exception. Large datasets are being made available 
to the scientifi c community, and off er the potential to answer clinical 
questions and to develop the next generation of clinical tools. A 
demonstration of such a tool is presented here, built using data from 
the Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC-II) 
open database.
Methods All of the adult patients who died during their stay in 
the ICU were included, as well as a matched cohort of patients who 
survived for more than 28  days after discharge. Data regarding their 
vital signs, laboratory tests and demographics were collected. Using 
Matlab, a graphical method involving principal component analysis 
was developed. The expected mortality was computed using the 
k-nearest neighbours’ method and compared with several classifi cation 
algorithms (logistic regression, random forest, support vector machine, 
Gaussian mixture models).
Results A total of 6,084 patients were included in the analyses, adding 
up to more than 12  million data points. Using this multidimensional 
dataset, a 3D representation of the clusters of survivors and 
nonsurvivors was built, showing how their trajectories diverge through 
time. Patterns in the evolution of individuals or subgroups of patients 
can be identifi ed using this approach. For example, the evolution of a 
new patient can be visualised, progressing through the clusters as his 
severity changes. His expected mortality can be predicted at any point 
in time, with an AUC ROC constantly above 0.85.
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Conclusion Machine learning tools off er an appealing mathematical 
framework for modelling complex medical situations. This proof of 
concept demonstrates that the application of computational sciences 
to high-quality data such as the MIMIC-II database has the potential 
to lead to the development of meaningful tools which will ultimately 
be capable of assisting physicians in making the right decision at the 
right time for an individual patient. Only tight cooperation between 
clinicians and data scientists can help close the gap that currently 
separates these two worlds, for the ultimate benefi t of patients.
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Introduction The aim was to investigate the impact of organizational 
factors on patient outcomes in a large sample of Brazilian ICUs.
Methods A retrospective cohort study of 59,483 patients admitted to 
78 ICUs in 51 hospitals during 2013. We retrieved demographic, clinical 
and outcome data from an electronic ICU quality registry (Epimed 
Monitor System). We surveyed ICUs using a standardized questionnaire 
regarding hospital and ICU structure, organization, staffi  ng patterns, 
process of care, and family care policies. We used multilevel logistic 
regression analysis to identify characteristics associated with hospital 
mortality.
Results ICUs were mostly medical or medical–surgical (62.79%) and 
located in private hospitals (67.86%). Approximately half (40.51%) 
had critical care training programs. Median physician and nurse staff –
bed ratios were 0.15 (IQR, 0.12 to 0.19) and 0.71 (0.61 to 0.84); board-
certifi ed intensivists were present 24/7 in 16 (21%) of ICUs. Routine 
clinical rounds occurred in 67 (86%) and daily clinical checklists were 
used in 36 (46%) ICUs. Most frequently implemented protocols focused 
on sepsis management and VAP and CLABSI prevention. Median 
number of patients per center was 898 (IQR 585 to 1,715) and there 
were 67% medical admissions; 18% patients received mechanical 
ventilation (MV). Median SAPS 3 score was 41 (33 to 52) points. ICU and 
hospital mortality rates were 9.6% and 14.3%, respectively. Adjusting 
for relevant patients’ characteristics (SAPS 3 score, diagnostic admission 
category, chronic health status, comorbidities, MV use), case-volume 
and type of ICU, the ICU size (OR = 1.50 (95% CI, 1.45 to 1.95), for 11 to 
20 beds; OR = 2.02 (1.40 to 2.92), for >20 beds) and ≥2 clinical protocols 
(OR  = 0.65 (0.42 to 0.99)) were the organizational characteristics 
associated with mortality.
Conclusion In a large sample of Brazilian ICUs, the implementation of 
clinical protocols was associated with better outcomes. Conversely, 
mortality was higher in larger ICUs.
Acknowledgements Funded by IDOR, CNPq and FAPERJ. Endorsed by 
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Introduction This study determined the pattern of decline prior to an 
inpatient arrest. We implemented the Hamilton Early Warning Score 
(HEWS) within our electronic vital signs documentation to track and 
trigger care for deteriorating patients. Other EWS have been described 
in the literature with varying success [1]. In contrast to previous 
observational studies, we chose to implement a score modifi ed from 
published EWS using the consensus opinion of a steering committee 
and evaluate the score in real time.
Methods We conducted a prospectively identifi ed, retrospectively 
gathered cohort study at two hospitals of consecutively admitted 
medical and surgical patients over a 6-month period. One hospital had 
a rapid response team (RRT) and used HEWS with a trigger of 5 while 
the other was undergoing implementation of the HEWS without a RRT. 
HEWS was calculated for each patient on the fi rst day of admission and 
for the 3  days prior to inpatient arrest or death. A study investigator 
reviewed all events for accuracy. Our outcome of interest was a 
composite of inpatient cardiac arrest and hospital mortality.
Results There were 7,138 patients admitted over 6 months. We found 
0.5% of patients suff ered an inpatient arrest and 3.6% of patients 
died. Moreover, 66% of patients who died or arrested were admitted 
to the hospital without a RRT. Patients who arrested or died had more 
comorbidities defi ned by the Charlson Comorbidity Index (CCI) of 6.0 
and 8.2 respectively compared with the general population, which had 
a CCI of 5.2. The median and mean HEWS at time of admission was 1 
and 1.7 for the general population, 2 and 2.4 for patients who suff ered 
an inpatient arrest and fi nally 3 and 3.8 for those who died. There was a 
rise in median HEWS from 2 to 5 in the 24 hours prior to in patient arrest 
or death. See Figure 1.
Conclusion We found that a 2.5-fold increase in HEWS occurred 
24  hours prior to critical events. Similar to previous studies, a RRT in 
conjunction with HEWS is the best system to reduce unanticipated 
adverse events. An absolute HEWS of 5 and/or a rapidly increasing 
HEWS should trigger rapid assessment and treatment to reduce 
preventable inpatient deaths and arrests.
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Introduction Surrogate consent and time-sensitive recruitment in 
critical care research is challenging, yet low enrolment numbers or 
omitting ethnic groups skew results and conclusions. Patients from 
diff erent ethnic groups may respond diff erently to therapeutics [1]. 
There are few data about the eff ect of ethnicity on recruitment into ICU 
trials. Our ICU recruits to national trials and serves an increasingly non-
White British population (24% of population). We undertook this study 
to determine whether ethnicity aff ects ICU consent rates.
Methods We performed a retrospective review of screening logs from 
three national UK trials (PROMISE, BALTI-P, GAiNS) and one local trial 
(Nociceptin in Sepsis). We analysed consent rates of eligible patients by 
ethnicity, age, sex, interventional or observational trial, and ethnicity 
of the researcher seeking consent. We performed chi-squared analysis, 
and entered signifi cant values into a logistic regression model using 
SPSS v22.
Figure 1 (abstract P501). HEWS prior to critical event.
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Results We identifi ed 332 eligible patients across all trials, of whom 
37 (11%) were not White British (nWB). Analysis demonstrated 
consent/assent refusal being signifi cantly associated with: nWB (14, 
38%, P  <0.001), interventional trial (21, 25%, P  = 0.003) and diff erent 
researcher–patient ethnicities (P  <0.001). Logistic regression analysis 
confi rmed these as independent factors (nWB OR = 4.5, 95% CI = 2.1 
to 9.8, P <0.001; interventional trial OR = 2.7, 95% CI = 1.4 to 5.2, P = 
0.003; data points missing for researcher–patient ethnicity so variable 
excluded).
Conclusion This initial study suggests that ethnicity may aff ect assent/
consent to ICU research, with patients from diff erent ethnicities being 
four times less likely to be recruited. Whilst data are incomplete for 
researcher–patient ethnicity, our data suggest that this may be an 
important factor and may infl uence future consent processes. We 
believe that the role of ethnicity warrants further investigation, not 
only in clinical trials but also in areas such as organ donation.
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Introduction Decision tree analysis uses an algorithm to classify 
data items by recursively posing a series of questions about items 
within a dataset. Each question leads to another node and potentially 
more questions until a predefi ned end condition is reached or no 
more questions can be asked (Figure  1). We hypothesize that scores 
generated using the decision tree method will improve upon our 
existing Hamilton Early Warning Score (HEWS) for a composite 
endpoint of cardiac arrest, unplanned ICU admission or death.
Methods A database of 156,642 electronically captured vital signs from 
6,757 consecutively admitted patients to eight medical and surgical 
wards will be used to train and test the decision tree early warning 
score. One-third of the data will be withheld from the algorithm for use 
as a testing set. The algorithm will look for signifi cant changes in vitals 
72 hours prior to an outcome and develop the score based upon the 
resulting relative risk of the composite endpoint happening given a 
certain vital sign. The scores and predictions generated by the decision 
tree analysis will then be compared with that of the inception HEWS 
cohort.
Results The planned analysis for determining the discriminatory 
and predictive ability of the decision tree HEWS will be conducted 
with area under the receiver operating characteristic curves. We will 
test whether the current HEWS has the appropriate sensitivity and 
specifi city when compared with that of the decision tree score. The 
AUROC will be calculated for both the training set of data as well as the 
separate population of additional medical and surgical patients. The 
two scores will also be plotted along an effi  ciency curve, comparing the 
percentage of vitals that precede a critical event with the percentage 
of vitals that produce a EWS value greater than or equal to a given EWS 
value.
Conclusion Decision tree analysis methodology with real-life vital signs 
can produce an EWS superior to previous observational studies. Using 
a decision tree, especially one that composites all vitals, may show that 
certain vitals are more predictive of critical events than others. Data will 
be used to further improve our current HEWS score.
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Introduction Timely availability of a kidney specialist poses a 
formidable challenge in ICUs located in tier II and tier III cities of the 
developing world. Renal replacement therapy (RRT) is often required in 
the ICU for acute renal failure patients but availability of a nephrologist/
specialist is scarce, leading to unnecessary and risky transfer to higher 
centers in metropolitans or even worse to death. We explored whether 
a remotely monitored ICU  – an electronic ICU (eICU)  – would help 
mitigate this demand–supply gap.
Methods This retrospective study was conducted at four Critinext 
affi  liates where the eICU was being used to provide 24  × 7 support 
on 89 ICU beds from a remote command center with intensivist and 
other requisite staff . The eICU had complete access to the patient’s 
real-time vitals, hemodynamic parameters, imaging, laboratory 
values, audiovisuals and appropriately engineered smart alerts. The 
eICU model was further extended in initiating and getting RRT done 
in patients whenever deemed necessary in times of unavailability of 
a specialist at the same site. Patient baseline demographics, including 
risk factors, severity score, all-cause mortality at 30  days, transfers to 
higher center for RRT and its prevention were recorded. Descriptive 
analysis was performed. Between-group comparison was performed 
by applying the chi-squared statistic, signifi cance was assumed at a 
value of P <0.05. Out of a total of 5,146 admissions, 752 inpatient fi les 
with acute kidney injury/acute renal failure were reviewed, January to 
July 2013 (n = 373) and July 2013 to January 2014 (n = 379) pre and post 
eICU implementation respectively.
Results While baseline demographics and the patient profi le in the 
two groups did not show statistically signifi cant diff erence, mean 
APACHE II score was 14.25 ± 1.94 and 14.65 ± 1.76 pre and post eICU 
respectively; there was a statistically signifi cant diff erence in all-cause 
mortality at 30 days which decreased from 31 (8.3%) to 16 (4.2%) pre 
and post eICU respectively, a reduction of >49% (P = 0.030) and transfer 
out for RRT came down by >77%, from 15 (4%) to two (0.5%) post eICU 
implementation (P <0.002).
Conclusion Over the years there is now broad consensus over the 
benefi ts of eICU intervention in deprived areas [1]. There is now a need 
for a paradigm shift to elevate specialized care to improve outcomes. 
Our small study has clearly indicated the benefi ts in outcome and 
economics even while providing intervention in such remote areas. An 
eICU as a bridge to the demand–supply gap needs to be explored and 
utilized further to its full potential in the emerging world.
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Figure 1 (abstract P503). Sample heart rate decision tree.
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Introduction The aim was to evaluate outcomes and resource use 
and to investigate the association between organizational factors and 
effi  cient resource use in a large sample of Brazilian ICUs.
Methods A retrospective cohort study in 59,483 patients (medical 
admissions: 39,734 (67%)) admitted to 78 ICUs (private hospitals, n = 
67 (86%); medical or medical–surgical, n = 62 (79%)) during 2013. We 
retrieved demographic, clinical and outcome data from an electronic 
ICU quality registry (Epimed Monitor System). We surveyed ICUs using 
a standardized questionnaire regarding hospital and ICU structure, 
organization, staffi  ng patterns, process of care and family care policies. 
Effi  cient resource use was assessed by estimating standardized 
mortality rates (SMR) and standardized resource use (SRU) adjusted for 
the severity of illness according to the SAPS 3 score, as proposed by 
Rothen and colleagues [1].
Results The median admissions per center was 898 (IQR 585 to 1,715) 
and SAPS 3 score was 41 (33 to 52) points. Median ICU length of stay 
was 2 (1 to 5) days, and ICU and hospital mortality rates were 9.6% and 
14.3%, respectively. Estimated SMR and SRU were 0.97 (0.72 to 1.15) 
and 1.06 (0.89 to 1.37), respectively. There were 28 (36%) most effi  cient 
(ICUs with both SMR and SRU <median), 28 (36%) least effi  cient (ICUs 
with both SMR and SRU >median), 11 (14%) overachieving (ICUs with 
low SMR and high SRU) and 11 (14%) underachieving (ICUs with high 
SMR and low SRU) ICUs. Most effi  cient ICUs were usually located in 
private and accredited hospitals, with step-down units and training 
programs in critical care. In univariate analyses comparing most and 
least effi  cient ICUs, ≥2 clinical protocols (OR  = 7.22 (95% CI, 1.41 to 
36.97)) and graduated nurse/bed ratio >0.25 (OR = 4.40 (1.04 to 18.60)) 
were associated with effi  cient resource use. Daily checklists also tended 
to be associated with effi  cient resource use (OR = 2.89 (0.95 to 8.72), 
P = 0.057).
Conclusion We observed a great variability in outcome and resources 
in a large sample of Brazilian ICUs. Implementation of clinical protocols 
and nursing staffi  ng patterns can be targets to improve the effi  ciency 
in resource use in emerging countries such as Brazil.
Acknowledgements Funded by IDOR, CNPq and FAPERJ. Endorsed by 
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Introduction The aim of the study was to assess the blood pressure 
(BP) and heart rate (HR) changes during shifts in ICU nurses in relation 
to their work experience. Our hypothesis was that less experienced 
nurses, in comparison with more experienced ones, would be subjected 
to more work stress and this could be demonstrated by higher changes 
in BP and HR during shifts.
Methods We enrolled 23 nurses working in an 8-hour shift schedule at 
a general adult ICU. Demographic and clinical data were obtained by 
completing a short questionnaire. The nurses were invited to measure 
their BP and HR at the beginning, in the middle and at the end of their 
shift. An ESH/BSH-certifi ed automatic device was used for the BP and 
HR measurements.
Table 1 (abstract P506). Mean change in systolic and diastolic BP and HR in 
relation to ICU work experience
 Group 1 Group 2 P value
SBP (mmHg) 3.22 –0.40 0.053
DBP (mmHg) 2.08 –0.27 0.061
HR (bpm) 4.46 1.16 0.048
Results The mean duration of working in an ICU was 7.3 ± 5.32 years 
(from 2 to 18 years). The nurses were grouped according to experience – 
Group A: 17 nurses with <10  years of experience (mean: 4.4  years), 
Group B: six nurses with >10 years (mean: 15.6 years). There were 640 
BP–HR measurements. The mean systolic BP, diastolic BP and HR did 
not diff er between the two groups (systolic BP: 111.2 ± 10.9 vs. 113.7 ± 
14.1  mmHg, P  = 0.654; diastolic BP: 72.8  ± 8.2 vs. 71.9  ± 8.1  mmHg, 
P = 0.835; HR: 81.4 ± 7.2 vs. 78.1 ± 8.4 bpm, P = 0.365). Nevertheless, 
the mean change in BP and HR during the shift did diff er between 
the two groups, with the more experienced nurses showing a trivial 
reduction in systolic and diastolic BP and minor increase in HR whereas 
the less experienced ones showed slight increase in both BP and HR 
measurements (Table  1), reaching almost statistical signifi cance. For 
the less experienced nurses in Group 1, it was noted that the mean 
changes were bigger in night shifts although the limited number of 
measurements did not allow robust statistical analysis.
Conclusion The less experienced ICU nurses, with <10 years of ICU work 
experience, tended to increase their BP and HR levels during the shift, 
a fi nding probably heightened during night shifts. Further research, 
including not only cardiovascular parameters, is warranted to uncover 
the eff ects of shift-work pattern in ICU nurses, taking into account this 
specifi cally stressful work environment.
P507
Prehospital transported patients: a resource for accessing 
prognostic risk factors
C Bech1, M Brabrand2, A Lassen1
1Odense University Hospital, Odense, Denmark; 2Sydvestjysk Sygehus Esbjerg, 
Denmark
Critical Care 2015, 19(Suppl 1):P507 (doi: 10.1186/cc14587)
Introduction The survival of patients transported by ambulance 
to the emergency department (ED) depends on clinical conditions, 
patient-related factors and organisational prehospital set up. Data and 
information concerning patients in the prehospital system could form 
a valuable resource for assessing potential risk factors associated with 
adverse outcomes and mortality. Our aim was to describe ambulance 
transports to the ED and identify prognostic factors accessible in the 
prehospital phase and associated with 7-day mortality.
Methods We included all adult patients (≥18  years) with a fi rst-time 
ambulance transport to the ED at Odense University Hospital in the 
period 1 April 2012 to 30 September 2013. Ambulance personnel 
recorded vital signs and other clinical fi ndings on a structured form 
on paper during the ambulance transport. Each contact was linked 
to information from population-based healthcare registers in order 
to identify comorbid conditions and information on mortality. 
Demographic factors and fi rst registered vital sign were analysed by 
univariate logistic regression analysis, with 7-day mortality as outcome.
Results In total, 18,572 fi rst-time ambulance contacts were identifi ed 
in the period of inclusion. Overall 7-day mortality was 4.3% (95% 
CI  = 4.0 to 4.6). Univariate analysis showed increasing age, Charlson 
Comorbidity Index ≥2, vital parameters outside the normal reference 
range and summoned physician-assisted mobile emergency care units 
to be associated with 7-day mortality. Further analyses are currently 
being carried out.
Conclusion We found that several prehospital-registered vital signs 
recorded by ambulance personnel at fi rst contact with the patient were 
prognostic factors of 7-day mortality.
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Introduction In Irish hospitals, the medical senior house offi  cer (SHO) is 
the most junior fully qualifi ed doctor on the medical on-call team. After 
a patient has been seen by an emergency department doctor of any 
level, they are almost always referred directly to the medical SHO. This 
process has been shown to delay a patient’s ward admission by 3 hours 
30 minutes [1]. We attempted to quantify the additional benefi t for the 
patient of being seen by the on-call medical SHO, in terms of patients 
discharged, new diagnoses reached, and new treatments initiated.
Methods The emergency department notes and clinical charts of 182 
patients were assessed. This constituted a random sample of patients 
referred by emergency department doctors to the medical team on call 
over a 2-month period (November to December 2011).
Results Discharged: 3/182 (1.6%) of patients referred to the medical 
team were discharged directly by the medical SHO. Diagnosed: medical 
SHOs suggested a diagnosis which was diff erent from, or additional 
to, the ED doctor, in 52/182 cases (28.6%). However, the medical 
consultant only agreed with this diagnosis in 25 cases (13.7%). This 
means an incorrect new diagnosis was reached more often than not 
(14.9%). Treatment: the majority of cases (116/182 (63.7%)) saw no new 
treatment initiated by the medical SHO. Of the rest, only 31 (17%) had 
a new treatment initiated by the medical SHO which was continued on 
by the medical consultant through the admission.
Conclusion Few direct discharges, new diagnoses, or key new 
treatments were initiated by the medical SHO in the emergency 
department. A paper from our hospital shows that more patients 
referred in by GPs to ED are admitted compared with those referred in 
to the acute medical assessment unit, with comparable disease severity 
(43% vs. 12.5) [2]. That paper highlighted the fact that the junior level of 
the medical NCHDs who see patients in the ED may contribute to their 
lack of discharging/decision-making zeal. Our survey further illustrated 
this feature. Our study provided no evidence that a formal medical 
assessment should delay a patient progressing to the medical ward. 
Additional genuine urgent OPD appointment slots could be another 
benefi cial measure.
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Introduction In 2007, the Acute Medicine Task Force made 
recommendations about the operation and staffi  ng of acute medical 
units (AMU). Consultant-led care was seen as critical to ensuring high 
standards of care for patients and maintaining effi  cient patient fl ow [1]. 
It also recommended that during the hours when the AMU is staff ed 
by a consultant, all new patients should be seen within 6 to 8 hours. 
Patients admitted overnight should have a consultant review within 12 
to 14 hours. Following the introduction of a 4:00 pm consultant ward 
round of newly admitted acute medical patients to the existing 8:00 am 
and 2:00 pm rounds, it was our intention to establish whether our trust 
was meeting those recommendations.
Methods We conducted a prospective survey of all new acute medical 
admissions over a 2-week period. Data collected included date and 
time of admission to the hospital, location on arrival, time of fi rst 
medical clerking, and time of fi rst consultant review.
Results Data were collected for 420 admissions. Sixty-seven percent of 
patients were admitted to the hospital between 12:00 am and 12:00 pm 
with a peak occurring between 4:00 pm and 6:00 pm. Sixty-two percent 
of patients were fi rst seen by a consultant within 12 hours of admission, 
with a range from 23 minutes to 26 hours. When looking at patients 
admitted during the weekdays, 63% of them were seen within 12 hours; 
for those admitted at the weekend the fi gure was 57%.
Conclusion In 2011 the Royal College of Physicians emphasized the 
impact that the quality of the care provided within the fi rst 48 to 
72 hours had on clinical outcomes. An evaluation of consultant input 
into acute admissions management revealed that hospitals in which 
two or more ward rounds of all acute medical unit patients were 
performed daily had a lower adjusted case fatality rate for patients with 
hospital stays over 7 days. Despite twice-daily consultant ward rounds 
of all new acute admissions and the addition of a third 4:00 pm round 
from Monday to Friday, only 62% of patients were seen by a consultant 
within 12  hours. With 67% of patients being admitted between the 
hours of 12:00  am and 12:00  pm, it is possible that the substitution 
of an evening round for one of the afternoon rounds would help 
increase the number of patients seen within the target time frame. This 
would require a change in the working pattern of the acute medicine 
consultants.
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Introduction Critically ill patients may require interhospital transfer 
for specialist care or because of a lack of local ICU capacity. Harm is 
assumed from delays that result, but it is not clear whether these delays 
are due to transfer distances or defi ciencies in the organisation of care.
Methods In total, 151 of 15,602 deteriorating ward patients in the 
(SPOT)light study [1] were transferred rather than admitted locally. 
We defi ned delay as the time from critical care assessment in the 
fi rst hospital to arrival in critical care in the second hospital. We used 
hospital postcodes to derive latitude and longitude, and calculated 
both geodesic (straight-line) distances (Figure  1) and road distances 
between the sites using R version 3.1.1 [2]. We compared daytime versus 
overnight (7:00  pm to 7:00  am) transfer durations assuming traffi  c 
would contribute less to delay overnight. Mapping and visualisation 
was performed on Quantum GIS version 2.4 [3].
Results The median delay to admission was 22  hours (range 41 to 
167  hours). The median geodesic distance was 18  km (range 1 to 
141 km), and road distance was 24 km (range 2 to 180 km). Correlations 
between time delay and geodesic/road distances were weak (Figure 2, 
Figure 1 (abstract P510). Map of transfers.
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R2 = 0.015 and 0.011, respectively). Transfer delays in the daytime and 
overnight were similar (Wilcoxon rank sum, P = 0.6).
Conclusion Interhospital transfers are subject to clinically signifi cant 
delays, and substantial travel distances. Delays are only weakly correlated 
to distances travelled and may refl ect delays resulting from organisational 
ineffi  ciencies. We infer that eff orts to improve the effi  ciency of transfer 
should focus on local organisational issues. There was no diff erence in 
the duration taken for overnight versus daytime transfers.
References




Delayed ICU discharges and medical follow-up: a cause of increased 
mortality?
M Whitaker, MH Spivey
Royal Cornwall Hospital, Truro, UK
Critical Care 2015, 19(Suppl 1):P511 (doi: 10.1186/cc14591)
Introduction Discharge from intensive care is a potentially vulnerable 
time for patients who are recovering from critical illness. Recent data 
from the ANZICS group have highlighted that the mortality diff erence 
in those patients who are discharged out of hours is nearly twice that of 
those discharged during the day [1]. These results have been replicated 
in our institution with a mortality of 8.7% (discharged 22:00 to 06:59) 
versus 4.8% (discharged 07:00 to 21:59). In the UK, NICE CG50 advised 
that transfer from critical care to the ward out of hours should be 
avoided and documented as an adverse event. We postulated that one 
important factor in our hospital is the decreased medical and nursing 
cover overnight and so looked at the delay from discharge to fi rst 
medical review and to outreach review.
Methods The case notes of 100 consecutive patients discharged to the 
ward between September 2013 and October 2013 were examined to 
identify the time of discharge from the ICU and the subsequent fi rst 
review by the receiving medical team and the Critical Care Outreach 
team. The grade of the doctor reviewing the patient was recorded.
Results Of these 100 patients, 22 were discharged between 22:00 and 
07:59. From the 100 case notes requested, only 50 were available for 
examination. Forty patients were discharged to the wards, with only 
37 having further documented medical reviews in the notes. Only 62% 
of patients were reviewed by a consultant following intensive care, 
with over 20% of patients waiting more than 24 hours for any medical 
review. During this time 18% of patients received a review by the nurse-
led outreach team. See Figure 1.
Conclusion It is clear that a highly vulnerable group of patients who are 
recovering from critical illness [2] receive inadequate early follow-up 
within the hospital. We postulate that the delay in medical review and 
the lack of senior review may be caused by over 40% being discharged 
overnight and contribute to the increased mortality seen in our 
institution and the ANZICS study [1] with nighttime discharges.
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Introduction Wild mushroom poisoning (MP) is an important medical 
emergency that may have bad clinical outcome. We aimed to evaluate 
the clinical and laboratory features of patients with wild MP admitted 
to our emergency department in the Central Black Sea Region and to 
inform the emergency department physicians about early diagnosis 
and management of wild MP in the light of obtained data.
Methods This study was designed retrospectively by examining fi les 
of the patients with wild MP who were admitted to Ondokuz Mayis 
University Emergency Department, between January 2008 and December 
2012. Patients older than 18  years were included in the study. Patients 
were evaluated according to gender, age, location, duration between 
mushroom intake and the start of clinical symptoms, time of application 
to hospital, clinical features and fi ndings and treatment method. The 
number of patients has been compared with the regional distribution of 
population, monthly temperature and average annual rainfall.
Figure 2 (abstract P510). (a) Time duration versus geodesic distance 
(R2 = 0.015). (b) Time duration versus road distance (R2 = 0.011).
Figure 1 (abstract P511).
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Results A total of 420 patients poisoned by wild mushrooms were 
studied. The male/female ratio was 1/1.5. The age of patients changed 
from 18 to 92 and mean age was 46  years. MP constituted 13.3% of 
all intoxication cases. The time when the fi rst symptom occurred after 
mushroom intake was a mean 2 (0.17 to 2.15) hours. Of the patients, 
47.6% lived in villages, 38.6% in towns and 13.8% in city centers. 
Admissions were mostly made in autumn, with 57.6%. Eighty-six 
percent of intoxications happened because of wild mushrooms 
collected in nature. The most frequent symptoms were nausea (93.8%), 
and vomiting (87.1%). Increase in liver function tests in 47 patients was 
observed. Two of these patients died while 10 patients were transferred 
to further centers for liver transplantation. The remaining patients were 
discharged from the hospital.
Conclusion Wild MP can cause bad clinical outcome. The public should 
be informed about the probable hazards of wild mushroom ingestion 
because collection and consumption of wild mushrooms from nature 
is common. Public health units should take protective precautions 
against wild MP. Education of health personals regarding MP will lead 
to successful results in patient management.
P513
Triage after drug overdose: eff ect of the introduction of a medical 
psychiatry unit on the allocation of ICU beds
D Kleinloog, F Braam Houckgeest, D Sierink
Tergooiziekenhuizen, Hilversum, the Netherlands
Critical Care 2015, 19(Suppl 1):P513 (doi: 10.1186/cc14593)
Introduction Many patients with drug overdose are sedated, but 
do not have medical reasons to warrant ICU admission. Historically, 
monitoring behavior and suicide risk was done in the ICU, until the 
patient was awake enough for psychiatric consultation.
Methods A medical psychiatry unit (MPU) was instituted as part of the 
Department of Clinical Psychiatry. For all patients with drug overdose 
in the emergency department, a risk assessment was made by the 
intensivist. Those without ICU indication (such as cardiac or respiratory 
monitoring) were admitted to the MPU. Alternatively, when awake 
enough, they were seen by the psychiatrist immediately. We performed 
an analysis of all patients with drug overdose, admitted to our ICU 
(before MPU n = 88, after MPU n = 191). We used the Welch t test for 
comparisons.
Results After institution of the MPU, there was a 28% reduction in the 
number of patients with drug overdose per month, admitted to the 
ICU. Also, patients admitted to the ICU were sicker and stayed longer 
(see Table 1). There were no patients admitted to the ICU after initial 
MPU admission.
Table 1 (abstract P513). Patient numbers and disease severity before and 
after introduction of MPU
 Before MPU Since MPU   
 (18 months) (51 months) Diff erence 95% CI P value
Admissions per month 4.9 3.5 –1.4 –2.7 to –0.1 0.04
APACHE II score 8.4 12.5 +4.0 +1.8 to +6.2 0.0004
APACHE III score 30.9 40.3 + 9.4 +2.6 to +16.2 0.0069
Length of stay 0.8 1.3 + 0.5 –0.0 to +1.0 0.05
Conclusion Introduction of an MPU was associated with reduced 
numbers of patients with drug overdose admitted to the ICU. Those 
admitted to the ICU after the institution of the MPU were sicker, 
probably indicating more appropriate use of ICU beds.
P514
Prospective controlled study to compare the eff ects of a basic 
patient safety course on healthcare worker patient safety culture
L Ling, G Joynt, A Lee, W Samy, H Fung, CD Gomersall
The Chinese University of Hong Kong, Shatin, Hong Kong
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Introduction It is estimated that about one in 10 patients may be 
harmed by adverse events during their hospital stay [1]. Transforming 
organizational culture to improve patient safety culture is considered 
important. We conducted a prospective, controlled study to assess 
the impact of a standardized patient safety course on an ICU’s patient 
safety culture, using a validated patient safety culture assessment tool.
Methods Staff  from two ICUs – ICU1 (tertiary referral hospital) and ICU2 
(district hospital) – in Hong Kong were recruited to compare changes 
in the measured safety culture before and after a patient safety course. 
The BASIC Patient Safety course was only administered to staff  from 
ICU1, and safety culture was assessed in both units before and after, 
using a survey based on the Hospital Survey on Patient Safety Culture 
[2]. Relative risk (95% CI) of improvement: baseline to follow-up in 
hospitals in patient safety domains, adjusted for duration of work in 
the unit (≤10  years vs. >10  years), was calculated. Responses were 
coded according to the Survey User’s Guide, and positive response 
percentages for each patient safety domain were compared with the 
2012 Agency for Healthcare Research and Quality (AHRQ) ICU sample 
of 36,120 respondents.
Results Preintervention and postintervention period response rates for 
ICU1 were 88.1% (37/42) and 79.3% (23/29); and for ICU2 63% (20/32) 
and 63% (15/24). Post intervention, compared with ICU2, ICU1 showed 
signifi cantly improved perceptions of teamwork within the hospital 
unit, RR (95% CI for diff erence between ICUs) 1.55 (1.10 to 2.19, P  = 
0.01); and overall perception of safety, 1.94 (1.11 to 3.37, P = 0.02); but 
not increased frequency of reporting mistakes, 0.90 (0.33 to 2.49, P = 
0.84). Overall, ICU1 demonstrated a greater improvement in positive 
responses in fi ve safety culture domains than staff  from ICU2. Patient 
safety culture indices were generally poorer in the two ICUs than the 
average ICU in the AHRQ database.
Conclusion The study provides supportive evidence that a structured, 
reproducible short course on patient safety is associated with a general 
improvement in the ICU’s patient safety culture, measured with a 
validated safety culture assessment tool.
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Audit of imaging documentation on an ICU
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Introduction The Ionising Radiation (Medical Exposure) Regulations 
2001 recommend to ‘ensure that a clinical evaluation of the outcome 
of each medical exposure is recorded’ [1]. This audit looked at 
whether ICU documentation of investigations involving ionising 
radiation could be improved. Anticipated benefi ts would be improved 
communication between the multidisciplinary team and better-
informed decision-making.
Methods Patients admitted to the ICU between 21  September 2014 
and 2 October 2014 were included. If an investigation did not involve 
ionising radiation or was not requested by intensive care clinicians it 
was excluded. The indication for imaging was noted, and patient notes 
were analysed no less than 48 hours after the imaging was reported.
Figure 1 (abstract P515).
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Results As shown in Figure 1, imaging requests were generally poorly 
documented (61%). In total, 17/26 (65%) chest X-rays (CXRs) were 
documented. A total of 0/2 CT scans were documented, despite one 
showing acute changes. In total, 17/20 (85%) CXRs requested following 
procedures carried out on ITU (such as insertion of central venous 
catheters) were documented, and the three not documented had no 
signifi cant fi ndings. The six other CXRs were requested to investigate 
worsening respiratory function. None were documented. Five had 
signifi cant fi ndings.
Conclusion Investigations following procedures were generally 
well documented, but investigations seeking pathology were not 
documented at all, regardless of the fi ndings. This may have infl uenced 
the management of the patient and compromised patient safety. As 
such, the audit was presented at a departmental meeting to emphasise 
the importance of imaging documentation. A place for investigations 
was added to the ICU patient list to improve communication between 
the team, and a second audit is planned to assess the impact of this.
Reference
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Barriers to the implementation of checklists in the ICU: a survey on 
the perceptions of 314 Brazilian critical care nurses and physicians
J Salluh1, W Viana2, F Machado3, A Cavalvanti4, F Bozza1, M Soares1
1IDOR, Rio de Janeiro, Brazil; 2Hospital Copa D’OR, Rio de Janeiro, Brazil; 
3UNIFESP, São Paulo, Brazil; 4Hcor, São Paulo, Brazil
Critical Care 2015, 19(Suppl 1):P516 (doi: 10.1186/cc14596)
Introduction Checklists have been used increasingly in the ICU aiming 
at mitigating avoidable adverse events, but their content is variable and 
little is known about barriers to their full implementation. This survey 
reported practices on the use of checklists and perceptions regarding 
barriers on its implementation.
Methods A web-based survey was conducted among a convenience 
sample of Brazilian ICU nurses and physicians between August and 
October 2014. Standard descriptive statistics were used.
Results A total of 314 professionals, 104 nurses (33.1%) and 210 physicians 
(66.9%), responded. The majority (82.4%) had more than 5  years of 
experience in intensive care. Checklists were applied every day, including 
weekends, in only 49.8% (n  = 227). When we compared the barriers 
perceived by those working in smaller versus larger ICUs (<10  beds vs. 
>20 beds), the absence of a more comprehensive checklist content (93.6% 
vs. 81.9%, P = 0.026), the absence of specialized software or app (80.8% 
vs. 63.8%, P = 0.014), low availability of mobile devices (87.2% vs. 72.4%, 
P  = 0.019), Internet unavailability (83.3% vs. 67.6%, P  = 0.017), and the 
limited number of computers (88.5% vs. 76.2%, P = 0.0366) were the most 
often barriers to implementation. Checklists were applied with similar 
frequencies (<3 times a week, three to fi ve times a week, and every day, 
including on weekends, P  >0.05) regardless of the ICU size. When the 
type of tool used (paper vs. electronic) was considered, the main barrier 
highlighted was the lack of 100% Internet availability in the ICU (64.8% 
vs. 100%, P = 0.009). Users of paper form had higher demands for more 
comprehensive checklist content (84.3% vs. 63.6%, respectively, P = 0.037) 
and experienced more barriers to team adherence (98.1% vs. 86.4%, 
respectively, P = 0.034) as compared with those using specialized software.
Conclusion Although checklists are recognized as valuable tools 
for the adherence to best practice in the ICU, it is diffi  cult to ensure 
the uniformity of their daily use. Resource limitations in smaller ICUs 
and the absence of comprehensive digital tools, mobile devices and 
Internet availability preclude full compliance at the bedside.
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After Round Comprehensive Plan Summary tool: an effi  ciency 
approach for the ICU
R Marktanner, M Mostafa, A Shafei, H Hon, R Ashraf, P Sreedhara, N Syed, 
D Gharaibeh, A Taha
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Introduction ICU workfl ow for physicians, nurses and other healthcare 
providers is often complicated by distractions, interruptions, diffi  culties 
to concentrate, multitasking and the need to frequently change 
priorities in patient care-related procedures. It is therefore a continuous 
challenge to communicate and implement plans in an early, effi  cient 
and reliable way within the team and to constantly keep track about 
tasks that are completed, postponed or that are about to be forgotten. 
To facilitate every caregiver’s workfl ow and to early and effi  ciently 
communicate, we implemented the After Round Comprehensive Plan 
Summary (ARCoPS) tool.
Methods Most of our patient care-related therapeutic and diagnostic 
decisions are made during the morning round consisting of intensivists, 
nursing team, surgeons, respiratory therapists, dieticians, clinical 
pharmacists and physiotherapists. Immediately thereafter, all plans for 
the next 24-hour period are again discussed, summarized, confi rmed, 
prioritized and organized by the multidisciplinary team under aspects 
of optimal patient care and workfl ow effi  ciency by entering the plan 
data into a fl at screen visualized template connected to our intranet 
immediately accessible at every physician and nursing caregiver 
workstation.
Results Twelve months after implementation of the ARCoPS tool 
we conducted caregiver interviews and identifi ed the following 
eff ects: increase in treatment confi dence through standardized 
multidisciplinary decision-making; reduced loss of information 
through immediate plan summarization by the whole team; reduction 
of ambiguity and misunderstanding about care plans through early 
written documentation; higher level of security not to forget procedures 
or tasks; positive acceptance of the tool to fl exibly change priorities of 
care procedures; positive acceptance of the tool to mark accomplished 
tasks providing visual feedback about the care plan status; individual 
caregiver workfl ow economization through permanent treatment plan 
availability; and higher job satisfaction throughout the caregiver team.
Conclusion ARCoPS tool utilization has become a daily routine in our 
ICU. It functions as an eff ective communication and workfl ow tool and 
has helped us to reduce patient care-related misunderstandings and 
delays. It also enhanced the economics of our work sequence, which 
also highly contributes to a better level of patient safety. Furthermore, 
it has markedly contributed to an improved level of quality of work for 
caregivers.
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study): adverse events and outcome in the SICU
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Introduction The aim of this Thai-SICU was to study the incidence and 
outcome of adverse events in nine SICU university-based hospitals in 
Thailand.
Methods This multicenter prospective observational study was done 
in >18 years old, admission >6 hours surgical patients admitted to the 
large, postgraduate medical training university-based SICU during 
April 2011 to January 2012. Patient data were divided into three main 
phases as admission, discharge data and daily CRFs during the ICU stay. 
The patients were followed until they were discharged from the ICU 
or up to 28  days of their ICU admission and up to 28  days following 
discharge from the ICU if they survived.
Results Following a 19.7-month recruitment period, a total of 4,654 
patients (17,579 ICU-days) were included in the analysis process. 
Admitted patients had the median age of 64 years. Most of the patients 
were admitted directly from the OR for postoperative monitoring with 
median APACHE II score 10, 23% were admitted with priority I who 
needed aggressive hemodynamic resuscitation and respiratory support. 
ICU mortality and 28-day mortality were 9.61% and 13.80%. Each day 
of ICU increment was associated with a 1.38-day increase of hospital 
stay (95% CI, 1.24 to 1.53; P <0.01). On the surveillance periods, the six 
most common adverse events were sepsis (19.5%), AKI (16.9%), new 
cardiac arrhythmias (6.17%), respiratory failure (5.83%), cardiac arrest 
(4.86%) and delirium (3.5%) respectively. The other events including 
reintubation within 72 hours, intraabdominal hypertension, acute MI, 
unplanned extubation, upper GI hemorrhage, pneumohemothorax, 
seizure, drug error and pulmonary aspiration were <3% each. The risk 
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of adverse events on 28-day mortality were signifi cant on cardiac arrest 
(RR = 9.45; P <0.01), ARDS (RR = 4.58; P <0.01), AKI (RR = 4.18; P <0.01), 
sepsis (RR = 3.62; P <0.01), iatrogenic pneumohemothorax (RR = 3.23; 
P <0.01), seizure (RR = 3.12; P <0.01), upper GI hemorrhage (RR = 2.97; 
P <0.01), cardiac arrhythmia (RR = 2.91; P <0.01), ALI (RR = 2.71; P <0.01), 
delirium (RR  = 2.13; P  <0.01), MI (RR  = 2.12; P  <0.01), unplanned 
extubation (RR  = 2.06; P  <0.01), abdominal hypertension (RR  = 1.75; 
P <0.01) and reintubation within 72 hours (RR = 1.51; P = 0.02).
Conclusion This is the largest systemic surveillance observation in the 
SICU. The study results are the reference for future research and also 
provide information for patient and relative advice when confronted 
with adverse events during SICU admission.
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Introduction A signifi cant number require a postoperative ICU stay 
which may be prolonged [1]. Very limited data exist to characterise 
mortality and ICU length of stay (LOS) in diff erent surgical specialties 
[2,3]. We aim to describe this relationship in a large cohort of surgical 
patients.
Methods We performed a retrospective observational cohort study of 
adult surgical admissions to the ICU of a large academic tertiary medical 
centre. The primary endpoint was 28-day mortality. We used simple 
descriptive statistics to characterise the population. The Wilcoxon rank-
sum test or Kruskall–Wallis test was used, as appropriate, for tests of 
continuous data.
Results There were 6,203 surgical admissions during the 8-year study 
period. For both ICU and in-hospital mortality; the median LOS in days 
for survivors was 2.2 (IQR: 1.2 to 4.9) and that of nonsurvivors was 3.2 
(IQR: 1.5 to 7.9). At 28 days, 1 year, and 2 years, the respective values 
were 2.2 (1.2 to 4.9) and 3.3 (1.5 to 6.7); 2.1 (1.2 to 4.7) and 3.1 (1.5 to 
7.3); and 2.1 (1.2 to 4.6) and 3.0 (1.5 to 7.0), all P <0.0001. The greatest 
median LOS was found in neurosurgery and cardiothoracic surgery; 
3.3 days (IQR: 1.7 to 9.5) and 3.1 days (IQR: 1.5 to 8.0) respectively. They 
corresponded to the specialities with the greatest percentage ICU 
(9.7% and 10.2%) and 2-year mortality (27.9%, and 35%). The greatest 
mortality and median LOS was found in ventriculostomy cases; 40.8% 
at 2 years and 10.6 days (IQR: 4.8 to 18.2).
Conclusion There is an association between postoperative ICU LOS and 
mortality that persists for at least 2 years after admission. Neurosurgery 
and cardiothoracic surgery patients appear to have a worse prognosis 
and also a more prolonged LOS. Our results may provide a more 
objective basis for clinical decisions, the use of limited resources, and 
inform on appropriate expectations of treatment.
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Introduction Emergency department observation units are often 
used to monitor critical patients in a situation of constant emergency 
department overcrowding and lack of intensive care beds. However, 
those units are often understaff ed and might not have enough 
personnel and equipment to provide the same quality of care as a 
conventional ICU.
Methods We performed an observational study in a 17-bed, mixed 
clinical and surgical emergency department observation. Before the 
year 2012, the staff  were composed of fi rst-year internal medicine 
and surgical residents. There were no senior physicians specifi cally 
assigned to this unit, and residents were supervised by the members 
of the emergency department team, who changed shifts on a daily 
basis. In February 2012, two senior physicians (one cardiologist and 
one intensive care doctor) were specifi cally assigned to supervise the 
internal medicine residents and provide horizontal care for medical 
patients during the day, from Monday to Friday. There was no change in 
assistance for surgical patients. The schedule for nights and weekends 
remained unchanged. Mortality and length of stay for medical and 
surgical patients were measured in 2011, 2012 and 2013.
Results In the fi rst year after the implementation of the clinic intensive 
care team, mortality in internal medicine patients decreased from 47% 
to 34% in 2012 and 33% in 2013. Although other changes happened in 
this period (the number of beds decreased from 24 to 17, nurses and 
physical therapists were hired and trained specifi cally for this unit), we 
believe the horizontal staff  was critical, because mortality between 
surgical patients remained almost unchanged in the same period 
of time (23% in 2011, 22% in 2012 and 23% in 2013), in spite of the 
structural improvements that equally aff ected those patients. Length 
of stay decreased from 6.35 days in 2011 to 3.43 in 2012 and 3.15 in 
2013 in medical patients and from 3.9 days on average in 2011 to 3.2 in 
2012 and 2.8 in 2013 in surgical patients.
Conclusion Emergency department observation units are an 
alternative to alleviate emergency room overcrowding when there are 
no intensive care beds available. However, patients end up staying in 
those units for days and horizontal care by senior doctors may improve 
outcomes.
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Introduction The aim was to know the frequency, criteria and 
implications of rejection for ICU admission to our ICU unit, a second-
level hospital (18 beds).
Methods An observational retrospective study in a time interval of 
6  months (January to June 2013). We retrospectively registered all 
patients rejected for admission to our unit, analyzing the clinical 
rejection report used in our hospital. From this report we extracted 
diff erent variables: demographical (age, sex), provenance (emergency 
room, hospital), clinical (comorbidity, functional situation, diagnosis, 
reason of requesting admission), rejection motive (‘too good’, ‘too bad’, 
futility, lack of beds, patient rejection), whether it was defi nitive or 
conditional, whether the patient was admitted afterwards, and the state 
at hospital discharge. We realized a descriptive analysis (frequencies) and 
multivariant analysis of the factors related to futility rejection.
Results There were 165 rejections, which represents 25% of total 
ICU patients evaluated for admission. A total of 59.4% were male. 
Mean age was 69 ± 7 years (19 to 98). In total, 53.9% had more than 
two comorbidities (pluripathological) and 31.5% moderate to severe 
functional disability. The cause of rejection was in 55.2% of situations 
that the patient was ‘too good’, 37.6% related to qualitative futility, 
4.8% was ‘too bad’ and in 1.2% a mix of lack of space (beds) and patient 
rejection. In the multivariant analysis the signifi cant variables related to 
futility rejection were age (by years) with an OR of 1.05 (1.02 to 1.08), 
severe functional disability, OR of 4.35 (2.09 to 9.06), and the hospital 
provenance with an OR of 2.82 (1.1 to 7.2).
Conclusion Rejection for admission to ICU units is a frequent medical 
activity in our day-to-day job. The type of patient most rejected is 
cardiologic, mostly evaluated for thoracic pain probably ischemic but 
with low risk. In second place we found patients for which we decide 
rejection based on subjective qualitative futility, related mostly to age, 
prior functional disability and provenance.




Impact of age, physiological status and APACHE score on 
acceptance of patients to the ICU
L Terry, S Passey, D Porter, F Clark, R Matsa
Royal Stoke University Hospital, Stoke on Trent, UK
Critical Care 2015, 19(Suppl 1):P522 (doi: 10.1186/cc14602)
Introduction Evidence suggests that age, chronic health status and 
acute illness severity aff ect the decision-making of clinicians regarding 
admission to the ICU (ITU) [1-3]. This prospective service review assesses 
the impact of age, APACHE II score and WHO functional score towards 
admission acceptance or refusal to ITU in a tertiary-level facility.
Methods Design: a planned prospective review of all referrals over a 14-
day period. Data collection: review (LT, DP, SP) of case notes of patients 
referred to ITU with the following variables collected: age, sex, APACHE 
II scores, WHO functional status score, grade of referrer and source of 
referral. Data were collected on 37 patients: 22 accepted to ITU and 
15 refused admission. Statistics: data were analyzed using GraphPad 
6.05. Categorical variables were expressed as mean and standard error 
of mean. For unpaired variables, statistical signifi cance is determined 
using unpaired t test. P <0.05 is considered statistically signifi cant.
Results The WHO functional status was the most signifi cant variable 
aff ecting admission (P <0.001). The APACHE score of patients admitted 
to ITU was signifi cantly lower than refused patients (P = 0.039). Patient 
age did not aff ect admission status (P = 0.15). See Table 1.
Table 1 (abstract P522)
 Accepted Refused P value
Mean age 56.5 ± 4.4 65.3 ± 3.6 0.15
Sex 73% male 56% male N/A
WHO 0.45 ± 0.2 2.21 ± 0.3 <0.001
APACHE 13.5 ± 1.6 18.8 ± 2.0 0.039
Conclusion This study was performed to assess decision-making 
for admission to the ITU in times of increased demand and limited 
availability. We want to validate our fi ndings from this short pilot 
study in a larger prospective study. Multivariate regression analysis will 
be used to identify signifi cant features that aff ect clinician decision-
making in critical care admission.
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Introduction This Six Sigma project was initiated to evaluate and 
improve the transfer of care of patients from the OR to the ICU. Medical 
errors are responsible for billions of dollars in increased healthcare 
spending. Miscommunication among healthcare providers is a major 
contributor to these errors, with handoff s a particularly vulnerable 
period in the care process. At our institution, surgical patients with 
scheduled admissions to the ICU are fi rst recovered in the postanesthesia 
care unit (PACU). With this process, multiple, unstructured, and 
individual handoff s occur in parallel between providers, which may 
lead to communication errors, diff erential information sharing, content 
variability, care delays, and ineffi  ciency.
Methods A multidisciplinary QI project was initiated with input from 
the ICU, anesthesia and surgical services. A series of PDSA cycles 
were conducted, which began by defi ning the current process via 
direct observation and value stream mapping of orthopedic and 
neurosurgical patients. A new process was then introduced, including 
direct transfer of the patient to the ICU and a single, structured, bedside 
report between all care providers. A standardized handoff  tool was 
implemented. We used process times, wait times and information 
content as process measures and handoff  errors as outcome measures. 
A 10-point satisfaction score was also measured.
Results Following implementation of the new transfer process, the 
average wait time decreased by 58  minutes, process time decreased 
by 9 minutes, and lead time decreased by 66.5 minutes. The handoff  
error rate decreased by 1.3 errors/patient and fi rst-time quality rate 
increased by 67%. Staff  satisfaction improved from 48% to 73%. By 
elimination of the PACU stay, the costs involved in admission to the 
PACU were deferred.
Conclusion A single, multidisciplinary bedside handoff  process 
between the OR and ICU leads to cost and time savings. By elimination 
of redundant, nonvalue-added processes, less opportunity for medical 
errors occurred, with substantial improvements in fi rst-time quality. 
Such a process can be successfully attained while aff ecting staff 
satisfaction positively.
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Improved interprofessional communication, handover and ward 
rounds in critical care (ICARUS)
P Hopkins, A Chan, S Rasoli, C Bell, K Peters, A Feehan, J Dawson
King’s Health Partners AHSC, London, UK
Critical Care 2015, 19(Suppl 1):P524 (doi: 10.1186/cc14604)
Introduction There is growing evidence that optimising communication 
and patient assessment practices including ward rounds and handoff s 
can improve clinical, safety and operational outcomes, particularly in 
the critical care setting [1,2]. Here we describe the design and baseline 
phases of a 5-year project utilising improvement sciences to optimise 
the quality of interprofessional communication, handoff s and rounding 
in one of the largest critical care units in the UK.
Methods We obtained institutional ethical and research approvals. 
We used mixed methods including interviews of opinion leaders and 
a representative cross-section of staff , roundtables, a survey targeting 
the whole critical care team (n = 546) and a Delphi exercise to generate 
a baseline consensus for the need to improve and a set of novel quality 
improvement interventions and tools. We tested two of these in a pilot 
plan–do–study–act (PDSA) cycle.
Results Baseline consensus for the need and potential to improve was 
obtained (97.4% and 94.5%). Despite a large degree of heterogeneity 
of perceptions around current communication and rounding practices, 
it was possible to develop a set of interventions based on consensus 
that could be applied in this complex setting. These included a handoff  
bundle, an operational touch-base, a unit-level safety briefi ng, a unit-
level safety check, a lean rounding bundle and board rounds. These 
core interventions were supported by several more detailed resources 
describing the evidence base around best handoff  and rounding 
practices; and a feedback document that described all outputs and 
recommendations from the ICARUS project. A pilot PDSA cycle 
demonstrated a 55.3% and 76.3% improvement in key information 
transfer using a safety briefi ng and board round summary.
Conclusion Despite wide heterogeneity in baseline beliefs, opinions 
and perceptions around inter-professional communication, rounding 
and handoff s, we were able to develop a novel set of feasible quality 
improvement interventions, targeting these areas, that can be applied 
in a large complex critical care setting. Furthermore, they can be driven 
by improvement science methodology and tested for eff ectiveness 
using qualitative and quantitative measures. We now plan to use these 
interventions to deliver quality improvements in communication 
practices in parallel with the planning and implementation phases of a 
new critical care facility and electronic clinical information system.
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Introduction Security policies for the patient are of interest to any 
health professional. The rates of adverse events in hospitals reach 
values ranging between 3.7 and 16.6%, being the highest range (40 
to 70%) considered preventable or avoidable [1]. The objective of 
this study is to assess the prevalence and types of adverse eff ects in 
intensive care patients according to readmission.
Methods During 4 years the data from 2,582 patients admitted to the 
coronary ICU (CICU) were analyzed in the coronary care unit of the city 
of Presidente Prudente, Brazil. We analyzed the rate of readmissions, 
length of stay and the mainly detected adverse events. We considered 
signifi cant P <0.05 two-tailed and confi dence intervals at 95% (CI).
Results The readmission rate was 15% (n  = 392), particularly among 
males (55% (n  = 214)). A 14.3% adverse event rate was observed 
among the readmitted patients (9.5% among those who were not 
readmitted). The readmitted patients were older (median (md): 68.0 
(95% CI: 65.7 to 67.3) vs. md: 71.0 (95% CI: 67.1 to 71.3); P <0.05) and 
remained hospitalized for a longer period of time (md: 5.0 (95% CI: 13.2 
to 20.7) vs. md: 11.0 (95% CI: 17.0 to 33.2); P <0.05), but not necessarily 
in the CICU (P = 106).The most prevalent adverse events in readmitted 
patients were pressure ulcers (n = 16 (4.1%)), drug administration error 
(n  = 13 (3.3%)) and enteral feeding tube (n  = 10 (2.6%)). Meanwhile, 
among the nonreadmitted, phlebitis due to peripheral vein access and 
pressure ulcers (n = 42 (1.9%)), drug administration error (n = 41 (1.9%)) 
and enteral feeding tube (n  = 31 (1.4%)). There was a tendency (P  = 
0.71) that readmitted patients were presented with higher prevalence 
of pressure ulcers (n = 16 (4.1%) vs. n = 42 (1.9%)).
Conclusion There is a higher prevalence of adverse events in 
readmitted patients with similarity in the type of adverse eff ects 
despite readmission.
Reference
1. Forster AJ, et al. CMAJ. 2004;170:345-9.
P526
Out-of-hours discharge from critical care: does it matter?
M Ahmed, G Lumley, S Nourse, A Hurding, A Thomas, M Healy
The Royal London Hospital, London, UK
Critical Care 2015, 19(Suppl 1):P526 (doi: 10.1186/cc14606)
Introduction The aim of this audit was to assess the clinical impact of 
out-of-hours (OOH) discharge from the adult critical care unit (ACCU) 
in a tertiary care hospital. Discharging patients from critical care OOH 
has been associated with both higher mortality and increased rate of 
readmissions [1,2]. As a result, national guidance stipulates that OOH 
discharges from critical care should be avoided [3].
Methods A retrospective snapshot analysis of patients was conducted 
at least 48  hours after discharge from the ACCU in October 2014. 
Patients discharged OOH (20:00 to 07:59) were compared with 
those discharged in hours (IH; 08:00 to 19:59). Analysis included: 
patient demographics, APACHE II score, handover procedure prior to 
discharge, follow-up by the receiving team, appropriate and timely 
drug prescribing, recognising and acting upon clinical deterioration 
and readmission rates.
Results A total of 161 patients were discharged from the ACCU in 
October 2014. Of these, 46% of the patients were discharged OOH. 
Forty-one (of 74) OOH and 19 (of 87) IH discharges were sampled 
for further analysis. The baseline demographics and APACHE II score 
were similar between both groups. The majority of discharges were 
delayed (>4  hours, 90% IH vs. 93% OOH). More patients had nursing 
handover completed if discharged IH (88% IH vs. 61% OOH) and 
doctors’ summaries were less frequently completed OOH (83% OOH 
vs. 94.4% IH). A management plan for the ward was outlined in 94% 
of IH versus 65.% of OOH discharges. Seventy-eight per cent OOH 
versus 95% IH patients discharged were reviewed by a doctor within 
24 hours. Twenty-nine per cent OOH versus 67% IH patients discharged 
were reviewed by a consultant within 24 hours. Following discharge a 
management plan was followed in 94% of IH patients versus 44% OOH, 
patients had drug charts correctly charted in 100% of IH cases versus 
66% OOH and missed/delayed doses were documented in 11.1% of IH 
cases versus 61% OOH. There was no diff erence between the groups 
in incidence of clinical deterioration and recognition and follow-up of 
clinical deterioration. Two patients were readmitted within 48  hours 
from the OOH group.
Conclusion This audit compares with current evidence suggesting 
harm from OOH discharge despite most discharges being delayed. 
Discharging patients is a complex hospital process, but focus needs 
to be on discharging patients IH. Therefore, areas for improvement 
include targeting forward fl ow of patients throughout the hospital, 
completion of handover documents IH and publication of guidance for 
receiving teams.
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mortality
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Introduction Prolonged hospital stay prior to admission to the ICU was 
previously shown to be independently associated with poorer outcome 
[1,2]. This is probably due to slow deterioration of physiological 
function in hospital and infl uenced by processes leading to critical care 
admission [2]. We investigated whether commonly measured severity 
scoring systems (Acute Physiology and Chronic Health Evaluation 
(APACHE) II, Intensive Care National Audit and Research Centre 
(ICNARC) and Sequential Organ Failure Assessment (SOFA) scores) are 
signifi cantly diff erent in patients admitted with prolonged pre-ICU 
hospital length of stay, and describe mortality and hospital length of 
stay.
Methods A retrospective analysis of prospectively collected data of 
all emergency admissions in the ICNARC database of a 44-bed adult 
critical care unit within a major trauma centre over a 2-year period. 
Demographic data, APACHE II score, SOFA score, ICNARC model score, 
mortality, and length of hospital stay prior to and after ICU admission 
were collected. Five groups of patients were defi ned as follows: those 
admitted to ICU within 1 week of hospitalization (group 1), within 8 to 
14 days (group 2), within 15 to 21 days (group 3), within 22 to 28 days 
(group 4), and more than 28 days (group 5). Chi-squared and ANOVA 
tests were performed using the SOFA statistics package.
Results A total of 2,248 emergency admissions were analysed. The 
majority of patients were admitted within 1 week of hospital admission 
(n  = 1,897). They were younger and had lower APACHE II scores (15 
vs. 19; P <0.001). APACHE II scores were the same in all other groups 
(groups 2 to 5). Patients admitted to the ICU 3 weeks following hospital 
admission had signifi cantly higher hospital mortality (up to 50%; 
P  <0.001) and ICU length of stay (12  ± 15 vs. 8  ± 10  days; P  <0.001). 
ICU mortality remained the same in all groups (20 to 28%). ICNARC and 
SOFA scores were equal between the groups. The post-ICU lengths of 
stay were signifi cantly longer in groups 3 to 5. In-hospital CPR prior to 
admission to ICU was lower in patients from groups 4 and 5, probably 
signifying appropriate DNAR decisions made on the ward.
Conclusion Prolonged pre-ICU hospital admission is associated with 
higher hospital but not ICU mortality. Commonly measured scores do 
not refl ect this higher mortality in patients admitted after prolonged 
stay in hospital. Further research into parameters that may refl ect 
changes in physiological reserves may strengthen these scores for such 
patients.
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Introduction Hospital costs are a constant concern within health, 
especially in the ICU. Hospital admissions and average life expectancy 
have been growing gradually mainly in older and critical patients. This 
study is aimed to observe the direct costs of patients admitted to an 
ICU and their relation to the SAPS 3, length of stay in the ICU and fi nal 
outcome.
Methods A retrospective observational study in which the direct costs 
were studied (materials, medicines, oxygen therapy and hospital fees) 
for 1,790 ICU patients from November 2013 to November 2014. The 
readmissions within 48 hours were excluded and also 10% of patients 
who had the highest and lowest costs. The remaining 1,401 patients 
were divided by age groups.
Results Of the patients studied, 54.6% were male. Average age was 
57.8 years (18 to 105 years). The biggest ICU average cost was in the 
group of patients 81 to 90 years old (US$793.00), as well as longest ICU 
stay (9.25 days), highest SAPS 3 (53.96) and higher ICU and in-hospital 
mortality (14.29% and 19.25% respectively). This study shows that the 
direct cost of the ICU stay for older patients was higher than for younger 
patients. The diff erence was explained by the higher severity measured 
by SAPS 3 in the older age groups (Figure 1), and the required greater 
length of stay in the ICU (Figure 2). As might be expected, the mortality 
in the group of older patients was also signifi cantly higher.
Conclusion This study showed that greater age is associated with 
higher severity measured by SAPS 3, higher direct costs, and higher 
mortality both in the ICU and in-hospital environment.
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Critical care in a maternity hospital: a retrospective observational 
study
F Kavanagh, I Browne
National Maternity Hospital, Dublin, Ireland
Critical Care 2015, 19(Suppl 1):P530 (doi: 10.1186/cc14610)
Introduction Pregnancy and labour usually progress uneventfully; 
however, serious complications can occur and develop rapidly, 
necessitating critical care admission and support. Successive 
confi dential enquires have highlighted defi ciencies in this area and 
suboptimal care leading to increased morbidity and mortality [1]. The 
National Maternity Hospital is the largest maternity hospital in the 
Republic of Ireland where a total of 8,954 babies were delivered in 
2013. It is a stand-alone institution and onsite facilities include a two-
bed dedicated anaesthesia lead high-dependency unit.
Methods A retrospective observational study was carried out from 
January 2011 to January 2014 especially looking at the following 
parameters: admitting diagnosis, demographics, length of stay and the 
number of admissions requiring transfer for tertiary-level care.
Results In total, 29,344 deliveries occurred. A total of 376 HDU 
admissions were recorded in this period, representing 1.28% of all 
admissions. The average age of patients admitted to the HDU was 
34  years. The predominant reasons for admission were hypertensive 
disease of pregnancy (49.7%), haemorrhage (antepartum/postpartum) 
(36.4%), sepsis (4.2%) and other reasons (11.1%) including cardiac 
rhythm disturbances, neurological complications and pre-existing 
medical disease. In 2013 the average length of stay was 2 days. A total 
6.1% of those admitted to HDU required transfer for tertiary-level ICU 
care in other centres during the study period, this represented 0.07% 
of all deliveries.
Conclusion There is signifi cant demand within our institution for HDU 
care for our patients, with the number of admissions increasing in 2013. 
The main admitting diagnoses are hypertensive disease of pregnancy 
and haemorrhage with an increase in the number of patients being 
admitted for management of sepsis in 2013. This highlights the 
increasing awareness, recognition and management of this condition 
in pregnancy. The increased number of HDU admissions in 2013 could 
also be explained by the recent introduction of an early warning score 
for the deteriorating patient in our hospital but this would require 
further evaluation. The low number of transfers of patients to other 
tertiary centres underpins the importance of an anaesthesia lead 
service.
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Introduction The objectives of this survey were to establish the 
prevalence of symptoms of post-traumatic stress in mixed staff  groups 
working in adult and paediatric intensive care settings and to examine 
the main themes in staff  descriptions of the most traumatic event they 
had experienced at work.
Methods A total of 355 health professionals working on three adult 
and four paediatric units at two centres were asked to rate their current 
level of post-traumatic stress symptoms on the Trauma Screening 
Questionnaire (TSQ).
Results Paediatric/neonatal intensive care staff  were more likely to 
score above the clinical cutoff  point for post-traumatic stress symptoms 
on the TSQ in relation to an incident at work than adult intensive care 
staff  in this sample (PICU n = 33/193 (17%) vs. AICU n = 13/162 (8%), 
P  <0.001). For the 172 staff  who provided a description of the most 
traumatic event they had experienced, the following themes were 
Figure 1 (abstract P528).
Figure 2 (abstract P528).
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most commonly endorsed: patient death (and particularly untimely 
deaths on adult units); handling distressed families; and concerns 
about the quality of care and dealing with staff  confl ict (see Figure 1).
Conclusion A signifi cant minority of staff  reported clinically signifi cant 
levels of post-traumatic stress related to their work. The facts that post-
traumatic stress levels were higher on paediatric units despite their 
lower rates of mortality and that untimely deaths were frequently 
mentioned by adult unit staff  suggest it may be that untimely deaths 
are particularly hard to deal with. More research is needed on the 
prevalence of distress in staff  working in these settings.
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Distribution and mortality factors of cases with traumatic and 
nontraumatic brain damage treated in ICU
S Goksu Tomruk, N Bakan, G Karaören, E Akcay, S Keskin
Umraniye Research and Training Hospital, Istanbul, Turkey
Critical Care 2015, 19(Suppl 1):P532 (doi: 10.1186/cc14612)
Introduction Cases of traumatic and nontraumatic brain damage 
have high rates of morbidity and mortality. In this study of cases being 
treated in the ICU for a diagnosis of brain damage, it was aimed to 
evaluate the relationship between mortality and the distribution of 
reason for and resulting type of brain damage and to determine other 
factors aff ecting mortality.
Methods After local ethics committee approval, a total of 1,004 
patients (2012, n = 492; 2013, n = 454; 2014, n = 58) treated in the ICU in 
a 2-year period were reviewed. This study included for evaluation 135 
patients determined with traumatic or nontraumatic brain damage, 
with a more than 24-hour stay in the ICU. Reasons for brain damage 
were determined as brain damage associated with head trauma (Group 
HT), head trauma accompanying general body trauma (Group HT  + 
GBT) and spontaneous haemorrhage (Group SH). The type of brain 
damage was defi ned from the radiological diagnosis (CT and/or MRI) as 
subarachnoid haemorrhage, intracranial haemorrhage (ICH), subdural 
haematoma (SDH), epidural haematoma (EDH), skull fracture, brain 
contusion or a combination of these (COM). Operations were evaluated 
as performed by the brain surgery department.
Results The patients comprised 73.3% males and 26.7% females with a 
mean age of 40.58 ± 24.14 years (range, 1 to 87 years), mean APACHE II 
score of 19.07 ± 10.19 (range, 2 to 41), mean GCS of 9.17 ± 4.42 (range, 
3 to 15) and 68.1% of whom were discharged and 31.9% were exitus. 
When the causes of brain damage were evaluated according to the 
type, the most frequently seen in the HT and HT + GBT groups were 
COM (37.3%, 42.9%), followed by EDH (13.6%, 28.6%). In the SH group, 
the most common reason was ICH (43.9%) followed by SDH (24.4%). 
Directly proportionally, only an increase in APACHE II score increased 
the mortality risk 1.3-fold (logistic regression analyses, coeffi  cient 
0.658) but the duration of intubation and ICH ratio was statistically 
signifi cantly high and GCS was low in the exitus cases, and rates of EDH 
were determined as high in discharged cases compared with exitus 
(P <0.01). No statistical diff erence was determined in mortality in terms 
of age, gender, duration in ICU, surgical treatment or not, or reasons for 
brain damage (P >0.05).
Conclusion There is considerable variation in causes of head injury. 
From this retrospective study it can be suggested that mortality of 
neurological/neurosurgical patients, regardless of management 
method, depends on APACHE II, arrival GCS, number of ventilator-days 
and type of brain damage.
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Introduction Unexpected trauma is a one of the most major causes 
of death for children in the world. However, pediatric severe trauma 
patients are rare and scattered. Although there is a strong association 
between patient’s volume of trauma center volume and outcomes in 
adults, such a report is less in children. In this study, we aimed to clarify 
the relationship of the amount of registration and outcome in pediatric 
trauma patients.
Methods This retrospective study analyzed data of the Japan Trauma 
Data Bank from 2004 to 2012. We registered pediatric patients 
aged younger than 12  years with severe multiple or torso trauma 
(maximum Abbreviated Injury Scale score ≥3 or Injury Severity Score 
≥9, and excluded patients with cardiopulmonary arrest on arrival, burn, 
isolated head or limb injury, lack of data). We divided the facilities into 
six groups according to every 10 patients registered and compared 
mortality between each group.
Results A total of 1,015 patients from 105 facilities were included in 
the study. Number of registrations: 0 to 10 patients: 673 patients/68 
facilities, 11 to 20: 381/28, 21 to 30: 141/6, 31 to 40: 101/3, 41 to 50: 45/1, 
51 to 60: 58/1. Victims of blunt trauma accounted for 98.1%. Median 
age was 7 (interquartile range: 5 to 10) years, median injury severity 
score (ISS) was 17 (10 to 26). Multivariate analysis adjusted for age, 
revised trauma score and ISS revealed that the amount of registration 
(every 10 patients) was independently associated with survival (odds 
ratio: 1.55, 95% confi dence interval: 1.06 to 2.26, P = 0.023).
Conclusion There was a strong association between amount of 
registration and outcome.
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Introduction Factors associated with mortality in severely burned 
patients are well known. We aimed to assess the seasonal variations of 
the mortality of patients admitted to the main French military intensive 
care burn unit (ICBU) and to determine their relations to seasonal 
variations of severity or other factors (for example, staffi  ng).
Methods We performed a retrospective study analysing the medical 
records of all patients admitted to the ICBU of Percy Military Hospital 
(France) between January 2000 and December 2011. Statistical analysis 
was performed with R version 3.1.2. We fi rst conducted univariate 
analyses with simple logistic regression, then a simple periodic 
regression for seasonal variations (with and without harmonics for 
robustness), and fi nally a multivariate logistic regression with periodic 
terms in order to adjust seasonal variations for known severity factors.
Results A total of 1,913 patients were admitted for acute burn injury 
during the study period, with a male to female ratio of 2.34. Mean total 
body surface area burned (TBSA) was 23.2% (IQR: 10 to 30) and mean 
full thickness total body surface area burned (FTBSA) was 13.4% (IQR: 0 
to 15). Inhalation injury was present in 441 (23.1%) cases, intoxication 
(CO, CN) was present in 88 (4.6%) cases, and associated traumatisms also 
Figure 1 (abstract P531). Main themes of staff  descriptions of traumatic 
events on ICU.
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in 88 (4.6%) cases. The mortality rate was 10.9%. The following factors 
were associated with mortality in univariate logistic regression: age, 
body mass index, past medical history, TBSA, FTBSA, intoxication (CO, 
CN), inhalation injury, fl ame burns, self-infl icted burns (all P <0.0001), 
sex (P <0.001), and admission date (P <0.01). Simple periodic regression 
showed a biannual seasonal eff ect on mortality, documented with a 
1-year periodic (P <0.01) and a 6-month periodic (P = 0.01) dependency. 
Multivariate analysis with or without periodic terms identifi ed age, past 
medical history, TBSA, FTBSA, inhalation, intoxication and admission 
date as the only factors independently associated with mortality.
Conclusion Predictive factors for mortality in our ICBU are in line with 
the literature. The documented seasonal variations in mortality are 
fully explained by variations in these severity factors. Complementary 
analyses are under way to further study a nonlinear age eff ect.
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Introduction This study aims to describe both the clinical course 
and prognostic factors of patients suff ering granulomatosis with 
polyangitis (Wegener granulomatosis) (GP) who were admitted to the 
Salvador Zubirán National Medical Sciences and Nutrition ICU.
Methods Twenty-two patients suff ering GP admitted to the ICU, 
between January 2002 and December 2012, were included. The Acute 
Physiology and Chronic Health Evaluation (APACHE) II prognostic score 
scale was used in order to assess the severity of illness on the fi rst ICU 
day. The Sequential Organ Failure Assessment (SOFA) score was used 
to measure organ dysfunction, and the Birmingham vasculitis activity 
score for Wegener granulomatosis (BVAS/WG) was used to assess 
vasculitis activity. The outcome measurements taken into account were 
ICU mortality and ICU length of stay.
Results One patient was admitted twice during this period. The sample 
comprised 11 males and 11 females (50%, respectively). Featuring an 
average age of 52 years, 78% of them were admitted to the ICU because 
of respiratory failure, 50% were due to diff use alveoli hemorrhage, 
36% due to sepsis, 4% hypovolemic shock and fi nally 4% because of 
tuberculosis. According to the BVAS/WG, 20 patients corresponded to 
severe disease, one to limited diseases and one to persistent disease. 
The average ICU length of stay was 20.6 days and as inpatients 43 days. 
While comparing the SOFA score between alive and deceased patients 
there was a 0.5-point diff erence (P = 0.077), 63% of the alive patients 
were diagnosed while they were in the ICU. Plasmapheresis was found 
to be a protector factor (P <0.05).
Conclusion The BVAS/WG score was signifi cantly diff erent between 
alive and deceased patients. Plasmapheresis was found to be a survival 
predictor. This study has shown that both SOFA and APACHE II scores 
have no prognostic value in these patients.
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Introduction Knowledge of the impact of liver dysfunction on 
mortality during septic shock is limited. However, the liver appears 
to play a key role during septic illness. To better explore this issue, we 
investigated the data collected during the Prospective Recombinant 
Human Activated Protein C Worldwide Evaluation in Severe Sepsis 
and Septic Shock (PROWESS-SHOCK) trial in which a cohort of 1,697 
septic shock patients were constituted [1]. The study aimed to assess 
the relationship of liver dysfunction at the onset and during the course 
of septic shock on short-term and long-term mortality.
Methods All of the patients enrolled in the PROWESS-SHOCK were 
included. Liver dysfunction at baseline was defi ned by a liver Sequential 
Organ Function Assessment (SOFA) score >0. The onset of a liver 
dysfunction post baseline was defi ned as any post-baseline increase of 
the hepatic SOFA score from 0. The worsening of liver dysfunction post 
baseline was defi ned as any increase of the hepatic SOFA score from the 
baseline assessment. The post-baseline period studied extended from 
study drug infusion to day 28. The main outcome was the mortality at 
day 180, and the secondary outcomes were the mortality at day 28 and 
at day 90. Cox proportional hazard models were used to estimate the 
hazard ratio of death.
Results Baseline liver function was assessed in 1,565 patients. Of those, 
522 (33%) exhibited liver dysfunction at baseline. No relationship was 
found with mortality according to baseline liver dysfunction status at 
day 28 (HR, 0.847 (95% CI, 0.647 to 1.109); P = 0.2267), day 90 (HR, 0.883 
(95% CI, 0.701 to 1.112); P = 0.2892) and day 180 (HR, 0.885 (95% CI, 
0.710 to 1.103); P = 0.2761). A total of 403 (26%) patients developed a 
new liver dysfunction (257/1,043, 25%) or worsened liver dysfunction 
(146/522, 28%) in the 28-day post-baseline period. The overall median 
time to develop or to worsen liver dysfunction was 2 (1 to 4) days. 
Signifi cant relationships between the new onset or the worsening of 
liver dysfunction post baseline and mortality at day 28 (HR, 1.67 (95% 
CI, 1.26 to 2.21); P  = 0.0004), day 90 (HR, 1.65 (95% CI, 1.30 to 2.09); 
P <0.0001) and day 180 (HR, 1.57 (95% CI, 1.26 to 1.97); P <0.0001) were 
found.
Conclusion The new onset or the worsening of liver dysfunction during 
the course of septic shock impacts strongly on long-term mortality. 
Septic patients with liver dysfunction need long-term follow-up. Future 
research should focus on developing specifi c septic liver therapeutics 
and new tools for earlier detection of septic liver dysfunction.
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Introduction In cancer patients, sepsis is the main cause of admission 
to the ICU and is associated with elevated mortality rates and 
healthcare costs. In this population, specifi c factors such as poor 
functional status and immunosuppression secondary to malignancy 
and/or antineoplastic treatment contribute to decreased survival. The 
aim of this study is to identify predictors of mortality in cancer patients 
admitted to the ICU with septic shock.
Methods This is a retrospective study that analyzed predictors of 30-
day mortality in 269 patients admitted to the ICU of the Institute of 
Cancer of State of São Paulo, Brazil, from February 2012 to November 
2014.
Results From 1,250 patients admitted to the ICU, 269 patients had the 
admission diagnosis of septic shock and were analyzed. The mean age 
was 62 ± 14 years and 152 patients (56.5%) were male. Most patients 
had solid cancer (93.6%), and 87 patients (34.5%) had gastrointestinal 
neoplasm. Upon admission, the median SOFA score was 4 (IQR: 2 to 7), 
median SAPS 3 score was 55 (IQR: 48 to 68) and median lactate level was 
1.88 mmol/l (IQR: 1.22 to 3.21). After 48 hours of ICU admission, acute 
kidney injury (AKI) was diagnosed according to AKIN classifi cation as 
follows: 202 patients (75.1%) had grade 0, 49 (18.2%) grade 1, seven 
(2.6%) grade 2 and 11 (4.1%) had grade 3. The 30-day mortality rate 
was 24.9%. In the univariate analysis, associated variables with 30-day 
mortality were age, urea and creatinine levels at admission, SOFA score 
at admission, SAPS 3 score and 48-hour AKI. In multivariate analysis, the 
predictive factors for 30-day mortality were SOFA score at admission 
(OR = 1.12; 95% CI: 1.04 to 1.21, P = 0.002) and 48-hour AKI defi ned as 
AKIN grades 1, 2 and 3 (OR = 2.69; 95% CI: 1.45 to 4.97, P = 0.002).
Conclusion In cancer patients with septic shock, SOFA score at 
admission and acute kidney injury at 48  hours of admission were 
predictors of 30-day mortality. These fi ndings reinforce the needing of 
early strategies of diagnosis and therapy in this subset of patients.
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Introduction The admission of malignant hematology patients to the 
ICU is combined with poor prognosis [1]. A young population on one 
side and serious prognosis on the other are the main characteristics. 
Do we help? We are analyzing continuously clinical characteristics, 
treatment, and outcomes of critically ill patients with hematologic 
malignancies admitted to the medical ICU to identify predictors of 
adverse outcome [2].
Methods Demographic characteristics, hematologic diagnosis, reasons 
for ICU admission, transplant status, the presence of neutropenia, and 
APACHE II and SOFA scores were analyzed. Predictors of ICU mortality 
were evaluated using univariate analysis.
Results There was a total of 194 patients (103 male), APACHE II score 
by admission was 27 ± 8, SOFA 9 ± 3. Acute leukemia (L) in 81 patients 
(41.8%), chronic L in 19 patients (9.8%), lymphoma in 58 patients 
(29.9%), and multiple myeloma in 28 patients (14.4%) were the 
etiology. Respiratory insuffi  ciency, hemodynamic instability, AKI and 
CNS disturbances were responsible for the admission of 169 patients 
(87.1%) from the hematology ward to the ICU. In total, 127 patients 
(59.7%) were mechanically ventilated; 93 required invasive mechanical 
ventilation (MV). Non-invasive ventilation started in 34 patients and 
was successful in 14 (6.5%). The ICU mortality rate was 104 patients 
(53.6%), and the mortality of MV patients was 98 (77.2%). Need for 
vasopressors at admission, MV, neutropenia, and APACHE II and SOFA 
scores were identifi ed as independent predictors of fatal outcome. 
Overall mortality of admitted patients was 53.6% (104 patients), and in 
ventilated patients was 77.2% (98 patients).
Conclusion The ICU mortality of critically ill patients with HM is high, 
particularly in the group on MV. Diff erent factors were independent 
predictors of mortality, but 46.4% of admitted patients survived 
because of adequate support possibilities and were transferred back to 
hematology ward. The ICU admission with organ support is according 
results important for life saving in this extremely high-risk patient 
group.
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Introduction In recent decades, therapeutic advances resulted in 
increased survival of patients with hematologic malignancies. These 
patients are increasingly admitted to the ICU due to infections, 
treatment toxicity and decompensation of chronic diseases. The aim of 
this study is to evaluate ICU, hospital and 6-month mortality in patients 
with hematological malignancies admitted to the ICU and to identify 
predictors of ICU mortality.
Methods We performed a retrospective study of 277 consecutive 
patients with hematological malignancies admitted to the ICU of the 
Institute of Cancer of State of São Paulo, Brazil, from January 2010 
to December 2013. Patient clinical and laboratory characteristics, 
evaluation of organ dysfunctions and need for hemodialysis, 
mechanical ventilation and vasoactive agents in the ICU were collected. 
The primary outcome was ICU mortality. Data were analyzed with 
univariate and multivariate logistic regression.
Results The median age of the population was 57  years and 144 
patients (52%) were male. Upon admission, 15 patients (5.4%) had 
disease remission and 31 (11.2%) had newly diagnosed disease. The 
ICU mortality rate was 26%, hospital mortality was 35.7% and 6-month 
mortality was 55.2%. The median number of organ dysfunction was 
3 (IQR 2 to 4) and respiratory failure was the leading dysfunction, 
being present in 209 patients (75.5%). During the ICU stay, 21 patients 
needed hemodialysis (8%), 69 (25%) needed mechanical ventilation, 
162 (58%) used vasoactive agents and 22 (8%) had a decision for 
limitation of medical treatment. On univariate analysis, risk factors for 
hospital mortality were acute myeloid leukemia, hospital stay prior to 
ICU admission >4 days, number of organ dysfunction ≥2, colonization 
and infection by a multidrug-resistant (MDR) agent, use of mechanical 
ventilation, use of vasoactive agents and renal replacement therapy. 
Multivariate analysis revealed that renal replacement therapy (OR  = 
6.35 (95% CI: 1.5 to 25.92), P = 0.010), SOFA score (OR = 1.69 (95% CI: 
1.38 to 2.06), P <0.001), RDW (OR = 1.27 (95% CI: 1.11 to 1.46), P = 0.001), 
lactate (OR = 1.04 (95% CI: 1.02 to 1.06), P <0.001), colonization of MDR 
agent (OR = 10.73 (95% CI: 2.13 to 53.96), P = 0.004) and hospital stay 
prior to ICU admission >4  days (OR  = 4.72 (95% CI: 1.8 to 12.3), P  = 
0.002) were predictive factors of ICU mortality.
Conclusion Patients from our institution have survival rates comparable 
with data from the literature. Our study suggests that mortality is 
associated with late ICU admission and colonization of MDR bacteria.
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Introduction Despite multiple reports demonstrating an improvement 
in outcomes of critically ill cancer patients admitted to ICUs over the last 
two decades [1], there is concern that admission policies for patients 
with cancer are overly restrictive [2]. The purpose of this study was to 
identify factors associated with mortality in the 180  days following 
unplanned ICU admission in patients with nonhaematological 
malignancy.
Methods We carried out a retrospective analysis of all patients with 
solid tumours admitted to the Guy’s Critical Care Unit (13-bed level 3 
ICU) as an emergency between August 2008 and July 2012. Data were 
collected regarding patient demographics, type of cancer, reason for 
referral and organ support required during the ICU stay.
Results During the 4-year study period there were 356 unplanned 
admissions of patients with solid cancer (8.3% of all admissions). Three 
hundred individual patients were admitted and 180-day survival 
data were available for 293 of these. Mean age at fi rst admission was 
65.2  years, 115 (38.3%) were female. The most frequently present 
malignancies were lung (42.7%), head and neck (17.3%) and renal 
(6.7%). ICU, hospital and 180-day mortality were 19.1%, 31.0% 
and 52.2% respectively. Those factors found to be independently 
associated (in multivariate analysis) with increased risk of 180-day 
mortality include: metastases (OR = 4.0, 95% CI = 2.1 to 7.6); sepsis on 
admission (OR = 2.2, 95% CI = 1.2 to 4.1); APACHE II score on admission 
(OR  = 1.06, 95% CI  = 1.004 to 1.12); need for inotropes/vasopressors 
during admission (OR = 2.3, 95% CI = 1.05 to 4.8); and need for renal 
replacement therapy during admission (OR = 4.65, 1.7 to 12.8).
Conclusion In our study, ICU and hospital mortality were lower than 
the pooled mortalities seen in a recent large systematic review [3]  – 
despite our study excluding planned postoperative admissions (who 
are known to have better outcomes). The 180-day mortality was 
signifi cantly lower than in a previous study at our own institution [4]. 
Our study looked at a number of factors that might reasonably be 
expected to be associated with short-term and long-term outcomes 
and identifi ed several that were independent predictors of death by 
180 days.
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Introduction The aim was to evaluate clinical characteristics and 
outcomes of patients with lung cancer requiring ventilatory support.
Methods Secondary analysis of a prospective multicenter study 
including patients requiring either invasive (IMV) or non-invasive 
(NIV) mechanical ventilation for >24 hours admitted to 22 ICUs in six 
countries from Europe and South America during 2011. We used shared 
frailty models to identify factors associated with 6-month survival.
Results Out of 449 patients admitted to the ICUs, 239 (small-cell 
(SCLC) = 34; non-SCLC = 205) required ventilatory support (NIV = 104; 
IMV = 135). Out of NIV patients, 31 (30%) were subsequently intubated 
for IMV. Main reasons for ventilatory support were sepsis (n  = 119; 
among them, 102 patients had pneumonia), airway involvement by 
tumor (n = 79), ARDS (n = 47) and coma (n = 18). Mean SAPS II score 
was 54 ± 20 and median SOFA score was 7 (4 to 12) points. Hospital 
and 6-month mortality rates were 55% and 67%; 94 (39%) patients 
received treatment limitations in the ICU. Mortality according to 
ventilatory strategy was 56% for NIV only, 77% for NIV followed by 
IMV, and 70% for IMV only. In the multilevel model, adjusting for the 
hospital size, presence of step-down units, type of admission and 
treatment limitation, performance status (PS) 3 to 4 (HR = 2.25 (95% CI, 
1.52 to 3.34)), metastasis (HR = 1.66 (1.18 to 2.33)) and the ventilatory 
strategy compared with NIV only (HR  = 1.73 (1.02 to 2.92), for NIV 
followed by IMV; HR = 2.25 (1.51 to 3.35), for IMV only) were associated 
with increased mortality. Conversely, patients with sepsis had higher 
survival (HR = 0.67 (0.46 to 0.96)).
Conclusion In a multinational study, 6-month survival in lung cancer 
patients requiring ventilatory support is better than perceived a priori. 
Palliative care should be preferred in patients with poor PS.
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Introduction Not all patients in need of critical care arrive in clinical 
distress and some deteriorate after arrival. Identifying these patients 
early in their clinical course could potentially improve outcome. The 
present study was performed with the aim of assessing whether 
nursing and physician staff  were able to identify patients in need of 
critical care using only clinical judgment and to compare this with the 
National Early Warning Score (NEWS).
Methods This was a prospective cohort study of all adult patients with 
a fi rst-time admission to a medical admission unit at a 450-bed regional 
teaching hospital over a 3-month period in 2010. All subspecialties of 
internal medicine are present as well as a level 2 ICU. Upon fi rst contact 
with the patient after arrival, nursing staff  and physicians were asked 
to report their estimation of the probability of ICU admission (0 to 
100%). Survival status was extracted from the Danish Civil Registry. All 
administrative details (including transfers to other hospitals, wards and 
ICUs) were extracted from the National Patient Registry, both ensuring 
complete follow-up. The discriminatory power (ability to identify 
patients at increased risk) was estimated using area under the receiver-
operating characteristics curve. Calibration (accuracy) was assessed 
using Hosmer–Lemeshow goodness of fi t test. Data will be reported as 
median (range) or proportions (95% confi dence interval).
Results A total of 2,769 patients were included, median age 65 (18 to 
100) years and 52% female. Thirty-day mortality was 4.5% and 2.2% 
were admitted to ICU. Median time to ICU admission was 1 (0 to 70) 
day. Nursing staff  assessed 65% and physicians 26% of admissions. 
NEWS could be calculated for 85%. Nursing staff  had a discriminatory 
power of 0.865 (0.786 to 0.944) with little variation with experience. 
Calibration was acceptable, except for the least experienced nurses 
(<5  years). Physicians had a discriminatory power of 0.789 (0.641 
to 0.937), with little variation with experience. Calibration was very 
good, regardless of experience. NEWS had a discriminatory power of 
0.809 (0.727 to 0.891) and poor calibration. There was no signifi cant 
diff erence in discriminatory power between the three assessments.
Conclusion Both nursing staff  and physicians were as good as NEWS at 
identifying patients at increased risk of ICU admission after admission 
to a medical admission unit. However, both nursing staff  and physicians 
had better calibration (accuracy) than NEWS.
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Introduction In recent years the proportion of older people admitted 
to the ICU has increased. A variety of clinical and physiological factors 
are associated with outcome in these patients. The aim of this study is 
to determine the clinical characteristics associated with survival of ICU 
mechanically ventilated older patients.
Methods We retrospectively studied 74 patients, aged >65  years, 
admitted to the ICU who underwent mechanical ventilation. Standard 
demographic, clinical, and physiologic data were recorded. We 
examined the signifi cant diff erences in clinical characteristics between 
survivors and nonsurvivors using the Student t and chi-square tests.
Results The mean age of patients studied (43 men and 31 women) 
was 79  ± 6.4  years. The type of admission was surgical 18%, trauma 
26% and medical 57%. The ICU mortality of these patients was 57% 
and it was not associated with gender and cause of admission to ICU. 
Patients who survived had lower Charlson Comorbidity Index (P <0.05) 
and shorter duration of mechanical ventilation (P <0.01). The episodes 
of ventilation-associated pneumonia, sepsis and renal failure were 
less frequently in survivors (P <0.05). Also, in addition serum iron and 
cholesterol levels were signifi cantly lower in nonsurvivors (P <0.01).
Conclusion The mortality of ICU older patients is high. VAP, sepsis and 
renal failure are frequent complications in nonsurvivors. Pre-existing 
comorbidities considerably aff ect mortality.
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Introduction There is increasing demand for revision hip surgery 
in older patients with poor frailty. Our previously submitted work 
demonstrated that frailty predicts the need for medical review [1]. We 
reviewed patients for a further 16 months to see whether frailty impacts 
on care [2]. This is the largest reported study reviewing frailty and 
the need for organ supports and outcomes in complex orthopaedic 
surgery.
Methods A retrospective note review of all patients from January 2012 
to April 2014 undergoing revision hip surgery. Data collected included 
frailty, comorbidities, operative blood loss, anaesthetic technique and 
level of organ supports and patient location at 30 days.
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Results A total of 389 patients with a mean age of 68.7  years were 
identifi ed. Frail patients were signifi cantly more likely to need 
vasopressors postoperatively (P  = 0.012). Each increase in frailty 
score was associated with 0.16 increase in length of stay on the HDU 
(P  = 0.025). Analysis of patient location at 30  days shows that frail 
patients stay in hospital longer (P = 0.00). Frail patients also bleed more 
intraoperatively (P  = 0.00 with a coeffi  cient value of 239; that is, for 
every point increase in frailty, average blood loss increases by 239 ml). 
For each increase by unit of blood transfused, the length of stay 
increased by 5.3 days (P = 0.000). The use of epidural is not associated 
with increased need for postoperative vasopressors (P  = 0.598). See 
Figure 1.
Conclusion Frailty is associated with increased intraoperative resource 
use and postoperative care requirements independent of choice of 
anaesthetic technique. This type of surgery should be subject to health 
economic analysis as demand amongst the frailer surgical population 
increases.
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Introduction ICU mortality prediction models provide robust tools 
for research and benchmarking in the developed world, but an ICU 
mortality prediction model has not been validated in a resource-poor 
setting. We sought to validate the Mortality Probability Admission 
Model, version III (MPMo-III) in two public ICUs in Rwanda and to 
develop a simplifi ed Rwanda Mortality Probability Model (R-MPM) for 
use in developing countries.
Methods We prospectively collected data on 339 adult patients 
admitted to two ICUs in Rwanda between August 2013 and July 
2014. We described demographic and presenting characteristics 
and outcomes. We assessed the discrimination and calibration of the 
MPMo-III model. Using stepwise selection, we then developed a new 
logistic model for mortality prediction, the R-MPM.
Results Patient median age was 34 (IQR 26 to 49) years; 48.7% were 
male. Mortality was 50.3%. The variables most predictive of mortality in 
univariate analyses were: age, sepsis within 24 hours of ICU admission, 
hypotension or shock at ICU admission, Glasgow Coma Scale score 
at ICU admission, and heart rate (beats per minute) at ICU admission. 
Using these fi ve variables, the R-MPM predicted mortality with area 
under the curve of 0.829 and Hosmer–Lemeshow chi-square statistic 
of 8.881. The MPMo-III predicted mortality with area under the curve of 
0.720 and Hosmer–Lemeshow chi-square statistic of 16.391, indicating 
that the predictive risk scores of the MPMo-III were not well calibrated 
to the Rwandan data.
Conclusion The MPMo-III had modest risk prediction capacity in a 
population of Rwandan ICU patients. The R-MPM is an alternative 
severity score with fewer and more accessible variables that provides 
better predictive power. This model needs to be validated in other ICUs.
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Introduction Emergency laparotomies have poor outcomes with 
variable postoperative critical care provision [1-3]. All patients requiring 
an emergency laparotomy with an estimated risk of death of >10% 
should go to critical care. Time of surgery should not aff ect standard 
of care [3,4]. In advance of the National Emergency Laparotomy 
Audit (NELA) results [2], our objective was to see whether the level of 
postoperative care and time of surgery aff ect outcome.
Methods Retrospective data were collected across the Imperial NHS 
trust for all emergency laparotomies over 3 months in 2014: length of 
stay in days (LOS); mortality; age; ASA; surgery time and postoperative 
care level, that is ward (L1), high dependency (L2), or ICU (L3). Statistical 
tests: Mann–Whitney, Pearson correlation (PCC) and multilinear 
regression analysis.
Results Seventy-one patients underwent surgery. Overall mortality was 
13% and 70% of patients went to a L2/3 bed. More ASA 1/2 patients 
went to L1 and all ASA 4/5 went to L2/3. Median (IQR) for age was 61 
(44 to 67) for L1, 65 (48 to 73) for L2/3 (P = 0.11), LOS was 10 (7 to 16) 
for L1, 19 (12 to 57) for L2/3 (P = 0.002), and mortality (%) was 0 for L1 
and 18 for L2/3. For surgery between 08:00 and 17:59, 14 went to L1, 
28 to L2/3. Mortality was 5% and LOS 15 (9 to 24). Between 18:00 and 
21:59, two went to L1, 10 to L2/3. Mortality was 17% and LOS 22 (8 to 
34). Between 22:00 and 07:59, fi ve went to L1, 12 to L2/3. Mortality was 
29% and LOS 15 (9 to 36). ASA strongly predicted mortality (P = 0.006, 
PCC 0.32). There was a negative correlation between postoperative 
destination and mortality with all deaths happening in those who went 
to L2/3 (P = 0.038 and PCC –0.25); however, sicker patients may have 
gone here. There was a strong correlation between mortality and time 
of surgery, night surgery being a strong predictor of mortality (PCC 
0.31, P = 0.008). LOS can be predicted by a combination of ASA, age and 
care level (P = 0.027); the postoperative care regression coeffi  cient was 
negative (–18.04, SE 10.41) with prolonged LOS in patients admitted to 
L2/3, which could also be explained by illness severity.
Conclusion Trust mortality is similar to that in the Emergency 
Laparotomy Network audit [1]. Higher ASA patients are appropriately 
going to L2/3 care. Baseline health status and time of surgery are the 
strongest predictors of mortality in emergency laparotomy patients.
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Introduction Scoring systems can be used to predict mortality in 
patients admitted to the ICU. They are produced using variables that 
are associated with an increased risk of mortality such as patient 
Figure 1 (abstract P544). Frailty versus length of stay.
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demographics, physiological measurements and coexisting conditions 
and can be used to evaluate ICU performance, to stratify patients in 
clinical trials and to assist in-hospital and healthcare decisions such as 
resource allocation. The aim of the project was to determine whether 
a general score derived from routine laboratory parameters could be 
used to predict mortality rates in patients admitted to the ICU in the 
UK.
Methods P values were calculated using the t test, Mann–Whitney 
U test and chi-squared test, depending on distribution of data, in 
order to determine which variables were signifi cantly diff erent in 
the survivors and nonsurvivors of critical illness. Signifi cant variables 
were categorised into subgroups according to medically relevant 
landmarks and univariately analysed by assessing the correlation with 
mortality. Forward logistic regression models were used to choose the 
parameters to include in our score. ROC curves illustrated the sensitivity 
and specifi city of selected variables via their AUC.
Results Age, platelets, ALT and APACHE II were selected to be included 
in the new laboratory-based score. The AUC for the score was 0.714, 
which was higher than each of the individual laboratory parameters. 
The AUC was increased further to 0.781 by including all 14 variables 
(age, lactate, FiO2, urea, creatinine, ALT, APACHE II, platelet, bicarbonate, 
haemoglobin, pH, ionised Ca, carboxyhaemoglobin and albumin), 
although this improvement was not considered signifi cant as the 
confi dence intervals of the two scores (4 and 14 variables) overlapped.
Conclusion A laboratory-based score was successfully established 
in ICU patients, revealing an AUC of 0.714 which is comparable 
with established scores in a similar population. The compilation of 
the variables to produce a laboratory-based score showed greater 
prognostic power than individual variables. Model developers require 
an AUC of >0.7 to be termed useful; however, in order to be used in a 
clinical setting the AUC must be at least 0.75. Further research including 
internal and external validation studies must be performed to optimise 
the model before clinical implementation.
P548
Patient preferences for outcomes in critical care trials (OPTICS): 
preliminary results
J Muscedere1, F Lamontagne2, G Boyd1, M Herridge3, S Fleury1, T Sinuff 3
1Queen’s University, Kingston, ON, Canada; 2University of Sherbrooke, QC, 
Canada; 3University of Toronto, ON, Canada
Critical Care 2015, 19(Suppl 1):P548 (doi: 10.1186/cc14628)
Introduction Although patient-centered outcomes are important to 
inform therapeutic choices for critically ill patients, patient preferences 
for outcomes in critical care studies are unknown. It is also unknown 
whether outcome preferences diff er between researchers, decision-
makers and those who have never been critically ill (citizens). The aim 
of the OPTICS Program is to investigate these preferences. Herein we 
report the preliminary results for outcomes preferences in citizens.
Methods We recruited and surveyed lay public members without a 
history of critical illness as to their preferences for outcomes in critical 
care trials. After an in-person educational session, citizens were asked 
to rank 11 potential critical care trial outcomes in order of personal 
preference. Each outcome was also rated for importance on a 7-point 
Likert scale. Participants were then asked to indicate their agreement 
with potential tradeoff s between potential outcomes.
Results The in-person session was attended by 31 citizens whose had a 
mean age (SD) of 71.6 (5.9) years and 1.5 (1.4) chronic health conditions; 
25 (81%) had partially or fully completed post-secondary school 
education. Of the 11 potential outcomes, the three outcomes ranked of 
highest importance were: permanent brain dysfunction, quality of life, 
and requirement for long-term institutional care. The three outcomes 
ranked of least importance were: duration of hospitalization, death 
after a prolonged illness, and occurrence of delirium. When rated on a 
7-point Likert scale the results were similar. Of the participants, 24/27 
(89%) indicated that they would be willing to receive a therapy which 
was associated with a higher mortality rate but resulted in an improved 
quality of life in survivors. Conversely, 16/27 (59%) indicated that they 
would not be willing to receive a therapy which increased the chances 
of survival but was associated with a reduced quality of life in the 
survivors.
Conclusion The citizens surveyed valued outcomes associated with 
quality of life and intact neurological function. Mortality and other 
indices of duration of critical illness were valued less. These preferences 
need to be confi rmed in larger groups with greater diversity. Future 
research also needs to further understand these outcome preferences in 
survivors of critical illness, clinicians, decision-makers, and researchers. 
Understanding the outcome preferences of pertinent stakeholders and 
whether these preferences are congruent is imperative to inform the 
design of future critical care trials.
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Introduction The aim of this prospective pilot study was to test how 
melatonin levels follow the circadian cycle in ICU patients. There 
is strong evidence that changes of circadian rhythm are refl ected 
in melatonin levels with peak levels at dawn and low levels during 
daytime [1]. The ICU stay is accompanied by disturbed circadian rhythm 
[2], which could potentially be the result of artifi cial lighting conditions.
Methods Melatonin levels were determined in eight medical ICU 
patients on mechanical ventilation, without brain injury or infection. 
Arterial blood samples were taken on the day of admission at 18:00 
(TE0) and 03:00 in the morning (TM0), then at the same time points 
48  hours later (TE1, TM1). Blood samples were centrifuged at 3,000 
rpm for 8  minutes, and then serum samples were stored at –80°C. 
Measurements were performed using a US-CEA908Ge melatonin 
ELISA kit. For statistical analysis, a binary (yes/no) variable was created 
from the pairs for each day, assigning ‘Yes’ if the TE values were greater 
than TM (melatonin peak reversion). The proportion of reversals and 
their 95% confi dence intervals were estimated using a GEE model for 
repeated binary data, assuming a binomial distribution and log link, 
and accounting for subject as a repetition factor. All calculations were 
done in SAS 9.4.
Results Melatonin levels were not normally distributed and were 
ranging between 9.2 and 23.7  pg/ml at T0 and 11.3 and 17.9  pg/
ml at T1. The median diff erences of the morning and evening serum 
melatonin levels were: TM0 – TE0 = –2.8 (–3.8 – (–0.2)); TM1 – TE1 = –1.2 
(–2.5  – (–0.4)) presented as median (IQR). The proportion of subjects 
with peak reversals was 92.9% (80.8 to 100.0%).
Conclusion Our preliminary data suggest that circadian rhythm 
disturbances may occur in critically ill patients within 48  hours after 
admission, and can be detected by inversion of melatonin peaks. 
Despite the limitations of this study, it may justify the need for larger 
observational and randomized trials on the eff ect of light on melatonin 
levels and on outcomes in ICU patients.
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Introduction ICU survivors are at risk for post-traumatic stress disorder 
(PTSD) and depression. The development of psychopathology 
depends partially on stable personality factors such as trait anxiety. 
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Among ICU patients a high level of trait anxiety is relatively common 
and associated with intrusions, a symptom of PTSD. Independently, 
childhood trauma and stress exposure throughout life have been 
associated with depression. In cardiac surgery patients admitted to 
the ICU postoperatively, the eff ect of trait anxiety on the relationship 
between cumulative life stress and stress-related psychopathology 
remains unknown. Therefore we aimed to assess the mediating or 
moderating role of trait anxiety in this at-risk patient population.
Methods In this multicenter follow-up study of the Dexamethasone for 
Cardiac Surgery (DECS) trial, validated self-report questionnaires were 
sent 1.5 to 4  years after cardiac surgery and ICU treatment to assess 
symptoms of PTSD and depression, in relation to cumulative life stress 
(that is, childhood trauma, major stressful life events) and trait anxiety 
as determinants of psychopathology. Data were available for 1,125 
out of 1,244 (90.4%) eligible participants. Mediating and moderating 
analyses were performed with multivariable linear regression to assess 
the eff ect of trait anxiety. Subgroup analyses were performed for both 
sexes.
Results Trait anxiety partially mediates the relationship between 
cumulative life stress and PTSD (β-value reduction from 0.325 to 0.068; 
P  = 0.000 to P  = 0.003) and fully mediates the association between 
cumulative life stress and depression (β-value reduction from 0.282 to 
0.015; P = 0.000 to P = 0.507). Trait anxiety was not a moderating factor 
between cumulative life stress and psychopathology. Full mediation 
of trait anxiety was found in female patients (n = 247), whereas only 
partial mediation was seen in male patients (n = 878) with regard to 
PTSD symptoms. As for depression, full mediation was present in both 
female and male patients.
Conclusion In cardiac ICU patients, trait anxiety mediates the infl uence 
of cumulative life stress on the occurrence of PTSD and depression 
symptoms. Further prospective research is necessary to establish these 
factors as reliable measures for the early identifi cation of ICU patients 
at risk for stress-related psychopathology.
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Introduction Sleep disruption and deprivation is a continuing 
problem in the ICU. Strategies to improve sleep are confounded by 
diffi  culties in monitoring and measuring sleep in the ICU; traditional 
polysomnography cannot be utilized. Practical, non-intrusive 
diagnostic monitoring of sleep is required. The aims were to test 
two new ambulatory sleep diagnostic devices to monitor sleep in 
the ICU, compare sleep data generated by the diff erent devices, and 
characterize sleep in the ICU.
Methods The devices were: Watch PAT 200 (Itamar), simple wristwatch 
style, employing peripheral arterial tone and actigraphy to evaluate 
sleep time and sleep stage by an automatic algorithm (PAT device); 
and ALICE PDx (Respironics Philips), miniature polysomnographic 
device utilizing EEG and EMG recordings, requiring post-study sleep 
technician scoring (PSG device). Nineteen ICU patients provided 
informed consent (mean age 37 years, two female). Diagnosis of most 
patients was trauma. Device technical problems terminated one ALICE 
PDx study and three Watch PAT study; one patient revoked consent. 
Therefore, 14 patients were recorded successfully in a private room 
in the ICU, while simultaneously wearing both devices, from 20:00 
to 06:00. No patient received sedation. Subjective sleep quality was 
estimated by the visual analog scale.
Results Both devices calculated total sleep time (TST), but the results 
were signifi cantly diff erent (P <0.05), with mean TST reported as 443.07 
and 270.8 minutes for PAT and PSG devices. VAS correlated tightly with 
TST calculated by the PSG device (r  = 0.559, P  <0.05). Both devices 
were able to successfully discern diff erent sleep stages, summarized as 
light sleep, deep sleep, and REM. Measurements of sleep stage were 
generally in agreement between the two devices; REM sleep time 
correlated strongly between PAT and PSG devices (P <0.05). Sleep stage 
distribution was light sleep 62.2% (PAT) and 74.1% (PSG); REM 13.0% 
(PAT) and 10.7% (PSG); deep sleep 14.5% (PAT) and 7.9% (PSG).
Conclusion Both wristwatch-style PAT and miniature PSG devices 
successfully recorded sleep in ICU patients. Although the simple 
PAT device overestimated TST, sleep stage times were generally in 
agreement, especially REM time which correlated strongly. Both 
devices can be used to eff ectively monitor and characterize sleep in 
the ICU environment.
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Introduction Although the ICU survival rate has increased in the last 
decade, the negative eff ects on mental health and related quality 
of life become more clear. In the literature the prevalence of anxiety 
and depressive symptoms post ICU ranges from 10 to 43% [1]. Early 
recognition and treatment of anxiety and depressive symptoms is 
important because depression caries a risk for suicide, limited quality 
of life, and delayed return to work. We studied hospital anxiety and 
depression (HAD) symptoms after ICU discharge.
Methods Patients who were treated in our ICU from 1 January 2013 
until 31 December 2013 for more than 5 days were invited to visit our 
post-ICU aftercare clinic. Six weeks after discharge they received a letter 
of invitation together with a health-related questionnaire, the Hospital 
Anxiety and Depression Scale (HADS) questionnaire [2]. Patients were 
asked to return the questionnaire prior to their visit. All data were 
analyzed and if the HADS score indicated a clinically signifi cant anxiety 
or depression, patients were referred to a psychologist for further 
analyses and treatment. All patient data were analyzed retrospectively.
Results Seventy-nine patients, 54 men and 43 women, mean age 
57 years. Median APACHE II and IV was 18 and 60 respectively. Median 
ICU and hospitals days were 9 and 20 respectively. Seventy-six percent 
were mechanically ventilated with a median of 5  days. Median time 
after ICU discharge to aftercare visit was 165 days. Patients were divided 
into three categories: 1, no HAD (45.4%); 2, possible HAD (9.3%); and 3, 
clinically signifi cant HAD (45.4%). Women compared with men showed 
signifi cantly more HAD symptoms (26.8% vs. 18.6%, P <0.05). Patients 
with subarachnoid hemorrhage, neurotrauma and multitrauma 
patients showed more HAD symptoms. Pain, fatigue, muscle weakness, 
impairment of daily activity dyspnea, and hoarseness were signifi cantly 
associated with clinically signifi cant HAD. No association between age 
and HAD was found. Diagnosis at ICU admission, length of stay, severity 
of illness, delirium and use of sedatives were not associated with HAD.
Conclusion Prevalence of clinically signifi cant post-ICU HAD was 45.4%. 
Female sex and post-ICU physical complaints  – pain, fatigue, muscle 
weakness, impairment in daily activities, hoarseness and dyspnea  – 
were signifi cantly associated with HAD.
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Introduction Patients who survive ICU treatment may experience 
psychological distress for some time after discharge from the ICU. In 
the literature the reported prevalence of post-traumatic stress disorder 
(PTSD) ranges from 5 to 64% [1]. We studied PTSD symptoms in relation 
to ICU factors, demographic data and physical complaints reported by 
patients 4 to 6 months after ICU discharge.
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Methods Patients who were treated in our ICU from 1 January 2013 
until 31 December 2013 for more than 5  days were invited to visit 
our ICU aftercare clinic. Six weeks after discharge a letter of invitation 
together with a health-related questionnaire, the Hospital Anxiety 
and Depression Scale questionnaire and Impact of Event Scale (IES-R) 
questionnaire, was sent to the patient. Patients were asked to return 
the questionnaires prior to visiting the aftercare clinic. All data were 
analyzed and if the IES-R score indicated a possible PTSD, patients 
were referred to a psychologist for further analyses and treatment. All 
patient data were analyzed retrospectively. The Pearson chi-squared 
test was used to compare groups and Cramer’s V analyses was used to 
examine strength of the association between groups.
Results Seventy-nine patients, 54 male and 43 women, with mean age 
57 years. Median APACHE II and APACHE IV were 18 and 60 respectively. 
Median ICU days and hospital days were 9 and 20 respectively. Seventy-
six percent of patients were mechanically ventilated with a median of 
5 days. Median time of ICU discharge to aftercare visit was 165 days. 
Delirium occurred in 22 (22.7%) patients during ICU treatment. The 
prevalence of PTSD was 43.3% and was most seen in patients after 
subarachnoid hemorrhage (SAH) (28.6%). Pain, muscle weakness, 
fatigue, impairment in daily activity, dyspnea, and hoarseness reported 
during the ICU aftercare clinic visit were signifi cantly associated with 
PTSD. There was no signifi cant diff erence in men and women. Sedation, 
opiates, benzodiazepine, inotropic medication and delirium during ICU 
treatment were not associated with higher prevalence of PTSD. None 
of the other demographic data analyzed were signifi cantly associated 
with PTSD.
Conclusion Prevalence of PTSD was 43.3% and most seen in patients 
after SAH, refl ecting the majority of patients treated in our ICU. PTSD 
was associated signifi cantly with pain, muscle weakness, fatigue, 
dyspnea, hoarseness and impairment of daily activity after a median 
165 days post ICU treatment.
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Introduction Critical illness today is well recognized as being associated 
with new or worsening physical impairment, diminished mental health 
and cognitive dysfunction. We studied the scope of somatic complaints 
in ICU survivors 4 to 6 months after ICU treatment.
Methods Patients who were treated in our ICU from 1  January 2013 
until 31 December 2013, for 5 or more days, were invited to visit our 
ICU aftercare clinic. Six weeks after ICU discharge a letter of invitation 
together with a health-related questionnaire, the Hospital Anxiety 
and Depression Scale questionnaire [1] and Impact of Event Scale 
Revised questionnaire [2], was sent. Patients were asked to return the 
questionnaires before visiting our clinic. The main purpose of the post-
ICU aftercare was to screen for somatic complaints, mental health and 
cognitive dysfunction. If necessary, further examination or treatment 
was advised. All data were retrospectively analyzed.
Results Ninety-seven patients visited our aftercare program in 2013. 
Median time after ICU discharge and visit to our after care clinic was 
165  days. Twenty-fi ve patients died after ICU discharge. Fifty-four 
patients were excluded because of various reasons; that is, language 
barrier, psychiatric illness, mental handicap, hospital admittance 
elsewhere, great distance. Seventy patients (81.4%) had somatic 
complaints infl uencing daily performance and quality of life. Fatigue 
(74.4%), muscle weakness (48.8%), dyspnea (34.9%), impairment of 
daily activity (81.4%), pain (38.4%) and weight loss (33.3%) were the 
most frequently reported complaints. Pain was most reported in 
patients with subarachnoid hemorrhage (27.3%), multitrauma (15.2%) 
and pneumonia (12.1%). Pain was most localized in the head (15.6%), 
one or both legs (15.6%), back (10.9%), shoulder (9.3%), hip (9.3%) and 
thorax (6.3%). Muscle weakness, fatigue, dyspnea, impairment of daily 
activity, pain and hoarseness were associated signifi cantly with PTSD 
and HAD. There was no signifi cant diff erence in somatic complaints 
between men and women.
Conclusion Somatic complaints after ICU discharge are frequently 
reported in our post-ICU aftercare patients, infl uencing daily 
performance and quality of life. Patient-centered research and 
treatment focusing on somatic complaints is of great importance.
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Introduction Among North American survivors of critical illness, we 
aim to describe the prevalence of post-traumatic stress disorder (PTSD), 
and its subtypes of intrusion, avoidance, and hyperarousal.
Methods In this prospective, observational, multicenter cohort study 
from 2009 to 2010, we screened adults (age ≥18  years) with new-
onset respiratory failure, cardiogenic shock, or septic shock, who were 
admitted to medical and surgical ICUs in four facilities. At 3-month 
and 12-month follow-ups, high probability of PTSD was defi ned by 
17-symptom PTSD Checklist – Event Specifi c Version (PCL-S) score ≥50. 
Also, PCL-S responses were mapped onto DSM-IV criteria for PTSD. 
To augment PTSD identifi cation, those with a moderate probability 
of post-ICU PTSD (PCL-S score ≥35) were further confi rmed with 
the Clinician Administered PTSD Scale (CAPS) structured interview. 
Moderate or greater symptoms for each PTSD subtype of intrusion, 
avoidance, and hyperarousal were categorized.
Results Of the 180 eligible participants at 3  months, PTSD was 
identifi ed in 10 (6%) using PCL-S scores and 15 (8%) using DSM-IV 
mapping of the PCL-S. Of the 160 eligible participants at 12 months, 
PTSD was identifi ed in two (1%) using PCL-S scores and 10 (6%) using 
DSM-IV mapping of the PCL-S. Of those eligible for CAPS assessments, 
at 3 months only 13 of 24 (54%) interviews were completed resulting 
in three extra PTSD diagnoses, and at 12 months only six of 22 (27%) 
interviews were completed resulting in two extra PTSD diagnoses. At 
3 and 12 months, the intrusion subtype was present in 25 (14%) and in 
25 (16%), the avoidance subtype was present in 78 (43%) and 60 (38%), 
and the hyperarousal subtype was present in 82 (46%) and 71 (44%).
Conclusion Irrespective of defi nition using PCL-S or DSM-IV mapping, 
PTSD was identifi ed in no more than one in 10 survivors of critical 
illness at either 3 or 12  months post ICU, which is still nearly double 
the US population past-year PTSD prevalence. In ICU survivors with 
moderate probability PTSD by PCL-S, the CAPS gold-standard interview 
is challenging to complete and adds only a small number of diagnoses. 
However, two in fi ve ICU survivors will develop PTSD subtypes of 
avoidance or hyperarousal, which both occur twice as frequently as 
the intrusion subtype. Targeting predominant PTSD subtypes may help 
optimize treatment strategies for the ICU survivor, such as prolonged 
exposure and eye movement desensitization and reprocessing for 
those with the avoidance subtype, and pharmacologic antidepressants 
targeting the sympathetic nervous system to produce anxiolysis for 
those with the hyperarousal subtype.
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Introduction A systematic review was performed of studies of 
nonpharmacological interventions aiming to reduce short-term or 
long-term stress in intensive care patients, as little is known about the 
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effi  cacy of such interventions. Previous work has shown that intensive 
care patients undergo many stressful experiences, which can aff ect 
their long-term psychological well-being. Studies have demonstrated 
a high prevalence of depression, anxiety or post-traumatic stress 
disorder after intensive care admissions.
Methods A systematic review was carried out according to the Prisma 
statement. A search was conducted of Medline, Embase and Psychinfo 
databases. Inclusion criteria included studies of populations of adult 
patients in mixed or general ICUs. No study designs were excluded, but 
studies that focused on specifi c disease states were excluded. Included 
studies were assessed for risk of bias, using a quality checklist.
Results A total of 1,743 papers were retrieved, of which 18 studies were 
eligible for inclusion in the review. Studies had a combined population 
of 1,970 patients admitted to 38 ICUs from Europe, Asia and North 
America. Eleven studies were randomized controlled trials (RCTs). 
Interventions were classifi ed as four groups – music; therapeutic touch; 
diary and psychotherapeutic interventions. Ten studies found that 
music interventions were eff ective in the short term; however, follow-
up results were limited and some studies were low quality. There was 
moderate quality evidence from three studies for the eff ectiveness of 
diary interventions, with medium-term follow-up results. There was 
mixed-quality evidence for therapeutic touch interventions in the short 
term from three studies. The two psychotherapeutic interventions 
studied were of moderate quality, and one showed promising results 
at 12-month follow-up.
Conclusion The evidence for the effi  cacy of nonpharmacological 
interventions to reduce short-term or long-term stress in intensive care 
patients was of low to moderate quality. Studies included mainly short-
term and medium-term follow-up. This highlights the need for larger-
scale, better-quality RCTs with longer-term outcome measurement. 
However, the results indicate that nonpharmacological, including 
psychological, approaches are likely to be benefi cial for reducing short-
term or long-term stress in intensive care patients.
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Introduction Patients recovering from critical illness suff er many 
physical and psychological problems during their recovery, including 
muscle weakness, fatigue, signs and symptoms of PTSD, anxiety 
and depression [1]. At present, specialist intensive care follow-up 
and rehabilitation is inconsistent and in many geographical areas is 
nonexistent. As a result, many survivors of critical illness will require 
using existing community rehabilitation services [2]. The aim of 
this present service evaluation was to understand the utilisation of 
community rehabilitation services by critical care survivors.
Methods A database of acute referrals to community rehabilitation 
services was retrospectively analysed from 1 May 2014 to 31 October 
2014. Age, referring specialty and reason for referral for rehabilitation 
were documented. This database was cross-checked with the critical 
care database in Glasgow Royal Infi rmary to identify which individuals 
had been admitted to critical care during their admission.
Results Over this 6-month period 769 patients were referred from their 
parent specialty for community rehabilitation in North East Glasgow. 
Thirty-three of the 769 patients (4.3%) referred had a critical care 
stay during their admission. Of these, eight patients were referred 
for rehabilitation by orthopaedics, eight by medicine for the older 
patients, 11 from acute medicine and the remaining six from other 
specialties. Six of the 769 patients who had a critical care admission 
were of working age (<1%). Two individuals were admitted to critical 
care following trauma whilst four had complex social needs prior to 
their critical care admission. This included an individual with a high 
body mass index. None of the individuals of working age were referred 
as a consequence of their critical care stay.
Conclusion This service evaluation demonstrates that very few critical 
care survivors are referred to community rehabilitation services, 
particularly those of working age. More work is required to understand 
optimal rehabilitation pathways in this patient group.
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Introduction Evidence-based, expert-driven, practical statements 
improve quality and eff ectiveness of the diagnostic and therapeutic 
process of patient care. Although the eff ectiveness of physiotherapy 
treatment strategies in ICU patients has been described, statements 
or guidelines of physiotherapy for ICU patients are not available 
[1]. Guidelines on safety management and on the diagnostic and 
therapeutic process may support and guide clinical decision-making 
leading towards evidence-based tailored care. The aim of this study 
was to develop an evidence-based statement for the physiotherapy 
treatment of ICU patients with recommendations for eff ective and safe 
diagnostic assessment and intervention strategies.
Methods For the development of this evidence statement, we used the 
EBRO method, as recommended by the Dutch Evidence Based Guideline 
Development Platform [2]. This method consists of the identifi cation of 
clinically relevant research questions, followed by a systematic literature 
search, quality assessment, and summary of the evidence eventually 
leading to establishing of concept and fi nal recommendations based 
on feedback from experts. The fi nal recommendations were prepared 
according to this methodical approach and summarized in fi gures, 
fl owcharts and appendices.
Results Three expert-based relevant clinical questions were formulated 
within the physiotherapy clinical reasoning process and were classifi ed 
according to the International Classifi cation of Functioning, Disability 
and Health. In a systematic literature search, 129 studies were identifi ed 
and assessed for methodological quality and classifi ed according 
to the level of evidence. The fi nal Evidence Statement consisted of 
recommendations for physiotherapy in ICU patients including safety 
criteria, a core set of instruments to assess impairments and activity 
restrictions and eff ective interventions.
Conclusion The Evidence Statement for physiotherapeutic diagnostics 
and intervention in ICU patients will contribute to the quality of clinical 
practice by supporting the clinical decision-making process.
References
1. Kayambu G, Boots R, Paratz J. Physical therapy for the critically ill in the ICU: a 
systematic review and meta-analysis. Crit Care Med. 2013;41:1543-54.
2.  Burgers JS, van Everdingen JJE. Evidence-based richtlijnontwikkeling in 
Nederland: the EBRO-platform. Ned Tijdschr Geneeskd. 2004;148:2057-9.
P559
Early mobilization according to diagnosis in a Brazilian coronary ICU
GS Zavanelli1, SA Padulla1, MR Franco1, RZ Pinto1, LL Faccioli1, DN Barbosa1, 
DT Neves2, CE Bosso2
1Universidade Estadual Paulista – UNESP, Presidente Prudente, Brazil; 2Instituto 
do Coração de Presidente Prudente, Brazil
Critical Care 2015, 19(Suppl 1):P559 (doi: 10.1186/cc14639)
Introduction Early mobilization has been advocated to improve muscle 
function and, consequently, the patient quality of life after discharge. 
Nevertheless, few studies have explored it in a coronary ICU (CICU). 
The aims of the present study were to describe the use of an early 
mobilization protocol in a CICU and to investigate whether diff erent 
groups of diagnoses respond similarly to this protocol.
Methods This is a retrospective observational study conducted in 
a medium-sized hospital located in the city of Presidente Prudente, 
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Brazil. The early mobilization protocol consists of fi ve phases: 1  – 
passive exercises for the unconscious patient; 2  – active exercises 
associated with respiratory exercises (patient lying on the bed); 3  – 
phase 2 exercises with the patient sitting on the bed; 4  – phase 2 
exercises with the patient sitting on a chair or in a standing position; 
5 – phase 4 exercises plus walking. All hospital records from patients, 
between September 2013 and August 2014, were included in this 
study. Data extracted from hospital records were: age, gender, 
diagnosis (arrhythmia, coronariopathies, congestive heart failure and 
other pathologies), length of stay, number of discharge and number in 
each phase of the early mobilization protocol. Pearson chi-square test 
was used to compare the number of mobilizations (phase 4 and 5) per 
group of diagnoses. Odds ratios were calculated for those comparisons 
found to be statistically signifi cant (P <0.05).
Results A total of 697 hospitals records were analyzed. Patients had 
on average (SD) 67.8 (13.1) years and the majority of them were males 
(57%). Our results revealed that 65% of patients in the CICU received 
phase 4 and 43% of patients in the CICU received phase 5 of the early 
mobilization protocol. No diff erences in the proportion of patients 
receiving phase 4 or 5 were found among arrhythmia, coronariopathies 
and congestive heart failure groups. The only diff erence found was 
between congestive heart failure group and other cardiovascular 
pathologies (P  <0.001). The congestive heart failure group was 
mobilized 5.6 times (95% CI: 2.7 to 11.5) and 3.2 times (95% CI: 1.7 to 
5.7) more than the other cardiovascular pathologies group in phase 4 
and 5, respectively.
Conclusion A considerable proportion of patients was mobilized 
without any serious complications in the CICU. Our fi ndings suggest 
that patients diagnosed with arrhythmia, coronariopathies and 
congestive heart failure can be equally mobilized in an ICU.
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Introduction Various therapeutic interventions needed in critical care 
may refl ect a high risk of death. We evaluated associations between 
commonly used interventions and hospital mortality in Finnish ICU 
patients.
Methods We retrieved data on adult patients treated in Finnish ICUs 
between 2003 and 2013 from the Finnish Intensive Care Consortium 
database. We used the Therapeutic Intervention Scoring System 
(TISS-76) for categorizing ICU interventions and the Simplifi ed Acute 
Physiology Score (SAPS II) for quantifying severity of illness. We 
excluded readmissions, patients with missing outcome, SAPS II and 
TISS data. We also excluded very common interventions (arterial line, 
bolus intravenous medication), very rare ones (prevalence <1%), and 
interventions only applicable in specifi c populations (intracranial 
pressure monitoring, intra-aortic balloon assist). We grouped several 
TISS categories when applicable. We performed a backward stepwise 
binary logistic regression analysis with TISS items to assess the impact 
of each intervention on hospital mortality (expressed as odds ratio (OR) 
with 95% confi dence intervals (CIs)). Age, admission type, and SAPS 
score (minus age and admission type scores) were adjusted for in the 
multivariate analysis.
Results We identifi ed 161,134 patients eligible for analysis. The 
multivariate analysis showed that the highest risk for hospital mortality 
in all patients was associated with cardiac arrest and/or countershock, 
OR 2.58 (95% CI = 2.43 to 2.73), SAPS II emergency admission, OR 2.52 
(95% CI  = 2.32 to 2.74), vasoactive drug infusion (>1 drug), OR 1.66 
(95% CI = 1.59 to 1.73) and blood transfusion (a combined TISS item), 
OR 1.53 (95% CI = 1.44 to 1.63). TISS items associated with the lowest 
risk of mortality in general population were: active anticoagulation, 
OR 0.51 (95% CI = 0.49 to 0.53), induced hypothermia, OR 0.68 (95% 
CI = 0.62 to 0.74) and measurement of cardiac output by any method, 
OR 0.87 (95% CI = 0.83 to 0.91). All aforementioned associations were 
statistically signifi cant (P  <0.001). There was no notable association 
with mortality for pulmonary artery catheter, platelet transfusion and 
vasoactive drug infusion (one drug) (P >0.05).
Conclusion In this large retrospective multicenter study, the TISS item 
associated with the highest risk of death was cardiac arrest and/or 
countershock. Unexpectedly, the independent eff ect of emergency 
admission was of comparable magnitude in terms of impact on 
hospital mortality. Of these, in-ICU cardiac arrest might be amenable to 
preventive measures and should be studied further.
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Introduction Increasing cost is an important issue in critical care 
medicine. We tried to analyze in a level 3 care ICU in Kolkata of a tertiary 
care hospital whether the diff erent payment options (self-paying vs. 
insurance/corporate paying) do aff ect the outcome in the critically ill.
Methods Our prospective study included 1,520 patients admitted 
consecutively to a level 3 care ICU for a period of 20 months. Readmitted 
patients during the same period were excluded. Payment method 
was documented for all and divided into two groups as self-paying 
and insurance/corporate paying. Outcome assessment was done 
using the APACHE IV model for all cases. Demographic data, number 
of observed deaths, predicted mortality rate (PMR), standardized 
mortality ratio (SMR), average length of stay (ALOS), predicted length 
of stay, and number of discharge against medical advice (DAMA) were 
documented for each group. Statistical analysis was carried out using 
unpaired Student t test and P <0.05 was considered signifi cant.
Results Of 1,520 patients, 995 (65.46%) cases were self-paying while 
525 (34.54%) cases were insurance/corporate paying. In the self-paying 
group, mean age was 59.65 years ± 17.26 SD (median 62), APACHE IV 
score mean was 62.50 ± 33.61 SD (median 57), average LOS 4.67 days ± 
4.29 SD (median 3), PMR was 22.71, 226 observed deaths, 85 cases 
of DAMA, and SMR was 1.00 (CI  = 0.87 to 1.14). In the insurance/
corporate-paying group, mean age was 61.75 years ± 17.19 SD (median 
65), APACHE IV score mean was 58.53 ± 32.94 SD (median 54), average 
LOS was 5.64 days ± 5.61 SD (median 4), PMR was 21.26, 113 observed 
deaths, six cases of DAMA, and SMR was 1.01 (CI  = 0.83 to 1.21). In 
the two compared groups, predicted mortality and SMR were not 
statistically signifi cant (P  = 0.2808); however, ALOS in the insurance/
corporate paying group was signifi cantly higher than the self-paying 
group (P  = 0.0002), mean age of the insurance/corporate paying 
group was signifi cantly higher than the self-paying group (P  = 0.02), 
and incidence of DAMA is signifi cantly higher in the self-paying group 
(8.54%) as compared with insurance/corporate paying group (1.14%). 
Root-cause analysis showed DAMA cases are mostly fi nancial (>95%).
Conclusion Statistically signifi cant diff erences in ALOS and DAMA in the 
two groups are probably due to cost of healthcare not aff ordable to all.
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Source of ICU admission: does it really matter?
A Datta, A Kar, A Ahmed
Medica Superspecialty Hospital, Kolkata, India
Critical Care 2015, 19(Suppl 1):P562 (doi: 10.1186/cc14642)
Introduction Source of admission to the ICU is of importance. We tried 
to identify the diff erent sources of ICU admission to a level 3 ICU of a 
tertiary care hospital in Kolkata and analyze whether the overall patient 
outcome is aff ected by the diff erent sources of admission.
Methods Our prospective study included 2,056 patients admitted to 
a level 3 care ICU over a period of 2  years. Numbers of readmissions 
were not considered. ICU outcome was analyzed using the APACHE IV 
model and source of admission to the ICU was documented as either 
from emergency (ER), from the fl oor or from other hospital. Analysis 
was carried out between diff erent groups based on admission using 
unpaired Student t test and P  <0.05 was considered signifi cant. 
Number of ventilations and the mortality rate in each group were also 
documented.
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Results Of 2,056 admissions, 1,223 cases (59.48%) were from ER, 809 
cases (39.35%) were from fl oor and 24 cases (1.16%) were from other 
hospitals. In the ER group, mean APACHE IV was 55.03  ± 31.49 SD 
(median 50), PMR 16.26, observed deaths 198, ALOS 4.78 days ± 4.83 SD 
(median 3), SMR 0.995 (CI = 0.86 to 1.14), mean age 60.52 years ± 17.63 
SD (median 63), 323 ventilations. In the fl oor group, mean APACHE IV 
was 65.17  ± 34.40 SD (median 60), PMR 27.03, observed deaths 234, 
ALOS 5.23 days ± 5.22 SD (median 3), SMR 1.07 (CI = 0.94 to 1.21), mean 
age 61.38 years ± 15.72 SD (median 64), 302 ventilations. In the other 
hospital group, mean APACHE IV was 55.29  ± 29.82 SD (median 50), 
PMR 18.0, observed deaths 2, ALOS 6 days ± 5.85 SD (median 3), SMR 
0.46 (CI: 0.23 to 0.88), mean age 56.08 years ± 17.79 SD (median 56.5), 
six ventilations. During analysis, the other hospital group was omitted 
because of inadequate sample size. There was statistically signifi cant 
diff erences in APACHE IV (fl oor >ER, P  <0.0001), PMR (fl oor >ER, 
P <0.0001), ALOS (fl oor >ER, P = 0.04) noted between the fl oor and ER 
groups. Number of ventilations (37.33% vs. 26.4%), SMR (1.07 vs. 0.995), 
and mortality rate (28.92% vs. 16.19%) were also signifi cantly higher 
for patients admitted from the fl oor. No signifi cant statistical diff erence 
was observed in age between two groups (P = 0.26).
Conclusion The severity of illness index in patients admitted to the 
ICU from fl oors is signifi cantly higher than emergency admissions. 
Overall outcome for patients transferred to the ICU from the fl oor is 
worse based on mortality rate, SMR, and ALOS when compared with 
the emergency group.
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Readmission to the ICU: is it a big concern? An analysis
A Ahmed, A Datta, A Kar
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Critical Care 2015, 19(Suppl 1):P563 (doi: 10.1186/cc14643)
Introduction Readmission to the ICU is an important quality indicator 
of ICU care. We conducted a prospective study in a level 3 care ICU in 
Kolkata of a tertiary care hospital to analyze whether there are overall 
outcome diff erences when comparing the readmission group with the 
entire group.
Methods Our prospective study included 2,140 patients admitted to 
a level 3 care ICU over a period of 1 year. The number of readmissions 
(n  = 85) during the same period was also documented. Readmission 
was defi ned as all patients who were transferred back to the ICU prior 
to hospital death/discharge during the above period. ICU outcome was 
calculated using the predictive APACHE IV model. Payment methods 
were documented as either self-paying or corporate/insurance paying. 
A comparison analysis between the entire group with the readmission 
group was done using unpaired Student t test and P  <0.05 was 
considered statistically signifi cant.
Results In the entire group (n = 2,140), mean APACHE IV was 50.34 ± 
31.54 SD (median 42), PMR 15.49, observed deaths 327, ALOS 
4.05 days ± 4.55 SD (median 3), SMR 0.99 (CI = 0.88 to 1.1), mean age 
60.55 years ± 15.68 SD (median 63), 490 ventilations, 72.71% of patients 
were self-paying while 27.29% of patients were corporate/insurance 
paying. In the readmission group (n = 85), mean APACHE IV was 77.16 ± 
33.72 SD (median 73), PMR 38.89, observed deaths 42, ALOS 5.23 days ± 
4.18 SD (median 4), SMR 1.27 (CI = 0.95 to 1.67), mean age 64.79 years ± 
14.40 SD (median 67), 43 ventilations, 75.3% of patients were self-
paying while 24.7% of patients were corporate/insurance paying. 
During comparison between the two groups there were statistically 
signifi cant diff erences, with the readmission group having signifi cantly 
higher APACHE IV (P <0.0001), PMR (P <0.0001), ALOS (P = 0.002), age 
(P  = 0.005), and SMR (1.27 vs. 0.99) compared with the entire group. 
Percentage of patients requiring ventilation (50.59% vs. 22.90%) and 
mortality rate (49.11% vs. 15.28%) were also signifi cantly higher in the 
readmission group. Readmission was signifi cantly higher in the self-
paying group. Root-cause analysis showed most readmissions were 
due to deteriorating conditions (desaturation, hypotension, sepsis, 
arrhythmias); however, it was also associated with cases where transfer 
policy from the ICU was not followed by stakeholders and fi nancial 
issues were a cause of early transfer.
Conclusion Readmission to the ICU was associated with worse outcome 
in our study group. Lack of adherence to transfer policy by concerned 
stakeholders was a concern as well as increasing cost of healthcare.
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Association between out-of-hours discharge and mortality in adult 
patients leaving critical care
S Edie, K Burt, J Paddle
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Critical Care 2015, 19(Suppl 1):P564 (doi: 10.1186/cc14644)
Introduction Out-of-hours (OOH) discharge from critical care is 
associated with a signifi cantly increased mortality rate in Australasia 
[1]. In the UK, daytime discharges from critical care are considered a 
core standard [2]. We sought to assess the impact of OOH discharge 
from critical care on mortality in a large general ICU, where operational 
pressures appear to have led to a high rate of OOH discharges.
Methods Retrospective data for all patients admitted to our ICU from 
April 2007 to September 2014 were recorded, using routinely collected 
data from our databases. Adult patients (>15  years) discharged from 
their fi rst ICU admission during each hospital stay (episode) were 
included. Patients that died on the unit and those discharged for 
palliative care were excluded. Patients transferred to other centres were 
no longer subject to discharge within our control and were therefore 
also excluded. Patients discharged directly home from ICU were 
excluded. We defi ned OOH discharges as those occurring between 
22:00 and 06:59, a standard defi nition in UK practice. Mortality status 
at the time of hospital discharge for each episode was used. We also 
recorded the readmission rate to ICU. The relative risk (RR) for OOH 
mortality and readmission was calculated. Statistical signifi cance was 
accepted at P <0.05.
Results Of 4,476 index cases, 714 died on the unit and 80 were 
discharged for palliative care. A total of 490 patients were excluded 
for transfer to other centres and discharge directly home. Data were 
missing for three patients, which left 3,189 records for analysis. In total, 
2,711 patients were discharged during daytime hours, of which 145 
(5.35%) died. A total of 478 patients were discharged at night, 40 died 
(8.37%). The RR for OOH mortality was 1.56 (95% CI = 1.12 to 2.19, P = 
0.0091). Readmission rate was 5.2% by day, 6.1% at night. The RR for 
readmission was 1.17 (95% CI = 0.79 to 1.72, P = 0.436).
Conclusion Our data demonstrate an association between critical 
care discharge time and mortality, to a statistically signifi cant level. 
Due to the retrospective observational nature of the study, causation 
cannot be assumed; however, a number of factors may contribute 
to the increased risk of harm to patients discharged from the ICU at 
night. Further work will focus on annual OOH mortality trends, thereby 
gaining an insight into whether bed occupancy demands impact on 
the necessity for nighttime discharges.
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Introduction Severe critical illness requiring treatment in the ICU may 
have a serious impact on patients and their families. However, optimal 
follow-up periods are not defi ned and data on health-related quality 
of life (HRQOL) before ICU admission as well as those beyond 2-year 
follow-up are limited. The aim of our study was to assess the impact of 
ICU stay up to 5 years after ICU discharge.
Methods We performed a long-term prospective cohort study in 
patients admitted >48 hours to a medical–surgical ICU. The Short-Form 
36 was used to evaluate HRQOL before admission (by proxy within 
48 hours after admission of the patient), at ICU discharge and at 1, 2 
and 5 years following ICU discharge (all by patients). Changes in HRQOL 
were assessed using linear mixed modeling.
Results We included a total of 749 patients (from 2000 to 2007). At 
5  years after ICU discharge, 234 patients could be evaluated. After 
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correction for natural decline in HRQOL, the mean scores of four 
dimensions – physical functioning (P <0.001), physical role (P <0.001), 
general health (P <0.001) and social functioning (P = 0.003) – were still 
signifi cantly lower 5  years after ICU discharge compared with their 
preadmission levels, although eff ect sizes were small (<0.5).
Conclusion Five years after ICU discharge, survivors still perceived 
a signifi cantly lower HRQOL than their preadmission HRQOL (by 
proxies), and that of an age-matched general population. Importantly 
however, after correction for natural decline, the eff ect sizes were small 
suggesting that patients regain their age-specifi c HRQOL 5 years after 
their ICU stay.
P566
Determination of brain death for adult patients with ECMO
I Ceylan, R Iscimen, E Cizmeci, N Kelebek Girgin, F Kahveci
Uludag University Faculty of Medicine, Bursa, Turkey
Critical Care 2015, 19(Suppl 1):P566 (doi: 10.1186/cc14646)
Introduction ECMO support in ARDS is an emerging strategy when 
conventional treatment modalities fail. ECMO has advantages on 
oxygenation and circulation but also it has some unfavorable eff ects. 
The most serious complication is brain death due to cerebrovascular 
hemorrhage. An apnea test is the most important component in 
confi rming brain death. For patients supported by ECMO, apnea testing 
remains challenging. Brain-death diagnosis is often made without an 
apnea test.
Methods We present two cases who receive V-V ECMO support after 
progression to ARDS. After initiation of ECMO we used sedation to 
prevent movement and improve adaptation to mechanical ventilation. 
Also we used anticoagulation with heparin to prevent thromboembolic 
events and ECMO circuit occlusion. On daily follow-up we noticed 
that patients had lost their pupil reactions to light. Their sedation 
was ceased and a computed brain tomography was performed. Both 
patients had intracerebral hemorrhage. We decided to determine brain 
death with apnea tests. We increased ECMO blood fl ow and fi O2 and 
then decreased sweep gas fl ow and disconnected the patient from 
mechanical ventilation respectively. In one patient we did not see 
any spontaneous breathing eff orts after carbon dioxide retention. We 
concluded that the apnea test was successful and confi rmed brain 
death. On the other hand, we confi rmed the brain death of the other 
patient with cerebral angiography due to the occurrence of hypoxia 
and hypotension during apnea testing.
Results We experienced some challenges while determining brain 
death in patients under ECMO support for ARDS. It is challenging 
to conduct the apnea testing during ECMO support. Auxiliary tests 
are required for patients who cannot tolerate the changes needed 
to conduct the apnea test. With increasing use of ECMO therapies, 
clinicians may come face to face with more complicated life-ending 
decisions.
Conclusion Current guidelines do not include brain death criteria using 
supportive therapies such as ECMO and therefore should be updated.
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Introduction Psychological safety (PS), for example safety of speaking 
up, fosters team learning and prevents treatment errors on the ICU 
[1]. Since speaking up might also prevent excessive and inappropriate 
(futile) care for patients, we hypothesized that teams with higher PS 
report less perceived futile care (PFC). We also expected that attending 
physicians’ inclusive leadership (IL), which invites nurses’ and residents’ 
participation [2], would decrease PFC and that PS mediates this 
relationship.
Methods The hypotheses were tested in a cross-sectional, multicenter 
paper-and-pencil survey addressing medical staff  on participating 
ICUs. A total of 22 ICUs and four intermediate care units were included 
in the sample and 73 attendings, 147 residents and 659 nurses 
participated in the study (52% participation). Psychometric properties 
were tested by confi rmatory factor analysis (CFA), Cronbach’s α and 
intraclass correlations (ICC). A series of hierarchical linear models 
(HLM) were conducted to test the study hypotheses separately among 
nurses/residents and attendings. IL and PS were entered as unit-level 
predictors (mean values per unit). Covariates were demographics, 
working hours per week, workload and unit size (number of staff ). 
Mediation eff ects were tested.
Results The CFA showed a good fi t indicating factorial validity (CFI: 
0.97), reliabilities were from α 0.79 to 0.93 and ICCs were signifi cant 
(~0.20, P <0.001). HLM revealed that unit-level IL of nurses and residents 
was positively related to PS (b  = 0.34, P  <0.001). Being a resident and 
working in a smaller unit also predicted PS. As expected, unit-level PS 
was negatively related to individual PFC (b = –0.38, P = 0.025). Further 
predictors of higher PFC were: being a nurse, having more than 5 years 
of job experience and higher workload. PS mediated the relationship 
between unit-level IL and individual PFC (indirect eff ect: –0.13, P <0.001). 
Additional analyses revealed that attendings’ PFC was negatively related 
to their perception of residents PS (b = –0.44, P = 0.019).
Conclusion A sense of PS in an ICU team might reduce futile care by 
increasing the safety of speaking-up behavior of nurses and residents. 
PS can be enhanced by attending physicians who practice inclusive 
leadership behavior to foster autonomy and participation of residents 
and nurses.
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Introduction One of the main goals of intensive care medicine is to 
reduce the mortality of critically ill patients. However, it is essential 
to recognize end-of-life care as an integral component of critical care. 
Besides survival, the success of intensive care should also include the 
quality of lives preserved and the quality of dying. The objective of this 
study was to evaluate the incidence and type of end-of-life decisions 
(ELD) in critical patients that died in an ICU.
Methods Analysis of all patients included in an ICU running database 
and who died from 1 November 2013 to 31 October 2014. The 
following variables were evaluated: age, gender, reason for admission, 
SAPS II, length of ICU stay and type of ELD. To classify ELD, four concepts 
were defi ned: ‘Comfort care’, a change from curative therapy to comfort 
care therapy; ‘Limited therapy’, maintenance of curative therapy but 
without escalating it (for example, no renal substitution); ‘Decision not 
to resuscitate’, not to perform advanced life support if cardiac arrest 
occurs; and ‘Without previous end-of-life decisions’, when there was no 
prior decision regarding the ELD.
Results A total of 507 patients were admitted to the ICU and 132 died 
(26%). Reasons for admission in those who died were septic shock (47%), 
post cardiac arrest (13%), cardiogenic shock (8%), and nontraumatic 
brain bleeding (8%). Fifty-three patients (40%) died after a ‘Comfort 
care’ decision, 28 patients (21%) after ‘Decision not to resuscitate’ and 
14 (11%) after a ‘Limited therapy’ decision. Thirty-seven patients died 
‘Without previous end-of-life decisions’. However, specifi cally in this 
group, when looking for individual records, 32 patients died (86%) in 
the fi rst 48 hours after the admission and four (11%) had evidence of 
brain death and were organ donors, which leaves one patient (3%) in 
whom there was no ELD.
Conclusion In this study, ‘Comfort care’ was the main ELD, which is in line 
with the concept that ELD are essential to ensure that care provided is 
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consistent with quality of life and death. The apparent large proportion 
of patients ‘Without previous end-of-life decisions’ was due to patients 
who died in the fi rst 48  hours after ICU admission corresponding to 
conditions refractory to treatment. Additionally, this study also draws 
our attention to better plan ICU admissions and hospital outreach in 
order to reduce early ICU mortality.
P569
Do intensivists prognosticate patients diff erently from themselves 
or their loved ones?
S Gupta, C Green, R Tiruvoipati, J Botha
Peninsula Health, Frankston, Australia
Critical Care 2015, 19(Suppl 1):P569 (doi: 10.1186/cc14649)
Introduction There is a paucity of data about whether our treatment 
philosophy is diff erent for our patients as compared with what we 
would have wanted for ourselves, or while acting as surrogate decision-
makers for our loved ones.
Methods An anonymous survey was sent to all the members of Australia 
and New Zealand Intensive Care Society and the College of Intensive 
Care Medicine (CICM). The fi rst section comprised a hypothetical case 
scenario spanning over 6 weeks of ICU stay for a patient. At four diff erent 
stages of the ICU stay, responders were requested to answer multiple-
choice questions regarding the philosophy of treatment, based on their 
perceived prognosis of the patient at that particular time. The following 
two sections contained the same set of questions with the hypothetical 
scenario of responders acting as surrogate decision-makers for the 
patient and that of responders being patients themselves, in the same 
situation. The responses were compared amongst three sections at 
each stage using the chi-square test.
Results A total of 115 responses were received from the fellows of 
CICM. The results are presented in Tables 1 and 2.
Table 1 (abstract P569). Respondents advocating withdrawal for the patient
 Withdrawal self (%) Withdrawal family (%)
Day 3 71 67
Day 7 83 76
Day 28 96 88
Day 42 98 97
Table 2 (abstract P569). Respondents advocating continuing care for the 
patient
 Withdrawal self (%) Withdrawal family (%)
Day 3 16 10
Day 7 23 15
Day 14 25 19
Day 42 42 29
Conclusion Of the ICU physicians who would withdraw care for their 
patient, the majority would also want the same for themselves. The 
disparity between decision to continue to treat the patients versus 
treating self or family increased with increasing length of stay.
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Introduction A high percentage of patients admitted to ICUs fulfi ll 
one or more criteria for palliative care. There are currently few 
comprehensive studies in critical care settings that have set out to 
examine the association of palliative care screening criteria with 
adverse patient outcomes.
Methods We performed an observational unicentric study on a 12-bed, 
medical emergency department intensive care unit (EDICU). A three-
item palliative care screen was developed from consensus reports. A 
senior critical care physician screened patients upon admission using 
these questions during a 10-week period. The questions were: does this 
patient suff er from a life-limiting disease (end-stage lung, liver, heart 
or kidney disease, severe neurological disability, extreme frailty, locally 
advanced or metastatic cancer, advanced-stage AIDS). If the answer to 
the fi rst question is yes, we proceed to the next one: do you believe this 
patient will survive to hospital discharge? Answers to those questions 
were recorded, SAPS III was calculated and all patients were followed 
until death, discharge or transfer to another center. Diff erences in 
mortality and SAPS III score between groups were examined using a 
Student’s t test. Proportions were compared using chi-square test. 
P <0.05 was considered statistically signifi cant.
Results During the period, 191 patients were admitted to the EDICU, 
from which 151 had complete data and follow-up. A total of 63 patients 
(41.7%) suff ered from a life-limiting disease and were evaluated as 
having a high probability of death in 1  year. This group was further 
divided between 35 patients who in the moment of initial screening 
were expected to die in this hospital admission and 28 patients who 
were believed to survive to discharge. Comparison between these two 
groups showed patients believed to die at this hospital admission had 
higher SAPS III scores (66.9 vs. 59, P  = 0.010) and hospital mortality 
(48.6% vs. 10.7%, P = 0.001).
Conclusion A high percentage of patients admitted to our EDICU 
have life-limiting disease and might benefi t from palliative care. 
These patients can be identifi ed using simple screening questions at 
admission and positive answers to those questions can be associated 
with worse outcomes.
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Introduction To analyze the perception of parents regarding their 
return to the hospital where their children died to participate in a 
conversation with doctors and to analyze the feelings of parents 
about their participation in a study evaluating the care provided in the 
moments leading up to the death of children.
Methods A descriptive exploratory qualitative study. The study sites 
were the pediatric ICUs of the Hospital São Lucas and Hospital de 
Clinicas de Porto Alegre. Fifteen parents of children who died in the 
PICUs studied participated in the study. Data collection occurred in 
2010 and was conducted through semistructured interviews. Data 
were analyzed using thematic content analysis. The research was 
approved by the research ethics committees of both hospitals.
Results The ability to return to the hospital and talk to medical assistants 
was considered by parents as a positive and enlightening opportunity. 
Parents who participated in the study understood this moment as an 
opportunity to be heard and demonstrated the intention to contribute 
with their experiences in order to improve care in the hospitals studied.
Conclusion We conclude that there is a need to implement measures 
to provide palliative care to parents after the death of their children. 
It is necessary to consider the possibility of providing families with 
follow-up meetings with the multidisciplinary team after the death of 
children.
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Introduction We often need to obtain consent for clinical studies in the 
ICU. Participant Information Sheets (PIS) can be diffi  cult to understand. 
A recent French publication [1] supports our hypothesis that PIS have 
poor readability scores.
Methods Protocols submitted for ethics approval between 2008 
and 2009 were obtained with permission from the Scotland A Ethics 
Research Committee. Ethical approval was not required for this 
observational study. All header, footers, diagrams and tables were 
removed. Readability scoring was performed using the Flesch Reading 
Ease and Flesch–Kincaid (FK) grades. Statistical analysis using Excel and 
MiniTab was then performed. The readability of these documents was 
compared with everyday documents – newspaper articles, politicians’ 
speeches [2] and standard contract agreements.
Results A total of 104 protocols containing 209 PIS were reviewed. Of 
these, 99 (47%) were written for patients, 56 (27%) for GPs, 26 (12%) for 
relatives, 17 (8%) for carers, fi ve (2%) for legal representatives and six 
(3%) were summary sheets only. Sixty-seven (64%) of these protocols 
were submitted by academic institutions (for example, university or 
health boards) and 37 (36%) by pharmaceutical companies. Results 
are expressed as the median and 25th and 75th percentiles. The word 
count and number of pages were higher for those PIS submitted by 
pharmaceutical companies compared with academic institutions: 
1,561 (471; 5,167) versus 1,177 (626.5; 1,559.8) with P <0.05 and 4 (2; 
10) versus 3 (2; 4) with P <0.05 respectively. The Flesch Reading Ease 
(63 (56; 69) vs. 60 (52.6; 65.4)) and FK grades (3 (5.4; 7.2) vs. 6.8 (6; 7.6)) 
were similar for both groups. Further subanalysis demonstrated that 
PIS designed for GPs had a lower word count, lower Flesch and higher 
FK grade compared with those for patients – the diff erence in Flesch 
and FK grade were compared using a Mann–Whitney test and were 
statistically signifi cant.
Conclusion The FK grade is equivalent to US school grade level. The 
US government advises all policies produced should have a FK grade 
of <9. Our study suggests that protocols submitted to the ethics 
committee are easy to read, comparing favourably with broadsheet 
journalism and standard contract, for example loan contract. However, 
the average reading age in the UK is 9 years [3], suggesting participants 
may struggle with the information provided.
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Introduction Healthcare systems do not make optimal use of 
evidence, which results in suboptimal patient care. Large amounts of 
scientifi c evidence are generated but not implemented into patient 
care (knowledge to care gap). We sought to identify and prioritize 
knowledge to care gaps in critical care medicine as opportunities to 
improve quality and value in care.
Methods Using a modifi ed RAND/UCLA Appropriateness Methodology, 
a committee of 38 providers and decision-makers representing a 
population-based clinical network of adult (n = 14) and pediatric (n = 
2) medical–surgical ICUs in Alberta, Canada (population 4 million) 
serially proposed, rated and revised potential knowledge to care 
gaps as priorities for improvement. The priorities developed by the 
committee were sent to the network’s 1,790 frontline providers to rate 
their importance. The fi nal list of priorities that were rated as important 
was disseminated to all network members for feedback.
Results Sixty-eight knowledge to care gaps were proposed, rated and 
revised by the committee over three rounds of review, resulting in 13 
priorities for improvement. Then, 1,103 providers (62% response rate) 
representing nurses, respiratory therapists, allied health professionals 
and physicians evaluated the priorities and rated nine as necessary. 
In multivariable logistic regression analyses, provider (profession, 
experience and teaching status of ICU) and knowledge to care gap 
characteristics (strength of supporting evidence, potential to benefi t 
the patient, potential to improve patient/family experience, and 
potential to decrease costs) were associated with priorities rated as 
necessary. After disseminating the results to all network members, 627 
responded (35% response rate) and indicated that the priorities were 
reasonable choices for quality improvement initiatives (87%), that they 
were highly supportive of working on initiatives targeting the priorities 
(61%) and would be willing to act as local champions for the initiatives 
(n = 92 individuals).
Conclusion Our research approach engaged a diverse group of 
stakeholders to identify nine priorities for improving the quality and 
value of care provided to critically ill patients. This methodology can 
be used to engage stakeholders and identify priorities for quality 
improvement in other healthcare systems and domains. Additional 
work is required to reconcile provider/decision-maker and patient/
family priorities.
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Introduction With increasing emphasis on patient and family-centred 
care, it follows that patients and their family members should be 
included when priorities for improving care are established. We 
therefore used a novel methodology that employs former patients and 
family members as researchers to describe the experiences of critically 
ill patients and their families with ICUs and to identify opportunities for 
improvement.
Methods Using the patient engagement framework developed 
by Marlett and Emes, we engaged four former patients and family 
members trained in qualitative research methods to conduct and 
analyse semistructured focus groups and interviews with adult patients 
who had recovered from critical illness and family members of both 
surviving and deceased patients. Participants were recruited from 13 
ICUs in Alberta, Canada. Focus groups and interviews were recorded, 
transcribed and analysed using phenomenological reduction. Data 
collection continued until thematic saturation was reached.
Results Thirty-two participants including patients (n = 11) and family 
members (n = 21) participated in fi ve focus groups (n = 23 participants) 
and eight interviews (n  = 9 participants). Participants articulated 
themes refl ecting important components of care organised across 
three phases of the ICU experience; admission to ICU, daily care in ICU 
and after ICU discharge. Admission to ICU comprised three themes: 
patient and family transition into ICU, patient and family disorientation 
upon admission to ICU and preferred staff  actions to help patients/
family adapt to the ICU. The daily care phase of ICU consisted of 
fi ve themes: honouring patient’s voices, needing to know, making 
decisions, culture in ICU and medical care. The experience after ICU 
discharge comprised two themes: transition from ICU to a hospital 
ward and long-term eff ects of critical illness. Participants identifi ed fi ve 
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priorities for improvement: provide families with a guide/navigator; 
educate providers about the fragility of family trust; improve provider 
communication skills; inform patients about the long-term eff ects of 
critical illness; and develop strategies to facilitate continuity of care 
between providers.
Conclusion Patients and family members are an untapped resource 
and engaging them as researchers is a viable strategy to identify 
opportunities for quality improvement that are patient and family 
centred.
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Introduction The purpose of this study was to assess the visiting 
restrictions placed on families visiting adult patients on critical care 
units within trauma hospitals in England. Whilst it is well recognised 
that high-quality care for patients is of paramount importance, we 
should also be aware that supporting patients’ families off ers long-
term benefi ts for patient, family and hospital. In our own unit we are 
reviewing whether we could adopt a more fl exible attitude to visiting 
times and assessing how to provide a more welcoming environment 
to relatives. To inform our own review and in order to develop a best 
practise approach, we surveyed all of the major trauma centres in 
England.
Methods A telephone survey on visiting times was conducted in 53 
adult critical care units in trauma centres in England. A list of trauma 
centres was obtained from the NHS England website. All critical care 
units (other than obstetric high dependency units and coronary care 
units, unless part of a cardiothoracic critical care unit) within each 
hospital were surveyed. Each respondent was asked about the visiting 
hours, whether children were allowed to visit and how many visitors to 
a bed space.
Results Fifty-three units with between four and 75 beds and covering 
the whole of England were surveyed: there was a 100% response rate. 
Visiting hours varied between hospitals and between units within the 
same hospital. Nine units (17%) had open visiting hours, although most 
gave advice on times to avoid such as nursing handover. The majority 
of units (44.83%) operated restricted visiting with a median (range) 
of 6 (2 to 9) hours. All units allowed a maximum of two visitors to the 
bedspace. Children were allowed in nine units without restriction, the 
remaining units advised that it may not be appropriate for children to 
visit and it was at the discretion of the parents and medical staff .
Conclusion The majority of adult critical care units in England, 
including our own, have restricted visiting policies. Visiting policies 
are a source of debate amongst staff  in intensive care with concerns 
about open visiting including increased workload and interruptions 
to normal routine [1]. This is consistent with the views of staff  at our 
own unit who, in appreciative enquiry, have expressed mixed opinions 
about extending visiting times. Extending visiting times is only part of 
a wider project to improve the way relatives experience intensive care 
whilst ensuring both medical and nursing staff  feel supported, creating 
an environment for optimal communication.
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Introduction Patient satisfaction is a crucial part of clinical care and 
there is now increasing recognition of the importance of family 
involvement and satisfaction in the provision of care for the critically 
ill. Since 2012 our unit has introduced a consultant-led family ward 
round (FWR), to enhance and standardise communication and improve 
satisfaction. Following introduction of the FWR we have audited family 
satisfaction using the validated FS-ICU questionnaire [1].
Methods This was a prospective study of relatives’ satisfaction for 
patients completing their critical care episode. The questionnaire was 
completed anonymously and data collected. This was a pragmatic 
study, no changes were made to communication strategies.
Results There is a high degree of satisfaction across all domains of 
the FS-ICU including treatment of family and provision of information 
(Figure 1). One hundred per cent found FWR to be helpful, only 55% 
had anticipated this. Fifteen per cent changed their perception of 
critical care. It enabled 15% to raise new concerns. One hundred per 
cent were able have questions answered satisfactorily. Linked to the 
FS-ICU, we have seen marked improvements in decision-making and 
satisfaction.
Conclusion We have shown progressive improvement over 3  years 
across all domains. Marked improvement in information provision 
and decision-making support from 53% to 96% over 3  years since 
introducing the FWR correlates with the improved overall satisfaction 
(Figure 1). Interestingly FWR is more helpful than relatives anticipated. 
The FWR was very well received and our results suggest an unrecognised 
need is being met. Because this was a pragmatic study, we feel this 
is a true representation of family satisfaction. It is encouraging that 
communication, information and decision-making support continue to 
improve. They have become embedded in the fabric of our critical care 
practice and lead to marked improvement in satisfaction for families.
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Introduction For the families of critically ill patients, the death 
of a loved one in the ICU is often an unexpected and traumatic 
event, characterised by diffi  cult decisions regarding withholding or 
withdrawing life-sustaining therapy. Increasingly the importance of 
bereavement care (BC) in the ICU is being acknowledged, although 
reports continue to highlight the inadequacies around end-of life care 
in the critical care environment. In 1998, the Intensive Care Society 
(ICS) published guidelines mapping out BC in the ICU [1]. We aimed to 
compare BC in ICUs across England against the recommendations set 
out by the ICS.
Methods All adult ICUs in England were contacted over a 2-week 
period, using a standardised questionnaire based on the nine domains 
identifi ed by the ICS. All answers were collected anonymously using 
SurveyMonkey®. An 80% compliance rate was deemed acceptable.
Results From the 148 ICUs identifi ed, 113 answered the questionnaire 
(76%). Forty-three per cent of the responders had access to training 
in BC and in communication skills, and 54% had a named member 
of staff  responsible for training, writing, auditing and developing the 
Figure 1 (abstract P577). Trends in family satisfaction.
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BC policy. When asked about the presence of a written BC policy only 
45% responded positively, and even less (19%) had provisions for audit 
and development of the service. Information to staff  about cultural 
and religious rites around the time of death, and to relatives on what 
to do after a death was available in 81% and 96% respectively. The 
general practitioner was informed of the deaths taking place in the 
ICU in 77% of the cases. In more than 70% of the participating ICUs, 
eff orts were made to ensure privacy of the grieving relatives and to 
have dedicated follow-up facilities for the bereaved. Even though staff  
support programmes were recognised as paramount, only 54% of the 
ICUs had formal ones set up.
Conclusion This is the fi rst national audit of BC in the ICU since the initial 
ICS guideline publication. Even though most ICUs provided relatives 
with information around the time of death, training, auditing and 
adequate facilities do not meet the recommended standards. The lack 
of adherence is defi nitely multifactorial and requires further research. 
In the meantime, vigorous implementation of these guidelines is 
warranted in order to ensure optimal care for the bereaved families.
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